<SEC-DOCUMENT>0000021076-21-000009.txt : 20210430
<SEC-HEADER>0000021076-21-000009.hdr.sgml : 20210430
<ACCEPTANCE-DATETIME>20210430161557
ACCESSION NUMBER:		0000021076-21-000009
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		74
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210430
DATE AS OF CHANGE:		20210430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		21878200

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clx-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6,d:b3b60db826a84bed9fbe6ae9e2f741c7--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:clx="http://www.clorox.com/20210331" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>clx-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N18zLTEtMS0xLTA_52eed232-93e7-46bc-a2ee-5fb952d123f8">0000021076</ix:nonNumeric><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N180LTEtMS0xLTA_96649b86-e467-4864-829d-a1f4b2543a56">false</ix:nonNumeric><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N181LTEtMS0xLTA_0c22a753-4c99-4b3a-ba56-0c96a751f8d6">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N182LTEtMS0xLTA_99f5bb45-0d15-43aa-b1d6-8bea79cb8aed">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N183LTEtMS0xLTA_11d663e2-f8dc-432c-8eeb-760141ee1834">2021</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="clx-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8f5775917fd4473eac612f8753710d3b_I20210416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e8d63f491f423baa88abae57588736_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996c29b523bf485f8accca37c4bb6e71_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i70dc6fb701fd4f5da398121fd36e0360_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf6b73a611c5439c9ddb772f505d1455_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df9eff9aad24233b734b8a995abf5f0_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bfdd2f36fa40ae8884cec528927862_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e26e45946444a8a31e317e4a6335eb_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e347afcab74ff6bc8d31a740d9a89c_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb066f8d893346ca9951f248d0dcb802_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib928fec9941c44d881ae5b71182e1e12_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185542c2acc246eabdad2e53c4d02ecd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fbc5f5127cf42d98d38f3b2282c7508_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86cded78606f40eda58cf54289cc6c46_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b5e8efae404d60976021d1249edef6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df6541afbcc471caf5020183b1aae27_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea72635ffc9249a5b85b28d91061578c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0abb07fff33f4729b2158873d5eaa9ef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6521a378432044e2818b18ae9a3f504f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0bf84a649f46e6b8628a79d40bb4bc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e8e270257da49d0ba55eec6af3548a5_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37bcf0ca8f2c418d8e3ad8f1d725a7e8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ac31a8e85142168910ba397dd1998f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a21685ce7e9490d85a6bb3145bbe8b4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f50a3afc8254aee87ec15cc7d3a1236_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087ce4ee5c5f43ffbc5df3b0be560c27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c431b3b55c4f679f28a6d7fe216a9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43cba4b272444bd38c66ff3c5246316d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8b5149e800a4c518f7685d164029449_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a82930ba8c46a8842474109384e6c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26539d9b96f845d3ba4ab21e4452925f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba8774be3fa46a89129787dadbdd87d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4784aa0c2eb497085b38aac10a12a6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08739ec82f9f487e9a3a1aaf8f12513d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41c41f5deb14768a1eb5a2210283ea4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f481c5813194dcb93b50f7c42cd5640_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">clx:ImpairedTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af70af2cbfa4de0b7bbcc6d6076615a_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11c4432843d48beb47ab04de9835fd8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7fec97eb2b445d82bb2f5c366219eb_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib505795eadb0415688775b76ca687bd7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877f6bf072f447b0a08ba92a32ceae0b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53cc8d65018745bcb4a5a483db2fe918_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1484f195af54610a54afe24e3990c37_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i848015c104c6489dbc76c581af351d33_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b70b530cbd34611accfb86ef4f0c9f8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81bb94cec74c44ec934873bc2cbde692_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2602ddacb1ba4d48b483893d5a5811f5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:JetFuelSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if877153b764b4c2199980313d42e92fa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e18e05c20e542f2b56a8cfae3ddca8e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ecb0a1520954103b71df562030763b3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:JetFuelSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d14bf1a42bf48728f273cb7dbb88206_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i446ee7bb6f85446389955f7c3cb5789e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb6e03daa5243e9b7e14504d53fa628_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eed352fc1a5487bb2a201702a083bc5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89286b72adb64ceeae58323f4cbca98f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6317a205f64e888817536ae25aba65_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0048ff33e90f4209aee6b35dd0d9663e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i803bb7cea1a64da4926148b2b30bf8b9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a130bb3d2e4856b978cf675b54b49f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7becfdbf9a624acdb1b709bc3dc25c7e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24afdfe415c34061ab653ffa84c5b114_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f08e7cdcd93457ea49df833bde0b187_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d8da7beaf442bd9043f1f6db402d82_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72856990c40d4c8e8edcc82b8f7f1500_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie244b1b1e0424bdbb85739588f77cd6f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493b6bcb04674e4eae776d98c6e32549_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic53a10bdd3c443149d70aa1b9344fa89_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57197fa8f0f041218d4589f2a589885a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bb08d66214c4f6a8e0e2cad3359efe0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09939d37bb3048269d0cb0a44386b194_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f1a042de7b4e569e2d27c2d5dad9e1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1996c058fbf040f8908e8c394fc5c89e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd2366b5b7844fe8e3445d45c197945_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da90ff065be4c999e8fe274b11c5b63_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07087f939caf4a5fbe9aba0283c385cf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie34cc22e3e8345758a12debb39ff6929_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f4d36e4c26464da0167188a60de71c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987768d7a6a84e038b10c8aaeca7130c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d72659b4ccc4ad89a4324978711b52a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a413c3b7e924aa38bf7da6938de615f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85534346744b432e8cea4e97ccc5909d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3795ebf2a81e444eb73637647767d786_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91f439ccd2a45f5a6efaa8d896c7909_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c33022caf44489f9f113ac89dbf91b8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86dd42a80b9c41f69b404d2b1eba64a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfb4666ee19476e8443974cdf719623_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef0e5a952734b418963b327a95bcc4f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e24c8554ebe46388a798da32706e97a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda03dcb1c30410ea2b0bbca9847e228_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d4ed82486f441a84472bb6b87db08f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7add7ef54944efa99bed6cbd73f7f56_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbce1f0e07b471880107186a9d2dbf0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c5e68eec1f4975a44f0ee291e1b433_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fec6298f6c24ef6ac7e3ee30b63cd54_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01dc6b5c81694d3a8ce02fb89916e04e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fdc3ee65556409abf6845da148f19ba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8032a0d84e405fa3da93df1c46964d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4dbc98d539d45729f9fac03fccb02f8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd770eb1c3840cda9e1bfb6823cff18_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c2212de48a40c08c45b2267d5c2553_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa872fb1c8a741e08e01d0b0035e14a9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4814dfcd3ba499aa945030b7001616e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00ae1de87094cf89d76a74b042495cf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3093b0d16ed04d6f8781b4a8dc97c5f4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a2cf9cee0f45fcb02a4c337563805e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fac87255172412484f55ebbbbeea3f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621c78ef217946caa48daba642080fc7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47dfa7d737eb4754a2c5b8e3a44f18a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3432462f36cc45c7bd8205bca273122e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b79f9121d141459b8db7faff712c18_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i108954c232d04d49920930c949d00216_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie032edb36eed4e7fbd867455fbb3151c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95af929fa2ea40cfbc21af9dc7f5c5b9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da205cd9b70413683ab2bbaa7533b9c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied37b00018c54177824f2ad238767344_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a1026fe1c8944ff86a32c927ef217f4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i603fda767f6844baadd48df615fb009e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec9af00fbc343c7a22d3f94f5287cdf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e24c9e768043d999c666a316d95f12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6930765739894f11878ad45a82a55846_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf821b273c5e405fb6940c37f931f302_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dff6b4bc5ac419481696f8476fdaa42_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22da98082521415a9ea0e1210c75a6c0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782a0b76608c42b8a82e90d7a7ea4654_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e407cf409ae4bdb83e47faa0f5730af_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac622ad60c646dd848b717d07c7c1c6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148c7405ee9c472db3556c314ddfc829_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0e638f74ad54f28b43e008437b87090_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id820cc1b67e64799bfc374a16f6c1038_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e062e41cfc74e44acb07fd26a397d64_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i637250d82b784de7b529ed70ed515d07_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba474f7dc35d462dbbf5c28ece8066da_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1ef0e38ead43729ec512b3ee29802f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8d54a976ed4611b6e63671c8bd89e7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id11b8ffb8d49487096c194160392c5dd_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida18a217ec684932b3629eb9e338973a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4c6fa0129c464ab8995dcf39d5f97f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1ba4ba9cb441a0b2d31c4fd01bcf43_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95eac61641474597a335d7aa40b97c09_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27d44bf18a1a4061ac3a7e5409698cba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5806947a885c43eabab88a1bd7699531_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb5b41725ce84b268abfb90cdf704e87_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb1218945cd84b80a0826a8dedfda008_D20201118-20201118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-18</xbrli:startDate><xbrli:endDate>2020-11-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="repurchaseprogram"><xbrli:measure>clx:repurchaseProgram</xbrli:measure></xbrli:unit><xbrli:context id="i018e05de2fce4bcaae18e50cf9517af9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b3d2ba010b48fbb9e64b975eb1f926_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75957ffb916249c88259d57dddd74735_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27d27b067a347619468898121fdfd72_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7cc8b46a7c6407daee478103960b9cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a6b8cee95f47f38c868dc0f83738cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f82341c90d8488392c430a697f9ad8d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a85957e12343c3b6d10c076ee4eb33_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic31a8c3f66c64539b477a0e822466880_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419066cdc87943e4af8d2639f21bf325_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e20738f6dc4450bbd4b15b69a7e6581_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d3d6307a914434b95e460604d9d99f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ec840bf78e43008b395cb5e1e9dc56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61ae387d81f4cd787169a4aa986b749_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i648911325f984984a9226827d9c4ade9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287ed9572278419fa5ed70f8a892d17b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1829b8f6a940fa9109f3a38603cdcc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e31ef39780c49909cf68f429ec68689_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e05a3f921945f18703bab7f65ac87c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15cda9f6bf6342a597e07a9eec7230e9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa822c4df064199a3d14eff7dcc4d7e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97439b6734784a439903d4ca1f2ab98b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62293d2d37bf4c4988f6c74ea00a7c89_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d9925f9b914e0993a80905523974d8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iababf4350ccf465da7e9156cd84d16b3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173c3aa326c84df085c6251cbd51be86_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231dec8719174078bc40595afca4dbde_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife71daed3a804771b19315df743bc445_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ec03781c4364b8eb6a53fc946376745_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94703f8812a94078aa3f69523823f506_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a83729a2ab84c53a192961000f37527_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1379ef5a7284cb29a9aed3da06988b6_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8784fe904d7468a9509d946755aa75a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id29606025bd94286b0f0595ed8010676_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d430c56b2d45ea938542ba1ac62191_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75803f96d3a484c8dbb2e4d3901e6b9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegment"><xbrli:measure>clx:reportableSegment</xbrli:measure></xbrli:unit><xbrli:context id="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975190927cc64325b214048019388e7e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad2a51e50b3452cb6ae64126212de08_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cfe0f219db7465c981c5d00e3d79dcc_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e65e42dcaee41a8aa5344602e39584a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eac904b7e824f788b24e686c7bc1d56_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5699b6f9a46b48c5bec7a3e5ba13b8a7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd7644fe81e43fcb2a9ae7f33ce5f3b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eb102946ac9445592b664e481c220fb_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia632e6efb55e4038b06caacaa950ee58_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if62aad3baf484220b5c2b3c5607bcf73_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fc121a4a2da4a36b4069a1d12d0b8ca_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c504e6a0e8e49379abef45f151e6867_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506a64ba3d1741e8a790673d8cd8f3c6_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15818785c195423aa0fecc36f1c2582f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie147f6c9542045d2bc2b75081d38abde_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8caf281c758e491a861b00f823d7979d_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b9ae5110404e8e812297d5d6b2d42b_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47db18debc494da4b9575bc13dde6879_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ad656aa5c747ea869192f42c6b654f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8812b42a862f45728955cc5a6fd0e98d_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128d754517744d14bf0d13fc3d3cf0b3_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c55fd9240674a3b9f72e4cbb7d515dc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifad0e0cfdad747e9bf36f5473f6d8f03_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e1002466a64130bc0c173f011c16d7_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e0648e0b884c8184d3468dad255a59_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187b861787ca41e3b58b23b46c5faf63_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b809796270b46368d7995f9e91a9c90_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1e24f176213492e981a7a7fe85e20a0_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a795ff3b4c4adaa82835e56a401845_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2ea66f0180479c96f3dd09cab6e243_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a5a929489a4b42bb6fce0495516584_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d5d2046dae465496bfa06a4ce81663_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6de7ab384894152aca3960aaa565203_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a114b1ca84437a9ecaf7bf79fb57ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237934c2afde4ed0a6ab8a5fa7df13eb_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f613b6d1e54231bf06050b363647cd_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88583fbc1c434496bf8b9e52b80d9067_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483c1116882345a89188168be2d76bc8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia02727d1fe8147ce863007dd69cdd4ef_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6479f56abf874bc88fcc7c452a280a08_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if10aa250273f4428bc10f6ba3c689231_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8ec145f089a480fb32a14926e0eec81_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61184552c2644513b3d633d0928a8112_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba7f614f662c4fdaac724b9dbdc9b0ec_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053ab554d68d4004b7cc5e97f743f92d_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie08eb37c570741b6adbb80e59db8e81b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005732996c5443e98325ccaca9851e73_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88cf12ca5cc441158bed63419f14048d_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55cd924b746a43e7bb45ffa60c315720_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18be5d4fbe524e47a3029107ff86582b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c74269eba445e0b373d38d49c2ea96_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e2335ca8894224947f5ebe34faec14_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd2e74bb030744169bd9895fd5ff97e7_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie49d4996c5414e89885bb395950c44cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7f4b076b16b412f97df8f6635593f56_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i816a0ac0739d40dbb754308ccc3bb074_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5bde4bb3614689b5997373fdce9d38_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647346da3c594fa1b168b90be5aab738_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b50c8db5f674487bbe612c1077374b8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e050195d1c47c698983818dc2bb144_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d206ce9aae94891b7aefcc647ef716b_D20190701-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF84NQ_9d9799c4-72a6-4b6c-bfdd-ce7dee87ce62">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.768%"><tr><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6MWNjNDkyNzM3ZTBjNDFhMTlmMGQ2OTg3M2U4ZTdmYmIvdGFibGVyYW5nZToxY2M0OTI3MzdlMGM0MWExOWYwZDY5ODczZThlN2ZiYl8xLTAtMS0xLTA_72a80408-f6f8-4a5b-8687-885551aafc94">&#9745;</ix:nonNumeric></span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xMjI_0ecce2e8-b941-4247-ad06-6731e8b9f565">March&#160;31, 2021</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.623%"><tr><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNkMzU4YTAyODU4NDkyNmJlMzE5M2QzYTYyMDk2ZTIvdGFibGVyYW5nZTpmY2QzNThhMDI4NTg0OTI2YmUzMTkzZDNhNjIwOTZlMl8wLTAtMS0xLTA_66d2ebeb-a6c7-4159-8601-2558a0e6f755">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yMDY_cf9df5ce-62d4-4709-bebd-c8548e08d5c7">1-07151</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yMzY_969f9949-cb6e-49d2-bd43-d4319cbb9133">THE CLOROX COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6YThiMTQ5Mjc5OTNmNGEyZGJhN2YxNzQ4MmRiMWY4ZWQvdGFibGVyYW5nZTphOGIxNDkyNzk5M2Y0YTJkYmE3ZjE3NDgyZGIxZjhlZF8wLTAtMS0xLTA_a93f930f-2e95-462c-85ff-05fa3dc0e28b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6YThiMTQ5Mjc5OTNmNGEyZGJhN2YxNzQ4MmRiMWY4ZWQvdGFibGVyYW5nZTphOGIxNDkyNzk5M2Y0YTJkYmE3ZjE3NDgyZGIxZjhlZF8wLTEtMS0xLTA_3f74f456-c012-4a40-8cc9-4a2e6427abc3">31-0595760</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yOTg_a58a859d-840c-4f9c-8c6f-5788c06cd340">1221 Broadway</ix:nonNumeric>, <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMDI_34999c0d-52e6-46e4-a331-d24d71ad1fdc">Oakland</ix:nonNumeric>, <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMDY_f8775c5b-04c9-4f41-af27-ef88d5fb6297">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMTA_54638fee-7fb5-4140-ba7c-ca65eb2b7d83">94612-1888</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zNjc_52a88b24-deb0-47ce-94e0-55c705b86ce3">510</ix:nonNumeric>) <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zNzE_9eb50097-0461-4d2b-86fe-008b2ed28ff4">271-7000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.420%"><tr><td style="width:1.0%"></td><td style="width:36.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former name, former address and former fiscal year, if changed since last report)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">___________________</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTAtMS0xLTA_aef18ce2-0e61-4a70-8cb9-d67707650849">Common Stock - $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTEtMS0xLTA_50d2e3a6-c26b-4fb7-8261-622a4c028338">CLX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTItMS0xLTA_837ebe39-cc07-49bd-bcc4-46f906e8eef2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF83Nzc_2f1f8bfa-eecc-45dc-ac40-8e1cf3b3024e">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xMDk5_90986b60-ff7c-4eff-9082-fd7143e4699d">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.942%"><tr><td style="width:1.0%"></td><td style="width:15.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTAtMS0xLTA_5e8da6cc-ab86-48f1-ba3a-67f570c44d2a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTctMS0xLTA_c89762e9-9831-45cd-9891-2db85cbb8b0f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTktMS0xLTA_b2531627-0067-4047-8daf-1e01d0cb98e8">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xODMy_3899532f-1b91-42ee-b2d5-e2f84c598104">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;16, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i8f5775917fd4473eac612f8753710d3b_I20210416" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xODYz_59792959-e6b6-49c7-a8ed-3f4e1f77faf0">124,372,035</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock ($1.00 par value).</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.985%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_10"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi0zLTEtMS0w_3ccbb7e4-c4b8-416f-bc68-5edee4863bf2">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi02LTEtMS0w_fff0b42c-3d6e-4c31-8a9c-4a6de79c4326">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi05LTEtMS0w_a22d0af5-67cc-4639-bc8a-88a998ecd06c">5,539</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi0xMi0xLTEtMA_259370bb-e27c-4cfe-af9c-e007f49f0178">4,738</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy0zLTEtMS0w_b1fedfcc-9ffd-4aa0-8ebd-0d25db8fdbbb">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy02LTEtMS0w_afbbb005-a156-48db-ad97-139519e6b1cd">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy05LTEtMS0w_33644f92-5f26-49c2-b737-8bce0fa83265">3,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy0xMi0xLTEtMA_7ab8fa3b-d401-4d42-a4c7-2a86b9b4ef4c">2,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC0zLTEtMS0w_ec858cea-4486-4fe3-81de-6c7ad1037b78">774</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC02LTEtMS0w_409fab7f-5003-4f20-8bfc-40c7c3d6a539">832</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC05LTEtMS0w_a49c2f95-1949-48d8-93ab-bc99cd55e294">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC0xMi0xLTEtMA_9635c482-337c-4b53-9750-63422f6dd750">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS0zLTEtMS0w_360b6a69-08b8-44c6-9a84-ead66cd8d61c">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS02LTEtMS0w_0275d867-916c-48cc-bbcf-1438934f69c3">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS05LTEtMS0w_bfa98a34-ec62-470e-885f-eddda661ee0e">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS0xMi0xLTEtMA_1c318d41-5b66-48ea-becc-ddee70bbe00e">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi0zLTEtMS0w_3d1d4a62-fdde-4655-9273-fa78b8b37419">200</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi02LTEtMS0w_c891896b-f450-48a2-a540-b9c09a7d7913">184</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi05LTEtMS0w_bce7127b-ac02-4213-84a0-e9572ce40912">566</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi0xMi0xLTEtMA_88d2af98-671e-4748-8ffa-68ac2e08ce34">461</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy0zLTEtMS0w_33bc0566-877e-4839-acd7-7244c1a3d70c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy02LTEtMS0w_b11c54b5-819f-43ea-8a1e-5aeb215d0571">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy05LTEtMS0w_28193ec4-ea64-4665-9317-7a204517577c">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy0xMi0xLTEtMA_6d22a038-285a-492b-ba76-85d51dbd44de">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0zLTEtMS0xNzky_22a159e6-d25c-4617-b13d-82bb1e441ad1">329</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC02LTEtMS0xNzky_4824d9fe-9ff7-4a17-ab34-cce26330b5fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC05LTEtMS0xNzky_9d8e1baf-2041-4448-9680-c1d5adad6057">329</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0xMi0xLTEtMTc5Mg_e7ec0cee-9373-4a81-b9dc-597279ab2f5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0zLTEtMS0w_0c8f375c-ed0b-417a-8353-871e385523b2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC02LTEtMS0w_47a1aefb-aa51-45fc-8ddd-2a469efc3045">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC05LTEtMS0w_69ed50f5-31aa-41ee-8421-1eb508dd1f61">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0xMi0xLTEtMA_5583f21a-e586-447d-98ce-d8beb384c06b">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS0zLTEtMS0w_bfca9928-3708-4f43-b203-eac8d866a6d9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS02LTEtMS0w_18e4bdba-9572-447f-8b38-4e76b2df2759">19</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS05LTEtMS0w_d08e5848-5b9f-49b6-a72c-ea80127d9fe3">85</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS0xMi0xLTEtMA_3224c852-6177-420f-bd2f-727cd4774035">16</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtMy0xLTEtMA_6695d441-d1f8-4ca1-ad0b-bae8990eeafb">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtNi0xLTEtMA_f5f4f9cf-a276-4d98-85da-8a7ae5412229">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtOS0xLTEtMA_125ac9db-d9e0-4207-b93b-50c7125ed8a3">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtMTItMS0xLTA_a05bc22d-8aba-4d66-ac46-96f3636e5bb6">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtMy0xLTEtMA_22c6668d-d310-45a6-8677-790e43f3a1d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtNi0xLTEtMA_ae0d613d-f15c-4827-b1ba-52ef96b01261">56</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtOS0xLTEtMA_4497f69a-e893-45d3-9fd5-e0d05bc57445">180</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtMTItMS0xLTA_0388630d-7312-4d92-878e-2e76efa9a0b1">161</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItMy0xLTEtMA_d1d5745b-cf5c-4f76-83e2-538825cb92e6">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItNi0xLTEtMA_b815ea6e-f751-4386-a0e5-b6b43154096d">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItOS0xLTEtMA_95da1983-d712-496c-b3c8-cd881c2dc697">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItMTItMS0xLTA_1ef5e935-3382-4e94-bbab-b59d5747f466">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtMy0xLTEtMA_5d3ad2ee-ba53-44c7-ba0b-612dda443d25">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtNi0xLTEtMA_b47dedf6-94c0-4837-84b5-3dcb779958a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtOS0xLTEtMA_7f5ff0be-7f9f-4470-8148-2eb836ab743d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtMTItMS0xLTA_3aca952c-3357-49f6-adfe-cc4e0d6caba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Clorox</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtMy0xLTEtMA_22cec1a9-b88c-489c-922b-9117fc3df428">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtNi0xLTEtMA_2ff6a3f1-fd71-4935-ae44-27e5fddd6b0e">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtOS0xLTEtMA_2c7018ad-b07d-42d4-a00b-0ceaf28e9f67">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtMTItMS0xLTA_d6bee922-941e-4907-a4d8-b97e2f731625">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) per share attributable to Clorox</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings (losses) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtMy0xLTEtMA_62a9ed2c-9451-46a2-9029-08e786f60bb9">0.49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtNi0xLTEtMA_1bb68cd7-b4b4-43a1-99fd-8ffc7e6cd54d">1.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtOS0xLTEtMA_bec2b156-7d7c-469a-93a7-091c7e532dda">4.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtMTItMS0xLTA_e2cbca35-3b74-4805-a234-ffa04fcf15af">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings (losses) per share</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctMy0xLTEtMA_0d30de19-34af-4480-b70b-5f97a3cada2d">0.49</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctNi0xLTEtMA_c8473de1-9ba4-4e1d-b6f6-952d6cd094aa">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctOS0xLTEtMA_a61587e7-5058-4ee8-8814-d45f2c27c503">4.78</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctMTItMS0xLTA_37f30885-2611-4ada-b401-e7a45380d457">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktMy0xLTEtMA_0f073799-e73c-4d98-834c-7232ea98a6ff">125,610</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktNi0xLTEtMA_a899c6d7-6318-407f-a940-bb66a5a996a5">125,661</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktOS0xLTEtMA_832dd781-87b4-4e95-be49-b65497c15600">126,057</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktMTItMS0xLTA_7a938e5c-a509-407b-a4ba-994c80c9a3f9">125,641</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtMy0xLTEtMA_2e5561b5-cc4a-4b1e-867c-5fbd24ebed0a">125,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtNi0xLTEtMA_5adff037-cd36-4607-a6f3-1752d8909760">127,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtOS0xLTEtMA_c3bbec71-d751-4ea7-9ddd-6dab5ec62cf1">128,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtMTItMS0xLTA_a9510c66-1ba1-48d9-a24b-8e74a38710cb">127,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItMy0xLTEtMA_7c37ff19-dc71-4bf7-93d8-cfaa54da4326">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItNi0xLTEtMA_7bd86b81-259f-46f1-a0f3-1b3496ff6027">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItOS0xLTEtMA_cb70b2cd-49f3-4144-8ce5-483a568d53a1">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItMTItMS0xLTA_fcd6ab18-abd1-4c2b-9ac1-f9bd99023ba5">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtMy0xLTEtMA_e0ae4333-a9d0-4428-9fbb-1d3bcf5d16a2">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtNi0xLTEtMA_5653acf4-72fc-4629-b7a5-52f9db3689e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtOS0xLTEtMA_d210955e-6aa3-4a65-81ea-c7badcbee563">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtMTItMS0xLTA_6a0b8fb5-4303-443d-aa87-b4e63db05ab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtMy0xLTEtMA_9d8b49cb-cfea-4ecb-8459-def9c5a1e3ca">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtNi0xLTEtMA_ae1c7177-5514-4728-958f-d78b1f228e72">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtOS0xLTEtMA_21759436-9cbc-4af5-b422-b634ed4d7a28">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtMTItMS0xLTA_3c834e54-2a01-4844-a4d1-429e21f4bdc3">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_13"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="6" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNC0yLTEtMS0w_dc738182-24f9-4105-a53c-001ed2f32241">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNC01LTEtMS0w_25e7483a-e65c-4d5e-a8b6-1fdf8bda75b9">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNS0yLTEtMS0w_211959d0-017a-4d6a-937a-0e2df5e086bf">643</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNS01LTEtMS0w_438df0ae-ba06-4d80-bae2-3f094b51f3ca">648</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNi0yLTEtMS0w_8e996716-f12c-465e-8860-35ae9ecce79d">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNi01LTEtMS0w_54d031d4-4d7c-4c35-b793-ef0121d291a3">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNy0yLTEtMS0w_a3eefe73-f265-4c84-b774-72b5e8b01119">139</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNy01LTEtMS0w_8b2b9df2-d113-44de-83eb-b2f005b0a17b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOC0yLTEtMS0w_6a254e4b-717f-45ef-99e8-01a9077c9320">1,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOC01LTEtMS0w_ce419d24-4ba7-4fa6-830a-db4cca0d4b0e">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation and amortization </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0wLTEtMS0wL3RleHRyZWdpb246NWJkYTQwMjYzMjlkNDU3ZTkyOTdlYmE5NjQ0MGM1YTdfOTY_7eb18b70-b383-4231-853d-da7538e8b9f9">2,351</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0wLTEtMS0wL3RleHRyZWdpb246NWJkYTQwMjYzMjlkNDU3ZTkyOTdlYmE5NjQ0MGM1YTdfMTAz_e171fc51-c167-4e03-8a70-2f0c673681e2">2,224</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0yLTEtMS0w_cac56a14-b0c1-4192-8e92-9d230c5b317e">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS01LTEtMS0w_5a5abd8e-75f7-406f-9f64-f0e687056c4a">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTAtMi0xLTEtMA_97cafca0-442a-410f-85dc-c3b1080ef2d8">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTAtNS0xLTEtMA_742b81fb-2cd8-4a35-995f-ec0be3e6ebf8">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTEtMi0xLTEtMA_d292aef5-a113-4b93-a892-56b80017941a">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTEtNS0xLTEtMA_84fc3f9d-09e1-472f-903a-ba702ef0ed12">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTItMi0xLTEtMA_c961fffc-b44b-4d6f-a3ce-a5c45468cb4a">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTItNS0xLTEtMA_d8d9fe86-7a8b-4c5a-b77b-5256fefa8e64">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTMtMi0xLTEtMA_c367541a-87e7-4470-a407-89073245c8a7">246</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTMtNS0xLTEtMA_0820cda9-4a2c-4f95-b774-431915ab3761">109</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTQtMi0xLTEtMA_1af0e357-1b3d-4dd8-90b9-590b81b6043b">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTQtNS0xLTEtMA_af1aab63-2822-4f31-921b-e7b32e200ecf">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTUtMi0xLTEtMA_160ce2f3-6dab-4ccb-a1d4-9a0cfd990dc9">6,441</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTUtNS0xLTEtMA_f74a9b26-d572-4b25-a92f-6e4184da8026">6,213</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTktMi0xLTEtMA_0e5a5528-eaf3-429d-bc28-1501e172521b">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTktNS0xLTEtMA_ea80f321-181b-450d-af19-26f89b0184d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjAtMi0xLTEtMA_a263f553-c42b-4821-9485-f50325559412">74</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjAtNS0xLTEtMA_2af36b19-c2b6-4b8a-a835-7634537827e2">64</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjEtMi0xLTEtMA_69541083-f977-4b8f-b355-4c1445ec1d73">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjEtNS0xLTEtMA_5e5aa93e-b361-4076-af41-de24bacd6d67">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjItMi0xLTEtMA_dd5e63a0-a5e2-439b-befc-82f55ad8aa6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjItNS0xLTEtMA_3ad3ef0f-fbc0-4695-ac51-c037dc8cd1d0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjMtMi0xLTEtMA_15fe5315-0f50-4852-b7f2-e0275d2ce7a5">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjMtNS0xLTEtMA_64177fdf-60ab-438a-9d17-61d706761ba8">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjQtMi0xLTEtMA_5893d3fb-9267-42be-92f4-ac9cf30e7969">2,483</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjQtNS0xLTEtMA_e4ba9893-0c7e-47ad-81f8-ef531d64248d">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjUtMi0xLTEtMA_f5bda79f-3b4f-40d8-96fc-a46621c2c88d">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjUtNS0xLTEtMA_20800eb9-b3ea-48b0-8d56-31c45d3a0046">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjYtMi0xLTEtMA_cf7a58d6-1929-4473-aaf7-a7bf54e00713">819</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjYtNS0xLTEtMA_3aa029eb-baaa-4a2d-983d-581847059398">767</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjctMi0xLTEtMA_fd3f45e6-fd6a-45b9-a19f-be5630f18ba7">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjctNS0xLTEtMA_e699a1f6-87ed-406b-b0d1-7026260d47f5">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjgtMi0xLTEtMA_791219d2-12dc-41ea-a572-4062509d4b46">5,503</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjgtNS0xLTEtMA_411901f7-a96e-43d1-92ed-0a6d3e09a34a">5,305</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjktMi0xLTEtMA_2c59feeb-9ca5-44b2-bc52-06a905a0b33d"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjktNS0xLTEtMA_cd988e56-164a-4c39-928e-e921b29d2f02"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzIx_151cf77b-de33-42b1-ab0b-f55c67383601"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzIx_f842d027-7635-444c-bcf4-be38d25c93be">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzM1_a78e8023-c054-477d-979b-e2d06384b8ff"><ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzM1_ffdcffdd-33e1-48df-a51f-b58587dadfff">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_70c3f543-f0d7-40b1-bd80-a788cadf39e4"><ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_85f6a7a5-8e56-41c0-b8b6-7c5da7ed168b"><ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_ebdc538d-8b8b-409b-be73-13b6d2e365bb"><ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_fdb7c311-b9f2-47fc-a2c8-b9a4a1326bdf">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMi0xLTEtMA_fa94fc95-6d57-4119-9b62-3bb9a790183d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtNS0xLTEtMA_450d34a6-ed1b-4b3a-accb-a4aef5e63a90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE5_285eb170-289b-4a67-b9ea-cc14360a5cab"><ix:nonFraction unitRef="usdPerShare" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE5_f25f6281-2767-4d37-85b7-7e2981650fd3">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzMz_67518330-ae10-4b71-97ed-95b172bb3772"><ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzMz_c7e1c13f-ea59-4d56-af72-17050f5c46c0">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzU1_a2a779c6-834b-468e-a4b6-c50826556c69">130,741,461</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzYy_fddfa76e-0e71-4476-9176-f2c939c08437">158,741,461</ix:nonFraction> shares issued as of March&#160;31, 2021 and June 30, 2020, respectively; and <ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE0MA_7804082e-a91a-42b6-acb4-978eb5e983e8">124,359,712</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE0Nw_9830e209-469f-49ed-bd74-04159896d30e">126,198,606</ix:nonFraction> shares outstanding as of March&#160;31, 2021 and June 30, 2020, respectively</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMi0xLTEtMA_66d9da20-1533-4366-b4d6-f08fb356d36b">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItNS0xLTEtMA_9c1086a3-f8c4-4d8e-afee-3574c919c0a9">159</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzMtMi0xLTEtMA_4fae882e-2b2e-4664-b3b7-0f8ecf13cb78">1,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzMtNS0xLTEtMA_3da8e3db-09ef-43ef-b8bb-bd7a44a50fde">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzQtMi0xLTEtMA_b5a7d4c2-469f-4536-8f19-6ca896ccec96">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzQtNS0xLTEtMA_5d359f95-55b3-4d58-a5fb-58439fa0f428">3,567</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMwYjY5OTE4ZDhjODRjNjU5ZDNmYmQ3YjYxMDNkN2UzXzMw_a1b00cf9-af27-43e0-acc2-fa15b78d120a">6,381,749</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMwYjY5OTE4ZDhjODRjNjU5ZDNmYmQ3YjYxMDNkN2UzXzM3_0e983c03-adda-4c37-bdaf-1ba4a9f34c66">32,542,855</ix:nonFraction> shares as of March&#160;31, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and June 30, 2020, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMi0xLTEtMA_fd521187-8909-4374-b022-f294e6a9006a">1,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtNS0xLTEtMA_6612fd45-3e6d-481d-9a2f-032f78e5be1c">3,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive net (loss) income</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzYtMi0xLTEtMA_2c9f5860-f4d9-4093-a134-ae73801a6a6f">553</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzYtNS0xLTEtMA_d4db6d13-059c-4aa6-a59c-b2904cd2f5d4">640</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Clorox stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzctMi0xLTEtMA_3a581c0b-ff64-4623-ad91-0fb4702447b6">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzctNS0xLTEtMA_948a770b-711f-4d8a-a25f-813322a405ea">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzgtMi0xLTEtMA_18c42826-2ae2-4bc0-aacb-5725d122b392">195</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzgtNS0xLTEtMA_3df4640a-f8c7-4223-81cb-27e5bfe889a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzktMi0xLTEtMA_7dc463ec-0bc9-4e35-b38c-feefd59d9ede">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzktNS0xLTEtMA_c9f846a3-92b0-4e42-b778-f7ad81a5d254">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNDAtMi0xLTEtMA_cc12a62d-2096-4166-b2ee-cfeeea621ff3">6,441</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNDAtNS0xLTEtMA_35744141-3501-4501-b3a7-b2a71ba186d0">6,213</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMy0yLTEtMS0w_cb8c06ee-1d56-435a-a300-51b90e16b201">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMy01LTEtMS0w_d4a87edb-f242-47ac-919e-2aa68159169c">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operations:</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNS0yLTEtMS0w_7ac338ee-f305-4158-8508-54a77c7e0492">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNS01LTEtMS0w_9c59cf1c-8339-4c91-9c16-ee10754f76f3">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNi0yLTEtMS0w_18908c95-7b18-4c9b-b23a-bde83b2d7672">52</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNi01LTEtMS0w_69046f7a-153d-4378-b477-6e0e4cc180bc">37</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNy0yLTEtMS0w_51c08a79-a04e-4535-b15d-7869e77b0d86">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNy01LTEtMS0w_dfb78a35-335b-4774-a352-49d8e2637151">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC0yLTEtMS0xMjcw_e2b91f01-c2e8-4d32-891d-c7e03076a1f7">329</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC01LTEtMS0xMjY3_56c0ff16-06c5-476f-8e0f-64ef0d0156c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC0yLTEtMS0w_91ee3e9e-8565-4f2c-80c2-3e9e00002f64">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC01LTEtMS0w_2b80b538-7656-487c-887b-9c50432678ba">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTAtMi0xLTEtMA_efae1199-4741-4b3c-97f2-5c21838fdda2">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTAtNS0xLTEtMA_be7ec451-dfcc-4c5b-9482-fa4db1c82723">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTEtMi0xLTEtMA_65970894-f89c-4254-a8e3-bbc4848eedb3">220</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTEtNS0xLTEtMA_86f57b3a-56e9-4b64-9d2f-16a405f3f3a9">50</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTItMi0xLTEtMA_89e6ca24-bd96-4168-bc24-ef03b626a604">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTItNS0xLTEtMA_a37f40aa-d43b-4834-8786-28cb569f266a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTMtMi0xLTEtMA_8f65d91e-d6ad-4e49-8365-8fc7a5e353df">94</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTMtNS0xLTEtMA_435a9ebd-7bf4-4a8b-8398-b832894454f4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTQtMi0xLTEtMA_87fcf3dd-eea5-48c7-a30b-ccea698faccc">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTQtNS0xLTEtMA_951f501c-cbcc-436c-959f-b0d355cdad58">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable / prepaid</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTUtMi0xLTEtMA_f4606428-27a7-4985-b279-ad6c8ec501f0">80</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTUtNS0xLTEtMA_3db5952f-bc1b-4972-a9b7-0642b6717f11">26</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTYtMi0xLTEtMA_c8f642ff-a8dc-4735-bede-df88da906f72">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTYtNS0xLTEtMA_7b306c2c-717d-4805-be16-95bd0fbba3f4">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTgtMi0xLTEtMA_26bd523b-0bae-4f75-8015-89956974e38a">232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTgtNS0xLTEtMA_4fe6e080-1573-4d09-b6ad-80bbd71d6a04">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Businesses acquired, net of cash acquired</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTktMi0xLTEtMA_c1b742c9-f6e2-485e-ba19-38fd5415edd6">85</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTktNS0xLTEtMA_b87cee24-3c56-4da3-b998-82e66d3ffba4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjAtMi0xLTEtMA_e5f221b5-3157-4553-a600-2a0b7be4e25c">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjAtNS0xLTEtMA_13c85099-c514-4c8c-a3ee-7a963c44cc81">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjEtMi0xLTEtMA_ec8dac78-4724-40c7-8342-8ffcae331b8b">341</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjEtNS0xLTEtMA_27c3276d-c03f-4061-bbc2-51fb89d55df7">145</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjMtMi0xLTEtMA_a97a6091-0180-41f6-8001-d8210409d7fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjMtNS0xLTEtMA_a1c2bcdb-fc0b-483a-b106-d6aa56b49776">234</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjQtMi0xLTEtMA_1f5f1683-b26c-4a87-8eee-93cca0c7ae9e">605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjQtNS0xLTEtMA_7965d57e-19cc-49ce-989a-6976d64425bc">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid to Clorox stockholders</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjUtMi0xLTEtMA_da5741c4-8da7-4ff6-8f10-96d6e1dc8cb3">420</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjUtNS0xLTEtMA_292a875e-0137-4def-8ebd-1e3f8a23d807">399</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjYtMi0xLTEtMA_05154e7c-165c-4258-801e-e6b74e2ec952">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjYtNS0xLTEtMA_89ab1dac-69e3-4314-bbf5-86688ba44b67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock plans and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjctMi0xLTEtMA_788d8cc9-248b-405f-b825-38f485e926ef">99</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjctNS0xLTEtMA_0c4a38e2-d3a9-490f-a76d-36e2aedaf5e6">129</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjgtMi0xLTEtMA_ccbc1695-92dc-4a6d-81f6-00c9fdb66fcf">944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjgtNS0xLTEtMA_ef2357d5-7441-46d3-98d9-cd1df8c016c0">261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjktMi0xLTEtMA_38d0dfe6-6dba-4041-9ccb-d79e20ef3a4d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjktNS0xLTEtMA_1e7c917a-d182-48b3-b34f-079e6f00f498">8</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzAtMi0xLTEtMA_d0f67844-06e0-4844-a0cf-2124d465eb3d">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzAtNS0xLTEtMA_708b7b67-ac22-4a94-bed2-27b31d6b8d8e">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash:</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzItMi0xLTEtMA_b13fefd0-9d93-4049-b55a-dc1b9e3b9372">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e8d63f491f423baa88abae57588736_I20190630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzItNS0xLTEtMA_c508bb42-ad22-4585-ac7c-deaccff9de02">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period</span></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzMtMi0xLTEtMA_e20c8e7f-6b99-4b10-a12a-24fea7c9d58a">497</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzMtNS0xLTEtMA_84d02b54-11bf-4594-9342-0f8bd4485aad">505</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data) </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ1OA_226f0626-ddd4-45e1-9411-82242ce83733" continuedAt="i1d03decf4d8b42ffa8dc9ec178425b2c" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1d03decf4d8b42ffa8dc9ec178425b2c" continuedAt="i8e08f11c958b4d9895e9d6f774bc55f7"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ2OA_779ca856-8a2a-4b62-965f-29aac855c278" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2020, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ2MQ_1f3133fe-51f9-4da1-8b8c-8f5e0e41cb20" continuedAt="id0ce94ebc5874ded94ece5cd9bc5613e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, &#8220;Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,&#8221; which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8e08f11c958b4d9895e9d6f774bc55f7"><ix:continuation id="id0ce94ebc5874ded94ece5cd9bc5613e">In January 2017, the FASB issued ASU No. 2017-04, &#8220;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#8221; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company&#8217;s consolidated financial statements at the time of adoption. The impairment identified in the third quarter of fiscal year 2021 was calculated in accordance with this guidance. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzUwOQ_232cd3fe-2344-4dd9-b7d6-296e905ea8b3" continuedAt="i587ffb58dc2f49b1ab596db376abd1fd" escape="true">BUSINESS ACQUIRED</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i587ffb58dc2f49b1ab596db376abd1fd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Saudi Joint Venture Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 9, 2020, the Company increased its investment in each of the two entities comprising its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture). The joint venture offers customers in the Gulf region a range of cleaning and disinfecting products. The Company had previously accounted for its <ix:nonFraction unitRef="number" contextRef="i70dc6fb701fd4f5da398121fd36e0360_I20200709" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzc2_d83ebd2b-331e-4592-a61d-689e2fea311c">30</ix:nonFraction> percent investment of $<ix:nonFraction unitRef="usd" contextRef="i70dc6fb701fd4f5da398121fd36e0360_I20200709" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzkz_aad9b792-6e0a-435c-aa7b-6e02bd49b48f">27</ix:nonFraction> as of June 30, 2020, under the equity method of accounting. Subsequent to the closing of this transaction, the Company&#8217;s total ownership interest in each of the entities increased to <ix:nonFraction unitRef="number" contextRef="icf6b73a611c5439c9ddb772f505d1455_I20200709" decimals="2" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfNTc5_463e94ec-607d-4633-8ba8-a5fb5ece9d16">51</ix:nonFraction> percent. The Company has consolidated this joint venture into the Company&#8217;s consolidated financial statements from the date of acquisition and reflects operations within the International reportable segment. The equity and income attributable to the other joint venture owners is recorded and presented as noncontrolling interests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfOTQz_9d71a166-5fde-468a-b54c-5ca5b9efb980">111</ix:nonFraction> consisted of $<ix:nonFraction unitRef="usd" contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfOTU5_2d92ebd6-d31f-4faf-90e7-c433ccead52b">100</ix:nonFraction> cash paid, which was sourced from operations, and $<ix:nonFraction unitRef="usd" contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709" decimals="-6" name="clx:BusinessCombinationSettlementOfPreExistingNetLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTAxMg_e375ad7b-f0ad-4625-bec2-72a9c3d33d48">11</ix:nonFraction> from the net effective settlement of preexisting arrangements between the Company and the joint venture. The assets and liabilities of the joint venture were recorded at their respective estimated fair value as of the acquisition date using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill in the International reportable segment in the amount of $<ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTUwNQ_b5ea7664-f944-4e94-b204-0d08cf733c3a">208</ix:nonFraction>. The goodwill is primarily attributable to the synergies expected to arise after the acquisition and reflects the value of further growth anticipated in the Gulf region. <ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTY3OA_760d3680-4304-428f-831f-70eb5c20c101">No</ix:nonFraction>ne of the goodwill is deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of this transaction, the carrying value of the Company&#8217;s previously held equity investment was remeasured to fair value, and resulted in an $<ix:nonFraction unitRef="usd" contextRef="ia0bfdd2f36fa40ae8884cec528927862_D20200701-20201231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTg4Mg_9c47dd89-f7c6-41f9-80c2-9807436ec554">85</ix:nonFraction> non-recurring, non-cash gain recorded in Other (income) expense, net in the condensed consolidated statement of earnings and adjusted in Other operating activities in the condensed consolidated statement of cash flows for the first quarter of fiscal year 2021. The fair values of the noncontrolling interests and previously held equity interest were determined using a discounted cash flow (DCF) method under the income approach. Under this approach, the Company estimates future cash flows and discounts these cash flows at a rate of return that reflects the entities&#8217; relative risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price allocation was finalized during the second quarter of fiscal year 2021. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzUwOA_f4b3db99-7ef0-4002-a0fa-de819744c983" continuedAt="iaa347548bcdb44c3ba084ee28b1e1e7b" escape="true">The following table summarizes the final purchase price allocation for the fair value of the joint venture&#8217;s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is <ix:nonNumeric contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzIwNQ_b753fc5e-c1de-445a-9da8-cea2c39d9a6f">9</ix:nonNumeric> years.</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="iaa347548bcdb44c3ba084ee28b1e1e7b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Venture</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMS0xLTEtMS0w_319d536a-3bd0-4175-bda5-d9d3e3301510">208</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired rights (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26e45946444a8a31e317e4a6335eb_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMi0xLTEtMS0w_c6d067c5-185f-4b14-821f-538ca2c13593">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMy0xLTEtMS0w_a360d620-49cd-40a1-adc5-cebe4447705f">46</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e347afcab74ff6bc8d31a740d9a89c_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNC0xLTEtMS0w_59198380-5eaf-4c28-aab5-6aea179e89fd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital, net (includes cash acquired of $<ix:nonFraction unitRef="usd" contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNS0wLTEtMS0wL3RleHRyZWdpb246ZjIxMzllN2NkODNlNDJjNDg2ZWM2NTQyZThlYTRkZDNfNTI_f82591a9-35e1-4f3e-848f-d964fa3a0040">26</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="clx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNS0xLTEtMS0w_858735aa-3b70-4cd0-943b-9ecb5c811fc8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNi0xLTEtMS0w_1d326792-576d-42a5-ad07-3f3c04a2f977">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNy0xLTEtMS0w_71d86870-1427-402d-8b0b-5c17d658bd37">19</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfOC0xLTEtMS0w_9679e736-32f9-41d8-b223-349bf291b1b6">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfOS0xLTEtMS0w_4ed320b7-8b3d-4b38-97b5-eca7ecb87e5c">198</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of previously held equity interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTAtMS0xLTEtMA_fac6e427-d5c3-4e34-8125-7e9c25c8cb26">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTEtMS0xLTEtMA_65ac997b-c6e5-41bd-856c-4dbe335625bd"><ix:nonFraction unitRef="usd" contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTEtMS0xLTEtMA_fe0ec3fe-eaa8-465c-a38e-a455f9c6262a">111</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Included in the Company&#8217;s results for the three and nine months ended March 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzMwNA_b8c28599-24fa-4f99-807b-2359218a2f65">19</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzMxMQ_6c7dd4a6-ac34-4799-980f-207b7c226156">65</ix:nonFraction>, respectively, of net sales from the joint venture. Pro forma results reflecting this transaction were not presented because it is not significant to the Company&#8217;s consolidated financial results.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RleHRyZWdpb246MDA3OTNkODE4MDc2NGM0Nzk4Nzg0YmI0Nzg3ZWFjMDRfODQ_0070ab55-c236-4a65-92fe-390ae8276e10" continuedAt="i77fea4a1210b4e878d76236aafb0f06a" escape="true">INVENTORIES, NET</ix:nonNumeric></span></div><ix:continuation id="i77fea4a1210b4e878d76236aafb0f06a"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RleHRyZWdpb246MDA3OTNkODE4MDc2NGM0Nzk4Nzg0YmI0Nzg3ZWFjMDRfODk_e6a0c4c8-b5e9-4516-9990-b6b7d804e328" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMS0xLTEtMS0w_a3fde5a6-8d92-46cc-b836-cc2fda95b989">522</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMS0zLTEtMS0w_c5ae3b2e-1249-40d4-92a0-97d6a6c80984">340</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMi0xLTEtMS0w_6a2d82bb-4069-462c-adf8-1b17ca92f86d">188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMi0zLTEtMS0w_79956b7f-9eea-42c0-818a-4fe04aaa44d9">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMy0xLTEtMS0w_60c86ca3-0577-4869-82e3-a35c06a6ee7d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMy0zLTEtMS0w_a0797e3c-6518-4318-8c99-9d88dd4eccf4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNC0xLTEtMS0w_da7d503e-98f2-4d9b-a030-30d5a4259963">32</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNC0zLTEtMS0w_f58615fc-63b8-4ccf-a56d-f3605e4eac0d">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNS0xLTEtMS0w_4cab4ab6-e1f7-4015-8d27-e594361ad3ff">688</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNS0zLTEtMS0w_581597f7-4170-4e50-970d-f1c66a5eda44">454</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_962"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzA_dc8b26a8-509c-418a-8ce1-8b6059a5f779" continuedAt="i20dac70aaaf046b0812d868e4d84d3b7" escape="true">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i20dac70aaaf046b0812d868e4d84d3b7" continuedAt="id0b83a833d554597aef35d65829aba9e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, as a result of lower than expected actual and projected net sales growth and operating performance for the Vitamins, Minerals and Supplements (VMS) strategic business unit (SBU), a strategic review was initiated by management that resulted in updated financial and operational plans. These events were considered a triggering event requiring interim impairment assessments to be performed on the VMS reporting unit, indefinite-lived trademarks and other assets. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NTQwNzA_80f0a641-c169-4d0f-b01c-bf0606ea6c36" continuedAt="iaa003a6ceaaa4ecba5335c0b5f499673" escape="true">Based on the outcome of these assessments, the following pre-tax impairment charges were recorded:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:4pt"><ix:continuation id="iaa003a6ceaaa4ecba5335c0b5f499673"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment Charge</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzEtMS0xLTEtMTYxNA_78153768-4e50-4f02-a287-a600be40b36d">228</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzItMS0xLTEtMTYxOQ_6aa9511f-e782-4a41-aa88-788cbca6f704">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb066f8d893346ca9951f248d0dcb802_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzMtMS0xLTEtMTYyMw_fa131bcb-7912-491f-87ec-5ff48b036e1e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzQtMS0xLTEtMjE0NQ_9cf9ec3d-98b8-4f0d-a1b6-d208eaea7fcc">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzQtMS0xLTEtMTYyOA_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac">329</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of $<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNjQ_107f87e1-bce6-460b-8084-6256cebd3b36">62</ix:nonFraction> due to the partial tax deductibility of these charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment charges are a result of a higher level of competitive activity than originally assumed, accelerated declines in the channel where the business is over-developed, and higher than anticipated investments to grow the business, which have adversely affected the assumptions used to determine the fair value of the respective assets held by the VMS reporting unit for growth and the estimates of expenses necessary to achieve that growth. These impairment charges are based on the Company&#8217;s current estimates regarding the future financial performance of the VMS SBU and macroeconomic factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. Under this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, and a terminal growth rate.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzE_954a731b-e242-4c86-b905-cac28150c1e8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2021 from June&#160;30, 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:30.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.272%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib928fec9941c44d881ae5b71182e1e12_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItMS0xLTEtMTMxNQ_8563a75f-a93d-428b-a581-7dac5d46ebf2">857</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185542c2acc246eabdad2e53c4d02ecd_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItMy0xLTEtMTMxNQ_6c4f296a-13ae-4f91-90a9-2ea02a78dde9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbc5f5127cf42d98d38f3b2282c7508_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItNS0xLTEtMTMxNQ_5df8597c-47dc-4885-86eb-9378c8972f89">244</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86cded78606f40eda58cf54289cc6c46_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItNy0xLTEtMTMxNQ_b54247be-32b9-47b8-929f-b5ec9c55422a">391</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItOS0xLTEtMTMxNQ_2e3b1272-197b-47d0-8f26-0dafd5e116e2">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtMS0xLTEtMTMxNQ_4df27b11-2d4a-4090-8a92-81b04fda1a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtMy0xLTEtMTMxNQ_299bc8fd-f514-49b7-8109-b185a194397d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtNS0xLTEtMTMxNQ_cb214208-e6bd-46a6-895c-1b51aada7222">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtNy0xLTEtMTMxNQ_0ccfcc05-9b41-40a0-89cc-0881123e418b">212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b5e8efae404d60976021d1249edef6_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtOS0xLTEtMTMxNQ_e727c942-b24e-4d97-aa83-e71b4c3433d4">212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtMS0xLTEtMTMxNQ_c251f936-1ec7-4766-9ec6-fa66090e89bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtMy0xLTEtMTMxNQ_24007cc3-2b50-4509-9cd3-577cef60bfdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtNS0xLTEtMTMxNQ_752b1564-05af-41d9-8f0d-32674cdffe8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtNy0xLTEtMTMxNQ_465edf3d-42a8-4d0e-a3cb-3375e9401132">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b5e8efae404d60976021d1249edef6_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtOS0xLTEtMTMxNQ_f123826a-b7ad-49f7-8dd4-05a52ae99813">4</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df6541afbcc471caf5020183b1aae27_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtMS0xLTEtMTMxNQ_9057909d-3d92-4211-9302-222f0c360ad0">857</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea72635ffc9249a5b85b28d91061578c_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtMy0xLTEtMTMxNQ_fd65fc0a-735b-4c9f-b392-e38714c115a7">85</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abb07fff33f4729b2158873d5eaa9ef_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtNS0xLTEtMTMxNQ_6d32a871-b2c4-4aac-9bbd-a264f584fdb6">244</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6521a378432044e2818b18ae9a3f504f_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtNy0xLTEtMTMxNQ_d950a82a-bcff-496d-946c-05f73c6c8129">607</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0bf84a649f46e6b8628a79d40bb4bc_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtOS0xLTEtMTMxNQ_8c97877b-5809-4a20-8348-96e2b69ae1ec">1,793</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8e270257da49d0ba55eec6af3548a5_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtMS0xLTEtMTMxNQ_9e847cff-c66e-4016-b83f-a0a025765aeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37bcf0ca8f2c418d8e3ad8f1d725a7e8_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtMy0xLTEtMTMxNQ_2105aafe-3659-4e56-ac3f-87849b8f01e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ac31a8e85142168910ba397dd1998f_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtNS0xLTEtMTMxNQ_7c8436d5-ec69-41ea-a7be-daee550c8288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a21685ce7e9490d85a6bb3145bbe8b4_D20201001-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtNy0xLTEtMTMxNQ_86731d79-2c3c-448d-b39b-e678a288bd87">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f50a3afc8254aee87ec15cc7d3a1236_D20201001-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtOS0xLTEtMTMxNQ_c6937a56-aaff-4cb5-84ea-692e23822f64">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087ce4ee5c5f43ffbc5df3b0be560c27_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctMS0xLTEtMTMxNQ_a7d57791-6793-46c7-8cf7-bcc1b495a062">857</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c431b3b55c4f679f28a6d7fe216a9e_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctMy0xLTEtMTMxNQ_c5a034ef-2f81-4d8c-adb4-f58164efa163">85</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43cba4b272444bd38c66ff3c5246316d_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctNS0xLTEtMTMxNQ_fbda71cb-5bf0-45d2-8881-65748feb531d">244</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b5149e800a4c518f7685d164029449_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctNy0xLTEtMTMxNQ_5228eec0-c255-46ea-9d83-98a25ea0dac2">617</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a82930ba8c46a8842474109384e6c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctOS0xLTEtMTMxNQ_9786771f-74df-4afe-b663-9aba1f48bbc3">1,803</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtMS0xLTEtMTMxNQ_687960fe-0b2f-4d30-9d62-ceb40cb1d18e">228</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtMy0xLTEtMTMxNQ_daff3223-bd59-4f32-8724-680391a8eb6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtNS0xLTEtMTMxNQ_c117c91f-0d55-461c-9915-eeed012ca3c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtNy0xLTEtMTMxNQ_8e132233-8ff0-4431-ba26-4e781d38e707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtOS0xLTEtMTMxNQ_c2616cbd-ec71-43f4-97c7-4dec1d32a255">228</ix:nonFraction>)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktMS0xLTEtMTMxNQ_ba81f269-4ac6-4ec2-b410-3fe3513c3940">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktMy0xLTEtMTMxNQ_99da77eb-f806-477b-9d07-5cb5e710579f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktNS0xLTEtMTMxNQ_617d8451-1e1b-4845-b5b2-09d7f0c2c2bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktNy0xLTEtMTMxNQ_9c09b160-44d4-48a8-8729-f0d2c46d4634">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktOS0xLTEtMTMxNQ_6b7339b4-7c9a-41cb-a4d0-3205b92f557f">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26539d9b96f845d3ba4ab21e4452925f_I20210331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTEtMS0xLTEzMTU_524071c3-f066-4ee3-858d-4a1be0e68be9">629</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba8774be3fa46a89129787dadbdd87d_I20210331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTMtMS0xLTEzMTU_421cbec9-6959-4c8d-adc6-c7c40864138f">85</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4784aa0c2eb497085b38aac10a12a6c_I20210331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTUtMS0xLTEzMTU_55375fc3-dc6b-46f3-abb4-fbf489cd9b62">244</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08739ec82f9f487e9a3a1aaf8f12513d_I20210331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTctMS0xLTEzMTU_440b8dc9-53c9-4632-9c71-5b46cccadf2f">616</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTktMS0xLTEzMTU_649d0f03-60a1-43f5-9b98-7c7758123e57">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes $(<ix:nonFraction unitRef="usd" contextRef="ie41c41f5deb14768a1eb5a2210283ea4_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNzE_a7350621-31d9-4347-b5c2-b6a3c5f2224b">4</ix:nonFraction>) purchase price allocation adjustment related to the Saudi joint venture acquisition. Refer to Note 2 of the Notes to Condensed Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="id0b83a833d554597aef35d65829aba9e" continuedAt="i58a49876902448d6bc6652136cf5d83c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the estimated fair values of the VMS related indefinite-lived trademarks, which were included within the Health and Wellness reportable segment, the Company used the income approach. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4f481c5813194dcb93b50f7c42cd5640_I20210331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ5MDQzMjQ_33311253-f137-4316-800b-323d6a8c8282">13</ix:nonFraction> as of March 31, 2021, were changed from indefinite to definite beginning on April 1, 2021, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is&#160;<ix:nonNumeric contextRef="i2af70af2cbfa4de0b7bbcc6d6076615a_D20200701-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzEwOTk1MTE2NDA4NjY_a04650e1-20ac-4b9f-9391-383a76c62a0f">16</ix:nonNumeric> years.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzI_666b5aba-144b-4a14-801e-c701e972c0d5" escape="true"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzI_7c451279-b231-4d38-9649-d13d674e0326" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:33.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.672%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.672%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.923%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11c4432843d48beb47ab04de9835fd8_I20210331" decimals="-6" name="clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMS0xLTEtMTM0Nw_7e5293d4-22ad-4465-8c21-52a03afe1ffc">769</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7fec97eb2b445d82bb2f5c366219eb_D20200701-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMy0xLTEtMTM0Nw_2ae6f4f3-6e65-4c24-a1ee-6b67ec7d1b85">86</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11c4432843d48beb47ab04de9835fd8_I20210331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItNS0xLTEtMTM0Nw_b6a3b3d5-c6fa-426a-8650-6ab5f21857c8">683</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItNy0xLTEtMTM0Nw_3423a376-3c31-4058-b657-29c6bd220fe2">766</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib505795eadb0415688775b76ca687bd7_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItOS0xLTEtMTM0Nw_4959ce51-233a-4fdb-a381-cb4ddf3b5739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMTEtMS0xLTEzNDc_787e93c0-0adc-4d19-a6e2-e3d244bb58df">766</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMS0xLTEtMTM0Nw_1e98fd34-a90c-408a-a167-539e0790de0c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMy0xLTEtMTM0Nw_e29917d0-1b5a-4ec5-ba0e-e49494f731cf">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtNS0xLTEtMTM0Nw_d33447aa-ab47-402c-be08-faec1d5a8ff0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtNy0xLTEtMTM0Nw_ae78a83c-8403-45ea-a226-4f03dae3cbd9">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtOS0xLTEtMTM0Nw_a0b3f0c2-3d65-48df-bd6b-f59e46c360eb">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMTEtMS0xLTEzNDc_f7b0c0d8-b5f3-4635-abe7-db445c4bfc37">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1484f195af54610a54afe24e3990c37_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMS0xLTEtMTM0Nw_e47c8354-40fa-4cdd-a847-6d576d2db4c0">583</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1484f195af54610a54afe24e3990c37_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMy0xLTEtMTM0Nw_efab60fc-2f0e-41a3-af1b-d4bfb5ee5920">337</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1484f195af54610a54afe24e3990c37_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtNS0xLTEtMTM0Nw_2b31f0c1-1a9d-4c91-8ed7-c6f4ce4f74ca">246</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtNy0xLTEtMTM0Nw_e68a27db-c586-413b-84f8-06891d8a4ea5">424</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtOS0xLTEtMTM0Nw_8faefd8c-97e1-4422-9110-fe9eaf0d8c04">315</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMTEtMS0xLTEzNDc_6f6f514d-18b9-4e43-8b65-2eba59b2c7ee">109</ix:nonFraction>&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMS0xLTEtMTM0Nw_a9e95845-1a37-415e-a47d-6ac8166f9607">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMy0xLTEtMTM0Nw_e1a2b5f0-64b8-40ff-9a45-8f41a1557334">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtNS0xLTEtMTM0Nw_e08fe892-bc3d-4f4a-80c3-bd4b3c299612">940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtNy0xLTEtMTM0Nw_82ebd234-e9ff-43f4-a1b0-810fdf301c49">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtOS0xLTEtMTM0Nw_724008c3-68c4-4e0d-8d80-159c7e962f9c">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMTEtMS0xLTEzNDc_b17b7858-0ec8-4fcc-94cc-a255af0a729a">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i58a49876902448d6bc6652136cf5d83c">Amortization expense relating to the Company&#8217;s intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMjg_c1e7cbe6-faf2-4a0e-9ef3-424571c5e69c">8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMzM_e1c47901-d78d-40f3-8768-45038a655db4">23</ix:nonFraction> for the three and nine months ended March&#160;31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMzg_206c1fcd-cd17-430c-9e54-f99bc58ab596">3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNDM_9fe150dd-6202-44f4-a9df-c0e71536fe91">10</ix:nonFraction> for the three and nine months ended March&#160;31, 2020, respectively. Estimated amortization expense for these intangible assets is $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMDM_6134076d-a7e8-4369-a265-3f7efb2f82b3">8</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMDg_170fc7d7-abc6-43f5-87a3-97059598ee5f">32</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMTM_16485b27-8633-4f79-8874-30956af71c64">30</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMTg_9e6272e1-18b8-48a5-84c6-ff95fd12c44d">29</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMjM_28801c2e-0db4-4d71-9d97-c076f242d4ec">28</ix:nonFraction> for the remainder of fiscal year 2021 and fiscal years 2022, 2023, 2024 and 2025, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2MA_b1b1709a-9aa6-41a7-859e-d82c9ccb66d3" continuedAt="ic04bb9d722504cc09ad1a5037b02813d" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic04bb9d722504cc09ad1a5037b02813d" continuedAt="i0f09f6b07c0f46679595b1212da5be73"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity exchange traded futures and over-the-counter swap contracts, which are generally no longer than <ix:nonNumeric contextRef="i848015c104c6489dbc76c581af351d33_D20200701-20210331" format="ixt-sec:duryear" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNDgw_05e415e4-8903-4e80-9c62-5bb7abdebafa">2</ix:nonNumeric> years, to fix the price of a portion of its forecasted raw material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the notional amount of commodity derivatives was $<ix:nonFraction unitRef="usd" contextRef="i7b70b530cbd34611accfb86ef4f0c9f8_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODAx_a080ae2b-5a9d-4c34-b99e-7d45c046814c">24</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i81bb94cec74c44ec934873bc2cbde692_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODE0_efaed0b1-d05f-4981-bca1-37b617dac797">15</ix:nonFraction> related to soybean oil futures used for the Food products business and $<ix:nonFraction unitRef="usd" contextRef="i2602ddacb1ba4d48b483893d5a5811f5_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODg4_77ee7635-5844-4542-ae38-8a1d3ee17bf8">9</ix:nonFraction> related to jet fuel swaps used for the Grilling business. As of June&#160;30, 2020, the notional amount of commodity derivatives was $<ix:nonFraction unitRef="usd" contextRef="if877153b764b4c2199980313d42e92fa_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTAwOA_184110bf-6768-47b5-9e9c-895486bda344">27</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i4e18e05c20e542f2b56a8cfae3ddca8e_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTAyMQ_a7a072a4-d15d-4d46-94f2-307042287ce0">14</ix:nonFraction> related to soybean oil futures and $<ix:nonFraction unitRef="usd" contextRef="i6ecb0a1520954103b71df562030763b3_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTA1OQ_7d27bedc-3a2c-4a17-953f-bcae7cf59132">13</ix:nonFraction> related to jet fuel swaps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" format="ixt-sec:duryear" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTM5NQ_e83606fd-f5db-483a-9e60-6722863cb84e">2</ix:nonNumeric> years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $<ix:nonFraction unitRef="usd" contextRef="i6d14bf1a42bf48728f273cb7dbb88206_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTY2Ng_db37f2ee-3d61-42e1-ba25-09bac4291512">68</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i446ee7bb6f85446389955f7c3cb5789e_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTY3Mw_78758cfb-da9e-41c7-a5d1-303b545c0e86">70</ix:nonFraction>, respectively, as of March&#160;31, 2021 and June&#160;30, 2020. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i0f09f6b07c0f46679595b1212da5be73" continuedAt="ie61cd55fad664f7aa94a477fc9724053"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate forward or swap contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage the Company&#8217;s level of fixed and floating rate debt. These interest rate forward or swap contracts historically have had durations of less than <ix:nonNumeric contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331" format="ixt-sec:duryear" name="us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjA4Mw_53d47d4a-ce4e-415d-9243-829224858987">3</ix:nonNumeric> years. The interest rate contracts are measured at fair value using information quoted by U.S. government bond and interest rate derivative dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notional amounts of outstanding interest rate contracts used by the Company were $<ix:nonFraction unitRef="usd" contextRef="iceb6e03daa5243e9b7e14504d53fa628_I20210331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjMxNQ_9d7a8df0-caf5-4d7d-a5e8-8e98ed62a643">300</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9eed352fc1a5487bb2a201702a083bc5_I20200630" decimals="INF" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjMyMg_5aef4a3a-b0fc-47c2-a437-0fd4beb7c48b">225</ix:nonFraction>, respectively, as of March&#160;31, 2021 and June&#160;30, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These contracts represent forward starting interest rate swap contracts with a maturity date of September 2022 to manage the exposure to interest rate volatility associated with future interest payments on a forecasted debt issuance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward and futures contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate forward contracts for forecasted interest payments as cash flow hedges.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA1MQ_c3290cd5-6804-4756-b771-f97026088161" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy0xLTEtMS0w_b34b0472-ca8c-42f4-a22b-d2d69f427b02">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy0zLTEtMS0w_5a109b66-545f-4cbb-82c3-244a1c466e97">11</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy01LTEtMS0w_57c1d07b-ba84-4b3d-9117-82c1ef556563">12</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy03LTEtMS0w_3477233c-4175-41b1-9f54-83ff3a2b2aab">8</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC0xLTEtMS0w_5571bb89-3906-4832-b773-36394feb2ed3">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC0zLTEtMS0w_0c275f28-8199-4d04-8983-0157342772a5">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC01LTEtMS0w_91ff46dd-b005-49e8-b63a-68ee16dd4b3d">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC03LTEtMS0w_d037ff02-f886-4316-8a86-da4d40fa66f7">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS0xLTEtMS0w_e91fde08-056b-4f59-ba14-4869061a983d">26</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS0zLTEtMS0w_5f4ee269-f5a7-4b99-9d1e-ec94abb8deb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS01LTEtMS0w_db2db35e-a1e9-4968-bdfa-fc8808a01c79">36</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS03LTEtMS0w_23d75b13-ed17-41e7-be4a-2144b4c06e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi0xLTEtMS0w_81016ba1-58e1-46fd-9247-0cc45da65baa">33</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi0zLTEtMS0w_a6918d3b-3727-429b-95c6-affbc12d4764">9</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi01LTEtMS0w_41798531-00c8-4bbd-b424-dd708e0344c3">47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi03LTEtMS0w_55acc0f6-aac3-4f21-8cd2-fcb91e2b678f">6</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA1Mg_4b551ebb-9f05-4582-a425-4d2e719e8a43" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy0yLTEtMS0w_81fe21de-f795-4c26-910c-06706343fd5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy00LTEtMS0w_fdc2a302-1029-49ed-8ded-264bda8d98f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy02LTEtMS0w_cc73750e-95c7-45a5-ad5a-7bfbbe4d112a">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy04LTEtMS0w_fe4e469f-6894-4206-a68a-48e271105442">1</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC0yLTEtMS0w_6708040d-ce4f-4ffb-a329-e1557dc158ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC00LTEtMS0w_824d56fb-b513-43e6-a7da-8bf61f5617e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC02LTEtMS0w_540cf889-bf25-4d4e-8a65-570c96e6809a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC04LTEtMS0w_e8fab796-018e-4c4e-91d5-981eb4d7e40b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS0yLTEtMS0w_555642fa-a980-48e3-942c-9eed7046cf41">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS00LTEtMS0w_cc0909a0-583d-4391-b83d-392d2b3e8b66">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS02LTEtMS0w_61120e07-8e08-418b-99d7-f8bbd144a9d4">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS04LTEtMS0w_7f709cb9-b821-4e9b-8863-0192d0c034ea">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi0yLTEtMS0w_3d0c5356-701c-4eb1-84a8-60790991b341">2</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi00LTEtMS0w_1c91a4d6-6e87-48ad-9969-a7b540c27de9">2</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi02LTEtMS0w_f1a6b208-370d-4616-9c5e-551a4d57ea9e">7</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi04LTEtMS0w_a90b6c41-9050-4b11-9a43-319016857c57">6</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2021, that is expected to be reclassified into Net earnings (losses) within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI3OA_988bb52e-4dee-494d-8b0a-904c20bda824">2</ix:nonFraction>. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="ie61cd55fad664f7aa94a477fc9724053" continuedAt="i6d7b15db5f244ed6b323ee6d2ba036de"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of March&#160;31, 2021 and June&#160;30, 2020, $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzk5Mg_5cf1e8c0-a281-4b5d-a71a-d86b1cf283b8">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzk5OQ_5a0f97d1-ad1c-4cfb-876c-4a29f3d3e82b">3</ix:nonFraction>, respectively, contained such terms. As of March&#160;31, 2021 and June&#160;30, 2020, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2021 and June&#160;30, 2020, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange-traded futures contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of March&#160;31, 2021 and June&#160;30, 2020, the Company maintained cash margin balances related to exchange-traded futures contracts of $<ix:nonFraction unitRef="usd" contextRef="i89286b72adb64ceeae58323f4cbca98f_I20210331" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNTIyNQ_31434859-d350-4f67-a604-999cd2c7bb49">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibb6317a205f64e888817536ae25aba65_I20200630" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNTIzMg_910b5a31-9979-4c8b-b94a-7ae7718e2d53">2</ix:nonFraction>, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has held interests in mutual funds and cash equivalents as part of the trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which to invest their compensation deferrals in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2Mg_1dc9dbfc-55e9-4b0c-bf85-c789084528be" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and June&#160;30, 2020, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i6d7b15db5f244ed6b323ee6d2ba036de"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2NQ_e6f4b24c-4573-4b1e-8282-e07be5738004" continuedAt="i6393d1ebc4af41b2b364b11b076d7690" escape="true">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</ix:nonNumeric></span></div><ix:continuation id="i6393d1ebc4af41b2b364b11b076d7690"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:24.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0048ff33e90f4209aee6b35dd0d9663e_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy01LTEtMS0w_aa4c876c-bad5-4eee-ae92-8f04a80548e3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803bb7cea1a64da4926148b2b30bf8b9_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy03LTEtMS0w_08012d95-52b8-4179-b500-3ab9e2a019f1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a130bb3d2e4856b978cf675b54b49f_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy05LTEtMS0w_cfa67152-deb0-433a-8b35-6071c964c266">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becfdbf9a624acdb1b709bc3dc25c7e_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy0xMS0xLTEtMA_5b3e9c7e-c7f4-4242-b3a1-4bda3915d74a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24afdfe415c34061ab653ffa84c5b114_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC01LTEtMS0w_3ab988c0-0d76-48c9-ae24-a79d9a7b8229">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f08e7cdcd93457ea49df833bde0b187_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC03LTEtMS0w_b3ab938c-921f-4e77-972c-7aa86faa10fd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d8da7beaf442bd9043f1f6db402d82_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC05LTEtMS0w_1251038f-4a82-4a78-a34b-2be0dbac6395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72856990c40d4c8e8edcc82b8f7f1500_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC0xMS0xLTEtMA_83ad0bcb-8927-429f-ad1b-70929b753e79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie244b1b1e0424bdbb85739588f77cd6f_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS01LTEtMS0w_20e41e3d-05a0-468c-9c48-005d028e6f89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493b6bcb04674e4eae776d98c6e32549_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS03LTEtMS0w_1fc2653e-4547-4598-9382-6521f34d1161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53a10bdd3c443149d70aa1b9344fa89_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS05LTEtMS0w_d9f8ccc2-dbdd-47b3-8185-5f54a29f318b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57197fa8f0f041218d4589f2a589885a_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS0xMS0xLTEtMA_8911dd01-a9ba-45d8-af3b-1121875d0f8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate forward contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb08d66214c4f6a8e0e2cad3359efe0_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi01LTEtMS0w_1c85c385-7046-4e3d-aa0e-1ec6c7cca9e9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09939d37bb3048269d0cb0a44386b194_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi03LTEtMS0w_a009df9f-76ab-4d72-b1b1-ba34969d7081">37</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f1a042de7b4e569e2d27c2d5dad9e1_I20200630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi05LTEtMS0w_2d78c656-1309-4a2d-98f4-ea2ee9cc000e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1996c058fbf040f8908e8c394fc5c89e_I20200630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi0xMS0xLTEtMA_a189486d-27c0-4ebf-af11-fc0725eee1ca">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy01LTEtMS0w_4308227d-3295-4cc8-9584-2ebf97958348">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy03LTEtMS0w_5d0c4506-1124-48a5-acab-67210865a350">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy05LTEtMS0w_cdac9c55-4c9b-4959-aeda-d71a64656705">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy0xMS0xLTEtMA_0777ab43-6e78-42aa-ba76-cb6e7fcfb8e5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f4d36e4c26464da0167188a60de71c_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS01LTEtMS0w_190da349-a8e6-465d-8a75-cb1492ecfb7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987768d7a6a84e038b10c8aaeca7130c_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS03LTEtMS0w_9cccf893-359a-423a-9ece-2a6e23caab7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d72659b4ccc4ad89a4324978711b52a_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS05LTEtMS0w_c6a6084e-f885-4351-aaf4-956c06d68b13">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a413c3b7e924aa38bf7da6938de615f_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS0xMS0xLTEtMA_0a43b361-5443-49b9-a906-722e4d1d5bc9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85534346744b432e8cea4e97ccc5909d_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtNS0xLTEtMA_a6d3754b-0966-4256-8b96-a4cf4947a3b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3795ebf2a81e444eb73637647767d786_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtNy0xLTEtMA_ee97d477-2117-4f4a-97d4-a11ad1015a29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91f439ccd2a45f5a6efaa8d896c7909_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtOS0xLTEtMA_d33440c4-5766-4d10-8d4b-e47544fc6980">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c33022caf44489f9f113ac89dbf91b8_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtMTEtMS0xLTA_d564b001-8612-42b1-93c1-24c9efab6bb6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86dd42a80b9c41f69b404d2b1eba64a1_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtNS0xLTEtMA_ee916dcb-4b86-4dae-9a37-cbebcd4e7bc0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfb4666ee19476e8443974cdf719623_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtNy0xLTEtMA_d35db20b-e76e-4d68-8dda-2e37b6804559">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef0e5a952734b418963b327a95bcc4f_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtOS0xLTEtMA_e71c0938-cd77-4b07-871b-6e1038993d3b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e24c8554ebe46388a798da32706e97a_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtMTEtMS0xLTA_4a18cc4d-79cf-40de-a8a5-351fa2475c72">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItNS0xLTEtMA_97f05b7d-ddfd-48ad-85f9-04a4b9517883">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItNy0xLTEtMA_395c0ea9-3d16-4adc-b75b-2c3dacbf0a64">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItOS0xLTEtMA_d624c50c-f50e-43eb-ae7c-ed5fd47358fe">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItMTEtMS0xLTA_975e989e-68e2-4642-b8e7-516947d5dfcc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:24.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.942%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.506%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda03dcb1c30410ea2b0bbca9847e228_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy01LTEtMS0w_8df4b60d-7db2-48e2-8311-8dfabc3b1810">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d4ed82486f441a84472bb6b87db08f_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy03LTEtMS0w_4e074e26-3e21-462c-8ab1-b260f4c7d0bc">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7add7ef54944efa99bed6cbd73f7f56_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy05LTEtMS0w_a43dda27-68c4-461b-bff0-8b79a12664e7">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbce1f0e07b471880107186a9d2dbf0_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy0xMS0xLTEtMA_d536263a-479d-475c-aee6-a572f9d382b1">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c5e68eec1f4975a44f0ee291e1b433_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC01LTEtMS0w_346b568d-579a-4196-9d32-096863d17e36">146</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fec6298f6c24ef6ac7e3ee30b63cd54_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC03LTEtMS0w_41aa5219-7fc0-4b83-aca5-ebead31fa752">146</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dc6b5c81694d3a8ce02fb89916e04e_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC05LTEtMS0w_7108b153-9d10-4a7b-af3c-ec0925086802">165</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fdc3ee65556409abf6845da148f19ba_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC0xMS0xLTEtMA_e6519861-4b4c-45be-a7bc-17dda6279568">165</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8032a0d84e405fa3da93df1c46964d_I20210331" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy01LTEtMS0w_7f54bc8d-3575-4f14-8fe6-a9d5766933be">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4dbc98d539d45729f9fac03fccb02f8_I20210331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy03LTEtMS0w_35c7eb58-a60c-46e4-aa95-e0967267221e">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd770eb1c3840cda9e1bfb6823cff18_I20200630" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy05LTEtMS0w_30f57505-f7cb-4cbd-8b78-b67bc0b7a2da">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c2212de48a40c08c45b2267d5c2553_I20200630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy0xMS0xLTEtMA_8f07afad-7861-422b-ab1d-43d871ef6f28">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC01LTEtMS0w_73e84238-04ac-4caf-83b2-6d6cd0f016e4">490</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC03LTEtMS0w_f82eecbb-16cd-4c72-a56f-c2488271c224">490</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC05LTEtMS0w_df9d454f-1f97-4d2f-afe2-7c8c000b428b">849</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC0xMS0xLTEtMA_a610e5cb-b262-464c-957a-b018e763d230">849</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa872fb1c8a741e08e01d0b0035e14a9_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItNS0xLTEtMA_bee49b2a-f19d-4254-aad4-2b9c32b3b87c">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4814dfcd3ba499aa945030b7001616e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItNy0xLTEtMA_d3cf2a57-a5c3-4a26-8f66-eacdc9ff2ab0">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00ae1de87094cf89d76a74b042495cf_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItOS0xLTEtMA_63223381-6c39-487d-b970-8ebb1b2a20e2">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3093b0d16ed04d6f8781b4a8dc97c5f4_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItMTEtMS0xLTA_8cb45941-81ef-4095-aa8f-b879fc72222b">3,051</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtNS0xLTEtMA_5c638256-617b-4d5b-9c98-d9d178da7124">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtNy0xLTEtMA_3bec2603-fab3-4230-9e16-9589e7e5d086">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtOS0xLTEtMA_c7e3965f-0e92-4d9b-aec2-3396a3f48e39">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtMTEtMS0xLTA_bc4e7025-8610-49ef-b92d-c6f2eb21b96e">3,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODQ5OQ_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac">329</ix:nonFraction> were recorded during the third quarter of fiscal 2021, of which $<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODUwNw_78153768-4e50-4f02-a287-a600be40b36d">228</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODUwMw_6aa9511f-e782-4a41-aa88-788cbca6f704">86</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i13a2cf9cee0f45fcb02a4c337563805e_D20210101-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDkwMTA2Mw_09d1f8d3-9f41-42e8-a4dd-e5b6e01d8e65">15</ix:nonFraction> related to the goodwill of the VMS reporting unit, certain indefinite-lived trademarks and other assets, respectively. These adjustments were included as non-cash charges in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#8217;s best estimates and assumptions. For additional information, refer to Note 4 of the Notes to Condensed Consolidated Financial Statements</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfMTAwNA_3e21380a-b2bb-4fca-b059-766ae28df352" continuedAt="iaff0dcee274849ddab0b8bfd9888d570" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iaff0dcee274849ddab0b8bfd9888d570">In determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings (losses) was (<ix:nonFraction unitRef="number" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAyMw_274cb35c-efcb-4d17-87aa-8f9b0e0d8478">1.4</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAzMQ_8498e5b6-c71a-4438-92b0-691849d9f8e4">22.5</ix:nonFraction>% for the current three and nine months ended March 31, 2021, respectively, and <ix:nonFraction unitRef="number" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAzOQ_782a9bce-479c-4968-9f33-6c7b17b10b73">18.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODA0Nw_eade6177-0ee9-4cdd-ac37-0896fda49d2e">20.4</ix:nonFraction>% for the prior three and nine months ended March 31, 2020, respectively. The substantially lower tax rate on loss before income taxes in the current three month period and higher tax rate on earnings before income taxes in the current nine month period were driven by the partial non-deductibility of impaired VMS goodwill.</ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_34"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RleHRyZWdpb246ZDkxOGZhZTdkYmIzNDQ5ZWFjNDQwOTlkZjhkMzJmNWFfMzUy_2975c0b1-81b5-47b9-bdf6-247b1dd21fb7" continuedAt="ib0925484377b4958bbf133b3ffd6352e" escape="true">NET EARNINGS (LOSSES) PER SHARE (EPS)</ix:nonNumeric></span></div><ix:continuation id="ib0925484377b4958bbf133b3ffd6352e"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RleHRyZWdpb246ZDkxOGZhZTdkYmIzNDQ5ZWFjNDQwOTlkZjhkMzJmNWFfMzQ1_5791e3ee-651f-4738-8701-f9787073c317" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi0xLTEtMS0w_f9e739c9-0d0e-47d6-a803-dcffb4725093">125,610</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi0zLTEtMS0w_2b084d85-9c1a-41c4-b9a9-c28681e8dff3">125,661</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi01LTEtMS0w_bfde0da0-50e0-4cb5-b51a-bfe26e5aef6e">126,057</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi03LTEtMS0w_cf4a2777-343e-4813-b195-f74c499ecac7">125,641</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy0xLTEtMS0w_effd1a71-35b7-481d-9158-65f5a3209c65">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy0zLTEtMS0w_6cd778b9-367f-46c1-8a29-5480d2689964">1,667</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy01LTEtMS0w_cdb3b25d-2e23-46ff-897d-7fa40654e573">1,973</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy03LTEtMS0w_a141d8b1-3030-49f8-9e1e-c3a6fbbf2921">1,595</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC0xLTEtMS0w_a2506865-1794-4f50-ab78-75a9b249b8e5">125,610</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC0zLTEtMS0w_74e6da35-d2e6-4d78-b510-9b236adf6c71">127,328</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC01LTEtMS0w_ecf9db0b-0513-4674-8e3a-7f7e219f1a80">128,030</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC03LTEtMS0w_60d05a6a-c23d-44c5-ab96-7a643d273ae7">127,236</ix:nonFraction></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi0xLTEtMS0w_6bcbbae1-6ed5-4a55-8c4c-38999d93a367">4,826</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi0zLTEtMS0w_ce78f789-bafb-499a-9c1c-c9df7ea054e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi01LTEtMS0w_b0fa9729-8fea-44e9-add0-c0e726131aff">428</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi03LTEtMS0w_2c4a77a5-6ff1-4b80-abce-445abe169810">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since the Company generated net losses attributable to Clorox for the three months ended March 31, 2021, there was no dilutive effect of stock options and other instruments because their impact would be antidilutive.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RleHRyZWdpb246NWVmMWYzNDczZGM0NGJkM2JjZGI1YWViYWVjMDhhZDlfMTI3_cd0e0dc6-a4f6-419b-90d5-c22581a2b8e1" continuedAt="iad77e0034e9041e1ad3c9f5335a7aa7f" escape="true">COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="iad77e0034e9041e1ad3c9f5335a7aa7f"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RleHRyZWdpb246NWVmMWYzNDczZGM0NGJkM2JjZGI1YWViYWVjMDhhZDlfMTMy_6db32f4a-6934-403a-af95-eec29571e54f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi0xLTEtMS0w_c4cf85b9-1874-4f70-bba8-af814efcdb41">59</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi0zLTEtMS0w_1bb42b5f-8392-46ee-9e0d-f5f35dd4755f">241</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi01LTEtMS0w_916fb825-1444-48f4-8c68-443a934e7dd9">619</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi03LTEtMS0w_5a220418-30cd-43b0-b960-c415732431bc">629</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC0xLTEtMS0w_8fdb9fcb-5e1c-4e24-958a-54cc507590f5">7</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC0zLTEtMS0w_d3bf7c3c-9fc6-48a7-ae90-2903a28243e9">51</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC01LTEtMS0w_ae7d63bd-3586-4749-ab8f-c9758af2124f">40</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC03LTEtMS0w_c33c5b13-66b7-4f52-aa5c-bb1805f9a8a5">58</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS0xLTEtMS0w_d0392315-6d37-47bf-8942-baffb490692a">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS0zLTEtMS0w_420aa332-eece-4408-8e56-f1a5b3869762">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS01LTEtMS0w_75297282-7799-466d-acd0-5f8fffab92d1">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS03LTEtMS0w_03c2cd54-4c9b-436e-8874-09235460306d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi0xLTEtMS0w_d058a772-bf47-4cd0-8846-3869fb315f34">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi0zLTEtMS0w_bd741138-ff92-44fe-8384-37be8dddccae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi01LTEtMS0w_d6b4e5b8-b97a-4122-ae62-98bfef4b7e2f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi03LTEtMS0w_e5b6a2c1-30e0-402d-b003-375031bd95f2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy0xLTEtMS0w_aa6cb751-6034-4863-bb27-e4e8ec8dee89">22</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy0zLTEtMS0w_b628ac8d-fac3-41bf-8b88-1333d4c996f0">55</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy01LTEtMS0w_03ec8227-256b-4874-9b1b-a051cb3a8b20">87</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy03LTEtMS0w_7e67237c-0de1-442a-9102-8cc6fe959b02">54</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC0xLTEtMS0w_4c2223dc-f98f-40c9-94ca-62590f397ee9">37</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC0zLTEtMS0w_d590620d-0a65-4d19-bf53-ffead8464e7d">186</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC01LTEtMS0w_031ca64d-51e9-477a-bd5d-8c23f0549c28">706</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC03LTEtMS0w_b440fa90-7c88-470b-a7fb-fef1254a904e">575</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS0xLTEtMS0w_a97b5d37-7bf3-420b-971d-bcd143cc89db">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS0zLTEtMS0w_af36c94c-8c71-40e4-93ab-1bb2e1e587f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS01LTEtMS0w_6cd0e0f3-c1b0-4dc6-8867-8485b71bd838">6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS03LTEtMS0w_2849f728-ac23-4404-b6ff-ff660bb6d6f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtMS0xLTEtMA_991311b6-9ddf-44b6-999b-e807313affc3">39</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtMy0xLTEtMA_68e7568b-5e51-4407-8189-23c35df19328">186</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtNS0xLTEtMA_09c66261-533b-4a2b-a943-faec96db1830">700</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtNy0xLTEtMA_ed37ff79-1ae6-4bbb-ae12-1fdc75dd4a18">575</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyNw_6122e7b7-ad31-4060-9091-bdf23183713b" continuedAt="iac6dd3cce13b4d1fa8c9e19a8a583a75" escape="true">STOCKHOLDERS</ix:nonNumeric></span><ix:continuation id="iac6dd3cce13b4d1fa8c9e19a8a583a75" continuedAt="ib2ac37285fa746f1ae655dca2ee1a873"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY</span></ix:continuation></div><div><span><br/></span></div><ix:continuation id="ib2ac37285fa746f1ae655dca2ee1a873" continuedAt="i7d4e47ff7853459eb87af656d5a15f2d"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyOA_c173fa55-d398-458e-af23-47edad9454aa" continuedAt="i8ce21b29447b4622a244e749c8fb8e9c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac87255172412484f55ebbbbeea3f1_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xLTEtMS0w_0a51f156-3b58-4957-94e0-cadec70b0720">159</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac87255172412484f55ebbbbeea3f1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0zLTEtMS0w_f9d10f79-d7fe-4c58-96b3-67c1f3ad05a3">158,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621c78ef217946caa48daba642080fc7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy01LTEtMS0w_a4dd5a39-f8a3-4041-8384-d95803fe5b1a">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47dfa7d737eb4754a2c5b8e3a44f18a3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy03LTEtMS0w_40dc3e41-cd4c-457d-9cb3-b2d038a7e124">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3432462f36cc45c7bd8205bca273122e_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy05LTEtMS0w_13f8210d-1318-4c01-a677-fd0488d52cc4">3,357</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3432462f36cc45c7bd8205bca273122e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xMS0xLTEtMA_132ba3eb-cf12-4490-8097-8b117d607bc9">33,717</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77b79f9121d141459b8db7faff712c18_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xMy0xLTEtMA_82cd7e32-57e2-45b8-b493-7d04187d21d8">601</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108954c232d04d49920930c949d00216_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xNS0xLTEtMA_85221c9d-0eb1-478b-825b-097d7de63835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie032edb36eed4e7fbd867455fbb3151c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xNy0xLTEtMA_b970df38-76c8-4ecf-a1e2-1abe2302a528">555</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNC03LTEtMS0w_ac3c46b1-7d6f-4854-be18-e4697633e8fa">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNC0xNy0xLTEtMA_22aa1b45-6089-4f16-a887-91853032ed0d">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95af929fa2ea40cfbc21af9dc7f5c5b9_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNS0xMy0xLTEtMA_11883090-b7c2-4abb-8dd0-379e149e40fe">55</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNS0xNy0xLTEtMA_8b9fe3c1-d4bf-4cef-969e-68f3523181f2">55</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($<ix:nonFraction unitRef="usdPerShare" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi0wLTEtMS0wL3RleHRyZWdpb246OTc5MmU0MDY2ZTE1NDdkMWFlYjMxYzVlY2M0MTgxYjNfMzk_e0e5f9c6-3409-46df-803b-bc20a0c77c3d">1.06</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi03LTEtMS0w_934ca908-f192-4e3d-93db-2c0c2d02ace7">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi0xNy0xLTEtMA_69afc6b7-384e-4a95-aca6-23f59e940d3e">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNy01LTEtMS0w_7078bfbc-7205-4ff3-8f11-28145637b693">18</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNy0xNy0xLTEtMA_00b75b2e-9e25-422c-816f-37e3f864cb28">18</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC01LTEtMS0w_df543f8a-0acb-49b1-b820-b1d9fe582af7">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC03LTEtMS0w_12981097-7879-4d52-aaa5-4a2c35ddd317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC05LTEtMS0w_0eb3d079-8ddc-4ecd-911e-78020cf22ea1">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC0xMS0xLTEtMA_53ffe7d6-5df6-46f4-9c75-e386059689a2">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC0xNy0xLTEtMA_31e8b295-dbc6-4340-ace8-86e4b52932d6">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS05LTEtMS0w_b099101d-9e66-44d4-8bd6-1de0319f60ff">30</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS0xMS0xLTEtMA_e9b6c50b-f583-4c37-9969-88c18eeec7cd">184</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS0xNy0xLTEtMA_6c79a9a2-68ef-4cc0-9a62-c1446591ca28">30</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMS0xLTEtMA_cc7514c6-301e-414f-b10f-7ce53ada3872">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMy0xLTEtMA_2d164b23-ffc6-4a66-ac74-612a30ad63bf">158,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtNS0xLTEtMA_9d0d5fe7-9337-4eb2-a5d3-68873678c8cc">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied37b00018c54177824f2ad238767344_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtNy0xLTEtMA_e8bc7eec-8f45-4acd-bb26-8be0ac438bf6">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtOS0xLTEtMA_01903937-3181-4d3e-8dc7-8c601c2d8898">3,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTEtMS0xLTA_be209b31-020e-40f4-9a7a-6afc57446db2">32,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTMtMS0xLTA_378c514f-5f3f-41a9-a744-fb02a2c7c740">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTUtMS0xLTA_ea949777-38f4-49c8-a2d5-7de810d7ebf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTctMS0xLTA_4dd4af93-3158-46c2-a37e-04bf67d623ce">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i603fda767f6844baadd48df615fb009e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMS0xLTEtMA_ea6f9984-e931-40a5-8ba8-d9af6395781c">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i603fda767f6844baadd48df615fb009e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMy0xLTEtMA_6feb9e8d-4635-4e5b-8f2e-5a10ac351c4f">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec9af00fbc343c7a22d3f94f5287cdf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItNS0xLTEtMA_5f2b02b6-fc46-4f02-88b2-90b51c6aa242">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e24c9e768043d999c666a316d95f12_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItNy0xLTEtMA_080b1268-6dee-4767-b512-375444f1348f">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItOS0xLTEtMA_d75ca6d8-93d0-4c54-9e22-69536e48cbde">850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTEtMS0xLTA_b4095c76-8691-41ee-b27f-5157ccf7d6c7">5,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6930765739894f11878ad45a82a55846_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTMtMS0xLTA_8933defb-b065-47ca-90f0-d499332f070a">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf821b273c5e405fb6940c37f931f302_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTUtMS0xLTA_a8090940-d1bb-4af1-9c94-d1379e698845">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a82930ba8c46a8842474109384e6c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTctMS0xLTA_63f023c3-77e3-4edc-bdfc-6a9dcf2761ee">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtNy0xLTEtMA_1f1f08a5-4685-41cd-9255-66683e2b04dc">61</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtMTUtMS0xLTA_0f42f2af-1be4-4614-99b5-e65f51bdce8d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtMTctMS0xLTA_a83cfcaf-7119-4ff8-9d51-364c06e0731f">59</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dff6b4bc5ac419481696f8476fdaa42_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTQtMTMtMS0xLTA_fc897a62-b693-471e-b2c0-f9dad65806af">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTQtMTctMS0xLTA_dd64fb42-258d-4c0c-8cfe-a49995686b21">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($<ix:nonFraction unitRef="usdPerShare" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjlhMTRkMTUyMjZmZTQ2YjdhY2Y5YzE4MmI0YWE0YTJiXzM5_b294ea3d-dd6f-4fe3-a3ff-40d20cfc513a">1.11</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtNy0xLTEtMA_2fda268f-092c-4105-8d4b-d0f2aa3a1c23">139</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtMTctMS0xLTA_062d0169-6bdc-4cc2-ac59-4f88b3d71d06">139</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTYtMTUtMS0xLTA_db800de8-59c7-4d10-ba48-6c79f9fa5a4f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTYtMTctMS0xLTA_430d1a79-077a-440e-ae17-b318193a2aa3">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTctNS0xLTEtMA_1f1bc0d1-47da-48af-b6e7-b4a334914be8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTctMTctMS0xLTA_efc8a987-3d1a-4bce-b84d-75a9440b2cdd">17</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtNS0xLTEtMA_47ab19fb-8ab9-4756-87bf-061fa423af71">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtNy0xLTEtMA_737d0d64-2846-4375-857d-9bfc7eb99997">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtOS0xLTEtMA_dbbfeda1-1f27-40a0-a2ed-4f930f9b4e72">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtMTEtMS0xLTA_25e7c1b2-28d3-4526-ad77-854cae3c60a0">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtMTctMS0xLTA_338a50e4-53f6-4e92-84c3-5370e97383d2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktOS0xLTEtMA_93539a08-7611-46ff-8ba5-83847e0e2d8f">305</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTEtMS0xLTA_263554d5-4179-4b30-957d-4defa67f424e">1,648</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTUtMS0xLTMyNDI_2977cd1a-a50c-47b2-a7e7-f8ef7c249b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTctMS0xLTA_20ef848f-fda6-45ac-9870-df552d96136b">305</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMS0xLTEtMA_6ec88015-f97c-4cd0-9f32-0ba89df6e6cb">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMy0xLTEtMA_1c50bd9e-6d04-4966-8f40-6ec08e0ad135">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782a0b76608c42b8a82e90d7a7ea4654_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtNS0xLTEtMA_0b4a0684-ad67-4ba9-96d0-a04bdadc2acf">1,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e407cf409ae4bdb83e47faa0f5730af_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtNy0xLTEtMA_a3fa8a12-aadd-44d4-a0e4-2ec3297394f1">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtOS0xLTEtMA_26871dd1-55e7-47da-b8af-aa10abd79431">1,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTEtMS0xLTA_ce2fe253-16af-4213-bc60-6ea23382e05d">6,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTMtMS0xLTA_81bdb408-f36b-4a1c-a95e-f083ed3d36e0">553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e638f74ad54f28b43e008437b87090_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTUtMS0xLTA_05077fab-72ec-44a9-b359-784d5b08c24a">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTctMS0xLTA_226e32b8-65b4-4847-880b-6884f303968b">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. STOCKHOLDERS&#8217; EQUITY (Continued)</span></div></div><ix:continuation id="i7d4e47ff7853459eb87af656d5a15f2d" continuedAt="if7415a4bbda144f5a4e285ed62b1be49"><div style="margin-top:6pt"><ix:continuation id="i8ce21b29447b4622a244e749c8fb8e9c" continuedAt="ia3a0a3011a0a45dd9676648508d8770b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id820cc1b67e64799bfc374a16f6c1038_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMS0xLTEtMA_4b1f6c95-a1be-4d27-891d-d929af42c4fb">159</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id820cc1b67e64799bfc374a16f6c1038_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMy0xLTEtMA_8c276944-b5a9-423a-8523-31bb6c239298">158,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e062e41cfc74e44acb07fd26a397d64_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtNS0xLTEtMA_e657b363-2b28-4cec-94b2-e58e231e216a">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i637250d82b784de7b529ed70ed515d07_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtNy0xLTEtMA_cb8076d5-588c-4f6a-abba-a1b4a260f3bb">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtOS0xLTEtMA_159658aa-e31d-487d-b9d5-bf519c48e080">3,194</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTEtMS0xLTA_cd74a9a7-7a9b-4a83-b73c-91cdfd63d872">33,055</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTMtMS0xLTA_580c554e-ba0f-4e0f-8cfa-1b297866cedd">602</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba474f7dc35d462dbbf5c28ece8066da_I20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTUtMS0xLTA_8a556c12-d3ab-4e31-9b1a-48d0cdc44eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e8d63f491f423baa88abae57588736_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTctMS0xLTA_1ecdf46b-1b1c-44b9-8496-cd8766bfd49d">559</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of accounting changes, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1ef0e38ead43729ec512b3ee29802f_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjctNy0xLTEtMA_2503f2a7-3a70-43d1-89d2-a263b46ce00c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8d54a976ed4611b6e63671c8bd89e7_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjctMTctMS0xLTA_1930128a-a2de-41e4-9970-725bc3f838eb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjgtNy0xLTEtMA_9962877c-5259-4d8f-8394-0cd04ca01093">629</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjgtMTctMS0xLTA_355002be-c71b-4a64-b8cd-54b13f2d8b86">629</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id11b8ffb8d49487096c194160392c5dd_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjktMTMtMS0xLTA_08a54651-4c9e-4195-824b-3fa15882a297">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjktMTctMS0xLTA_1e50c249-d1e9-46f4-b710-11cb3e4048f3">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjAwZGUzYmZiNmQ4MjQzYmVhMDcwOTBjNDAzZDA3MzdkXzM4_2e42a0d8-ddc5-45ee-aa23-601601c62487">3.18</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtNy0xLTEtMA_59ec0a34-6b7d-4d6f-b0c0-971d5ec3c4d0">402</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtMTctMS0xLTA_f1fdedaf-79b9-4357-9fd6-014aff96cdd3">402</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzEtNS0xLTEtMA_5314c9e6-5636-4661-8a7e-f785e370d2d8">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzEtMTctMS0xLTA_685059aa-944c-4802-a277-bb29dcf40444">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItNS0xLTEtMA_61ab58ff-8b8d-4f67-969d-28406ae753c5">28</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItNy0xLTEtMA_7ef37db4-8813-4879-a53d-4867343c8dbe">1</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItOS0xLTEtMA_d038ea9e-1070-47f5-bae5-33a053355fcd">96</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItMTEtMS0xLTA_9f32dfa7-306d-4e2f-839f-5c8690e217bd">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItMTctMS0xLTA_b75e8db2-ca6c-47f8-b094-1d5fc64ec109">123</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtOS0xLTEtMA_7638ce5d-ec56-4a9f-b2cc-1f47f5f09120">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtMTEtMS0xLTA_857691ee-da24-43b6-b73b-51918f1f7b9a">1,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtMTctMS0xLTA_40edda66-1de5-4733-bf05-2d88b64e1d79">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMS0xLTEtMA_edc2b753-b49f-4878-af1b-755ce6ed338c">159</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMy0xLTEtMA_3f0f5de4-4c61-4caa-8806-89ee10bc93cb">158,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtNS0xLTEtMA_b28e46b9-eb12-4b53-be20-d56e2b5378fb">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied37b00018c54177824f2ad238767344_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtNy0xLTEtMA_3e96abc3-944d-401e-8da2-89e6caee0f5c">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtOS0xLTEtMA_50197e84-819a-4b75-bc9f-12d3a919a161">3,317</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTEtMS0xLTA_ef94abba-0934-47f5-95cc-2e12027adf51">32,818</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTMtMS0xLTA_a8b9e819-9b91-461f-b52a-bbf6ee4d8e40">656</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTUtMS0xLTA_f56a2c7f-46f3-4f94-a7b3-c0cd16dbdb95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTctMS0xLTA_aa3088b3-c745-42dc-ba58-9cf9a7ebe98b">695</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida18a217ec684932b3629eb9e338973a_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMS0xLTEtMA_701493ff-6f73-487a-991d-032a6b9cd1fc">159</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida18a217ec684932b3629eb9e338973a_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMy0xLTEtMA_65ce20f0-522b-4843-bf16-8321c333cd8f">158,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4c6fa0129c464ab8995dcf39d5f97f_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtNS0xLTEtMA_08ccfd53-18e7-41e4-909c-01287ac0b22c">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1ba4ba9cb441a0b2d31c4fd01bcf43_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtNy0xLTEtMA_7d85e01b-0643-495b-a0eb-b7027aee270f">3,567</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95eac61641474597a335d7aa40b97c09_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtOS0xLTEtMA_45d5f441-7135-448a-a551-162430110a91">3,315</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i95eac61641474597a335d7aa40b97c09_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTEtMS0xLTA_5780962d-59b8-4bdb-8555-9d9383a4d4ef">32,543</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTMtMS0xLTA_a2f3dc46-e1a4-4deb-a3e5-91598fed3e63">640</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d44bf18a1a4061ac3a7e5409698cba_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTUtMS0xLTA_55cfe1fc-149c-458c-9055-57d83c5b792d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTctMS0xLTA_68dfd76c-9c11-4ccb-ba56-0915f051803b">908</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctNy0xLTEtMA_cb4e5cc9-e1f1-439a-8511-07072ab312f6">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctMTUtMS0xLTA_e5ef80a2-5f74-4351-a9bc-6078b679cecb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctMTctMS0xLTA_a39de25b-a392-42bc-9b54-52592a02a84c">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5b41725ce84b268abfb90cdf704e87_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzgtMTMtMS0xLTA_c6051ac1-80c2-401f-ace3-f7cbd29053b9">87</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzgtMTctMS0xLTA_eaa76140-0b2d-4ccc-a25d-9adfdf03015f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmNjZjQwZTRjODU2MTQwZWVhMjE1NTE2MmJlNzNjMGI3XzM4_4cdddeba-5f14-4a3a-94cb-330ed79298a9">3.33</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktNy0xLTEtMA_f4aaeeb5-580e-4a6c-9850-fdee34085a47">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktMTctMS0xLTA_eb4aee6e-05d2-411b-a681-73f7968fad36">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDAtMTUtMS0xLTA_68228826-8dff-415d-b0cd-3f7c3550a6d2">9</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDAtMTctMS0xLTA_f94e7105-c4c7-4b31-8139-6d26926c9adb">9</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business combinations including purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDEtMTUtMS0xLTA_586ae770-dd43-4e0f-a71f-c0be1ad11971">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDEtMTctMS0xLTA_a97f183a-0b96-4a6a-94ff-570e21347626">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDItNS0xLTEtMA_516783b6-345c-4bec-9f18-a98c3c8ef025">52</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDItMTctMS0xLTA_593f0a64-b051-4cc0-8c3b-8d051af04ee3">52</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtNS0xLTEtMA_588c240d-e90f-4210-a6b0-1b574b418509">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtNy0xLTEtMA_a5fe7836-d170-48ea-8dcd-b0aea779b766">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtOS0xLTEtMA_34ebb220-2c76-4949-9f2a-075da7d0054b">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtMTEtMS0xLTA_45535a1a-248e-44f5-92df-f4e2ce483915">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtMTctMS0xLTA_edf7c32f-d564-49f6-84ae-4e0ee381943f">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtOS0xLTEtMA_dcde1170-dbe9-476d-ab19-544a3d6c0b8b">605</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtMTEtMS0xLTA_a4042dfb-b117-416d-b9a9-c577614daceb">3,072</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtMTctMS0xLTA_04af46c7-f944-4515-a1a0-d46b130dac52">605</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock retirement </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMS0xLTEtMA_896a1eec-51e3-4855-8bf0-40dea00253ae">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMy0xLTEtMA_2c58452e-bafe-4e11-9b9d-148ac9297de9">28,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtNy0xLTEtMA_4d9c6283-3a65-4893-a053-13168d677b00">2,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtOS0xLTEtMA_d3e299e0-7230-47c9-8650-be81982f3229">2,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTEtMS0xLTA_0712540e-a825-4936-89bf-ae59ef0ea89e">28,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTUtMS0xLTA_2977cd1a-a50c-47b2-a7e7-f8ef7c249b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTctMS0xLTA_2de967f4-57f7-4bb2-a15b-b61093f2e9e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMS0xLTEtMA_3a6ad14f-825d-40e1-98bd-636efaff938e">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMy0xLTEtMA_5a49b7fd-a981-4328-9308-025c424ef5d5">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782a0b76608c42b8a82e90d7a7ea4654_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtNS0xLTEtMA_3e8bea64-73b6-41d1-8070-5a62ee9f9de2">1,190</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e407cf409ae4bdb83e47faa0f5730af_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtNy0xLTEtMA_bef66f8f-4202-4a40-84e9-df85aa62e790">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtOS0xLTEtMA_a7ff27a3-2eb2-4678-b6b8-9d6a0c9f4539">1,111</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTEtMS0xLTA_fe9ac126-2edc-4158-8dc6-5efc2b483964">6,382</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTMtMS0xLTA_e2511d80-694f-47b2-9090-398c31ccdbba">553</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e638f74ad54f28b43e008437b87090_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTUtMS0xLTA_47b40160-3085-4260-9469-beea631da6f7">195</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTctMS0xLTA_8dbc1af2-fbbe-49b2-81b4-73c9b160e435">938</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia3a0a3011a0a45dd9676648508d8770b">(1) As a result of adopting ASU No. 2016-02, &#8220;Leases (Topic 842),&#8221; on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.</ix:continuation> </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2020 the Company retired <ix:nonFraction unitRef="shares" contextRef="ieb1218945cd84b80a0826a8dedfda008_D20201118-20201118" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNDE2_fa0aea55-790f-4db1-b62c-45e284e19fa6">28</ix:nonFraction>&#160;million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company&#8217;s overall equity position as a result of the retirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="repurchaseprogram" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="clx:NumberOfRepurchasePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNjA0_36f19861-d0ec-49d1-b57f-a2239ac9925a"><ix:nonFraction unitRef="repurchaseprogram" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="clx:NumberOfRepurchasePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNjA0_8fef8200-ac57-45f2-8ac7-5449b502925d">two</ix:nonFraction></ix:nonFraction> stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $<ix:nonFraction unitRef="usd" contextRef="i018e05de2fce4bcaae18e50cf9517af9_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNzIw_ad0c87af-1bf6-40f5-880f-f161f36312f8">2,000</ix:nonFraction>, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has <ix:nonFraction unitRef="usd" contextRef="i01b3d2ba010b48fbb9e64b975eb1f926_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="clx:StockRepurchaseProgramAuthorizationLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfODc4_9d759736-8afe-4a99-96c3-a887a1136cd3">no</ix:nonFraction> authorization limit on the dollar amount and no expiration date.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyMw_017580d4-adc7-493b-87b6-20678a29e7ba" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases under the <ix:nonFraction unitRef="repurchaseprogram" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="clx:NumberOfRepurchasePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfOTc1_36f19861-d0ec-49d1-b57f-a2239ac9925a"><ix:nonFraction unitRef="repurchaseprogram" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="clx:NumberOfRepurchasePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfOTc1_8fef8200-ac57-45f2-8ac7-5449b502925d">two</ix:nonFraction></ix:nonFraction> stock repurchase programs were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-market purchase program</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75957ffb916249c88259d57dddd74735_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xLTEtMS0w_5f15729c-5816-47af-afc5-c95f22443fd3">200</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75957ffb916249c88259d57dddd74735_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0zLTEtMS0w_9ff2f889-849c-4d6e-825c-236e851cb57d">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy01LTEtMS0w_f3cb2318-6ddd-4290-95b4-8f6426fb329a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy03LTEtMS0w_d2ec81d8-4346-4209-9376-950ddf9aa576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy05LTEtMS0w_80e424cc-0a0d-4e9a-9eef-b65d02e6aa3c">200</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xMS0xLTEtMA_eb4bb576-a04a-491a-af87-03c2b4be0f9c">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27d27b067a347619468898121fdfd72_D20190701-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xMy0xLTEtMA_0231f6ff-de23-4dd7-9a19-feb3dea59bec">85</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if27d27b067a347619468898121fdfd72_D20190701-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xNS0xLTEtMA_51348617-dd86-418b-9509-684e3007148b">577</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evergreen Program</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xLTEtMS0w_5514d7c1-112c-4135-b49d-86cba69fc557">105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0zLTEtMS0w_b68c8bdf-a632-491b-a2a1-f0b07d38249b">560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC01LTEtMS0w_0bab3d5c-4691-4531-9a49-839afeecdda0">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC03LTEtMS0w_a02acb5d-9435-45d5-a4ac-3bd61af0abcd">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC05LTEtMS0w_c34670e4-5e1a-493f-aa0f-3c4eb51a390f">405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xMS0xLTEtMA_230a991b-4467-4364-a705-4d7093df41ee">1,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xMy0xLTEtMA_6b10df87-1690-4bae-90ed-2d1872937123">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xNS0xLTEtMA_c2d9db7d-4a37-4183-a1fb-df1eb68f11bf">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock repurchases</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xLTEtMS0w_dc3ab64f-3830-4a10-ace6-0420d68b7529">305</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0zLTEtMS0w_78728366-cdf5-45ff-ad0e-389e0e3157b3">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS01LTEtMS0w_d57df376-3bca-4250-a585-92b3901b2662">30</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS03LTEtMS0w_477a6720-5356-430d-85af-295121b8a471">184</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS05LTEtMS0w_8c229f0d-4087-478f-98ca-a053cb09bf75">605</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xMS0xLTEtMA_51bfe511-e437-4b11-a070-fabf334edc9d">3,072</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xMy0xLTEtMA_e0d2e7d4-c3ca-4a1a-997c-b7a067d47b31">219</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xNS0xLTEtMA_b0c320f0-b49f-4883-a4f1-15ebbb702084">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:14pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. STOCKHOLDERS&#8217; EQUITY (Continued)</span></div></div><ix:continuation id="if7415a4bbda144f5a4e285ed62b1be49"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyNA_dbe33a33-a60b-47f5-9eb0-6fc7f3554dea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7cc8b46a7c6407daee478103960b9cf_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi0xLTEtMS0w_55598a2a-2e1c-4290-be34-dcd14b83778b">421</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4a6b8cee95f47f38c868dc0f83738cb_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi0zLTEtMS0w_c172d7e7-bd3a-4efd-aa43-fd327c787609">17</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f82341c90d8488392c430a697f9ad8d_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi01LTEtMS0w_490ef8e1-b506-4dc7-945e-32af1974d558">163</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77b79f9121d141459b8db7faff712c18_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi03LTEtMS0w_470eeb69-ee1e-4cf5-b547-6575a131efd7">601</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy0xLTEtMS0w_90cfe264-19ac-407e-9c84-aa7d2ce9789a">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy0zLTEtMS0w_04841bcc-4db5-47bd-8e71-0e179bba7329">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy01LTEtMS0w_c73f7541-5750-4394-a076-09685e7d4d32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy03LTEtMS0w_207fb0e5-7c6a-4c45-ae71-4acfedd66abd">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC0xLTEtMS0w_dbf3f3b9-c534-4093-9dbe-56a2defec0f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC0zLTEtMS0w_ffff7830-1971-4fc8-b0a9-fedb6d6597a5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC01LTEtMS0w_ac3e3b7f-44dc-4538-96be-b05ac2adef7d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC03LTEtMS0w_99f25fae-9409-4fd9-9acd-44d6cfd85358">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS0xLTEtMS0w_acb0c0e8-2fda-4603-a5d2-7f6b8cad6155">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS0zLTEtMS0w_28b267d0-b347-4e7b-ab47-17fd286d278f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS01LTEtMS0w_fea1644d-559f-46a4-ae4f-15397789a66e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS03LTEtMS0w_a3da0755-18b4-4620-8cd0-fa5d5a7822e2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi0xLTEtMS0w_87a8aadc-b015-4a1b-8d88-844aeb0f081d">51</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi0zLTEtMS0w_c506cf7d-9d3f-4245-a84e-69d3343afdbb">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi01LTEtMS0w_97df0ad8-d73b-46f0-816b-f7e18d5f6ae5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi03LTEtMS0w_a60662e6-cff8-415d-af8a-461e233e23d4">55</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3a85957e12343c3b6d10c076ee4eb33_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy0xLTEtMS0w_645b1670-f379-483f-ab34-6ab2afe10be0">472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic31a8c3f66c64539b477a0e822466880_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy0zLTEtMS0w_8b74e949-b440-46fb-935c-a27ac95e3b18">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419066cdc87943e4af8d2639f21bf325_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy01LTEtMS0w_e41ef6bc-c14b-4cde-a726-aec7f6f5db90">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy03LTEtMS0w_901c241d-8800-43e8-9369-13d3404f8ea4">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e20738f6dc4450bbd4b15b69a7e6581_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS0xLTEtMS0w_bf2c1cd8-82b0-4399-8f89-b3dde102f420">403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8d3d6307a914434b95e460604d9d99f_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS0zLTEtMS0w_7727079d-e9a7-476e-acb8-46fa38542187">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8ec840bf78e43008b395cb5e1e9dc56_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS01LTEtMS0w_58d5d194-df56-4b3e-b1ce-67a37ad44f4c">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6930765739894f11878ad45a82a55846_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS03LTEtMS0w_34169cf6-38df-4133-be7a-12d43d0ca412">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtMS0xLTEtMA_f40fbbf0-8a5a-4d63-bfd0-4f0bfdd90ce1">6</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtMy0xLTEtMA_85a017e3-e366-402d-8d34-78d3c27ff949">33</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtNS0xLTEtMA_7a3930b5-13fd-4506-8a12-e07355f61cc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtNy0xLTEtMA_010b788e-8e36-4308-9667-3e00e412b421">27</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtMS0xLTEtMA_47ab69d4-70c1-4caf-a738-fcf22ab171de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtMy0xLTEtMA_94d5af31-84e1-4491-9188-ff4b77946ed1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtNS0xLTEtMA_f8dfad30-9302-4d46-b95c-3a4a624b5d91">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtNy0xLTEtMA_bcc5467d-344f-469f-a7f3-cfba02bf6ef7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItMS0xLTEtMA_319dec10-8a06-445c-a089-9daa74e5ff45">1</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItMy0xLTEtMA_3eff70e5-310d-468c-8d34-5780c928b0b7">8</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItNS0xLTEtMA_9251e101-c189-44a5-b684-b3782c59be46">1</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItNy0xLTEtMA_d6136b01-ad1e-43f0-93f5-f299f42932a5">10</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtMS0xLTEtMA_bf8c2fda-8366-4715-9855-47b4ce834bcf">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtMy0xLTEtMA_2084d1b3-1853-4e50-9d62-2323b4c7a15b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtNS0xLTEtMA_37d05685-8a2a-4e5e-98f9-d37dc2769a5e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtNy0xLTEtMA_86da447f-c34e-4a98-b65a-d6a7cde2bd74">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61ae387d81f4cd787169a4aa986b749_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtMS0xLTEtMA_5a0a28b6-6267-48f2-8c46-29d72664af8b">410</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i648911325f984984a9226827d9c4ade9_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtMy0xLTEtMA_16c8bf49-d3b4-4a41-8ba4-848e34e29047">24</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i287ed9572278419fa5ed70f8a892d17b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtNS0xLTEtMA_807c935c-e027-4e3d-a119-f04bab9d51af">167</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtNy0xLTEtMA_3e717ee9-ba7a-46ee-b69c-65516af37705">553</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida1829b8f6a940fa9109f3a38603cdcc_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtMS0xLTEtMA_f75031f1-1277-4b19-888a-5b7570f04697">414</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e31ef39780c49909cf68f429ec68689_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtMy0xLTEtMA_38dde837-9144-4b03-87e1-9ec915d39a89">23</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e05a3f921945f18703bab7f65ac87c_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtNS0xLTEtMA_2ffe13e4-0af4-4449-98ef-1afac1a261d6">165</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtNy0xLTEtMA_7e63b211-86b6-4a08-87d0-49ad96a0f4ef">602</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktMS0xLTEtMA_feb848fe-db91-402b-8a17-0e229443e766">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktMy0xLTEtMA_32155803-a9c3-4f42-af81-96ebcb35ee5a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktNS0xLTEtMA_4d2eac97-848f-4a7e-a004-f47013d58f0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktNy0xLTEtMA_4a881d07-591d-4bd4-9ba5-c52476bd1a52">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtMS0xLTEtMA_6c84fa43-be8d-4c85-85f0-3a0796e48b68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtMy0xLTEtMA_f79ceb54-abf6-4b48-bf51-059331c143f0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtNS0xLTEtMA_aecd3a4b-4f3f-4c54-83ef-51617beb149e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtNy0xLTEtMA_e244cd9a-fe33-403a-9d7e-0d2b2d589697">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtMS0xLTEtMA_a44c8be4-9198-4c8a-8168-39bed7c77ee0">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtMy0xLTEtMA_4f97e4bd-6273-454a-9724-fece3701e3a4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtNS0xLTEtMA_ca0d9b47-ce4c-4621-88ed-9efe6c87d9a3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtNy0xLTEtMA_0d7057ad-91b9-4ecb-8d67-b61ac25e35db">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItMS0xLTEtMA_da7bf81d-07e9-4734-aa97-bda58f16976b">58</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItMy0xLTEtMA_c874cb00-09f9-46f4-a2d1-8a2a0ca8bb89">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItNS0xLTEtMA_0a992bcc-38ca-4030-a35f-738c7ab64691">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItNy0xLTEtMA_70d79913-cbef-4736-b0c1-18d76fc8edcd">54</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3a85957e12343c3b6d10c076ee4eb33_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtMS0xLTEtMA_ddcad85c-6537-4cc5-8e04-161f13e27005">472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic31a8c3f66c64539b477a0e822466880_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtMy0xLTEtMA_9789c1ec-d1bc-461b-8eb5-b72eb26afb32">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419066cdc87943e4af8d2639f21bf325_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtNS0xLTEtMA_8ec4f4c5-ecc1-4178-aadb-0ae6f90f6d88">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtNy0xLTEtMA_acd42322-912a-4922-84f9-fb71db746eb7">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15cda9f6bf6342a597e07a9eec7230e9_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtMS0xLTEtMA_13030d39-ea7a-46b5-8664-e642aa75f126">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa822c4df064199a3d14eff7dcc4d7e_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtMy0xLTEtMA_9d9e829b-dc2d-4bbb-91c7-329ab1b81edb">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97439b6734784a439903d4ca1f2ab98b_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtNS0xLTEtMA_07c47360-3ad0-4d15-be18-22cb9ec92020">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtNy0xLTEtMA_e904d61a-1523-4381-9714-9c812354ed51">640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtMS0xLTEtMA_415a2b74-1d7a-4d9c-bc20-cca598dbb74d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtMy0xLTEtMA_fc99996a-c68b-4fb0-a069-941f05b80e00">47</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtNS0xLTEtMA_8dba3e30-5b19-4e3b-b858-821b6f8b9e94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtNy0xLTEtMA_cbe0691a-c1e8-47e5-95f2-34e91ecbd432">85</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctMS0xLTEtMA_a3868d4a-d3c7-437a-b250-f1ea917803eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctMy0xLTEtMA_622b1435-07d6-485b-bdbe-1d011500f346">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctNS0xLTEtMA_9917dc98-20ec-46f3-a652-192b5a7e7c88">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctNy0xLTEtMA_0e43e8c7-4d60-4899-82f4-ed3a4c38efaa">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtMS0xLTEtMA_ee8fc03b-4312-455a-bc3f-913f19823876">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtMy0xLTEtMA_698d7ec5-e471-4acf-bdb5-ed8afcf163b6">12</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtNS0xLTEtMA_2002a391-1dad-489e-a117-7c8b0d56965f">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtNy0xLTEtMA_b92c84b0-c8d5-4d55-9b8a-7ecf7decf54a">12</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktMS0xLTEtMA_eb42b6bd-fcea-40ec-916d-eac42b617eca">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktMy0xLTEtMA_6efb9e3a-cbfd-4de0-8958-a45a99da2cef">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktNS0xLTEtMA_f47184b5-481b-46ae-80b4-8e5563211eac">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktNy0xLTEtMA_4c079d59-b8bc-42eb-8be0-f7634c3a9389">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61ae387d81f4cd787169a4aa986b749_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtMS0xLTEtMA_26d076f0-34c7-48a8-adc7-09e7168b7c7e">410</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i648911325f984984a9226827d9c4ade9_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtMy0xLTEtMA_c947f866-72d9-42d4-8084-d91cedd8254b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i287ed9572278419fa5ed70f8a892d17b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtNS0xLTEtMA_97f90b59-e8ab-4748-9671-ded8dd1f7b4d">167</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtNy0xLTEtMA_690f822d-ca35-4af5-b641-cadd45b47886">553</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were <ix:nonFraction unitRef="usd" contextRef="i62293d2d37bf4c4988f6c74ea00a7c89_D20200701-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_38c7cbdf-dee1-4153-983a-b600031c1653"><ix:nonFraction unitRef="usd" contextRef="ie6d9925f9b914e0993a80905523974d8_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_62f88ba3-2807-4dc0-8260-a2a7b04fb0bd"><ix:nonFraction unitRef="usd" contextRef="iababf4350ccf465da7e9156cd84d16b3_D20200101-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_b86a34da-9127-4f7b-ad49-04977004799e"><ix:nonFraction unitRef="usd" contextRef="i173c3aa326c84df085c6251cbd51be86_D20190701-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_e38c9519-735f-46b6-912a-4c5a2d977344">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfODAy_476937db-a550-4c39-8bdf-3f1ad665e643" continuedAt="ib8910cc7a99042f795ce43b2390786ae" escape="true">EMPLOYEE BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="ib8910cc7a99042f795ce43b2390786ae"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfODAz_a01c6591-11b5-4713-b697-41ba6fd52d4c" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi0xLTEtMS0w_5c36899c-50c1-45a2-88e3-94c122dfd68e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi0zLTEtMS0w_9a00d6c8-70b5-4e38-9eb8-2d93897c2bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi01LTEtMS0w_6b745049-c623-4318-bcea-f79e0df6cb70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi03LTEtMS0w_536d4a7c-8b6e-4744-a1dd-540f7bef67ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy0xLTEtMS0w_33da99d5-96af-4ce5-b0c1-164e7969949f">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy0zLTEtMS0w_355a9578-82d3-48d7-8d74-de95d50c3054">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy01LTEtMS0w_607edf48-4927-49b6-a987-351ccf1dc977">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy03LTEtMS0w_d5504718-6438-4fa5-90d3-dee1bca6e5db">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC0xLTEtMS0w_219fbf71-82e9-40a5-b712-d320d5ac9abf">4</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC0zLTEtMS0w_47d03858-106f-44bb-9d37-18afc9138adb">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC01LTEtMS0w_86a39d26-0397-4677-8fc3-42dda9166d84">11</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC03LTEtMS0w_8461c56c-7b62-4dfa-8371-be8410abfbd5">14</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS0xLTEtMS0w_7cdaff46-3e06-416a-9b7a-b441c9c54d7d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS0zLTEtMS0w_8deb25c4-a4c0-4ba9-9e7a-24a46d9ccab9">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS01LTEtMS0w_31291e57-3357-4142-acf4-ba871187d2e6">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS03LTEtMS0w_69aabda4-a7ab-448d-b255-7fbc289a8522">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi0xLTEtMS0w_520971fa-e6f0-4410-8a5d-65d602561826">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi0zLTEtMS0w_0fcc1405-c745-4274-b451-ee73118b9b48">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi01LTEtMS0w_71279c8e-d9a6-406d-8dcf-2ca792dc687b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi03LTEtMS0w_8c5c2d2a-32b1-4d8e-99cb-0fad4aadf442">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is <ix:nonFraction unitRef="number" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMjk2_86d9c549-f954-49f2-b8dc-ae6ced7aaa0f">3.1</ix:nonFraction>%.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $<ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc1NA_e0df81ab-6bb8-49c2-b111-0d4c47ebbc27"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc1NA_eb724770-c7b8-4829-b371-2405321a9623">0</ix:nonFraction></ix:nonFraction> for both the three months ended March 31, 2021 and 2020, and $(<ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2NA_119bca42-12eb-4700-bb1f-a8f2c09961f1"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2NA_beb66e43-4223-455f-b1cb-10b0709f53f5">1</ix:nonFraction></ix:nonFraction>) for both the nine months ended March 31, 2021 and 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021 and 2020, the Company made $<ix:nonFraction unitRef="usd" contextRef="i1ec03781c4364b8eb6a53fc946376745_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2Nw_c22807a3-d57a-4e1b-94be-5f8443a5a40c">6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i94703f8812a94078aa3f69523823f506_D20200101-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNTM0_d82c2710-30ba-4474-b195-02a36b825d3b">7</ix:nonFraction> in contributions to its domestic retirement income plans, respectively. During the nine months ended March 31, 2021 and 2020, the Company made $<ix:nonFraction unitRef="usd" contextRef="i0a83729a2ab84c53a192961000f37527_D20190701-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNjY4_6942ca2a-314f-4ffc-a120-cf323877ea4d"><ix:nonFraction unitRef="usd" contextRef="if1379ef5a7284cb29a9aed3da06988b6_D20200701-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNjY4_99a32b7a-d63e-40f6-bdb8-5741f8deef20">10</ix:nonFraction></ix:nonFraction> in contributions to its domestic retirement income plans. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs are reflected in Other (income) expense, net.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="clx:OTHERCONTINGENCIESANDGUARANTEESTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDU1Nw_600dc279-002b-4834-b4ec-d912ce6839b1" continuedAt="iae6fd2b865d84ac9ba9db916372f18f1" escape="true">OTHER CONTINGENCIES AND GUARANTEES</ix:nonNumeric></span></div><ix:continuation id="iae6fd2b865d84ac9ba9db916372f18f1"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMjE2_7add3bbf-c6b2-42a4-bccb-32413f55f09a">27</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTA5OTUxMTYzMjM3NA_9e5c2270-c723-4bda-ad6d-e9f026ffedc3">28</ix:nonFraction> as of March&#160;31, 2021 and June&#160;30, 2020, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted for $<ix:nonFraction unitRef="usd" contextRef="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMzQ3_87c15ddf-7a39-4edd-825b-e5501d0ad375"><ix:nonFraction unitRef="usd" contextRef="ic8784fe904d7468a9509d946755aa75a_I20200630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMzQ3_a6b60c4b-add4-44c3-8c0e-3c0c7047398a">14</ix:nonFraction></ix:nonFraction> of the recorded liability as of March&#160;31, 2021 and June&#160;30, 2020, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. As a result, the Company recorded in Other (income) expense, net an undiscounted liability for costs estimated to be incurred over a <ix:nonNumeric contextRef="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331" format="ixt-sec:duryear" name="clx:RemediationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfOTAy_e2cba7ae-2176-410a-9878-26ff183f7b28">30</ix:nonNumeric>-year period, based on the option recommended in the Feasibility Study. However, as a result of ongoing discussions with regulators, in June 2017, the Company increased its recorded liability to $<ix:nonFraction unitRef="usd" contextRef="id29606025bd94286b0f0595ed8010676_I20170630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTA5OQ_e6cf7e0a-e255-4ff1-84e6-edae8e346a9d">14</ix:nonFraction>, which reflects anticipated costs to implement additional remediation measures at this site. While the Company believes its latest estimate is reasonable, regulators could require the Company to implement one of the other options evaluated in the Feasibility Study, with estimated undiscounted costs of up to $<ix:nonFraction unitRef="usd" contextRef="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331" decimals="-6" name="clx:MaximumExposureUndiscountedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTQxMQ_dd737f82-e2b7-4628-ab10-4652d0410853">28</ix:nonFraction> over an estimated <ix:nonNumeric contextRef="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331" format="ixt-sec:duryear" name="clx:RemediationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTQzMg_e4b7e9a7-8c09-41e2-b047-2c83b15e2bcf">30</ix:nonNumeric>-year period, or require the Company to take other actions and incur costs not included in the study. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $<ix:nonFraction unitRef="usd" contextRef="ib3d430c56b2d45ea938542ba1ac62191_I20200630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTcwNg_552e0b25-4796-4907-9994-6efcd31cc37f"><ix:nonFraction unitRef="usd" contextRef="id75803f96d3a484c8dbb2e4d3901e6b9_I20210331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTcwNg_79b5602e-2f1a-43a2-9a31-cb765b887b62">10</ix:nonFraction></ix:nonFraction> of the recorded liability, as of March&#160;31, 2021 and June&#160;30, 2020. This amount reflects the Company&#8217;s agreement to be liable for <ix:nonFraction unitRef="number" contextRef="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331" decimals="3" name="clx:SiteContingencyAgreedPercentageOfCostSharing" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTgxNQ_75c33f6d-a3b3-496f-92dc-bf6417fdb1e4">24.3</ix:nonFraction>% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated <ix:nonNumeric contextRef="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331" format="ixt-sec:duryear" name="clx:RemediationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMjMzMw_1d963435-85ed-4d13-b42d-40d7d80fb1f5">30</ix:nonNumeric>-year remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements, and the future availability of alternative clean-up technologies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned guarantees as of March&#160;31, 2021 and June&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company was party to a letter of credit of $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="clx:LetterOfCreditBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDQ3NA_e22fabf0-4a2e-407a-9b0a-5024c7956107">11</ix:nonFraction>, related to one of its insurance carriers, of which $<ix:nonFraction unitRef="usd" contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDUyOQ_ae8fed5c-3f7a-4e26-981a-fa584ae19694">0</ix:nonFraction> had been drawn upon.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12. <ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU3NA_903d63ce-e22d-42f2-a8d5-ed108ffdfebc" continuedAt="iefb1041ca111451d8de47afc6f0d7d0a" escape="true">SEGMENT RESULTS</ix:nonNumeric></span></div><ix:continuation id="iefb1041ca111451d8de47afc6f0d7d0a" continuedAt="i4bbef250d333488ca0adc9e01fb59515"><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU3Ng_14f5fd50-b4a3-472d-85d0-da9c6d465dcf" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates through SBUs that are aggregated into <ix:nonFraction unitRef="reportablesegment" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTE2_a6bbb8ff-3b0d-407d-94f8-580c1441587e">four</ix:nonFraction> reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU4Mg_0d0b86c6-e5c7-4a4a-ae75-090e68dfb5d8" continuedAt="ib2b38f12c9044ba6b4f02111b3475566" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy0yLTEtMS0w_588994de-df87-4604-ab12-c9a17713350e">680</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy00LTEtMS0w_0875cccc-fe75-4646-a08b-8240424c870b">736</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy02LTEtMS0w_7703b505-924f-4476-89c0-7c8782b0cd2f">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy04LTEtMS0w_e8b487fd-f1ce-43e5-b2aa-2a84a0ed2278">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC0yLTEtMS0w_8cd8b607-cd74-45a4-beee-7db35260ce5c">510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC00LTEtMS0w_9cc26a96-cab0-453a-b01e-55906169a1dc">480</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC02LTEtMS0w_53dd4f99-ab19-4302-b928-310e6e2933a5">1,421</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC04LTEtMS0w_adda1069-b5d1-4868-a07f-7bdc5e0b9d93">1,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS0yLTEtMS0w_d2b46299-7576-4ca1-b3eb-f3a447c9e07e">293</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS00LTEtMS0w_fa1218ed-51a1-4c8f-9c76-f10308bd6979">294</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS02LTEtMS0w_fba1d6b1-b48b-489b-9b1a-6f975428eb03">928</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS04LTEtMS0w_94b6c8af-6f10-45e8-bf18-2e5204ba8cf0">856</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi0yLTEtMS0w_18823479-d751-43d2-847c-c0cad802f718">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi00LTEtMS0w_79afe52f-73bb-45dd-aed9-94cfb44a3158">273</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi02LTEtMS0w_6e17622e-44a3-401b-9803-67fdac247cc3">880</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi04LTEtMS0w_c694c938-7cb2-43d9-8a35-d74d3430bad5">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975190927cc64325b214048019388e7e_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy0yLTEtMS0w_be9b0ddd-acd8-4847-b7da-f7231f00d268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy00LTEtMS0w_3cfbf865-dbd0-4786-ac3b-8a9e6afa5c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy02LTEtMS0w_cc4b5f3a-a886-444d-8838-00361c7bfb73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy04LTEtMS0w_bf6a7849-46dc-4753-a04c-bb1be122454c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC0yLTEtMS0w_db16ffeb-56e7-489b-96b3-5bfec0589e91">1,781</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC00LTEtMS0w_9160fcad-b479-4dd8-a1d5-8682f8b83294">1,783</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC02LTEtMS0w_a95d05d2-304b-44b0-8e22-3bf9335eb5f1">5,539</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC04LTEtMS0w_2c4a0050-d3b4-4c69-b14a-cb5b9a8c2329">4,738</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtMi0xLTEtMA_8ef347ac-3072-4b7b-bf65-a5ed8ae56fa0">183</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtNC0xLTEtMA_3301f02d-6db7-4c87-9046-84f4c0bc6a17">210</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtNi0xLTEtMA_38e5bcac-6147-4640-a016-f13a4e086750">315</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtOC0xLTEtMA_d63f3748-9978-4495-b036-8d3b941fb96b">514</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtMi0xLTEtMA_d27bb336-376b-4445-b1e3-9377ad01999f">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtNC0xLTEtMA_2d160d12-7ea6-4ce9-8d77-a86e3746558b">114</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtNi0xLTEtMA_c37cd2ac-8c27-40a3-a860-52ef7cb5b0f2">266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtOC0xLTEtMA_4bba7886-461c-4fbc-ab26-3bc14b56d476">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtMi0xLTEtMA_74b9a8bc-9d4a-4cab-a0b5-9e87dbf510b6">68</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtNC0xLTEtMA_d37f52e0-79ca-4bd1-a5ca-5d4ddf600dc4">80</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtNi0xLTEtMA_9bb033b4-8e65-47ba-ad32-d6f5e7d19c43">259</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtOC0xLTEtMA_023455bd-9699-4f24-af40-4c6332d5c0bb">242</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtMi0xLTEtMA_1aaab681-3302-46f4-8df8-5ccf6839593b">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtNC0xLTEtMA_9fff68cf-1b5c-418a-95c7-9fc062a48178">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtNi0xLTEtMA_3461cb6e-d935-4de0-9556-9c0110cd4289">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtOC0xLTEtMA_42bbe2de-b796-4a65-b770-e128c1fba019">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975190927cc64325b214048019388e7e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctMi0xLTEtMA_6f999b78-fa68-4471-8f43-9264ca23c7bf">71</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctNC0xLTEtMA_b26772b5-b9b6-45b4-ac06-e5ed0d21987c">143</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctNi0xLTEtMA_8729d945-e234-4c34-abfa-55bd0a4935b4">225</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctOC0xLTEtMA_0dbe9b45-c7e1-4a96-89db-6330bf9942ae">262</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtMi0xLTEtMA_2952de06-a8ba-40d5-a22d-25c9874001d0">59</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtNC0xLTEtMA_0076b9cc-3a6f-470c-9db5-d05737190ce4">297</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtNi0xLTEtMA_2e154791-43e1-4452-b08b-e74e11c152d3">799</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtOC0xLTEtMA_b390493a-b465-4722-bc2f-1b084ef9c258">790</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The earnings (losses) before income taxes for the Health and Wellness segment include a $<ix:nonFraction unitRef="usd" contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMzI5ODUzNDg4NTQyNw_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac">329</ix:nonFraction> non-cash goodwill, trademark and other asset impairment charge for the VMS SBU for the three and nine months ended March 31, 2021.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were <ix:nonFraction unitRef="number" contextRef="i4ad2a51e50b3452cb6ae64126212de08_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTI2MQ_2f997b5e-9e91-4990-bf8e-8ae5c6f4148b"><ix:nonFraction unitRef="number" contextRef="i9cfe0f219db7465c981c5d00e3d79dcc_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTI2MQ_a0541c9c-3a32-4815-b701-09579c7a3b4a">24</ix:nonFraction></ix:nonFraction>% for each of the three and nine months ended March 31, 2021, respectively, and <ix:nonFraction unitRef="number" contextRef="i7e65e42dcaee41a8aa5344602e39584a_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTM0Mw_0950caa5-e2be-4fd4-9217-512b22ea552e"><ix:nonFraction unitRef="number" contextRef="i8eac904b7e824f788b24e686c7bc1d56_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTM0Mw_306f5db4-4d2a-4dab-8fe2-7b8ccfd914da">25</ix:nonFraction></ix:nonFraction>% for each of the three and nine months ended March 31, 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12. SEGMENT RESULTS (Continued)</span></div></div><ix:continuation id="i4bbef250d333488ca0adc9e01fb59515"><ix:continuation id="ib2b38f12c9044ba6b4f02111b3475566"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales for the Company&#8217;s SBUs and for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5699b6f9a46b48c5bec7a3e5ba13b8a7_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy0yLTEtMS0w_88d30e15-c6a8-428f-8d2b-448515c470bf">29</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bd7644fe81e43fcb2a9ae7f33ce5f3b_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy00LTEtMS0w_dbfa692b-ff6f-4e3f-a4c2-823570622837">32</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2eb102946ac9445592b664e481c220fb_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy02LTEtMS0w_f8e6e7f4-ffe0-4d7e-85b2-301e68a3636e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia632e6efb55e4038b06caacaa950ee58_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy04LTEtMS0w_1a5e27e8-7b18-4946-a2f1-78de7d140733">31</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if62aad3baf484220b5c2b3c5607bcf73_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC0yLTEtMS0w_798f901d-6e40-4847-8735-fc01fd2ffd0f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3fc121a4a2da4a36b4069a1d12d0b8ca_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC00LTEtMS0w_899e62ef-7f6b-4f79-acd6-7c82debd6a3d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c504e6a0e8e49379abef45f151e6867_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC02LTEtMS0w_e527f8cf-6ecd-48a8-ac7c-6213291f64e6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i506a64ba3d1741e8a790673d8cd8f3c6_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC04LTEtMS0w_55a1ad0b-23a0-4573-ad40-0ffd615dd71d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15818785c195423aa0fecc36f1c2582f_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS0yLTEtMS0w_ad691d0b-7425-4739-bfa0-a6beba73e17b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie147f6c9542045d2bc2b75081d38abde_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS00LTEtMS0w_cab34fce-c338-4192-bf7a-5ec395fbfa16">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8caf281c758e491a861b00f823d7979d_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS02LTEtMS0w_01e5c936-50ff-45ef-896b-c599872b7298">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53b9ae5110404e8e812297d5d6b2d42b_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS04LTEtMS0w_1eea05a5-2713-4f58-8324-91274553b0a6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47db18debc494da4b9575bc13dde6879_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi0yLTEtMS0w_f43761db-bb32-4c16-af98-8431c5c0003c">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64ad656aa5c747ea869192f42c6b654f_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi00LTEtMS0w_72205885-ebf8-4dc4-89d8-e3561b4b9208">42</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8812b42a862f45728955cc5a6fd0e98d_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi02LTEtMS0w_f45cfe33-1f18-450d-b6f2-ac6f3e4f3768">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i128d754517744d14bf0d13fc3d3cf0b3_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi04LTEtMS0w_81b72422-11d3-46ce-bc8d-bf5dc95c24fb">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c55fd9240674a3b9f72e4cbb7d515dc_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy0yLTEtMS0w_bcd74438-c73f-4d9f-af8f-c4cec660823b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifad0e0cfdad747e9bf36f5473f6d8f03_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy00LTEtMS0w_6ffafc51-d323-43e5-b2e9-607577baff73">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2e1002466a64130bc0c173f011c16d7_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy02LTEtMS0w_59b1f7c2-2865-493e-bf22-31d16c2720c2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58e0648e0b884c8184d3468dad255a59_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy04LTEtMS0w_0c650735-4898-430c-a84f-1f70e32618fb">12</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i187b861787ca41e3b58b23b46c5faf63_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC0yLTEtMS0w_c93aa08d-ae36-493f-ae22-2b135d7287da">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b809796270b46368d7995f9e91a9c90_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC00LTEtMS0w_c1038898-fea4-4f66-949e-d1735e3ff868">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1e24f176213492e981a7a7fe85e20a0_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC02LTEtMS0w_5aec7482-a151-44cf-9a5f-3678e62c96bb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3a795ff3b4c4adaa82835e56a401845_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC04LTEtMS0w_578552dd-0a82-4717-910a-1460d3b25a88">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc2ea66f0180479c96f3dd09cab6e243_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS0yLTEtMS0w_3dbc52cd-7279-4df2-8764-321bed4abec0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1a5a929489a4b42bb6fce0495516584_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS00LTEtMS0w_b88ec184-b68b-481b-9832-ebb807e9681c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3d5d2046dae465496bfa06a4ce81663_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS02LTEtMS0w_c6a6fe14-154a-4f53-a6d8-9802e0e6f21c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6de7ab384894152aca3960aaa565203_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS04LTEtMS0w_d06a4d87-404e-40e2-8739-7de4ffad41e4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37a114b1ca84437a9ecaf7bf79fb57ca_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtMi0xLTEtMA_5e8a081b-57f5-4947-b4c5-482bd1a0a768">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i237934c2afde4ed0a6ab8a5fa7df13eb_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtNC0xLTEtMA_01f3e019-78e1-47ff-ab2f-a16e66954bf6">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93f613b6d1e54231bf06050b363647cd_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtNi0xLTEtMA_71ca9314-aaf8-4e59-8599-0d2b3660beff">26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88583fbc1c434496bf8b9e52b80d9067_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtOC0xLTEtMA_99c49143-06a3-43f4-8eee-ea8d7753cdcd">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food Products</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i483c1116882345a89188168be2d76bc8_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtMi0xLTEtMA_b909acf5-6954-4fdb-95b7-bc566826f05f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia02727d1fe8147ce863007dd69cdd4ef_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtNC0xLTEtMA_b9b4da71-7b6d-4901-b196-945d5ea9f4c2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6479f56abf874bc88fcc7c452a280a08_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtNi0xLTEtMA_40fe1efe-bfbd-4f21-a4ff-3c40122e71bf">9</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if10aa250273f4428bc10f6ba3c689231_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtOC0xLTEtMA_06c6d21d-010d-4a99-9e73-128605191ec9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8ec145f089a480fb32a14926e0eec81_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItMi0xLTEtMA_c14dcf4c-5f6a-4004-b2b7-d85fc0386049">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61184552c2644513b3d633d0928a8112_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItNC0xLTEtMA_8794985b-161f-482e-abcc-48a46991ae44">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba7f614f662c4fdaac724b9dbdc9b0ec_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItNi0xLTEtMA_e8d57707-ff4a-44b8-b184-05a20c9e98bd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i053ab554d68d4004b7cc5e97f743f92d_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItOC0xLTEtMA_ee210ab7-3b6f-463f-b0c6-932e0bf27914">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie08eb37c570741b6adbb80e59db8e81b_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtMi0xLTEtMA_f83b76db-8392-42e1-917b-d29cf450048e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i005732996c5443e98325ccaca9851e73_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtNC0xLTEtMA_824c2f3c-f458-4e0c-b45a-7583daa9310d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88cf12ca5cc441158bed63419f14048d_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtNi0xLTEtMA_4827f6aa-5603-47f0-a2dd-170f48199379">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55cd924b746a43e7bb45ffa60c315720_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtOC0xLTEtMA_f8dc0f4c-cd60-41c2-8035-147d8791bde3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18be5d4fbe524e47a3029107ff86582b_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtMi0xLTEtMA_001f76e5-e5a2-45f3-a1cc-e6bde617b0e0">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4c74269eba445e0b373d38d49c2ea96_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtNC0xLTEtMA_9ab4b78d-a724-4635-9e17-43cbfe128253">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9e2335ca8894224947f5ebe34faec14_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtNi0xLTEtMA_bc109c5e-beb1-48ba-8417-854fbd06cf00">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd2e74bb030744169bd9895fd5ff97e7_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtOC0xLTEtMA_02828141-dad1-4e16-88c1-83e0937865f9">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie49d4996c5414e89885bb395950c44cf_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtMi0xLTEtMA_023c152d-df4e-4951-8d2f-10c60be76ce9">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7f4b076b16b412f97df8f6635593f56_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtNC0xLTEtMA_9751b79b-64fc-4cb8-bbd4-d00d8fddf7df">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i816a0ac0739d40dbb754308ccc3bb074_D20200701-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtNi0xLTEtMA_31464d5e-ba9f-44da-a99d-595c04bd996d">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a5bde4bb3614689b5997373fdce9d38_D20190701-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtOC0xLTEtMA_6e783269-9824-494f-a07c-a8d6642652fa">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i647346da3c594fa1b168b90be5aab738_D20210101-20210331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtMi0xLTEtMA_8c5a9584-139a-47cd-9358-a0182d74bd59">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b50c8db5f674487bbe612c1077374b8_D20200101-20200331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtNC0xLTEtMA_913b676a-7f0a-46ed-8747-648bf1539466">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0e050195d1c47c698983818dc2bb144_D20200701-20210331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtNi0xLTEtMA_3b262920-cef5-4f88-8ee1-466014433b74">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d206ce9aae94891b7aefcc647ef716b_D20190701-20200331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtOC0xLTEtMA_118a2be0-e9fc-4f88-a5d3-b5e6480fac97">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (MD&amp;A) is designed to provide a reader of The Clorox Company&#8217;s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company&#8217;s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company&#8217;s financial condition and results of operations should be read in conjunction with MD&amp;A and the consolidated financial statements and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020, which was filed with the SEC on August 13, 2020, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&amp;A compares the three and nine month periods ended March&#160;31, 2021 (the current period) to the three and nine month periods ended March&#160;31, 2020 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.</span></div><div style="margin-top:8pt"><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_55"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clorox is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,800 employees worldwide. Clorox sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products, Pine-Sol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cleaners; Liquid-Plumr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> clog removers; Poett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> home care products; Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cat litter; Glad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bags and wraps; Kingsford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> grilling products; Hidden Valley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dressings; Brita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> water-filtration products; Burt&#8217;s Bees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> natural personal care products; and RenewLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Rainbow Light</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Natural Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Stop Aging Now</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vitamins, minerals and supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro</span><span style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the Clorox Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand names. The Company has operations in more than 25 countries or territories and sells its products in more than 100 markets.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company&#8217;s products compete with other nationally advertised brands within each category and with &#8220;private label&#8221; brands.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) which are also the Company&#8217;s operating segments. These SBUs are then aggregated into four reportable segments. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020. The four reportable segments consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of cleaning products, professional products, and vitamins, minerals and supplement products mainly marketed and sold in the U.S. Products within this segment include cleaning products such as laundry additives, including bleach products under the Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand and Clorox 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stain fighter and color booster; home care products, primarily under the Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scentiva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Formula 409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Liquid-Plumr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Pine-Sol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Tilex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brands; professional cleaning and disinfecting products under the CloroxPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorox Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total 360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and professional food service products under the Hidden Valley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand; and vitamins, minerals and supplement products under the RenewLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Rainbow Light</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Natural Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Stop Aging Now</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brands.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Household</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of grilling products; bags and wraps; and cat litter products marketed and sold in the U.S. Products within this segment include grilling products under the Kingsford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Kingsford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Match Light</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands; bags and wraps under the Glad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand; and cat litter products under the Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Scoop Away</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Ever Clean</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Lifestyle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the U.S. Products within this segment include dressings and sauces, primarily under the Hidden Valley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand; water-filtration systems and filters under the Brita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand; and natural personal care products under the Burt&#8217;s Bees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of products sold outside the U.S. Products within this segment include laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products primarily under the Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Ayudin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorinda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Poett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pine-Sol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Glad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Brita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, RenewLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Ever Clean</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Burt&#8217;s Bees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_58"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT EVENTS RELATED TO COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The novel coronavirus (COVID-19) pandemic has caused a severe global health crisis, along with economic and societal disruptions and uncertainties. As a result, we have taken an active role in addressing the ongoing pandemic&#8217;s impact on our employees, operations, customers, consumers, and communities, including taking precautionary measures, such as implementing contingency plans, making operational adjustments where necessary, and providing support to organizations that support front-line workers. The impact of COVID-19 and responses of governments, consumers, and others to the pandemic are affecting our business in many ways; however, we believe that the actions we are taking will help us emerge from this global pandemic operationally sound, and well positioned for continued long-term growth.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our fiscal third quarter ended March 31, 2021, we continued to experience elevated demand for many of our products, especially our disinfecting cleaning products, in response to COVID-19 in comparison to periods before the pandemic. The extent of COVID-19&#8217;s effect on our operational and financial performance in the future will depend on future developments, including the duration, spread and intensity of the pandemic, our continued ability to manufacture and distribute our products, as well as any future government actions affecting consumers and the economy generally, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For additional information on the impacts and our response to the coronavirus pandemic, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.</span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONSOLIDATED RESULTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,539&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported (GAAP) Net Sales Growth / (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Volume</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions &amp; Divestitures</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price/Mix/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Sales Growth / (Decrease) (Non-GAAP) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported (GAAP) Net Sales Growth / (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Volume</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions &amp; Divestitures</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price/Mix/Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Sales Growth / (Decrease) (Non-GAAP) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures as well as changes in foreign exchange rate.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Organic volume represents volume excluding the effect of any acquisitions and divestitures. In the three months ended March 31, 2021, the volume impact of acquisitions was 5% and 1% for International and Total Company, respectively. In the nine months ended March 31, 2021, the volume impact of acquisitions was 7% and 1% for International and Total Company, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the current three month period was essentially flat when compared to the prior period, reflecting lower sales in the Health and Wellness reportable segment, partially offset by sales growth in the Household and International reportable segments.  Volume decreased by 4% versus the prior period. The variance between volume growth and net sales growth was primarily due to the impact of lower trade promotion spending and favorable mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the current nine month period increased by 17%, reflecting higher shipments across all reportable segments driven by increased demand due to COVID-19 and related behavioral shifts. Volume increased by 13% versus the prior period. The variance between volume growth and net sales growth was primarily due to the impact of favorable mix, partially offset by unfavorable foreign currency exchange rates.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> defined as gross profit as a percentage of net sales, decreased by 320 basis points in the current three month period from 46.7% to 43.5%. The decrease was primarily driven by higher manufacturing and logistics costs and unfavorable commodity costs, partially offset by lower trade promotion spending and the benefit of cost savings initiatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased by 70 basis points in the current nine month period from 45.0% to 45.7%. The increase was primarily driven by higher volume, cost savings, and lower trade promotion spending, partially offset by higher manufacturing and logistics costs. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Selling and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as a percentage of net sales, decreased by 180 basis points and 120 basis points in the current three and nine month periods, respectively. The change in the current three month period was primarily due to lower incentive compensation expenses. The change in the current nine month period was primarily due to increased investments in several growth opportunities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as a percentage of net sales, increased by 90 basis points and 50 basis points in the current three and nine month periods, respectively. The increase in advertising expenses reflected the Company&#8217;s continued support behind its brands. The Company&#8217;s U.S. retail advertising spend as a percentage of net sales was approximately 12% in the current and prior three month periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and development costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as a percentage of net sales, decreased by 40 basis points and 30 basis points in the current three and nine month periods, respectively. The decrease in research and development expenses was primarily due to lower incentive compensation expenses in the current three month period. The Company continues to invest behind product innovation and cost savings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, trademark and other asset impairments, Interest expense, Other (income) expense, net, and the effective tax rate on earnings</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, trademark and other asset impairments</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate on earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Goodwill, trademark and other asset impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of $329 in the current three and nine month periods reflect non-cash impairment charges related to goodwill, trademarks, and other assets held by the VMS business (included within the Health and Wellness segment).  See Notes to Condensed Consolidated Financial Statements for further information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was $10 and $19 in the current and prior three month periods, respectively, and ($85) and $16 in the current and prior nine month periods, respectively. The variance between the current and prior three month periods was not significant. The variance between the current and prior nine month periods was primarily due to the one-time, non-cash remeasurement gain recognized in the current period from the Company&#8217;s previously held equity interest in the Saudi joint venture in the first quarter of fiscal year 2021 (see Notes to Condensed Consolidated Financial Statements).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The effective tax rate on earnings (losses)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was (1.4)% and 22.5% for the current three and nine month periods, respectively, and 18.9% and 20.4% for the prior three and nine month periods, respectively. The substantially lower tax rate on loss before income taxes in the current three month period and higher tax rate on earnings before income taxes in the current nine month period were driven by the partial non-deductibility of impaired VMS goodwill.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted net earnings (losses) per share</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings (losses) per share</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Diluted net earnings (losses) per share (EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased by $2.38, or 126%, in the current three month period, primarily due to the non-cash impairment charges on assets held by the VMS business and lower gross margin, partially offset by lower selling and administrative expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted net earnings per share decreased by $0.16, or 3%, in the current nine month period, primarily due to the non-cash impairment charges on assets held by the VMS business, increased advertising investments and higher selling and administrative expenses, partially offset by gross margin expansion and the remeasurement gain recognized on the previously held equity interest in the Saudi joint venture.</span></div><div><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_64"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEGMENT RESULTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the results of operations from the Company&#8217;s reportable segments and certain unallocated costs reflected in Corporate (see Notes to Condensed Consolidated Financial Statements for a reconciliation of segment results to consolidated results):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Wellness</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume, net sales and earnings (losses) before income taxes decreased by 11%, 8% and 187%, respectively, during the current three month period. The volume and sales decreases were primarily driven by lower shipments in Cleaning and Professional Products as well as supply constraints for some key products. The variance between volume and net sales was primarily due to lower trade promotion spending. The decrease in earnings (losses) before income taxes in the current period was primarily due to the non-cash impairment charges on assets held by the VMS business, higher manufacturing and logistics costs, and net sales decline. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume, and net sales increased by 15%, and 19%, respectively, and earnings before income taxes  decreased by 39%, during the current nine month period. The volume and sales growth reflected higher shipments in Cleaning and Professional Products portfolios due to greater demand inside and outside of the home. The variance between volume and net sales was primarily due to lower trader promotion and favorable mix. The decrease in earnings before income taxes in the current period was primarily due to the non-cash impairment charges on assets held by the VMS business, higher manufacturing and logistics costs, and higher advertising investment, partially offset by net sales growth. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Household</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume and net sales increased by 4% and 6%, respectively, and earnings before income taxes decreased by 15%, during the current three month period. The volume growth reflected higher shipments in Grilling from higher consumer demand. The variance between volume and net sales was primarily due to favorable mix and lower trade promotion spending. The decrease in earnings before income taxes was mainly due to higher manufacturing and logistics costs, unfavorable commodity costs, and higher advertising investments, partially offset by net sales growth. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume, net sales and earnings before income taxes increased by 14%, 20% and 40%, respectively, during the current nine month period. The volume growth reflected higher shipments across all SBUs, primarily driven by strong consumer demand. The variance between volume and net sales was primarily due to favorable mix and lower trade promotion spending. The increase in earnings before income taxes was mainly due to net sales growth, partially offset by higher manufacturing and logistics costs and higher advertising investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lifestyle&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume and earnings before income taxes decreased by 1% and 15%, respectively, and net sales were essentially flat during the current three month period as compared to the prior period. The volume decrease was primarily driven by lower shipments of Natural Personal Care and Brita water filtration products, partially offset by higher shipments in Food products. The decrease in earnings before income taxes was primarily due to higher manufacturing and logistics costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume, net sales and earnings before income taxes increased by 8%, 8% and 7%, respectively, during the current nine month period. Both volume growth and net sales growth were primarily driven by higher shipments of Food and Brita water filtration products mainly due to greater demand by consumers and strategic brand investments. The Natural Personal Care business declined as the brand continued to adapt to new consumer shopping and usage habits. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher manufacturing and logistics costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume and net sales increased by 2% and 9%, respectively, and earnings before income taxes decreased by 17% during the current three month period. The volume increase was driven by higher shipments from ongoing demand for disinfecting and other household products in most geographic regions, as well as the impact of the Saudi joint venture acquisition. The variance between volume and net sales was mainly due to favorable mix and the benefit of price increases implemented to offset inflation in certain markets, partially offset by the impact of unfavorable foreign currency exchange rates. The decrease in earnings before income taxes was primarily due to higher manufacturing and logistics costs, unfavorable foreign currency exchange rates and higher commodity costs, partially offset by net sales growth.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume, net sales and earnings before income taxes increased by 13%, 17% and 74%, respectively, during the current nine month period. The volume increase was primarily driven by higher shipments from ongoing demand for disinfecting and other household products in every geographic region, as well as the impact of the Saudi joint venture acquisition. The variance between volume and net sales was mainly due to favorable mix and the benefit of price increases implemented to offset inflation, partially offset by the impact of unfavorable foreign currency exchange rates. The increase in earnings before income taxes was primarily due to the remeasurement gain recognized on the previously held equity interest in the Saudi joint venture.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Argentina</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, and as a result the U.S. dollar replaced the Argentine peso as the functional currency of the Company&#8217;s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the consolidated statement of earnings. The business environment in Argentina continues to be challenging due to significant volatility in Argentina&#8217;s currency, high inflation, an economic recession and impacts of COVID-19 that include temporary strict price controls. As of March 31, 2021 and June 30, 2020, the net asset position, excluding goodwill, of Clorox Argentina was $45 and $44, respectively. Of these net assets, cash balances were approximately $9 and $19 as of March 31, 2021 and June 30, 2020, respectively. Net sales from Clorox Argentina represented approximately 2% of the Company&#8217;s consolidated net sales for the nine months ended March 31, 2021 and the fiscal year ended June 30, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the impacts of, and our response to, the business environment in Argentina, refer to &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate includes certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses before income taxes</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses before income taxes decreased by $72 in the current three month period primarily due to lower employee and incentive compensation and COVID-19 related expenses. Losses before income taxes decreased by $37 in the current nine month period primarily due to lower COVID-19 related expenses.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION AND LIQUIDITY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial condition and liquidity remained strong as of March&#160;31, 2021. The following table summarizes cash activities:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by operations was $893 in the current nine month period, compared with $806 in the prior nine month period. The increase was primarily driven by the Company&#8217;s profitable sales growth, partially offset by higher tax payments and higher employee incentive compensation payments made in the current nine month period versus the prior period. Working capital changes were essentially flat in the comparative period (increased inventories in the current year primarily to meet customer demand, offset by cash inflows from collections from increased quarter-end sales in the prior fiscal year, and higher payables in the current period due to the extension of payment terms with suppliers and increased production levels primarily to improve inventory availability).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash used for investing activities was $341 in the current nine month period, compared with $145 in the prior nine month period. The year-over-year increase was mainly due to the acquisition of additional interest in the Company's Saudi joint venture and higher capital spending to increase manufacturing capacity in the current nine month period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash used for financing activities was $944 in the current nine month period, compared with $261 in the prior nine month period. The year-over-year increase was mainly due to higher treasury stock repurchases in the current nine month period and net cash sourced from short-term borrowings in the prior period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources and Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Global financial markets have experienced a significant increase in volatility due to heightened uncertainty over the adverse economic impact caused by the COVID-19 outbreak. Notwithstanding these potential adverse market conditions, the Company believes it will have the funds necessary to support our short-term liquidity and operating needs based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings, and current borrowing availability under the credit agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2021, the Company maintained a $1,200 revolving credit agreement that matures in November 2024 (the Credit Agreement). There were no borrowings under the Credit Agreement as of March 31, 2021 and June 30, 2020, and the Company believes that borrowings under the Credit Agreement are and will continue to be available for general corporate purposes. The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0, calculated as total earnings before interest, taxes, depreciation and amortization and other similar non-cash charges (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement. Refer to the section entitled &#8220;Non-GAAP Financial Measures&#8221; below for further discussion of these measures.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of the Interest Coverage ratio as of March&#160;31, 2021, using Consolidated EBITDA for the trailing four quarters, as contractually defined in the Credit Agreement:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deduct:</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-recurring, non-cash gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated EBITDA</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Coverage ratio</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes goodwill, trademark and other asset impairments recorded impacting the VMS SBU (see Notes to Condensed Consolidated Financial Statements)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Non-recurring, non-cash gain from the remeasurement of the Company&#8217;s previously held investment in its Saudi joint venture (see Notes to Condensed Consolidated Financial Statements).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of March&#160;31, 2021, and anticipates being in compliance with all restrictive covenants for the foreseeable future. The Company continues to monitor the financial markets and assess its ability to continue to draw on the Credit Agreement, and currently expects it will continue to have access to borrowings under the Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company maintained $35 of foreign and other credit lines, of which $8 was outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases and Dividend Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-market purchase program</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evergreen Program</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock repurchases</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends per share declared and total dividends paid to Clorox stockholders were as follows for the periods indicated: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per share declared</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTINGENCIES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for information on the Company&#8217;s contingencies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENTLY ISSUED ACCOUNTING STANDARDS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for a summary of recently issued accounting standards relevant to the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_76"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-GAAP FINANCIAL MEASURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-GAAP financial measures that are included in this MD&amp;A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">because it is a term used in the Credit Agreement. As defined in the Credit Agreement, Consolidated EBITDA represents earnings before interest, taxes, depreciation and amortization, and other similar non-cash charges (such as non-cash asset impairment charges and other non-cash, non-recurring gains or losses). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Coverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the ratio of Consolidated EBITDA to interest expense. The Company&#8217;s management believes disclosure of Consolidated EBITDA provides useful information to investors because it is used in determining compliance with the primary restrictive covenant in the Credit Agreement. For additional discussion of the Interest Coverage ratio and a reconciliation of Consolidated EBITDA to net earnings, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Position and Liquidity - Financing Activities - Credit Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organic sales growth / (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions and divestitures.&#160;Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating throughout the relevant periods, and the impact of foreign exchange rate changes, which are out of the control of the Company and management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales growth / (decrease) (GAAP)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Foreign Exchange</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(Subtract): Divestitures/Acquisitions</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic sales growth / (decrease) (non-GAAP)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales growth / (decrease) (GAAP)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Foreign Exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(Subtract): Divestitures/Acquisitions</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic sales growth / (decrease) (non-GAAP)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline">Cautionary Statement</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Report, including the exhibits hereto and the information incorporated by reference herein, contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the COVID-19 pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the Company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings attributable to the Company, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management&#8217;s estimates, beliefs, assumptions and projections. Words such as &#8220;could,&#8221; &#8220;may,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;targets,&#8221; &#8220;goals,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;will,&#8221; &#8220;predicts,&#8221; and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management&#8217;s expectations, or could affect the Company&#8217;s ability to achieve its strategic goals, are described in the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020 and in this Report, as updated from time to time in the Company&#8217;s Securities and Exchange Commission filings. These factors include, but are not limited to, the uncertainties relating to the continued impact of COVID-19 on the Company&#8217;s business, operations, employees, financial condition and results of operations, as well as:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intense competition in the Company&#8217;s markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company&#8217;s products, including any significant disruption to such systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term changes in consumer preference or demand for the Company&#8217;s products as a result of any shortages or lack of availability of any products in the near-term;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to supply chain issues and product shortages as a result of reliance on a limited base of suppliers and the significant increase in demand for disinfecting and other products due to the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on key customers and risks related to customer consolidation and ordering patterns;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the Company&#8217;s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions, especially at a time when a large number of the Company&#8217;s employees are working remotely and accessing its technology infrastructure remotely;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks relating to acquisitions, including the recent acquisition of the majority interest in the company&#8217;s Saudi joint venture, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks, and goodwill, in particular the impairment charges relating to the carrying value of the company&#8217;s Vitamins, Minerals and Supplements business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable worldwide, regional and local economic and financial market conditions, including as a result of fear of exposure to or actual impacts of a widespread disease outbreak, such as COVID-19;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to maintain its business reputation and the reputation of its brands and products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower revenue, increased costs or reputational harm resulting from government actions and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and increases in commodity costs such as resin, sodium hypochlorite and agricultural commodities, and increases in energy, transportation or other costs;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to international operations and international trade, including foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls, including periodic changes in such controls; changes in U.S. immigration or trade policies, including the imposition of new or additional tariffs; labor claims and labor unrest; inflationary pressures, particularly in Argentina; impact of the United Kingdom&#8217;s exit from, and the related on-going negotiations with, the European Union; government-imposed price controls or other regulations; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the facilities of the Company and its suppliers being subject to disruption by events beyond the Company&#8217;s control, including work stoppages, cyber-attacks, natural disasters, disease outbreaks or pandemics, such as COVID-19, and terrorism;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to implement and generate cost savings and efficiencies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of the Company&#8217;s business strategies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to additional increases in the estimated fair value of The Procter &amp; Gamble Company&#8217;s interest in the Glad business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the accuracy of the Company&#8217;s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to attract and retain key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased focus by governmental and non-governmental organizations, customers, consumers and investors on sustainability issues, including those related to climate change;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to effectively utilize, assert and defend its intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any infringement or claimed infringement by the Company of third-party intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the Company&#8217;s indebtedness and credit rating on its business operations and financial results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to access capital markets and other funding sources, as well as continued or increased market volatility;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to pay and declare dividends or repurchase its stock in the future;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties relating to tax positions, tax disputes and any changes in tax rates and regulations on the Company;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to maintain an effective system of internal controls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of potential stockholder activism; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the Company&#8217;s discontinuation of operations in Venezuela. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s forward-looking statements in this Report are based on management&#8217;s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Report, unless the context requires otherwise, the terms &#8220;the Company,&#8221; &#8220;Clorox,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to The Clorox Company and its subsidiaries. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes to the Company&#8217;s market risk since June&#160;30, 2020. For additional information, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in the Company&#8217;s internal control over financial reporting occurred during the third fiscal quarter of the fiscal year ending June&#160;30, 2021, that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding Risk Factors, please refer to Item 1.A. in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020 and the information in &#8220;Cautionary Statement&#8221; included in this Report.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, the Board of Directors authorized the Company to repurchase up to $2,000 million in shares of common stock on the open market (the 2018 Open-Market Program), which has no expiration date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 1999, the Board of Directors authorized a stock repurchase program to reduce or eliminate dilution upon the issuance of common stock pursuant to the Company&#8217;s stock compensation plans (the Evergreen Program). In November 2005, the Board of Directors authorized the extension of the Evergreen Program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company&#8217;s 2005 Stock Incentive Plan. The Evergreen Program has no expiration date and has no specified limit as to dollar amount and therefore is not included in column [d] below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the purchases of the Company&#8217;s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the third quarter of fiscal year 2021. </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[a]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[b]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[c]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[d]</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid<br/>per Share (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased as<br/>Part of Publicly<br/>Announced Plans or<br/>Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maximum Number (or<br/>Approximate Dollar<br/>Value) of Shares that<br/>May Yet Be Purchased<br/>Under the Plans or<br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to 31, 2021</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,493 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to 28, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,428 million</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to 31, 2021</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,130&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.40&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,130&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,293 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.96&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Of the shares purchased in February 2021, 560,000 shares were acquired pursuant to the Evergreen Program and 350,000 shares were acquired pursuant to the Open-Market Program. All shares purchased in March 2021 were acquired pursuant to the Open-Market Program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Average price paid per share in the period includes commission.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Exhibit Index below, which is incorporated by reference herein.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit101.htm">The Clorox Company Annual Incentive Plan, amended and restated as of February 9, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit102.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit102.htm">The Clorox Company Executive Incentive Compensation Plan, amended and restated as of February 9, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit103.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit103.htm">The Clorox Company 2005 Stock Incentive Plan, First Amendment and Restatement as of November 14, 2012; Second Amendment and Restatement as of September 22, 2020; Third Amendment and Restatement as of February 9, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit104.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit104.htm">Form of Nonqualified Stock Option Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit105.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit105.htm">Form of Performance Share Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan for awards made in 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit106.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit106.htm">Form of Restricted Stock Unit Award Agreement under the Company's 2005 Stock Incentive Plan (Annual Grant).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit107.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="clxq3fy21exhibit107.htm">Form of Restricted Stock Unit Award Agreement under the Company's 2005 Stock Incentive Plan (Off-Cycle Grant).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit108.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit108.htm">Severance Plan for Clorox Executive Committee Members, third amended and restated effective February 9, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit311.htm">Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit312.htm">Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit32.htm">32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq3fy21exhibit32.htm">Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ib3b60db826a84bed9fbe6ae9e2f741c7_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE CLOROX COMPANY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE: April 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey R. Baker</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey R. Baker<br/>Vice President &#8211; Chief Accounting Officer and Corporate Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>clxq3fy21exhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id08d06c7466a4c68a146e0ca5e9e00e3_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Amended and Restated Effective</font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of February 9, 2021</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Purpose.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of The Clorox Company Annual Incentive Plan (the &#8220;Plan&#8221;) is to attract and retain the best available personnel for positions of substantial responsibility and to provide an incentive for employees of The Clorox Company, a Delaware corporation (the &#8220;Company&#8221;) and its subsidiaries to recognize and reward those employees.  The Company&#8217;s executives are eligible to earn short-term incentive awards under this Plan and under the Company&#8217;s Executive Incentive Compensation Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Definitions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms will have the following meaning for purposes of the Plan&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;Award&#8221; means a bonus paid in cash.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;Board&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;Chief Executive Officer&#8221; means the chief executive officer of the Company.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;Committee&#8221; means the Management Development and Compensation Committee of the Board, or such other Committee designated by the Board to administer the Plan.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;Employee&#8221; means any person employed by the Company or any Subsidiary.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;Executive Committee&#8221; means the executives who are members of the Company&#8217;s management executive committee.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;Vice President&#8221; means a regular salaried Employee scheduled to work more than 20 hours per week who is in salary grade 30 or above and who is not a member of the Executive Committee, but is a Vice President.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;Participant&#8221; means an Employee selected by the Committee to participate in the Plan.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;Retirement&#8221; means termination of employment with the Company, other than by reason of death or disability, (1)&#160;at age 65, (2)&#160;at least age 55 with at least ten years of vesting service, which solely for purposes of this Plan, shall be calculated under Article&#160;III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Participant with respect to the 401(k) Plan or (3)&#160;with at least 20 years of vesting service (as defined in clause&#160;(2)).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;Subsidiary&#8221; means any corporation in which the Company, directly or indirectly, controls 50 percent or more of the total combined voting power of all classes of stock.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;Year&#8221; means a fiscal year of the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Awards.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Within 90 days after the beginning of each Year, the Committee will select Participants for the Year and establish in writing the method by which the Awards will be calculated for that Year.  The Committee may provide for payment of all or part of the Award in the case of retirement, death, disability or change of ownership of control of the Company or a Subsidiary during the Year in accordance with Section&#160;409A (as defined in Section&#160;16 below).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">For the Chief Executive Officer and the Executive Committee, the Committee shall determine and certify the amount of the Award, if any, to be made.  The Committee may increase, decrease or eliminate, any Award calculated under the methodology established in accordance with paragraph&#160;(a) in order to reflect additional considerations relating to performance.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">For Vice Presidents and all other participants, the Chief Executive Officer shall determine and certify the amount of the Award, if any, to be made.  The Chief Executive Officer may increase, decrease or eliminate, any Award calculated under the methodology established in accordance with paragraph&#160;(a) in order to reflect additional considerations relating to performance.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Awards will be paid to the Participants following certification and no later than ninety (90) days following the close of the Year with respect to which the Awards are made, unless all or a portion of a Participant&#8217;s Award is deferred pursuant to the Participant&#8217;s timely and validly made election made in accordance with such terms as the Company, the Board or a committee thereof may determine.  A timely election is one that satisfies the requirements of Section&#160;409A (as defined in Section&#160;16 below) and typically for performance based compensation must be made at least six months before the end of the Performance Period, provided that the Participant performs services continuously from the later of the beginning of the Performance Period or the date the performance criteria are established through the date an election is made and provided further that in no event may a deferral be made after such compensation has become readily ascertainable as set forth in Section&#160;409A (as defined in Section&#160;16 below).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The Company shall withhold from the payment of any Award hereunder any amount required to be withheld for taxes.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">In the event of a restatement of the Company&#8217;s financial results to correct a material error resulting from fraud or intentional misconduct, as determined by the Board or the Committee, the Board, or the Committee, will review all compensation that was made pursuant to this Plan on the basis of having met or exceeded specific performance targets for performance periods beginning after June&#160;30, 2008 which occur during the years for which financial statements are restated.  If a lower payment of performance-based compensation would have been made to the Participants based upon the restated financial results, the Board or the Committee, as applicable, will, to the extent permitted by governing law and subject to the following sentence, seek to recoup for the benefit of the Company the amount by which the individual Participant&#8217;s Award(s) for the restated years exceeded the lower payment that would have been made based on the restated financial results, plus a reasonable rate of interest&#59; provided, however, that neither the Board nor the Committee will seek to recoup Awards paid more than three years prior to the date on which the Company announces the need for the applicable financial statements to be restated.  The Board, or the Committee, will only seek to recoup Awards paid to Participants whose fraud or intentional misconduct was a significant contributing factor to the need for such restatement, as determined by the Board or the Committee, as applicable. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notwithstanding the foregoing, this Section 3(f) shall not apply to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) and subject instead to the clawback provisions contained in the Policy, as provided in Section 7 hereof.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Termination of Employment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as may be specifically provided in an Award pursuant to Section&#160;3(a), a Participant shall have no right to an Award under the Plan for any Year in which the Participant is not actively employed by the Company or its Subsidiaries on June&#160;30 of such Year.  When establishing Awards each Year, the Committee may also provide that in the event a Participant is not employed by the Company or its Subsidiaries on the date on which the Award is paid, the Participant may forfeit his or her right to the Award paid under the Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Administration.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan will be administered by the Committee.  The Committee will have the authority to interpret the Plan, to prescribe rules relating to the Plan and to make all determinations necessary or advisable in administering the Plan.  Decisions of the Committee with respect to the Plan will be final and conclusive.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Unfunded Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards under the Plan will be paid from the general assets of the Company, and the rights of Participants under the Plan will be only those of general unsecured creditors of the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Clawback. </font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Policy) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Amendment or Termination of the Plan.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee may from time to time suspend, revise, amend or terminate the Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Applicable Law.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent not preempted by federal law, the Plan shall be construed in accordance with and governed by the laws of the State of California, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">No Rights to Employment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing contained in the Plan shall give any person the right to be retained in the employment of the Company or any of its Subsidiaries.  The Company reserves the right to terminate any Participant at any time for any reason notwithstanding the existence of the Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">No Assignment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise required by applicable law, any interest, benefit, payment, claim or right of any Participant under the Plan shall not be sold, transferred, assigned, pledged, encumbered or hypothecated by any Participant and shall not be subject in any manner to any claims of any creditor of any Participant or beneficiary, and any attempt to take any such action shall be null and void.  During the lifetime of any Participant, payment of an Award shall only be made to such Participant.  Notwithstanding the foregoing, the Committee may establish such procedures as it deems necessary for a Participant to designate a beneficiary to whom any amounts would be payable in the event of any Participant&#8217;s death.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Gender, Number and References.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular and the singular shall include the plural.  Any reference in the Plan to a Section of the Plan either in the Plan or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Severability.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any one or more of the provisions contained in this Plan, or any application thereof, shall be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and all other applications thereof shall not in any way be affected or impaired thereby.  This Plan shall be construed and enforced as if such invalid, illegal or unenforceable provision has never comprised a part hereof, and the remaining provisions hereof shall remain in full force and effect and shall not be affected by the invalid, illegal or unenforceable provision or by its severance herefrom.  In lieu of such invalid, illegal or unenforceable provisions there shall be added automatically as a part hereof a provision as similar in terms and economic effect to such invalid, illegal or unenforceable provision as may be possible and be valid, legal and enforceable.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Requirements of Law.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of cash under the Plan shall be subject to all applicable laws and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Non-Exclusive Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of the Plan by the Board shall not be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Section&#160;409A Compliance.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent applicable, it is intended that this Plan and any Awards granted hereunder comply with the requirements of Section&#160;409A of the Code and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section&#160;409A&#8221;).  Any provision that would cause the Plan or any Award granted hereunder to fail to satisfy Section&#160;409A shall have no force or effect until amended to comply with Section&#160;409A, which amendment may be retroactive to the extent permitted by Section&#160;409A.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>clxq3fy21exhibit102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3606f129c4164db8bd88afaec280843a_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE INCENTIVE COMPENSATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Amended and Restated Effective</font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of February&#160;9, 2021</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Establishment, Objectives, Duration.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company, a Delaware corporation (hereinafter referred to as the &#8220;Company&#8221;) hereby establishes a short-term incentive compensation plan to be known as the &#8220;The Clorox Company Executive Incentive Compensation Plan&#8221; (hereinafter referred to as the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Plan is to enhance the Company&#8217;s ability to attract and retain highly qualified executives and to provide such executives with additional financial incentives to promote the success of the Company and its Subsidiaries.  Awards payable under the Plan are intended to constitute &#8220;performance-based compensation&#8221; under Section&#160;162(m) of the Code and the regulations promulgated thereunder, and the Plan shall be construed consistently with such intention.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is effective as of July&#160;1, 2005, subject to the approval of the Plan by the stockholders of the Company at the 2005 Annual Meeting.  The Plan will remain in effect until such time as it shall be terminated by the Board or the Committee, pursuant to Section&#160;11 herein.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Definitions.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms, when capitalized, shall have the meanings set forth below&#58;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a bonus paid in cash, Shares or any combination thereof.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Committee, as specified in Section&#160;3(a), appointed by the Board to administer the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Clorox Company.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings Before Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the earnings before income taxes of the Company as reported in the Company&#8217;s income statement for the applicable Performance Period.  For purposes of the foregoing definition, Earnings Before Income Taxes shall be adjusted to exclude the impact of charges for restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring items, as well as the cumulative effect of tax or accounting changes, each as determined in accordance with generally accepted accounting principles or identified in the Company&#8217;s financial statements, notes to the financial statements, management&#8217;s discussion and analysis or other filings with the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of a Share determined as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:8.57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)Where there exists a public market for the Share, the Fair Market Value shall be (A)&#160;the closing sales price for a Share on the date of the determination (or, if no sales were reported on that date, on the last trading date on which sales were reported) on the New York Stock Exchange, the NASDAQ Global Market or the principal securities exchange on which the Share is listed for trading, whichever is applicable, or (B)&#160;if the Share is not traded on any such exchange or national market system, the average of the closing bid and asked prices of a Share on the NASDAQ Capital Market, in each case, as reported in The Wall Street Journal or such other source as the Committee deems reliable&#59; or</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:5.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)In the absence of an established market of the type described above for the Share, the Fair Market Value thereof shall be determined by the Committee in good faith, and such determination shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s Chief Executive Officer and each other executive officer of the Company that the Committee determines, in its discretion, is or may be a &#8220;covered employee&#8221; of the Company within the meaning of Section&#160;162(m) of the Code and regulations promulgated thereunder who is selected by the Committee to participate in the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the fiscal year of the Company, or such shorter or longer period as determined by the Committee&#59; provided, however, that a Performance Period shall in no event be less than six (6) months nor more than five (5) years.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Clorox Company Executive Incentive Compensation Plan.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a share of common stock of the Company, par value $1.00 per share.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation in which the Company owns, directly or indirectly, at least fifty percent (50%) of the total combined voting power of all classes of stock, or any other entity (including, but not limited to, partnerships and joint ventures) in which the Company owns, directly or indirectly, at least fifty percent (50%) of the combined equity thereof.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Administration of the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">The Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan shall be administered by the Management Development and Compensation Committee of the Board or such other committee (the &#8220;Committee&#8221;) as the Board shall select consisting of two or more members of the Board each of whom is intended to be a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 (or any successor rule) of the Exchange Act, an &#8220;outside director&#8221; under regulations promulgated under Section&#160;162(m) of the Code, and an &#8220;independent director&#8221; under New York Stock Exchange Listing standards.  The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Authority of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to applicable laws and the provisions of the Plan (including any other powers given to the Committee hereunder), and except as otherwise provided by the Board, the Committee shall have full and final authority in its discretion to establish rules and take all actions, including, without limitation, interpreting the terms of the Plan and any related rules or regulations or other documents enacted hereunder and deciding all questions of fact arising in their application, determined by the Committee to be necessary in the administration of the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Effect of Committee&#8217;s Decision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions, determinations and interpretations of the Committee shall be final, binding and conclusive on all persons, including the Company, its Subsidiaries, its stockholders, the Participants and their estates and beneficiaries.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Eligibility.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eligibility under this Plan is limited to Participants designated by the Committee, in its sole and absolute discretion.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Form of Payment of Awards.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Awards under the Plan shall be made in cash, Shares or a combination thereof, as the Committee shall determine, subject to the limitations set forth in Sections&#160;6 and 7 herein.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Shares Subject to the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Award payments that are made in the form of Shares, in whole or in part, shall be made from the aggregate number of Shares authorized to be issued under and otherwise in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (or any successor stock incentive plan approved by the stockholders of the Company).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Awards.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Selection of Participants and Designation of Performance Period and Terms of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within 90 days after the beginning of each Performance Period or, if less than 90 days, the number of days which is equal to twenty-five percent (25%) of the relevant Performance Period applicable to an Award, the Committee shall, in writing, (i)&#160;select the Participants to whom Awards shall be granted, (ii)&#160;designate the applicable Performance Period, and (iii)&#160;specify terms and conditions for the determination and payment of the Award for each Participant for such Performance Period, including, without limitation, the extent to which the Participant shall have the right to receive an Award following termination of the Participant&#8217;s employment.  Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Awards, and may reflect distinctions based on the reasons for termination of employment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Maximum Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The maximum Award that may be paid to any Participant other than the Company&#8217;s chief executive officer under the Plan for any Performance Period shall not exceed 0.6% of Earnings Before Income Taxes.  The maximum Award that may be paid to the Company&#8217;s chief executive officer under the Plan for any Performance Period shall not exceed 1.0% of Earnings Before Income Taxes.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Actual Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the limitation set forth in paragraph&#160;(b) hereof, each Participant under the Plan shall be eligible to receive an Award equal to 0.6% of Earnings Before Income Taxes for the designated Performance Period, except for the Company&#8217;s chief executive officer who shall be eligible to receive an Award equal to 1.0% of Earnings Before Income Taxes for the designated Performance Period&#59; provided, however, that the Committee may condition payment of an Award upon the satisfaction of such objective or subjective standards as the Committee shall determine to be appropriate, in its sole and absolute discretion, and shall </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retain the discretion to reduce the amount of any Award that would otherwise be payable to a Participant, including a reduction in such amount to zero.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:8.57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of a restatement of the Company&#8217;s financial results to correct a material error resulting from fraud or intentional misconduct, as determined by the Board or the Committee, the Board, or the Committee, will review all compensation that was made pursuant to this Plan on the basis of having met or exceeded specific performance targets for performance periods beginning after June&#160;30, 2008 which occur during the years for which financial statements are restated.  If a lower payment of performance-based compensation would have been made to the Participants based upon the restated financial results, the Board or the Committee, as applicable, will, to the extent permitted by governing law and subject to the following sentence, seek to recoup for the benefit of the Company the amount by which the individual Participant&#8217;s Award(s) for the restated years exceeded the lower payment that would have been made based on the restated financial results, plus a reasonable rate of interest&#59; provided, however, that neither the Board nor the Committee will seek to recoup Awards paid more than three years prior to the date on which the Company announces the need for the applicable financial statements to be restated.  The Board, or the Committee, will only seek to recoup Awards paid to Participants whose fraud or intentional misconduct was a significant contributing factor to the need for such restatement, as determined by the Board or the Committee, as applicable. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notwithstanding the foregoing, this Section 7(d)(i) shall not apply to Participants who are  &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) and subject instead to the clawback provisions contained in the Policy, as provided in Section 7(d)(ii) hereof.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:5.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Policy) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Committee Certification and Payment of Awards.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As soon as reasonably practicable following the end of each Performance Period, the Committee shall determine the amount of the Award to be paid to each Participant for such Performance Period and shall certify such determination in writing.  Awards shall be paid to the Participants following such certification by the Committee no later than ninety (90) days following the close of the Performance Period with respect to which the Awards are made, unless all or a portion of a Participant&#8217;s Award is deferred pursuant to the Participant&#8217;s timely and validly made election made in accordance with such terms as the Company, the Board or a committee thereof may determine.  A timely election is one that satisfies the requirements of Section&#160;409A (as defined in Section&#160;14(g) below) and typically for performance based compensation must be made at least six months before the end of the Performance Period, provided that the Participant performs services continuously from the later of the beginning of the Performance Period or the date the performance criteria are established through the date an election is made and provided further that in no event may a deferral be made after such compensation has become readily ascertainable as set forth in Code Section&#160;409A (as defined in Section&#160;14(g) below).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Termination of Employment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as may be specifically provided in an Award pursuant to Section&#160;7(a) or in any written agreement executed between the Participant and the Company, including employment or change in control agreements, a Participant shall have no right to an Award under the Plan for any Performance Period in which the Participant is not actively employed by the Company or a Subsidiary on the last day of the Performance Period to which such Award relates.  In establishing Awards under Section&#160;7(a), the Committee may also provide that in the event a Participant is not employed by the Company or a Subsidiary on the date on which the Award is paid, the Participant may forfeit his or her right to the Award paid under the Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Taxes.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall have the power and right to deduct or withhold, or require a Participant to remit to the Company (or a Subsidiary), an amount (in cash or Shares) sufficient to satisfy any applicable tax withholding requirements applicable to an Award.  Whenever under the Plan payments are to be made in cash, such payments shall be net of an amount sufficient to satisfy any applicable tax withholding requirements.  Subject to such restrictions as the Committee may prescribe, a Participant may satisfy all or a portion of any tax withholding requirements relating to Awards payable in Shares by electing to have the Company withhold Shares having a Fair Market Value equal to the amount to be withheld.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Amendment or Termination of the Plan.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board or the Committee may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part&#59; provided, however, that no amendment that requires stockholder approval in order to maintain the qualification of Awards as performance-based compensation pursuant to Code Section&#160;162(m) and regulations promulgated thereunder shall be made without such stockholder approval.  If changes are made to Code Section&#160;162(m) or regulations promulgated thereunder to permit greater flexibility with respect to any Award or Awards available under the Plan, the Committee may, subject to this Section&#160;11, make any adjustments to the Plan and&#47;or Awards it deems appropriate.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">No Rights to Employment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan shall not confer upon any Participant any right with respect to continuation of employment with the Company, nor shall it interfere in any way with his or her right or the Company&#8217;s right to terminate his or her employment at any time, with or without cause.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">No Assignment.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise required by applicable law, any interest, benefit, payment, claim or right of any Participant under the Plan shall not be sold, transferred, assigned, pledged, encumbered or hypothecated by any Participant and shall not be subject in any manner to any claims of any creditor of any Participant or beneficiary, and any attempt to take any such action shall be null and void.  During the lifetime of any Participant, payment of an Award shall only be made to such Participant.  Notwithstanding the foregoing, the Committee may establish such procedures as it deems necessary for a Participant to designate a beneficiary to whom any amounts would be payable in the event of any Participant&#8217;s death.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Legal Construction.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Gender, Number and References</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular and the singular shall include the plural.  Any reference in the Plan to a Section of the Plan either in the Plan or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any one or more of the provisions contained in this Plan, or any application thereof, shall be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and all other applications thereof shall not in any way be affected or impaired thereby.  This Plan shall be construed and enforced as if such invalid, illegal or unenforceable provision has never comprised a part hereof, and the remaining provisions hereof shall remain in full force and effect and shall not be affected by the invalid, illegal or unenforceable provision or by its severance herefrom.  In lieu of such invalid, illegal or unenforceable provisions there shall be added automatically as a part hereof a provision as similar in terms and economic effect to such invalid, illegal or unenforceable provision as may be possible and be valid, legal and enforceable.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The granting of Awards and the issuance of cash or Shares under the Plan shall be subject to all applicable laws and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Unfunded Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Awards under the Plan will be paid from the general assets of the Company, and the rights of Participants under the Plan will be only those of general unsecured creditors of the Company.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent not preempted by federal law, the Plan shall be construed in accordance with and governed by the laws of the State of California, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt;text-decoration:underline">Non-Exclusive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Code Section&#160;409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that this Plan and any Awards granted hereunder comply with the requirements of Section&#160;409A of the Code and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section&#160;409A&#8221;).  Any provision that would cause the Plan or any Award granted hereunder to fail to satisfy Section&#160;409A shall have no force or effect until amended to comply with Section&#160;409A, which amendment may be retroactive to the extent permitted by Section&#160;409A.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>clxq3fy21exhibit103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i710a1b9a9c6348d4b378d35f8f5b6b28_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of November 16, 2005</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First Amendment and Restatement as of November 14, 2012</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second Amendment and Restatement as of September 22, 2020</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third Amendment and Restatement as of February 9, 2021</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Establishment, Objectives and Duration. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Clorox Company, a Delaware corporation (hereinafter referred to as the &#8220;Company&#8221;), hereby establishes an incentive compensation plan to be known as &#8220;The Clorox Company 2005 Stock Incentive Plan&#8221; (hereinafter referred to as the &#8220;Plan&#8221;). The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Stock-Based Awards. The Plan was originally adopted effective as of November 16, 2005 and was subsequently amended and restated effective as of November 14, 2012 (the &#8220;Effective Date&#8221;) and as of September 22, 2020. The current amendment and restatement of the Plan is adopted effective as of February 9, 2021.  Definitions of capitalized terms used in the Plan are contained in the attached Glossary, which is an integral part of the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Objectives of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The objectives of the Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to Participants and to optimize the profitability and growth of the Company through incentives that are consistent with the Company&#8217;s goals and that link the personal interests of Participants to those of the Company&#8217;s stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of Participants who make or are expected to make significant contributions to the Company&#8217;s success and to allow Participants to share in the success of the Company. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Duration of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Award may be granted under the Plan after the day immediately preceding the tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Effective Date, or such earlier date as the Board or the Committee shall determine. The Plan will remain in effect with respect to outstanding Awards until no Awards remain outstanding.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Administration of the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Management Development and Compensation Committee of the Board or such other committee (the &#8220;Committee&#8221;) as the Board shall select consisting of two or more members of the Board, each of whom is intended to be an &#8220;independent director&#8221; under New York Stock Exchange listing standards and also may be a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 (or any successor rule) of the Exchange Act and&#47;or an &#8220;outside director&#8221; under regulations promulgated under Section 162(m) of the Code. The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Authority of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Committee hereunder), and except as otherwise provided by the Board, the Committee shall have full and final authority in its discretion to take all actions determined by the Committee to be necessary in the administration of the Plan, including, without limitation, discretion to&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) select the Employees, Directors and Consultants to whom Awards may from time to time be granted hereunder&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) determine whether and to what extent Awards are granted hereunder&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) determine the size and types of Awards granted hereunder&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) approve forms of Award Agreement for use under the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) determine the terms and conditions of any Award granted hereunder&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:7.5pt;padding-right:7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) establish performance goals for any Performance Period and determine whether such goals were satisfied&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) amend the terms of any outstanding Award granted under the Plan, whether in the event of a Participant&#8217;s termination of employment, in the event of a Change in Control or otherwise, provided that, except as otherwise provided in Section 18, no such amendment shall reduce the Exercise Price of an outstanding Option or the grant price of an outstanding SAR, and at any time when the Exercise Price of an outstanding Option or the grant price of an outstanding SAR is above the Fair Market Value of a share of Common Stock, no such amendment shall provide for the cancellation and re-grant or the exchange of any such outstanding Option or SAR for either cash or a new Award with a lower (or no) exercise price without the approval of the stockholders of the Company, and provided further, that any amendment that would materially adversely affect the Participant&#8217;s rights under an outstanding Award shall not be made without the Participant&#8217;s written consent&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii) construe and interpret the terms of the Plan and any Award Agreement entered into under the Plan, and to decide all questions of fact arising in its application&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix) take such other action, not inconsistent with the terms of the Plan, as the Committee deems appropriate.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except to the extent prohibited by Applicable Laws, the Committee may delegate its authority as identified herein, including the power and authority to make Awards to Participants who are not &#8220;insiders&#8221; subject to Section 16(b) of the Exchange Act, Awards intended to satisfy the Performance-Based Exception and&#47;or Awards intended to satisfy the exception under Rule 16b-3(d)(1) promulgated under the Exchange Act, pursuant to such conditions and limitations as the Committee may establish. References to the Committee in this Plan shall refer to a delegate with respect to any action of such delegate within the scope of the authority delegated to such delegate by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Committee&#8217;s Decision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All decisions, determinations and interpretations of the Committee shall be final, binding and conclusive on all persons, including the Company, its Subsidiaries, its stockholders, Employees, Directors, Consultants and their estates and beneficiaries. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Shares Subject to the Plan&#59; Effect of Grants&#59; Individual Limits.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares Available for Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to adjustment as provided in Section 18 hereof, the maximum number of Shares which may be issued pursuant to Awards under the Plan granted after June 30, 2012 shall be 7,100,000 Shares, plus the number of Shares deemed not issued under the Plan or the Prior Plans pursuant to paragraphs (i), (ii), (iii) or (iv) of this Section 3(a). For the avoidance of doubt, the Company shall be entitled to issue Shares under awards granted under the Plan or the Prior Plans that were outstanding on June 30, 2012 and such issuances shall not reduce the foregoing. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) Shares that are potentially deliverable under an Award or a Prior Plan award that expires or is canceled, forfeited, settled in cash or otherwise settled without the delivery of Shares shall not be treated as having been issued under the Plan or a Prior Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) Shares that are held back or tendered (either actually or constructively by attestation) to cover the exercise price or tax withholding obligations with respect to an Award or Prior Plan award shall not be treated as having been issued under the Plan or a Prior Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) Shares that are issued pursuant to awards that are assumed, converted or substituted in connection with a merger, acquisition, reorganization or similar transaction shall not be treated as having been issued under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) Shares that are repurchased in the open market with Option Proceeds from Awards or Prior Plan awards shall not be treated as having been issued under the Plan or a Prior Plan&#59; provided, however, that the aggregate number of Shares deemed not issued pursuant to the repurchase of Shares with Option Proceeds shall not be greater than the amount of such proceeds divided by the Fair Market Value of a Share on the date of exercise of the Option or Prior Plan option giving rise to such proceeds. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding paragraphs (i) through (iv) above, for purposes of determining the number of Shares available for grant as Incentive Stock Options, only Shares that are subject to an Award or a Prior Plan award that expires or is cancelled, forfeited or settled in cash shall be treated as not having been issued under the Plan or a Prior Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shares to be issued pursuant to Awards may be authorized but unissued Shares or treasury Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Individual Limits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to adjustment as provided in Section 18 hereof, the following rules shall apply with respect to Awards&#58; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) Options and SARs&#58; The maximum aggregate number of Shares with respect to which Options and SARs may be granted in any 36-month period to any one Participant shall be 2,000,000 Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) Restricted Stock, Restricted Stock Units, Performance Shares and Other Stock-Based Awards&#58; The maximum aggregate number of Shares of Restricted Stock and Shares with respect to which Restricted Stock Units, Performance Shares and Other Stock-Based Awards may be granted in any 36-month period to any one Participant shall be 800,000 Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) Performance Units&#58; The maximum aggregate compensation that can be paid pursuant to Performance Units awarded in any one fiscal year to any one Participant shall be $10,000,000 or a number of Shares having an aggregate Fair Market Value on the date of grant not in excess of such amount.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Eligibility and Participation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Persons eligible to participate in the Plan include all Employees, Directors and Consultants. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Actual Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the provisions of the Plan, the Committee may, from time to time, select from all eligible Employees, Directors and Consultants, those to whom Awards shall be granted and shall determine the nature and amount of each Award. The Committee may establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable foreign jurisdictions and to afford Participants favorable treatment under such laws&#59; provided, however, that no Award shall be granted under any such additional terms, conditions, rules or procedures with terms or conditions which are inconsistent with the provisions of the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Types of Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Type of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards under the Plan may be in the form of Options (both Nonqualified Stock Options and&#47;or Incentive Stock Options), SARs, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Stock-Based Awards. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designation of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award shall be designated in the Award Agreement. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Options.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, Options may be granted to Participants in such number and upon such terms, and at any time and from time to time, as shall be determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Option grant shall be evidenced by an Award Agreement that shall specify the Exercise Price, the duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine including, but not limited to, the Option vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement of the Award, and payment contingencies. The Award Agreement also shall specify whether the Option is intended to be an Incentive Stock Option or a Nonqualified Stock Option. Options that are intended to be Incentive Stock Options shall be subject to the limitations set forth in Section 422 of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for Options adjusted pursuant to Section 18 herein, and replacement Options granted in connection with a merger, acquisition, reorganization or similar transaction, the Exercise Price for each grant of an Option shall not be less than one hundred percent (100%) of the Fair Market Value of a Share on the date the Option is granted. However, in the case of an Incentive Stock Option granted to a Participant who, at the time the Option is granted, owns stock representing more </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">than ten percent (10%) of the voting power of all classes of stock of the Company or any Subsidiary, the Exercise Price for each grant of an Option shall not be less than one hundred ten percent (110%) of the Fair Market Value of a Share on the date the Option is granted. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Term of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of an Option granted under the Plan shall be determined by the Committee, in its sole discretion&#59; provided, however, that such term shall not exceed ten (10) years. However, in the case of an Incentive Stock Option granted to a Participant who, at the time the Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Award Agreement. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Options granted under this Section 6 shall be exercisable at such times and be subject to such restrictions and conditions as set forth in the Award Agreement and as the Committee shall in each instance approve, which need not be the same for each grant or for each Participant. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Options granted under this Section 6 shall be exercised by the delivery of a written notice to the Company, setting forth the number of Shares with respect to which the Option is to be exercised and specifying the method of the Exercise Price. The Exercise Price of an Option shall be payable to the Company&#58; (i) in cash or its equivalent, (ii) by tendering (either actually or constructively by attestation or through authorization to withhold Shares otherwise issuable upon exercise of an Option) Shares having an aggregate Fair Market Value at the time of exercise equal to the Exercise Price, (iii) in any other manner then permitted by the Committee that is determined to provide a benefit to the Company, or (iv) by a combination of any of the permitted methods of payment. The Committee may limit any method of payment, other than that specified under (i), for administrative convenience, to comply with Applicable Laws or otherwise. Shares issued upon exercise shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictions on Share Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an Option granted under this Section 6 as it may deem advisable, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and&#47;or traded, and under any blue sky or state securities laws applicable to such Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant&#8217;s Option Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&#8217;s employment or, if the Participant is a Director or Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Options, and may reflect distinctions based on the reasons for termination of employment or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Repricing without Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall not, without the approval of the stockholders of the Company, reduce the Exercise Price of an outstanding Option. And, at any time when the Exercise Price of an outstanding Option is above the Fair Market Value of a share of Common Stock, the Company shall not, without the approval of the stockholders of the Company, provide for the cancellation and re-grant or the exchange of such outstanding Option for either cash or a new Award with a lower (or no) exercise price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Stock Appreciation Rights.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, SARs may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee. The Committee may grant Freestanding SARs, Tandem SARs, or any combination of these forms of SAR. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each SAR grant shall be evidenced by an Award Agreement that shall specify the grant price, the term of the SAR, and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The grant price of a Freestanding SAR shall not be less than one hundred percent (100%) of the Fair Market Value of a Share on the date of grant of the SAR, and the grant price of a Tandem SAR shall equal the Exercise Price of the related Option&#59; provided, however, that these limitations shall not apply to Awards that are adjusted pursuant to Section 18 herein. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Term of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of a SAR granted under the Plan shall be determined by the Committee, in its sole discretion&#59; provided, however, that such term shall not exceed ten (10) years.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Tandem SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Tandem SAR may be exercised only with respect to the Shares for which its related Option is then exercisable. To the extent exercisable, Tandem SARs may be exercised for all or part of the Shares subject to the related Option. The exercise of all or part of a Tandem SAR shall result in the forfeiture of the right to purchase a number of Shares under the related Option equal to the number of Shares with respect to which the SAR is exercised. Conversely, upon exercise of all or part of an Option with respect to which a Tandem SAR has been granted, an equivalent portion of the Tandem SAR shall similarly be forfeited.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision of the Plan to the contrary, with respect to a Tandem SAR granted in connection with an ISO&#58; (i) the Tandem SAR will expire no later than the expiration of the underlying ISO&#59; (ii) the value of the payout with respect to the Tandem SAR may be for no more than one hundred percent (100%) of the difference between the Exercise Price of the underlying ISO and the Fair Market Value of the Shares subject to the underlying ISO at the time the Tandem SAR is exercised&#59; and (iii) the Tandem SAR may be exercised only when the Fair Market Value of the Shares subject to the ISO exceeds the Exercise Price of the ISO.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Freestanding SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Freestanding SARs may be exercised upon whatever terms and conditions the Committee, in its sole discretion, imposes upon them and sets forth in the Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of SAR Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the difference between the Fair Market Value of a Share on the date of exercise over the grant price&#59; by</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the number of Shares with respect to which the SAR is exercised.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the discretion of the Committee, the payment upon SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof. Shares issued upon SAR exercise shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each SAR Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the SAR following termination of the Participant&#8217;s employment or, if the Participant is a Director or Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all SARs, and may reflect distinctions based on the reasons for termination of employment or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Repricing without Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall not, without the approval of the stockholders of the Company, reduce the grant price of an outstanding SAR. And at any time when the grant price of an outstanding SAR is above the Fair Market Value of a share of Common Stock, the Company shall not, without the approval of the stockholders of the Company, provide for the cancellation and re-grant or the exchange of such outstanding SAR for either cash or a new Award with a lower (or no) exercise price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Restricted Stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, Restricted Stock may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Restricted Stock grant shall be evidenced by an Award Agreement that shall specify the applicable restrictions, the number of Shares of Restricted Stock granted and issued on the grant date, and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall impose such other conditions and&#47;or restrictions on any Shares of Restricted Stock granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Share of Restricted Stock, a requirement that the issuance of Shares of Restricted Stock be delayed, restrictions based upon the achievement of specific performance goals, time-based restrictions requiring a minimum period of service as a condition of vesting any or all Shares of Restricted Stock, and&#47;or restrictions under Applicable Laws or under the requirements of any stock exchange or market upon which such Shares are listed or traded, or holding requirements or sale restrictions placed on the Shares by the Company upon vesting of such Restricted Stock. The Company may retain in its custody any certificate evidencing the Shares of Restricted Stock and place thereon a legend and institute stop-transfer orders on such Shares, and the Participant shall be obligated to sign any stock power requested by the Company relating to the Shares to give effect to the forfeiture provisions and any other restrictions of the Restricted Stock. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Removal of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Applicable Laws, Restricted Stock shall become freely transferable by the Participant after the lapse of all of the restrictions applicable thereto. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise determined by the Committee and set forth in a Participant&#8217;s Award Agreement, to the extent permitted or required by Applicable Laws, as determined by the Committee, Participants holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends and Other Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in a Participant&#8217;s Award Agreement, to the extent permitted or required under Applicable Laws, Participants holding Shares of Restricted Stock shall receive all regular cash Dividends paid with respect to all Shares while they are so held, and, except as otherwise determined by the Committee, to the extent permitted or required under Applicable Laws, all other distributions paid with respect to such Restricted Stock shall be credited to Participants subject to the same restrictions on transferability and forfeitability as the Restricted Stock with respect to which they were paid and shall be delivered to Participants in conjunction with the Shares of Restricted Stock with respect to which such distributions were made. Notwithstanding the foregoing, Dividends or other distributions that relate to performance-based Restricted Stock will be subject to the same performance conditions as the underlying Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award Agreement shall set forth the extent to which the Participant shall have the right to retain unvested Restricted Stock following termination of the Participant&#8217;s employment or, if the Participant is a Director or Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Awards of Restricted Stock, and may reflect distinctions based on the reasons for termination of employment or service. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Restricted Stock Units. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, Restricted Stock Units may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each grant of Restricted Stock Units shall be evidenced by an Award Agreement that shall specify the applicable restrictions, the number of Restricted Stock Units granted, and such other provisions as the Committee shall determine. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Value of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The initial value of a Restricted Stock Unit shall equal the Fair Market Value of a Share on the date of grant&#59; provided, however, that this restriction shall not apply to Awards that are adjusted pursuant to Section 18 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall impose such other conditions and&#47;or restrictions on any Restricted Stock Units and&#47;or the Shares issuable upon the settlement of Restricted Stock Units granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Restricted Stock Unit, time-based restrictions requiring a minimum period of service as a condition of settlement of any or all Restricted Stock Units, and&#47;or restrictions under Applicable Laws or under the requirements of any stock exchange or market, or holding requirements or sale restrictions placed on any Shares issued by the Company upon vesting and in settlement of such Restricted Stock Units. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in Section 19 herein or a Participant&#8217;s Award Agreement, payment of Restricted Stock Units shall be made at a specified settlement date that shall not be earlier than the last day that any time-based restrictions have lapsed. The Committee, in its sole discretion, may settle Restricted Stock Units by delivery of Shares or by payment in cash of an amount equal to the Fair Market Value of such Shares (or a combination thereof). The Committee may provide that settlement of Restricted Stock Units shall be deferred, either on a mandatory basis or at the election of the Participant. Shares issued at the settlement date shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award Agreement shall set forth the extent to which the Participant shall have the right to receive a payout respecting an Award of Restricted Stock Units following termination of the Participant&#8217;s employment or, if the Participant is a Director or Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Restricted Stock Units, and may reflect distinctions based on the reasons for termination of employment or service. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends and Other Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares underlying Restricted Stock Units shall be entitled to Dividends or other distributions only to the extent provided by the Committee. In the event that the Committee decides to grant Restricted Stock Units that are entitled to Dividends or other distributions, Dividends or other distributions that relate to performance-based Restricted Stock Units shall be subject to the same performance conditions as the underlying Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Performance Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, Performance Shares may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each grant of Performance Shares shall be evidenced by an Award Agreement that shall specify the applicable Performance Period(s) and Performance Measure(s), the number of Performance Shares granted and issued on the grant date, and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period and Other Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall impose such conditions and&#47;or restrictions on any Performance Shares granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Performance Share, time-based restrictions requiring a minimum period of service as a condition of vesting of any or all Performance Shares, and&#47;or restrictions under Applicable Laws or under the requirements of any stock exchange or market upon which the Shares are listed or traded, or holding requirements or sale restrictions placed on the Shares by the Company upon vesting of such Performance Shares. The Company may retain in its custody any certificate evidencing the Shares and place thereon a legend and institute stop-transfer orders on such Shares, and the Participant shall be obligated to sign any stock power requested by the Company relating to the Shares to give effect to the forfeiture provisions and any other restrictions of the Performance Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Removal of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Applicable Laws, Performance Shares shall become freely transferable by the Participant after the lapse of all of the restrictions applicable thereto. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise determined by the Committee and set forth in a Participant&#8217;s Award Agreement, to the extent permitted or required by Applicable Laws, as determined by the Committee, Participants holding Performance Shares granted hereunder may exercise full voting rights with respect to those Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends and Other Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in a Participant&#8217;s Award Agreement, to the extent permitted or required under Applicable Laws, Participants holding Performance Shares shall receive all regular cash Dividends paid with respect to all Shares while they are so held&#59; provided, however, that all Dividends or other distributions shall be subject to the same performance conditions as the underlying Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award Agreement shall set forth the extent to which the Participant shall have the right to retain unvested Performance Shares following termination of the Participant&#8217;s employment or, if the Participant is a Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Participants, and may reflect distinctions based on the reasons for termination of employment or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Performance Units.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Performance Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms and conditions of the Plan, Performance Units may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each grant of Performance Units shall be evidenced by an Award Agreement that shall specify the number of Performance Units granted, the Performance Period(s) and Performance Measure(s), the performance goals and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Value of Performance Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall set performance goals in its discretion that, depending on the extent to which they are met, will determine the number and&#47;or value of Performance Units that will be paid out to the Participants.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in Section 19 herein or a Participant&#8217;s Award Agreement, payment of Performance Units shall be made following the close of the applicable Performance Period on a settlement date selected by the Committee. The Committee, in its sole discretion, may settle Performance Units in cash or in Shares that have an aggregate Fair Market Value equal to the value of the Performance Units (or a combination thereof). The Committee may provide that settlement of Performance Units shall be deferred, either on a mandatory basis or at the election of the Participant. Shares issued at the settlement date shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant shall have no voting rights with respect to any Performance Units granted hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award Agreement shall set forth the extent to which the Participant shall have the right to receive a payout respecting an Award of Performance Units following termination of the Participant&#8217;s employment or, if the Participant is a Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Performance Units and may reflect distinctions based on reasons for termination of employment or service. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends and Other Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares underlying Performance Units shall be entitled to Dividends or other distributions only to the extent provided by the Committee. In the event that the Committee decides to grant Performance Units that are entitled to Dividends or other distributions, Dividends or other distributions shall be subject to the same performance conditions as the underlying Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Other Stock-Based Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the right to grant other Awards that may include, without limitation, the grant of Shares based on attainment of performance goals established by the Committee, the payment of Shares as a bonus or in lieu of cash based on attainment of performance goals established by the Committee, and the payment of Shares in lieu of cash under other Company incentive or bonus programs. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall impose such conditions and&#47;or restrictions on Other Stock-Based Awards granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Share subject to the Award, time-based restrictions requiring a minimum period of service as a condition of vesting in any or all Shares subject to the Award, and&#47;or restrictions under Applicable Laws or under the requirements of any stock exchange or market, or holding requirements or sale restrictions placed on any Shares issued by the Company upon vesting and in settlement of Other Stock-Based Awards. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Other Stock-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Settlement of any such Awards shall be made in such manner and at such times as the Committee may determine. The Committee may provide that settlement of Other Stock-Based Awards shall be deferred, either on a mandatory basis or at the election of the Participant. Shares issued upon settlement shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine the extent to which the Participant shall have the right to receive Other Stock-Based Awards following termination of the Participant&#8217;s employment or, if the Participant is a Director or Consultant, service with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, such provisions may be included in an agreement entered into with each Participant, but need not be uniform among all Other Stock-Based Awards, and may reflect distinctions based on the reasons for termination of employment or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Equivalents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At the discretion of the Committee, Awards granted pursuant to the Plan may provide Participants with the right to receive Dividend Equivalents, which may be paid currently or credited to an account for the Participants, and may be settled in cash and&#47;or Shares, as determined by the Committee in its sole discretion, subject in each case to such terms and conditions as the Committee shall establish. Notwithstanding the foregoing, Dividend Equivalents that relate to performance-based Awards will either not be made at all or shall be subject to the same performance conditions as the underlying Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Performance-Based Exception.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Committee may specify that the attainment of one or more of the Performance Measures set forth in this Section 14 shall determine the degree of granting, vesting and&#47;or payout with respect to Awards that the Committee intends will qualify for the Performance-Based Exception. The performance goals to be used for such Awards shall be chosen from among the following performance measures (the &#8220;Performance Measures&#8221;)&#58; total shareholder return, stock price, net customer sales, volume, gross profit, gross margin, operating profit, operating margin, management profit, earnings from continuing operations before income taxes, earnings from continuing operations, earnings per share from continuing operations, earnings before interest and taxes (&#8220;EBIT&#8221;), earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;), net operating profit after tax, net earnings, net earnings per share, return on assets, return on investment, return on equity, return on invested capital, cost of capital, average capital employed, cash value added, economic value added, economic profit, cash flow, cash flow from operations, working capital, working capital as a percentage of net customer sales, asset growth, asset turnover, market share, customer satisfaction, and employee satisfaction. The targeted level or levels of performance with respect to such Performance Measures may be established at such levels and on such terms as the Committee may determine, in its discretion, on a corporate-wide basis or with respect to one or more business units, divisions, subsidiaries, business segments or functions, and in either absolute terms or relative to the current and&#47;or historical performance of one or more companies or an index covering multiple companies. Performance measures that are financial metrics may or may not be calculated in accordance with generally accepted accounting principles, at the Committee&#8217;s discretion. Awards that are not intended to qualify for the Performance-Based Exception may be based on these or such other performance measures as the Committee may determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Unless otherwise determined by the Committee, measurement of performance goals with respect to the Performance Measures above shall exclude the impact of charges for restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring items, including, for example, asset impairment charges and force majeure, as well as the cumulative effects of tax or accounting changes, each as determined in accordance with generally accepted accounting principles or identified in the Company&#8217;s financial statements, notes to the financial statements, management&#8217;s discussion and analysis or other filings with the SEC.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Performance goals may differ for Awards granted to any one Participant or to different Participants. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Achievement of performance goals in respect of Awards intended to qualify under the Performance-Based Exception shall be measured over a Performance Period specified in the Award Agreement, and the goals shall be established not later than 90 days after the beginning of the Performance Period or, if less than 90 days, the number of days which is equal to 25% of the relevant Performance Period applicable to the Award. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) The Committee shall have the discretion to adjust the determinations of the degree of attainment of the pre-established performance goals&#59; provided, however, that Awards that are designed to qualify for the Performance-Based Exception may not be adjusted upward (the Committee may, in its discretion, adjust such Awards downward). </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) The Committee shall certify the extent to which any Performance Measures have been satisfied, and the amount payable as a result thereof, prior to payment, settlement or vesting of any Award that is intended to satisfy the Performance-Based Exception. Shares issued upon full or partial achievement of the selected Performance Measure(s) shall be subject to such continuing restrictions as shall be provided in a Participant&#8217;s Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transferability of Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Incentive Stock Options may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, and shall be exercisable during a Participant&#8217;s lifetime only by such Participant. Other Awards shall be transferable to the extent provided in the Award Agreement, except that no Award may be transferred for consideration. Each Award may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated by a Participant other than by will or the laws of descent and distribution, and each Option or Stock Appreciation Right shall be exercisable only by the Participant during his or her lifetime. Notwithstanding the foregoing, to the extent permitted by the Committee, the person to whom an Award (other than an Incentive Stock Option) is initially granted (the &#8220;Grantee&#8221;) may transfer an Award to any &#8220;family member&#8221; of the Grantee (as such term is defined in Section 1(a)(5) of the General Instructions to Form S-8 under the Securities Act of 1933, as amended (&#8220;Form S-8&#8221;))&#59; provided that, (i) as a condition thereof, the transferor and the transferee must execute a written agreement containing such terms as may be specified by the Committee, and (ii) the transfer is pursuant to a gift or a domestic relations order to the extent permitted under the General Instructions to Form S-8.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company shall have the power and right, prior to the delivery of Shares pursuant to an Award, to deduct or withhold, or require a participant to remit to the Company (or a Subsidiary), an amount (in cash or Shares) sufficient to satisfy any applicable tax withholding requirements applicable to an Award. Whenever under the Plan payments are to be made in cash, such payments shall be net of an amount sufficient to satisfy any applicable tax withholding requirements. Subject to such restrictions as the Committee may prescribe, a Participant may satisfy all or a portion of any tax withholding requirements for an Award payable or settled in Shares by electing to have the Company withhold Shares having a Fair Market Value equal to the amount to be withheld up to the minimum statutory tax withholding rate (or such other rate that will not cause the Award to be accounted for under variable award account or otherwise result in a negative accounting impact). </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Conditions Upon Issuance of Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Shares shall not be issued pursuant to the exercise or settlement of an Award unless the exercise or settlement of such Award and the issuance and delivery of such Shares pursuant thereto shall comply with all Applicable Laws, and shall be further subject to the approval of counsel for the Company with respect to such compliance.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) As a condition to the exercise or settlement of an Award, the Company may require the person exercising such Award or receiving such settlement to represent and warrant at the time of any such exercise or settlement that the Shares are being acquired only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws. The Company may also require the person exercising such Award or receiving such settlement to acknowledge and affirm any restrictions applicable to the Shares issuable upon the exercise or settlement of an Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments Upon Changes in Capitalization.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Notwithstanding any other provision of the Plan to the contrary, in the event of any merger, reorganization, consolidation, recapitalization, liquidation, stock dividend, split-up, spin-off, stock split, reverse stock split, share combination, share exchange, extraordinary dividend, or any change in the corporate structure affecting the Shares, such adjustment shall be made in the number and kind of Shares or other securities or property that may be delivered under the Plan, the individual limits set forth in Section 3(b), and, with respect to outstanding Awards, in the number and kind of Shares or other securities or property subject to outstanding Awards, the Exercise Price, grant price or other price, if any, of Shares subject to outstanding Awards, any performance conditions relating to Shares, the market price of Shares, or per-Share results, and other terms and conditions of outstanding Awards, as may be determined to be appropriate and equitable by the Committee, </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in its sole discretion, to prevent dilution or enlargement of rights&#59; provided, however, that, unless otherwise determined by the Committee, the number of Shares or other securities or property subject to any Award shall always be rounded down to a whole number. Adjustments made by the Committee pursuant to this Section 18 shall be final, binding, and conclusive.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Change in Control, Cash-Out and Termination of Underwater Options&#47;SARs, and Subsidiary Disposition. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in a Participant&#8217;s Award Agreement or pursuant to Section 19(b) hereof, upon the occurrence of a Change in Control, unless otherwise specifically prohibited under Applicable Laws, or by the rules and regulations of any governing governmental agencies or national securities exchanges&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) any and all outstanding Options and SARs granted hereunder shall become immediately exercisable unless such Awards are assumed, converted, replaced or continued by the continuing entity&#59; provided, however, that in the event of a Participant&#8217;s termination of employment without Cause within twenty-four (24) months following consummation of a Change in Control, any Awards so assumed, converted, replaced or continued will become immediately exercisable&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) any Period of Restriction or other restriction imposed on Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Stock-Based Awards shall lapse unless such Awards are assumed, converted, replaced or continued by the continuing entity&#59; provided, however, that in the event of a Participant&#8217;s termination of employment without Cause within twenty-four (24) months following consummation of a Change in Control, the Period of Restriction on any Awards so assumed, converted, replaced or continued shall lapse&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) the portion of any and all Performance Shares, Performance Units and other Awards (if performance-based) that remain outstanding following the occurrence of a Change in Control shall be determined by applying actual performance from the beginning of the Performance Period through the date of the Change in Control using the formula set forth in the Award Agreement (&#8220;Performance Measure Formula&#8221;) to determine the amount of the payout or distribution rounded to the nearest whole Share. Notwithstanding the foregoing, if the Change in Control occurs prior to the end of a Performance Period for an Award, the Performance Measure Formula shall generally be adjusted to take into account the shorter period of time available to achieve the Performance Measures. If a quantitative Performance Measure Formula for the entire Performance Period has been determined by the Company by adding together one or more goals for Performance Measures (&#8220;Performance Measure Goals&#8221;) for multiple time periods within the Performance Period (each a &#8220;subperiod&#8221;), then the adjusted Performance Measure Formula for a given level of performance shall be equal to the sum of (1) the Performance Measure Goals for each completed subperiod for such level of performance and (2) a prorated Performance Measure Goal (determined by the number of days in such subperiod falling on or before the occurrence of the Change in Control divided by the total number of days in such subperiod) for such level of performance for each subperiod not completed on or before the occurrence of the Change in Control. If there are no subperiods, then the quantitative Performance Measure Formula shall be prorated by taking the Performance Measure Goal for each specified level of performance for the entire Performance Period and multiplying it by a fraction, the numerator of which is the number of days in the Performance Period falling on or before the occurrence of the Change in Control and the denominator of which is the total number of days in the Performance Period. Qualitative Performance Measures shall not be adjusted. In the unlikely event that the Company is unable to substantially adjust the target Performance Measure(s) for an Award as set forth above, then the portion of such Award that shall remain outstanding shall be based on the assumption that the target level of performance for each Performance Measure for the entire Performance Period has been achieved.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of the Award that remains outstanding following the occurrence of a Change in Control as determined in the preceding paragraph shall vest in full at the end of the Performance Period set forth in such Award so long as the Participant&#8217;s employment (or if the Participant is a Director or Consultant, service) with the Company or a Subsidiary does not terminate until the end of the Performance Period. Notwithstanding the foregoing, such portion shall vest in full upon the earliest to occur of the following events&#58; (1) the termination of the Participant by the Company without Cause, (2) the refusal of the continuing entity to assume, convert, replace or continue the Award, or (3) if applicable, the resignation of the Participant for a &#8220;good reason&#8221;, as described further in the following paragraph.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to paragraphs (i), (ii) and (iii) of Section 19(a) above, the Award Agreement may provide that any replacement awards will become immediately exercisable or any Period of Restriction shall lapse in the event of a termination of employment by the Participant for &#8220;good reason&#8221; if and as such term is defined in the Award Agreement or any employment agreement, severance agreement or other agreement or policy applicable to such Participant.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash-Out and Termination of Underwater Options&#47;SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may, in its sole discretion, provide that (i) all outstanding Options and SARs shall be terminated upon the occurrence of a Change in Control and that each Participant shall receive, with respect to each Share subject to such Options or SARs, an amount in cash and&#47;or Shares equal to the excess of the Fair Market Value of a Share immediately prior to the occurrence of the Change in Control over the Option Exercise Price or the SAR grant price&#59; and (ii) Options and SARs outstanding as of the date of the Change in Control may be cancelled and terminated without payment therefore if the Fair Market Value of a Share as of the date of the Change in Control is less than the Option Exercise Price or the SAR grant price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the authority, exercisable either in advance of any actual or anticipated Subsidiary Disposition or at the time of an actual Subsidiary Disposition and either at the time of the grant of an Award or at any time while an Award remains outstanding, to provide for the automatic full vesting and exercisability of one or more outstanding unvested Awards under the Plan and the termination of restrictions on transfer and repurchase or forfeiture rights on such Awards, in connection with a Subsidiary Disposition, but only with respect to those Participants who are at the time engaged primarily in Continuous Service with the Subsidiary involved in such Subsidiary Disposition. The Committee also shall have the authority to condition any such vesting and exercisability or release from the limitations of an Award upon the continuation or subsequent termination of the affected Participant&#8217;s Continuous Service with that Subsidiary within a specified period following the effective date of the Subsidiary Disposition. The Committee may provide that any Awards so vested or released from such limitations in connection with a Subsidiary Disposition, shall remain fully exercisable until the expiration or earlier termination of the Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Amendment, Suspension or Termination of the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Modification and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board or the Committee may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part&#59; provided, however, that no amendment that requires stockholder approval in order for the Plan to continue to comply with the New York Stock Exchange listing standards or any rule promulgated by the SEC or any securities exchange on which Shares are listed or any other Applicable Laws shall be effective unless such amendment shall be approved by the requisite vote of stockholders of the Company entitled to vote thereon within the time period required under such applicable listing standard or rule. Unless the Board or the Committee adopt resolutions providing for an earlier date, the Plan shall automatically terminate on November 14, 2022. For purposes of Section 422 of the Code and also relevant provisions of Applicable Laws, the adoption of the Plan as approved by the stockholders on November 14, 2012 shall be deemed to be the adoption of a new plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 18 hereof) affecting the Company or the financial statements of the Company or of changes in Applicable Laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan. With respect to any Awards intended to comply with the Performance-Based Exception, unless otherwise determined by the Committee, any such exception shall be specified at such times and in such manner as will not cause such Awards to fail to qualify under the Performance-Based Exception.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Awards Previously Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No termination, amendment or modification of the Plan or of any Award shall adversely affect in any material way any Award previously granted under the Plan without the written consent of the participant holding such Award, unless such termination, modification or amendment is required by Applicable Laws and except as otherwise provided herein. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall not, without the approval of the stockholders of the Company, reduce the Exercise Price of an outstanding Option or the grant price of an outstanding SAR. And, at any time when the Exercise Price of an outstanding Option or the grant price of an outstanding SAR is above the Fair Market Value of a share of Common Stock, no amendment shall provide that any such outstanding Option or outstanding SAR be cancelled and re-granted or exchanged for either cash or a new Award with a lower (or no) exercise price, without the approval of the stockholders of the Company. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance with the Performance-Based Exception</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If it is intended that an Award comply with the requirements of the Performance-Based Exception, the Committee may apply any restrictions it deems appropriate such that the Awards maintain eligibility for the Performance-Based Exception. If changes are made to Code Section 162(m) or regulations promulgated thereunder, the Committee may, subject to the other provisions of this Section 20, make any adjustments to the Plan and&#47;or Award Agreements it deems appropriate that does not prevent the Plan or any outstanding Awards intended to comply with the Performance-Based Exception from complying with Section 162(m) of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Reservation of Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Rights of Participants. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall not confer upon any Participant any right with respect to continuation of employment or consulting relationship with the Company, nor shall it interfere in any way with his or her right or the Company&#8217;s right to terminate his or her employment or consulting relationship at any time, with or without cause. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Employee, Director or Consultant shall have the right to be selected to receive an Award under the Plan, or, having been so selected, to be selected to receive future Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Successors.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All obligations of the Company under the Plan and with respect to Awards shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or other event, or a sale or disposition of all or substantially all of the business and&#47;or assets of the Company and references to the &#8220;Company&#8221; herein and in any Award Agreements shall be deemed to refer to such successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Legal Construction.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gender, Number and References</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular and the singular shall include the plural. Any reference in the Plan to a Section of the Plan either in the Plan or any Award Agreement or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The granting of Awards and the issuance of Shares or cash under the Plan shall be subject to all Applicable Laws and to such approvals by any governmental agencies or national securities exchanges as may be required. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent not preempted by federal law, the Plan, and all agreements hereunder, shall be construed in accordance with and governed by the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Exclusive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent applicable, it is intended that this Plan and any Awards granted hereunder either be exempt from the requirements of, or else comply with the requirements of, Section 409A of the Code and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;). Any provision that would cause any Award granted hereunder to incur additional taxes under Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GLOSSARY OF DEFINED TERMS</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As used in the Plan, the following definitions shall apply&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the legal requirements relating to the administration of stock incentive plans, if any, under applicable provisions of federal securities laws, state corporate and securities laws, the Code, and the rules of any applicable stock exchange or national market system.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, individually or collectively, Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Stock-Based Awards granted under the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the willful failure of the Participant substantially to perform the Participant&#8217;s duties with the Company (other than any such failure resulting from incapacity due to physical or mental illness)&#59; (ii) the Participant&#8217;s material violation of any policy of the Company as in effect from time to time&#59; or (iii) the Participant&#8217;s engagement in any conduct materially detrimental to the Company, including, but not limited to, the name, business interests or corporate, brand, business or other reputation of the Company. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No act or failure to act on the part of the Participant shall be considered to be &#8220;willful&#8221; unless it is done, or omitted to be done, by the Participant in bad faith or without reasonable belief that the Participant&#8217;s action or omission was in the best interests of the Company. Any act or failure to act based upon authority given pursuant to a resolution duly adopted by the Board or upon the instructions of the Chief Executive Officer of the Company or the Committee or another authorized officer of the Company or based upon the advice of counsel for the Company shall be conclusively presumed to be done or omitted to be done by the Participant in good faith and in the best interests of the Company. The cessation of employment of the Participant shall not be deemed to be for Cause unless and until the Chief Executive Officer, Chief People Officer or comparable most senior human resource executive and Chief Legal Officer or comparable most senior legal executive unanimously agree that, in their good faith opinion, the Participant is guilty of the conduct described in subsections (i), (ii) or (iii) above, and so notify the Participant specifying the particulars thereof in detail.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.694%"><tr><td style="width:0.1%"></td><td style="width:1.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.555%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.162%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:90.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act ) (a &#8220;Person&#8221;) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% of either the total fair market value of the then outstanding equity securities of the Company (the &#8220;Outstanding Company Common Stock&#8221;) or the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;Outstanding Company Voting Securities&#8221;)&#59; provided, however, that for purposes of this subsection (a), the following acquisitions shall not constitute a Change in Control&#58; (i) any acquisition directly from the Company, (ii) any acquisition by the Company, including any acquisition which, by reducing the number of shares outstanding, is the sole cause for increasing the percentage of shares beneficially owned by any such Person to more than the applicable percentage set forth above, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company or (iv) any acquisition by any corporation pursuant to a transaction which complies with clauses (i), (ii) and (iii) of subsection (c) of this definition&#59; or</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individuals who, as of the date hereof, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason within any period of 12 months to constitute at least a majority of the Board&#59; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board, shall be considered as</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board&#59; or</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.694%"><tr><td style="width:0.1%"></td><td style="width:1.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.555%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.162%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:90.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consummation by the Company of (i) a reorganization, merger, consolidation or similar transaction involving another business, (ii) a sale or other disposition of all or substantially all of the assets of the Company, or (iii) the acquisition of the securities or assets of another business (a &#8220;Business Combination&#8221;), in each case, unless, following such Business Combination, (A) more than 50% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the controlling parent entity resulting from such Business Combination (including without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) is represented by Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively, that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Outstanding Company Common Stock and Outstanding Company Voting Securities were converted pursuant to such Business Combination) and such ownership of common stock and voting power among the holders thereof is in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Business Combination and (iii) at least a majority of the members of the board of directors (or similar governing body) of the controlling parent entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision in this definition, to the extent required in order to avoid additional income taxation under Section 409A, any transaction defined in subsections (a) through (c) of this definition that does not constitute a &#34;change in the ownership or effective control&#34; of the Company, or &#34;change in the ownership of a substantial portion of the assets&#34; of the Company within the meaning of Treasury Regulations Sections 1.409A-3(a)(5) and 1.409A-3(i)(5) shall not be treated as a Change in Control.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Committee, as specified in Section 2(a), appointed by the Board to administer the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Clorox Company and any successor thereto as provided in Section 23 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any consultant or advisor to the Company or a Subsidiary.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means that the provision of services to the Company or any Subsidiary in any capacity of Employee, Director or Consultant is not interrupted or terminated. Continuous Service shall not be considered interrupted in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company or between the Company, any Subsidiary, or any successor. A leave of absence approved by the Company shall include sick leave, military leave, or any other personal leave approved by an authorized representative of the Company. For purposes of Incentive Stock Options, no such leave may exceed ninety (90) days, unless reemployment upon expiration of such leave is guaranteed by statute or contract.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any individual who is a member of the Board of Directors of the Company or a Subsidiary who is not an Employee. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the dividends declared and paid on Shares subject to an Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to Shares subject to an Award, a right to be paid an amount equal to the Dividends declared and paid on an equal number of outstanding Shares prior to the issuance of Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any employee of the Company or a Subsidiary.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the price at which a Share may be purchased by a Participant pursuant to an Option.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of a Share determined as follows&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.694%"><tr><td style="width:0.1%"></td><td style="width:1.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where there exists a public market for the Share, the Fair Market Value shall be (A) the closing sales price for a Share on the date of the determination (or, if no sales were reported on that date, on the last trading date on which sales were reported) on the New York Stock Exchange, the NASDAQ Global Market or the principal securities exchange on which the Share is listed for trading, whichever is applicable, or (B) if the Share is not traded on any such exchange or national market system, the average of the closing bid and asked prices of a Share on the NASDAQ Capital Market, in each case, as reported in The Wall Street Journal or such other source as the Committee deems reliable&#59; or</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the absence of an established market of the type described above, for the Share, the Fair Market Value thereof shall be determined by the Committee in good faith, and such determination shall be conclusive and binding on all persons.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Freestanding SAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a SAR that is granted independently of any Options, as described in Section 7 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ISO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is not intended to meet the requirement of Section 422 of the Code. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Incentive Stock Option or a Nonqualified Stock Option granted under the Plan, as described in Section 6 herein. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the cash received by the Company as payment of the Exercise Price upon exercise of an Option or a Prior Plan option plus the federal tax benefit that could be realized by the Company as a result of the Option of Prior Plan option exercise, which shall be determined by multiplying the amount that is deductible as a result of the Option or Prior Plan option exercise (currently equal to the amount upon which the Participant&#8217;s withholding tax obligation is calculated) by the maximum federal corporate income tax rate for the year of exercise. To the extent that a Participant pays the Exercise Price and&#47;or withholding taxes with Shares, Option Proceeds shall not be calculated with respect to the amount paid in such manner.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Stock-Based Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Share-based or Share-related Award granted pursuant to Section 12 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a current or former Employee, Director or Consultant who has rights relating to an outstanding Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance-Based Exception</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the performance-based exception from the tax deductibility limitations of Code Section 162(m). </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 14(a).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period during which a performance measure must be met.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted to a Participant, as described in Section 10 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted to a Participant, as described in Section 11 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Period of Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period Restricted Stock, Restricted Stock Units or Other Stock-Based Awards are subject to a substantial risk of forfeiture and are not transferable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Clorox Company 2005 Stock Incentive Plan.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Clorox Company 1996 Stock Incentive Plan, The Clorox Company 1987 Long Term Compensation Program, The Clorox Company Independent Directors&#8217; Stock-Based Compensation Plan, and the 1993 Directors&#8217; Stock Option Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted to a Participant, as described in Section 8 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted to a Participant, as described in Section 9 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a share of common stock of the Company, par value $1.00 per share, subject to adjustment pursuant to Section 18 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted to a Participant, either alone or in connection with a related Option, as described in Section 7 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation in which the Company owns, directly or indirectly, at least fifty percent (50%) of the total combined voting power of all classes of stock, or any other entity (including, but not limited to, partnerships and joint ventures) in which the Company owns, directly or indirectly, at least fifty percent (50%) of the equity securities thereof. Notwithstanding the foregoing, for purposes of determining whether any individual may be a Participant for purposes of any grant of Incentive Stock Options, the term &#8220;Subsidiary&#8221; shall have the meaning ascribed to such term in Code Section 424(f).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the disposition by the Company of some or all of its equity holdings in any Subsidiary effected by a merger, consolidation or a similar transaction involving that Subsidiary, (ii) the Company&#8217;s sale or distribution of substantially all of the outstanding capital stock of such Subsidiary, in either case such that the Subsidiary is not longer a Subsidiary following such transaction, or (iii) the sale of all or substantially all of the assets of that Subsidiary.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tandem SAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a SAR that is granted in connection with a related Option, as described in Section 7 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means voting securities of the Company entitled to vote generally in the election of Directors.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>clxq3fy21exhibit104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i752952f6831146ab8baab59e27a8392d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">NONQUALIFIED STOCK OPTION AWARD AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF STOCK OPTION GRANT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Optionee named below an option (the &#8220;Option&#8221;) to purchase, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this nonqualified stock option agreement (the &#8220;Agreement&#8221;), the number of shares of Common Stock of the Company (the &#8220;Shares&#8221;) at the exercise price per share (the &#8220;Exercise Price&#8221;) set forth as follows&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIONEE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Optionee Name - 1&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIONS GRANTED&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Total Shares Granted&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANT ID&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Grant ID&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXERCISE PER SHARE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Grant Price - 1&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATE OF GRANT&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Grant Date - 2&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPIRATION DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ten years from Date of Grant</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VESTING SCHEDULE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25% on each of the first four anniversaries of the Date of Grant</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company hereby grants to the Optionee the Option to purchase the Shares at the Exercise Price, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Option set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Right to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Option shall be exercisable prior to the expiration date set forth above (the &#8220;Expiration Date&#8221;), in accordance with the vesting schedule set forth above (the &#8220;Vesting Schedule&#8221;) and with the applicable provisions of the Plan and this Agreement.  Except as otherwise specifically provided in this Agreement, in no event may this Option be exercised after the Expiration Date.  Although vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists once the options become exercisable according to the Vesting Schedule above, the Options will not be earned until the Optionee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Sections 7(b), 7(c), 7(d), 7(e) and Section 8, and the Optionee shall have no right to retain the Shares or the value thereof upon vesting or exercise of the Options until all conditions precedent have been satisfied.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Option shall be exercisable only by delivery of an exercise notice (the &#8220;Exercise Notice&#8221;), available on the UBS website, the Company&#8217;s designee, which shall state the election to exercise the Option, the whole number of vested Shares in respect of which the Option is being exercised and such other provisions as may be required by the Committee. Such Exercise Notice shall be signed by the Optionee and shall be delivered by mail or fax, to the Company&#8217;s designee accompanied by payment of the Exercise Price.  The Company may require the Optionee to furnish or execute such other documents as the Company shall reasonably deem necessary (1) to evidence such exercise and (2) to comply with or satisfy </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the requirements of the Securities Act of 1933, as amended, the Exchange Act, or any Applicable Laws.  The Option shall be deemed to be exercised upon receipt by the Company&#8217;s designee of such written notice accompanied by the Exercise Price.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Shares will be issued pursuant to the exercise of the Option unless such issuance and such exercise shall comply with all Applicable Laws.  Assuming such compliance, for income tax purposes, the Shares shall be considered transferred to the Optionee on the date on which the Option is exercised with respect to such Shares.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Optionee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Option.  The Committee may condition the issuance of Shares upon the Optionee&#8217;s satisfaction of such withholding obligations.  The Optionee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Optionee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to Section 6(f) of the Plan and subject to such limitations as the Committee may impose (including prohibition of one or more of the following payment methods), payment of the Exercise Price may be made in cash or by check, Shares or a combination thereof.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service and Expiration of Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Optionee&#8217;s employment or service with the Company and its Subsidiaries is terminated, the Optionee may exercise all or part of this Option prior to the expiration dates set forth in paragraph (b) herein, but only to the extent that the Option had become vested before the Optionee&#8217;s employment or service terminated.  Notwithstanding the above, if the Optionee&#8217;s termination of employment or service is due to (1) Retirement and is more than 6 months from the Date of Grant set forth in this Agreement, then the Option shall continue to vest in accordance with the Vesting Schedule, or (2) death or Disability, the Option shall become 100% vested, and, in each case, shall remain exercisable until the expiration date determined pursuant to paragraph (b) of this Section.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Optionee&#8217;s employment or service with the Company and its Subsidiaries terminates (except when due to Retirement, death or Disability), this Option shall expire immediately with respect to the number of Shares for which the Option is not yet vested.  If the Optionee dies after termination of employment or service, but before the expiration of the Option, all or part of this Option may be exercised (prior to expiration) by the personal representative of the Optionee or by any person who has acquired this Option directly from the Optionee by will, bequest or inheritance, but only to the extent that the Option was vested and exercisable upon termination of the Optionee&#8217;s employment or service. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Expiration of Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon termination of the Optionee&#8217;s employment or service with the Company and its Subsidiaries, the Option shall expire on the earliest of the following occasions&#58;</font></div><div><font><br></font></div><div style="padding-left:63pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The Expiration Date&#59; </font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The date ninety (90) days following the termination of the Optionee&#8217;s employment or service for any reason other than Cause, death, Disability, or Retirement&#59;</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The date one year following the termination of the Optionee&#8217;s employment or service due to death or Disability&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The date five (5) years following the termination of the Optionee&#8217;s employment or service due to Retirement, provided the Optionee&#8217;s Retirement is more than 6 months from the Date of Grant set forth in this Agreement&#59; or</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-25.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The date of termination of the Optionee&#8217;s employment or service for Cause.</font></div><div style="padding-left:99pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Definition of &#8220;Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  For purposes of this Agreement, the Optionee&#8217;s employment or service shall be deemed to have terminated due to &#8220;Retirement&#8221; if the Optionee terminates employment or service as an Employee for any reason, including Disability (but other than for Cause) after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Optionee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five (55) with ten (10) or more years of Vesting Service.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Definition of &#8220;Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  For purposes of this Agreement, the Optionee&#8217;s employment shall be deemed to have terminated due to the Optionee&#8217;s Disability if the Optionee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Optionee&#8217;s employment.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the occurrence of a Change in Control, unless otherwise specifically prohibited under Applicable Laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, the Option shall become 100% vested and immediately exercisable, unless such Option is assumed, converted or replaced by the continuing entity&#59; provided, however, that in the event the Optionee&#8217;s employment is terminated without Cause or by the Optionee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control, any replacement awards will become immediately exercisable.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Optionee&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the assignment to the Optionee of any duties inconsistent in any material respect with the Optionee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Optionee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Optionee&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Optionee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Optionee&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Company&#8217;s requiring the Optionee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Optionee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) any purported termination by the Company of the Optionee&#8217;s employment other than (A) due to the death or Disability of the Optionee or (B) a termination of the Optionee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any termination by the Optionee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Optionee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Optionee&#8217;s employment under the provision so indicated and (3) the Optionee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Transferability of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Option shall not be transferable by the Optionee other than by will or the laws of descent and distribution, and the Option shall be exercisable during the Optionee&#8217;s lifetime only by the Optionee or on his or her behalf by the Optionee&#8217;s guardian or legal representative.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#8220;Affiliated Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means any organization controlling, controlled by or under common control with the Company.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#8220;Confidential Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Optionee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#8220;Conflicting Product&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Optionee shall have worked during the two years prior to the Optionee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Optionee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Optionee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#8220;Conflicting Organization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Right to Retain Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of this Option, the Optionee agrees that at all times, both during and after the term of the Optionee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Optionee, any and all Confidential Information of the Company or any Affiliated Company.  The Optionee understands </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that for purposes of this Section 7(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Optionee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the unexercised portion of the Option, whether vested or not, will be immediately forfeited and cancelled, and the Optionee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of this Option, in order to forestall the disclosure or use of Confidential Information as well as to avoid the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the term of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee breaches his&#47;her obligation not to Interfere, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of this Option, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee breaches his&#47;her obligation not to Solicit, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By acceptance of this Option, the Optionee acknowledges that, if the Optionee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Option pursuant to any of Sections&#160;7(b) through 7(d) above shall not restrict, abridge or limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Optionee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Optionee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Optionee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Optionee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 7(f) shall not result in the cancellation of Options. Optionee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Right to Retain Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of this Option in order to forestall the disclosure or use of Confidential Information, as well as to deter the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Optionee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Optionee and the Conflicting Organization that the Optionee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee shall render services to any Conflicting Organization other than as expressly permitted herein, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE OPTIONEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO RENDER SUCH SERVICES PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that (1) the Company issues a significant restatement of financial results and (2) the Committee determines, in good faith, that the Optionee&#8217;s fraud or misconduct was a significant contributing factor to such restatement and (3) some or all of the Option that was granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Optionee shall immediately return to the Company the unexercised portion of the Option and any Shares or the pre-tax income derived from any disposition of the Shares previously received in upon exercise of the Option that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  Notwithstanding anything herein to the contrary, in no event shall the Repayment Obligation apply to any portion of the Option that vested more than four years prior to the date the applicable restatement is announced.  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Optionee.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The award of this Option under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) is subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Optionee nor the Optionee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Option until the Option has been exercised and Share certificates have been issued to the Optionee, transferee or representative, as the case may be.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Accordingly, the Optionee agrees that any claim of any type relating to this </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#58; Grants should include either section 9(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> section 9(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> subject to the Policy).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Optionee hereby consents to the jurisdiction over the Optionee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Optionee, without such Optionee&#8217;s written consent. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Option for construction or interpretation.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Optionee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Optionee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Optionee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Options set forth in this Agreement.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.   </font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.71pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Receipt of any benefits under this Agreement by the Optionee shall constitute the Optionee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Its&#58;  Chief Executive Officer</font></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE OPTIONEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE OPTIONEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THE OPTION HEREOF IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE OPTIONEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE OPTIONEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE OPTIONEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE OPTIONEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Optionee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;investors.thecloroxcompany.com&#47;sec.cfm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Optionee hereby consents to receive the Prospectus Information electronically or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Optionee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Optionee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Optionee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Optionee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Optionee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>clxq3fy21exhibit105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib94cbd6641cd46ebb343ac927dffae54_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:3.6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div><div style="margin-bottom:0.03pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div style="margin-bottom:3.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2005 STOCK INCENTIVE PLAN</font></div><div style="margin-bottom:3.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">PERFORMANCE SHARE AWARD AGREEMENT</font></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF PERFORMANCE SHARE GRANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this performance share award agreement (the &#8220;Agreement&#8221;), the following number of Performance Shares on the terms set forth below&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:45.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANTEE&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Participant Name&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TARGET AWARD&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Target Shares Granted&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANT ID&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;&#60;&#60;Grant ID&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERFORMANCE PERIOD&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 1, 2020 through June 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATE OF GRANT&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#60;&#60;&#60;Grant Date - 2&#62;&#62;&#62;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SETTLEMENT DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within 90 days following the last day of the Performance Period, provided the Grantee has remained in the employment or service of the Company or its Subsidiaries through such date (except for a termination of employment or service due to death, Disability or Retirement, as provided below)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Grant of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company hereby grants to the Grantee the Target Award set forth above, payment of which is dependent upon the achievement of certain performance goals more fully described in Section 3 of this Agreement.  This Award is subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Performance Shares set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Performance Shares awarded pursuant to this Agreement represent the opportunity to receive Shares of the Company and Dividend Equivalents on such Shares (as described in Section 4 below). The Company shall issue to the Grantee one Share for each vested Performance Share (plus any Dividend Equivalents accrued with respect to such vested Performance Shares), rounded to the nearest whole share, less any Shares withheld in accordance with the provisions of Section 7 of this Agreement. Settlement shall occur on a date chosen by the Committee, which date shall be within ninety (90) days following the last day of the Performance Period (the &#8220;Settlement Date&#8221;), or any Deferred Settlement Date established pursuant to Section 6 of this Agreement, whichever is later, and except as specifically provided in Section 5 of this Agreement, provided the Grantee has remained in the employment or service of the Company or its Subsidiaries through the Settlement Date&#59; provided, that, in connection with a Change in Control as described in Section 8 of this Agreement, the Settlement Date shall be within sixty (60) days of either the Change in Control or the date of termination of employment without Cause or for &#8220;Good Reason&#8221; (as defined below), as applicable.  Although vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists at the Settlement Date, the Performance Shares (and any associated Dividend Equivalents) will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Sections 10(b), 10(c), 10(d), 10(e) and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 1 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 11, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Performance Shares until all such conditions precedent have been satisfied.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Determination of Number of Performance Shares Vested</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The number of Performance Shares vested, if any, for the Performance Period shall be determined in accordance with the following formula&#58;  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"># of Performance Shares &#61; Average Payout Percentage x Target Award</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;Average Payout Percentage&#8221; is equal to the sum of the Payout Percentage for each of the fiscal years in the Performance Period, divided by three.</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Payout Percentage&#8221; for each fiscal year in the Performance Period is based on the growth of annual economic profit (&#8220;EP&#8221;), calculated as described in the paragraph below, for the applicable fiscal year in the Performance Period as compared to the prior fiscal year (&#8220;EP Growth&#8221;), expressed as a percentage and calculated based upon EP at the end of each fiscal year of the Performance Period, determined in accordance with the following table&#58; </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.897%"><tr><td style="width:1.0%"></td><td style="width:48.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.647%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Growth <br>(for each fiscal year in the Performance Period)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Growth Threshold*</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Growth Target**</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Growth Max***</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Achievement of the EP Growth Threshold Amount (or below) shall result in a Payout Percentage of 0% for the applicable fiscal year of the Performance Period.</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**  Achievement of the EP Growth Target Amount shall result in a Payout Percentage of 100% for the applicable fiscal year of the Performance Period</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***  Achievement of the EP Growth Max Amount (or above) shall result in a Payout Percentage of 200% for the applicable fiscal year of the Performance Period</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note&#58; Achievement of EP Growth in between the Threshold and Target levels and in between the Target and Max levels shall be determined through linear interpolation. For the avoidance of doubt, if the EP Growth in excess of the Threshold level is not achieved, the Payout Percentage for the applicable fiscal year of the Performance Period shall be 0%.</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP is defined as Earnings Before Interest &#38; Taxes, adjusted for non-cash restructuring charges, times one minus the tax rate, less capital charge.</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For avoidance of doubt, while the expectation is that EP for a given fiscal year shall be calculated based upon the Company&#8217;s financial statements for such fiscal year that are filed with the SEC, the Committee shall have the authority to include information not reflected in such financial statements for purposes of determining EP for such fiscal year if the Committee determines that the inclusion of such information more accurately reflects the financial performance of the Company for such fiscal year.  To the extent that such information used in a prior fiscal year is reflected in the filed financial statements for a subsequent fiscal year, appropriate changes shall be made to relevant information in such filed financial statements for purposes of calculating EP for such subsequent fiscal year to avoid double counting of the same information.  </font></div><div style="margin-bottom:10.8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the above, the applicable EP amount for the corresponding fiscal year that is used as the basis for calculating EP Growth results for such fiscal year shall be adjusted, fairly and appropriately, in accordance with the Plan and, as provided in this Agreement, to reflect accurately the direct and measurable effect of the impact of each of the following events not otherwise reflected in the determination of the initial EP levels (each, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:10.8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an &#8220;Event&#8221;) including, without limitation, the financial statement impact on the Company on account of the occurrence or potential occurrence of an Event&#58; (1) the acquisition or divestiture of a business, (2) a Change in Control, (3) U.S Federal changes in tax statutes or the addition or deletion of taxes to which the Company or any Affiliated Company is subject, (4) force majeure (including events known as &#8220;Acts of God&#8221;), (5) the adoption of new or revised accounting pronouncements or changes to application of accounting pronouncements, and (6) any extraordinary, unusual or non-recurring item not previously listed. Notwithstanding the foregoing, an event listed in the preceding sentence shall not qualify as an Event, and therefore no adjustment shall be made to the EP levels, unless the impact of the occurrence or potential occurrence of such an event listed in the preceding sentence exceeds $2 million in EP.  The purpose of any adjustments on account of the occurrence of an Event is to keep the probability of achieving the EP Growth goals the same as if the Event triggering such adjustment had either not occurred or had not resulted in any financial statement impact. The determination of any adjustments shall be based on the Company&#8217;s accounting as set forth in its books and records (including business projections) and&#47;or in the annual budgets and&#47;or long range plans of the Company pursuant to which the EP Growth goals were established.  The amount of any such adjustment shall be approved by the Committee in its good faith determination in accordance with the provisions of this paragraph.  To the extent applicable, the Committee shall condition the determination of the number of Performance Shares vested under this Section 3 upon the satisfaction of the adjusted EP levels.  All Performance Shares that are not vested for the Performance Period shall be forfeited as of the last day of the Performance Period.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalent Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  No Dividend Equivalents shall be paid to the Grantee prior to the settlement of the award.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s Performance Share account and paid out at the Payout Percentage in the form of additional Shares rounded down to the nearest whole Share (the &#8220;Dividend Equivalent Shares&#8221;) upon settlement of the award, as described in Section 2 above. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided below, if the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason prior to the Settlement Date, all Performance Shares and Dividend Equivalents subject to this Agreement shall be immediately forfeited.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Termination due to Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Grantee&#8217;s termination of employment or service is due to death or Disability, all Performance Shares and Dividend Equivalents shall immediately vest and will be paid upon completion of the Performance Period based on the level of performance achieved as of the end of such Performance Period.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Termination due to Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Grantee&#8217;s termination of employment or service is due to Retirement, the Performance Shares shall vest on a pro rata monthly basis, including full credit for partial months elapsed and rounded to the nearest whole Share, and will be paid upon completion of the Performance Period based on the level of performance achieved as of the end of such Performance Period&#59; provided, however, that this provision shall not apply in the event the Grantee&#8217;s employment or service is terminated for Cause.  The amount of the vested Award may be computed under the following formula&#58;  Target Award times (number of full months elapsed in Performance Period (i.e., rounding up for any partial month) divided by number of full months in Performance Period) times percent performance level achieved as of the end of the Performance Period.  Dividend Equivalents accrued through the Grantee&#8217;s date of termination due to Retirement shall be paid at the same time as the settlement of the vested Performance Shares.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Definition of &#8220;Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  For purposes of this Agreement, the term &#8220;Retirement&#8221; shall mean termination of employment or service as an Employee after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Grantee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five with ten (10) or more years of Vesting Service.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Definition of &#8220;Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Election to Defer Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Prior to the commencement of the last year of the Performance Period, the Grantee may elect to defer the settlement of the Performance Shares from the last day of the Performance Period until a date at least two years following such date, or until the Grantee&#8217;s later termination of employment or service.  Such date shall be referred to as the &#8220;Deferred Settlement Date&#8221;.  If the Grantee makes such an election, it will become irrevocable on the date of such election.  If the Grantee makes such an election, any Dividend Equivalents awarded with respect to such deferred Performance Shares shall also be deferred under the same terms.  If the Grantee makes such an election, but a transaction occurs that subjects the Grantee&#8217;s Performance Shares to Section 19 of the Plan prior to the Deferred Settlement Date, the Grantee&#8217;s deferral election will terminate and the Grantee&#8217;s Performance Shares and Dividend Equivalents will be settled as of the date of that transaction.  The Company may terminate any deferral hereunder if a change in law requires such termination.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Grantee, and shall be subject to any restriction or limitations that the Committee, in its sole discretion, deems appropriate. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the occurrence of a Change in Control, unless otherwise specifically prohibited under Applicable Laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, the portion of any and all Performance Shares that remain outstanding following the occurrence of a Change in Control shall be determined by applying actual performance from the beginning of the Performance Period through the date of the Change in Control using the formula set forth above in Section 3 (&#8220;Performance Measure Formula&#8221;) to determine the amount of the payout or distribution rounded to the nearest whole Share. Notwithstanding the foregoing, if the Change in Control occurs prior to the end of the Performance Period, the Performance Measure Formula shall generally be adjusted to take into account the shorter period of time available to achieve the performance measures set forth above in Section 3 (the &#8220;Performance Measures&#8221;). If a quantitative Performance Measure Formula for the entire Performance Period has been determined by the Company by adding together one or more goals for Performance Measures (&#8220;Performance Measure Goals&#8221;) for multiple time periods within the Performance Period (each a &#8220;subperiod&#8221;), then the adjusted Performance Measure Formula for a given level of performance shall be equal to the sum of (1) the Performance Measure Goals for each completed subperiod for such level of performance and (2) a prorated Performance Measure Goal (determined by the number of days in such subperiod falling on or before the occurrence of the Change in Control divided by the total number of days in such subperiod) for such level of performance for each subperiod not completed on or before the occurrence of the Change in Control. If there are no subperiods, then the quantitative Performance Measure Formula shall be prorated by taking the Performance Measure Goal for each specified level of performance for the entire Performance Period and multiplying it by a fraction, the numerator of which is the number of days in the Performance Period falling on or before the occurrence of the Change in Control and the denominator of which is the total number of days in the Performance Period. In the unlikely event that the Company is unable to substantially adjust the target Performance Measure(s) as set forth above, then the portion of the Performance Shares that shall remain outstanding shall be based on the assumption that the target level of performance for each Performance Measure for the entire Performance Period has been achieved.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of the Performance Shares that remain outstanding following the occurrence of a Change in Control as determined in the preceding paragraph shall vest in full at the end of the Performance Period so long as the Grantee&#8217;s employment with the Company or a Subsidiary does not terminate until the end of the Performance Period. Notwithstanding the foregoing, such portion shall vest in full upon the earliest to occur of the following events&#58; (1) the termination of the Grantee by the Company without Cause, (2) the refusal of the continuing entity to assume, convert, replace or continue the Award, or (3) if applicable, the resignation of the Grantee for &#8220;Good Reason&#8221; (as defined below).</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Transferability of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Shares shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Performance Shares pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Definitions.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any organization controlling, controlled by or under common control with the Company. </font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div style="padding-left:58.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Right to Retain Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Performance Shares, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 10(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Performance Shares, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, for a period of one (1) year after the Settlement Date of the Performance Shares, for himself&#47;herself or any third party, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or to interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the term of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing , or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-25.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By acceptance of these Performance Shares, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Performance Shares pursuant to any of Sections 10(b) through 10(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company.  Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 10(f) shall not result in the cancellation of Performance Shares. Grantee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Right to Retain Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, during the term of the Performance Period and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Performance Shares that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company the Performance Shares or any Shares or the pre-tax income derived from any disposition of the Shares previously received in settlement of the Performance Shares that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-33.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Performance Shares have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.  </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 9 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Performance Shares set forth in this Agreement.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.   </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 13(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 10 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Its&#58;   Chief Executive Officer </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(FOR PURPOSES OF THIS PARAGRAPH, IGNORING ANY ELECTION TO DEFER SETTLEMENT PURSUANT TO SECTION 6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY ACHIEVEMENT OF THE PERFORMANCE CRITERIA AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;investors.thecloroxcompany.com&#47;sec.cfm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Grantee hereby consents to receive the Prospectus Information electronically or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of the Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; ____________________________&#160;&#160;&#160;&#160;Signed&#58; _________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grantee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence Address&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;__________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;__________________________________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 11 -</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>clxq3fy21exhibit106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib922419177144074b0c0938544ae0c49_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">(US Employees)</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMMARY OF RESTRICTED STOCK UNIT AWARD</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this restricted stock unit award agreement (the &#8220;Agreement&#8221;), the following number of Restricted Stock Units (the &#8220;Units&#8221;), on the terms set forth below&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GRANTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Participant ID&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TOTAL RESTRICTED UNITS AWARDED</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Units Granted&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DATE OF AWARD</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Grant Date&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PERIOD OF RESTRICTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25% vests on each of the first four anniversaries of the date of award&#59; provided that &#91;the Committee&#93;&#91;a committee consisting of the Chief Executive Officer and the Chief People Officer&#93; may provide in its sole discretion for the vesting of additional Units in an amount sufficient to satisfy any applicable tax withholding amounts arising due to Grantee&#8217;s eligibility under this Agreement to terminate employment or services due to &#8220;Retirement&#8221;.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1,2</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">TERMS OF AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Grant of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company hereby grants to the Grantee the Units set forth above, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Units set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Units represent an unfunded, unsecured promise by the Company to issue Shares.  Units will become vested and be settled in Shares on a one Share for one Unit basis, rounded to the nearest whole Share, less any Shares withheld in accordance with the provisions of Section 4 of this Agreement.  Settlement shall occur as soon as practicable after the Period of Restriction lapses as provided in the Summary of Restricted Stock Unit Award above, but in any event, within the period ending on the later to occur of  the date that is 2 &#189; months from the end of (1) the Grantee&#8217;s tax year that includes the date of the lapse of the Period of Restriction, or (2) the Company&#8217;s tax year that includes the date of the lapse of the Period of Restriction (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) (the &#8220;Settlement Date&#8221;).  Notwithstanding the foregoing, if the Grantee elects to receive any </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To be included in agreements for individuals who are members of the Clorox Executive Committee and&#47;or required to file disclosure statements under Section 16(a) of the Securities Exchange Act. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To be included in agreements for individuals who are neither members of the Clorox Executive Committee nor required to file disclosure statements under Section 16(a) of the Securities Exchange Act. </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 1 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares on a Deferred Settlement Date established pursuant to Section 6 of this Agreement, the Units to which such election applies shall be settled on the Deferred Settlement Date.  Although the Units shall be vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists after the Period of Restriction lapses, the Units will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Section 10(b), 10(c), 10(d), 10(e) and Section 11, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Units until all such conditions precedent have been satisfied.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Dividend Equivalents shall be paid to the Grantee prior to the lapse of the Period of Restriction.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s RSU account and paid out in the form of additional Shares, rounded down to the nearest whole Share, after the lapse of the Period of Restriction, within the time period described in Section 2 above.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares in settlement of Units upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Grantee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">If the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason, any Units (the &#8220;Unvested Units&#8221;) for which the Period of Restriction has not lapsed before such termination of employment or service and&#47;or any Dividend Equivalents related thereto shall be forfeited.  Notwithstanding the above, if the Grantee&#8217;s termination of employment or service is due to (i) Retirement and is more than 6 months from the date of award set forth in this Agreement, then the restrictions on the Units and all Dividend Equivalents related thereto shall continue to lapse in accordance with the Period of Restriction provided in the Summary of Restricted Stock Unit Award above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the &#8220;Settlement Date&#8221; for such Units and Dividend Equivalents shall occur no later than December 31 of the calendar year in which the applicable Period of Restriction lapses or (ii) death or Disability, the Units shall become 100% vested and the Period of Restriction on the Units shall lapse and all Dividend Equivalents related thereto shall become immediately vested and payable as of such termination date.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Definition of &#8220;Disability.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Definition of &#8220;Retirement.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment or service shall be deemed to have terminated due to  &#8220;Retirement&#8221; if the Grantee terminates employment or service as an Employee for any reason, including Disability (but other than for Cause) after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Grantee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five (55) with ten (10) or more years of Vesting Service.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Election to Defer Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the first four (4) months following the Date of Award set forth above, the Grantee may elect to defer the settlement of the date on which the Period of Restriction lapses until a date at </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">least two years following such date, or until the Grantee&#8217;s later termination of employment or service.  Such date shall be referred to as the &#8220;Deferred Settlement Date&#8221;.  If the Grantee makes such an election, it will become irrevocable on the date of such election.  If the Grantee makes such an election, any Dividend Equivalents awarded with respect to such deferred Shares shall also be deferred under the same terms.  If the Grantee makes such an election, but a transaction occurs that subjects the Grantee&#8217;s Shares to Section 19 of the Plan prior to the Deferred Settlement Date, the Grantee&#8217;s deferral election will terminate and the Grantee&#8217;s Shares and Dividend Equivalents will be settled as of the date of that transaction.  The Company may terminate any deferral hereunder if a change in law requires such termination.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Authorization to Return Forfeited Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   The Grantee authorizes the Company or its designee to return to the Company all Units and related Dividend Equivalents and Shares subject thereto which are forfeited along with any cash or other property held with respect to or in substitution of such Units, related Dividend Equivalents and&#47;or Shares.  Any such action shall comply with all applicable provisions of this Agreement or the Plan.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Transferability of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Committee, Units shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Units pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the occurrence of a Change in Control, unless otherwise specifically prohibited under Applicable Laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, any Unvested Units and related Dividend Equivalents shall become 100% vested and the Period of Restriction for the Units and related Dividend Equivalents shall lapse, unless the Units are assumed, converted or replaced by the continuing entity&#59; provided, however, that in the event the Grantee&#8217;s employment is terminated without Cause or by the Grantee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control, the Period of Restriction on any replacement awards shall lapse and all Dividend Equivalents related thereto shall become immediately payable.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any organization controlling, controlled by or under common control with the Company.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 9(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Units, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By acceptance of these Units and any Shares issued in settlement thereof, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Units pursuant to any of Sections&#160;10(b) through 10(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 10(f) shall not result in the cancellation of Shares.  Grantee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE PERIOD OF RESTRICTION OR WITHIN ONE YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Units that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company any Units or any Shares or the pre-tax income derived from any disposition of any Shares previously received in settlement of the Units that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Units have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy).</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Units set forth in this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Code, and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 13(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Its&#58;  Chief Executive Officer</font></div><div style="padding-left:216pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT (FOR PURPOSES OF THIS PARAGRAPH, IGNORING ANY ELECTION TO DEFER SETTLEMENT PURSUANT TO SECTION 6) AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox web site at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;CLOROXWEB&#47;hr&#47;stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Grantee hereby consents to receive the Prospectus Information electronically, or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grantee</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 9 -</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>clxq3fy21exhibit107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i402281c6defb45598c7289f9ae59a349_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">(US Employees)</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMMARY OF RESTRICTED STOCK UNIT AWARD</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this restricted stock unit award agreement (the &#8220;Agreement&#8221;), the following number of Restricted Stock Units (the &#8220;Units&#8221;), on the terms set forth below&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GRANTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Participant ID&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TOTAL RESTRICTED UNITS AWARDED</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Units Granted&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DATE OF AWARD</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#60;&#60;Grant Date&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PERIOD OF RESTRICTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">100% vests 36 months from the date of award</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">TERMS OF AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Grant of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company hereby grants to the Grantee the Units set forth above, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Units set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Units represent an unfunded, unsecured promise by the Company to issue Shares.  Units will become vested and be settled in Shares on a one Share for one Unit basis, rounded to the nearest whole Share, less any Shares withheld in accordance with the provisions of Section 4 of this Agreement.  Settlement shall occur as soon as practicable after the Period of Restriction lapses as provided in the Summary of Restricted Stock Unit Award above, but in any event, within the period ending on the later to occur of  the date that is 2 &#189; months from the end of (1) the Grantee&#8217;s tax year that includes the date of the lapse of the Period of Restriction, or (2) the Company&#8217;s tax year that includes the date of the lapse of the Period of Restriction (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) (the &#8220;Settlement Date&#8221;).  Notwithstanding the foregoing, if the Grantee elects to receive any Shares on a Deferred Settlement Date established pursuant to Section 6 of this Agreement, the Units to which such election applies shall be settled on the Deferred Settlement Date.  Although the Units shall be vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists after the Period of Restriction lapses, the Units will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Section 10(b), 10(c), 10(d), 10(e) and Section 11, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Units until all such conditions precedent have been satisfied.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Dividend Equivalents shall be paid to the Grantee prior to the lapse of the Period of Restriction.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s RSU account and paid out in the form of additional Shares, rounded down to the nearest whole Share, after the lapse of the Period of Restriction, within the time period described in Section 2 above.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 1 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares in settlement of Units upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Grantee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">If the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason, any Units (the &#8220;Unvested Units&#8221;) for which the Period of Restriction has not lapsed before such termination of employment or service and&#47;or any Dividend Equivalents related thereto shall be forfeited.  Notwithstanding the above, if the Grantee&#8217;s termination of employment or service is due to death or Disability, the Units shall become 100% vested and the Period of Restriction on the Units shall lapse and all Dividend Equivalents related thereto shall become immediately vested and payable as of such termination date.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Definition of &#8220;Disability.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Election to Defer Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the first four (4) months following the Date of Award set forth above, the Grantee may elect to defer the settlement of the date on which the Period of Restriction lapses until a date at least two years following such date, or until the Grantee&#8217;s later termination of employment or service.  Such date shall be referred to as the &#8220;Deferred Settlement Date&#8221;.  If the Grantee makes such an election, it will become irrevocable on the date of such election.  If the Grantee makes such an election, any Dividend Equivalents awarded with respect to such deferred Shares shall also be deferred under the same terms.  If the Grantee makes such an election, but a transaction occurs that subjects the Grantee&#8217;s Shares to Section 19 of the Plan prior to the Deferred Settlement Date, the Grantee&#8217;s deferral election will terminate and the Grantee&#8217;s Shares and Dividend Equivalents will be settled as of the date of that transaction.  The Company may terminate any deferral hereunder if a change in law requires such termination.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Authorization to Return Forfeited Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   The Grantee authorizes the Company or its designee to return to the Company all Units and related Dividend Equivalents and Shares subject thereto which are forfeited along with any cash or other property held with respect to or in substitution of such Units, related Dividend Equivalents and&#47;or Shares.  Any such action shall comply with all applicable provisions of this Agreement or the Plan.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Transferability of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Committee, Units shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Units pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the occurrence of a Change in Control, unless otherwise specifically prohibited under Applicable Laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, any Unvested Units and related Dividend Equivalents shall become 100% vested and the Period of Restriction for the Units and related Dividend Equivalents shall lapse, unless the Units are assumed, converted or replaced by the continuing entity&#59; provided, however, that in the event the Grantee&#8217;s employment is terminated without Cause or by the Grantee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control, the Period of Restriction on any replacement awards shall lapse and all Dividend Equivalents related thereto shall become immediately payable.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any organization controlling, controlled by or under common control with the Company.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:63pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 9(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Units, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By acceptance of these Units and any Shares issued in settlement thereof, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Units pursuant to any of Sections&#160;10(b) through 10(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 10(f) shall not result in the cancellation of Shares.  Grantee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In partial consideration for the award of these Units in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE PERIOD OF RESTRICTION OR WITHIN ONE YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Units that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company any Units or any Shares or the pre-tax income derived from any disposition of any Shares previously received in settlement of the Units that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subject to the Policy).</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Units have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Units set forth in this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Code, and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 13(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLOROX COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Its&#58;  Chief Executive Officer</font></div><div style="padding-left:216pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT (FOR PURPOSES OF THIS PARAGRAPH, IGNORING ANY ELECTION TO DEFER SETTLEMENT PURSUANT TO SECTION 6) AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox web site at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;CLOROXWEB&#47;hr&#47;stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Grantee hereby consents to receive the Prospectus Information electronically, or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grantee</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________________</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- 9 -</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>9
<FILENAME>clxq3fy21exhibit108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i22739b0d0f264cbc89e2a8fa052aceb9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.8</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Severance Plan for Clorox Executive Committee Members</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Third Amended and Restated Effective as of February 9, 2021</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Severance Plan for Clorox Executive Committee Members (the &#8220;Plan&#8221;) provides benefits in certain instances to Participants who are employed by The Clorox Company, a Delaware corporation (&#8220;Clorox&#8221;) or an Affiliate (as defined below) of Clorox (collectively, the &#8220;Company&#8221;) and whose employment is involuntarily terminated.  The Plan was originally adopted effective as of May 19, 2010.  The Plan was subsequently amended and restated for the first time effective as of November 20, 2014, for the second time effective as of February 11, 2020 and is hereby amended and restated for the third time effective as of February 9, 2021.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:26.07pt">Definitions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;&#8220;Affiliate&#8221; means any corporation or other entity that, now or hereafter, directly or indirectly owns, is owned by, or is under common ownership with Clorox.  A corporation or other entity shall be deemed to be &#8220;owned&#8221; by Clorox where Clorox owns more than fifty percent (50%) of the equity or other ownership interest in, or has the power to vote on or direct the affairs of, such corporation or other entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;&#8220;Average Annual Bonus&#8221; means the average annual incentive bonus that the Participant received for the three (3) completed fiscal years immediately preceding the Separation Date, or the average annual incentive bonus that the Participant received for the actual number of completed fiscal years immediately preceding the Separation Date if less than three (3), under the Company&#8217;s annual incentive cash bonus plan in which the Participant was a participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;&#8220;Base Salary&#8221; means the annual base salary of the Participant immediately prior to termination of employment by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;&#8220;Board&#8221; means the Board of Directors of Clorox.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5&#160;&#160;&#160;&#160;&#8220;Bonus Target&#8221; means the annual bonus that the Participant would have received in a fiscal year under the annual cash incentive bonus plan in which the Participant was then participating, if the target goals had been achieved.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6&#160;&#160;&#160;&#160;&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.7&#160;&#160;&#160;&#160;&#8220;General Release&#8221; means a general release of all claims substantially in the form attached as Exhibit 1, which may be amended by the Management Development and Compensation Committee of Clorox&#8217;s Board (the &#8220;Committee&#8221;) at its sole discretion from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.8&#160;&#160;&#160;&#160;&#8220;Medical Insurance Coverage&#8221; means any medical, dental, vision and prescription drug insurance coverage offered by the Company to its salaried employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.9&#160;&#160;&#160;&#160;&#8220;Misconduct&#8221; means any act or omission of the Participant through which the Participant&#58; (i)&#160;willfully neglects significant duties he or she is required to perform or willfully violates a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">material Company policy&#59; (ii)&#160;commits a material act of dishonesty, fraud, misrepresentation or other act of moral turpitude&#59; (iii)&#160;acts (or omits to act) with gross negligence in the course of employment&#59; (iv)&#160;fails to obey a lawful direction of the Board or, for Participants other than the Company&#8217;s Chief Executive Officer (the &#8220;CEO&#8221;), a corporate officer to whom he or she reports, directly or indirectly&#59; or (v)&#160; engages in any conduct materially detrimental to the Company, including, but not limited to, the name, business interests or corporate, brand, business or other reputation of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No act or failure to act on the part of the Participant shall be considered &#8220;willful&#8221; unless it is done, or omitted to be done, by the Participant in bad faith or without reasonable belief that the Participant&#8217;s action or omission was in the best interests of the Company.  Any act or failure to act based upon authority given pursuant to a resolution duly adopted by the Board, upon the instructions of the Chief Executive Officer (with respect to Participants other than the Chief Executive Officer), or upon the advice of counsel for the Company shall be conclusively presumed to be done or omitted to be done by the Participant in good faith and in the best interests of the Company.  The Participant shall not be deemed to have committed an act or omission of Misconduct unless and until the Authorized Person determines that, in its good faith opinion, the Participant is guilty of conduct described in subparagraphs&#160;(i) through (v) above, and so notifies the Participant specifying the particulars thereof.  For purposes of the Plan, the term &#8220;Authorized Person&#8221; shall mean&#58; (1) with respect to the CEO and any other executive who at the time is a &#8220;named executive officer&#8221; within the meaning of Item 402(b) of Regulation S-K promulgated by the Securities and Exchange Commission (&#8220;NEO&#8221;), the Committee, (2) with respect to all other Participants (except as expressly provided herein), the unanimous determination of the CEO, Chief People Officer or comparable most senior human resources executive (&#8220;CPO&#8221;) and Chief Legal Officer or comparable most senior legal executive (&#8220;CLO&#8221;), (3) with respect to the CPO, if the CPO is not an NEO, the CEO and the CLO, and (4) with respect to the CLO, if the CLO is not an NEO, the CEO and CPO.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.10&#160;&#160;&#160;&#160;&#8220;Participant&#8221; means a regular salaried employee of the Company scheduled to work more than twenty (20) hours per week who is a member of the Clorox Executive Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.11&#160;&#160;&#160;&#160;&#8220;Section 409A&#8221; means Section&#160;409A of the Code, and any related regulations or other guidance promulgated thereunder by the U.S. Department of the Treasury or the Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.12&#160;&#160;&#160;&#160;&#8220;Separation Date&#8221; means the last day a Participant is employed by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.13&#160;&#160;&#160;&#160;&#8220;Specified Employee&#8221; means a Participant who, for purposes of Section 409A of the Code on the Separation Date, is classified as&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.34pt">an officer of the Company having annual compensation greater than the compensation limit in Section&#160;416(i)(1)(A)(i) of the Code, provided that no more than fifty (50) officers of the Company shall be determined to be Specified Employees as of any Separation Date&#59;</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a five percent owner of the Company, regardless of compensation&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;a one percent owner of the Company having annual compensation from the Company of more than $150,000.  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s Specified Employees shall be determined in accordance with Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.14&#160;&#160;&#160;&#160;Other Definitions.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bonus&#160;&#160;&#160;&#160;Section 3.1(B)</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CIC Severance Plan&#160;&#160;&#160;&#160;Section 3.5</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Claimant&#160;&#160;&#160;&#160;Section 4.2</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Clorox&#160;&#160;&#160;&#160;Recital</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">COBRA&#160;&#160;&#160;&#160;Section 3.1(D)</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Committee&#160;&#160;&#160;&#160;Section 1.7</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company&#160;&#160;&#160;&#160;Recital</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ERISA&#160;&#160;&#160;&#160;Section 5.6</font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Other Benefits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Section 3.5</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan&#160;&#160;&#160;&#160;Recital</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator&#160;&#160;&#160;&#160;Section 4.1</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.41pt">Termination of Employment</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;By Company for Misconduct.  The Company may terminate the Participant&#8217;s employment for Misconduct (as defined in Section 1.9 above) at any time in accordance with such definition.  The Company shall pay the Participant the salary and other amounts (e.g., accrued but unused vacation) to which he or she is entitled by law through the Separation Date or under the terms of another compensation or benefit plan, program or arrangement sponsored by the Company, and thereafter the Company&#8217;s obligations shall terminate.  The Participant shall not be entitled to any unpaid cash incentive bonus for the prior fiscal year or the fiscal year in which termination occurs, and the Participant shall not be entitled to any benefits under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;By Participant.  The Participant may, after satisfying any obligation to provide advance written notice to the Company and continuing his or her employment until the end of such period, terminate his or her employment, for any reason or no reason.  The Company shall pay the Participant the salary and other amounts (e.g., accrued but unused vacation) to which he or she is entitled by law through the end of the Participant&#8217;s employment or under the terms of another compensation or benefit plan, program or arrangement sponsored by the Company, and thereafter the Company&#8217;s obligations shall terminate.  The Participant shall not be entitled to any benefits under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;By Company at Will.  The Company may, at any time, with or without notice, and for any reason or no reason, terminate the Participant&#8217;s employment.  If the Company terminates the Participant&#8217;s employment other than for Misconduct or on account of disability, the Company shall pay the Participant the salary and other amounts (e.g., accrued but unused vacation) to which he or she is entitled by law through the Separation Date or under the terms of another compensation or benefit plan, program or arrangement sponsored by the Company, the severance payment provisions of Article III </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall apply and the Company shall have no additional liability.  The Company&#8217;s progressive discipline policy and practice do not apply to such terminations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.75pt">Severance Benefits</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;A Participant whose employment with the Company is involuntarily terminated by the Company other than for Misconduct or on account of disability is entitled to receive the benefits described below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.34pt">An amount equal to two times the Participant&#8217;s Base Salary.  In the case of the CEO, an amount equal to the sum of (i) two times the CEO&#8217;s Base Salary and (ii) two times the CEO&#8217;s Bonus Target multiplied by 75%.  Such amount(s) shall be paid as soon as reasonably practicable and, subject to Section 3.4, no later than sixty (60) days after the Separation Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:25pt">An amount equal to&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bonus</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">X</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"># of days in the current fiscal year <br>through the Separation Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">X</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">75%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">365</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provided, however, that the amount under 3.1(B) shall not be multiplied by 75%, in the case of the CEO.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This amount under 3.1(B) will be paid after the close of the fiscal year at the same time that annual cash incentive award payments are made to then employed executives&#59; provided, however, that if the Participant is a Specified Employee (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) on the Separation Date, such payments shall be made in accordance with Section 3.4 below.  For purposes of this section, &#8220;Bonus&#8221; means a percentage of the Participant&#8217;s Bonus Target for such fiscal year based upon the application of the overall corporate results factor and the division and&#47;or functional results factor, if applicable, for the annual cash incentive bonus plan in which the Participant was then participating.  The Bonus will not be based on any personal objectives factor&#59; thus, the individual modifier to be applied to the corporate and business and&#47;or functional results, if any, will be calculated at 100% or otherwise in order to remove any influence of personal objectives from the calculation of the amount of the Bonus.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provided, however, that if the Participant meets retirement eligibility on the Separation Date and thus is eligible to receive a prorated bonus (&#8220;Retirement Bonus&#8221;) in the year of separation in accordance with the terms of the Company&#8217;s annual cash incentive bonus plan in which the Participant is then participating, the Company may determine, in its sole discretion, to either pay such Retirement Bonus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> pay the amount calculated in accordance with this Section 3.1(B), but it shall not be obligated to pay both.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Company shall pay the applicable Participant an amount equal to the product of (1) 24 multiplied by (2) the excess of (x) the monthly cost of health benefits of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">type applicable to the applicable Participant (including the Participant&#8217;s covered dependents) under the Consolidated Omnibus Budget Reconciliation Act of 1985 as of immediately prior to the Separation Date over (y) the portion of the monthly premium for such coverage that would be paid by an active employee (determined as of immediately prior to the Separation Date. Such amount shall be paid as soon as reasonably practicable and, subject to Section 3.4, no later than sixty (60) days after the Separation Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.&#160;&#160;&#160;&#160;In addition, solely for purposes of determining eligibility for retiree Medical Insurance Coverage, the Participant shall be credited with two additional years of age and service as of the Separation Date.  If, taking into account these additional credits, the Participant would meet the age and service requirements for non-subsidized or subsidized participation under the Company&#8217;s retiree Medical Insurance Coverage as and if offered to similarly situated former employees, the Participant shall have the right to continued participation under such retiree Medical Insurance Coverage on the same terms and conditions as for such former employees, including applicable retiree premium contributions from the Participant as in effect from time to time.  Such right to participate shall apply from the time such coverage would otherwise terminate pursuant to Section 3.1(D) above and shall continue until the Participant attains age 65&#59; thereafter the Participant may participate in the Company&#8217;s post-65 retiree Medical Insurance Coverage as and if it may exist from time to time in the future, if he or she would be eligible to participate pursuant to the terms of that plan.  The Company reserves the right to amend or eliminate retiree Medical Insurance Coverage and nothing in this paragraph guarantees such coverage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;A Participant shall not be entitled to the severance benefits set forth in this Article III if the Participant is terminated by the Company but continues to be employed by, or is offered employment with either (i) a third party or related entity in connection with an outsourcing of such Participant&#8217;s position to such third party or related entity&#59; or (ii) any entity or individual that acquires all or any portion of the assets or operations of the Company, or that assumes responsibility for the performance of the obligations of all or any portion of the Company. Notwithstanding the foregoing, if the continued or offered employment referenced above in this Section 3.2 is in a location that would result in an increase in the Participant&#8217;s commute of more than 35 miles from the commute to the Participant&#8217;s pre-relocation principal work location, and the Participant elects not to continue or accept such employment, then the Participant shall be deemed to have been involuntarily terminated by the Company other than for Misconduct or on account of disability and therefore shall be entitled to severance benefits, pursuant and subject to the other terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;As a condition to receipt of any severance benefits set forth in this Article III, a Participant must execute a General Release within the time specified therein.  If the Participant does not execute the General Release within the time provided, or having executed such General Release, effectively revokes the General Release, or fails to comply with his or her obligations and requirements under the General Release, then the Company will not be obligated to provide any benefits or payments of any kind to the Participant pursuant to the Plan and the Participant shall be obligated to return to the Company any payments or benefits previously provided to the Participant pursuant to the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if the Participant is a Specified Employee on the Separation Date, all payments specified in this Article III that are subject to Section 409A but are not made by March 15 of the year immediately following the Separation Date, may be made to the extent that the amount does not exceed two times the lesser of (i) the sum of the Participant&#8217;s annualized compensation based upon the annual rate of pay for services provided to the Company for the taxable year preceding the termination, or (ii) the maximum amount ($285,000 in 2020) that may be taken into account pursuant to Section 401(a)(17) of the Code for the year in which the Participant has terminated.  Any amounts exceeding such limit may not be made before the earlier of the date which is six (6) months after the Separation Date or the date of death of the Participant.  Furthermore, any payments pursuant to this Article III shall be postponed until six (6) months following the end of any consulting period so long as the Participant continues to work on a consulting basis for the Company following termination and such consulting requires the Participant to work more than 20% of his or her average hours worked during the 36 months preceding his or her termination.  Any payments that were scheduled to be paid during the six (6) month period following the Participant&#8217;s Separation Date, but which were delayed pursuant to this Section 3.4, shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Participant&#8217;s Separation Date (or, if earlier, the date of Participant&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Participant&#8217;s Separation Date shall continue to be paid in accordance to their predetermined schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;Notwithstanding any other provision of the Plan to the contrary, any benefits payable to a Participant under the Plan shall be in lieu of any severance benefits payable by the Company to such individual under any other arrangement covering the individual, unless expressly otherwise agreed to by the Company in writing.  Further, in the event that the Participant is entitled to receive severance benefits under (1) any agreement or contract with the Company, excluding The Clorox Company Executive Change in Control Severance Plan (&#8220;CIC Severance Plan&#8221;), (2) any plan, policy, program or other arrangement adopted or established by the Company&#59; (3) the Worker Adjustment and Retraining Notification (WARN) Act, 29&#160;U.S.C. &#167;&#160;2101 et seq., or (4) other applicable law providing for payments from Clorox or its subsidiaries or affiliates on account of termination of employment, including pay in lieu of advance notice of termination (&#8220;Other Benefits&#8221;), any severance benefits payable hereunder shall be reduced by the Other Benefits.  In the event that the Participant becomes entitled to receive benefits under the CIC Severance Plan, any benefits payable thereunder shall be in lieu of any severance benefits payable under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.6&#160;&#160;&#160;&#160;Recoupment in Event of Subsequently Discovered Misconduct.  If, after the Separation Date of a Participant, the Company discovers the Participant had engaged in acts or omissions during the course of the Participant&#8217;s employment with the Company that meet the definition of Misconduct (as defined in Section 1.9 above, excluding any notice, prior written warning and other similar procedural terms of that definition), then the Plan Administrator may immediately cease the delivery of any further payments or benefits provided for under this Article III. and shall be entitled to recoup from the Participant for the benefit of the Company any payments and&#47;or the value of any benefits provided to the Participant described in this Article III, plus interest at the then prevailing prime rate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:17.41pt">Plan Administration and Claims</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;Plan Administration.  The Committee shall serve as the person responsible for administration of the Plan (&#8220;Plan Administrator&#8221;).  As the Plan Administrator, the Committee has full discretionary authority to administer and interpret the Plan, including discretionary authority to determine eligibility for participation and for benefits under the Plan and to correct errors.  The Plan Administrator may delegate administrative duties to other Company personnel or to any other committee.  Any such delegation will carry with it the full discretionary authority of the Plan Administrator to carry out these duties.  Any determination by the Plan Administrator or its delegate will be final and conclusive upon all persons unless determined to be arbitrary and capricious or made in bad faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;Claims Procedure.  If an individual (&#8220;Claimant&#8221;) believes that he or she is entitled to a benefit under the Plan that is greater than the benefit about which the Claimant has received notice under the Plan, the Claimant may submit a written application to the Plan Administrator or its delegate within 90 days of having been denied such a benefit.  The Claimant will generally be notified of the approval or denial of this application within 90 days (180 days if the Plan Administrator (or its delegate) determines that an extension of time for processing is required and provides written notice to the Claimant) of the date that the Plan Administrator (or its delegate) receives the application.  If the claim is denied in whole or in part, the notification will state specific reasons for the denial, reference the Plan provisions on which the denial is based, include a description of any additional materials or information necessary for the Claimant to perfect the claim and an explanation of why such material or information is necessary, and describe the Plan&#8217;s claims review procedures.  The Claimant will have 60 days to file an appeal of the denial with the Plan Administrator (or its delegate).  This appeal will include the reasons for requesting an appeal, facts supporting the appeal and any other relevant comments.  The Plan Administrator (or its delegate), operating pursuant to its discretionary authority to administer and interpret the Plan and to determine eligibility for benefits under the terms of the Plan, will generally make a final, written determination of the Claimant&#8217;s appeal within 60 days (120 days if the Plan Administrator (or its delegate) determines that an extension of time for processing is required and provides written notice to the Claimant) of receipt of the request for review.  If the appeal is denied in whole or in part, the notification will state specific reasons for the denial, reference the Plan provisions on which the denial is based, and notify the Claimant of the right to initiate an arbitration proceeding in accordance with Section 4.3.  The Claimant must exhaust the procedures set forth in this Section 4.2 before initiating an arbitration proceeding relating to a claim for benefits under the Plan in accordance with Section 4.3.  Each Participant agrees as a condition of participating in the Plan that arbitration is the exclusive dispute resolution mechanism with respect to the Plan following a Claimant&#8217;s exhaustion of the procedures described in this Section 4.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3&#160;&#160;&#160;&#160;Arbitration.  Within one (1) year following a Claimant&#8217;s exhaustion of the procedures in Section 4.2, any remaining controversy relating to the Plan shall be settled by the Claimant and the Company solely pursuant to final and binding arbitration before a single arbitrator in accordance with the then current commercial arbitration rules of the American Arbitration Association, and judgment on the award rendered by the arbitrator may be entered by any court having jurisdiction thereof.  Failure by the Claimant to initiate arbitration within the one (1) year time period set forth above shall prevent the Claimant from any pursuit of such claim by any means, whether through arbitration or otherwise, and the resolution of such claim upon the completion of the claims procedure set forth in Section 4.2 shall be final and binding on Claimant and any and all successors in interest.  The arbitrator shall determine </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">whether to affirm or reverse the Plan Administrator&#8217;s (or its delegate&#8217;s) denial of the appeal, and shall reverse such denial it determines that the Plan Administrator&#8217;s (or its delegate&#8217;s) decision was arbitrary or capricious or made in bad faith.  The arbitrator shall have no power to alter, add to, or subtract from any provision of the Plan.  The arbitrator&#8217;s decision shall be final and binding on all parties, if warranted on the record and reasonably based on applicable law and the provisions of the Plan.  The arbitrator shall have no power to award any damages that are not permitted by ERISA, and under no circumstances shall an award contain any amount that in any way reflects any of such types of damages.  Each party shall bear its own attorney&#8217;s fees, but the Company shall bear the costs and expenses of arbitration (provided that if the Company prevails in the arbitration, the arbitrator may, in his or her discretion, require the Claimant to pay or reimburse the Company for all or a portion of such costs and expenses).  The location of the arbitration shall be within fifty (50) miles of the last place of employment with the Company of the Participant with respect to whose potential Plan benefit the claim is brought.  Service of legal process should be directed to the Legal Services Department of Clorox.  Process may also be served on the Corporate Secretary of Clorox.  Clorox&#8217;s employer identification number is 31-0595760.  Clorox&#8217;s address and telephone number are&#58;  1221 Broadway, Oakland, CA 94612, (510)&#160;271-7000.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.07pt">Miscellaneous Provisions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;Assignment.  To the fullest extent not prohibited by law, Plan benefits are not assignable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;Death of Participant.  If a Participant dies after an involuntary termination, the benefit that otherwise would have been payable to the Participant will be paid, in a single sum payment, as soon as administratively practicable to the Participant&#8217;s surviving spouse, or if there is no such spouse, to the Participant&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;Compliance.  Plan benefits are conditioned on a Participant&#8217;s compliance with any confidentiality agreement or release that the Participant has entered into with Clorox and&#47;or with an Affiliate in addition to any other requirement or obligation set forth in the Plan or the General Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4&#160;&#160;&#160;&#160;Amendment and Termination.  The Board or the Committee, by a signed writing, may amend or terminate the Plan at any time, with or without notice&#59; provided, however, that the Plan may not be amended or terminated to reduce or eliminate benefits that would otherwise be payable under the Plan to Participants who are entitled to benefits under Article III as of the date such amendment or termination is approved by the Board or the Committee, as applicable. Notwithstanding the foregoing, the CEO may amend the Plan if the amendments are ministerial in nature or necessary to comply with applicable law or other regulatory matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.5&#160;&#160;&#160;&#160;Continued Services.  The Plan does not provide a Participant with any right to continue employment with the Company or affect the right of the Company to terminate the services of any individual at any time with or without cause, for any reason or no reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.6&#160;&#160;&#160;&#160;Governing Law. The Plan is intended to be an unfunded welfare benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;).  To the extent applicable and not preempted by ERISA, the laws of the State of Delaware will govern the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.7&#160;&#160;&#160;&#160;Plan Year.  The Plan&#8217;s fiscal records are maintained on a fiscal year basis with a June 30 year end.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.8&#160;&#160;&#160;&#160;Source of Payments.  Benefits payable under the Plan are not funded and are payable only from the general assets of Clorox or the appropriate Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.9&#160;&#160;&#160;&#160;Section 409A.  To the extent applicable, it is intended that the Plan and any payment made hereunder shall comply with, or be exempt from, the requirements of Section&#160;409A.  Any provision that would cause the Plan or any payment hereunder to fail to satisfy Section&#160;409A shall have no force or effect until amended to the minimum extent required to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section&#160;409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.10&#160;&#160;&#160;&#160;Gender, Number and References.  Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular and the singular shall include the plural.  Any reference in the Plan to a Section of the Plan or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.11&#160;&#160;&#160;&#160;Severability.  The provisions of the Plan are severable and in the event that a court of competent jurisdiction determines that any provision of the Plan is in violation of any law or public policy, in whole or in part, only the portions of the Plan that violate such law or public policy shall be stricken.  All portions of the Plan that do not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect.  Further, any court order striking any portion of the Plan shall modify the stricken terms as narrowly as possible to give as much effect as possible to the intent of the Company under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.12&#160;&#160;&#160;&#160;Notices.  All notices or other communications required or permitted hereunder shall be made in writing.  Notice shall be effective on the date of delivery if delivered by hand, on the first business day following the date of dispatch if delivered utilizing next day service by a recognized next day courier to the applicable address set forth below, or if mailed, three business days after having been mailed, postage prepaid, by certified or registered mail, return receipt requested, and addressed to the applicable address set forth below.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">If to the Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the residence address for the Participant last shown on the Company&#8217;s payroll records.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">If to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Clorox Company </font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1221 Broadway </font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Oakland, California  94612 </font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Chief Legal Officer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to such other address as either party shall have furnished to the other in writing in accordance herewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.13&#160;&#160;&#160;&#160;Waiver.  No waiver of any breach of any term or provision of the Plan by the Company shall be construed to be, nor shall be, a waiver of any other breach of the Plan.  No waiver shall be binding unless in writing and signed by the Company.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.14&#160;&#160;&#160;&#160;Tax Withholding.  All amounts or benefits payable pursuant to the Plan shall be subject to such withholding taxes as may be required by law.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">END OF DOCUMENT</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-10-</font></div></div></div><div id="i22739b0d0f264cbc89e2a8fa052aceb9_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT 1</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">GENERAL RELEASE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This document is an important one.  You should review it carefully and, if you agree to it, sign at the end on the line indicated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">You have &#91;__&#93; &#91;21&#93; &#91;45&#93; days to sign this Release, during which time you are advised to consult with an attorney regarding its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;After signing this Release, you have seven days to revoke it.  Revocation should be made in writing and delivered so that it is received by the Corporate Secretary of The Clorox Company, 1221 Broadway, Oakland, CA 94612 no later than 4&#58;30 p.m. on the seventh day after signing this Release.  If you do revoke this Release within that time frame, you will have no rights under it.  This Release shall not become effective or enforceable until the seven day revocation period has expired.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;The agreement for payment of consideration in paragraph 2 will not become effective until the seven day revocation period has passed.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">This GENERAL RELEASE is entered into between The Clorox Company (hereinafter referred to as &#8220;Employer&#8221;) and _____________________ (hereinafter referred to as &#8220;Executive&#8221;).  Defined terms used in this General Release not defined herein shall have the meaning set forth in the Severance Plan (as defined below).  Employer and Executive agree as set forth herein, including as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Executive&#8217;s regular employment with Employer will terminate as of _________________, 20__.  Executive is ineligible for reemployment or reinstatement with Employer.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Upon Executive&#8217;s acceptance of the terms set forth herein, the Employer agrees to provide the Executive with compensation and benefits set forth in Article III of the Severance Plan for Clorox Executive Committee Members (the &#8220;Severance Plan&#8221;), which compensation and benefits shall be provided subject to the terms and conditions of the Severance Plan, a copy of which is attached to this General Release.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">  In consideration of the Employer providing Executive this compensation, Executive and Executive&#8217;s heirs, assignees and agents agree to release the Employer, all affiliated companies, and each of their respective directors, officers, employees, owners, contractors, representatives, and agents, and each of their respective successors and assigns (hereinafter referred to as &#8220;Releasees&#8221;) fully and finally from any claims, liabilities, demands or causes of action which Executive may have or claim to have against the Releasees at present or in the future, except for the following&#58;  (i) claims for vested benefits under the terms of an employee compensation or benefit plan, program or arrangement sponsored by the Company, (ii) claims for workers&#8217; compensation benefits under any of the Company&#8217;s workers&#8217; compensation insurance policies or funds, (iii) claims related to Executive&#8217;s COBRA rights, (iv) claims for indemnification to which Executive is or may become entitled, including but not limited to claims submitted to an insurance company providing the Company with directors and officers liability insurance, (v)&#160;claims for benefits to be provided in accordance with Article III of the Severance Plan, and (vi)&#160;claims that may not be legally waived.  The claims released include, but are not limited to, any tax obligations as a result of the payment of consideration referred to in paragraph 2, and claims arising under federal, state or local laws prohibiting discrimination in employment, including the Age Discrimination in Employment Act (ADEA) or claims growing out of any legal restrictions on the Employer&#8217;s right to terminate its employees.  Claims of discrimination, wrongful termination, age discrimination, and any claims for benefits other than for vested benefits are hereby released.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:22.7pt">By signing this document, Executive agrees not to file a lawsuit to assert such claims.  Executive also agrees that if Executive breaches this provision, Executive will be liable for all costs and attorneys&#8217; fees incurred by any Releasee resulting from such action and shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">pay all expenses incurred by a Releasee in defending any proceeding pursuant to this Section&#160;3(b) as they are incurred by the Releasee in advance of the final disposition of such proceedings, together with any tax liability incurred by the Releasee in connection with the receipt of such amounts&#59; provided, however, that the payment of such expenses incurred in advance of the final disposition of such proceeding shall be made only upon delivery to the Executive of an undertaking, by or on behalf of the Releasee, to repay all amounts so advanced to the extent the arbitrator in such proceeding affirmatively determines that the Executive is the prevailing party, taking into account all claims made by any party to such proceeding.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">By signing this document, Executive is also expressly waiving the provisions of California Civil Code Section 1542, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">By signing this document, Executive agrees and understands that Executive is releasing unknown as well as known claims related to Executive&#8217;s employment in exchange for the compensation set forth above.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Executive agrees to maintain in complete confidence the terms of this Release, except as it may be necessary to comply with a legally compelled request for information.  It is agreed since confidentiality of this Release is of the essence, damages for violation being impossible to assess with precision, that $10,000 is a fair estimate of the damage caused by each disclosure and is agreed to as the measure of damages for each violation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">To forestall the disclosure or use of Proprietary Information (as defined below) and in consideration of the Plan, Executive agrees that for a period of two years after termination </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">of his or her employment, he or she shall not, for himself or herself, or for any third party, directly or indirectly, use the Company&#8217;s trade secrets or other Proprietary Information to (i) divert or attempt to divert from the Employer (or any of its affiliated companies) any business of any kind in which it is engaged, including, without limitation, the solicitation of its customers as to products that are directly competitive with products sold by the Employer at the time of Executive&#8217;s termination, or interference with any of its customer or suppliers, or (ii) solicit for employment any person employed by the Employer, or any of its affiliates, during the period of such person&#8217;s employment and for a period of one year after the termination of such person&#8217;s employment with the Employer.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Executive&#8217;s execution of this General Release and the absence of an effective revocation of such General Release by Executive shall constitute Executive&#8217;s resignation from all offices, directorships and other positions then held with the Employer or any of its affiliates, and any other position held for the benefit of or at the request of the Employer or any of its affiliates, and Executive hereby agrees that this General Release constitutes such resignation.  Executive also agree to execute a confirmatory letter of resignation if requested.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Executive hereby acknowledges and agrees that all personal property and equipment furnished to or prepared by the Executive in the course of or incident to his or her employment, belong to the Employer and shall, if physically returnable, be promptly returned to the Employer upon termination of his or her employment.  &#8220;Personal property&#8221; includes, without limitation, all books, manuals, records, reports, notes, contracts, lists, blueprints, and other documents, computer media or materials, or copies thereof, and Proprietary Information.  Following termination, the Executive will not retain any written or other tangible material containing any Proprietary Information.  &#8220;Proprietary Information&#8221; is all information and any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-14-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">idea in whatever form, tangible or intangible, pertaining in any manner to the business of the Employer or any its affiliates, or to their respective clients, consultants, or business associates, unless&#58;  (i)&#160;the information is or becomes publicly known through lawful means&#59; (ii) the information was rightfully in the Executive&#8217;s possession or part of his or her general knowledge prior to his or her employment by the Employer&#59; or (iii) the information is disclosed to the Executive without confidential or proprietary restriction by a third party who rightfully possesses the information (without confidential or proprietary restriction) and did not learn of it, directly or indirectly, from the Employer.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:27pt">Following termination, Executive will continue to abide by the Employer&#8217;s policy and any obligations that the Executive has to protect the Company&#8217;s Proprietary Information.  In amplification of the foregoing, Executive agrees to hold all Proprietary Information in strict confidence and trust for the sole benefit of the Employer and not to, directly or indirectly, disclose, use, copy, publish, summarize or remove from the Employer&#8217;s premises any Proprietary Information (or remove from the premises any other property of the Company), except (i) during his or her employment to the extent necessary to carry out Executive&#8217;s responsibilities to the Employer, (ii) after termination of his or her employment as specifically authorized in writing by the Board, and (iii) pursuant to a subpoena. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">Each Executive covered by the Plan agrees that he or she will not do or say anything that could reasonably be expected to disparage or impact negatively the name or reputation in the marketplace of the Company, all affiliated companies, and each of their respective employees, officers, directors, stockholders, members, principals, contractors, representatives or agents, and each of their respective successors or assigns.  Nothing herein shall preclude Executive from complying with applicable disclosure requirements, responding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-15-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">truthfully to any legal process or truthfully testifying in a legal or regulatory proceeding, provided that, to the extent permitted by law, Executive promptly informs the Company of any such obligation prior to participating in any such proceedings.  The Company likewise agrees that it will not release any information or make any statements, and it shall instruct its officers, directors and other representatives who may reasonably be viewed as speaking on its behalf not to say anything that could reasonably be expected to disparage or impact negatively the name or reputation in the marketplace of an Executive.  Nothing herein shall preclude the Company from complying with applicable disclosure requirements, responding truthfully to any legal process or truthfully testifying in a legal or regulatory proceeding, provided that to the extent permitted by law, the Company will promptly inform an Executive in advance if they have reason to believe such response or testimony will directly relate to such Executive.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">Following termination, Executive will continue to abide by the Employer&#8217;s policy that prohibits discussing any aspect of the Employer&#8217;s business with representatives of the press without first obtaining the permission of the Employer&#8217;s public relations group.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">Nothing in this General Release is intended to limit any remedy of the Employer (or any of its affiliated companies) under  the California Uniform Trade Secrets Act (California Civil Code Section 3426), or otherwise available under law.  In addition, and notwithstanding any other provision in this General Release to the contrary, nothing contained in this General Release limits Executive&#8217;s ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (each a &#8220;Government Agency&#8221;).  Executive further understands that this General Release does not limit Executive&#8217;s ability to communicate with any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-16-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to Employer.  However, to the maximum extent permitted by law, Executive agrees that if such a charge or complaint is made, Executive shall not be entitled to recover any individual monetary relief or other individual remedies.  This General Release does not limit or prohibit Executive&#8217;s right to receive an award for information provided to any Government Agency to the extent that such limitation or prohibition is a violation of law.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">The provisions of this General Release are severable and in the event that a court of competent jurisdiction determines that any provision of this General Release is in violation of any law or public policy, in whole or in part, only the portions of this General Release that violate such law or public policy shall be stricken.  All portions of this General Release that do not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect.  Further, any court order striking any portion of this General Release shall modify the stricken terms as narrowly as possible to give as much effect as possible to the intent of the Employer and Executive under this General Release.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">Executive agrees to indemnify and hold Employer harmless from and against any tax obligations for which Executive may become liable as a result of this Release and&#47;or payments made pursuant to the Severance Plan, other than tax obligations of the Employer resulting from the nondeductibility of any payments made pursuant to this Release or the Severance Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">Agreeing to this Release shall not be deemed or construed by either party as an admission of liability or wrongdoing by either party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-17-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;padding-left:21pt">This Release, the Severance Plan and the plans of The Clorox Company referred to in the Severance Plan set forth the entire agreement between Executive and the Employer.  This Release is not subject to modification except in writing executed by both of the parties.  The Clorox Company plan documents of plans referred to in the Severance Plans may be amended in accordance with the provisions of those plans.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Executive acknowledges by signing below that Executive has not relied upon any representations, written or oral, not set forth in this Release.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE CLOROX COMPANY</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div><div style="margin-bottom:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-18-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>clxq3fy21exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idd9b2452295c4004baf812b84ae1756f_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Linda Rendle, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 30, 2021</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>clxq3fy21exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i47200ce102774982913468cc7a5abfd8_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin B. Jacobsen, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 30, 2021</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>12
<FILENAME>clxq3fy21exhibit32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i85cba9cece484ad4a0b7672750ab8858_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the periodic report of The Clorox Company (the &#8220;Company&#8221;) on Form 10-Q for the period ended March 31, 2021, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), we, Linda Rendle, Chief Executive Officer of the Company, and Kevin B. Jacobsen, Executive Vice President - Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to our knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Certification has not been, and shall not be deemed, &#8220;filed&#8221; with the Securities and Exchange Commission.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April 30, 2021</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>clx-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clx="http://www.clorox.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.clorox.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.clorox.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUIRED" roleURI="http://www.clorox.com/role/BUSINESSACQUIRED">
        <link:definition>2103102 - Disclosure - BUSINESS ACQUIRED</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUIREDTables" roleURI="http://www.clorox.com/role/BUSINESSACQUIREDTables">
        <link:definition>2304301 - Disclosure - BUSINESS ACQUIRED (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUIREDNarrativeDetails" roleURI="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails">
        <link:definition>2405401 - Disclosure - BUSINESS ACQUIRED (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2406402 - Disclosure - BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNET" roleURI="http://www.clorox.com/role/INVENTORIESNET">
        <link:definition>2107103 - Disclosure - INVENTORIES, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETTables" roleURI="http://www.clorox.com/role/INVENTORIESNETTables">
        <link:definition>2308302 - Disclosure - INVENTORIES, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETDetails" roleURI="http://www.clorox.com/role/INVENTORIESNETDetails">
        <link:definition>2409403 - Disclosure - INVENTORIES, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS">
        <link:definition>2110104 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables">
        <link:definition>2311303 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails">
        <link:definition>2412404 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails">
        <link:definition>2413405 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails">
        <link:definition>2414406 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails">
        <link:definition>2415407 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1" roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1">
        <link:definition>2415407 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>2116105 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>2317304 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2418408 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
        <link:definition>2419409 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
        <link:definition>2420410 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.clorox.com/role/INCOMETAXES">
        <link:definition>2121106 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2422411 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPS" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS">
        <link:definition>2123107 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPSTables" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables">
        <link:definition>2324305 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails">
        <link:definition>2425412 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails">
        <link:definition>2426413 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSS" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS">
        <link:definition>2127108 - Disclosure - COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSTables" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables">
        <link:definition>2328306 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails">
        <link:definition>2429414 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2130109 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2331307 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofEquityDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails">
        <link:definition>2432415 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2433416 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails">
        <link:definition>2434417 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
        <link:definition>2435418 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANS" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS">
        <link:definition>2136110 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSTables" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables">
        <link:definition>2337308 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
        <link:definition>2438419 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSNarrativeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails">
        <link:definition>2439420 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEES" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES">
        <link:definition>2140111 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEESDetails" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails">
        <link:definition>2441421 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTS" roleURI="http://www.clorox.com/role/SEGMENTRESULTS">
        <link:definition>2142112 - Disclosure - SEGMENT RESULTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSTables" roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables">
        <link:definition>2343309 - Disclosure - SEGMENT RESULTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSNarrativeDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails">
        <link:definition>2444422 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails">
        <link:definition>2445423 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="clx_AlamedaCountyCaliforniaMatterMember" abstract="true" name="AlamedaCountyCaliforniaMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_EvergreenProgramMember" abstract="false" name="EvergreenProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_NaturalPersonalCareMember" abstract="true" name="NaturalPersonalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_LifestyleMember" abstract="false" name="LifestyleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" abstract="false" name="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="clx_ProfessionalProductsMember" abstract="true" name="ProfessionalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_SiteContingencyAgreedPercentageOfCostSharing" abstract="false" name="SiteContingencyAgreedPercentageOfCostSharing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" abstract="false" name="CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_RetirementIncomeMember" abstract="false" name="RetirementIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" abstract="true" name="FinancialInstrumentsAndFairValueMeasurementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clx_VitaminsMineralsAndSupplementsMember" abstract="true" name="VitaminsMineralsAndSupplementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" abstract="false" name="BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_RemediationPeriod" abstract="false" name="RemediationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_DickinsonCountyMichiganMatterMember" abstract="true" name="DickinsonCountyMichiganMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_LongTermInterCompanyLoansMember" abstract="false" name="LongTermInterCompanyLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesAmount" abstract="false" name="OtherEmployeeStockPlanActivitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_ShareRepurchaseProgramsLineItems" abstract="true" name="ShareRepurchaseProgramsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesShares" abstract="false" name="OtherEmployeeStockPlanActivitiesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clx_InternationalMember" abstract="false" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_WalmartStoresIncMember" abstract="false" name="WalmartStoresIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_StockRepurchaseProgramAuthorizationLimit" abstract="false" name="StockRepurchaseProgramAuthorizationLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_HealthAndWellnessMember" abstract="true" name="HealthAndWellnessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_OperatingLeaseRightofUseAssetAndLiabilityNet" abstract="false" name="OperatingLeaseRightofUseAssetAndLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" abstract="false" name="BusinessCombinationSettlementOfPreExistingNetLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_ImpairedTrademarksMember" abstract="true" name="ImpairedTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_GrillingMember" abstract="true" name="GrillingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_MaximumExposureUndiscountedCost" abstract="false" name="MaximumExposureUndiscountedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" abstract="false" name="OTHERCONTINGENCIESANDGUARANTEESTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsAxis" abstract="true" name="CommodityPurchaseDerivativeContractsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="clx_FoodProductsMember" abstract="true" name="FoodProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_CleaningMember" abstract="false" name="CleaningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_OtherContingenciesAndGuaranteesAbstract" abstract="true" name="OtherContingenciesAndGuaranteesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clx_CatLitterMember" abstract="true" name="CatLitterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" abstract="false" name="IssuanceOfCommonStockForEmployeeStockPlansAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" abstract="false" name="ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" abstract="false" name="DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_ShareRepurchaseProgramsTable" abstract="true" name="ShareRepurchaseProgramsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="clx_JetFuelSwapsMember" abstract="true" name="JetFuelSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" abstract="false" name="IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_SoybeanOilFuturesMember" abstract="true" name="SoybeanOilFuturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_NumberOfRepurchasePrograms" abstract="false" name="NumberOfRepurchasePrograms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="clx_TrademarksNet" abstract="false" name="TrademarksNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_A2BillionOpenMarketPurchaseProgramMember" abstract="true" name="A2BillionOpenMarketPurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_PurchasesofInventoryMember" abstract="true" name="PurchasesofInventoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsDomain" abstract="true" name="CommodityPurchaseDerivativeContractsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_OtherExpenseIncomeNet" abstract="false" name="OtherExpenseIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" abstract="false" name="TrustAssetsForNonqualifiedDeferredCompensationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_JointVentureInKingdomOfSaudiArabiaMember" abstract="true" name="JointVentureInKingdomOfSaudiArabiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_WaterFiltrationMember" abstract="true" name="WaterFiltrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_LetterOfCreditBorrowingCapacity" abstract="false" name="LetterOfCreditBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_HouseholdMember" abstract="false" name="HouseholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_BagsWrapsAndContainersMember" abstract="true" name="BagsWrapsAndContainersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clx_TotalCommodityPurchaseDerivativeContractsMember" abstract="true" name="TotalCommodityPurchaseDerivativeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>clx-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CoverPage" xlink:type="simple" xlink:href="clx-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f2383ab6-ee60-49d5-ac72-871385eea280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_GrossProfit_f2383ab6-ee60-49d5-ac72-871385eea280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_026fc700-a4db-4005-9464-8e81b69c3749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_026fc700-a4db-4005-9464-8e81b69c3749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_bce6606c-dfdc-482f-91a4-1d5c797b5953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_AdvertisingExpense_bce6606c-dfdc-482f-91a4-1d5c797b5953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ba9b9b4c-c640-4aaf-b0f9-2cda5bff8659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ba9b9b4c-c640-4aaf-b0f9-2cda5bff8659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_96958fac-5aba-49fe-8633-fa450d2cf5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_InterestExpense_96958fac-5aba-49fe-8633-fa450d2cf5ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_bb3f60e1-f594-4239-b6e3-592f5aec90fa" xlink:href="clx-20210331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_clx_OtherExpenseIncomeNet_bb3f60e1-f594-4239-b6e3-592f5aec90fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_aae10590-59e2-44f6-920f-129c64f244ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88806f1b-4b2b-4d7e-ad8c-04e07cd1834f" xlink:to="loc_us-gaap_AssetImpairmentCharges_aae10590-59e2-44f6-920f-129c64f244ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ec5f1965-1737-45ae-ad92-6dcb44ec4ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a90915f8-fb08-4710-aebe-17282e6cedfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ec5f1965-1737-45ae-ad92-6dcb44ec4ce0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a90915f8-fb08-4710-aebe-17282e6cedfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4def3921-d14c-4ff4-92fa-43f766f7529b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ec5f1965-1737-45ae-ad92-6dcb44ec4ce0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4def3921-d14c-4ff4-92fa-43f766f7529b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_534b4a29-5c13-4f08-abbb-8f8a5e1f7f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94175aaf-9566-4843-947c-e05402e8facf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_534b4a29-5c13-4f08-abbb-8f8a5e1f7f80" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94175aaf-9566-4843-947c-e05402e8facf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f6e5700-5a41-484b-9c1a-a0cf45fc0c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_534b4a29-5c13-4f08-abbb-8f8a5e1f7f80" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f6e5700-5a41-484b-9c1a-a0cf45fc0c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1da9a5a8-a3b9-40e4-b478-1bb2651f201f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ee2b7c4-928c-4544-b87d-5fca8394fdc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1da9a5a8-a3b9-40e4-b478-1bb2651f201f" xlink:to="loc_us-gaap_ProfitLoss_1ee2b7c4-928c-4544-b87d-5fca8394fdc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c3ad7f92-5a7e-45e7-8b38-d4af5d6bf7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1da9a5a8-a3b9-40e4-b478-1bb2651f201f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c3ad7f92-5a7e-45e7-8b38-d4af5d6bf7d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_144cc951-cced-4290-801e-61f630cfce9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4d3f9537-4662-4f5a-8727-4e969319c8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_144cc951-cced-4290-801e-61f630cfce9e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4d3f9537-4662-4f5a-8727-4e969319c8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9951e6cd-1c0c-4ec5-a8e6-4c35f597d1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_144cc951-cced-4290-801e-61f630cfce9e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9951e6cd-1c0c-4ec5-a8e6-4c35f597d1e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28eb0e0b-37d4-4ad1-b39c-49b53e424069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_108218e5-a1b2-4a7d-a261-d4b68364639d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28eb0e0b-37d4-4ad1-b39c-49b53e424069" xlink:to="loc_us-gaap_MinorityInterest_108218e5-a1b2-4a7d-a261-d4b68364639d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e41b9600-2e7f-43f7-b666-a133f2931697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28eb0e0b-37d4-4ad1-b39c-49b53e424069" xlink:to="loc_us-gaap_StockholdersEquity_e41b9600-2e7f-43f7-b666-a133f2931697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_478d6133-dfe8-4324-bc73-988f7c8736c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_PreferredStockValue_478d6133-dfe8-4324-bc73-988f7c8736c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8625c1a1-43e8-4603-87f0-afffec2ad013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_CommonStockValue_8625c1a1-43e8-4603-87f0-afffec2ad013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ec0f3e8b-9fed-4ed9-bc68-cea4292e9375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ec0f3e8b-9fed-4ed9-bc68-cea4292e9375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f8025c1-060c-4015-a364-509367a621e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f8025c1-060c-4015-a364-509367a621e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_bd9ab08b-8a1b-4da1-8f20-7244ad451ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_TreasuryStockValue_bd9ab08b-8a1b-4da1-8f20-7244ad451ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2b9b203-2789-42e4-8e3d-436c2238a470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91d44c00-df21-40ef-9a3e-4fd4f4f35cb6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2b9b203-2789-42e4-8e3d-436c2238a470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_68a7b4a4-488e-43c4-bf2d-eb540f9690f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_33cab386-3f49-4c22-bcc6-16da4e4e6be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68a7b4a4-488e-43c4-bf2d-eb540f9690f1" xlink:to="loc_us-gaap_Liabilities_33cab386-3f49-4c22-bcc6-16da4e4e6be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_60ea23e7-9320-407d-99e6-7ce6f80e8cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68a7b4a4-488e-43c4-bf2d-eb540f9690f1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_60ea23e7-9320-407d-99e6-7ce6f80e8cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4a07d47-528e-42f0-8566-1209d9db0c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68a7b4a4-488e-43c4-bf2d-eb540f9690f1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4a07d47-528e-42f0-8566-1209d9db0c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_503a3442-a2ed-4a31-9e73-9f37f21eb98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:to="loc_us-gaap_LiabilitiesCurrent_503a3442-a2ed-4a31-9e73-9f37f21eb98f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4f391774-77d6-4608-9088-c51c6c29b5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4f391774-77d6-4608-9088-c51c6c29b5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c8fb0200-9809-4ed3-a0ca-1733fea8bb96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c8fb0200-9809-4ed3-a0ca-1733fea8bb96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_07366f63-c56c-42ab-96fb-5cce4484d0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_07366f63-c56c-42ab-96fb-5cce4484d0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ad093519-4cdc-4d99-9024-a4a8bced3c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5939524a-930f-468c-b179-a78a1a67bf40" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ad093519-4cdc-4d99-9024-a4a8bced3c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_761be976-8b14-4324-8c9a-defe779fc0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8cd29cf8-b5df-48ac-8d2d-a65845cfa617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_761be976-8b14-4324-8c9a-defe779fc0f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8cd29cf8-b5df-48ac-8d2d-a65845cfa617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ba14fe62-f52c-48de-b604-ab82b4ca3941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_761be976-8b14-4324-8c9a-defe779fc0f4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ba14fe62-f52c-48de-b604-ab82b4ca3941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6ea5eabc-8b8c-4bee-99d5-370ff868f867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_761be976-8b14-4324-8c9a-defe779fc0f4" xlink:to="loc_us-gaap_InventoryNet_6ea5eabc-8b8c-4bee-99d5-370ff868f867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bdfff2cf-3b08-423b-9637-b98694c64659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_761be976-8b14-4324-8c9a-defe779fc0f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bdfff2cf-3b08-423b-9637-b98694c64659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a015b169-d435-4650-bd20-e2710ff27436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0192d0b3-2244-4564-8faf-8ed1ebf4d5cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a015b169-d435-4650-bd20-e2710ff27436" xlink:to="loc_us-gaap_LongTermDebtCurrent_0192d0b3-2244-4564-8faf-8ed1ebf4d5cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cf896ec3-6aa5-4732-922b-9aa44f80eebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a015b169-d435-4650-bd20-e2710ff27436" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cf896ec3-6aa5-4732-922b-9aa44f80eebc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_66ede9f9-3b3f-4eb0-b8ff-5dc7ae0dc4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a015b169-d435-4650-bd20-e2710ff27436" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_66ede9f9-3b3f-4eb0-b8ff-5dc7ae0dc4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_cade1dc0-4a48-4d81-80e5-395a4443730d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a015b169-d435-4650-bd20-e2710ff27436" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_cade1dc0-4a48-4d81-80e5-395a4443730d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3c3ddc39-155b-4ae0-9a09-81de95b74430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_AssetsCurrent_3c3ddc39-155b-4ae0-9a09-81de95b74430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8af12e99-1ad7-4222-a4db-711c95d1858e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8af12e99-1ad7-4222-a4db-711c95d1858e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e9d3e409-20f2-4a33-bbda-436d57fc30b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e9d3e409-20f2-4a33-bbda-436d57fc30b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ed22904b-69a3-4ba4-a731-b62703d3b8ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_Goodwill_ed22904b-69a3-4ba4-a731-b62703d3b8ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_deb52251-57f1-44e3-8c2b-12a615cd20be" xlink:href="clx-20210331.xsd#clx_TrademarksNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_clx_TrademarksNet_deb52251-57f1-44e3-8c2b-12a615cd20be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_50159565-5f16-46a8-9e6b-65e526ff309f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_50159565-5f16-46a8-9e6b-65e526ff309f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a3e24588-6e79-4ce1-a1cd-6a59947ad975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e095bbbd-3891-44fc-a2a8-d9de214e9e92" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a3e24588-6e79-4ce1-a1cd-6a59947ad975" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0397b140-a32a-49a3-850c-ea11c44b28f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a03bea9-4308-4cf1-a649-7a560cf65c35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0397b140-a32a-49a3-850c-ea11c44b28f3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a03bea9-4308-4cf1-a649-7a560cf65c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64871117-319e-4cb2-af4f-ffbee7cbb737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0397b140-a32a-49a3-850c-ea11c44b28f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64871117-319e-4cb2-af4f-ffbee7cbb737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9f77d3a7-9ec3-4a73-9c02-fb370a419946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0397b140-a32a-49a3-850c-ea11c44b28f3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9f77d3a7-9ec3-4a73-9c02-fb370a419946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06579751-e7b5-4163-82ae-08807303979f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_155f9787-7253-491b-afca-3c6aa6558724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06579751-e7b5-4163-82ae-08807303979f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_155f9787-7253-491b-afca-3c6aa6558724" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e8685493-1ba8-49ee-9bd0-7e766dc0583c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06579751-e7b5-4163-82ae-08807303979f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e8685493-1ba8-49ee-9bd0-7e766dc0583c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad580077-8b26-4575-8b90-9c80b698f66e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06579751-e7b5-4163-82ae-08807303979f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad580077-8b26-4575-8b90-9c80b698f66e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5697bcf-bff3-49d3-9127-55aa51284b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06579751-e7b5-4163-82ae-08807303979f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5697bcf-bff3-49d3-9127-55aa51284b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_318f6d67-829d-4731-8edf-95523f8afc8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_ProfitLoss_318f6d67-829d-4731-8edf-95523f8afc8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1618972b-b20d-48fa-9126-4ac05458ec11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1618972b-b20d-48fa-9126-4ac05458ec11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_380e8600-bbbb-4e5d-b4ad-bcbf972159fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_ShareBasedCompensation_380e8600-bbbb-4e5d-b4ad-bcbf972159fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c12cc2c-6458-4205-add7-1b5556c62da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c12cc2c-6458-4205-add7-1b5556c62da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_439b1ee2-7ec4-4e34-b89a-fb53401f038e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_439b1ee2-7ec4-4e34-b89a-fb53401f038e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_52b03f07-26aa-4a7f-abb7-679b3c2fbfd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_52b03f07-26aa-4a7f-abb7-679b3c2fbfd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_21a1c2fe-c66c-4f3f-ba41-a77921d2d38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_21a1c2fe-c66c-4f3f-ba41-a77921d2d38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3e31ce0d-19a0-4b43-889c-6048e3754b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3e31ce0d-19a0-4b43-889c-6048e3754b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_137fe1e8-bf2c-4d83-bf4d-021d782e9acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_137fe1e8-bf2c-4d83-bf4d-021d782e9acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_2b624453-36b9-4aa8-b9ec-c3af0e9647fe" xlink:href="clx-20210331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_2b624453-36b9-4aa8-b9ec-c3af0e9647fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_ce74eb50-b3df-49f3-bddd-6e4f7cd18765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_ce74eb50-b3df-49f3-bddd-6e4f7cd18765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a2114209-33d4-4f1c-a7a0-efbec5192e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b8c8f0a-6ccd-4e72-88ee-d3938a47fa37" xlink:to="loc_us-gaap_AssetImpairmentCharges_a2114209-33d4-4f1c-a7a0-efbec5192e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_a5520379-23c6-4fff-98fa-b56ed8502970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_a5520379-23c6-4fff-98fa-b56ed8502970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1aa2fdb8-3015-4e18-b0f6-967fba49f7f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1aa2fdb8-3015-4e18-b0f6-967fba49f7f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_a8d50e63-f8de-4718-a5ec-ec0baf5b57ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_a8d50e63-f8de-4718-a5ec-ec0baf5b57ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_ea2a96e3-cd37-4403-9f6e-62679e8e9c46" xlink:href="clx-20210331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_ea2a96e3-cd37-4403-9f6e-62679e8e9c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_8fdb4644-7a34-4bf9-81ad-bb6bf2cebc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40abb17d-1564-4c39-a244-27fc7560fc83" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_8fdb4644-7a34-4bf9-81ad-bb6bf2cebc7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIRED"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ceea3923-2619-4339-8648-574536bbabb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_us-gaap_Goodwill_ceea3923-2619-4339-8648-574536bbabb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bf751a85-8cef-410b-8f57-c12b6233f581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bf751a85-8cef-410b-8f57-c12b6233f581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_83c7afb7-b4b1-4ab0-8dfe-d7d1438f9178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_83c7afb7-b4b1-4ab0-8dfe-d7d1438f9178" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_0104491c-fc61-4339-b2b4-680a571feac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_0104491c-fc61-4339-b2b4-680a571feac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f6ed456d-949d-4d74-b912-a9d12bbd4d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f6ed456d-949d-4d74-b912-a9d12bbd4d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_36b575bc-a284-4797-ae7b-22a9aeef4c86" xlink:href="clx-20210331.xsd#clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0df7f56d-e64e-4a52-9b80-4e32deb5c28a" xlink:to="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_36b575bc-a284-4797-ae7b-22a9aeef4c86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNET" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNET"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNET" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2449a2f9-e346-4183-82e9-e097d5c875a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a2824216-c5e7-4e34-a59f-624c0bd52366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2449a2f9-e346-4183-82e9-e097d5c875a7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a2824216-c5e7-4e34-a59f-624c0bd52366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_051bfb0f-81ba-4d28-a8f5-2c5a0f19b208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2449a2f9-e346-4183-82e9-e097d5c875a7" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_051bfb0f-81ba-4d28-a8f5-2c5a0f19b208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_44473849-f61f-418e-b4e6-56b35edf4511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2449a2f9-e346-4183-82e9-e097d5c875a7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_44473849-f61f-418e-b4e6-56b35edf4511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_6ea7f587-5ced-49af-a659-7f7cae21a2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2449a2f9-e346-4183-82e9-e097d5c875a7" xlink:to="loc_us-gaap_InventoryLIFOReserve_6ea7f587-5ced-49af-a659-7f7cae21a2a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ef4fb85e-9c20-4a53-90b5-dcc6f66c0333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30f3eb72-b87f-480d-85f4-7dbde916bb30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetImpairmentCharges_ef4fb85e-9c20-4a53-90b5-dcc6f66c0333" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30f3eb72-b87f-480d-85f4-7dbde916bb30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_f84bac45-08c8-4542-9b21-9a6eb8307465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetImpairmentCharges_ef4fb85e-9c20-4a53-90b5-dcc6f66c0333" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_f84bac45-08c8-4542-9b21-9a6eb8307465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_60678401-bee5-4d68-a131-1a75e9da2e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetImpairmentCharges_ef4fb85e-9c20-4a53-90b5-dcc6f66c0333" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_60678401-bee5-4d68-a131-1a75e9da2e4a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_31255d35-19de-4e9b-bcdf-f04675a4b819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_edf00875-6186-4b8e-9d77-49db056c3962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_31255d35-19de-4e9b-bcdf-f04675a4b819" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_edf00875-6186-4b8e-9d77-49db056c3962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cfd4a23a-dc4b-43e1-ae23-59b64161f047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_31255d35-19de-4e9b-bcdf-f04675a4b819" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cfd4a23a-dc4b-43e1-ae23-59b64161f047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb1bbb47-e922-46d8-b86d-61b1b9a5db2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cef0d88-dc1c-4378-ad36-1852108e5980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb1bbb47-e922-46d8-b86d-61b1b9a5db2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cef0d88-dc1c-4378-ad36-1852108e5980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_10f1536b-dfa9-4f88-b18f-c1987160f450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb1bbb47-e922-46d8-b86d-61b1b9a5db2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_10f1536b-dfa9-4f88-b18f-c1987160f450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49f4d461-750e-43c6-b8cb-f67e8d6e729c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_20e4e19a-4874-4003-9a9e-c9e3f8f93f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49f4d461-750e-43c6-b8cb-f67e8d6e729c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_20e4e19a-4874-4003-9a9e-c9e3f8f93f22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc8dd127-9f2f-49c3-bca9-3e14753485b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_49f4d461-750e-43c6-b8cb-f67e8d6e729c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc8dd127-9f2f-49c3-bca9-3e14753485b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_72c3593f-fd7a-41e8-83af-adcb32392201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fc7b6a88-2ee7-4897-a6e1-88393905108a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_72c3593f-fd7a-41e8-83af-adcb32392201" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fc7b6a88-2ee7-4897-a6e1-88393905108a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c9514d78-0e79-41c4-a3e1-14e40de5ca1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_72c3593f-fd7a-41e8-83af-adcb32392201" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c9514d78-0e79-41c4-a3e1-14e40de5ca1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0232c39b-9179-4bd4-8ad4-abffca17017c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6279b7ed-862e-40e5-9b76-7bf717b951b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0232c39b-9179-4bd4-8ad4-abffca17017c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6279b7ed-862e-40e5-9b76-7bf717b951b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_144b5bd7-5336-448d-a166-10ba4d2cb344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0232c39b-9179-4bd4-8ad4-abffca17017c" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_144b5bd7-5336-448d-a166-10ba4d2cb344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e0d70cd8-3bec-44ad-bcc1-ba4a88ca9d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5ad100f9-5f99-4f5d-b862-01a4461cc338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e0d70cd8-3bec-44ad-bcc1-ba4a88ca9d2e" xlink:to="loc_us-gaap_LongTermDebt_5ad100f9-5f99-4f5d-b862-01a4461cc338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bde475c1-5da4-4d5c-a235-c6ed504052b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c01bc7db-52b7-46f8-9835-224925fa74de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bde475c1-5da4-4d5c-a235-c6ed504052b9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c01bc7db-52b7-46f8-9835-224925fa74de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_563756f6-9a13-4034-b490-9167d502467f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bde475c1-5da4-4d5c-a235-c6ed504052b9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_563756f6-9a13-4034-b490-9167d502467f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_88800e8f-c8d0-4d37-ab4e-e3d0d412b4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9195ac74-0a9c-4edf-b645-bd9b0fe3990a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_88800e8f-c8d0-4d37-ab4e-e3d0d412b4f0" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9195ac74-0a9c-4edf-b645-bd9b0fe3990a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXES" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1b39f2d-f2b2-44e1-be65-66cab43366e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e60e34cd-a106-46af-a74a-acd4c71f5d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1b39f2d-f2b2-44e1-be65-66cab43366e8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e60e34cd-a106-46af-a74a-acd4c71f5d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cd51c0fb-6e4f-4b32-8afe-b88b3c367a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1b39f2d-f2b2-44e1-be65-66cab43366e8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cd51c0fb-6e4f-4b32-8afe-b88b3c367a1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_815c90b1-dfa0-4992-8910-4c77051de479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c9f4801-f2c5-4eab-96c1-17039c58181d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_815c90b1-dfa0-4992-8910-4c77051de479" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c9f4801-f2c5-4eab-96c1-17039c58181d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c5ec80b7-9f7b-4400-a52e-9eed00efe905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_815c90b1-dfa0-4992-8910-4c77051de479" xlink:to="loc_us-gaap_ProfitLoss_c5ec80b7-9f7b-4400-a52e-9eed00efe905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_827539f2-42df-43d2-94d5-320b5db540ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c96a73cd-e814-4a9b-8dab-006d4d7342c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_827539f2-42df-43d2-94d5-320b5db540ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c96a73cd-e814-4a9b-8dab-006d4d7342c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_c11026c0-bd98-4237-9ba8-123ff9a2f334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_827539f2-42df-43d2-94d5-320b5db540ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_c11026c0-bd98-4237-9ba8-123ff9a2f334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_300d67f6-4020-484f-8d9f-58e87efc5087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_827539f2-42df-43d2-94d5-320b5db540ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_300d67f6-4020-484f-8d9f-58e87efc5087" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_803f939b-e50f-4c09-8302-f7c860169b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1c50a77e-b6a4-4d92-a995-650dad47727c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_803f939b-e50f-4c09-8302-f7c860169b53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1c50a77e-b6a4-4d92-a995-650dad47727c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_e0facb48-928d-4afa-9cb1-51b3f4d4d771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_803f939b-e50f-4c09-8302-f7c860169b53" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_e0facb48-928d-4afa-9cb1-51b3f4d4d771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_7f604b10-b3bf-4db6-a9cd-8fe32c664cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_803f939b-e50f-4c09-8302-f7c860169b53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_7f604b10-b3bf-4db6-a9cd-8fe32c664cea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e59837f5-86bd-451c-bb8d-e7d13736d3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_da9b89a7-129f-414e-8d00-b80b378e09e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e59837f5-86bd-451c-bb8d-e7d13736d3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_da9b89a7-129f-414e-8d00-b80b378e09e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_695bc90c-1473-4906-80b0-97eda213bdcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e59837f5-86bd-451c-bb8d-e7d13736d3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_695bc90c-1473-4906-80b0-97eda213bdcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bd5b4752-b819-403d-ab5f-226b31a5342a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e59837f5-86bd-451c-bb8d-e7d13736d3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bd5b4752-b819-403d-ab5f-226b31a5342a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bce57d0-86cc-4ecd-ab96-19429937c29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e59837f5-86bd-451c-bb8d-e7d13736d3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bce57d0-86cc-4ecd-ab96-19429937c29c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTS"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSTables"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>clx-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CoverPage" xlink:type="simple" xlink:href="clx-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/CoverPage" xlink:type="extended" id="i6b8cd46facdd4947a2fe0f03d88a5df3_CoverPage"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended" id="i50e6ace874564657bbecfaa0b6f22955_CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i5f2a33d50a8e4ce4b993b8a65294a0e5_CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i6b982a719cd148318185aa89cdee5bd3_CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i89078be7d79c4504bc3944e57fe110c2_CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="i28563145f3bb49e4b2716e2d87a46dd4_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i4829903bb69f431d9fa04b2f94026ef4_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIRED"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="extended" id="ifae9031b1e4940b4a90db8f8a09eccc7_BUSINESSACQUIRED"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="extended" id="ide1572df58b14e909c6011d77a31097b_BUSINESSACQUIREDTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="extended" id="i53cb750d75c04cd0941d2555c4396a05_BUSINESSACQUIREDNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_8efb64cf-265c-49bf-ae2a-ee5eeeb596f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_8efb64cf-265c-49bf-ae2a-ee5eeeb596f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3b878c29-e5ab-4128-b674-490188263d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_EquityMethodInvestments_3b878c29-e5ab-4128-b674-490188263d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_2521d34c-064a-44a4-a743-7219a4235bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_2521d34c-064a-44a4-a743-7219a4235bb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_751fc6cd-b7bc-4191-b83a-c07cc006a728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_751fc6cd-b7bc-4191-b83a-c07cc006a728" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_83619e65-6473-4d68-bd77-7684cfc2ba1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_83619e65-6473-4d68-bd77-7684cfc2ba1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_b0eb4e1f-ccc4-404c-8a30-473ccd0916b1" xlink:href="clx-20210331.xsd#clx_BusinessCombinationSettlementOfPreExistingNetLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_b0eb4e1f-ccc4-404c-8a30-473ccd0916b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_59300ebb-ed4e-464b-b109-54c2ae0fd03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_Goodwill_59300ebb-ed4e-464b-b109-54c2ae0fd03f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7ff7d0e9-d212-482a-a6b8-ae04b878a16b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7ff7d0e9-d212-482a-a6b8-ae04b878a16b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_5af9c0fb-4bd8-4c36-85e1-9fa7dc96d2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_5af9c0fb-4bd8-4c36-85e1-9fa7dc96d2f9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d07163be-1ed1-421f-953e-7946af46f89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d07163be-1ed1-421f-953e-7946af46f89e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_ca6e734b-d11e-4395-ba50-24c0ccf22a98" xlink:href="clx-20210331.xsd#clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_ca6e734b-d11e-4395-ba50-24c0ccf22a98" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4b111096-5cac-41e9-86d4-e4f41031c657_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4b111096-5cac-41e9-86d4-e4f41031c657_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_c8e50908-02f1-4976-b670-680170a7d439" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_c8e50908-02f1-4976-b670-680170a7d439" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e423cac5-8c9e-4a72-883d-d4d89807d401_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:to="loc_srt_OwnershipDomain_e423cac5-8c9e-4a72-883d-d4d89807d401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:to="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_8b01c340-ebfd-464e-a963-a3c033e47eae" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_8b01c340-ebfd-464e-a963-a3c033e47eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee09d37c-bd00-4ff7-a7d1-2af35b278276_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee09d37c-bd00-4ff7-a7d1-2af35b278276_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_56a983ec-3487-45fb-98fd-ae3aa4c75a24" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_56a983ec-3487-45fb-98fd-ae3aa4c75a24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="ib9048db9dd304b9c89fa15658c45dd4d_BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d03ba525-3d19-4ef7-9edc-b857924204ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_Goodwill_d03ba525-3d19-4ef7-9edc-b857924204ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_facbdf68-a5c6-4ca0-bcea-deeae9ae84e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_facbdf68-a5c6-4ca0-bcea-deeae9ae84e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b6ae3e17-a73f-47e8-9646-68262c7beab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b6ae3e17-a73f-47e8-9646-68262c7beab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c4ff2e4-c3a0-44ea-9603-28d7907658da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_21737ae5-2158-4195-805f-733b3ed87898" xlink:href="clx-20210331.xsd#clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_21737ae5-2158-4195-805f-733b3ed87898" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_32df7422-20e5-421e-9346-610fec16abaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_32df7422-20e5-421e-9346-610fec16abaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a34c595-1056-4afb-8bbd-a34ed2a38f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a34c595-1056-4afb-8bbd-a34ed2a38f91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8a6e28a0-983d-44f4-a167-412ddeb2cc94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8a6e28a0-983d-44f4-a167-412ddeb2cc94" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8f498404-2a25-4f73-bbff-f11c8908c973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8f498404-2a25-4f73-bbff-f11c8908c973" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9473ecf3-e5b8-4606-93f3-9ce82165fd42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9473ecf3-e5b8-4606-93f3-9ce82165fd42" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4eb8a69b-f173-40bf-918a-71bb6da599ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4eb8a69b-f173-40bf-918a-71bb6da599ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_07df15d7-28ae-4d82-91da-9c28bc9bf81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_07df15d7-28ae-4d82-91da-9c28bc9bf81f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d094eb41-1b92-4a76-9a16-1362034b3601_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:to="loc_srt_OwnershipDomain_d094eb41-1b92-4a76-9a16-1362034b3601_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:to="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_e8d4c1ac-97a5-42bf-bdfe-79bba3408106" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_e8d4c1ac-97a5-42bf-bdfe-79bba3408106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_eebe27e5-dfb8-4d71-a54d-11998f36cc4a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_eebe27e5-dfb8-4d71-a54d-11998f36cc4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_9b14e604-64ae-47c5-9a0a-d824c6d182d7" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_9b14e604-64ae-47c5-9a0a-d824c6d182d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9a2cd5dc-3f44-44db-a95d-aef24b690180_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9a2cd5dc-3f44-44db-a95d-aef24b690180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_7f271712-c308-4ae1-9fb9-6ec157de29d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:to="loc_us-gaap_ContractualRightsMember_7f271712-c308-4ae1-9fb9-6ec157de29d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_635a9d80-9d84-45d5-80f3-fa484e3ca1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:to="loc_us-gaap_CustomerRelationshipsMember_635a9d80-9d84-45d5-80f3-fa484e3ca1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0d9bd78-9154-4788-8543-306b197d560e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0d9bd78-9154-4788-8543-306b197d560e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_f66994f1-6f3e-429d-a809-41ec957b4ce6" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_f66994f1-6f3e-429d-a809-41ec957b4ce6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNET" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNET"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/INVENTORIESNET" xlink:type="extended" id="i2e2c969eb2f84c3ca195dee1457c8df0_INVENTORIESNET"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="extended" id="i44d133f7a6f54ca7ace5cf2818b2d9a0_INVENTORIESNETTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended" id="i766d3100737546a8b316f620340e1f1d_INVENTORIESNETDetails"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="extended" id="ic5e0ee1fa14640059923899a7ff83765_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="extended" id="ic53d263fd67747d6aeb07861e573bbe9_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended" id="i40b271fc5c904dd3b3513d992d072302_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1830afd0-e993-4c32-ba72-709d0c5d3a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1830afd0-e993-4c32-ba72-709d0c5d3a18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_55165b14-1959-416e-806f-acdbefcf85d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_55165b14-1959-416e-806f-acdbefcf85d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_691cfb63-b9cc-436a-9815-ed6811327efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_691cfb63-b9cc-436a-9815-ed6811327efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_88cb6ea5-1e2e-4e93-8ca7-412239969444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_AssetImpairmentCharges_88cb6ea5-1e2e-4e93-8ca7-412239969444" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fac59f81-394c-4837-bf5c-b3cba3f2e191_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fac59f81-394c-4837-bf5c-b3cba3f2e191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4c132c5a-709d-4afd-87a3-64507dfcc97e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:to="loc_us-gaap_TrademarksMember_4c132c5a-709d-4afd-87a3-64507dfcc97e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_30299beb-1927-4fd1-a3bb-668a58dd5d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_30299beb-1927-4fd1-a3bb-668a58dd5d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_77a802f4-63c4-4260-a6b9-466e5430b8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:to="loc_us-gaap_TrademarksMember_77a802f4-63c4-4260-a6b9-466e5430b8d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_c9fed4de-7a16-44f1-a88d-08d5cb20ba89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_c9fed4de-7a16-44f1-a88d-08d5cb20ba89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="extended" id="ia88cdd59bc5b452196281fdad31b186b_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_ea6ca3ad-54d8-4a82-a614-f01c373fbd18" xlink:href="clx-20210331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_ea6ca3ad-54d8-4a82-a614-f01c373fbd18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7239988e-9227-45e5-80a3-e207a2bf342a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7239988e-9227-45e5-80a3-e207a2bf342a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ce573c5c-e3fa-4201-997f-5fd3fe2d27e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ce573c5c-e3fa-4201-997f-5fd3fe2d27e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9e4c28fe-d9b7-432d-8841-fab60f3f9615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9e4c28fe-d9b7-432d-8841-fab60f3f9615" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8ff1035f-31db-4796-8226-e423ecec0df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8ff1035f-31db-4796-8226-e423ecec0df7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1ec692ff-63fc-421b-9e7d-cc3c9304f1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1ec692ff-63fc-421b-9e7d-cc3c9304f1f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68b17108-ec60-4b3a-86e0-4b53b6f6cf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68b17108-ec60-4b3a-86e0-4b53b6f6cf5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ddeff130-c06a-4441-b4c0-1178ff1841e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ddeff130-c06a-4441-b4c0-1178ff1841e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c6c0d3f7-1b6c-4875-9de5-bb98563a4938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c6c0d3f7-1b6c-4875-9de5-bb98563a4938" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_08c37dcc-9357-4fdf-a5ff-0c29c269a688_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_08c37dcc-9357-4fdf-a5ff-0c29c269a688_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairedTrademarksMember_488ba9f8-e368-4681-a5e6-18f14260c681" xlink:href="clx-20210331.xsd#clx_ImpairedTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:to="loc_clx_ImpairedTrademarksMember_488ba9f8-e368-4681-a5e6-18f14260c681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_227f7739-d609-4322-b03c-e5811f402631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:to="loc_us-gaap_TrademarksMember_227f7739-d609-4322-b03c-e5811f402631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:to="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af593d46-5264-4c0d-8625-59e693a808a5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:to="loc_srt_RangeMember_af593d46-5264-4c0d-8625-59e693a808a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:to="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_17f608e4-94cc-4a7f-8a9c-94f8b86c1de9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:to="loc_srt_WeightedAverageMember_17f608e4-94cc-4a7f-8a9c-94f8b86c1de9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="extended" id="i0f9da5d02c4a48fe915a38b35149485f_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:to="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_edeecc84-0738-4c69-8ac4-e7f0b37523a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_Goodwill_edeecc84-0738-4c69-8ac4-e7f0b37523a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_953f59de-92e2-488e-8f38-4da9962160b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_953f59de-92e2-488e-8f38-4da9962160b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_30ab2db8-7cfb-4271-8acd-cef310989963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_30ab2db8-7cfb-4271-8acd-cef310989963" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_92d4d406-359c-40e6-a04a-14768fa3cc9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_92d4d406-359c-40e6-a04a-14768fa3cc9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_965fcb52-3623-4c15-acbc-5b26a4ab4ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0522748f-87c4-4b9b-b406-53f40b85ff56_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:to="loc_us-gaap_SegmentDomain_0522748f-87c4-4b9b-b406-53f40b85ff56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:to="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_0276ea1f-c88d-4b10-9518-43a221bc31a4" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_HealthAndWellnessMember_0276ea1f-c88d-4b10-9518-43a221bc31a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_623556d9-276e-4f5d-b1ce-bfa7c7ab462b" xlink:href="clx-20210331.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_HouseholdMember_623556d9-276e-4f5d-b1ce-bfa7c7ab462b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_7cb23166-4a61-4fb5-9ef5-536506f6c7c1" xlink:href="clx-20210331.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_LifestyleMember_7cb23166-4a61-4fb5-9ef5-536506f6c7c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_c2dada8c-0247-46d3-9f7d-3c9f3ed5a00e" xlink:href="clx-20210331.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_InternationalMember_c2dada8c-0247-46d3-9f7d-3c9f3ed5a00e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8bb6611d-6f00-4a6f-aef4-b93155813de8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8bb6611d-6f00-4a6f-aef4-b93155813de8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_77053568-d2d6-4490-94c2-154eb00bf893" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_77053568-d2d6-4490-94c2-154eb00bf893" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended" id="if5b2f532d04f4cf3bdb81f195c59dfeb_GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_7323a8a0-fe8b-4705-a878-226fe5c16920" xlink:href="clx-20210331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_7323a8a0-fe8b-4705-a878-226fe5c16920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_970ff609-c35e-44e0-b057-8e7e05eb7973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_970ff609-c35e-44e0-b057-8e7e05eb7973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97c3c97f-5e5f-4475-bec6-6cab19e304d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97c3c97f-5e5f-4475-bec6-6cab19e304d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5fbc7c6d-6b1e-43a1-b839-69aa99de1362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5fbc7c6d-6b1e-43a1-b839-69aa99de1362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28f2fbb1-959f-4774-b2ed-400013d52917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28f2fbb1-959f-4774-b2ed-400013d52917" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ceabed79-2ba5-48b3-88f2-fd313accc761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ceabed79-2ba5-48b3-88f2-fd313accc761" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1e965461-ff41-466b-afdf-390709fda117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1e965461-ff41-466b-afdf-390709fda117" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a346132-76e6-4d7e-8c61-38a739bdd007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a346132-76e6-4d7e-8c61-38a739bdd007" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_419d0af5-ad72-4e45-8041-101314b74c49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_419d0af5-ad72-4e45-8041-101314b74c49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_575387e6-9509-4b7c-9265-91c1a36fdbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:to="loc_us-gaap_TrademarksMember_575387e6-9509-4b7c-9265-91c1a36fdbbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_d9cbc485-00df-49b6-a5c8-9b314973a16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_d9cbc485-00df-49b6-a5c8-9b314973a16d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7c4e54eb-33e5-44e3-84ab-9b72c4c41139_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7c4e54eb-33e5-44e3-84ab-9b72c4c41139_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_65e3e36c-c893-4f0c-8560-461ed269a2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:to="loc_us-gaap_TrademarksMember_65e3e36c-c893-4f0c-8560-461ed269a2f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended" id="i1ac77587f08146548cf64230d7005ef8_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended" id="iba7f1ab17441433eab33ca5f84f03214_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="ib70cea7db71942dbbbd534ed44215770_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_b36f2038-2630-4f3a-bcb0-1e7050496642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_b36f2038-2630-4f3a-bcb0-1e7050496642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85518bbe-f66c-471f-81e5-cb18dc1315db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85518bbe-f66c-471f-81e5-cb18dc1315db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_5e4dd0e7-467c-4ed8-b1a5-b478b645eaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_5e4dd0e7-467c-4ed8-b1a5-b478b645eaf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ed5d4980-44e2-4e96-a62d-4ca381c81103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ed5d4980-44e2-4e96-a62d-4ca381c81103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_84e81943-3a2e-48c3-bb4d-ecdb9cd7fb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_84e81943-3a2e-48c3-bb4d-ecdb9cd7fb15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_6b267ec0-b69b-40e8-9b4a-c21d758a2ec2" xlink:href="clx-20210331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_6b267ec0-b69b-40e8-9b4a-c21d758a2ec2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_e43868e8-36f5-46ce-8647-19cd0329f469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarginDepositAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MarginDepositAssets_e43868e8-36f5-46ce-8647-19cd0329f469" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_70a71195-3e76-46d1-8354-be3f8cc885d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_AssetImpairmentCharges_70a71195-3e76-46d1-8354-be3f8cc885d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_30eefc64-e1a2-4703-abb1-3254f718c1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_30eefc64-e1a2-4703-abb1-3254f718c1bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_59e0f4f1-9029-4f86-8613-046f784d839f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_59e0f4f1-9029-4f86-8613-046f784d839f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_be14923f-d301-4f16-9068-921a157b33b4_default" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_be14923f-d301-4f16-9068-921a157b33b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_2a39a287-ff31-4bcf-aafd-a86cbee7de74" xlink:href="clx-20210331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_2a39a287-ff31-4bcf-aafd-a86cbee7de74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SoybeanOilFuturesMember_d07384dc-2b23-4fab-98a6-93c29b425548" xlink:href="clx-20210331.xsd#clx_SoybeanOilFuturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_SoybeanOilFuturesMember_d07384dc-2b23-4fab-98a6-93c29b425548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JetFuelSwapsMember_dc6d7ac5-d393-4c2b-8f1d-4a9a95a3a6fc" xlink:href="clx-20210331.xsd#clx_JetFuelSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_JetFuelSwapsMember_dc6d7ac5-d393-4c2b-8f1d-4a9a95a3a6fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_ef317917-5e9c-45ac-b38f-99e71b69d9ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:to="loc_us-gaap_TransactionDomain_ef317917-5e9c-45ac-b38f-99e71b69d9ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:to="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_a11a7514-3f43-4e61-94f2-1af3c0ed906f" xlink:href="clx-20210331.xsd#clx_PurchasesofInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:to="loc_clx_PurchasesofInventoryMember_a11a7514-3f43-4e61-94f2-1af3c0ed906f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9f494c8a-f448-42f1-986f-294230562bd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9f494c8a-f448-42f1-986f-294230562bd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_308dc7de-bba6-4a69-97cc-1da9dcf345cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_308dc7de-bba6-4a69-97cc-1da9dcf345cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_ee51e4fb-71f3-4233-9779-5a9b5216a699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_InterestRateContractMember_ee51e4fb-71f3-4233-9779-5a9b5216a699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6ec24bc0-7ad9-45bc-b95d-24cc93343030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_CommodityContractMember_6ec24bc0-7ad9-45bc-b95d-24cc93343030" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c674f780-c275-4a18-bc56-57b8fe226988_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:to="loc_us-gaap_SegmentDomain_c674f780-c275-4a18-bc56-57b8fe226988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:to="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_c197c43c-8ae0-4c26-8d7b-c2f3ca721b04" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:to="loc_clx_HealthAndWellnessMember_c197c43c-8ae0-4c26-8d7b-c2f3ca721b04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9033ae12-b4cd-4500-af91-839a490a964a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9033ae12-b4cd-4500-af91-839a490a964a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_2dbdd886-b417-43f6-9708-8797fde911d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:to="loc_us-gaap_OtherAssetsMember_2dbdd886-b417-43f6-9708-8797fde911d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b47547ab-be3c-4e7d-aaa2-a74c0ae21156_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b47547ab-be3c-4e7d-aaa2-a74c0ae21156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c6103165-94fa-4351-aa23-9f4bced1c945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:to="loc_us-gaap_TrademarksMember_c6103165-94fa-4351-aa23-9f4bced1c945" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="ia371924a7940456694635f4044eba9eb_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d757c9be-a2b4-44e9-95dd-e8bcf459161a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d757c9be-a2b4-44e9-95dd-e8bcf459161a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_08d27d96-f9ee-478b-ba6e-c0e28c9f8c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_08d27d96-f9ee-478b-ba6e-c0e28c9f8c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b46bc46f-58cc-4b38-8428-a43de9dada1c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b46bc46f-58cc-4b38-8428-a43de9dada1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_85d407a6-d24e-41d8-bed2-4522d4437339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_CommodityContractMember_85d407a6-d24e-41d8-bed2-4522d4437339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5d3766b3-f7fe-4300-b249-e53befb1c41d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5d3766b3-f7fe-4300-b249-e53befb1c41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_9b296ea3-f362-4097-a07d-c0a4733a6df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_InterestRateContractMember_9b296ea3-f362-4097-a07d-c0a4733a6df5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended" id="idfcf55b73d5c414c9946fe5826ca00b0_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d1b0d1e2-7384-4e8f-ac52-0718a04ec88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DerivativeAssets_d1b0d1e2-7384-4e8f-ac52-0718a04ec88d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_90c6db7a-0c7c-493a-9d18-033699e545b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DerivativeLiabilities_90c6db7a-0c7c-493a-9d18-033699e545b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b77b04f-ac43-48a2-8121-c4d8b43f8a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b77b04f-ac43-48a2-8121-c4d8b43f8a16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_3b8d0761-a736-4266-9d84-d72084317ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_3b8d0761-a736-4266-9d84-d72084317ad8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_97f6d2c7-70db-41f8-a83f-05586e50814a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_Assets_97f6d2c7-70db-41f8-a83f-05586e50814a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68ec61d2-f2c0-4479-961a-5cd281c0009c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68ec61d2-f2c0-4479-961a-5cd281c0009c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f458e86a-7256-47a5-a387-4e73884f16f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f458e86a-7256-47a5-a387-4e73884f16f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c348e0a9-d88c-4517-88df-7522c9d2fd16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c348e0a9-d88c-4517-88df-7522c9d2fd16" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b4eec6d8-d6e9-4f38-9037-86275fe172ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_LongTermDebt_b4eec6d8-d6e9-4f38-9037-86275fe172ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_930c0d1c-03fb-43de-a1f4-110e0f858b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_Liabilities_930c0d1c-03fb-43de-a1f4-110e0f858b88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1d8add05-0584-4876-ba63-8598750e91ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1d8add05-0584-4876-ba63-8598750e91ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_55583c50-6589-4c68-8951-a9ecb764b337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_55583c50-6589-4c68-8951-a9ecb764b337" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_06110437-8ffa-478b-b664-9c1837df5055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_06110437-8ffa-478b-b664-9c1837df5055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4bed7ca8-7d53-4260-a81d-7b5644fa6fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_OtherAssetsMember_4bed7ca8-7d53-4260-a81d-7b5644fa6fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_e345cc14-2bca-4a36-9ef7-33f646af5eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_e345cc14-2bca-4a36-9ef7-33f646af5eb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_6431e037-ec15-45b3-bb01-cc8c69fcca68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_6431e037-ec15-45b3-bb01-cc8c69fcca68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_9ef00b91-6f60-45c7-8a35-c7e97285c71d" xlink:href="clx-20210331.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_9ef00b91-6f60-45c7-8a35-c7e97285c71d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_5cd87152-ecfb-4df1-a9ca-deefda7dd2fd" xlink:href="clx-20210331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_5cd87152-ecfb-4df1-a9ca-deefda7dd2fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d6d3d510-43cd-4f0d-827a-f88abc1e40ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d6d3d510-43cd-4f0d-827a-f88abc1e40ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69551939-f227-4912-a471-0389c8bb7b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69551939-f227-4912-a471-0389c8bb7b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5fb6ec7b-f6b1-4461-b357-e39c2c733493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5fb6ec7b-f6b1-4461-b357-e39c2c733493" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0090f779-fa9a-4842-9c9f-5c43b6cfb676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0090f779-fa9a-4842-9c9f-5c43b6cfb676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dace63d9-070f-4f88-ab99-5bcaff3ad416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dace63d9-070f-4f88-ab99-5bcaff3ad416" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a097f1e3-c7a0-40df-93f7-0e21df8a21f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a097f1e3-c7a0-40df-93f7-0e21df8a21f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_354bfde9-2b2b-472c-8703-dbe255e790fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:to="loc_us-gaap_MoneyMarketFundsMember_354bfde9-2b2b-472c-8703-dbe255e790fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_864ed34c-36f8-43e1-901d-6264afeaca5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:to="loc_us-gaap_BankTimeDepositsMember_864ed34c-36f8-43e1-901d-6264afeaca5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_51dfa18b-f39e-44d6-b83f-4def9d902ed8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_51dfa18b-f39e-44d6-b83f-4def9d902ed8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_c08c46fd-3a67-4009-9839-6f64955e58a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_CommodityContractMember_c08c46fd-3a67-4009-9839-6f64955e58a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_f08b759e-be6a-44bf-8dc4-6960cd9aa98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_InterestRateContractMember_f08b759e-be6a-44bf-8dc4-6960cd9aa98f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c9520d0d-a556-4fab-8a5b-25ac4e2d33ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c9520d0d-a556-4fab-8a5b-25ac4e2d33ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d89a070c-e6d7-42e3-b036-a9981f586f6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d89a070c-e6d7-42e3-b036-a9981f586f6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_5345cb62-5992-4d20-8cdb-b1425c5f18a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:to="loc_us-gaap_LongTermDebtMember_5345cb62-5992-4d20-8cdb-b1425c5f18a6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXES" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/INCOMETAXES" xlink:type="extended" id="i19e3e71e18984fd29c4e20a4619a86c7_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="iaf76bd89c0f94b4a8a3d9dd926387876_INCOMETAXESNarrativeDetails"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="extended" id="i9052c21d258f454da71d4bc89eaaa24e_NETEARNINGSLOSSESPERSHAREEPS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="extended" id="i7b320e0a15174d0783b73fa6bfa8935d_NETEARNINGSLOSSESPERSHAREEPSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended" id="i12604d3c1c50440fa3240d6b8e509674_NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="extended" id="i8ed000f21de34ff6a6a326743744c020_NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="extended" id="i98e85b25f48746b3945454746738a9aa_COMPREHENSIVEINCOMELOSS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="extended" id="i03cce5a9314c4890b10edb95361eaf7e_COMPREHENSIVEINCOMELOSSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended" id="if34391a6b27e4b90b6d6848916b7e64d_COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="extended" id="ifa2e94ff6d5544559a19c767593307ff_STOCKHOLDERSEQUITY"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended" id="i20a682bd202c4dbfa957708a0bda5759_STOCKHOLDERSEQUITYTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended" id="i27c3cba4c01b4cfc9982a5449e7f746d_STOCKHOLDERSEQUITYScheduleofEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_589afdfd-deb9-4d5a-9581-2e961273c27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_589afdfd-deb9-4d5a-9581-2e961273c27a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f33af8cf-cb88-488f-b923-57b4b06a10cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f33af8cf-cb88-488f-b923-57b4b06a10cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_1b7bf634-bdba-423e-8ec8-c8a502b9af02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_SharesIssued_1b7bf634-bdba-423e-8ec8-c8a502b9af02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e05ba496-ecb0-4237-9ac2-520609ff9ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_ProfitLoss_e05ba496-ecb0-4237-9ac2-520609ff9ffa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_080c2ade-aeb9-4706-a45d-4fd13704155e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_080c2ade-aeb9-4706-a45d-4fd13704155e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_48e77e77-414a-4980-8888-47f73181df2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_Dividends_48e77e77-414a-4980-8888-47f73181df2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7b2c9076-521f-4148-bb2b-41cd7ae9f1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7b2c9076-521f-4148-bb2b-41cd7ae9f1ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d42730c8-ad55-4d64-a624-e0bb4921fdf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d42730c8-ad55-4d64-a624-e0bb4921fdf5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ac0d2057-8ac5-4ec1-9a3f-a096125801ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ac0d2057-8ac5-4ec1-9a3f-a096125801ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_275353b4-cbdb-4acd-bd1a-6835539cef07" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_275353b4-cbdb-4acd-bd1a-6835539cef07" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_c6c446ba-0020-49ae-9473-7725a3f1ceee" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_c6c446ba-0020-49ae-9473-7725a3f1ceee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_77df9826-b81a-4176-913b-60e582f483cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_77df9826-b81a-4176-913b-60e582f483cc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_06b26c9a-d504-4716-b033-d6268db2b453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_06b26c9a-d504-4716-b033-d6268db2b453" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bee227ac-eb56-4962-9e51-f1d865b28176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bee227ac-eb56-4962-9e51-f1d865b28176" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_7670a586-a431-4067-b3ad-2598eb4674d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_7670a586-a431-4067-b3ad-2598eb4674d3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1708e016-ddeb-4782-b9fc-1d5ffff10338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_107845a6-4e04-4166-afbf-8d49cd3ab6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6bd74082-fb1d-4363-88bf-028d7a6238a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:to="loc_us-gaap_EquityComponentDomain_6bd74082-fb1d-4363-88bf-028d7a6238a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:to="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e0d37f08-66a7-4255-abfe-13bb295900d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_CommonStockMember_e0d37f08-66a7-4255-abfe-13bb295900d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05ed258e-258c-4c9b-80de-258db792b114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05ed258e-258c-4c9b-80de-258db792b114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f696024c-e161-4006-bd07-24e23f38dc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_RetainedEarningsMember_f696024c-e161-4006-bd07-24e23f38dc37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_017ca075-c605-4dce-8d96-492ea6120a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_TreasuryStockMember_017ca075-c605-4dce-8d96-492ea6120a9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fed91e5-b0db-497a-8e9e-da27e6f2ca84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fed91e5-b0db-497a-8e9e-da27e6f2ca84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2ab0d003-75bf-4ab3-a193-372f4598f1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2ab0d003-75bf-4ab3-a193-372f4598f1d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_71bf4b31-e9ba-4da2-86c9-f54861e6728e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_71bf4b31-e9ba-4da2-86c9-f54861e6728e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i604e9fa271154db6ba86c55d23bdb410_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_259a0226-5301-43e0-92f9-4c83f4b9a9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_259a0226-5301-43e0-92f9-4c83f4b9a9c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NumberOfRepurchasePrograms_0548661f-dfd3-4c71-9c4d-1f51750bc8a2" xlink:href="clx-20210331.xsd#clx_NumberOfRepurchasePrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_clx_NumberOfRepurchasePrograms_0548661f-dfd3-4c71-9c4d-1f51750bc8a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2b317297-bc2b-45a8-b609-9ecc56b7c1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2b317297-bc2b-45a8-b609-9ecc56b7c1f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_StockRepurchaseProgramAuthorizationLimit_816c8571-13ae-4b32-b3c1-90aec8c21486" xlink:href="clx-20210331.xsd#clx_StockRepurchaseProgramAuthorizationLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_clx_StockRepurchaseProgramAuthorizationLimit_816c8571-13ae-4b32-b3c1-90aec8c21486" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_98a0dbd7-5809-4e8c-bd59-32f501e05997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_98a0dbd7-5809-4e8c-bd59-32f501e05997" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d851f584-0235-4c50-ab9c-20932934161e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d851f584-0235-4c50-ab9c-20932934161e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_A2BillionOpenMarketPurchaseProgramMember_50c4e290-e7f9-4e6f-87c8-9f41f2957a2e" xlink:href="clx-20210331.xsd#clx_A2BillionOpenMarketPurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:to="loc_clx_A2BillionOpenMarketPurchaseProgramMember_50c4e290-e7f9-4e6f-87c8-9f41f2957a2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_EvergreenProgramMember_40fe3794-2a1f-4c74-b9ac-081142573285" xlink:href="clx-20210331.xsd#clx_EvergreenProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:to="loc_clx_EvergreenProgramMember_40fe3794-2a1f-4c74-b9ac-081142573285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62d2518c-62e5-4c91-b366-bd589b0763d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:to="loc_us-gaap_EquityComponentDomain_62d2518c-62e5-4c91-b366-bd589b0763d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:to="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_511bb07b-1a5f-48e3-bc95-87cd74a166e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:to="loc_us-gaap_TreasuryStockMember_511bb07b-1a5f-48e3-bc95-87cd74a166e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_0766c09b-fcc7-4f51-a569-bfde50bf2520_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_0766c09b-fcc7-4f51-a569-bfde50bf2520_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_06c864da-0682-448c-920c-659f55e8cbbe" xlink:href="clx-20210331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:to="loc_clx_LongTermInterCompanyLoansMember_06c864da-0682-448c-920c-659f55e8cbbe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="extended" id="i34023a13309f4e40bd38d0e88d1edb87_STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a0ab4cee-e6d4-4b81-a4aa-458d50cf6662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a0ab4cee-e6d4-4b81-a4aa-458d50cf6662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_62d8d0d9-8101-447b-a0a0-3ed1c5c3cb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_62d8d0d9-8101-447b-a0a0-3ed1c5c3cb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:to="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5d0f42e6-2d10-4d43-9020-91ec5485604c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5d0f42e6-2d10-4d43-9020-91ec5485604c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_A2BillionOpenMarketPurchaseProgramMember_530d0d9f-1a24-4d3b-b651-bb888421a3f2" xlink:href="clx-20210331.xsd#clx_A2BillionOpenMarketPurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:to="loc_clx_A2BillionOpenMarketPurchaseProgramMember_530d0d9f-1a24-4d3b-b651-bb888421a3f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_EvergreenProgramMember_aee35c65-427b-4412-9348-2509f4ccb4d4" xlink:href="clx-20210331.xsd#clx_EvergreenProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:to="loc_clx_EvergreenProgramMember_aee35c65-427b-4412-9348-2509f4ccb4d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended" id="if03ba1770d214335bcde0fd045d498ec_STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f58e089-fd8d-478e-954e-35b0bc6a8a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_StockholdersEquity_6f58e089-fd8d-478e-954e-35b0bc6a8a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_94338db2-1490-45d7-9385-f0db30fdff23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_94338db2-1490-45d7-9385-f0db30fdff23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6f6a54ad-4122-49b4-9960-bc9ee284df73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6f6a54ad-4122-49b4-9960-bc9ee284df73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_67a3d590-b6e5-4c0d-8e27-932f4f5e1a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_67a3d590-b6e5-4c0d-8e27-932f4f5e1a4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_866b5271-1321-4bec-98f2-6d9d09fca852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_866b5271-1321-4bec-98f2-6d9d09fca852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3f12d023-838f-4aae-87ca-9d76d4eca2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0185376d-8c14-419f-90d6-abda82a9d8e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:to="loc_us-gaap_EquityComponentDomain_0185376d-8c14-419f-90d6-abda82a9d8e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:to="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_11599edf-d54e-4ae6-bdc4-5466331357c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_11599edf-d54e-4ae6-bdc4-5466331357c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_48748d46-f996-4848-b57d-700072753c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_48748d46-f996-4848-b57d-700072753c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9f17676-d4c0-4d5e-8971-119f40f0075c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9f17676-d4c0-4d5e-8971-119f40f0075c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_65f21fba-c4af-4407-83d0-fd534982b77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_65f21fba-c4af-4407-83d0-fd534982b77e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended" id="i74615fec59694077a926d85a18aa16eb_EMPLOYEEBENEFITPLANS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended" id="i5cba195116fb44e8a040ed2af656395c_EMPLOYEEBENEFITPLANSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended" id="ib17a756429cb4dcb9bd5d388cb7a7fa8_EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_844394d6-757c-4984-b67d-7c39bd45e9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_844394d6-757c-4984-b67d-7c39bd45e9d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_45ba810a-e1b7-4fa1-b5c5-407120b7766f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_45ba810a-e1b7-4fa1-b5c5-407120b7766f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6e623adf-dc36-425a-8cd2-45a9cb88bf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6e623adf-dc36-425a-8cd2-45a9cb88bf91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b94e4bd5-06d7-478e-8375-896cd852cc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b94e4bd5-06d7-478e-8375-896cd852cc0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_45189bd4-431a-4eba-9fb3-3029b3ddbc20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_45189bd4-431a-4eba-9fb3-3029b3ddbc20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e87f1a9a-be07-4c9a-b98a-20b77ab60610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e87f1a9a-be07-4c9a-b98a-20b77ab60610" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b60a3071-2849-4af5-815d-7b1e6be07ccb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b60a3071-2849-4af5-815d-7b1e6be07ccb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_30447b5e-aa36-4bb2-bc45-1fbc07fdf89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_30447b5e-aa36-4bb2-bc45-1fbc07fdf89b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:to="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:to="loc_us-gaap_PlanNameDomain_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:to="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_312858ea-8e5b-4faf-bb55-d786310cedd1" xlink:href="clx-20210331.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:to="loc_clx_RetirementIncomeMember_312858ea-8e5b-4faf-bb55-d786310cedd1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended" id="i302b7786e2734f429ec24b2bd91b58f2_EMPLOYEEBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b47aff15-8ed4-4086-8b74-a625e6632cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b47aff15-8ed4-4086-8b74-a625e6632cb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_600405a0-6237-4feb-8ca1-fc3b35fb5d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_600405a0-6237-4feb-8ca1-fc3b35fb5d4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:to="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b313db5f-ac72-4932-ae60-21a0dcbd9704_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:to="loc_us-gaap_PlanNameDomain_b313db5f-ac72-4932-ae60-21a0dcbd9704_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:to="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_ba6546b2-aeca-4990-88fa-4e6864266cd1" xlink:href="clx-20210331.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:to="loc_clx_RetirementIncomeMember_ba6546b2-aeca-4990-88fa-4e6864266cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ba60b279-30db-4181-b01a-e020a4726fa4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ba60b279-30db-4181-b01a-e020a4726fa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:to="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2e25d208-c7ab-412e-aeea-24a0feb140f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:to="loc_country_US_2e25d208-c7ab-412e-aeea-24a0feb140f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="extended" id="i0e6be97d96fb493da12368c97c8de62c_OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended" id="ibc8d2bb6d82047ce97b0c25661c15aa7_OTHERCONTINGENCIESANDGUARANTEESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_902ac786-8f9b-40f8-afc2-e81831f6aed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_902ac786-8f9b-40f8-afc2-e81831f6aed0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_0efba3ef-aaa0-4b7c-a05c-8badf1c7bef7" xlink:href="clx-20210331.xsd#clx_RemediationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_RemediationPeriod_0efba3ef-aaa0-4b7c-a05c-8badf1c7bef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_889468a6-2b54-4928-8e87-e946e2fabcec" xlink:href="clx-20210331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_MaximumExposureUndiscountedCost_889468a6-2b54-4928-8e87-e946e2fabcec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_6a81dbd8-1b4e-4923-8e0b-563d1c956307" xlink:href="clx-20210331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_6a81dbd8-1b4e-4923-8e0b-563d1c956307" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_7e5bdc85-54ed-4d92-a898-45a3021613c9" xlink:href="clx-20210331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_7e5bdc85-54ed-4d92-a898-45a3021613c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_12d40bf5-97f6-4384-81db-97ad86d8fdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_12d40bf5-97f6-4384-81db-97ad86d8fdc0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3c694f3a-694a-435c-ab71-0617dee14c84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3c694f3a-694a-435c-ab71-0617dee14c84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_bcbb122a-2b8c-427f-8f67-8062c9c45c7f" xlink:href="clx-20210331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_bcbb122a-2b8c-427f-8f67-8062c9c45c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_839ac533-bde0-4c26-a84b-62b11c1be41f" xlink:href="clx-20210331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_839ac533-bde0-4c26-a84b-62b11c1be41f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTS"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="extended" id="i9f09446216a046a0b3b01ad45c80002d_SEGMENTRESULTS"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSTables"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="extended" id="i0e71989eb5f24e5e986d60871b583e9b_SEGMENTRESULTSTables"/>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended" id="i25029409615d485c92094050c630a9eb_SEGMENTRESULTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_844ebcc6-8cea-4a1f-840e-7101bdb5f6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:to="loc_us-gaap_NumberOfReportableSegments_844ebcc6-8cea-4a1f-840e-7101bdb5f6b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5396f7fc-78ad-4d78-85d5-471d3def7bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5396f7fc-78ad-4d78-85d5-471d3def7bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:to="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0ce8363c-50b2-4472-ae2b-77102962eab4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0ce8363c-50b2-4472-ae2b-77102962eab4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_84ccfab2-1e40-480c-9780-1af76801b2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_84ccfab2-1e40-480c-9780-1af76801b2e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_79f1cecc-836f-46ff-ae72-acce59b97728_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_79f1cecc-836f-46ff-ae72-acce59b97728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2bcc3315-5ee9-46a3-a3a6-ea30e64be686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2bcc3315-5ee9-46a3-a3a6-ea30e64be686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9771f755-ce60-420b-bfd8-020a0f8ce783_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:to="loc_srt_NameOfMajorCustomerDomain_9771f755-ce60-420b-bfd8-020a0f8ce783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:to="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_421dff6d-72f6-4902-923e-80421074183f" xlink:href="clx-20210331.xsd#clx_WalmartStoresIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:to="loc_clx_WalmartStoresIncMember_421dff6d-72f6-4902-923e-80421074183f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="extended" id="i69afe76910f044a8ba1a8d7dba43e048_SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2146d9e0-553c-4a68-bc79-f3495de7ee76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2146d9e0-553c-4a68-bc79-f3495de7ee76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e5bfdd8-1fd3-427f-8655-713ad73a51c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e5bfdd8-1fd3-427f-8655-713ad73a51c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_19421eba-edeb-4d22-9053-34f2f1151cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_19421eba-edeb-4d22-9053-34f2f1151cb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7dff9e41-eb7d-4015-a4ce-e5aed5416c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7dff9e41-eb7d-4015-a4ce-e5aed5416c83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4d94f9df-36cf-42e9-847d-ff76818bb179_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:to="loc_srt_ConsolidationItemsDomain_4d94f9df-36cf-42e9-847d-ff76818bb179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:to="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6856d97b-cee7-4bab-a5ae-b4ae4a21fc96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:to="loc_us-gaap_OperatingSegmentsMember_6856d97b-cee7-4bab-a5ae-b4ae4a21fc96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_348d1f69-3ab2-49be-ae66-47aec90159bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:to="loc_us-gaap_CorporateNonSegmentMember_348d1f69-3ab2-49be-ae66-47aec90159bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31e8329d-4a7f-46d5-a3a1-8c96745b12c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:to="loc_us-gaap_SegmentDomain_31e8329d-4a7f-46d5-a3a1-8c96745b12c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:to="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_e4a94e52-f64a-44e6-8726-ffa25f026b4e" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_HealthAndWellnessMember_e4a94e52-f64a-44e6-8726-ffa25f026b4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_cad3c90e-dcc3-452a-8c19-5a3c859bdfd6" xlink:href="clx-20210331.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_HouseholdMember_cad3c90e-dcc3-452a-8c19-5a3c859bdfd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_fc0b5210-43c5-4cbe-904c-8dde65460789" xlink:href="clx-20210331.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_LifestyleMember_fc0b5210-43c5-4cbe-904c-8dde65460789" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_9d31e340-63c2-4b3a-8999-2726db49d3c5" xlink:href="clx-20210331.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_InternationalMember_9d31e340-63c2-4b3a-8999-2726db49d3c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_84d88a1c-482b-4360-88af-4ea3d653648d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:to="loc_us-gaap_SubsegmentsDomain_84d88a1c-482b-4360-88af-4ea3d653648d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:to="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_3f18a3b0-f43a-4e7a-88a8-8888f931956c" xlink:href="clx-20210331.xsd#clx_CleaningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_CleaningMember_3f18a3b0-f43a-4e7a-88a8-8888f931956c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_f919e051-a61b-4562-9930-d73432f482cc" xlink:href="clx-20210331.xsd#clx_ProfessionalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_ProfessionalProductsMember_f919e051-a61b-4562-9930-d73432f482cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_c4d4758c-54e3-43b9-88dc-9fe5d6cf52fa" xlink:href="clx-20210331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_c4d4758c-54e3-43b9-88dc-9fe5d6cf52fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_e9298768-05f5-4ff2-8d3d-d52744541e6f" xlink:href="clx-20210331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_BagsWrapsAndContainersMember_e9298768-05f5-4ff2-8d3d-d52744541e6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_f0b713de-04e3-44db-a74f-6ca080b611c6" xlink:href="clx-20210331.xsd#clx_CatLitterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_CatLitterMember_f0b713de-04e3-44db-a74f-6ca080b611c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_4c9a86c5-35fc-44be-ae44-9899b792b211" xlink:href="clx-20210331.xsd#clx_GrillingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_GrillingMember_4c9a86c5-35fc-44be-ae44-9899b792b211" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_04c5132e-e1f4-47c9-8bb5-964daee5fcc3" xlink:href="clx-20210331.xsd#clx_FoodProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_FoodProductsMember_04c5132e-e1f4-47c9-8bb5-964daee5fcc3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_2ce8db49-3f6e-4d00-86c8-8acd50141918" xlink:href="clx-20210331.xsd#clx_NaturalPersonalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_NaturalPersonalCareMember_2ce8db49-3f6e-4d00-86c8-8acd50141918" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_6e782f8f-b3e7-4c87-9adc-4a7334f737de" xlink:href="clx-20210331.xsd#clx_WaterFiltrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_WaterFiltrationMember_6e782f8f-b3e7-4c87-9adc-4a7334f737de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_808e7d83-8e33-45b7-b90b-a20e10afcaad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_808e7d83-8e33-45b7-b90b-a20e10afcaad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_ac2d3aa0-b2b0-40cf-878c-9e6f8fa73b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_ac2d3aa0-b2b0-40cf-878c-9e6f8fa73b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1445def3-d0b6-4193-935f-496f8c8432c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1445def3-d0b6-4193-935f-496f8c8432c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_137d96a7-28f1-4f1f-bcc2-73608c348abd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_137d96a7-28f1-4f1f-bcc2-73608c348abd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:to="loc_us-gaap_ReportingUnitDomain_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_73a8a497-e5dc-4796-94cf-78e698334771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:to="loc_us-gaap_ReportingUnitDomain_73a8a497-e5dc-4796-94cf-78e698334771" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>clx-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_da632c3c-d954-4f96-b84a-ecf93c67cf30_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_1920cbfb-90c6-4796-8855-b5a4fecbeeb2_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_a976b9c9-21eb-468b-a562-5fae0bdbd223_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retirement (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_7e4f8165-7c43-4ec2-a2f6-16591ca22a81_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_aad4b8d0-7784-41e3-aaa3-d3342f09eb71_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_65ca88d3-318e-4855-bd62-d12485426775_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ccd873e8-389f-41b7-92b1-858a58b3f4ce_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5d0be335-f58f-42c6-90b7-94a9fbb10681_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_180953f0-245b-4386-a308-f2ea977b0dfb_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_59ce494f-591b-4cae-986c-f39fd4c389a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_e2de53c4-e44a-4898-b472-3253523f2698_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_4e983a7c-819d-4a85-918a-2f38bc71bac1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_A2BillionOpenMarketPurchaseProgramMember_9047cf86-9491-43e6-97c9-2a15fbd9abfd_terseLabel_en-US" xlink:label="lab_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Open-Market Purchase Program [Member]</link:label>
    <link:label id="lab_clx_A2BillionOpenMarketPurchaseProgramMember_label_en-US" xlink:label="lab_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Open-Market Purchase Program [Member]</link:label>
    <link:label id="lab_clx_A2BillionOpenMarketPurchaseProgramMember_documentation_en-US" xlink:label="lab_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Open-Market Purchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:href="clx-20210331.xsd#clx_A2BillionOpenMarketPurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:to="lab_clx_A2BillionOpenMarketPurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c44bf2bc-0389-4516-9f8e-515878f12200_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26f440f1-87d5-4d9e-9668-5878629e28f9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_51fd31a8-d99f-4a20-b9d9-549de8fa3228_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5406ba86-1562-4dc8-9482-46355ea4a475_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_8c4fcf05-f5ae-4bfa-b0f1-01d93b482bcc_terseLabel_en-US" xlink:label="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on settlement</link:label>
    <link:label id="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_label_en-US" xlink:label="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Settlement Of Pre-Existing Net Liabilities</link:label>
    <link:label id="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_documentation_en-US" xlink:label="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Settlement Of Pre-Existing Net Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:href="clx-20210331.xsd#clx_BusinessCombinationSettlementOfPreExistingNetLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:to="lab_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_81685467-90f0-4c30-b555-d53baaf8d6ea_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_88ed81c0-a82f-4b22-aa14-a47f9c2f56a6_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_95dac9b4-d2b4-402d-a5eb-918d4312acbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retirement</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_139479ec-fe5d-4c70-8a06-e27bce5fcce0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_f8503411-e653-4e17-9836-d4f85c4220e8_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7153063f-fe64-4f81-b575-b95d097024d0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ef445add-fbee-4ca4-9a43-b1c1b635b231_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_033b4571-6d6f-49c1-a639-70ecf244a080_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations including purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a195170e-b747-4992-9cbe-cdb22012bc24_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b7c00f72-a081-4cd8-8539-fa2c5ba14a29_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d336c19-2487-4ed4-9318-07a31935fe43_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_c802e0bc-62d2-4e34-926c-0520d550fa72_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5b468572-dc00-47d8-890c-829af5806ea7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_EvergreenProgramMember_4142023d-800f-4805-a3fa-c43134213ec6_terseLabel_en-US" xlink:label="lab_clx_EvergreenProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evergreen Program [Member]</link:label>
    <link:label id="lab_clx_EvergreenProgramMember_label_en-US" xlink:label="lab_clx_EvergreenProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evergreen Program [Member]</link:label>
    <link:label id="lab_clx_EvergreenProgramMember_documentation_en-US" xlink:label="lab_clx_EvergreenProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evergreen Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_EvergreenProgramMember" xlink:href="clx-20210331.xsd#clx_EvergreenProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_EvergreenProgramMember" xlink:to="lab_clx_EvergreenProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0394c8ed-0285-4fb4-94c9-b4756ca3df3f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_5393bd0b-1791-4445-bb0d-705e2c2e53ad_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ab3070fc-4ab2-4cdb-aa44-5bfa10a9511a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e84f346a-5ced-43f9-bebe-71f4de977bfc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed49e074-9fd0-4620-aaf7-8285ad3ecfb8_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted-average estimated useful life of intangible assets subject to amortization</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_581a9f83-cae3-4944-b9e9-3fa5e0292155_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_49eae26c-ba43-42cd-a998-f4a99a1dacdb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7e0734ab-0e2b-4a9f-9a4b-8194b40f9548_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_21fa477a-a841-42e6-ac7a-48d9e64aef58_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities (in shares)</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Shares</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0e50e58e-47c0-40b7-a8c0-683fd3ed0b2f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_f042e762-6cfd-4cc6-8d0a-a2ed6ac23c6c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_cc8007c5-d1e9-4823-ae85-fcb45dbede55_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_4e44fa57-26d0-43b5-a937-e77b6a6804a9_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_03fd38b3-bf83-403b-9a2c-282614ebeb46_terseLabel_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans [Member]</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_label_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans [Member]</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_documentation_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term inter-company loans included in foreign currency adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember" xlink:href="clx-20210331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LongTermInterCompanyLoansMember" xlink:to="lab_clx_LongTermInterCompanyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_55b9ee90-6297-41da-8503-8614ac8809f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_b538081d-2ffc-42c0-8325-5bd03a6050ce_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and packaging</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d0b9d3c6-7a1c-409e-9b80-43af9ad12e09_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1a52628b-cf34-45b8-b42d-d62e1523babd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_443db159-6a29-4545-ad0f-4ae7176f04e5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bfc301e0-1b71-4639-bb42-849f9f9ad871_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ProfessionalProductsMember_100f4e35-d825-4381-a98e-36723275b633_terseLabel_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_label_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_documentation_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember" xlink:href="clx-20210331.xsd#clx_ProfessionalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ProfessionalProductsMember" xlink:to="lab_clx_ProfessionalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_3f17027e-87ed-4e8c-909f-5e3bbcabba72_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_cfff0eec-8a9c-43b7-9a6d-79e606863163_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0110b3e8-f3b8-4a72-94c2-ba71d0084fc7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8a59d9c5-bb71-4117-ac7b-a76866a09322_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_203dd320-9edf-4537-a3e7-ea2422a033ed_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9c9b7945-4142-45b3-9a62-3068d333c043_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e8963b8b-d503-4d7a-846b-a04817280131_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_33dc7adf-67a4-48f6-ba1a-eeed6b3a2942_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_8b3d909c-b123-4ad2-a1b6-6c8e619cb7db_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_436fa026-44e2-4d9e-b7fc-ef1ebe961b0c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HouseholdMember_09146df6-39dd-4125-b619-5df3d750f727_terseLabel_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household</link:label>
    <link:label id="lab_clx_HouseholdMember_label_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:label id="lab_clx_HouseholdMember_documentation_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember" xlink:href="clx-20210331.xsd#clx_HouseholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HouseholdMember" xlink:to="lab_clx_HouseholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_3a7916ac-a02f-4de1-b64e-cba640ed867d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_4af5ea15-569f-4ba4-b5bd-d70e5f01612d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_efb7ab26-9167-446d-ba62-43b586a3e711_terseLabel_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_label_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_documentation_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity" xlink:href="clx-20210331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LetterOfCreditBorrowingCapacity" xlink:to="lab_clx_LetterOfCreditBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_68829673-af20-4e43-8821-09afbe773304_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_26487b23-a3c8-42aa-a8c0-1be42ebfd398_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ce8ac0bb-07b7-4e71-9cfd-c402c3087484_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_ec200cf2-26ab-41f6-a7f1-d2883980847c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0aab21a2-a730-4f41-a0ce-332c7958d53a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_62174af5-2665-4f24-b832-228e63092bc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ba5d8f7a-57c9-48e7-94bc-5da545016a63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_8efbb959-6905-49c8-84d0-3d8ce103ad9a_terseLabel_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_label_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_documentation_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:href="clx-20210331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:to="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_377b39ab-d133-4ed8-bf7f-e32d2ee21c38_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_bc1cf491-12b9-4545-964d-f676cec524d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_c131e1ea-d747-4545-b289-2c25cc0ef575_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6c5cc637-d4a2-4b3a-9d5b-176f4a2d695f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f939ab00-58a2-45e1-9b75-d42c47c49440_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8d763b6f-6349-4588-b030-f5078d0e9e79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_5f5be904-9b31-4470-b37b-95d0df5cc784_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_87c62eb6-bf55-43bf-adbd-b20505c44046_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a5968f93-9ac4-4dcb-b0c6-1de420a8313b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_8ea1e5e7-b23b-4775-875a-1b97ed98d80b_terseLabel_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_label_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_documentation_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:href="clx-20210331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:to="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_26ce67be-a041-4057-80bd-ac89aa07630b_terseLabel_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags and Wraps [Member]</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_label_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_documentation_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember" xlink:href="clx-20210331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BagsWrapsAndContainersMember" xlink:to="lab_clx_BagsWrapsAndContainersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_b82b99cc-08af-42fd-a744-54f90a6d8bc4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable / prepaid</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fe3dd8f-2d23-4afd-a8b0-13fb536942cd_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in thousands)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_53d36bee-f143-4915-aa99-1f5ac2c4d182_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ec6759f5-df28-413c-95d4-cc86e4fc9f97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_909ac19a-80a8-4ab3-9417-684f446c406a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_9d66213a-08d9-4001-b3ee-a75f34beed69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchases Under Authorized Programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_218e1ea1-a180-48db-92ea-879a96f441ee_terseLabel_en-US" xlink:label="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture net sales</link:label>
    <link:label id="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_label_en-US" xlink:label="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Revenue Reported By Acquired Entity For Current Period</link:label>
    <link:label id="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_documentation_en-US" xlink:label="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Revenue Reported By Acquired Entity For Current Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:href="clx-20210331.xsd#clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:to="lab_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_72526fa6-0a85-46d7-a47e-2119724de605_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_30e37813-7f63-4d6f-b32c-62b39de1de6d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_aa7c6064-a689-4c44-8326-0c0ae63f24de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_6f880b7e-092f-436c-928c-b08bb4c1fb5e_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5bbfc4cd-c28f-40af-8330-c663319ee457_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5dab31e0-9c76-405b-a9e2-e6977739d8df_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9088f498-9cc6-4e01-aed7-45bb0354fe90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_42f821fd-fce6-4898-919c-e7e4eafbd16d_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8c8edc3d-286e-4813-b26f-70afb78e5dcf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities for Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_03e12627-c504-4aa0-a50d-c7d382d3a244_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e3e39edc-f86b-45e4-80fa-a747561c92b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8b34b4b3-76fe-42c1-be9b-c8222b20ab8b_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_53573512-1adc-49eb-bd70-9d0d42bc843a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9ff628bd-8648-4077-b79a-e9d77b378350_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherContingenciesAndGuaranteesAbstract_dc5f3b49-1fbc-4d43-bcb6-25554c568c67_terseLabel_en-US" xlink:label="lab_clx_OtherContingenciesAndGuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES [Abstract]</link:label>
    <link:label id="lab_clx_OtherContingenciesAndGuaranteesAbstract_label_en-US" xlink:label="lab_clx_OtherContingenciesAndGuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherContingenciesAndGuaranteesAbstract" xlink:href="clx-20210331.xsd#clx_OtherContingenciesAndGuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherContingenciesAndGuaranteesAbstract" xlink:to="lab_clx_OtherContingenciesAndGuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a6c67092-59f8-4453-88c4-2e28050f91c6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6c50f3a-7e67-4014-ab28-0fa77e7fb384_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f7b94245-3da4-4815-af8b-8567feb3a65c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_552570e8-6191-4fd2-a2d4-410ecc05a0ef_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_558e058b-546c-4957-b328-184614108565_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_899f7bb2-bcf4-4026-9096-ce8b5a2c047b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_14f2b00c-7980-4969-91d2-af796e593b86_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock_8913c79d-8d38-4e4d-9824-2978602b79e0_terseLabel_en-US" xlink:label="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES</link:label>
    <link:label id="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock_label_en-US" xlink:label="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES [Text Block]</link:label>
    <link:label id="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock_documentation_en-US" xlink:label="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:href="clx-20210331.xsd#clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:to="lab_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0664b603-a86f-41cb-8673-05b298886227_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e25c8ccd-64f9-40b4-a78b-48273e59295b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_952b2565-de18-4d95-9c40-91a0909ce292_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT RESULTS</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_229a5859-9371-4839-afac-5f282424f511_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_90e9e691-9f95-4f2b-bea9-585edefc1d84_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_9bcf8cb8-724b-481a-bdfd-d77ecf7b3fef_totalLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other liabilities in the fair value hierarchy</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_aa4e0b29-4117-49b3-a0a2-93d2963676fd_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f9e03753-44d8-4454-992a-4289e1581d50_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_6f0d0618-93fe-4ab8-a976-3d4828569102_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Member]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_091b0ed1-6cbf-47e7-a808-e88d71ce658a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_a3697c3b-4aea-460d-bb56-de9be132f4bf_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_2bbfb042-e596-4f95-a66d-45e6e7416315_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_7ac597b2-3e82-4f92-8f8d-fbcc9f336323_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_PurchasesofInventoryMember_0ced1f9a-71a9-4b7d-8286-99ea998b5048_terseLabel_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_label_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_documentation_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember" xlink:href="clx-20210331.xsd#clx_PurchasesofInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_PurchasesofInventoryMember" xlink:to="lab_clx_PurchasesofInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_e1f64a32-c207-4914-bc97-8e7dac103fbb_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_cf226426-6d80-467e-8e19-fd53e3417c9c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d6d53593-135d-44c2-b9b2-043c8b854aa2_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_0992f47c-b53c-4e09-babe-53f4dae69077_terseLabel_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not subject to amortization, before impairment</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_label_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</link:label>
    <link:label id="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_documentation_en-US" xlink:label="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:href="clx-20210331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:to="lab_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_58970bad-2f06-47d8-9e33-ace9610b3983_terseLabel_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_label_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_documentation_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember" xlink:href="clx-20210331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DickinsonCountyMichiganMatterMember" xlink:to="lab_clx_DickinsonCountyMichiganMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_55173ff7-f78d-4d7a-a532-8f4ab7f6320c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6737ed9f-b1aa-4f21-898c-a7e1645a2ec5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_33ee9693-8ea7-4d96-984e-0873a56d8f1e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_3e996ba1-dc73-4369-bcde-c85a4f7fe357_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_caaa09c3-46c2-43f1-8f7a-11e78142fee8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_832cf710-8082-4473-8890-a24f41f4a8fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ea176e2c-6d4e-4236-bb07-bc9823d35f4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognized in Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f6b6b5c6-0ccd-4daa-8771-34269c3b3f40_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c21f07ad-d129-4dad-a69b-d2ff0a6be62c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_05c21c17-1ebb-4a19-923e-56189bcb8257_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, commodity contracts</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4ac0a846-e948-4001-8548-b3d7287e1701_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ImpairedTrademarksMember_6d32e461-2ff6-4a1f-9ee8-1ec7a4fb0e33_terseLabel_en-US" xlink:label="lab_clx_ImpairedTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Trademarks</link:label>
    <link:label id="lab_clx_ImpairedTrademarksMember_label_en-US" xlink:label="lab_clx_ImpairedTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Trademarks [Member]</link:label>
    <link:label id="lab_clx_ImpairedTrademarksMember_documentation_en-US" xlink:label="lab_clx_ImpairedTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairedTrademarksMember" xlink:href="clx-20210331.xsd#clx_ImpairedTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ImpairedTrademarksMember" xlink:to="lab_clx_ImpairedTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_31b07f89-26f6-465d-a647-09727f72c468_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_529b7364-b8cd-432e-a560-3639f6e5266b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6c24ee77-f501-4489-a0c7-0fe8bf8b0700_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_4ce1d6c2-c64e-48d4-84a7-6850fc0c3d24_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_0e4ef78d-55f0-4f3b-bc7b-23dfa26b4a34_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_5596fd5e-012e-42f3-9776-16de193a311a_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_fa8fa96f-909c-4243-84d7-c88ed3135d6d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_7fec0997-883a-49f2-959c-10b2068e3331_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_12c9ea50-581c-44ae-b5c8-6a5298d5ab07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_662ce0af-2707-4d38-aad3-0c68684f0121_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_b1eaa898-443e-4113-997a-09aba8568044_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_7c4e3247-4c8a-4b93-a5c2-70162d66ed44_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_38fe0792-21e2-4c8b-92c4-e939e33349e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_8babc705-4783-4b7a-8ad5-2c97f3ad0b51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6cd2980e-563b-4517-98fe-c34a701a3e38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41ca1d52-9181-40f3-a858-6e74efd27e39_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_126b5db9-1f3b-4c6a-8731-fdd1d0bda647_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_7214845d-fe73-4569-8dd5-09367b18674b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_60469944-69c3-4536-a4bf-54a70f162a7c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_992c915f-59fb-4c9b-9b9f-efbe7d1bcd60_terseLabel_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_label_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_documentation_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_5f39cfe9-c998-4cd3-bc87-004ee485dffa_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit, amount outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_637166be-9858-4d42-bfad-797fa1caa179_terseLabel_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum undiscounted costs</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_label_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure, Undiscounted Cost</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_documentation_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost" xlink:href="clx-20210331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_MaximumExposureUndiscountedCost" xlink:to="lab_clx_MaximumExposureUndiscountedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_17010309-fe3a-4074-9f1c-77c04ef43bef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Businesses acquired, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_588be837-7d8a-43d1-8fe6-ae4b188778ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_52839990-9c93-4b79-98c7-9a7d04637d4d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1ba89629-2286-4f51-ada2-c877decccc34_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_660268a0-09e7-468c-a6ff-11269e2058e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Financial Information Relating to the Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_353247af-5712-4585-b0b0-efe75975d970_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f6990dfa-dd7e-44de-b680-a7fd26cb30d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a9e631f9-fa25-4bb0-b503-3a4614006f93_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_49e83d43-9a48-4208-92e0-5c0333a09714_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_613a4b3a-be4e-49c7-9c9d-42e50640558c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2447e290-3a62-4ce8-a3cb-b413a9d21fc3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1918eab1-deb0-4bb6-8d07-174fa59d8b46_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquired rights (included in Other intangible assets, net)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_530ce92d-bad8-4ac4-afa0-81049cf0cb0c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships (included in Other intangible assets, net)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1a0abe1f-6576-4824-8d97-4cc1f5ca3564_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_19b33e87-8232-48ae-8d1e-da8114298b58_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_c41e5931-bc74-4d9d-a890-6a46331bb49a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_d1bd64d0-3646-4168-beb7-71838a3dab10_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_0005687d-4e56-49a7-8959-5feb4dac00f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_add529d0-5f95-4ac9-9776-51586c1ae731_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_539d87c6-e834-4431-9207-64745ce318a0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss) attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_12d022e1-5726-4935-95a7-423c412e8403_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d5da7560-9c1d-4da2-b8b8-d052aab12194_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_13b72e0d-5677-4bbe-8086-b620166f22ec_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5ea38ba6-412b-41e8-b8fe-0e4963ac3fce_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b8c6fa5a-5e26-40b1-a0a6-5d7b8be8ef70_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_99adc404-d8c7-421d-b9f9-50031cc859fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_d0be11b2-af48-4479-a1f1-434470dbb0d7_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Fair value of previously held equity interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9d8dd94d-8e73-4ebb-a0e3-306bf863f6d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_SoybeanOilFuturesMember_99ff8a46-3baf-4e8d-bcc4-7b204ba14345_terseLabel_en-US" xlink:label="lab_clx_SoybeanOilFuturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soybean Oil Futures</link:label>
    <link:label id="lab_clx_SoybeanOilFuturesMember_label_en-US" xlink:label="lab_clx_SoybeanOilFuturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soybean Oil Futures [Member]</link:label>
    <link:label id="lab_clx_SoybeanOilFuturesMember_documentation_en-US" xlink:label="lab_clx_SoybeanOilFuturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soybean Oil Futures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SoybeanOilFuturesMember" xlink:href="clx-20210331.xsd#clx_SoybeanOilFuturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_SoybeanOilFuturesMember" xlink:to="lab_clx_SoybeanOilFuturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_84c1cbd4-f56a-4647-83cf-e42978b5e42f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_4c6e316b-f0f7-4c63-8bbe-aa6fb7994e86_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d552afb6-96c1-4272-bc23-56bfe428ebaa_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ed5e6d12-5c14-4bdf-8007-b92111b867a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_bfc610c7-5443-4d4f-b580-96930872acdb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_31aed42f-35f5-44f5-8a77-ba68a5e785fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_d9617368-c130-4735-a257-cb43b2a2f9d7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_5f693340-389e-4769-928b-6e36ec255b46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f3a3545b-c25a-4413-a7a0-e8feff9d7f7f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f1dfbc23-45aa-4175-8a38-9e17f58d72fa_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3e5c366a-c4ed-441c-bcb0-11b286dda2ee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_5f97ff18-84bf-45d7-8602-f998b70cf8fc_terseLabel_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_label_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_documentation_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:href="clx-20210331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b21da0-dbbd-406a-8807-ced3529e03f7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8f5c638a-dc34-4374-888f-4099fdfb4425_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_a0501b4e-4dd6-48ac-b6e8-44ab3deef57c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c6f05379-9fe3-4150-bb77-7a8d1852960b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_5f4972c3-20e3-411c-b3a3-598b82298646_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_44244b2c-c72a-4136-a183-5894aeb673b2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_7771de13-d8fc-4b31-8c5a-b58177bf4030_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9a4e6ca4-51ac-4c1d-8bdd-37af909e9f5a_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_45780268-e39f-4eec-9854-b4ce5d1f9056_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f611fd4e-b76a-41d9-86db-12a32aa53675_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_b9c14d13-bde2-4778-b25d-0522e96006c5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_2f2e2af2-b84b-4686-8c5a-381239286569_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_72db6534-8097-48c2-af4e-bb3e7b4258d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_7144383e-83d1-4d5f-913f-e7e6b5aeb3b7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ef51891e-1082-41fa-8403-2b3b3600b18f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4d544f6f-3d2a-476b-b631-81ca125f6cd9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized items</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_0167e897-46cf-4249-91e7-af6f0a5f50db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ecc85e53-10f1-4d6f-94ff-8d816faeb90c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_aa5bfd1c-2ca8-4433-b468-a89b81843578_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_97cf3df5-cced-4dc6-90e7-3e300aa6713c_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_219c674e-ac02-4539-929b-a4a6268f1972_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (benefit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c64e5d7e-add0-4ffb-afd2-624838a66d52_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RemediationPeriod_cbb80614-0e49-4f84-a2c2-e372c7b4b7cc_terseLabel_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period</link:label>
    <link:label id="lab_clx_RemediationPeriod_label_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period</link:label>
    <link:label id="lab_clx_RemediationPeriod_documentation_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod" xlink:href="clx-20210331.xsd#clx_RemediationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RemediationPeriod" xlink:to="lab_clx_RemediationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5e84bdc8-5e57-4605-9886-56340edc3241_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CleaningMember_74c7fa6a-4f82-41eb-9477-30e3debcba46_terseLabel_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:label id="lab_clx_CleaningMember_label_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:label id="lab_clx_CleaningMember_documentation_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember" xlink:href="clx-20210331.xsd#clx_CleaningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CleaningMember" xlink:to="lab_clx_CleaningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_01359ce2-638c-4bd9-befe-c835ec15212d_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_de0c0553-ef48-4c24-ad07-bb42f4ee5708_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c6561454-4993-49dc-aaec-c5bc52693ef1_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_308952f1-a658-45bb-b2a5-0ebf76bd6f15_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect of Accounting Changes, Net of Tax [Member]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LifestyleMember_6c54ebd1-9da6-4b89-98f3-0dbe5e33c105_terseLabel_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle</link:label>
    <link:label id="lab_clx_LifestyleMember_label_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:label id="lab_clx_LifestyleMember_documentation_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember" xlink:href="clx-20210331.xsd#clx_LifestyleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LifestyleMember" xlink:to="lab_clx_LifestyleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e1340741-f7a6-4c70-a073-292acc21c45c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8aeae778-4e40-4cd9-870d-b766d95954f7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_fe9c4134-4b38-4e7c-8097-afd0c16572ed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_1dce4412-56eb-4eb2-9ece-fdb06d4f898b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_cb78b03f-98c8-4ab6-a0ae-25bc0da97495_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-recurring, non-cash gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ec7a3756-68cd-4b01-91cf-6abe85b9750f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, trademark and other asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_9c31040f-6c80-42bd-a6cf-5a2415542824_totalLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, trademark and other asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_04c95549-e8c4-4739-b78a-7cde8be71fc5_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_01be578f-d9d3-4b76-8a50-4de0f0238825_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_JointVentureInKingdomOfSaudiArabiaMember_ad8449c6-4e19-45c3-9b41-2d2cb1578c18_terseLabel_en-US" xlink:label="lab_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Kingdom Of Saudi Arabia</link:label>
    <link:label id="lab_clx_JointVentureInKingdomOfSaudiArabiaMember_label_en-US" xlink:label="lab_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Kingdom Of Saudi Arabia [Member]</link:label>
    <link:label id="lab_clx_JointVentureInKingdomOfSaudiArabiaMember_documentation_en-US" xlink:label="lab_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Kingdom Of Saudi Arabia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:to="lab_clx_JointVentureInKingdomOfSaudiArabiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_d2112c28-a1f0-46a8-b7e2-3a34c16c1144_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_d53954d2-cfba-4aed-be78-7b16c61c08b8_negatedTerseLabel_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, tax benefit</link:label>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:href="clx-20210331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:to="lab_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_2413c8ef-8e43-432e-b752-747ae1a3d1f0_terseLabel_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_label_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_documentation_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:href="clx-20210331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:to="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_92dcc53b-0326-4660-ba09-e2c50ff49e6f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_56a2f6f6-295b-4175-b63f-38a7769daa44_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to Clorox stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_17b4bdbe-2d36-4736-ab4b-8fcd030d3a9e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7199e36a-dd5f-4ba8-a16c-2c39ed58a091_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_3272559c-64c7-4f72-bafb-2f591e92c803_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_8ea75439-8cd4-4954-85e5-15146ec548aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_9ab685d9-a45b-438f-8787-d4e9bb7c3c74_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_dbf9e540-1b32-4f73-89b9-1629ca8cc3e5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_GrillingMember_6fe5bcc5-d5f5-401d-9bd6-3f2ad1d71d42_terseLabel_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:label id="lab_clx_GrillingMember_label_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:label id="lab_clx_GrillingMember_documentation_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember" xlink:href="clx-20210331.xsd#clx_GrillingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_GrillingMember" xlink:to="lab_clx_GrillingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6de107c3-7c2d-4d79-866d-918d3cf28db6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_bbb83e77-af2a-4e41-8131-fac3182e7848_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_fee38f9b-9627-4c8a-b545-853b63d1a93a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_604cbe24-91e9-4931-ba10-f93fe4edb645_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c06ca47b-72c8-4902-a354-94eff4b3e8f1_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_9cebb30a-3aa7-4de5-aaf2-f93ac0b2a67d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_bfd7e475-5df0-4f6d-bfa3-49460a87854e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_697adfd1-e85d-4cd2-bde8-2c3647279c88_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_29d217ed-8c0b-409a-a907-ce0a8fdb5579_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_121f00d3-6b86-49fb-b9d7-18cf0dfc8c2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8ed0a8e2-43c0-426b-9160-7e20dfa115ae_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NumberOfRepurchasePrograms_f87578c1-c105-40a2-b753-5ac205ea88e3_terseLabel_en-US" xlink:label="lab_clx_NumberOfRepurchasePrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of repurchase programs</link:label>
    <link:label id="lab_clx_NumberOfRepurchasePrograms_label_en-US" xlink:label="lab_clx_NumberOfRepurchasePrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Repurchase Programs</link:label>
    <link:label id="lab_clx_NumberOfRepurchasePrograms_documentation_en-US" xlink:label="lab_clx_NumberOfRepurchasePrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Repurchase Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NumberOfRepurchasePrograms" xlink:href="clx-20210331.xsd#clx_NumberOfRepurchasePrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NumberOfRepurchasePrograms" xlink:to="lab_clx_NumberOfRepurchasePrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_080bbbc1-09cc-4233-b92b-8abd2a73a059_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_89afe528-1d4a-4207-85db-452dfddb306d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_4f4868d4-b1aa-4bbb-8930-e3c4214ff1e6_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_236cf1bd-1884-4a5e-ae23-c40c6b86e4eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_493b6f0e-8970-4e04-bb5e-b1e8863a9f62_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO allowances</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrademarksNet_d9a009ae-3451-4901-9d42-9dd0e2952d16_terseLabel_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_label_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_documentation_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet" xlink:href="clx-20210331.xsd#clx_TrademarksNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrademarksNet" xlink:to="lab_clx_TrademarksNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bed4bc18-ef21-4f74-afe5-f6fb9527bc55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_d4dd9ae0-e47f-4a91-adb0-d719487bf9bb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4c5a005d-49a4-4c34-b580-bbb9d47371b9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets in the fair value hierarchy</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_b4a1abc6-2cfc-439e-94de-d95981d0a4b5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_99182702-af3a-4265-b7e3-fe66b7bb6e5f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_b1e4fa26-26cf-4b04-9a18-151618cbbd27_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_2f1687d9-f4f0-4508-893e-6778163637cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89b92498-1ef1-431f-8e0b-a69ba8dffc5c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4f307cfe-c1e4-45c1-978f-5a7afe479d97_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c3c92cde-426c-4ce2-ad6e-2264c540d80c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2a4f2f00-0466-4a6b-bebb-4a9d217f3dca_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_27509302-a496-4f7c-b013-fa779adc0142_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_16e84209-5255-4cfd-87c3-235291219354_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ea11bec0-c03c-444f-98aa-34e44f62949a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of March&#160;31, 2021 and June 30, 2020, respectively; and 124,359,712 and 126,198,606 shares outstanding as of March&#160;31, 2021 and June 30, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_3be179ef-4bbc-4e08-878a-d551c5c2cae2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0d655648-278b-47bd-aa96-d10d7ad346ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_d730d38e-3799-4bc6-a12a-acb568016693_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RetirementIncomeMember_5305b1ef-5334-4134-bd72-b12a02c04fe8_terseLabel_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans [Member]</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_label_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans [Member]</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_documentation_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember" xlink:href="clx-20210331.xsd#clx_RetirementIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RetirementIncomeMember" xlink:to="lab_clx_RetirementIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_bd45d110-c849-49fc-9bc9-f29e7e15097e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_0cff4c7c-5ba2-4d51-9d0e-84908e03cd6a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_f6a80cb0-751f-45d2-a874-339eb8179c6e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_08b00cd0-da67-4479-a19e-196cabc911e1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e80523ee-fb95-4179-bba3-cbaacab14bb1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_72a3b2b6-b8c6-4280-bf1e-dd10d43ee8b1_verboseLabel_en-US" xlink:label="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_label_en-US" xlink:label="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</link:label>
    <link:label id="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_documentation_en-US" xlink:label="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Maturities of Long-term Debt and Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:href="clx-20210331.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:to="lab_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6ba0368b-9942-40e7-a37f-e26f4bbfdeb2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ede0c6c8-13eb-4866-b67e-5bca3efd6052_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d9a4e509-f40d-4798-a912-f82de16a14cd_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_aa196701-a599-43a4-b3b0-2d382fde4361_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_e0f75dfe-dc0e-4850-a480-1be2811994f9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarginDepositAssets_f2c705e3-c671-44cd-9760-5f6939f7eadb_terseLabel_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash margin balances amount</link:label>
    <link:label id="lab_us-gaap_MarginDepositAssets_label_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarginDepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarginDepositAssets" xlink:to="lab_us-gaap_MarginDepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ce5da284-df5f-4e3b-b9c8-cf17855bfd71_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, interest rate contracts</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a220c02f-d8c8-464d-bd2d-cb647fa7a4e2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_09e650c0-b79c-4e8e-ab3f-339a5aa04f00_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_38d6ab17-b92b-4fb6-8389-36aeeb13d8f5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_29dcfb63-8372-476e-a647-a5ed39801203_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_JetFuelSwapsMember_a12c38ec-1ff2-4596-beb8-c6810d203102_terseLabel_en-US" xlink:label="lab_clx_JetFuelSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jet Fuel Swaps</link:label>
    <link:label id="lab_clx_JetFuelSwapsMember_label_en-US" xlink:label="lab_clx_JetFuelSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jet Fuel Swaps [Member]</link:label>
    <link:label id="lab_clx_JetFuelSwapsMember_documentation_en-US" xlink:label="lab_clx_JetFuelSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jet Fuel Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JetFuelSwapsMember" xlink:href="clx-20210331.xsd#clx_JetFuelSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_JetFuelSwapsMember" xlink:to="lab_clx_JetFuelSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_acbb5771-ef38-408c-a94b-93e9d4e2bd7b_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_02d2c1cd-4e65-4c3d-a99f-8a64224c3f0d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_StockRepurchaseProgramAuthorizationLimit_79edbefe-d88c-4db5-8f29-f039d2be15ca_terseLabel_en-US" xlink:label="lab_clx_StockRepurchaseProgramAuthorizationLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization limit</link:label>
    <link:label id="lab_clx_StockRepurchaseProgramAuthorizationLimit_label_en-US" xlink:label="lab_clx_StockRepurchaseProgramAuthorizationLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorization Limit</link:label>
    <link:label id="lab_clx_StockRepurchaseProgramAuthorizationLimit_documentation_en-US" xlink:label="lab_clx_StockRepurchaseProgramAuthorizationLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorization Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_StockRepurchaseProgramAuthorizationLimit" xlink:href="clx-20210331.xsd#clx_StockRepurchaseProgramAuthorizationLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_StockRepurchaseProgramAuthorizationLimit" xlink:to="lab_clx_StockRepurchaseProgramAuthorizationLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c6ba9845-845e-4cc9-8f1b-a8a33be1bcd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_cbec9e97-0eed-4109-953b-f317b7e29d67_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_558f9230-79cc-4c18-8a4c-1e868f078dee_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_06852275-21c7-4f7c-a61c-c2078c63d3a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f6c72b4a-73ee-435c-af74-d16bf7808528_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_06a12eea-a7da-4ec2-97cf-ca558d495cfb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Clorox stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_570ec31f-b7d3-43e3-b175-6486854627ad_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3898e041-4d0d-46a1-be68-956e81b1c79b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_029f3b07-4a80-4236-a3af-d96063f2aa9c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_272d3e1c-69b1-458e-8da6-d0803ecf176e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_84cdd720-3af5-43e1-9ec0-11d33e3938b4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_9011ee67-d2dc-4384-b28a-9171a0bca3db_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_225268a8-53ae-4599-a4fc-8fd0656a17db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ae8aface-8848-49b6-90a1-7569c848a0ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9c678977-c35a-4dd8-84af-acd5cd0fed2f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_f19321bb-a234-4caa-8323-73c26c0086fc_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_de187104-c1fd-4499-a46b-66062266b57f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_765994e5-3a71-4c69-b010-30af3470b723_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_7bd5d873-f064-4641-aa13-b1ee482026d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_e5a8b47c-62b9-4111-a25f-729f463af0cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_69abefb2-d03f-4790-a8bd-a6f1bb5b3b0f_terseLabel_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_label_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_documentation_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:href="clx-20210331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:to="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5531ac8d-9337-4b6e-a474-9ed124235a8a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_08d8159e-1dea-4b3a-90ce-8c4e56626f87_terseLabel_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_label_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets for nonqualified deferred compensation plans [Member]</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_documentation_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets For Nonqualified Deferred Compensation Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:href="clx-20210331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:to="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_810650a3-962d-4537-bf67-c87e1972a198_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5128f384-6441-46da-bb81-706a08f209af_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c1ddfb20-4288-4f5b-a667-ee98a3335526_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_45b9d4a0-5784-4415-94f1-70648c14e0ca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_07e0c6b9-6408-4c16-8c58-6e6365ad4a2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e5887cad-3825-445d-953f-bc5ddc2c9f76_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7dad7a78-4184-4e94-9945-70d56bfd1b69_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation and amortization of $2,351 and $2,224, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_14c5bb67-21ce-41ef-98c6-0c4fba9f68ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b04cc1b0-e30b-473c-9240-a3b30fccccc7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_acac5fcb-f7bf-4c4a-8b67-c3f2614c1434_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_6d345280-a9b8-4cdc-946f-1fb12e11ca75_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9e8cb3b7-70b8-4117-abdd-e9205d4e485d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_51a0e3e3-c394-40df-9c7a-c468cc3f7a5d_terseLabel_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_label_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_documentation_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:href="clx-20210331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d88ff184-dae4-4a90-a463-3db7bf16d4d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_120c6b22-8f00-4f55-a245-dcb61276a38e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_InternationalMember_f30b50b4-c6fd-4d22-bef1-bf3c5bf08893_terseLabel_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_clx_InternationalMember_label_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_clx_InternationalMember_documentation_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember" xlink:href="clx-20210331.xsd#clx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InternationalMember" xlink:to="lab_clx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_86129a31-c96e-4505-81fb-2292bd0d7bc4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES, NET</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_c5fb8271-7ea1-40bf-91da-992ace63d8eb_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_7d63bfec-cfb4-4a6d-8481-8b5d5e55c544_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_dbcfa892-65aa-45ac-85c4-4e5c27844224_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_cac1d871-3365-4b09-9042-b47b42fbf2f2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_03c85bbd-8b64-4ff6-bb63-37d73725874c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_b75081ee-bc8b-4157-9c2c-1f1c079c4f36_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0ddc2b05-7709-4b9d-a742-2ecaa5bebb0a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Total comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3bcbe610-f82a-4cc0-8648-e906b0543f15_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) per share attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FoodProductsMember_5d0c5844-253b-4881-9715-22c9df111790_terseLabel_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:label id="lab_clx_FoodProductsMember_label_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:label id="lab_clx_FoodProductsMember_documentation_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember" xlink:href="clx-20210331.xsd#clx_FoodProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FoodProductsMember" xlink:to="lab_clx_FoodProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a251fccc-05e1-4f45-ae00-51e73b580d67_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_fb5d145e-c804-4352-aaca-3c4b3c156d18_terseLabel_en-US" xlink:label="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital, net (includes cash acquired of $26)</link:label>
    <link:label id="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_label_en-US" xlink:label="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Working Capital, Net</link:label>
    <link:label id="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_documentation_en-US" xlink:label="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Working Capital, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:href="clx-20210331.xsd#clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:to="lab_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_665fbd64-9c01-4460-a41c-c0d95b4e1968_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Fair value of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f9ddd274-06a8-4e78-b71d-cdb65bf54870_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2b3f96c4-c9cd-4079-8c0c-a28f979fed27_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d8e67f96-7014-4442-ac17-f4bcfa2d0c9b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_dc0c3aba-6453-46a2-8163-7abaf919f2e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3b795b92-ae5a-4e04-8516-cdc95429dcb2_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_b0fb18fc-27c4-4956-bc33-bc9688981986_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_207de8d1-3741-4f5c-b9bc-aed28f78be71_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c6e5f0e8-80c3-4914-9fa7-a177a6d765c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_749be8b8-0567-4419-932d-b6c8e412fd92_terseLabel_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_label_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_documentation_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for financial instruments and fair value measurements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:href="clx-20210331.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:to="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_185c848b-2860-4f10-806c-ca0293f5f17d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b28d743c-4893-4476-9465-38a57c857d9d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_7eece709-83ec-4d63-9daf-d4b2997422b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_91f76cac-7b42-441e-ac27-02557317c51f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_aef27044-0c38-4ace-9fea-e5ed4292b2dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_1ba583f0-704b-4c7f-b80c-326fae1e5a87_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_0d0fbbaa-b87f-4961-b5a4-a05499fbafb0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_2d009b02-a10c-4e33-a7b4-18c7a16c3cba_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, including money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e0708c88-d726-4791-9190-7b2ee24465c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d735e763-287f-4602-91c3-608a4ca75de4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_130c03da-11a4-44c1-9e25-caf9e2401527_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUIRED</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_b71d205b-38e0-4349-98aa-c09ac8c9bad9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_df39c87b-f822-4cf7-8742-0f137f7de28f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f86718a-0fda-49ea-8cea-ad90589443e5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_611eaa4d-0e3d-47e0-b2d1-fef3c9619f51_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Amount</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_42cccf00-09be-4de2-9c79-2443dc52ad54_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherExpenseIncomeNet_4bfbccda-83d9-4a72-b5b1-be90af1e6775_terseLabel_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_label_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_documentation_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet" xlink:href="clx-20210331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherExpenseIncomeNet" xlink:to="lab_clx_OtherExpenseIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_347a8a38-87c4-48f7-b018-1f8d692b1bc0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_27bf8344-28da-45da-8d74-1e9ddcb42bad_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WaterFiltrationMember_2251491d-e8c5-43d9-b79f-4611fb52712b_terseLabel_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_label_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_documentation_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember" xlink:href="clx-20210331.xsd#clx_WaterFiltrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WaterFiltrationMember" xlink:to="lab_clx_WaterFiltrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_720ee029-6cfc-40f4-a5b4-1702f3d10402_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_70c4bc15-958b-468d-8d94-f4f73fa3493c_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6bf6d534-7c11-4c9e-b51b-de74f2f8fd93_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5fee606d-9ffa-487f-b867-3536a2550fe2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average long-term expected rate or return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d6e909eb-6354-4f27-9389-26f5793778e2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NaturalPersonalCareMember_6ca9cfca-225b-49ad-9577-53d3faffdf25_terseLabel_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_label_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_documentation_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember" xlink:href="clx-20210331.xsd#clx_NaturalPersonalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NaturalPersonalCareMember" xlink:to="lab_clx_NaturalPersonalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_c3e977ad-7867-4b1e-9a6b-a7356f3de84c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b4ccb167-e780-466c-9624-eeffb48b1ed9_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f1794bf-2d99-40c0-a538-5caee0cf3de1_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10911422-2368-4184-824d-0a59ee09c5c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ShareRepurchaseProgramsTable_ff401a86-4b02-4ece-8f32-857ec4ea5328_terseLabel_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Programs [Table]</link:label>
    <link:label id="lab_clx_ShareRepurchaseProgramsTable_label_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Programs [Table]</link:label>
    <link:label id="lab_clx_ShareRepurchaseProgramsTable_documentation_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about share repurchase programs and shares repurchased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsTable" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ShareRepurchaseProgramsTable" xlink:to="lab_clx_ShareRepurchaseProgramsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b9bb394e-c130-4bba-a7a1-226b585fb1e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, year one</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_25563729-4f94-4aed-a716-b68518ad9119_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d980646d-4a32-4db6-b510-e38e918b4802_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e20c3056-56f8-4e03-9235-2db2fa69b0cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab9b4be6-66f7-4c07-8122-c94123c22296_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ddfa1434-6b0c-4bf5-8bd6-4a549c38b73e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c21deb5b-f10c-463f-847c-29a97b5d20c5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_800d692e-5a00-40ef-bb5c-ae258cc5de52_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ShareRepurchaseProgramsLineItems_fc0ade05-9dcd-42d5-bd77-c268e0c3592a_terseLabel_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Programs [Line Items]</link:label>
    <link:label id="lab_clx_ShareRepurchaseProgramsLineItems_label_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Programs [Line Items]</link:label>
    <link:label id="lab_clx_ShareRepurchaseProgramsLineItems_documentation_en-US" xlink:label="lab_clx_ShareRepurchaseProgramsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsLineItems" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems" xlink:to="lab_clx_ShareRepurchaseProgramsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2b71ca61-90c3-444a-9390-b5eb1114bd25_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b036f95f-2d02-45cc-8e86-debc9cac92ea_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_98eb2280-f05f-401a-a946-1b3c9a1ebffe_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c693ba50-0e0b-4d1e-8e5e-a3923d14bcae_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_2096f501-d531-44d1-9a9d-a9dcd99262ff_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_580a597e-3c19-43c5-b3e3-03f19f2b82fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_c4a2c062-5503-4b01-ab6f-e3292a303986_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_e1010b08-6240-47c4-96e9-bc22761cc58d_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for aggregate future remediation costs</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_707e0d8b-6f3c-4b70-8132-4cdd5f3e4789_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HealthAndWellnessMember_34ece40f-4cbb-4cdd-843d-c358971c6597_terseLabel_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_label_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness [Member]</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_documentation_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HealthAndWellnessMember" xlink:to="lab_clx_HealthAndWellnessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_40dc0c2b-77cd-4282-9677-d21a8271f854_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2cfb1b03-73a6-49ef-88ad-94c96add02e2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2d5e6610-38fc-419f-b15d-8a6be8b3965b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not subject to amortization</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7b19377b-3237-4faa-a8a6-137cc458bfed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_02cec11e-5ea7-4fdf-9842-777b7847a354_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2ba5e8cb-2c48-463d-84f7-d6661cceeb2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to amortization, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_833a2cbf-edd7-481f-a19e-5dd04ab26a56_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_8e514bef-cf2c-4994-bed4-803cca352c4a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_63edcba7-fbe6-4500-b530-813afb106427_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b2d6b285-ac34-4545-874c-597e33d9d693_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_3a978c06-39af-4bed-9ced-c507491e6756_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_9f752bd1-c709-4355-9e9b-64b8259eca0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_37315e7c-62d6-46d8-9b66-77256b0a3439_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate on earnings from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7dfba4e1-7753-40e7-8ebc-8e116d45988e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_450d47ae-092d-4c45-ac7e-1c637dc65518_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_eb6c61a6-0ea5-483d-8cef-d4abf12cccf9_terseLabel_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock plans and other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_label_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Of Common Stock For Employee Stock Plans And Other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_documentation_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:href="clx-20210331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:to="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_4289d49c-6bf2-4b8b-95c9-402b96a5d49f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CatLitterMember_5536a203-1311-46db-b62d-7546da770071_terseLabel_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:label id="lab_clx_CatLitterMember_label_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:label id="lab_clx_CatLitterMember_documentation_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember" xlink:href="clx-20210331.xsd#clx_CatLitterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CatLitterMember" xlink:to="lab_clx_CatLitterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ca84595d-a61b-40ca-afeb-88a3892d00ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7bc44244-9af5-4b0a-bfdf-a04f707f41ac_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_779abb4c-e985-44a0-843e-bbd9267c0f59_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_e9de5258-3859-4c72-a95b-92a0a881c264_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="lab_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WalmartStoresIncMember_9ac9e26d-77ff-48bf-a2f3-76d1c26859c6_terseLabel_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_label_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_documentation_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. and its affiliates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember" xlink:href="clx-20210331.xsd#clx_WalmartStoresIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WalmartStoresIncMember" xlink:to="lab_clx_WalmartStoresIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_9437a51d-d40f-475c-9236-7ffecfb27a10_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 6,381,749 and 32,542,855 shares as of March&#160;31, 2021 and June 30, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_85830648-c53f-4d15-80db-c03138837cf3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS (LOSSES) PER SHARE (EPS)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b981b4f2-2e86-4dd8-a209-2b0b0f93b2e3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_05c1c7f0-2e9f-43ee-bc16-5d7d09aa26cf_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bb2ff02c-eb5f-4922-a143-5b60cd7fc2bb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c697748-17eb-4a86-8e9d-fb389b60a490_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Results</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1e7fa64-f68c-4af5-ac93-5fe75527f634_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b2adc7c9-51e7-4ba0-ab33-9b7e910aca20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_f2e5686c-126b-4ed9-8b5d-176d6a49f97a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>clx-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:e6b5715e-ae0c-4f67-90b5-cbcbc768a8ae,g:aa36bfae-86cb-4316-9701-3c45515a13a6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CoverPage" xlink:type="simple" xlink:href="clx-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c1b09bef-b1ab-4ade-bc5d-8d5d503a3637" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentType_c1b09bef-b1ab-4ade-bc5d-8d5d503a3637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ddeb1bb1-3872-40e9-9595-0e5f7f87a0af" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentQuarterlyReport_ddeb1bb1-3872-40e9-9595-0e5f7f87a0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5965b176-b765-46bb-8dd6-8e43957f87e0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentPeriodEndDate_5965b176-b765-46bb-8dd6-8e43957f87e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_388fa675-316d-4ca3-b605-5ac61f959e47" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentTransitionReport_388fa675-316d-4ca3-b605-5ac61f959e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c0bf3e42-2ff2-400b-8749-fcb999093d93" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityFileNumber_c0bf3e42-2ff2-400b-8749-fcb999093d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ccb16926-cb7f-4b89-8eed-f7fe7e5a38a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityRegistrantName_ccb16926-cb7f-4b89-8eed-f7fe7e5a38a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a931a52e-8cbe-40f5-9f94-a21d1d44fe37" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a931a52e-8cbe-40f5-9f94-a21d1d44fe37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ad386606-38e6-4957-8283-382cb0dbd14f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityTaxIdentificationNumber_ad386606-38e6-4957-8283-382cb0dbd14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ba2f4b7b-6ab9-4f3f-a8ea-6614e90f99e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityAddressAddressLine1_ba2f4b7b-6ab9-4f3f-a8ea-6614e90f99e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4ee3e81e-4a0f-479f-906a-0c4c6dbe7ddc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityAddressCityOrTown_4ee3e81e-4a0f-479f-906a-0c4c6dbe7ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_58e3ab31-200e-4d8c-bb3b-2b57b312ccc0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityAddressStateOrProvince_58e3ab31-200e-4d8c-bb3b-2b57b312ccc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0241e9c2-90fe-449b-9cd1-2f6e93c909eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityAddressPostalZipCode_0241e9c2-90fe-449b-9cd1-2f6e93c909eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9dce2d15-c972-42e3-8faa-ca14107d8180" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_CityAreaCode_9dce2d15-c972-42e3-8faa-ca14107d8180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8cfe06c6-1e53-42eb-8dfb-f7a5b4ae04aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_LocalPhoneNumber_8cfe06c6-1e53-42eb-8dfb-f7a5b4ae04aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_10b8b4b7-d6d1-4a9a-82b3-732c08f04ebc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_Security12bTitle_10b8b4b7-d6d1-4a9a-82b3-732c08f04ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b119621a-ce17-45ce-a01a-f7d8dad1e13c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_TradingSymbol_b119621a-ce17-45ce-a01a-f7d8dad1e13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_090e0bbe-6a35-4724-885c-815423ef3ec1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_SecurityExchangeName_090e0bbe-6a35-4724-885c-815423ef3ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ed9b146b-7e8d-452c-bb79-4fc5e30341c7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityCurrentReportingStatus_ed9b146b-7e8d-452c-bb79-4fc5e30341c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_716ebc8d-f153-469e-864a-c9b43c56318d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityInteractiveDataCurrent_716ebc8d-f153-469e-864a-c9b43c56318d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5e268d73-938f-4f69-a740-0c61fd40ad4b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityFilerCategory_5e268d73-938f-4f69-a740-0c61fd40ad4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5cb8a91e-18bc-4844-a44a-187dcc1acc3f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntitySmallBusiness_5cb8a91e-18bc-4844-a44a-187dcc1acc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_30b34f99-2437-4fe3-bc89-1d88dda7a71e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityEmergingGrowthCompany_30b34f99-2437-4fe3-bc89-1d88dda7a71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_657539f1-e070-4847-ae53-944bfc83adfd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityShellCompany_657539f1-e070-4847-ae53-944bfc83adfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_06f5da7d-ab3c-4216-a614-90d6c9f25e8a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_06f5da7d-ab3c-4216-a614-90d6c9f25e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2bc20621-b227-4a13-b983-df78fec6d9a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_EntityCentralIndexKey_2bc20621-b227-4a13-b983-df78fec6d9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1f53fa44-9c48-488a-9169-21c66af42cde" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_AmendmentFlag_1f53fa44-9c48-488a-9169-21c66af42cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_78fe13e1-0b5d-4523-a284-883c5fda4114" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_CurrentFiscalYearEndDate_78fe13e1-0b5d-4523-a284-883c5fda4114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cbb9072e-77fe-462a-89b1-8613121f3f4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cbb9072e-77fe-462a-89b1-8613121f3f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_81113d15-b118-4e3b-b83d-53e8a119315c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d64b8323-c92e-4ca5-9eb1-5524fe785d26" xlink:to="loc_dei_DocumentFiscalYearFocus_81113d15-b118-4e3b-b83d-53e8a119315c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e1ea9bf-1970-4e39-84c0-270c11bfedd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e1ea9bf-1970-4e39-84c0-270c11bfedd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_35bf2187-f5f3-464b-81ca-5aa61e421873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_35bf2187-f5f3-464b-81ca-5aa61e421873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_454e106c-6038-4c86-8ba4-549640f515a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_GrossProfit_454e106c-6038-4c86-8ba4-549640f515a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b0baf385-e9cf-42f3-b10c-6e61532ec65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b0baf385-e9cf-42f3-b10c-6e61532ec65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_32880047-bce2-4794-8f7f-b17442011b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_AdvertisingExpense_32880047-bce2-4794-8f7f-b17442011b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6e1f181a-8c05-4f4d-bf01-dd7585a1e32f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6e1f181a-8c05-4f4d-bf01-dd7585a1e32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_79119e98-d373-485f-a34a-60842079d98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_AssetImpairmentCharges_79119e98-d373-485f-a34a-60842079d98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b03d85cf-7efc-45bd-8d34-6a1aab29eb83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_InterestExpense_b03d85cf-7efc-45bd-8d34-6a1aab29eb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_3eac6cf1-ce88-4de1-945f-c5db7d437c32" xlink:href="clx-20210331.xsd#clx_OtherExpenseIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_clx_OtherExpenseIncomeNet_3eac6cf1-ce88-4de1-945f-c5db7d437c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b8b1b3f-57e8-44b6-afbf-fe93ae9d81dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b8b1b3f-57e8-44b6-afbf-fe93ae9d81dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b02590a7-ae7b-49c6-99d4-1ca2a879ee06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b02590a7-ae7b-49c6-99d4-1ca2a879ee06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f4542ba5-b0f9-45a2-ac15-30bf2a3b46e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_ProfitLoss_f4542ba5-b0f9-45a2-ac15-30bf2a3b46e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c38aa952-cc42-4f6d-82da-0b32d86ee304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c38aa952-cc42-4f6d-82da-0b32d86ee304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_db17e9e5-b000-4de1-b839-b8f2808dc368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_NetIncomeLoss_db17e9e5-b000-4de1-b839-b8f2808dc368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_34c1d60d-d7b2-4f23-a342-f58d24c7ecbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_34c1d60d-d7b2-4f23-a342-f58d24c7ecbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d077598e-998b-4109-9ac5-a85532ecde5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c1d60d-d7b2-4f23-a342-f58d24c7ecbb" xlink:to="loc_us-gaap_EarningsPerShareBasic_d077598e-998b-4109-9ac5-a85532ecde5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ae8605a3-6659-4a12-bbce-727742dd6520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c1d60d-d7b2-4f23-a342-f58d24c7ecbb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ae8605a3-6659-4a12-bbce-727742dd6520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_85cef5a2-6ad1-45b3-bc89-f49ccc3d52f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_85cef5a2-6ad1-45b3-bc89-f49ccc3d52f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5e045e70-b9b8-4d56-90ec-cad084c4d24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_85cef5a2-6ad1-45b3-bc89-f49ccc3d52f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5e045e70-b9b8-4d56-90ec-cad084c4d24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d813e5d8-935e-4886-9e71-dea1deb5afa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_85cef5a2-6ad1-45b3-bc89-f49ccc3d52f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d813e5d8-935e-4886-9e71-dea1deb5afa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_beb6905e-cb31-4841-afb9-0db2be76aec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_beb6905e-cb31-4841-afb9-0db2be76aec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb66a4bf-954f-46ca-aaf8-1ab6159d9edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb66a4bf-954f-46ca-aaf8-1ab6159d9edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bad7e620-a06f-48d2-800f-77207b0e58b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9cb827d8-7136-418e-8818-20d61904957e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_bad7e620-a06f-48d2-800f-77207b0e58b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_da397691-378b-44ab-a1e4-4784fbfe8dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_da397691-378b-44ab-a1e4-4784fbfe8dd7" xlink:to="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75061849-fccb-4f73-a5e7-a2c5c104020c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75061849-fccb-4f73-a5e7-a2c5c104020c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_21ad9e0a-bb45-4600-b533-28e73d21ba37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_21ad9e0a-bb45-4600-b533-28e73d21ba37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f39e6a96-661b-4bf3-b010-ae1d57920293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:to="loc_us-gaap_InventoryNet_f39e6a96-661b-4bf3-b010-ae1d57920293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_73f32e50-32fa-4993-be4f-d854c5fdf564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_73f32e50-32fa-4993-be4f-d854c5fdf564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b0cce35-7378-4d7a-8177-63ab8368d3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a7ddeab9-9b4c-4f0f-8f14-a654ef1415c6" xlink:to="loc_us-gaap_AssetsCurrent_3b0cce35-7378-4d7a-8177-63ab8368d3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_25e99aa4-a115-4409-9412-dc9df4ad02d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_25e99aa4-a115-4409-9412-dc9df4ad02d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c8e5dab8-602a-4100-bbdd-a1a7098cd4fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c8e5dab8-602a-4100-bbdd-a1a7098cd4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26e00f69-02f1-45c4-a03e-87fa0479f6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_Goodwill_26e00f69-02f1-45c4-a03e-87fa0479f6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_b5569afb-6936-4192-9d23-b0bd0dbb0413" xlink:href="clx-20210331.xsd#clx_TrademarksNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_clx_TrademarksNet_b5569afb-6936-4192-9d23-b0bd0dbb0413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_2da0ef73-5e46-4e2d-b372-2b6a52a154d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_2da0ef73-5e46-4e2d-b372-2b6a52a154d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_048a88d8-1cd0-4b2a-8002-0b62c3cd4530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_048a88d8-1cd0-4b2a-8002-0b62c3cd4530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0936b5a2-27f6-41c4-b94b-5d7e28254216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea39e6a6-eeeb-4d30-b940-222bda93bcc7" xlink:to="loc_us-gaap_Assets_0936b5a2-27f6-41c4-b94b-5d7e28254216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_da397691-378b-44ab-a1e4-4784fbfe8dd7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d0de1aab-2f64-49b8-8729-74d63f1385e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:to="loc_us-gaap_LongTermDebtCurrent_d0de1aab-2f64-49b8-8729-74d63f1385e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e309dcbf-e997-466b-a6bd-dcc596bad7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e309dcbf-e997-466b-a6bd-dcc596bad7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_79cfe0f0-3f68-46b5-bfb5-3704f49cfb60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_79cfe0f0-3f68-46b5-bfb5-3704f49cfb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_aa5d3c7b-4639-4a5a-87f3-c1b86c98d8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_aa5d3c7b-4639-4a5a-87f3-c1b86c98d8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b1feb18b-9a0d-4fb6-9820-1180729bd91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_81baf8a5-131b-495c-ad7a-000487da6691" xlink:to="loc_us-gaap_LiabilitiesCurrent_b1feb18b-9a0d-4fb6-9820-1180729bd91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cf582f17-972b-47d2-a022-42357af158a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cf582f17-972b-47d2-a022-42357af158a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_965bf8b3-0861-4d15-843a-6a0002b0fcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_965bf8b3-0861-4d15-843a-6a0002b0fcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_edc523f3-a5ff-4d8c-9a5c-0fca1929aad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_edc523f3-a5ff-4d8c-9a5c-0fca1929aad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dcc9c088-ee0b-4646-84c6-89b43a6d06a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dcc9c088-ee0b-4646-84c6-89b43a6d06a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_18ca798b-21b5-4f76-9265-574d089780a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_Liabilities_18ca798b-21b5-4f76-9265-574d089780a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_76fd6f12-d90b-4ac3-884c-52772f1d16f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_76fd6f12-d90b-4ac3-884c-52772f1d16f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d4b65710-12ca-4c9b-a543-e57057182c10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_PreferredStockValue_d4b65710-12ca-4c9b-a543-e57057182c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_57a37df3-c3a0-4cce-bd00-9625558dd0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_CommonStockValue_57a37df3-c3a0-4cce-bd00-9625558dd0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0ee77b0f-ac43-44dd-8b79-394159499a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0ee77b0f-ac43-44dd-8b79-394159499a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c7e6458-2e9a-45ce-b9f7-406e77591223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c7e6458-2e9a-45ce-b9f7-406e77591223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d61db356-4b15-4baf-b890-7a6722db3bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_TreasuryStockValue_d61db356-4b15-4baf-b890-7a6722db3bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c2190c5c-648b-48f0-9299-345060e94759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c2190c5c-648b-48f0-9299-345060e94759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_33d7b405-fa14-471d-b19a-fc3b0591341b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_StockholdersEquity_33d7b405-fa14-471d-b19a-fc3b0591341b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c36581fa-734e-4c60-8b32-7c97dce53912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_MinorityInterest_c36581fa-734e-4c60-8b32-7c97dce53912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99829319-be75-446c-9aad-5c73659f3fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a6f843c8-f34b-4c1d-863b-1b5476bf9781" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99829319-be75-446c-9aad-5c73659f3fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fa369082-170b-48e9-9d01-d7c2543d17ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad4a5ac8-c5cc-43ce-aff1-1b4a62eb5b6e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fa369082-170b-48e9-9d01-d7c2543d17ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4c9e6045-4570-4481-b39b-d4f4e8725b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4c9e6045-4570-4481-b39b-d4f4e8725b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0e01943b-87cb-425b-9b6c-3d8de0422c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0e01943b-87cb-425b-9b6c-3d8de0422c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_46802c4d-8aba-43fd-a7c9-5fa10aeec17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_46802c4d-8aba-43fd-a7c9-5fa10aeec17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4e49ffbd-5e7a-41c4-b532-9d8a422f548c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4e49ffbd-5e7a-41c4-b532-9d8a422f548c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_aa2ff261-06bc-4a81-a75f-c678fea3d816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_aa2ff261-06bc-4a81-a75f-c678fea3d816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0db412e5-54f8-4d66-ac2b-58113e7ae482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0db412e5-54f8-4d66-ac2b-58113e7ae482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f5e06e86-030f-4987-92be-527835583e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f5e06e86-030f-4987-92be-527835583e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9a62b7f0-f8ae-44c9-beaa-8e977ea0ef1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_CommonStockSharesIssued_9a62b7f0-f8ae-44c9-beaa-8e977ea0ef1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0ad2924f-d18c-42b7-b4ea-cf2b0fa71556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0ad2924f-d18c-42b7-b4ea-cf2b0fa71556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c6f375ef-05dc-4197-b054-4f74f17fc6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ea55ac57-17fc-488b-98a9-c9bdbb071e3c" xlink:to="loc_us-gaap_TreasuryStockShares_c6f375ef-05dc-4197-b054-4f74f17fc6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3836a6ce-d636-4fcd-ac62-95700159ae6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3836a6ce-d636-4fcd-ac62-95700159ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_87415488-537d-4081-8dd7-943237188a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3836a6ce-d636-4fcd-ac62-95700159ae6f" xlink:to="loc_us-gaap_ProfitLoss_87415488-537d-4081-8dd7-943237188a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3836a6ce-d636-4fcd-ac62-95700159ae6f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f92d2579-812c-4f5e-83b4-ddd91f7555d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f92d2579-812c-4f5e-83b4-ddd91f7555d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_27813cdc-6204-410f-9509-330f3908a004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_ShareBasedCompensation_27813cdc-6204-410f-9509-330f3908a004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3a6ad013-cc57-4821-af29-67a6e30690e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3a6ad013-cc57-4821-af29-67a6e30690e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_fdd25bc5-97a5-4185-90e1-8bf7ebdcacc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_AssetImpairmentCharges_fdd25bc5-97a5-4185-90e1-8bf7ebdcacc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_6558c4bd-7aee-4173-9328-47ab6acb7a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_6558c4bd-7aee-4173-9328-47ab6acb7a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b421af-ce04-45de-a570-ff63b2776dce" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_168b20e3-f940-4823-bc46-2d8e8132c110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_168b20e3-f940-4823-bc46-2d8e8132c110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4c94729b-a048-40c8-a55e-e7847753048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4c94729b-a048-40c8-a55e-e7847753048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_52657882-d2dc-46e9-8f96-65e229f7fd1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_52657882-d2dc-46e9-8f96-65e229f7fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cf3e9632-b14f-4252-993d-be16d6765538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cf3e9632-b14f-4252-993d-be16d6765538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_16c16f73-bf52-4004-8d33-e96be3016138" xlink:href="clx-20210331.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_16c16f73-bf52-4004-8d33-e96be3016138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_cc2a3496-335f-43d2-ae86-67ffe2cab6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3fc276b3-570d-43bb-bceb-df96d92773f1" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_cc2a3496-335f-43d2-ae86-67ffe2cab6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44e76783-355c-4bf6-96df-955b6515fa63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3836a6ce-d636-4fcd-ac62-95700159ae6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44e76783-355c-4bf6-96df-955b6515fa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9aedbe19-218e-4ed2-984d-1bd423886b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9aedbe19-218e-4ed2-984d-1bd423886b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ea88e37-9ba1-4082-a92d-760db71034d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ea88e37-9ba1-4082-a92d-760db71034d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5d27b8f6-597a-4bbe-9aed-9e4e469bac38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5d27b8f6-597a-4bbe-9aed-9e4e469bac38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d091ff3-913e-4b2e-a8f8-576e8e05972a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2666aa28-f417-4665-ae6c-b99609b0a91d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d091ff3-913e-4b2e-a8f8-576e8e05972a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ac765b38-7d2d-463f-94f3-beabdc080fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ac765b38-7d2d-463f-94f3-beabdc080fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f71dcf2-c174-4bb7-a8de-02adb5c6318f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f71dcf2-c174-4bb7-a8de-02adb5c6318f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8a47424d-e3a0-4745-8954-dad75c276758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8a47424d-e3a0-4745-8954-dad75c276758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0aa2ed0c-ed21-4174-9944-9c035da863d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0aa2ed0c-ed21-4174-9944-9c035da863d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_2a5322ca-707d-4810-ac36-9e81f0608e33" xlink:href="clx-20210331.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_2a5322ca-707d-4810-ac36-9e81f0608e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5649252-1b8a-432e-9bfd-3207e5ddc36a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_acf4365d-e274-4950-9bdd-5bae8e2c78e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5649252-1b8a-432e-9bfd-3207e5ddc36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c3f9fb7-42fb-482f-bb03-4659c3cbea20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c3f9fb7-42fb-482f-bb03-4659c3cbea20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d020a59-ce9e-4151-9f24-a4e5dfb62f19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d020a59-ce9e-4151-9f24-a4e5dfb62f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_9ab6eaf0-2241-449e-9d1a-168339b975e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c96d305-3967-41ce-aba9-b6b8fd50197f" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_9ab6eaf0-2241-449e-9d1a-168339b975e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0625fc86-23eb-4ee6-9fdd-1c8f723bad73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_9ab6eaf0-2241-449e-9d1a-168339b975e9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0625fc86-23eb-4ee6-9fdd-1c8f723bad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ee2cb77-64a2-479a-9dec-c8c392870af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_9ab6eaf0-2241-449e-9d1a-168339b975e9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ee2cb77-64a2-479a-9dec-c8c392870af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_548498f7-a287-4cae-b636-4761d9e52b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_07bd1054-f238-4334-ac6a-0a706821b28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_548498f7-a287-4cae-b636-4761d9e52b5a" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_07bd1054-f238-4334-ac6a-0a706821b28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="clx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3291104a-bd9d-4660-8668-b7588df7ee14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3bb8058c-9cbb-42dd-a580-0f02ce73d48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3291104a-bd9d-4660-8668-b7588df7ee14" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3bb8058c-9cbb-42dd-a580-0f02ce73d48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e64d097-5bc8-41d7-a962-5710dbe8f95c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3291104a-bd9d-4660-8668-b7588df7ee14" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e64d097-5bc8-41d7-a962-5710dbe8f95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2e38d120-f049-4434-a9d1-13d995a0fc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3291104a-bd9d-4660-8668-b7588df7ee14" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2e38d120-f049-4434-a9d1-13d995a0fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a32be8b2-9edf-4de8-8fcb-79dd1f5e4520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3291104a-bd9d-4660-8668-b7588df7ee14" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a32be8b2-9edf-4de8-8fcb-79dd1f5e4520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIRED"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIRED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_cb548651-4dbd-4d90-b4aa-4d1297e73c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_dafd6445-b3bc-4dc2-b4b3-f0cc7510687e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cb548651-4dbd-4d90-b4aa-4d1297e73c3b" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_dafd6445-b3bc-4dc2-b4b3-f0cc7510687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_31f941b1-d5c8-40ae-90ad-059700f5d8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9511d76e-cfa1-42b8-a04f-2ecda75e06a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_31f941b1-d5c8-40ae-90ad-059700f5d8d2" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9511d76e-cfa1-42b8-a04f-2ecda75e06a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b88ddd8a-c62a-4267-9a93-c10ec66a4c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b88ddd8a-c62a-4267-9a93-c10ec66a4c85" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b111096-5cac-41e9-86d4-e4f41031c657" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_c8e50908-02f1-4976-b670-680170a7d439" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50e0937d-122f-403c-8d27-f313f5e30786" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_c8e50908-02f1-4976-b670-680170a7d439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_e423cac5-8c9e-4a72-883d-d4d89807d401" xlink:to="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_8b01c340-ebfd-464e-a963-a3c033e47eae" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_5c61623c-2637-4fed-a82b-3f50a9fd2e47" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_8b01c340-ebfd-464e-a963-a3c033e47eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee09d37c-bd00-4ff7-a7d1-2af35b278276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_56a983ec-3487-45fb-98fd-ae3aa4c75a24" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c17f0dd9-2d4e-4899-aa80-156f070a8159" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_56a983ec-3487-45fb-98fd-ae3aa4c75a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9e8d895f-bf5d-4e0b-983b-fb306ee65f6a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_8efb64cf-265c-49bf-ae2a-ee5eeeb596f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_8efb64cf-265c-49bf-ae2a-ee5eeeb596f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3b878c29-e5ab-4128-b674-490188263d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_EquityMethodInvestments_3b878c29-e5ab-4128-b674-490188263d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_2521d34c-064a-44a4-a743-7219a4235bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_2521d34c-064a-44a4-a743-7219a4235bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_751fc6cd-b7bc-4191-b83a-c07cc006a728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_751fc6cd-b7bc-4191-b83a-c07cc006a728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_83619e65-6473-4d68-bd77-7684cfc2ba1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_83619e65-6473-4d68-bd77-7684cfc2ba1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_b0eb4e1f-ccc4-404c-8a30-473ccd0916b1" xlink:href="clx-20210331.xsd#clx_BusinessCombinationSettlementOfPreExistingNetLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities_b0eb4e1f-ccc4-404c-8a30-473ccd0916b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_59300ebb-ed4e-464b-b109-54c2ae0fd03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_Goodwill_59300ebb-ed4e-464b-b109-54c2ae0fd03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7ff7d0e9-d212-482a-a6b8-ae04b878a16b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7ff7d0e9-d212-482a-a6b8-ae04b878a16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_5af9c0fb-4bd8-4c36-85e1-9fa7dc96d2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_5af9c0fb-4bd8-4c36-85e1-9fa7dc96d2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d07163be-1ed1-421f-953e-7946af46f89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d07163be-1ed1-421f-953e-7946af46f89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_ca6e734b-d11e-4395-ba50-24c0ccf22a98" xlink:href="clx-20210331.xsd#clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_60d794f4-6694-41e6-8809-4e9b38f16154" xlink:to="loc_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod_ca6e734b-d11e-4395-ba50-24c0ccf22a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_716df4fb-89d3-47ca-b733-9bbfce310cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_716df4fb-89d3-47ca-b733-9bbfce310cee" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d094eb41-1b92-4a76-9a16-1362034b3601" xlink:to="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_e8d4c1ac-97a5-42bf-bdfe-79bba3408106" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_51280f75-6883-43d4-8235-e38b06ea3877" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_e8d4c1ac-97a5-42bf-bdfe-79bba3408106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eebe27e5-dfb8-4d71-a54d-11998f36cc4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_9b14e604-64ae-47c5-9a0a-d824c6d182d7" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c09be000-2979-4bea-a529-070691d4a2c4" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_9b14e604-64ae-47c5-9a0a-d824c6d182d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a2cd5dc-3f44-44db-a95d-aef24b690180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_7f271712-c308-4ae1-9fb9-6ec157de29d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:to="loc_us-gaap_ContractualRightsMember_7f271712-c308-4ae1-9fb9-6ec157de29d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_635a9d80-9d84-45d5-80f3-fa484e3ca1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b26e959-ac63-4d5d-a7f5-6c61bb457cae" xlink:to="loc_us-gaap_CustomerRelationshipsMember_635a9d80-9d84-45d5-80f3-fa484e3ca1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0d9bd78-9154-4788-8543-306b197d560e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_f66994f1-6f3e-429d-a809-41ec957b4ce6" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ebbae3-4e1d-444d-84e2-de4b355b4e3b" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_f66994f1-6f3e-429d-a809-41ec957b4ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_18f63083-c064-4477-bbcf-b758d777be3d" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d03ba525-3d19-4ef7-9edc-b857924204ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_Goodwill_d03ba525-3d19-4ef7-9edc-b857924204ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_facbdf68-a5c6-4ca0-bcea-deeae9ae84e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_facbdf68-a5c6-4ca0-bcea-deeae9ae84e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b6ae3e17-a73f-47e8-9646-68262c7beab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b6ae3e17-a73f-47e8-9646-68262c7beab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c4ff2e4-c3a0-44ea-9603-28d7907658da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c4ff2e4-c3a0-44ea-9603-28d7907658da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_21737ae5-2158-4195-805f-733b3ed87898" xlink:href="clx-20210331.xsd#clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_21737ae5-2158-4195-805f-733b3ed87898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_32df7422-20e5-421e-9346-610fec16abaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_32df7422-20e5-421e-9346-610fec16abaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a34c595-1056-4afb-8bbd-a34ed2a38f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a34c595-1056-4afb-8bbd-a34ed2a38f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8a6e28a0-983d-44f4-a167-412ddeb2cc94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8a6e28a0-983d-44f4-a167-412ddeb2cc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8f498404-2a25-4f73-bbff-f11c8908c973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8f498404-2a25-4f73-bbff-f11c8908c973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9473ecf3-e5b8-4606-93f3-9ce82165fd42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9473ecf3-e5b8-4606-93f3-9ce82165fd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4eb8a69b-f173-40bf-918a-71bb6da599ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4eb8a69b-f173-40bf-918a-71bb6da599ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_07df15d7-28ae-4d82-91da-9c28bc9bf81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_6c57ce8f-4f42-4ac6-9753-d33577f761aa" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_07df15d7-28ae-4d82-91da-9c28bc9bf81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNET" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNET"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_93340acc-1506-4c8f-931a-0b1bbde83830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_e6243abd-a14c-43b0-a3ac-68dfaf1d0fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_93340acc-1506-4c8f-931a-0b1bbde83830" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_e6243abd-a14c-43b0-a3ac-68dfaf1d0fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_dfe2ee67-9852-4ffc-90d3-6ff9f34f3c18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5a4483ea-9c0a-4fca-9031-d62ee34e9c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dfe2ee67-9852-4ffc-90d3-6ff9f34f3c18" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5a4483ea-9c0a-4fca-9031-d62ee34e9c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INVENTORIESNETDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_040aa7da-5f4d-4a1f-9df3-6275970e9094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_040aa7da-5f4d-4a1f-9df3-6275970e9094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_6f36767c-bf0f-4952-8db0-8bf0970ee054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_6f36767c-bf0f-4952-8db0-8bf0970ee054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_30723584-dee7-427b-8850-d62fc1af811b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_30723584-dee7-427b-8850-d62fc1af811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_413b0c52-8a36-40a2-b45b-76f2773dec73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:to="loc_us-gaap_InventoryLIFOReserve_413b0c52-8a36-40a2-b45b-76f2773dec73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3bc3e567-595f-4c3e-9c62-ecbbc00e0601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_593aaf67-1c7d-4205-8f5f-cb4d07edc20a" xlink:to="loc_us-gaap_InventoryNet_3bc3e567-595f-4c3e-9c62-ecbbc00e0601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0752d7de-78a3-4861-bbc3-1c48c7d963df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0250dae8-b906-4afb-a7c6-d7736a6a761b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0752d7de-78a3-4861-bbc3-1c48c7d963df" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0250dae8-b906-4afb-a7c6-d7736a6a761b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20eeedb5-3a76-4cc0-80c5-031268f9d0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_ec4ccc94-8ee0-48af-aabd-258ba85c3a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20eeedb5-3a76-4cc0-80c5-031268f9d0e4" xlink:to="loc_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_ec4ccc94-8ee0-48af-aabd-258ba85c3a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_ccb219d0-5ceb-47db-ac1b-8e2b16a30eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20eeedb5-3a76-4cc0-80c5-031268f9d0e4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_ccb219d0-5ceb-47db-ac1b-8e2b16a30eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_7540be8d-47dd-4083-8ee6-d6b005d3c7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20eeedb5-3a76-4cc0-80c5-031268f9d0e4" xlink:to="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_7540be8d-47dd-4083-8ee6-d6b005d3c7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_194572bb-a506-43cc-a3b4-173b16a4cd18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20eeedb5-3a76-4cc0-80c5-031268f9d0e4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_194572bb-a506-43cc-a3b4-173b16a4cd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7a69156-5b2e-4679-ae17-fafd2c38ddb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7a69156-5b2e-4679-ae17-fafd2c38ddb6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fac59f81-394c-4837-bf5c-b3cba3f2e191" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4c132c5a-709d-4afd-87a3-64507dfcc97e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:to="loc_us-gaap_TrademarksMember_4c132c5a-709d-4afd-87a3-64507dfcc97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_30299beb-1927-4fd1-a3bb-668a58dd5d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223ae7fb-13c6-4f37-aa62-8cc863eb3584" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_30299beb-1927-4fd1-a3bb-668a58dd5d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd6a9e2-fb4a-46d5-9d48-b0d3ead5726a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_77a802f4-63c4-4260-a6b9-466e5430b8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:to="loc_us-gaap_TrademarksMember_77a802f4-63c4-4260-a6b9-466e5430b8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_c9fed4de-7a16-44f1-a88d-08d5cb20ba89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a23ccc7a-1a8f-4420-a4af-5a203c52da27" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_c9fed4de-7a16-44f1-a88d-08d5cb20ba89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_adab5bf1-1298-4ed9-8674-18d059298ecd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1830afd0-e993-4c32-ba72-709d0c5d3a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1830afd0-e993-4c32-ba72-709d0c5d3a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_55165b14-1959-416e-806f-acdbefcf85d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_55165b14-1959-416e-806f-acdbefcf85d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_691cfb63-b9cc-436a-9815-ed6811327efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_691cfb63-b9cc-436a-9815-ed6811327efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_88cb6ea5-1e2e-4e93-8ca7-412239969444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43084f2b-4262-4ee6-9383-7c3d798fd0e5" xlink:to="loc_us-gaap_AssetImpairmentCharges_88cb6ea5-1e2e-4e93-8ca7-412239969444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3706d86-50ee-4780-b8cd-622748d4ceb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3706d86-50ee-4780-b8cd-622748d4ceb6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08c37dcc-9357-4fdf-a5ff-0c29c269a688" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairedTrademarksMember_488ba9f8-e368-4681-a5e6-18f14260c681" xlink:href="clx-20210331.xsd#clx_ImpairedTrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:to="loc_clx_ImpairedTrademarksMember_488ba9f8-e368-4681-a5e6-18f14260c681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_227f7739-d609-4322-b03c-e5811f402631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f28ffed3-7119-465f-aa99-3ee65c537ab9" xlink:to="loc_us-gaap_TrademarksMember_227f7739-d609-4322-b03c-e5811f402631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:to="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_af593d46-5264-4c0d-8625-59e693a808a5" xlink:to="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_17f608e4-94cc-4a7f-8a9c-94f8b86c1de9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1951c657-bdfe-4e0b-8bf7-972497be24ac" xlink:to="loc_srt_WeightedAverageMember_17f608e4-94cc-4a7f-8a9c-94f8b86c1de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d3f524d-7ab7-450c-8a94-a12249596bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_ea6ca3ad-54d8-4a82-a614-f01c373fbd18" xlink:href="clx-20210331.xsd#clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit_ea6ca3ad-54d8-4a82-a614-f01c373fbd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7239988e-9227-45e5-80a3-e207a2bf342a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7239988e-9227-45e5-80a3-e207a2bf342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ce573c5c-e3fa-4201-997f-5fd3fe2d27e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ce573c5c-e3fa-4201-997f-5fd3fe2d27e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9e4c28fe-d9b7-432d-8841-fab60f3f9615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9e4c28fe-d9b7-432d-8841-fab60f3f9615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8ff1035f-31db-4796-8226-e423ecec0df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_8ff1035f-31db-4796-8226-e423ecec0df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1ec692ff-63fc-421b-9e7d-cc3c9304f1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1ec692ff-63fc-421b-9e7d-cc3c9304f1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68b17108-ec60-4b3a-86e0-4b53b6f6cf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68b17108-ec60-4b3a-86e0-4b53b6f6cf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ddeff130-c06a-4441-b4c0-1178ff1841e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ddeff130-c06a-4441-b4c0-1178ff1841e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c6c0d3f7-1b6c-4875-9de5-bb98563a4938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cd91b13f-bcd1-48b3-9be0-fc7b92c3c156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c6c0d3f7-1b6c-4875-9de5-bb98563a4938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35cd321f-646c-453f-97c6-83fc678dc605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35cd321f-646c-453f-97c6-83fc678dc605" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0522748f-87c4-4b9b-b406-53f40b85ff56" xlink:to="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_0276ea1f-c88d-4b10-9518-43a221bc31a4" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_HealthAndWellnessMember_0276ea1f-c88d-4b10-9518-43a221bc31a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_623556d9-276e-4f5d-b1ce-bfa7c7ab462b" xlink:href="clx-20210331.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_HouseholdMember_623556d9-276e-4f5d-b1ce-bfa7c7ab462b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_7cb23166-4a61-4fb5-9ef5-536506f6c7c1" xlink:href="clx-20210331.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_LifestyleMember_7cb23166-4a61-4fb5-9ef5-536506f6c7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_c2dada8c-0247-46d3-9f7d-3c9f3ed5a00e" xlink:href="clx-20210331.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_87735acf-c585-4bcd-a2b5-e1c26008a2ba" xlink:to="loc_clx_InternationalMember_c2dada8c-0247-46d3-9f7d-3c9f3ed5a00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bb6611d-6f00-4a6f-aef4-b93155813de8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_77053568-d2d6-4490-94c2-154eb00bf893" xlink:href="clx-20210331.xsd#clx_JointVentureInKingdomOfSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9029958b-6770-4878-8a2e-afac7f443c6a" xlink:to="loc_clx_JointVentureInKingdomOfSaudiArabiaMember_77053568-d2d6-4490-94c2-154eb00bf893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d8be103d-6d98-4900-81d0-10d2e61b3c95" xlink:to="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_263faacd-8fde-4445-a8e2-57692eb96a33" xlink:to="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_edeecc84-0738-4c69-8ac4-e7f0b37523a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_Goodwill_edeecc84-0738-4c69-8ac4-e7f0b37523a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_953f59de-92e2-488e-8f38-4da9962160b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_953f59de-92e2-488e-8f38-4da9962160b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_30ab2db8-7cfb-4271-8acd-cef310989963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_30ab2db8-7cfb-4271-8acd-cef310989963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_92d4d406-359c-40e6-a04a-14768fa3cc9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_92d4d406-359c-40e6-a04a-14768fa3cc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_965fcb52-3623-4c15-acbc-5b26a4ab4ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4a914c16-e7e5-45f3-8089-7275a1806b17" xlink:to="loc_us-gaap_Goodwill_965fcb52-3623-4c15-acbc-5b26a4ab4ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dde3a7f6-3e02-406f-afd7-9f00a948da41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dde3a7f6-3e02-406f-afd7-9f00a948da41" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419d0af5-ad72-4e45-8041-101314b74c49" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_575387e6-9509-4b7c-9265-91c1a36fdbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:to="loc_us-gaap_TrademarksMember_575387e6-9509-4b7c-9265-91c1a36fdbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_d9cbc485-00df-49b6-a5c8-9b314973a16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16ab761a-35eb-49f6-a8cd-7d9da34c95f0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_d9cbc485-00df-49b6-a5c8-9b314973a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7c4e54eb-33e5-44e3-84ab-9b72c4c41139" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_65e3e36c-c893-4f0c-8560-461ed269a2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3b455026-3cb5-429e-9652-926ff6fac6a6" xlink:to="loc_us-gaap_TrademarksMember_65e3e36c-c893-4f0c-8560-461ed269a2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_acfc9b6f-0fc2-45be-a048-20a5ae3c8ade" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_7323a8a0-fe8b-4705-a878-226fe5c16920" xlink:href="clx-20210331.xsd#clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment_7323a8a0-fe8b-4705-a878-226fe5c16920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_970ff609-c35e-44e0-b057-8e7e05eb7973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_970ff609-c35e-44e0-b057-8e7e05eb7973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97c3c97f-5e5f-4475-bec6-6cab19e304d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97c3c97f-5e5f-4475-bec6-6cab19e304d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5fbc7c6d-6b1e-43a1-b839-69aa99de1362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5fbc7c6d-6b1e-43a1-b839-69aa99de1362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28f2fbb1-959f-4774-b2ed-400013d52917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28f2fbb1-959f-4774-b2ed-400013d52917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ceabed79-2ba5-48b3-88f2-fd313accc761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ceabed79-2ba5-48b3-88f2-fd313accc761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1e965461-ff41-466b-afdf-390709fda117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1e965461-ff41-466b-afdf-390709fda117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a346132-76e6-4d7e-8c61-38a739bdd007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6ad96362-e881-4551-9f99-012b5043dfa1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a346132-76e6-4d7e-8c61-38a739bdd007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="clx-20210331.xsd#GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_821adce5-765e-4a96-89a7-de8adbbf3712" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_4b7ee4c5-a135-44a9-a4df-f4c1a8856645" xlink:href="clx-20210331.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_821adce5-765e-4a96-89a7-de8adbbf3712" xlink:to="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_4b7ee4c5-a135-44a9-a4df-f4c1a8856645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_5b6aaf7e-bb4d-45a3-912d-7a2ec1465cbc" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_33720aab-e005-4f37-a45f-01f04cdb4e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_5b6aaf7e-bb4d-45a3-912d-7a2ec1465cbc" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_33720aab-e005-4f37-a45f-01f04cdb4e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_e89acb03-4b83-4803-bbd4-556223b6d920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_5b6aaf7e-bb4d-45a3-912d-7a2ec1465cbc" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_e89acb03-4b83-4803-bbd4-556223b6d920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a0eb9835-8e1b-4015-9d8c-fb199ee46ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_5b6aaf7e-bb4d-45a3-912d-7a2ec1465cbc" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a0eb9835-8e1b-4015-9d8c-fb199ee46ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_9b03632d-0b7c-4e9b-bed9-e8ca616b652a" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_9b03632d-0b7c-4e9b-bed9-e8ca616b652a" xlink:to="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:href="clx-20210331.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_be14923f-d301-4f16-9068-921a157b33b4" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_2a39a287-ff31-4bcf-aafd-a86cbee7de74" xlink:href="clx-20210331.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_2a39a287-ff31-4bcf-aafd-a86cbee7de74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SoybeanOilFuturesMember_d07384dc-2b23-4fab-98a6-93c29b425548" xlink:href="clx-20210331.xsd#clx_SoybeanOilFuturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_SoybeanOilFuturesMember_d07384dc-2b23-4fab-98a6-93c29b425548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_JetFuelSwapsMember_dc6d7ac5-d393-4c2b-8f1d-4a9a95a3a6fc" xlink:href="clx-20210331.xsd#clx_JetFuelSwapsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_446020ff-0675-4aa5-9742-3b4cb74a8979" xlink:to="loc_clx_JetFuelSwapsMember_dc6d7ac5-d393-4c2b-8f1d-4a9a95a3a6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_ef317917-5e9c-45ac-b38f-99e71b69d9ad" xlink:to="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_a11a7514-3f43-4e61-94f2-1af3c0ed906f" xlink:href="clx-20210331.xsd#clx_PurchasesofInventoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_d3c1bc3d-0cfd-470a-8c90-6ec35f020782" xlink:to="loc_clx_PurchasesofInventoryMember_a11a7514-3f43-4e61-94f2-1af3c0ed906f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9f494c8a-f448-42f1-986f-294230562bd5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_308dc7de-bba6-4a69-97cc-1da9dcf345cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_308dc7de-bba6-4a69-97cc-1da9dcf345cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_ee51e4fb-71f3-4233-9779-5a9b5216a699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_InterestRateContractMember_ee51e4fb-71f3-4233-9779-5a9b5216a699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6ec24bc0-7ad9-45bc-b95d-24cc93343030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d760aa64-b965-4dab-8b7c-4f595e13f13c" xlink:to="loc_us-gaap_CommodityContractMember_6ec24bc0-7ad9-45bc-b95d-24cc93343030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c674f780-c275-4a18-bc56-57b8fe226988" xlink:to="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_c197c43c-8ae0-4c26-8d7b-c2f3ca721b04" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68452e6a-7d4a-434a-9e77-b61032a9281a" xlink:to="loc_clx_HealthAndWellnessMember_c197c43c-8ae0-4c26-8d7b-c2f3ca721b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_9033ae12-b4cd-4500-af91-839a490a964a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_2dbdd886-b417-43f6-9708-8797fde911d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e9d21b2-2d4c-4644-825d-0ad62b7636c4" xlink:to="loc_us-gaap_OtherAssetsMember_2dbdd886-b417-43f6-9708-8797fde911d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b47547ab-be3c-4e7d-aaa2-a74c0ae21156" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c6103165-94fa-4351-aa23-9f4bced1c945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_71b9f831-7570-42f8-aee3-1162a30d12f4" xlink:to="loc_us-gaap_TrademarksMember_c6103165-94fa-4351-aa23-9f4bced1c945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9f6bffc6-9b2d-41a0-8d43-fffb32bcc1cd" xlink:to="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_b36f2038-2630-4f3a-bcb0-1e7050496642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_b36f2038-2630-4f3a-bcb0-1e7050496642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85518bbe-f66c-471f-81e5-cb18dc1315db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85518bbe-f66c-471f-81e5-cb18dc1315db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_5e4dd0e7-467c-4ed8-b1a5-b478b645eaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_5e4dd0e7-467c-4ed8-b1a5-b478b645eaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ed5d4980-44e2-4e96-a62d-4ca381c81103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ed5d4980-44e2-4e96-a62d-4ca381c81103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_84e81943-3a2e-48c3-bb4d-ecdb9cd7fb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_84e81943-3a2e-48c3-bb4d-ecdb9cd7fb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_6b267ec0-b69b-40e8-9b4a-c21d758a2ec2" xlink:href="clx-20210331.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_6b267ec0-b69b-40e8-9b4a-c21d758a2ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_e43868e8-36f5-46ce-8647-19cd0329f469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarginDepositAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_MarginDepositAssets_e43868e8-36f5-46ce-8647-19cd0329f469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_70a71195-3e76-46d1-8354-be3f8cc885d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_AssetImpairmentCharges_70a71195-3e76-46d1-8354-be3f8cc885d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_30eefc64-e1a2-4703-abb1-3254f718c1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_30eefc64-e1a2-4703-abb1-3254f718c1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_59e0f4f1-9029-4f86-8613-046f784d839f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d26c8c36-2c91-4766-9d6a-0aa057353a0b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_59e0f4f1-9029-4f86-8613-046f784d839f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_c638caf4-4a4c-484c-9cd9-71e239d27c9e" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_c638caf4-4a4c-484c-9cd9-71e239d27c9e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b46bc46f-58cc-4b38-8428-a43de9dada1c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_85d407a6-d24e-41d8-bed2-4522d4437339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_CommodityContractMember_85d407a6-d24e-41d8-bed2-4522d4437339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5d3766b3-f7fe-4300-b249-e53befb1c41d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5d3766b3-f7fe-4300-b249-e53befb1c41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_9b296ea3-f362-4097-a07d-c0a4733a6df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd0473b4-9e4d-42d0-9b4d-c6f4bdac2185" xlink:to="loc_us-gaap_InterestRateContractMember_9b296ea3-f362-4097-a07d-c0a4733a6df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f23eebac-25d4-4ab9-9894-d534bbf032d4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d757c9be-a2b4-44e9-95dd-e8bcf459161a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d757c9be-a2b4-44e9-95dd-e8bcf459161a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_08d27d96-f9ee-478b-ba6e-c0e28c9f8c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b70c8b9f-99c1-4a13-a7b1-44936a4cb01d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_08d27d96-f9ee-478b-ba6e-c0e28c9f8c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_effe5b89-4d2d-4e93-a03b-ce32e72f934b" xlink:href="clx-20210331.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_effe5b89-4d2d-4e93-a03b-ce32e72f934b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1bed4e89-a2c4-4fe7-8d50-c9efaa57497e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_06110437-8ffa-478b-b664-9c1837df5055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_06110437-8ffa-478b-b664-9c1837df5055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4bed7ca8-7d53-4260-a81d-7b5644fa6fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_OtherAssetsMember_4bed7ca8-7d53-4260-a81d-7b5644fa6fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_e345cc14-2bca-4a36-9ef7-33f646af5eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_e345cc14-2bca-4a36-9ef7-33f646af5eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_6431e037-ec15-45b3-bb01-cc8c69fcca68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_6431e037-ec15-45b3-bb01-cc8c69fcca68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_9ef00b91-6f60-45c7-8a35-c7e97285c71d" xlink:href="clx-20210331.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a0b1d7c-24e9-4a39-9a2f-fc40c0bdc73e" xlink:to="loc_clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_9ef00b91-6f60-45c7-8a35-c7e97285c71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2df216b6-1a2b-4c93-bdc1-a4e9d41f27f3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_5cd87152-ecfb-4df1-a9ca-deefda7dd2fd" xlink:href="clx-20210331.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_844d4f1a-1efe-4103-803d-40977d787273" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_5cd87152-ecfb-4df1-a9ca-deefda7dd2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bd2db55-5ff3-4dbd-9cc8-75d2322a95b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d6d3d510-43cd-4f0d-827a-f88abc1e40ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d6d3d510-43cd-4f0d-827a-f88abc1e40ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69551939-f227-4912-a471-0389c8bb7b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8cdcaa91-5fd1-46cb-b6c5-655888c055d8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69551939-f227-4912-a471-0389c8bb7b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_09b66092-4a49-4f23-92b2-b0d2c0e2eb7a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5fb6ec7b-f6b1-4461-b357-e39c2c733493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5fb6ec7b-f6b1-4461-b357-e39c2c733493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0090f779-fa9a-4842-9c9f-5c43b6cfb676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0090f779-fa9a-4842-9c9f-5c43b6cfb676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dace63d9-070f-4f88-ab99-5bcaff3ad416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f411a5ec-8824-45b4-ab1a-ea5b394565d3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dace63d9-070f-4f88-ab99-5bcaff3ad416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_a097f1e3-c7a0-40df-93f7-0e21df8a21f6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_354bfde9-2b2b-472c-8703-dbe255e790fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:to="loc_us-gaap_MoneyMarketFundsMember_354bfde9-2b2b-472c-8703-dbe255e790fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_864ed34c-36f8-43e1-901d-6264afeaca5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7e07b256-354e-40a4-b22e-734b373a94ae" xlink:to="loc_us-gaap_BankTimeDepositsMember_864ed34c-36f8-43e1-901d-6264afeaca5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_51dfa18b-f39e-44d6-b83f-4def9d902ed8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_c08c46fd-3a67-4009-9839-6f64955e58a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_CommodityContractMember_c08c46fd-3a67-4009-9839-6f64955e58a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_f08b759e-be6a-44bf-8dc4-6960cd9aa98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_InterestRateContractMember_f08b759e-be6a-44bf-8dc4-6960cd9aa98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c9520d0d-a556-4fab-8a5b-25ac4e2d33ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7a48a1d1-3ee3-443f-b132-14a28a33c602" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c9520d0d-a556-4fab-8a5b-25ac4e2d33ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d89a070c-e6d7-42e3-b036-a9981f586f6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_5345cb62-5992-4d20-8cdb-b1425c5f18a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22960729-8fe1-44ef-941c-6313cf0b645a" xlink:to="loc_us-gaap_LongTermDebtMember_5345cb62-5992-4d20-8cdb-b1425c5f18a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1325dc9d-a236-4a94-be9a-41b7108e88bb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d1b0d1e2-7384-4e8f-ac52-0718a04ec88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DerivativeAssets_d1b0d1e2-7384-4e8f-ac52-0718a04ec88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_90c6db7a-0c7c-493a-9d18-033699e545b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DerivativeLiabilities_90c6db7a-0c7c-493a-9d18-033699e545b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b77b04f-ac43-48a2-8121-c4d8b43f8a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b77b04f-ac43-48a2-8121-c4d8b43f8a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_3b8d0761-a736-4266-9d84-d72084317ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_3b8d0761-a736-4266-9d84-d72084317ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_97f6d2c7-70db-41f8-a83f-05586e50814a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_Assets_97f6d2c7-70db-41f8-a83f-05586e50814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68ec61d2-f2c0-4479-961a-5cd281c0009c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68ec61d2-f2c0-4479-961a-5cd281c0009c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f458e86a-7256-47a5-a387-4e73884f16f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f458e86a-7256-47a5-a387-4e73884f16f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c348e0a9-d88c-4517-88df-7522c9d2fd16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c348e0a9-d88c-4517-88df-7522c9d2fd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b4eec6d8-d6e9-4f38-9037-86275fe172ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_LongTermDebt_b4eec6d8-d6e9-4f38-9037-86275fe172ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_930c0d1c-03fb-43de-a1f4-110e0f858b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_Liabilities_930c0d1c-03fb-43de-a1f4-110e0f858b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1d8add05-0584-4876-ba63-8598750e91ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1d8add05-0584-4876-ba63-8598750e91ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_55583c50-6589-4c68-8951-a9ecb764b337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_370bc5ba-e76c-4c60-bf29-debf3a3d1030" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_55583c50-6589-4c68-8951-a9ecb764b337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXES" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ebb44b29-97ec-4d13-9019-7cd39c4ef2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_13a02e8e-b413-4f14-b999-f8f7f780f800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ebb44b29-97ec-4d13-9019-7cd39c4ef2ff" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_13a02e8e-b413-4f14-b999-f8f7f780f800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9b98381a-4594-41f4-9cfb-2985d22951c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e0de9681-ef8d-43b1-a6b3-cebaf1fc4f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b98381a-4594-41f4-9cfb-2985d22951c0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e0de9681-ef8d-43b1-a6b3-cebaf1fc4f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_752f2798-9672-4653-8bfe-a93d5790ac89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b6bf5910-5826-4c5a-bc1d-b16df547d9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_752f2798-9672-4653-8bfe-a93d5790ac89" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b6bf5910-5826-4c5a-bc1d-b16df547d9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bce2d193-5353-479c-9354-00ce8c2b4d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_c24a2d99-13de-4ccc-97ca-c311f4770fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bce2d193-5353-479c-9354-00ce8c2b4d88" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_c24a2d99-13de-4ccc-97ca-c311f4770fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ec765bc1-275a-4762-9b8c-194421d74185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e63297e-97a0-4dde-a3d2-61615599cac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec765bc1-275a-4762-9b8c-194421d74185" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e63297e-97a0-4dde-a3d2-61615599cac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8e784a49-920f-4a58-a7d1-b013e3087f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec765bc1-275a-4762-9b8c-194421d74185" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8e784a49-920f-4a58-a7d1-b013e3087f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2ed13217-b218-4438-a36b-0a32598cd88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec765bc1-275a-4762-9b8c-194421d74185" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2ed13217-b218-4438-a36b-0a32598cd88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3730b133-6ce1-492d-a0c7-9ac79dd68b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec765bc1-275a-4762-9b8c-194421d74185" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3730b133-6ce1-492d-a0c7-9ac79dd68b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4f545eab-0dbc-4e30-af83-905b6af73d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_56611e47-6aea-4aa1-b6ce-4ecc2c247357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4f545eab-0dbc-4e30-af83-905b6af73d0d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_56611e47-6aea-4aa1-b6ce-4ecc2c247357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0e331736-ef7a-4f9e-ae59-4cd4f2f63abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_e6f02e2b-f28b-475e-b3a8-c0c1f0e0db5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0e331736-ef7a-4f9e-ae59-4cd4f2f63abb" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_e6f02e2b-f28b-475e-b3a8-c0c1f0e0db5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7ebb2bc0-6089-4e5c-8afb-b57dee255771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_87e84dd7-3c04-475a-8e08-6f24663a9f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7ebb2bc0-6089-4e5c-8afb-b57dee255771" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_87e84dd7-3c04-475a-8e08-6f24663a9f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d6dd91f0-8e76-4502-9372-46ac7cf54d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_686d9d03-db3d-49c1-a070-d21ff4c1d52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6dd91f0-8e76-4502-9372-46ac7cf54d84" xlink:to="loc_us-gaap_ProfitLoss_686d9d03-db3d-49c1-a070-d21ff4c1d52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6dd91f0-8e76-4502-9372-46ac7cf54d84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9b6c10cc-f9dd-430d-a618-b1fb591f0c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9b6c10cc-f9dd-430d-a618-b1fb591f0c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_016a99b0-dfeb-4b12-bf84-704a995d2855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_016a99b0-dfeb-4b12-bf84-704a995d2855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9911ea16-cce6-4262-824c-730cbcddd759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9911ea16-cce6-4262-824c-730cbcddd759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f7386b7a-5c43-4af7-8d4f-ef9bada4adb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f7386b7a-5c43-4af7-8d4f-ef9bada4adb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_738bd1ec-7abf-40a9-9a50-acd92e7be1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_738bd1ec-7abf-40a9-9a50-acd92e7be1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_71dde32a-c506-41c5-b474-9a2f619be2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_801e5c28-66ec-41e9-83ba-38d406513eb7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_71dde32a-c506-41c5-b474-9a2f619be2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39b55148-7ef6-4deb-9097-ded447abe4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6dd91f0-8e76-4502-9372-46ac7cf54d84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_39b55148-7ef6-4deb-9097-ded447abe4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fc78513c-ac2b-49f9-ab7b-5f3c498a046c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_29f6bb3f-de1e-47a6-8f46-188ec545bcae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fc78513c-ac2b-49f9-ab7b-5f3c498a046c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_29f6bb3f-de1e-47a6-8f46-188ec545bcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e2b4a61c-00a6-44a0-959f-2239e6b81364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_b58e2675-4e17-45ca-82d5-56ae157031bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e2b4a61c-00a6-44a0-959f-2239e6b81364" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_b58e2675-4e17-45ca-82d5-56ae157031bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_8b003b05-f55d-4bf1-abf4-e56c9c76cfb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e2b4a61c-00a6-44a0-959f-2239e6b81364" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_8b003b05-f55d-4bf1-abf4-e56c9c76cfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_49a0e0f6-fb43-45b3-abc6-a328d86614b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e2b4a61c-00a6-44a0-959f-2239e6b81364" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_49a0e0f6-fb43-45b3-abc6-a328d86614b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ef627a50-b50e-482d-b58d-8cc040dca136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ef627a50-b50e-482d-b58d-8cc040dca136" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6bd74082-fb1d-4363-88bf-028d7a6238a5" xlink:to="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e0d37f08-66a7-4255-abfe-13bb295900d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_CommonStockMember_e0d37f08-66a7-4255-abfe-13bb295900d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05ed258e-258c-4c9b-80de-258db792b114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05ed258e-258c-4c9b-80de-258db792b114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f696024c-e161-4006-bd07-24e23f38dc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_RetainedEarningsMember_f696024c-e161-4006-bd07-24e23f38dc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_017ca075-c605-4dce-8d96-492ea6120a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_TreasuryStockMember_017ca075-c605-4dce-8d96-492ea6120a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fed91e5-b0db-497a-8e9e-da27e6f2ca84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fed91e5-b0db-497a-8e9e-da27e6f2ca84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2ab0d003-75bf-4ab3-a193-372f4598f1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3d4ca9c-0227-4e09-b153-c1492cd628ea" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2ab0d003-75bf-4ab3-a193-372f4598f1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6b0a9a41-ce95-4a15-9ffb-00a4c6723e02" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_71bf4b31-e9ba-4da2-86c9-f54861e6728e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_44a7d5fa-d5c4-4dd2-a9b0-b351c3304be1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_71bf4b31-e9ba-4da2-86c9-f54861e6728e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a59d2609-16f4-4ac0-847e-7f36db3ff419" xlink:to="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_589afdfd-deb9-4d5a-9581-2e961273c27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_589afdfd-deb9-4d5a-9581-2e961273c27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6cc659e4-cec7-4072-9d5e-d145d7906eae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f33af8cf-cb88-488f-b923-57b4b06a10cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f33af8cf-cb88-488f-b923-57b4b06a10cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_1b7bf634-bdba-423e-8ec8-c8a502b9af02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_SharesIssued_1b7bf634-bdba-423e-8ec8-c8a502b9af02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e05ba496-ecb0-4237-9ac2-520609ff9ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_ProfitLoss_e05ba496-ecb0-4237-9ac2-520609ff9ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_080c2ade-aeb9-4706-a45d-4fd13704155e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_080c2ade-aeb9-4706-a45d-4fd13704155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_48e77e77-414a-4980-8888-47f73181df2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_Dividends_48e77e77-414a-4980-8888-47f73181df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7b2c9076-521f-4148-bb2b-41cd7ae9f1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7b2c9076-521f-4148-bb2b-41cd7ae9f1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d42730c8-ad55-4d64-a624-e0bb4921fdf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d42730c8-ad55-4d64-a624-e0bb4921fdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ac0d2057-8ac5-4ec1-9a3f-a096125801ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ac0d2057-8ac5-4ec1-9a3f-a096125801ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_275353b4-cbdb-4acd-bd1a-6835539cef07" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_275353b4-cbdb-4acd-bd1a-6835539cef07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_c6c446ba-0020-49ae-9473-7725a3f1ceee" xlink:href="clx-20210331.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_c6c446ba-0020-49ae-9473-7725a3f1ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_77df9826-b81a-4176-913b-60e582f483cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_77df9826-b81a-4176-913b-60e582f483cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_06b26c9a-d504-4716-b033-d6268db2b453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_06b26c9a-d504-4716-b033-d6268db2b453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bee227ac-eb56-4962-9e51-f1d865b28176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_bee227ac-eb56-4962-9e51-f1d865b28176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_7670a586-a431-4067-b3ad-2598eb4674d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_7670a586-a431-4067-b3ad-2598eb4674d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1708e016-ddeb-4782-b9fc-1d5ffff10338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1708e016-ddeb-4782-b9fc-1d5ffff10338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_107845a6-4e04-4166-afbf-8d49cd3ab6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83ee7a9d-9581-4d49-86b2-a473ff4d85a0" xlink:to="loc_us-gaap_SharesIssued_107845a6-4e04-4166-afbf-8d49cd3ab6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f230a98c-3802-4b86-9c71-f9f251c07ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f230a98c-3802-4b86-9c71-f9f251c07ab7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d851f584-0235-4c50-ab9c-20932934161e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_A2BillionOpenMarketPurchaseProgramMember_50c4e290-e7f9-4e6f-87c8-9f41f2957a2e" xlink:href="clx-20210331.xsd#clx_A2BillionOpenMarketPurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:to="loc_clx_A2BillionOpenMarketPurchaseProgramMember_50c4e290-e7f9-4e6f-87c8-9f41f2957a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_EvergreenProgramMember_40fe3794-2a1f-4c74-b9ac-081142573285" xlink:href="clx-20210331.xsd#clx_EvergreenProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_023c0999-2f65-48ba-9847-3c94c8aee27b" xlink:to="loc_clx_EvergreenProgramMember_40fe3794-2a1f-4c74-b9ac-081142573285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d2518c-62e5-4c91-b366-bd589b0763d7" xlink:to="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_511bb07b-1a5f-48e3-bc95-87cd74a166e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b975cf8a-9040-4a7c-99e0-0cb8361ab827" xlink:to="loc_us-gaap_TreasuryStockMember_511bb07b-1a5f-48e3-bc95-87cd74a166e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_0766c09b-fcc7-4f51-a569-bfde50bf2520" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_06c864da-0682-448c-920c-659f55e8cbbe" xlink:href="clx-20210331.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_7e978afc-a4a5-4c1e-a12e-081071546943" xlink:to="loc_clx_LongTermInterCompanyLoansMember_06c864da-0682-448c-920c-659f55e8cbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5334775f-e4d6-4fa8-84f9-45219027b8ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_259a0226-5301-43e0-92f9-4c83f4b9a9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_259a0226-5301-43e0-92f9-4c83f4b9a9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NumberOfRepurchasePrograms_0548661f-dfd3-4c71-9c4d-1f51750bc8a2" xlink:href="clx-20210331.xsd#clx_NumberOfRepurchasePrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_clx_NumberOfRepurchasePrograms_0548661f-dfd3-4c71-9c4d-1f51750bc8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2b317297-bc2b-45a8-b609-9ecc56b7c1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2b317297-bc2b-45a8-b609-9ecc56b7c1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_StockRepurchaseProgramAuthorizationLimit_816c8571-13ae-4b32-b3c1-90aec8c21486" xlink:href="clx-20210331.xsd#clx_StockRepurchaseProgramAuthorizationLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_clx_StockRepurchaseProgramAuthorizationLimit_816c8571-13ae-4b32-b3c1-90aec8c21486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_98a0dbd7-5809-4e8c-bd59-32f501e05997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_49035b76-8ac5-4e59-a98b-175a5a31e379" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_98a0dbd7-5809-4e8c-bd59-32f501e05997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1b7df6c7-7d2c-4f0a-82e8-9bad873fa3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1b7df6c7-7d2c-4f0a-82e8-9bad873fa3f5" xlink:to="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d0f42e6-2d10-4d43-9020-91ec5485604c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_A2BillionOpenMarketPurchaseProgramMember_530d0d9f-1a24-4d3b-b651-bb888421a3f2" xlink:href="clx-20210331.xsd#clx_A2BillionOpenMarketPurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:to="loc_clx_A2BillionOpenMarketPurchaseProgramMember_530d0d9f-1a24-4d3b-b651-bb888421a3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_EvergreenProgramMember_aee35c65-427b-4412-9348-2509f4ccb4d4" xlink:href="clx-20210331.xsd#clx_EvergreenProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_906b302e-e65c-4bca-b533-bb5472795167" xlink:to="loc_clx_EvergreenProgramMember_aee35c65-427b-4412-9348-2509f4ccb4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:href="clx-20210331.xsd#clx_ShareRepurchaseProgramsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_ShareRepurchaseProgramsTable_747e2536-49be-4cb0-8fe1-892a4460ede6" xlink:to="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a0ab4cee-e6d4-4b81-a4aa-458d50cf6662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a0ab4cee-e6d4-4b81-a4aa-458d50cf6662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_62d8d0d9-8101-447b-a0a0-3ed1c5c3cb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_ShareRepurchaseProgramsLineItems_7e3660e1-9814-4312-aaea-5a73026d1238" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_62d8d0d9-8101-447b-a0a0-3ed1c5c3cb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7467c6c5-f919-4da2-80ab-f57e32c92552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7467c6c5-f919-4da2-80ab-f57e32c92552" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0185376d-8c14-419f-90d6-abda82a9d8e1" xlink:to="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_11599edf-d54e-4ae6-bdc4-5466331357c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_11599edf-d54e-4ae6-bdc4-5466331357c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_48748d46-f996-4848-b57d-700072753c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_48748d46-f996-4848-b57d-700072753c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9f17676-d4c0-4d5e-8971-119f40f0075c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9f17676-d4c0-4d5e-8971-119f40f0075c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_65f21fba-c4af-4407-83d0-fd534982b77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d8191114-20f0-4784-b4ee-47daf635ec47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_65f21fba-c4af-4407-83d0-fd534982b77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ba6e947b-e60f-4113-8bd8-413bc8f8673b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c0bf1e85-2e3c-4b1f-ab25-18c6382af480" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f58e089-fd8d-478e-954e-35b0bc6a8a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_StockholdersEquity_6f58e089-fd8d-478e-954e-35b0bc6a8a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_94338db2-1490-45d7-9385-f0db30fdff23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_94338db2-1490-45d7-9385-f0db30fdff23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6f6a54ad-4122-49b4-9960-bc9ee284df73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6f6a54ad-4122-49b4-9960-bc9ee284df73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_67a3d590-b6e5-4c0d-8e27-932f4f5e1a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_67a3d590-b6e5-4c0d-8e27-932f4f5e1a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_866b5271-1321-4bec-98f2-6d9d09fca852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_866b5271-1321-4bec-98f2-6d9d09fca852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3f12d023-838f-4aae-87ca-9d76d4eca2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_599c2e57-82a3-4ccf-aa01-b40d459e2f87" xlink:to="loc_us-gaap_StockholdersEquity_3f12d023-838f-4aae-87ca-9d76d4eca2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f67d2969-af74-42d4-b93c-35cce0b744a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b6faab05-80d7-401a-9457-08ff4f976020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f67d2969-af74-42d4-b93c-35cce0b744a3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b6faab05-80d7-401a-9457-08ff4f976020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19f90ee8-05d3-4607-af71-1b4ae0964613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_cb7a88bc-0069-4613-8616-a40b11470d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19f90ee8-05d3-4607-af71-1b4ae0964613" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_cb7a88bc-0069-4613-8616-a40b11470d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_086fba19-b940-42a9-aed3-7df0b014ca8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_086fba19-b940-42a9-aed3-7df0b014ca8a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b60a3071-2849-4af5-815d-7b1e6be07ccb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_30447b5e-aa36-4bb2-bc45-1fbc07fdf89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_712a3125-01c3-4725-af6f-96fca28c9123" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_30447b5e-aa36-4bb2-bc45-1fbc07fdf89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:to="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5cbf54ce-c812-4fa9-b7c4-2f18b2e99b63" xlink:to="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_312858ea-8e5b-4faf-bb55-d786310cedd1" xlink:href="clx-20210331.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77b85136-d80d-41cd-a9ab-7894077da823" xlink:to="loc_clx_RetirementIncomeMember_312858ea-8e5b-4faf-bb55-d786310cedd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_482043fe-9b6c-4128-a32a-7882fb69f446" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_844394d6-757c-4984-b67d-7c39bd45e9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_844394d6-757c-4984-b67d-7c39bd45e9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_45ba810a-e1b7-4fa1-b5c5-407120b7766f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_45ba810a-e1b7-4fa1-b5c5-407120b7766f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6e623adf-dc36-425a-8cd2-45a9cb88bf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6e623adf-dc36-425a-8cd2-45a9cb88bf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b94e4bd5-06d7-478e-8375-896cd852cc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b94e4bd5-06d7-478e-8375-896cd852cc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_45189bd4-431a-4eba-9fb3-3029b3ddbc20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_45189bd4-431a-4eba-9fb3-3029b3ddbc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e87f1a9a-be07-4c9a-b98a-20b77ab60610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_40ec52fe-5de0-4b21-a93d-8c49351a1476" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e87f1a9a-be07-4c9a-b98a-20b77ab60610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7d3aa6b8-545d-49c9-8c98-dc30667f93ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7d3aa6b8-545d-49c9-8c98-dc30667f93ae" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:to="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b313db5f-ac72-4932-ae60-21a0dcbd9704" xlink:to="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_ba6546b2-aeca-4990-88fa-4e6864266cd1" xlink:href="clx-20210331.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_db8a5b4d-06d2-467b-84d7-531831bac6b8" xlink:to="loc_clx_RetirementIncomeMember_ba6546b2-aeca-4990-88fa-4e6864266cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ba60b279-30db-4181-b01a-e020a4726fa4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb700d8c-1b1d-477d-ba34-11b3021bd811" xlink:to="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2e25d208-c7ab-412e-aeea-24a0feb140f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_3abe0fed-eb06-48a9-8600-39aae8f4103b" xlink:to="loc_country_US_2e25d208-c7ab-412e-aeea-24a0feb140f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f154373d-f95d-4ef3-a4bc-81252505388d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b47aff15-8ed4-4086-8b74-a625e6632cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b47aff15-8ed4-4086-8b74-a625e6632cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_600405a0-6237-4feb-8ca1-fc3b35fb5d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87ac94f1-fba4-4b88-a364-1eea243d28ea" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_600405a0-6237-4feb-8ca1-fc3b35fb5d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherContingenciesAndGuaranteesAbstract_21f3c782-5665-42b4-876b-1acd0218c4a4" xlink:href="clx-20210331.xsd#clx_OtherContingenciesAndGuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock_09a398c2-e40c-466b-8697-1a3b24805945" xlink:href="clx-20210331.xsd#clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_OtherContingenciesAndGuaranteesAbstract_21f3c782-5665-42b4-876b-1acd0218c4a4" xlink:to="loc_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock_09a398c2-e40c-466b-8697-1a3b24805945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherContingenciesAndGuaranteesAbstract_89425337-06d0-4f4d-b157-69d686d39067" xlink:href="clx-20210331.xsd#clx_OtherContingenciesAndGuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_OtherContingenciesAndGuaranteesAbstract_89425337-06d0-4f4d-b157-69d686d39067" xlink:to="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c694f3a-694a-435c-ab71-0617dee14c84" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_bcbb122a-2b8c-427f-8f67-8062c9c45c7f" xlink:href="clx-20210331.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_bcbb122a-2b8c-427f-8f67-8062c9c45c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_839ac533-bde0-4c26-a84b-62b11c1be41f" xlink:href="clx-20210331.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e3c32877-6581-4388-be5d-dc68864d06cd" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_839ac533-bde0-4c26-a84b-62b11c1be41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_51ad72dd-3158-45e7-baf0-6c61248d0d2e" xlink:to="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_902ac786-8f9b-40f8-afc2-e81831f6aed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_902ac786-8f9b-40f8-afc2-e81831f6aed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_0efba3ef-aaa0-4b7c-a05c-8badf1c7bef7" xlink:href="clx-20210331.xsd#clx_RemediationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_RemediationPeriod_0efba3ef-aaa0-4b7c-a05c-8badf1c7bef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_889468a6-2b54-4928-8e87-e946e2fabcec" xlink:href="clx-20210331.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_MaximumExposureUndiscountedCost_889468a6-2b54-4928-8e87-e946e2fabcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_6a81dbd8-1b4e-4923-8e0b-563d1c956307" xlink:href="clx-20210331.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_6a81dbd8-1b4e-4923-8e0b-563d1c956307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_7e5bdc85-54ed-4d92-a898-45a3021613c9" xlink:href="clx-20210331.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_7e5bdc85-54ed-4d92-a898-45a3021613c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_12d40bf5-97f6-4384-81db-97ad86d8fdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2abeeb9f-f44e-4cdf-a07a-8085ff437293" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_12d40bf5-97f6-4384-81db-97ad86d8fdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7150d953-8797-4f23-968f-571aa75c7af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_45dd043f-9228-4e65-a659-39430d8954e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7150d953-8797-4f23-968f-571aa75c7af4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_45dd043f-9228-4e65-a659-39430d8954e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d06022fb-bb30-4cfc-ad24-62b020c06d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e90716d8-a5aa-4205-8976-b7d42d4874fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d06022fb-bb30-4cfc-ad24-62b020c06d28" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e90716d8-a5aa-4205-8976-b7d42d4874fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7a21736b-9ff7-42d3-8fcf-da8e805ef3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7a21736b-9ff7-42d3-8fcf-da8e805ef3a8" xlink:to="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0ce8363c-50b2-4472-ae2b-77102962eab4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_84ccfab2-1e40-480c-9780-1af76801b2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_689e2876-98be-4ae1-a493-870409e7a44a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_84ccfab2-1e40-480c-9780-1af76801b2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_79f1cecc-836f-46ff-ae72-acce59b97728" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2bcc3315-5ee9-46a3-a3a6-ea30e64be686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0d8c32e1-3f19-4d63-9e12-d1baa4cb8be4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2bcc3315-5ee9-46a3-a3a6-ea30e64be686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_9771f755-ce60-420b-bfd8-020a0f8ce783" xlink:to="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_421dff6d-72f6-4902-923e-80421074183f" xlink:href="clx-20210331.xsd#clx_WalmartStoresIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_62866e14-3dc4-4a33-8ff4-1c817e1b72f8" xlink:to="loc_clx_WalmartStoresIncMember_421dff6d-72f6-4902-923e-80421074183f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_017eb552-c37e-46aa-b9bb-d8f27844900d" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_844ebcc6-8cea-4a1f-840e-7101bdb5f6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:to="loc_us-gaap_NumberOfReportableSegments_844ebcc6-8cea-4a1f-840e-7101bdb5f6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5396f7fc-78ad-4d78-85d5-471d3def7bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_fa509a9c-5e31-4556-b014-d398d3768966" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5396f7fc-78ad-4d78-85d5-471d3def7bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" xlink:href="clx-20210331.xsd#SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1f6d2a11-77de-4607-a7e5-9002fc5af7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1f6d2a11-77de-4607-a7e5-9002fc5af7ee" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4d94f9df-36cf-42e9-847d-ff76818bb179" xlink:to="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6856d97b-cee7-4bab-a5ae-b4ae4a21fc96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:to="loc_us-gaap_OperatingSegmentsMember_6856d97b-cee7-4bab-a5ae-b4ae4a21fc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_348d1f69-3ab2-49be-ae66-47aec90159bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d97f6864-8329-4bef-ac1d-bce989d73aac" xlink:to="loc_us-gaap_CorporateNonSegmentMember_348d1f69-3ab2-49be-ae66-47aec90159bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_31e8329d-4a7f-46d5-a3a1-8c96745b12c4" xlink:to="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_e4a94e52-f64a-44e6-8726-ffa25f026b4e" xlink:href="clx-20210331.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_HealthAndWellnessMember_e4a94e52-f64a-44e6-8726-ffa25f026b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_cad3c90e-dcc3-452a-8c19-5a3c859bdfd6" xlink:href="clx-20210331.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_HouseholdMember_cad3c90e-dcc3-452a-8c19-5a3c859bdfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_fc0b5210-43c5-4cbe-904c-8dde65460789" xlink:href="clx-20210331.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_LifestyleMember_fc0b5210-43c5-4cbe-904c-8dde65460789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_9d31e340-63c2-4b3a-8999-2726db49d3c5" xlink:href="clx-20210331.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_831cab6f-5ce0-4a3a-b53b-17e46ee2cacf" xlink:to="loc_clx_InternationalMember_9d31e340-63c2-4b3a-8999-2726db49d3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_84d88a1c-482b-4360-88af-4ea3d653648d" xlink:to="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_3f18a3b0-f43a-4e7a-88a8-8888f931956c" xlink:href="clx-20210331.xsd#clx_CleaningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_CleaningMember_3f18a3b0-f43a-4e7a-88a8-8888f931956c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_f919e051-a61b-4562-9930-d73432f482cc" xlink:href="clx-20210331.xsd#clx_ProfessionalProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_ProfessionalProductsMember_f919e051-a61b-4562-9930-d73432f482cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_c4d4758c-54e3-43b9-88dc-9fe5d6cf52fa" xlink:href="clx-20210331.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_c4d4758c-54e3-43b9-88dc-9fe5d6cf52fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_e9298768-05f5-4ff2-8d3d-d52744541e6f" xlink:href="clx-20210331.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_BagsWrapsAndContainersMember_e9298768-05f5-4ff2-8d3d-d52744541e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_f0b713de-04e3-44db-a74f-6ca080b611c6" xlink:href="clx-20210331.xsd#clx_CatLitterMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_CatLitterMember_f0b713de-04e3-44db-a74f-6ca080b611c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_4c9a86c5-35fc-44be-ae44-9899b792b211" xlink:href="clx-20210331.xsd#clx_GrillingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_GrillingMember_4c9a86c5-35fc-44be-ae44-9899b792b211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_04c5132e-e1f4-47c9-8bb5-964daee5fcc3" xlink:href="clx-20210331.xsd#clx_FoodProductsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_FoodProductsMember_04c5132e-e1f4-47c9-8bb5-964daee5fcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_2ce8db49-3f6e-4d00-86c8-8acd50141918" xlink:href="clx-20210331.xsd#clx_NaturalPersonalCareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_NaturalPersonalCareMember_2ce8db49-3f6e-4d00-86c8-8acd50141918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_6e782f8f-b3e7-4c87-9adc-4a7334f737de" xlink:href="clx-20210331.xsd#clx_WaterFiltrationMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_378e6b10-5c0f-4cab-998a-69f2e7823a4d" xlink:to="loc_clx_WaterFiltrationMember_6e782f8f-b3e7-4c87-9adc-4a7334f737de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_808e7d83-8e33-45b7-b90b-a20e10afcaad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_ac2d3aa0-b2b0-40cf-878c-9e6f8fa73b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2cfc1741-855f-429a-9e4a-b50ef4d529f6" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_ac2d3aa0-b2b0-40cf-878c-9e6f8fa73b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1445def3-d0b6-4193-935f-496f8c8432c3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_137d96a7-28f1-4f1f-bcc2-73608c348abd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d99ddc78-0955-41bb-bde2-dad592f68d3a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_137d96a7-28f1-4f1f-bcc2-73608c348abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_73a8a497-e5dc-4796-94cf-78e698334771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_de5b8e7e-ea7a-425e-b7d3-0c708ba2409b" xlink:to="loc_us-gaap_ReportingUnitDomain_73a8a497-e5dc-4796-94cf-78e698334771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5986eedf-cb1f-4838-a3ea-c5f12f2064ac" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2146d9e0-553c-4a68-bc79-f3495de7ee76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2146d9e0-553c-4a68-bc79-f3495de7ee76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e5bfdd8-1fd3-427f-8655-713ad73a51c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e5bfdd8-1fd3-427f-8655-713ad73a51c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_19421eba-edeb-4d22-9053-34f2f1151cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_19421eba-edeb-4d22-9053-34f2f1151cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7dff9e41-eb7d-4015-a4ce-e5aed5416c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609720fe-f635-4535-ad6c-f15d54ef97f7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7dff9e41-eb7d-4015-a4ce-e5aed5416c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>clx-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clx="http://www.clorox.com/20210331"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clx-20210331.xsd" xlink:type="simple"/>
    <context id="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f5775917fd4473eac612f8753710d3b_I20210416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7e8d63f491f423baa88abae57588736_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i996c29b523bf485f8accca37c4bb6e71_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i70dc6fb701fd4f5da398121fd36e0360_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="icf6b73a611c5439c9ddb772f505d1455_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i4df9eff9aad24233b734b8a995abf5f0_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="ia0bfdd2f36fa40ae8884cec528927862_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="ic7e26e45946444a8a31e317e4a6335eb_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="i89e347afcab74ff6bc8d31a740d9a89c_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icb066f8d893346ca9951f248d0dcb802_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib928fec9941c44d881ae5b71182e1e12_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i185542c2acc246eabdad2e53c4d02ecd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9fbc5f5127cf42d98d38f3b2282c7508_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i86cded78606f40eda58cf54289cc6c46_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i69b5e8efae404d60976021d1249edef6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2df6541afbcc471caf5020183b1aae27_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iea72635ffc9249a5b85b28d91061578c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0abb07fff33f4729b2158873d5eaa9ef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6521a378432044e2818b18ae9a3f504f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4a0bf84a649f46e6b8628a79d40bb4bc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7e8e270257da49d0ba55eec6af3548a5_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37bcf0ca8f2c418d8e3ad8f1d725a7e8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1ac31a8e85142168910ba397dd1998f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a21685ce7e9490d85a6bb3145bbe8b4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f50a3afc8254aee87ec15cc7d3a1236_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i087ce4ee5c5f43ffbc5df3b0be560c27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95c431b3b55c4f679f28a6d7fe216a9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43cba4b272444bd38c66ff3c5246316d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8b5149e800a4c518f7685d164029449_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56a82930ba8c46a8842474109384e6c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i26539d9b96f845d3ba4ab21e4452925f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6ba8774be3fa46a89129787dadbdd87d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie4784aa0c2eb497085b38aac10a12a6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i08739ec82f9f487e9a3a1aaf8f12513d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie41c41f5deb14768a1eb5a2210283ea4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:JointVentureInKingdomOfSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f481c5813194dcb93b50f7c42cd5640_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">clx:ImpairedTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2af70af2cbfa4de0b7bbcc6d6076615a_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic11c4432843d48beb47ab04de9835fd8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a7fec97eb2b445d82bb2f5c366219eb_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib505795eadb0415688775b76ca687bd7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i877f6bf072f447b0a08ba92a32ceae0b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i53cc8d65018745bcb4a5a483db2fe918_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if1484f195af54610a54afe24e3990c37_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i848015c104c6489dbc76c581af351d33_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7b70b530cbd34611accfb86ef4f0c9f8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i81bb94cec74c44ec934873bc2cbde692_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2602ddacb1ba4d48b483893d5a5811f5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:JetFuelSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if877153b764b4c2199980313d42e92fa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4e18e05c20e542f2b56a8cfae3ddca8e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6ecb0a1520954103b71df562030763b3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:JetFuelSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d14bf1a42bf48728f273cb7dbb88206_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i446ee7bb6f85446389955f7c3cb5789e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iceb6e03daa5243e9b7e14504d53fa628_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9eed352fc1a5487bb2a201702a083bc5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i89286b72adb64ceeae58323f4cbca98f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb6317a205f64e888817536ae25aba65_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:SoybeanOilFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0048ff33e90f4209aee6b35dd0d9663e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i803bb7cea1a64da4926148b2b30bf8b9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13a130bb3d2e4856b978cf675b54b49f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7becfdbf9a624acdb1b709bc3dc25c7e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i24afdfe415c34061ab653ffa84c5b114_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6f08e7cdcd93457ea49df833bde0b187_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04d8da7beaf442bd9043f1f6db402d82_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i72856990c40d4c8e8edcc82b8f7f1500_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie244b1b1e0424bdbb85739588f77cd6f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i493b6bcb04674e4eae776d98c6e32549_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic53a10bdd3c443149d70aa1b9344fa89_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i57197fa8f0f041218d4589f2a589885a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8bb08d66214c4f6a8e0e2cad3359efe0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i09939d37bb3048269d0cb0a44386b194_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i55f1a042de7b4e569e2d27c2d5dad9e1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1996c058fbf040f8908e8c394fc5c89e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1dd2366b5b7844fe8e3445d45c197945_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1da90ff065be4c999e8fe274b11c5b63_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i07087f939caf4a5fbe9aba0283c385cf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie34cc22e3e8345758a12debb39ff6929_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i45f4d36e4c26464da0167188a60de71c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i987768d7a6a84e038b10c8aaeca7130c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d72659b4ccc4ad89a4324978711b52a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2a413c3b7e924aa38bf7da6938de615f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i85534346744b432e8cea4e97ccc5909d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3795ebf2a81e444eb73637647767d786_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie91f439ccd2a45f5a6efaa8d896c7909_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0c33022caf44489f9f113ac89dbf91b8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i86dd42a80b9c41f69b404d2b1eba64a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3bfb4666ee19476e8443974cdf719623_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5ef0e5a952734b418963b327a95bcc4f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0e24c8554ebe46388a798da32706e97a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifda03dcb1c30410ea2b0bbca9847e228_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i01d4ed82486f441a84472bb6b87db08f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7add7ef54944efa99bed6cbd73f7f56_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0bbce1f0e07b471880107186a9d2dbf0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i26c5e68eec1f4975a44f0ee291e1b433_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8fec6298f6c24ef6ac7e3ee30b63cd54_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i01dc6b5c81694d3a8ce02fb89916e04e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4fdc3ee65556409abf6845da148f19ba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5a8032a0d84e405fa3da93df1c46964d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if4dbc98d539d45729f9fac03fccb02f8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7bd770eb1c3840cda9e1bfb6823cff18_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i72c2212de48a40c08c45b2267d5c2553_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifa872fb1c8a741e08e01d0b0035e14a9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic4814dfcd3ba499aa945030b7001616e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib00ae1de87094cf89d76a74b042495cf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3093b0d16ed04d6f8781b4a8dc97c5f4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i13a2cf9cee0f45fcb02a4c337563805e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fac87255172412484f55ebbbbeea3f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i621c78ef217946caa48daba642080fc7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47dfa7d737eb4754a2c5b8e3a44f18a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3432462f36cc45c7bd8205bca273122e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i77b79f9121d141459b8db7faff712c18_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i108954c232d04d49920930c949d00216_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie032edb36eed4e7fbd867455fbb3151c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i95af929fa2ea40cfbc21af9dc7f5c5b9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0da205cd9b70413683ab2bbaa7533b9c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied37b00018c54177824f2ad238767344_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6a1026fe1c8944ff86a32c927ef217f4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i603fda767f6844baadd48df615fb009e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ec9af00fbc343c7a22d3f94f5287cdf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27e24c9e768043d999c666a316d95f12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6930765739894f11878ad45a82a55846_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf821b273c5e405fb6940c37f931f302_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8dff6b4bc5ac419481696f8476fdaa42_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22da98082521415a9ea0e1210c75a6c0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i782a0b76608c42b8a82e90d7a7ea4654_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e407cf409ae4bdb83e47faa0f5730af_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icac622ad60c646dd848b717d07c7c1c6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i148c7405ee9c472db3556c314ddfc829_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0e638f74ad54f28b43e008437b87090_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id820cc1b67e64799bfc374a16f6c1038_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6e062e41cfc74e44acb07fd26a397d64_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i637250d82b784de7b529ed70ed515d07_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iba474f7dc35d462dbbf5c28ece8066da_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ida1ef0e38ead43729ec512b3ee29802f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0a8d54a976ed4611b6e63671c8bd89e7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id11b8ffb8d49487096c194160392c5dd_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ida18a217ec684932b3629eb9e338973a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2d4c6fa0129c464ab8995dcf39d5f97f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ieb1ba4ba9cb441a0b2d31c4fd01bcf43_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i95eac61641474597a335d7aa40b97c09_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i27d44bf18a1a4061ac3a7e5409698cba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5806947a885c43eabab88a1bd7699531_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idb5b41725ce84b268abfb90cdf704e87_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iadaf769931a14483bf937ae29c61736e_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb1218945cd84b80a0826a8dedfda008_D20201118-20201118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-18</startDate>
            <endDate>2020-11-18</endDate>
        </period>
    </context>
    <context id="i018e05de2fce4bcaae18e50cf9517af9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i01b3d2ba010b48fbb9e64b975eb1f926_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75957ffb916249c88259d57dddd74735_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if27d27b067a347619468898121fdfd72_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:A2BillionOpenMarketPurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if7cc8b46a7c6407daee478103960b9cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia4a6b8cee95f47f38c868dc0f83738cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f82341c90d8488392c430a697f9ad8d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id3a85957e12343c3b6d10c076ee4eb33_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic31a8c3f66c64539b477a0e822466880_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i419066cdc87943e4af8d2639f21bf325_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1e20738f6dc4450bbd4b15b69a7e6581_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8d3d6307a914434b95e460604d9d99f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8ec840bf78e43008b395cb5e1e9dc56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id61ae387d81f4cd787169a4aa986b749_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i648911325f984984a9226827d9c4ade9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i287ed9572278419fa5ed70f8a892d17b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ida1829b8f6a940fa9109f3a38603cdcc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8e31ef39780c49909cf68f429ec68689_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie8e05a3f921945f18703bab7f65ac87c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i15cda9f6bf6342a597e07a9eec7230e9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2fa822c4df064199a3d14eff7dcc4d7e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i97439b6734784a439903d4ca1f2ab98b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i62293d2d37bf4c4988f6c74ea00a7c89_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie6d9925f9b914e0993a80905523974d8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iababf4350ccf465da7e9156cd84d16b3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i173c3aa326c84df085c6251cbd51be86_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i231dec8719174078bc40595afca4dbde_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife71daed3a804771b19315df743bc445_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1ec03781c4364b8eb6a53fc946376745_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i94703f8812a94078aa3f69523823f506_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0a83729a2ab84c53a192961000f37527_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if1379ef5a7284cb29a9aed3da06988b6_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic8784fe904d7468a9509d946755aa75a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id29606025bd94286b0f0595ed8010676_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="ib3d430c56b2d45ea938542ba1ac62191_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id75803f96d3a484c8dbb2e4d3901e6b9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i975190927cc64325b214048019388e7e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4ad2a51e50b3452cb6ae64126212de08_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9cfe0f219db7465c981c5d00e3d79dcc_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7e65e42dcaee41a8aa5344602e39584a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8eac904b7e824f788b24e686c7bc1d56_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5699b6f9a46b48c5bec7a3e5ba13b8a7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0bd7644fe81e43fcb2a9ae7f33ce5f3b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2eb102946ac9445592b664e481c220fb_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia632e6efb55e4038b06caacaa950ee58_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if62aad3baf484220b5c2b3c5607bcf73_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fc121a4a2da4a36b4069a1d12d0b8ca_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9c504e6a0e8e49379abef45f151e6867_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i506a64ba3d1741e8a790673d8cd8f3c6_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i15818785c195423aa0fecc36f1c2582f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie147f6c9542045d2bc2b75081d38abde_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8caf281c758e491a861b00f823d7979d_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i53b9ae5110404e8e812297d5d6b2d42b_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i47db18debc494da4b9575bc13dde6879_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i64ad656aa5c747ea869192f42c6b654f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8812b42a862f45728955cc5a6fd0e98d_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i128d754517744d14bf0d13fc3d3cf0b3_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1c55fd9240674a3b9f72e4cbb7d515dc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifad0e0cfdad747e9bf36f5473f6d8f03_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if2e1002466a64130bc0c173f011c16d7_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58e0648e0b884c8184d3468dad255a59_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i187b861787ca41e3b58b23b46c5faf63_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0b809796270b46368d7995f9e91a9c90_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id1e24f176213492e981a7a7fe85e20a0_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib3a795ff3b4c4adaa82835e56a401845_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idc2ea66f0180479c96f3dd09cab6e243_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1a5a929489a4b42bb6fce0495516584_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie3d5d2046dae465496bfa06a4ce81663_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia6de7ab384894152aca3960aaa565203_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i37a114b1ca84437a9ecaf7bf79fb57ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i237934c2afde4ed0a6ab8a5fa7df13eb_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i93f613b6d1e54231bf06050b363647cd_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i88583fbc1c434496bf8b9e52b80d9067_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i483c1116882345a89188168be2d76bc8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia02727d1fe8147ce863007dd69cdd4ef_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6479f56abf874bc88fcc7c452a280a08_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if10aa250273f4428bc10f6ba3c689231_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic8ec145f089a480fb32a14926e0eec81_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i61184552c2644513b3d633d0928a8112_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iba7f614f662c4fdaac724b9dbdc9b0ec_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i053ab554d68d4004b7cc5e97f743f92d_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie08eb37c570741b6adbb80e59db8e81b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i005732996c5443e98325ccaca9851e73_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i88cf12ca5cc441158bed63419f14048d_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i55cd924b746a43e7bb45ffa60c315720_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i18be5d4fbe524e47a3029107ff86582b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic4c74269eba445e0b373d38d49c2ea96_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie9e2335ca8894224947f5ebe34faec14_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifd2e74bb030744169bd9895fd5ff97e7_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie49d4996c5414e89885bb395950c44cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia7f4b076b16b412f97df8f6635593f56_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i816a0ac0739d40dbb754308ccc3bb074_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8a5bde4bb3614689b5997373fdce9d38_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i647346da3c594fa1b168b90be5aab738_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2b50c8db5f674487bbe612c1077374b8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie0e050195d1c47c698983818dc2bb144_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0d206ce9aae94891b7aefcc647ef716b_D20190701-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="repurchaseprogram">
        <measure>clx:repurchaseProgram</measure>
    </unit>
    <unit id="reportablesegment">
        <measure>clx:reportableSegment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N18zLTEtMS0xLTA_52eed232-93e7-46bc-a2ee-5fb952d123f8">0000021076</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N180LTEtMS0xLTA_96649b86-e467-4864-829d-a1f4b2543a56">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N181LTEtMS0xLTA_0c22a753-4c99-4b3a-ba56-0c96a751f8d6">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N182LTEtMS0xLTA_99f5bb45-0d15-43aa-b1d6-8bea79cb8aed">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180L2ZyYWc6YjQyNDVjZTdmZDU4NDFhMDkwYjNkNzZhY2ZiMDkzNTQvdGFibGU6OTM5MTJkNzQ0NDFhNDUzZWFiYmY1ZDQwMWIzZDljNjcvdGFibGVyYW5nZTo5MzkxMmQ3NDQ0MWE0NTNlYWJiZjVkNDAxYjNkOWM2N183LTEtMS0xLTA_11d663e2-f8dc-432c-8eeb-760141ee1834">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF84NQ_9d9799c4-72a6-4b6c-bfdd-ce7dee87ce62">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6MWNjNDkyNzM3ZTBjNDFhMTlmMGQ2OTg3M2U4ZTdmYmIvdGFibGVyYW5nZToxY2M0OTI3MzdlMGM0MWExOWYwZDY5ODczZThlN2ZiYl8xLTAtMS0xLTA_72a80408-f6f8-4a5b-8687-885551aafc94">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xMjI_0ecce2e8-b941-4247-ad06-6731e8b9f565">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNkMzU4YTAyODU4NDkyNmJlMzE5M2QzYTYyMDk2ZTIvdGFibGVyYW5nZTpmY2QzNThhMDI4NTg0OTI2YmUzMTkzZDNhNjIwOTZlMl8wLTAtMS0xLTA_66d2ebeb-a6c7-4159-8601-2558a0e6f755">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yMDY_cf9df5ce-62d4-4709-bebd-c8548e08d5c7">1-07151</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yMzY_969f9949-cb6e-49d2-bd43-d4319cbb9133">THE CLOROX COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6YThiMTQ5Mjc5OTNmNGEyZGJhN2YxNzQ4MmRiMWY4ZWQvdGFibGVyYW5nZTphOGIxNDkyNzk5M2Y0YTJkYmE3ZjE3NDgyZGIxZjhlZF8wLTAtMS0xLTA_a93f930f-2e95-462c-85ff-05fa3dc0e28b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6YThiMTQ5Mjc5OTNmNGEyZGJhN2YxNzQ4MmRiMWY4ZWQvdGFibGVyYW5nZTphOGIxNDkyNzk5M2Y0YTJkYmE3ZjE3NDgyZGIxZjhlZF8wLTEtMS0xLTA_3f74f456-c012-4a40-8cc9-4a2e6427abc3">31-0595760</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8yOTg_a58a859d-840c-4f9c-8c6f-5788c06cd340">1221 Broadway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMDI_34999c0d-52e6-46e4-a331-d24d71ad1fdc">Oakland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMDY_f8775c5b-04c9-4f41-af27-ef88d5fb6297">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zMTA_54638fee-7fb5-4140-ba7c-ca65eb2b7d83">94612-1888</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zNjc_52a88b24-deb0-47ce-94e0-55c705b86ce3">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8zNzE_9eb50097-0461-4d2b-86fe-008b2ed28ff4">271-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTAtMS0xLTA_aef18ce2-0e61-4a70-8cb9-d67707650849">Common Stock - $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTEtMS0xLTA_50d2e3a6-c26b-4fb7-8261-622a4c028338">CLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmQxZTY0MzkxMmQ3NGQyM2E2ZjQ4MDJkOTg0ODdjOWEvdGFibGVyYW5nZTpmZDFlNjQzOTEyZDc0ZDIzYTZmNDgwMmQ5ODQ4N2M5YV81LTItMS0xLTA_837ebe39-cc07-49bd-bcc4-46f906e8eef2">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF83Nzc_2f1f8bfa-eecc-45dc-ac40-8e1cf3b3024e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xMDk5_90986b60-ff7c-4eff-9082-fd7143e4699d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTAtMS0xLTA_5e8da6cc-ab86-48f1-ba3a-67f570c44d2a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTctMS0xLTA_c89762e9-9831-45cd-9891-2db85cbb8b0f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGFibGU6ZmNiZGYwNWNmZjliNDQyMmJkZGI4M2ZiMzU0NjE1YWYvdGFibGVyYW5nZTpmY2JkZjA1Y2ZmOWI0NDIyYmRkYjgzZmIzNTQ2MTVhZl8wLTktMS0xLTA_b2531627-0067-4047-8daf-1e01d0cb98e8">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xODMy_3899532f-1b91-42ee-b2d5-e2f84c598104">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8f5775917fd4473eac612f8753710d3b_I20210416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xL2ZyYWc6NTc5MGE0YjA0ZTg5NDFiMjk3OTRmNTIxYmE5OGNkOTQvdGV4dHJlZ2lvbjo1NzkwYTRiMDRlODk0MWIyOTc5NGY1MjFiYTk4Y2Q5NF8xODYz_59792959-e6b6-49c7-a8ed-3f4e1f77faf0"
      unitRef="shares">124372035</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi0zLTEtMS0w_3ccbb7e4-c4b8-416f-bc68-5edee4863bf2"
      unitRef="usd">1781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi02LTEtMS0w_fff0b42c-3d6e-4c31-8a9c-4a6de79c4326"
      unitRef="usd">1783000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi05LTEtMS0w_a22d0af5-67cc-4639-bc8a-88a998ecd06c"
      unitRef="usd">5539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMi0xMi0xLTEtMA_259370bb-e27c-4cfe-af9c-e007f49f0178"
      unitRef="usd">4738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy0zLTEtMS0w_b1fedfcc-9ffd-4aa0-8ebd-0d25db8fdbbb"
      unitRef="usd">1007000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy02LTEtMS0w_afbbb005-a156-48db-ad97-139519e6b1cd"
      unitRef="usd">951000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy05LTEtMS0w_33644f92-5f26-49c2-b737-8bce0fa83265"
      unitRef="usd">3008000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMy0xMi0xLTEtMA_7ab8fa3b-d401-4d42-a4c7-2a86b9b4ef4c"
      unitRef="usd">2604000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC0zLTEtMS0w_ec858cea-4486-4fe3-81de-6c7ad1037b78"
      unitRef="usd">774000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC02LTEtMS0w_409fab7f-5003-4f20-8bfc-40c7c3d6a539"
      unitRef="usd">832000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC05LTEtMS0w_a49c2f95-1949-48d8-93ab-bc99cd55e294"
      unitRef="usd">2531000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNC0xMi0xLTEtMA_9635c482-337c-4b53-9750-63422f6dd750"
      unitRef="usd">2134000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS0zLTEtMS0w_360b6a69-08b8-44c6-9a84-ead66cd8d61c"
      unitRef="usd">237000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS02LTEtMS0w_0275d867-916c-48cc-bbcf-1438934f69c3"
      unitRef="usd">269000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS05LTEtMS0w_bfa98a34-ec62-470e-885f-eddda661ee0e"
      unitRef="usd">744000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNS0xMi0xLTEtMA_1c318d41-5b66-48ea-becc-ddee70bbe00e"
      unitRef="usd">690000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi0zLTEtMS0w_3d1d4a62-fdde-4655-9273-fa78b8b37419"
      unitRef="usd">200000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi02LTEtMS0w_c891896b-f450-48a2-a540-b9c09a7d7913"
      unitRef="usd">184000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi05LTEtMS0w_bce7127b-ac02-4213-84a0-e9572ce40912"
      unitRef="usd">566000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNi0xMi0xLTEtMA_88d2af98-671e-4748-8ffa-68ac2e08ce34"
      unitRef="usd">461000000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy0zLTEtMS0w_33bc0566-877e-4839-acd7-7244c1a3d70c"
      unitRef="usd">32000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy02LTEtMS0w_b11c54b5-819f-43ea-8a1e-5aeb215d0571"
      unitRef="usd">39000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy05LTEtMS0w_28193ec4-ea64-4665-9317-7a204517577c"
      unitRef="usd">104000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfNy0xMi0xLTEtMA_6d22a038-285a-492b-ba76-85d51dbd44de"
      unitRef="usd">103000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0zLTEtMS0xNzky_22a159e6-d25c-4617-b13d-82bb1e441ad1"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC02LTEtMS0xNzky_4824d9fe-9ff7-4a17-ab34-cce26330b5fc"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC05LTEtMS0xNzky_9d8e1baf-2041-4448-9680-c1d5adad6057"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0xMi0xLTEtMTc5Mg_e7ec0cee-9373-4a81-b9dc-597279ab2f5e"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:InterestExpense
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0zLTEtMS0w_0c8f375c-ed0b-417a-8353-871e385523b2"
      unitRef="usd">25000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC02LTEtMS0w_47a1aefb-aa51-45fc-8ddd-2a469efc3045"
      unitRef="usd">24000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC05LTEtMS0w_69ed50f5-31aa-41ee-8421-1eb508dd1f61"
      unitRef="usd">74000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOC0xMi0xLTEtMA_5583f21a-e586-447d-98ce-d8beb384c06b"
      unitRef="usd">74000000</us-gaap:InterestExpense>
    <clx:OtherExpenseIncomeNet
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS0zLTEtMS0w_bfca9928-3708-4f43-b203-eac8d866a6d9"
      unitRef="usd">10000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS02LTEtMS0w_18e4bdba-9572-447f-8b38-4e76b2df2759"
      unitRef="usd">19000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS05LTEtMS0w_d08e5848-5b9f-49b6-a72c-ea80127d9fe3"
      unitRef="usd">-85000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfOS0xMi0xLTEtMA_3224c852-6177-420f-bd2f-727cd4774035"
      unitRef="usd">16000000</clx:OtherExpenseIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtMy0xLTEtMA_6695d441-d1f8-4ca1-ad0b-bae8990eeafb"
      unitRef="usd">-59000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtNi0xLTEtMA_f5f4f9cf-a276-4d98-85da-8a7ae5412229"
      unitRef="usd">297000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtOS0xLTEtMA_125ac9db-d9e0-4207-b93b-50c7125ed8a3"
      unitRef="usd">799000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTAtMTItMS0xLTA_a05bc22d-8aba-4d66-ac46-96f3636e5bb6"
      unitRef="usd">790000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtMy0xLTEtMA_22c6668d-d310-45a6-8677-790e43f3a1d1"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtNi0xLTEtMA_ae0d613d-f15c-4827-b1ba-52ef96b01261"
      unitRef="usd">56000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtOS0xLTEtMA_4497f69a-e893-45d3-9fd5-e0d05bc57445"
      unitRef="usd">180000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTEtMTItMS0xLTA_0388630d-7312-4d92-878e-2e76efa9a0b1"
      unitRef="usd">161000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItMy0xLTEtMA_d1d5745b-cf5c-4f76-83e2-538825cb92e6"
      unitRef="usd">-59000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItNi0xLTEtMA_b815ea6e-f751-4386-a0e5-b6b43154096d"
      unitRef="usd">241000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItOS0xLTEtMA_95da1983-d712-496c-b3c8-cd881c2dc697"
      unitRef="usd">619000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTItMTItMS0xLTA_1ef5e935-3382-4e94-bbab-b59d5747f466"
      unitRef="usd">629000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtMy0xLTEtMA_5d3ad2ee-ba53-44c7-ba0b-612dda443d25"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtNi0xLTEtMA_b47dedf6-94c0-4837-84b5-3dcb779958a9"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtOS0xLTEtMA_7f5ff0be-7f9f-4470-8148-2eb836ab743d"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTMtMTItMS0xLTA_3aca952c-3357-49f6-adfe-cc4e0d6caba2"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtMy0xLTEtMA_22cec1a9-b88c-489c-922b-9117fc3df428"
      unitRef="usd">-61000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtNi0xLTEtMA_2ff6a3f1-fd71-4935-ae44-27e5fddd6b0e"
      unitRef="usd">241000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtOS0xLTEtMA_2c7018ad-b07d-42d4-a00b-0ceaf28e9f67"
      unitRef="usd">613000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTQtMTItMS0xLTA_d6bee922-941e-4907-a4d8-b97e2f731625"
      unitRef="usd">629000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtMy0xLTEtMA_62a9ed2c-9451-46a2-9029-08e786f60bb9"
      unitRef="usdPerShare">-0.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtNi0xLTEtMA_1bb68cd7-b4b4-43a1-99fd-8ffc7e6cd54d"
      unitRef="usdPerShare">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtOS0xLTEtMA_bec2b156-7d7c-469a-93a7-091c7e532dda"
      unitRef="usdPerShare">4.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTYtMTItMS0xLTA_e2cbca35-3b74-4805-a234-ffa04fcf15af"
      unitRef="usdPerShare">5.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctMy0xLTEtMA_0d30de19-34af-4480-b70b-5f97a3cada2d"
      unitRef="usdPerShare">-0.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctNi0xLTEtMA_c8473de1-9ba4-4e1d-b6f6-952d6cd094aa"
      unitRef="usdPerShare">1.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctOS0xLTEtMA_a61587e7-5058-4ee8-8814-d45f2c27c503"
      unitRef="usdPerShare">4.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTctMTItMS0xLTA_37f30885-2611-4ada-b401-e7a45380d457"
      unitRef="usdPerShare">4.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktMy0xLTEtMA_0f073799-e73c-4d98-834c-7232ea98a6ff"
      unitRef="shares">125610000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktNi0xLTEtMA_a899c6d7-6318-407f-a940-bb66a5a996a5"
      unitRef="shares">125661000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktOS0xLTEtMA_832dd781-87b4-4e95-be49-b65497c15600"
      unitRef="shares">126057000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMTktMTItMS0xLTA_7a938e5c-a509-407b-a4ba-994c80c9a3f9"
      unitRef="shares">125641000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtMy0xLTEtMA_2e5561b5-cc4a-4b1e-867c-5fbd24ebed0a"
      unitRef="shares">125610000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtNi0xLTEtMA_5adff037-cd36-4607-a6f3-1752d8909760"
      unitRef="shares">127328000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtOS0xLTEtMA_c3bbec71-d751-4ea7-9ddd-6dab5ec62cf1"
      unitRef="shares">128030000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjAtMTItMS0xLTA_a9510c66-1ba1-48d9-a24b-8e74a38710cb"
      unitRef="shares">127236000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItMy0xLTEtMA_7c37ff19-dc71-4bf7-93d8-cfaa54da4326"
      unitRef="usd">-37000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItNi0xLTEtMA_7bd86b81-259f-46f1-a0f3-1b3496ff6027"
      unitRef="usd">186000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItOS0xLTEtMA_cb70b2cd-49f3-4144-8ce5-483a568d53a1"
      unitRef="usd">706000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjItMTItMS0xLTA_fcd6ab18-abd1-4c2b-9ac1-f9bd99023ba5"
      unitRef="usd">575000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtMy0xLTEtMA_e0ae4333-a9d0-4428-9fbb-1d3bcf5d16a2"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtNi0xLTEtMA_5653acf4-72fc-4629-b7a5-52f9db3689e6"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtOS0xLTEtMA_d210955e-6aa3-4a65-81ea-c7badcbee563"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjMtMTItMS0xLTA_6a0b8fb5-4303-443d-aa87-b4e63db05ab0"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtMy0xLTEtMA_9d8b49cb-cfea-4ecb-8459-def9c5a1e3ca"
      unitRef="usd">-39000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtNi0xLTEtMA_ae1c7177-5514-4728-958f-d78b1f228e72"
      unitRef="usd">186000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtOS0xLTEtMA_21759436-9cbc-4af5-b422-b634ed4d7a28"
      unitRef="usd">700000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMC9mcmFnOjg5ZDY1NmMyY2Q3NTQ1NGI4MmNkNGQ2NjNiYjIyODhmL3RhYmxlOjdmNTZmZjY3YTZhYjQ2MDM4OGM1MmY0NDJkZTQ0YWY0L3RhYmxlcmFuZ2U6N2Y1NmZmNjdhNmFiNDYwMzg4YzUyZjQ0MmRlNDRhZjRfMjQtMTItMS0xLTA_3c834e54-2a01-4844-a4d1-429e21f4bdc3"
      unitRef="usd">575000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNC0yLTEtMS0w_dc738182-24f9-4105-a53c-001ed2f32241"
      unitRef="usd">492000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNC01LTEtMS0w_25e7483a-e65c-4d5e-a8b6-1fdf8bda75b9"
      unitRef="usd">871000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNS0yLTEtMS0w_211959d0-017a-4d6a-937a-0e2df5e086bf"
      unitRef="usd">643000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNS01LTEtMS0w_438df0ae-ba06-4d80-bae2-3f094b51f3ca"
      unitRef="usd">648000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNi0yLTEtMS0w_8e996716-f12c-465e-8860-35ae9ecce79d"
      unitRef="usd">688000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNi01LTEtMS0w_54d031d4-4d7c-4c35-b793-ef0121d291a3"
      unitRef="usd">454000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNy0yLTEtMS0w_a3eefe73-f265-4c84-b774-72b5e8b01119"
      unitRef="usd">139000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNy01LTEtMS0w_8b2b9df2-d113-44de-83eb-b2f005b0a17b"
      unitRef="usd">47000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOC0yLTEtMS0w_6a254e4b-717f-45ef-99e8-01a9077c9320"
      unitRef="usd">1962000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOC01LTEtMS0w_ce419d24-4ba7-4fa6-830a-db4cca0d4b0e"
      unitRef="usd">2020000000</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0wLTEtMS0wL3RleHRyZWdpb246NWJkYTQwMjYzMjlkNDU3ZTkyOTdlYmE5NjQ0MGM1YTdfOTY_7eb18b70-b383-4231-853d-da7538e8b9f9"
      unitRef="usd">2351000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0wLTEtMS0wL3RleHRyZWdpb246NWJkYTQwMjYzMjlkNDU3ZTkyOTdlYmE5NjQ0MGM1YTdfMTAz_e171fc51-c167-4e03-8a70-2f0c673681e2"
      unitRef="usd">2224000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS0yLTEtMS0w_cac56a14-b0c1-4192-8e92-9d230c5b317e"
      unitRef="usd">1251000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfOS01LTEtMS0w_5a5abd8e-75f7-406f-9f64-f0e687056c4a"
      unitRef="usd">1103000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTAtMi0xLTEtMA_97cafca0-442a-410f-85dc-c3b1080ef2d8"
      unitRef="usd">328000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTAtNS0xLTEtMA_742b81fb-2cd8-4a35-995f-ec0be3e6ebf8"
      unitRef="usd">291000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTEtMi0xLTEtMA_d292aef5-a113-4b93-a892-56b80017941a"
      unitRef="usd">1574000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTEtNS0xLTEtMA_84fc3f9d-09e1-472f-903a-ba702ef0ed12"
      unitRef="usd">1577000000</us-gaap:Goodwill>
    <clx:TrademarksNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTItMi0xLTEtMA_c961fffc-b44b-4d6f-a3ce-a5c45468cb4a"
      unitRef="usd">694000000</clx:TrademarksNet>
    <clx:TrademarksNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTItNS0xLTEtMA_d8d9fe86-7a8b-4c5a-b77b-5256fefa8e64"
      unitRef="usd">785000000</clx:TrademarksNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTMtMi0xLTEtMA_c367541a-87e7-4470-a407-89073245c8a7"
      unitRef="usd">246000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTMtNS0xLTEtMA_0820cda9-4a2c-4f95-b774-431915ab3761"
      unitRef="usd">109000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTQtMi0xLTEtMA_1af0e357-1b3d-4dd8-90b9-590b81b6043b"
      unitRef="usd">386000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTQtNS0xLTEtMA_af1aab63-2822-4f31-921b-e7b32e200ecf"
      unitRef="usd">328000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTUtMi0xLTEtMA_160ce2f3-6dab-4ccb-a1d4-9a0cfd990dc9"
      unitRef="usd">6441000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTUtNS0xLTEtMA_f74a9b26-d572-4b25-a92f-6e4184da8026"
      unitRef="usd">6213000000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTktMi0xLTEtMA_0e5a5528-eaf3-429d-bc28-1501e172521b"
      unitRef="usd">300000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMTktNS0xLTEtMA_ea80f321-181b-450d-af19-26f89b0184d6"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjAtMi0xLTEtMA_a263f553-c42b-4821-9485-f50325559412"
      unitRef="usd">74000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjAtNS0xLTEtMA_2af36b19-c2b6-4b8a-a835-7634537827e2"
      unitRef="usd">64000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjEtMi0xLTEtMA_69541083-f977-4b8f-b355-4c1445ec1d73"
      unitRef="usd">1445000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjEtNS0xLTEtMA_5e5aa93e-b361-4076-af41-de24bacd6d67"
      unitRef="usd">1329000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjItMi0xLTEtMA_dd5e63a0-a5e2-439b-befc-82f55ad8aa6e"
      unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjItNS0xLTEtMA_3ad3ef0f-fbc0-4695-ac51-c037dc8cd1d0"
      unitRef="usd">25000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjMtMi0xLTEtMA_15fe5315-0f50-4852-b7f2-e0275d2ce7a5"
      unitRef="usd">1819000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjMtNS0xLTEtMA_64177fdf-60ab-438a-9d17-61d706761ba8"
      unitRef="usd">1418000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjQtMi0xLTEtMA_5893d3fb-9267-42be-92f4-ac9cf30e7969"
      unitRef="usd">2483000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjQtNS0xLTEtMA_e4ba9893-0c7e-47ad-81f8-ef531d64248d"
      unitRef="usd">2780000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjUtMi0xLTEtMA_f5bda79f-3b4f-40d8-96fc-a46621c2c88d"
      unitRef="usd">305000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjUtNS0xLTEtMA_20800eb9-b3ea-48b0-8d56-31c45d3a0046"
      unitRef="usd">278000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjYtMi0xLTEtMA_cf7a58d6-1929-4473-aaf7-a7bf54e00713"
      unitRef="usd">819000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjYtNS0xLTEtMA_3aa029eb-baaa-4a2d-983d-581847059398"
      unitRef="usd">767000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjctMi0xLTEtMA_fd3f45e6-fd6a-45b9-a19f-be5630f18ba7"
      unitRef="usd">77000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjctNS0xLTEtMA_e699a1f6-87ed-406b-b0d1-7026260d47f5"
      unitRef="usd">62000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjgtMi0xLTEtMA_791219d2-12dc-41ea-a572-4062509d4b46"
      unitRef="usd">5503000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjgtNS0xLTEtMA_411901f7-a96e-43d1-92ed-0a6d3e09a34a"
      unitRef="usd">5305000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjktMi0xLTEtMA_2c59feeb-9ca5-44b2-bc52-06a905a0b33d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMjktNS0xLTEtMA_cd988e56-164a-4c39-928e-e921b29d2f02"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzIx_151cf77b-de33-42b1-ab0b-f55c67383601"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzIx_f842d027-7635-444c-bcf4-be38d25c93be"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzM1_a78e8023-c054-477d-979b-e2d06384b8ff"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzM1_ffdcffdd-33e1-48df-a51f-b58587dadfff"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_70c3f543-f0d7-40b1-bd80-a788cadf39e4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_85f6a7a5-8e56-41c0-b8b6-7c5da7ed168b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_ebdc538d-8b8b-409b-be73-13b6d2e365bb"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmM1MzcyMDJiZjlhNjRhYzRhN2NjNmQyMjM4Y2FlYjA2XzU3_fdb7c311-b9f2-47fc-a2c8-b9a4a1326bdf"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtMi0xLTEtMA_fa94fc95-6d57-4119-9b62-3bb9a790183d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzEtNS0xLTEtMA_450d34a6-ed1b-4b3a-accb-a4aef5e63a90"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE5_285eb170-289b-4a67-b9ea-cc14360a5cab"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE5_f25f6281-2767-4d37-85b7-7e2981650fd3"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzMz_67518330-ae10-4b71-97ed-95b172bb3772"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzMz_c7e1c13f-ea59-4d56-af72-17050f5c46c0"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzU1_a2a779c6-834b-468e-a4b6-c50826556c69"
      unitRef="shares">130741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzYy_fddfa76e-0e71-4476-9176-f2c939c08437"
      unitRef="shares">158741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE0MA_7804082e-a91a-42b6-acb4-978eb5e983e8"
      unitRef="shares">124359712</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjk5MWVjNWI0MDhlMjQzN2E4MGE4OTQxODNlYjU5OGIxXzE0Nw_9830e209-469f-49ed-bd74-04159896d30e"
      unitRef="shares">126198606</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItMi0xLTEtMA_66d9da20-1533-4366-b4d6-f08fb356d36b"
      unitRef="usd">131000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzItNS0xLTEtMA_9c1086a3-f8c4-4d8e-afee-3574c919c0a9"
      unitRef="usd">159000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzMtMi0xLTEtMA_4fae882e-2b2e-4664-b3b7-0f8ecf13cb78"
      unitRef="usd">1190000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzMtNS0xLTEtMA_3da8e3db-09ef-43ef-b8bb-bd7a44a50fde"
      unitRef="usd">1137000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzQtMi0xLTEtMA_b5a7d4c2-469f-4536-8f19-6ca896ccec96"
      unitRef="usd">1086000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzQtNS0xLTEtMA_5d359f95-55b3-4d58-a5fb-58439fa0f428"
      unitRef="usd">3567000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMwYjY5OTE4ZDhjODRjNjU5ZDNmYmQ3YjYxMDNkN2UzXzMw_a1b00cf9-af27-43e0-acc2-fa15b78d120a"
      unitRef="shares">6381749</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMwYjY5OTE4ZDhjODRjNjU5ZDNmYmQ3YjYxMDNkN2UzXzM3_0e983c03-adda-4c37-bdaf-1ba4a9f34c66"
      unitRef="shares">32542855</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtMi0xLTEtMA_fd521187-8909-4374-b022-f294e6a9006a"
      unitRef="usd">1111000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzUtNS0xLTEtMA_6612fd45-3e6d-481d-9a2f-032f78e5be1c"
      unitRef="usd">3315000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzYtMi0xLTEtMA_2c9f5860-f4d9-4093-a134-ae73801a6a6f"
      unitRef="usd">-553000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzYtNS0xLTEtMA_d4db6d13-059c-4aa6-a59c-b2904cd2f5d4"
      unitRef="usd">-640000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzctMi0xLTEtMA_3a581c0b-ff64-4623-ad91-0fb4702447b6"
      unitRef="usd">743000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzctNS0xLTEtMA_948a770b-711f-4d8a-a25f-813322a405ea"
      unitRef="usd">908000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzgtMi0xLTEtMA_18c42826-2ae2-4bc0-aacb-5725d122b392"
      unitRef="usd">195000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzgtNS0xLTEtMA_3df4640a-f8c7-4223-81cb-27e5bfe889a0"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzktMi0xLTEtMA_7dc463ec-0bc9-4e35-b38c-feefd59d9ede"
      unitRef="usd">938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfMzktNS0xLTEtMA_c9f846a3-92b0-4e42-b778-f7ad81a5d254"
      unitRef="usd">908000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNDAtMi0xLTEtMA_cc12a62d-2096-4166-b2ee-cfeeea621ff3"
      unitRef="usd">6441000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xMy9mcmFnOjJmMjE1ODFiYmVlNzQ0ZDNhYjgzNThjZGQxZjIyYzI3L3RhYmxlOmI4MjU1Y2JjMWJlMTQ2MThiYWM3OWQ4NmQwYTQ3MGM4L3RhYmxlcmFuZ2U6YjgyNTVjYmMxYmUxNDYxOGJhYzc5ZDg2ZDBhNDcwYzhfNDAtNS0xLTEtMA_35744141-3501-4501-b3a7-b2a71ba186d0"
      unitRef="usd">6213000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMy0yLTEtMS0w_cb8c06ee-1d56-435a-a300-51b90e16b201"
      unitRef="usd">619000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMy01LTEtMS0w_d4a87edb-f242-47ac-919e-2aa68159169c"
      unitRef="usd">629000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNS0yLTEtMS0w_7ac338ee-f305-4158-8508-54a77c7e0492"
      unitRef="usd">157000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNS01LTEtMS0w_9c59cf1c-8339-4c91-9c16-ee10754f76f3"
      unitRef="usd">133000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNi0yLTEtMS0w_18908c95-7b18-4c9b-b23a-bde83b2d7672"
      unitRef="usd">52000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNi01LTEtMS0w_69046f7a-153d-4378-b477-6e0e4cc180bc"
      unitRef="usd">37000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNy0yLTEtMS0w_51c08a79-a04e-4535-b15d-7869e77b0d86"
      unitRef="usd">-21000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfNy01LTEtMS0w_dfb78a35-335b-4774-a352-49d8e2637151"
      unitRef="usd">5000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AssetImpairmentCharges
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC0yLTEtMS0xMjcw_e2b91f01-c2e8-4d32-891d-c7e03076a1f7"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC01LTEtMS0xMjY3_56c0ff16-06c5-476f-8e0f-64ef0d0156c8"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC0yLTEtMS0w_91ee3e9e-8565-4f2c-80c2-3e9e00002f64"
      unitRef="usd">53000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfOC01LTEtMS0w_2b80b538-7656-487c-887b-9c50432678ba"
      unitRef="usd">-26000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTAtMi0xLTEtMA_efae1199-4741-4b3c-97f2-5c21838fdda2"
      unitRef="usd">-46000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTAtNS0xLTEtMA_be7ec451-dfcc-4c5b-9482-fa4db1c82723"
      unitRef="usd">102000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTEtMi0xLTEtMA_65970894-f89c-4254-a8e3-bbc4848eedb3"
      unitRef="usd">220000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTEtNS0xLTEtMA_86f57b3a-56e9-4b64-9d2f-16a405f3f3a9"
      unitRef="usd">-50000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTItMi0xLTEtMA_89e6ca24-bd96-4168-bc24-ef03b626a604"
      unitRef="usd">29000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTItNS0xLTEtMA_a37f40aa-d43b-4834-8786-28cb569f266a"
      unitRef="usd">6000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTMtMi0xLTEtMA_8f65d91e-d6ad-4e49-8365-8fc7a5e353df"
      unitRef="usd">94000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTMtNS0xLTEtMA_435a9ebd-7bf4-4a8b-8398-b832894454f4"
      unitRef="usd">53000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTQtMi0xLTEtMA_87fcf3dd-eea5-48c7-a30b-ccea698faccc"
      unitRef="usd">-1000000</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTQtNS0xLTEtMA_951f501c-cbcc-436c-959f-b0d355cdad58"
      unitRef="usd">7000000</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTUtMi0xLTEtMA_f4606428-27a7-4985-b279-ad6c8ec501f0"
      unitRef="usd">-80000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTUtNS0xLTEtMA_3db5952f-bc1b-4972-a9b7-0642b6717f11"
      unitRef="usd">-26000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTYtMi0xLTEtMA_c8f642ff-a8dc-4735-bede-df88da906f72"
      unitRef="usd">893000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTYtNS0xLTEtMA_7b306c2c-717d-4805-be16-95bd0fbba3f4"
      unitRef="usd">806000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTgtMi0xLTEtMA_26bd523b-0bae-4f75-8015-89956974e38a"
      unitRef="usd">232000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTgtNS0xLTEtMA_4fe6e080-1573-4d09-b6ad-80bbd71d6a04"
      unitRef="usd">158000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTktMi0xLTEtMA_c1b742c9-f6e2-485e-ba19-38fd5415edd6"
      unitRef="usd">85000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMTktNS0xLTEtMA_b87cee24-3c56-4da3-b998-82e66d3ffba4"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjAtMi0xLTEtMA_e5f221b5-3157-4553-a600-2a0b7be4e25c"
      unitRef="usd">24000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjAtNS0xLTEtMA_13c85099-c514-4c8c-a3ee-7a963c44cc81"
      unitRef="usd">-13000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjEtMi0xLTEtMA_ec8dac78-4724-40c7-8342-8ffcae331b8b"
      unitRef="usd">-341000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjEtNS0xLTEtMA_27c3276d-c03f-4061-bbc2-51fb89d55df7"
      unitRef="usd">-145000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjMtMi0xLTEtMA_a97a6091-0180-41f6-8001-d8210409d7fc"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjMtNS0xLTEtMA_a1c2bcdb-fc0b-483a-b106-d6aa56b49776"
      unitRef="usd">234000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjQtMi0xLTEtMA_1f5f1683-b26c-4a87-8eee-93cca0c7ae9e"
      unitRef="usd">605000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjQtNS0xLTEtMA_7965d57e-19cc-49ce-989a-6976d64425bc"
      unitRef="usd">225000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjUtMi0xLTEtMA_da5741c4-8da7-4ff6-8f10-96d6e1dc8cb3"
      unitRef="usd">420000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjUtNS0xLTEtMA_292a875e-0137-4def-8ebd-1e3f8a23d807"
      unitRef="usd">399000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjYtMi0xLTEtMA_05154e7c-165c-4258-801e-e6b74e2ec952"
      unitRef="usd">18000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjYtNS0xLTEtMA_89ab1dac-69e3-4314-bbf5-86688ba44b67"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsMinorityInterest>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjctMi0xLTEtMA_788d8cc9-248b-405f-b825-38f485e926ef"
      unitRef="usd">99000000</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjctNS0xLTEtMA_0c4a38e2-d3a9-490f-a76d-36e2aedaf5e6"
      unitRef="usd">129000000</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjgtMi0xLTEtMA_ccbc1695-92dc-4a6d-81f6-00c9fdb66fcf"
      unitRef="usd">-944000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjgtNS0xLTEtMA_ef2357d5-7441-46d3-98d9-cd1df8c016c0"
      unitRef="usd">-261000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjktMi0xLTEtMA_38d0dfe6-6dba-4041-9ccb-d79e20ef3a4d"
      unitRef="usd">10000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMjktNS0xLTEtMA_1e7c917a-d182-48b3-b34f-079e6f00f498"
      unitRef="usd">-8000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzAtMi0xLTEtMA_d0f67844-06e0-4844-a0cf-2124d465eb3d"
      unitRef="usd">-382000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzAtNS0xLTEtMA_708b7b67-ac22-4a94-bed2-27b31d6b8d8e"
      unitRef="usd">392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzItMi0xLTEtMA_b13fefd0-9d93-4049-b55a-dc1b9e3b9372"
      unitRef="usd">879000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id7e8d63f491f423baa88abae57588736_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzItNS0xLTEtMA_c508bb42-ad22-4585-ac7c-deaccff9de02"
      unitRef="usd">113000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzMtMi0xLTEtMA_e20c8e7f-6b99-4b10-a12a-24fea7c9d58a"
      unitRef="usd">497000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xNi9mcmFnOjQ4MjQ4M2RjYTE3YjRkMTBiZWVkMDAzZTNiMDg1YWVlL3RhYmxlOjE0YTA3Y2JmYmYwMDRhZGU4MzlmNTZjMDljMTRlYzc1L3RhYmxlcmFuZ2U6MTRhMDdjYmZiZjAwNGFkZTgzOWY1NmMwOWMxNGVjNzVfMzMtNS0xLTEtMA_84d02b54-11bf-4594-9342-0f8bd4485aad"
      unitRef="usd">505000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ1OA_226f0626-ddd4-45e1-9411-82242ce83733">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2020, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, &#x201c;Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,&#x201d; which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;In January 2017, the FASB issued ASU No. 2017-04, &#x201c;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#x201d; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company&#x2019;s consolidated financial statements at the time of adoption. The impairment identified in the third quarter of fiscal year 2021 was calculated in accordance with this guidance. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ2OA_779ca856-8a2a-4b62-965f-29aac855c278">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2020, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18xOS9mcmFnOjhjZDMwM2Y0MjZiMDQ4YTJiNGQwYjRkYTA4ZDE4M2JlL3RleHRyZWdpb246OGNkMzAzZjQyNmIwNDhhMmI0ZDBiNGRhMDhkMTgzYmVfMzQ2MQ_1f3133fe-51f9-4da1-8b8c-8f5e0e41cb20">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, &#x201c;Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,&#x201d; which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;In January 2017, the FASB issued ASU No. 2017-04, &#x201c;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#x201d; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company&#x2019;s consolidated financial statements at the time of adoption. The impairment identified in the third quarter of fiscal year 2021 was calculated in accordance with this guidance. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzUwOQ_232cd3fe-2344-4dd9-b7d6-296e905ea8b3">BUSINESS ACQUIRED&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Saudi Joint Venture Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 9, 2020, the Company increased its investment in each of the two entities comprising its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture). The joint venture offers customers in the Gulf region a range of cleaning and disinfecting products. The Company had previously accounted for its 30 percent investment of $27 as of June 30, 2020, under the equity method of accounting. Subsequent to the closing of this transaction, the Company&#x2019;s total ownership interest in each of the entities increased to 51 percent. The Company has consolidated this joint venture into the Company&#x2019;s consolidated financial statements from the date of acquisition and reflects operations within the International reportable segment. The equity and income attributable to the other joint venture owners is recorded and presented as noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The total purchase consideration of $111 consisted of $100 cash paid, which was sourced from operations, and $11 from the net effective settlement of preexisting arrangements between the Company and the joint venture. The assets and liabilities of the joint venture were recorded at their respective estimated fair value as of the acquisition date using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill in the International reportable segment in the amount of $208. The goodwill is primarily attributable to the synergies expected to arise after the acquisition and reflects the value of further growth anticipated in the Gulf region. None of the goodwill is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As a result of this transaction, the carrying value of the Company&#x2019;s previously held equity investment was remeasured to fair value, and resulted in an $85 non-recurring, non-cash gain recorded in Other (income) expense, net in the condensed consolidated statement of earnings and adjusted in Other operating activities in the condensed consolidated statement of cash flows for the first quarter of fiscal year 2021. The fair values of the noncontrolling interests and previously held equity interest were determined using a discounted cash flow (DCF) method under the income approach. Under this approach, the Company estimates future cash flows and discounts these cash flows at a rate of return that reflects the entities&#x2019; relative risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price allocation was finalized during the second quarter of fiscal year 2021. The following table summarizes the final purchase price allocation for the fair value of the joint venture&#x2019;s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired rights (included in Other intangible assets, net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships (included in Other intangible assets, net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Working capital, net (includes cash acquired of $26)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Fair value of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Fair value of previously held equity interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Included in the Company&#x2019;s results for the three and nine months ended March 31, 2021 was $19 and $65, respectively, of net sales from the joint venture. Pro forma results reflecting this transaction were not presented because it is not significant to the Company&#x2019;s consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i70dc6fb701fd4f5da398121fd36e0360_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzc2_d83ebd2b-331e-4592-a61d-689e2fea311c"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i70dc6fb701fd4f5da398121fd36e0360_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzkz_aad9b792-6e0a-435c-aa7b-6e02bd49b48f"
      unitRef="usd">27000000</us-gaap:EquityMethodInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="icf6b73a611c5439c9ddb772f505d1455_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfNTc5_463e94ec-607d-4633-8ba8-a5fb5ece9d16"
      unitRef="number">0.51</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfOTQz_9d71a166-5fde-468a-b54c-5ca5b9efb980"
      unitRef="usd">111000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfOTU5_2d92ebd6-d31f-4faf-90e7-c433ccead52b"
      unitRef="usd">100000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <clx:BusinessCombinationSettlementOfPreExistingNetLiabilities
      contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTAxMg_e375ad7b-f0ad-4625-bec2-72a9c3d33d48"
      unitRef="usd">11000000</clx:BusinessCombinationSettlementOfPreExistingNetLiabilities>
    <us-gaap:Goodwill
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTUwNQ_b5ea7664-f944-4e94-b204-0d08cf733c3a"
      unitRef="usd">208000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTY3OA_760d3680-4304-428f-831f-70eb5c20c101"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
      contextRef="ia0bfdd2f36fa40ae8884cec528927862_D20200701-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMTg4Mg_9c47dd89-f7c6-41f9-80c2-9807436ec554"
      unitRef="usd">85000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzUwOA_f4b3db99-7ef0-4002-a0fa-de819744c983">The following table summarizes the final purchase price allocation for the fair value of the joint venture&#x2019;s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired rights (included in Other intangible assets, net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships (included in Other intangible assets, net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Working capital, net (includes cash acquired of $26)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Fair value of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Fair value of previously held equity interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzIwNQ_b753fc5e-c1de-445a-9da8-cea2c39d9a6f">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMS0xLTEtMS0w_319d536a-3bd0-4175-bda5-d9d3e3301510"
      unitRef="usd">208000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic7e26e45946444a8a31e317e4a6335eb_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMi0xLTEtMS0w_c6d067c5-185f-4b14-821f-538ca2c13593"
      unitRef="usd">138000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMy0xLTEtMS0w_a360d620-49cd-40a1-adc5-cebe4447705f"
      unitRef="usd">46000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i89e347afcab74ff6bc8d31a740d9a89c_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNC0xLTEtMS0w_59198380-5eaf-4c28-aab5-6aea179e89fd"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNS0wLTEtMS0wL3RleHRyZWdpb246ZjIxMzllN2NkODNlNDJjNDg2ZWM2NTQyZThlYTRkZDNfNTI_f82591a9-35e1-4f3e-848f-d964fa3a0040"
      unitRef="usd">26000000</us-gaap:CashAcquiredFromAcquisition>
    <clx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNS0xLTEtMS0w_858735aa-3b70-4cd0-943b-9ecb5c811fc8"
      unitRef="usd">34000000</clx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNi0xLTEtMS0w_1d326792-576d-42a5-ad07-3f3c04a2f977"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfNy0xLTEtMS0w_71d86870-1427-402d-8b0b-5c17d658bd37"
      unitRef="usd">19000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfOC0xLTEtMS0w_9679e736-32f9-41d8-b223-349bf291b1b6"
      unitRef="usd">412000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i4df9eff9aad24233b734b8a995abf5f0_I20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfOS0xLTEtMS0w_4ed320b7-8b3d-4b38-97b5-eca7ecb87e5c"
      unitRef="usd">198000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTAtMS0xLTEtMA_fac6e427-d5c3-4e34-8125-7e9c25c8cb26"
      unitRef="usd">103000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6207481623664ec1814a48acc2f0fad1_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTEtMS0xLTEtMA_65ac997b-c6e5-41bd-856c-4dbe335625bd"
      unitRef="usd">111000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RhYmxlOmNhOTYzMGFmNzI0NTQyNDM4YTBjMWY2MjMxNWU3MGRhL3RhYmxlcmFuZ2U6Y2E5NjMwYWY3MjQ1NDI0MzhhMGMxZjYyMzE1ZTcwZGFfMTEtMS0xLTEtMA_fe0ec3fe-eaa8-465c-a38e-a455f9c6262a"
      unitRef="usd">111000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzMwNA_b8c28599-24fa-4f99-807b-2359218a2f65"
      unitRef="usd">19000000</clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod>
    <clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yMi9mcmFnOjhhNDkxM2E2ZThjZDRiNmQ5NDg1MzFkYjBiZTc4NWM5L3RleHRyZWdpb246OGE0OTEzYTZlOGNkNGI2ZDk0ODUzMWRiMGJlNzg1YzlfMzMxMQ_6c7dd4a6-ac34-4799-980f-207b7c226156"
      unitRef="usd">65000000</clx:BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RleHRyZWdpb246MDA3OTNkODE4MDc2NGM0Nzk4Nzg0YmI0Nzg3ZWFjMDRfODQ_0070ab55-c236-4a65-92fe-390ae8276e10">INVENTORIES, NET&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RleHRyZWdpb246MDA3OTNkODE4MDc2NGM0Nzk4Nzg0YmI0Nzg3ZWFjMDRfODk_e6a0c4c8-b5e9-4516-9990-b6b7d804e328">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMS0xLTEtMS0w_a3fde5a6-8d92-46cc-b836-cc2fda95b989"
      unitRef="usd">522000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMS0zLTEtMS0w_c5ae3b2e-1249-40d4-92a0-97d6a6c80984"
      unitRef="usd">340000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMi0xLTEtMS0w_6a2d82bb-4069-462c-adf8-1b17ca92f86d"
      unitRef="usd">188000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMi0zLTEtMS0w_79956b7f-9eea-42c0-818a-4fe04aaa44d9"
      unitRef="usd">140000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMy0xLTEtMS0w_60c86ca3-0577-4869-82e3-a35c06a6ee7d"
      unitRef="usd">10000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfMy0zLTEtMS0w_a0797e3c-6518-4318-8c99-9d88dd4eccf4"
      unitRef="usd">7000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryLIFOReserve
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNC0xLTEtMS0w_da7d503e-98f2-4d9b-a030-30d5a4259963"
      unitRef="usd">32000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNC0zLTEtMS0w_f58615fc-63b8-4ccf-a56d-f3605e4eac0d"
      unitRef="usd">33000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryNet
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNS0xLTEtMS0w_4cab4ab6-e1f7-4015-8d27-e594361ad3ff"
      unitRef="usd">688000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yNS9mcmFnOjAwNzkzZDgxODA3NjRjNDc5ODc4NGJiNDc4N2VhYzA0L3RhYmxlOjk3MTY0NmNlZTljMjRiNmU5OWM0YjQ0MmEwMzBjYmM3L3RhYmxlcmFuZ2U6OTcxNjQ2Y2VlOWMyNGI2ZTk5YzRiNDQyYTAzMGNiYzdfNS0zLTEtMS0w_581597f7-4170-4e50-970d-f1c66a5eda44"
      unitRef="usd">454000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzA_dc8b26a8-509c-418a-8ce1-8b6059a5f779">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal 2021, as a result of lower than expected actual and projected net sales growth and operating performance for the Vitamins, Minerals and Supplements (VMS) strategic business unit (SBU), a strategic review was initiated by management that resulted in updated financial and operational plans. These events were considered a triggering event requiring interim impairment assessments to be performed on the VMS reporting unit, indefinite-lived trademarks and other assets. Based on the outcome of these assessments, the following pre-tax impairment charges were recorded:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment Charge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of $62 due to the partial tax deductibility of these charges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment charges are a result of a higher level of competitive activity than originally assumed, accelerated declines in the channel where the business is over-developed, and higher than anticipated investments to grow the business, which have adversely affected the assumptions used to determine the fair value of the respective assets held by the VMS reporting unit for growth and the estimates of expenses necessary to achieve that growth. These impairment charges are based on the Company&#x2019;s current estimates regarding the future financial performance of the VMS SBU and macroeconomic factors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. Under this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, and a terminal growth rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of Goodwill as of March&#160;31, 2021 from June&#160;30, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes $(4) purchase price allocation adjustment related to the Saudi joint venture acquisition. Refer to Note 2 of the Notes to Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the estimated fair values of the VMS related indefinite-lived trademarks, which were included within the Health and Wellness reportable segment, the Company used the income approach. This approach requires significant judgments in determining the royalty rates and the assets&#x2019; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $13 as of March 31, 2021, were changed from indefinite to definite beginning on April 1, 2021, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is&#160;16 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks not subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense relating to the Company&#x2019;s intangible assets was $8 and $23 for the three and nine months ended March&#160;31, 2021, respectively, and $3 and $10 for the three and nine months ended March&#160;31, 2020, respectively. Estimated amortization expense for these intangible assets is $8, $32, $30, $29 and $28 for the remainder of fiscal year 2021 and fiscal years 2022, 2023, 2024 and 2025, respectively.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NTQwNzA_80f0a641-c169-4d0f-b01c-bf0606ea6c36">Based on the outcome of these assessments, the following pre-tax impairment charges were recorded:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment Charge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzEtMS0xLTEtMTYxNA_78153768-4e50-4f02-a287-a600be40b36d"
      unitRef="usd">228000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzItMS0xLTEtMTYxOQ_6aa9511f-e782-4a41-aa88-788cbca6f704"
      unitRef="usd">86000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="icb066f8d893346ca9951f248d0dcb802_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzMtMS0xLTEtMTYyMw_fa131bcb-7912-491f-87ec-5ff48b036e1e"
      unitRef="usd">14000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzQtMS0xLTEtMjE0NQ_9cf9ec3d-98b8-4f0d-a1b6-d208eaea7fcc"
      unitRef="usd">1000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTowMmQyZGMzNWZjYjI0YWM1YTY0MTRlOGY2MmQ3MGI5Zi90YWJsZXJhbmdlOjAyZDJkYzM1ZmNiMjRhYzVhNjQxNGU4ZjYyZDcwYjlmXzQtMS0xLTEtMTYyOA_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNjQ_107f87e1-bce6-460b-8084-6256cebd3b36"
      unitRef="usd">62000000</clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzE_954a731b-e242-4c86-b905-cac28150c1e8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of Goodwill as of March&#160;31, 2021 from June&#160;30, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes $(4) purchase price allocation adjustment related to the Saudi joint venture acquisition. Refer to Note 2 of the Notes to Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib928fec9941c44d881ae5b71182e1e12_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItMS0xLTEtMTMxNQ_8563a75f-a93d-428b-a581-7dac5d46ebf2"
      unitRef="usd">857000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i185542c2acc246eabdad2e53c4d02ecd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItMy0xLTEtMTMxNQ_6c4f296a-13ae-4f91-90a9-2ea02a78dde9"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9fbc5f5127cf42d98d38f3b2282c7508_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItNS0xLTEtMTMxNQ_5df8597c-47dc-4885-86eb-9378c8972f89"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i86cded78606f40eda58cf54289cc6c46_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItNy0xLTEtMTMxNQ_b54247be-32b9-47b8-929f-b5ec9c55422a"
      unitRef="usd">391000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzItOS0xLTEtMTMxNQ_2e3b1272-197b-47d0-8f26-0dafd5e116e2"
      unitRef="usd">1577000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtMS0xLTEtMTMxNQ_4df27b11-2d4a-4090-8a92-81b04fda1a85"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtMy0xLTEtMTMxNQ_299bc8fd-f514-49b7-8109-b185a194397d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtNS0xLTEtMTMxNQ_cb214208-e6bd-46a6-895c-1b51aada7222"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtNy0xLTEtMTMxNQ_0ccfcc05-9b41-40a0-89cc-0881123e418b"
      unitRef="usd">212000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i69b5e8efae404d60976021d1249edef6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzMtOS0xLTEtMTMxNQ_e727c942-b24e-4d97-aa83-e71b4c3433d4"
      unitRef="usd">212000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib84d4c91a5a6499f9dc4a85aeaad1227_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtMS0xLTEtMTMxNQ_c251f936-1ec7-4766-9ec6-fa66090e89bf"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i34c8f7dbc5844f42ac9ce3c931a475ab_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtMy0xLTEtMTMxNQ_24007cc3-2b50-4509-9cd3-577cef60bfdc"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="idb68cd51fbc54f60b2fee361a939ed9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtNS0xLTEtMTMxNQ_752b1564-05af-41d9-8f0d-32674cdffe8e"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ief9e8d97c32e48749e4fcf82a2f8383f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtNy0xLTEtMTMxNQ_465edf3d-42a8-4d0e-a3cb-3375e9401132"
      unitRef="usd">4000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i69b5e8efae404d60976021d1249edef6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzQtOS0xLTEtMTMxNQ_f123826a-b7ad-49f7-8dd4-05a52ae99813"
      unitRef="usd">4000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i2df6541afbcc471caf5020183b1aae27_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtMS0xLTEtMTMxNQ_9057909d-3d92-4211-9302-222f0c360ad0"
      unitRef="usd">857000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iea72635ffc9249a5b85b28d91061578c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtMy0xLTEtMTMxNQ_fd65fc0a-735b-4c9f-b392-e38714c115a7"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0abb07fff33f4729b2158873d5eaa9ef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtNS0xLTEtMTMxNQ_6d32a871-b2c4-4aac-9bbd-a264f584fdb6"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6521a378432044e2818b18ae9a3f504f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtNy0xLTEtMTMxNQ_d950a82a-bcff-496d-946c-05f73c6c8129"
      unitRef="usd">607000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4a0bf84a649f46e6b8628a79d40bb4bc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzUtOS0xLTEtMTMxNQ_8c97877b-5809-4a20-8348-96e2b69ae1ec"
      unitRef="usd">1793000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i7e8e270257da49d0ba55eec6af3548a5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtMS0xLTEtMTMxNQ_9e847cff-c66e-4016-b83f-a0a025765aeb"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i37bcf0ca8f2c418d8e3ad8f1d725a7e8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtMy0xLTEtMTMxNQ_2105aafe-3659-4e56-ac3f-87849b8f01e4"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib1ac31a8e85142168910ba397dd1998f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtNS0xLTEtMTMxNQ_7c8436d5-ec69-41ea-a7be-daee550c8288"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i6a21685ce7e9490d85a6bb3145bbe8b4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtNy0xLTEtMTMxNQ_86731d79-2c3c-448d-b39b-e678a288bd87"
      unitRef="usd">10000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5f50a3afc8254aee87ec15cc7d3a1236_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzYtOS0xLTEtMTMxNQ_c6937a56-aaff-4cb5-84ea-692e23822f64"
      unitRef="usd">10000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i087ce4ee5c5f43ffbc5df3b0be560c27_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctMS0xLTEtMTMxNQ_a7d57791-6793-46c7-8cf7-bcc1b495a062"
      unitRef="usd">857000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i95c431b3b55c4f679f28a6d7fe216a9e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctMy0xLTEtMTMxNQ_c5a034ef-2f81-4d8c-adb4-f58164efa163"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i43cba4b272444bd38c66ff3c5246316d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctNS0xLTEtMTMxNQ_fbda71cb-5bf0-45d2-8881-65748feb531d"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic8b5149e800a4c518f7685d164029449_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctNy0xLTEtMTMxNQ_5228eec0-c255-46ea-9d83-98a25ea0dac2"
      unitRef="usd">617000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i56a82930ba8c46a8842474109384e6c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzctOS0xLTEtMTMxNQ_9786771f-74df-4afe-b663-9aba1f48bbc3"
      unitRef="usd">1803000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtMS0xLTEtMTMxNQ_687960fe-0b2f-4d30-9d62-ceb40cb1d18e"
      unitRef="usd">228000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtMy0xLTEtMTMxNQ_daff3223-bd59-4f32-8724-680391a8eb6b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtNS0xLTEtMTMxNQ_c117c91f-0d55-461c-9915-eeed012ca3c6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtNy0xLTEtMTMxNQ_8e132233-8ff0-4431-ba26-4e781d38e707"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzgtOS0xLTEtMTMxNQ_c2616cbd-ec71-43f4-97c7-4dec1d32a255"
      unitRef="usd">228000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i80fa8d30884647faa73e643d4fc1fdd4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktMS0xLTEtMTMxNQ_ba81f269-4ac6-4ec2-b410-3fe3513c3940"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i740b11a627da4c1c834349c8e1db9936_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktMy0xLTEtMTMxNQ_99da77eb-f806-477b-9d07-5cb5e710579f"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i6679aff2a2ce4117bb16c501a4c79fbf_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktNS0xLTEtMTMxNQ_617d8451-1e1b-4845-b5b2-09d7f0c2c2bc"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="id70fbe4e75514f58af161bc0fa7fda4f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktNy0xLTEtMTMxNQ_9c09b160-44d4-48a8-8729-f0d2c46d4634"
      unitRef="usd">-1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzktOS0xLTEtMTMxNQ_6b7339b4-7c9a-41cb-a4d0-3205b92f557f"
      unitRef="usd">-1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i26539d9b96f845d3ba4ab21e4452925f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTEtMS0xLTEzMTU_524071c3-f066-4ee3-858d-4a1be0e68be9"
      unitRef="usd">629000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ba8774be3fa46a89129787dadbdd87d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTMtMS0xLTEzMTU_421cbec9-6959-4c8d-adc6-c7c40864138f"
      unitRef="usd">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie4784aa0c2eb497085b38aac10a12a6c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTUtMS0xLTEzMTU_55375fc3-dc6b-46f3-abb4-fbf489cd9b62"
      unitRef="usd">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i08739ec82f9f487e9a3a1aaf8f12513d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTctMS0xLTEzMTU_440b8dc9-53c9-4632-9c71-5b46cccadf2f"
      unitRef="usd">616000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpkYzZhYmQ1ZjhmNDk0MDc0YWQ1ZjI4MjM3NmIzZjUwYS90YWJsZXJhbmdlOmRjNmFiZDVmOGY0OTQwNzRhZDVmMjgyMzc2YjNmNTBhXzEwLTktMS0xLTEzMTU_649d0f03-60a1-43f5-9b98-7c7758123e57"
      unitRef="usd">1574000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ie41c41f5deb14768a1eb5a2210283ea4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNzE_a7350621-31d9-4347-b5c2-b6a3c5f2224b"
      unitRef="usd">-4000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4f481c5813194dcb93b50f7c42cd5640_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ5MDQzMjQ_33311253-f137-4316-800b-323d6a8c8282"
      unitRef="usd">13000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2af70af2cbfa4de0b7bbcc6d6076615a_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzEwOTk1MTE2NDA4NjY_a04650e1-20ac-4b9f-9391-383a76c62a0f">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzI_666b5aba-144b-4a14-801e-c701e972c0d5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks not subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzkzNDU4NDg4NDQzMzI_7c451279-b231-4d38-9649-d13d674e0326">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization / Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks not subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks subject to amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment
      contextRef="ic11c4432843d48beb47ab04de9835fd8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMS0xLTEtMTM0Nw_7e5293d4-22ad-4465-8c21-52a03afe1ffc"
      unitRef="usd">769000000</clx:IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i3a7fec97eb2b445d82bb2f5c366219eb_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMy0xLTEtMTM0Nw_2ae6f4f3-6e65-4c24-a1ee-6b67ec7d1b85"
      unitRef="usd">86000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic11c4432843d48beb47ab04de9835fd8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItNS0xLTEtMTM0Nw_b6a3b3d5-c6fa-426a-8650-6ab5f21857c8"
      unitRef="usd">683000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItNy0xLTEtMTM0Nw_3423a376-3c31-4058-b657-29c6bd220fe2"
      unitRef="usd">766000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ib505795eadb0415688775b76ca687bd7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItOS0xLTEtMTM0Nw_4959ce51-233a-4fdb-a381-cb4ddf3b5739"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i008eec5c4b1e49faa6c5b0985ffde7bd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzItMTEtMS0xLTEzNDc_787e93c0-0adc-4d19-a6e2-e3d244bb58df"
      unitRef="usd">766000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMS0xLTEtMTM0Nw_1e98fd34-a90c-408a-a167-539e0790de0c"
      unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMy0xLTEtMTM0Nw_e29917d0-1b5a-4ec5-ba0e-e49494f731cf"
      unitRef="usd">36000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i877f6bf072f447b0a08ba92a32ceae0b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtNS0xLTEtMTM0Nw_d33447aa-ab47-402c-be08-faec1d5a8ff0"
      unitRef="usd">11000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtNy0xLTEtMTM0Nw_ae78a83c-8403-45ea-a226-4f03dae3cbd9"
      unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtOS0xLTEtMTM0Nw_a0b3f0c2-3d65-48df-bd6b-f59e46c360eb"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i53cc8d65018745bcb4a5a483db2fe918_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzMtMTEtMS0xLTEzNDc_f7b0c0d8-b5f3-4635-abe7-db445c4bfc37"
      unitRef="usd">19000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1484f195af54610a54afe24e3990c37_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMS0xLTEtMTM0Nw_e47c8354-40fa-4cdd-a847-6d576d2db4c0"
      unitRef="usd">583000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1484f195af54610a54afe24e3990c37_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMy0xLTEtMTM0Nw_efab60fc-2f0e-41a3-af1b-d4bfb5ee5920"
      unitRef="usd">337000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if1484f195af54610a54afe24e3990c37_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtNS0xLTEtMTM0Nw_2b31f0c1-1a9d-4c91-8ed7-c6f4ce4f74ca"
      unitRef="usd">246000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtNy0xLTEtMTM0Nw_e68a27db-c586-413b-84f8-06891d8a4ea5"
      unitRef="usd">424000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtOS0xLTEtMTM0Nw_8faefd8c-97e1-4422-9110-fe9eaf0d8c04"
      unitRef="usd">315000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9e0bac96d55949a7a5c1e4956cd2edac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzQtMTEtMS0xLTEzNDc_6f6f514d-18b9-4e43-8b65-2eba59b2c7ee"
      unitRef="usd">109000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMS0xLTEtMTM0Nw_a9e95845-1a37-415e-a47d-6ac8166f9607"
      unitRef="usd">1399000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMy0xLTEtMTM0Nw_e1a2b5f0-64b8-40ff-9a45-8f41a1557334"
      unitRef="usd">459000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtNS0xLTEtMTM0Nw_e08fe892-bc3d-4f4a-80c3-bd4b3c299612"
      unitRef="usd">940000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtNy0xLTEtMTM0Nw_82ebd234-e9ff-43f4-a1b0-810fdf301c49"
      unitRef="usd">1237000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtOS0xLTEtMTM0Nw_724008c3-68c4-4e0d-8d80-159c7e962f9c"
      unitRef="usd">343000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90YWJsZTpjMTBkNWIwNzZiMzI0MGI3YTNmODcxNGFkNzNhM2EzNy90YWJsZXJhbmdlOmMxMGQ1YjA3NmIzMjQwYjdhM2Y4NzE0YWQ3M2EzYTM3XzUtMTEtMS0xLTEzNDc_b17b7858-0ec8-4fcc-94cc-a255af0a729a"
      unitRef="usd">894000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMjg_c1e7cbe6-faf2-4a0e-9ef3-424571c5e69c"
      unitRef="usd">8000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMzM_e1c47901-d78d-40f3-8768-45038a655db4"
      unitRef="usd">23000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMzg_206c1fcd-cd17-430c-9e54-f99bc58ab596"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzNDM_9fe150dd-6202-44f4-a9df-c0e71536fe91"
      unitRef="usd">10000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMDM_6134076d-a7e8-4369-a265-3f7efb2f82b3"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMDg_170fc7d7-abc6-43f5-87a3-97059598ee5f"
      unitRef="usd">32000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMTM_16485b27-8633-4f79-8874-30956af71c64"
      unitRef="usd">30000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMTg_9e6272e1-18b8-48a5-84c6-ff95fd12c44d"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN185NjIvZnJhZzo0MzdjMDk5OWY2ZDg0MzM2YTMxMTE1NmJlYjBlYmZjNy90ZXh0cmVnaW9uOjQzN2MwOTk5ZjZkODQzMzZhMzExMTU2YmViMGViZmM3XzMyOTg1MzQ4OTEzMjM_28801c2e-0db4-4d71-9d97-c076f242d4ec"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2MA_b1b1709a-9aa6-41a7-859e-d82c9ccb66d3">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Risk Management and Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may use commodity exchange traded futures and over-the-counter swap contracts, which are generally no longer than 2 years, to fix the price of a portion of its forecasted raw material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the notional amount of commodity derivatives was $24, of which $15 related to soybean oil futures used for the Food products business and $9 related to jet fuel swaps used for the Grilling business. As of June&#160;30, 2020, the notional amount of commodity derivatives was $27, of which $14 related to soybean oil futures and $13 related to jet fuel swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#x2019;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of outstanding foreign currency forward contracts used by the Company&#x2019;s subsidiaries to hedge forecasted purchases of inventory were $68 and $70, respectively, as of March&#160;31, 2021 and June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may enter into over-the-counter interest rate forward or swap contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage the Company&#x2019;s level of fixed and floating rate debt. These interest rate forward or swap contracts historically have had durations of less than 3 years. The interest rate contracts are measured at fair value using information quoted by U.S. government bond and interest rate derivative dealers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The notional amounts of outstanding interest rate contracts used by the Company were $300 and $225, respectively, as of March&#160;31, 2021 and June&#160;30, 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;These contracts represent forward starting interest rate swap contracts with a maturity date of September 2022 to manage the exposure to interest rate volatility associated with future interest payments on a forecasted debt issuance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity, Foreign Exchange and Interest Rate Derivatives &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company designates its commodity forward and futures contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate forward contracts for forecasted interest payments as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2021, that is expected to be reclassified into Net earnings (losses) within the next twelve months is $2. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Risk Management and Derivative Contract Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of March&#160;31, 2021 and June&#160;30, 2020, $1 and $3, respectively, contained such terms. As of March&#160;31, 2021 and June&#160;30, 2020, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain terms of the agreements governing the Company&#x2019;s over-the-counter derivative instruments require the credit ratings, as assigned by Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#x2019;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2021 and June&#160;30, 2020, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s exchange-traded futures contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#x2019;s broker for trades conducted on that exchange. As of March&#160;31, 2021 and June&#160;30, 2020, the Company maintained cash margin balances related to exchange-traded futures contracts of $0 and $2, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trust Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has held interests in mutual funds and cash equivalents as part of the trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#x2019;s current and former employees, may select among certain mutual funds in which to invest their compensation deferrals in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and June&#160;30, 2020, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, impairment charges of $329 were recorded during the third quarter of fiscal 2021, of which $228, $86, and $15 related to the goodwill of the VMS reporting unit, certain indefinite-lived trademarks and other assets, respectively. These adjustments were included as non-cash charges in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#x2019;s best estimates and assumptions. For additional information, refer to Note 4 of the Notes to Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;</clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i848015c104c6489dbc76c581af351d33_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNDgw_05e415e4-8903-4e80-9c62-5bb7abdebafa">P2Y</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7b70b530cbd34611accfb86ef4f0c9f8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODAx_a080ae2b-5a9d-4c34-b99e-7d45c046814c"
      unitRef="usd">24000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i81bb94cec74c44ec934873bc2cbde692_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODE0_efaed0b1-d05f-4981-bca1-37b617dac797"
      unitRef="usd">15000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2602ddacb1ba4d48b483893d5a5811f5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODg4_77ee7635-5844-4542-ae38-8a1d3ee17bf8"
      unitRef="usd">9000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if877153b764b4c2199980313d42e92fa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTAwOA_184110bf-6768-47b5-9e9c-895486bda344"
      unitRef="usd">27000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4e18e05c20e542f2b56a8cfae3ddca8e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTAyMQ_a7a072a4-d15d-4d46-94f2-307042287ce0"
      unitRef="usd">14000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ecb0a1520954103b71df562030763b3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTA1OQ_7d27bedc-3a2c-4a17-953f-bcae7cf59132"
      unitRef="usd">13000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTM5NQ_e83606fd-f5db-483a-9e60-6722863cb84e">P2Y</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6d14bf1a42bf48728f273cb7dbb88206_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTY2Ng_db37f2ee-3d61-42e1-ba25-09bac4291512"
      unitRef="usd">68000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i446ee7bb6f85446389955f7c3cb5789e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMTY3Mw_78758cfb-da9e-41c7-a5d1-303b545c0e86"
      unitRef="usd">70000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1
      contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjA4Mw_53d47d4a-ce4e-415d-9243-829224858987">P3Y</us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iceb6e03daa5243e9b7e14504d53fa628_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjMxNQ_9d7a8df0-caf5-4d7d-a5e8-8e98ed62a643"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9eed352fc1a5487bb2a201702a083bc5_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMjMyMg_5aef4a3a-b0fc-47c2-a437-0fd4beb7c48b"
      unitRef="usd">225000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA1MQ_c3290cd5-6804-4756-b771-f97026088161">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy0xLTEtMS0w_b34b0472-ca8c-42f4-a22b-d2d69f427b02"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy0zLTEtMS0w_5a109b66-545f-4cbb-82c3-244a1c466e97"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy01LTEtMS0w_57c1d07b-ba84-4b3d-9117-82c1ef556563"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfMy03LTEtMS0w_3477233c-4175-41b1-9f54-83ff3a2b2aab"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC0xLTEtMS0w_5571bb89-3906-4832-b773-36394feb2ed3"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC0zLTEtMS0w_0c275f28-8199-4d04-8983-0157342772a5"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC01LTEtMS0w_91ff46dd-b005-49e8-b63a-68ee16dd4b3d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNC03LTEtMS0w_d037ff02-f886-4316-8a86-da4d40fa66f7"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS0xLTEtMS0w_e91fde08-056b-4f59-ba14-4869061a983d"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS0zLTEtMS0w_5f4ee269-f5a7-4b99-9d1e-ec94abb8deb0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS01LTEtMS0w_db2db35e-a1e9-4968-bdfa-fc8808a01c79"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNS03LTEtMS0w_23d75b13-ed17-41e7-be4a-2144b4c06e1f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi0xLTEtMS0w_81016ba1-58e1-46fd-9247-0cc45da65baa"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi0zLTEtMS0w_a6918d3b-3727-429b-95c6-affbc12d4764"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi01LTEtMS0w_41798531-00c8-4bbd-b424-dd708e0344c3"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjJmZGFiMWNkYjIyNjRlYTk4ODI4ODA4ZWJlMmJjNjM4L3RhYmxlcmFuZ2U6MmZkYWIxY2RiMjI2NGVhOTg4Mjg4MDhlYmUyYmM2MzhfNi03LTEtMS0w_55acc0f6-aac3-4f21-8cd2-fcb91e2b678f"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA1Mg_4b551ebb-9f05-4582-a425-4d2e719e8a43">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icea4ded2a2c241ae84ab85c02c799e3a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy0yLTEtMS0w_81fe21de-f795-4c26-910c-06706343fd5a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icd4cb21de4544c35afad7fe08fe4a904_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy00LTEtMS0w_fdc2a302-1029-49ed-8ded-264bda8d98f0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2ebcaa17e3d14abba5b97ca4b93fcef5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy02LTEtMS0w_cc73750e-95c7-45a5-ad5a-7bfbbe4d112a"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2bae856aa1bd4f958f32d88f0af615ea_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfMy04LTEtMS0w_fe4e469f-6894-4206-a68a-48e271105442"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i75b8569977ad4535abd02e47beebfc95_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC0yLTEtMS0w_6708040d-ce4f-4ffb-a329-e1557dc158ef"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia1976d49c2f44e55acfa8f723391c922_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC00LTEtMS0w_824d56fb-b513-43e6-a7da-8bf61f5617e2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i942569d3fdfc42d18bd23866541fc7f5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC02LTEtMS0w_540cf889-bf25-4d4e-8a65-570c96e6809a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i19e0f0c773af4cb48965cf7d8ce7fb15_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNC04LTEtMS0w_e8fab796-018e-4c4e-91d5-981eb4d7e40b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7cb3ed09c92543d8a204dfab7cd35dbe_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS0yLTEtMS0w_555642fa-a980-48e3-942c-9eed7046cf41"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib42274bcc9784b64b65ec2090fb4191c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS00LTEtMS0w_cc0909a0-583d-4391-b83d-392d2b3e8b66"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6bae2a7dadcb4f079e5afffbff2a9c21_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS02LTEtMS0w_61120e07-8e08-418b-99d7-f8bbd144a9d4"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i95f5ae9d2c5f4b71ab6f72edcd93b451_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNS04LTEtMS0w_7f709cb9-b821-4e9b-8863-0192d0c034ea"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi0yLTEtMS0w_3d0c5356-701c-4eb1-84a8-60790991b341"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi00LTEtMS0w_1c91a4d6-6e87-48ad-9969-a7b540c27de9"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi02LTEtMS0w_f1a6b208-370d-4616-9c5e-551a4d57ea9e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOmFjZDU0ODgzOGU4YzRmNDc4ZGY4NTUzZTliMjBiOThjL3RhYmxlcmFuZ2U6YWNkNTQ4ODM4ZThjNGY0NzhkZjg1NTNlOWIyMGI5OGNfNi04LTEtMS0w_a90b6c41-9050-4b11-9a43-319016857c57"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI3OA_988bb52e-4dee-494d-8b0a-904c20bda824"
      unitRef="usd">2000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzk5Mg_5cf1e8c0-a281-4b5d-a71a-d86b1cf283b8"
      unitRef="usd">1000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzk5OQ_5a0f97d1-ad1c-4cfb-876c-4a29f3d3e82b"
      unitRef="usd">3000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <us-gaap:MarginDepositAssets
      contextRef="i89286b72adb64ceeae58323f4cbca98f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNTIyNQ_31434859-d350-4f67-a604-999cd2c7bb49"
      unitRef="usd">0</us-gaap:MarginDepositAssets>
    <us-gaap:MarginDepositAssets
      contextRef="ibb6317a205f64e888817536ae25aba65_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfNTIzMg_910b5a31-9979-4c8b-b94a-7ae7718e2d53"
      unitRef="usd">2000000</us-gaap:MarginDepositAssets>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2Mg_1dc9dbfc-55e9-4b0c-bf85-c789084528be">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and June&#160;30, 2020, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfODA2NQ_e6f4b24c-4573-4b1e-8282-e07be5738004">The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i0048ff33e90f4209aee6b35dd0d9663e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy01LTEtMS0w_aa4c876c-bad5-4eee-ae92-8f04a80548e3"
      unitRef="usd">3000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i803bb7cea1a64da4926148b2b30bf8b9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy03LTEtMS0w_08012d95-52b8-4179-b500-3ab9e2a019f1"
      unitRef="usd">3000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i13a130bb3d2e4856b978cf675b54b49f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy05LTEtMS0w_cfa67152-deb0-433a-8b35-6071c964c266"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i7becfdbf9a624acdb1b709bc3dc25c7e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMy0xMS0xLTEtMA_5b3e9c7e-c7f4-4242-b3a1-4bda3915d74a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i24afdfe415c34061ab653ffa84c5b114_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC01LTEtMS0w_3ab988c0-0d76-48c9-ae24-a79d9a7b8229"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6f08e7cdcd93457ea49df833bde0b187_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC03LTEtMS0w_b3ab938c-921f-4e77-972c-7aa86faa10fd"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i04d8da7beaf442bd9043f1f6db402d82_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC05LTEtMS0w_1251038f-4a82-4a78-a34b-2be0dbac6395"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i72856990c40d4c8e8edcc82b8f7f1500_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNC0xMS0xLTEtMA_83ad0bcb-8927-429f-ad1b-70929b753e79"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie244b1b1e0424bdbb85739588f77cd6f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS01LTEtMS0w_20e41e3d-05a0-468c-9c48-005d028e6f89"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i493b6bcb04674e4eae776d98c6e32549_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS03LTEtMS0w_1fc2653e-4547-4598-9382-6521f34d1161"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic53a10bdd3c443149d70aa1b9344fa89_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS05LTEtMS0w_d9f8ccc2-dbdd-47b3-8185-5f54a29f318b"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i57197fa8f0f041218d4589f2a589885a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNS0xMS0xLTEtMA_8911dd01-a9ba-45d8-af3b-1121875d0f8b"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i8bb08d66214c4f6a8e0e2cad3359efe0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi01LTEtMS0w_1c85c385-7046-4e3d-aa0e-1ec6c7cca9e9"
      unitRef="usd">37000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i09939d37bb3048269d0cb0a44386b194_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi03LTEtMS0w_a009df9f-76ab-4d72-b1b1-ba34969d7081"
      unitRef="usd">37000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i55f1a042de7b4e569e2d27c2d5dad9e1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi05LTEtMS0w_2d78c656-1309-4a2d-98f4-ea2ee9cc000e"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1996c058fbf040f8908e8c394fc5c89e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNi0xMS0xLTEtMA_a189486d-27c0-4ebf-af11-fc0725eee1ca"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy01LTEtMS0w_4308227d-3295-4cc8-9584-2ebf97958348"
      unitRef="usd">42000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy03LTEtMS0w_5d0c4506-1124-48a5-acab-67210865a350"
      unitRef="usd">42000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy05LTEtMS0w_cdac9c55-4c9b-4959-aeda-d71a64656705"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfNy0xMS0xLTEtMA_0777ab43-6e78-42aa-ba76-cb6e7fcfb8e5"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i45f4d36e4c26464da0167188a60de71c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS01LTEtMS0w_190da349-a8e6-465d-8a75-cb1492ecfb7b"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i987768d7a6a84e038b10c8aaeca7130c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS03LTEtMS0w_9cccf893-359a-423a-9ece-2a6e23caab7a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1d72659b4ccc4ad89a4324978711b52a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS05LTEtMS0w_c6a6084e-f885-4351-aaf4-956c06d68b13"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2a413c3b7e924aa38bf7da6938de615f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfOS0xMS0xLTEtMA_0a43b361-5443-49b9-a906-722e4d1d5bc9"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i85534346744b432e8cea4e97ccc5909d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtNS0xLTEtMA_a6d3754b-0966-4256-8b96-a4cf4947a3b2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3795ebf2a81e444eb73637647767d786_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtNy0xLTEtMA_ee97d477-2117-4f4a-97d4-a11ad1015a29"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie91f439ccd2a45f5a6efaa8d896c7909_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtOS0xLTEtMA_d33440c4-5766-4d10-8d4b-e47544fc6980"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0c33022caf44489f9f113ac89dbf91b8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTAtMTEtMS0xLTA_d564b001-8612-42b1-93c1-24c9efab6bb6"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i86dd42a80b9c41f69b404d2b1eba64a1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtNS0xLTEtMA_ee916dcb-4b86-4dae-9a37-cbebcd4e7bc0"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3bfb4666ee19476e8443974cdf719623_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtNy0xLTEtMA_d35db20b-e76e-4d68-8dda-2e37b6804559"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5ef0e5a952734b418963b327a95bcc4f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtOS0xLTEtMA_e71c0938-cd77-4b07-871b-6e1038993d3b"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0e24c8554ebe46388a798da32706e97a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTEtMTEtMS0xLTA_4a18cc4d-79cf-40de-a8a5-351fa2475c72"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItNS0xLTEtMA_97f05b7d-ddfd-48ad-85f9-04a4b9517883"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItNy0xLTEtMA_395c0ea9-3d16-4adc-b75b-2c3dacbf0a64"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItOS0xLTEtMA_d624c50c-f50e-43eb-ae7c-ed5fd47358fe"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjg5NDViOTNhZTJmZTRlMWZhYTA4YjQzMTljZDc4Mjc2L3RhYmxlcmFuZ2U6ODk0NWI5M2FlMmZlNGUxZmFhMDhiNDMxOWNkNzgyNzZfMTItMTEtMS0xLTA_975e989e-68e2-4642-b8e7-516947d5dfcc"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifda03dcb1c30410ea2b0bbca9847e228_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy01LTEtMS0w_8df4b60d-7db2-48e2-8311-8dfabc3b1810"
      unitRef="usd">213000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i01d4ed82486f441a84472bb6b87db08f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy03LTEtMS0w_4e074e26-3e21-462c-8ab1-b260f4c7d0bc"
      unitRef="usd">213000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if7add7ef54944efa99bed6cbd73f7f56_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy05LTEtMS0w_a43dda27-68c4-461b-bff0-8b79a12664e7"
      unitRef="usd">584000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0bbce1f0e07b471880107186a9d2dbf0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMy0xMS0xLTEtMA_d536263a-479d-475c-aee6-a572f9d382b1"
      unitRef="usd">584000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i26c5e68eec1f4975a44f0ee291e1b433_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC01LTEtMS0w_346b568d-579a-4196-9d32-096863d17e36"
      unitRef="usd">146000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8fec6298f6c24ef6ac7e3ee30b63cd54_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC03LTEtMS0w_41aa5219-7fc0-4b83-aca5-ebead31fa752"
      unitRef="usd">146000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i01dc6b5c81694d3a8ce02fb89916e04e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC05LTEtMS0w_7108b153-9d10-4a7b-af3c-ec0925086802"
      unitRef="usd">165000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4fdc3ee65556409abf6845da148f19ba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNC0xMS0xLTEtMA_e6519861-4b4c-45be-a7bc-17dda6279568"
      unitRef="usd">165000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i5a8032a0d84e405fa3da93df1c46964d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy01LTEtMS0w_7f54bc8d-3575-4f14-8fe6-a9d5766933be"
      unitRef="usd">131000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if4dbc98d539d45729f9fac03fccb02f8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy03LTEtMS0w_35c7eb58-a60c-46e4-aa95-e0967267221e"
      unitRef="usd">131000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i7bd770eb1c3840cda9e1bfb6823cff18_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy05LTEtMS0w_30f57505-f7cb-4cbd-8b78-b67bc0b7a2da"
      unitRef="usd">100000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i72c2212de48a40c08c45b2267d5c2553_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfNy0xMS0xLTEtMA_8f07afad-7861-422b-ab1d-43d871ef6f28"
      unitRef="usd">100000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC01LTEtMS0w_73e84238-04ac-4caf-83b2-6d6cd0f016e4"
      unitRef="usd">490000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC03LTEtMS0w_f82eecbb-16cd-4c72-a56f-c2488271c224"
      unitRef="usd">490000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC05LTEtMS0w_df9d454f-1f97-4d2f-afe2-7c8c000b428b"
      unitRef="usd">849000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfOC0xMS0xLTEtMA_a610e5cb-b262-464c-957a-b018e763d230"
      unitRef="usd">849000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LongTermDebt
      contextRef="ifa872fb1c8a741e08e01d0b0035e14a9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItNS0xLTEtMA_bee49b2a-f19d-4254-aad4-2b9c32b3b87c"
      unitRef="usd">2783000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic4814dfcd3ba499aa945030b7001616e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItNy0xLTEtMA_d3cf2a57-a5c3-4a26-8f66-eacdc9ff2ab0"
      unitRef="usd">2944000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="ib00ae1de87094cf89d76a74b042495cf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItOS0xLTEtMA_63223381-6c39-487d-b970-8ebb1b2a20e2"
      unitRef="usd">2780000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3093b0d16ed04d6f8781b4a8dc97c5f4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTItMTEtMS0xLTA_8cb45941-81ef-4095-aa8f-b879fc72222b"
      unitRef="usd">3051000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:Liabilities
      contextRef="i1dd2366b5b7844fe8e3445d45c197945_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtNS0xLTEtMA_5c638256-617b-4d5b-9c98-d9d178da7124"
      unitRef="usd">2783000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i1da90ff065be4c999e8fe274b11c5b63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtNy0xLTEtMA_3bec2603-fab3-4230-9e16-9589e7e5d086"
      unitRef="usd">2944000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:Liabilities
      contextRef="i07087f939caf4a5fbe9aba0283c385cf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtOS0xLTEtMA_c7e3965f-0e92-4d9b-aec2-3396a3f48e39"
      unitRef="usd">2780000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ie34cc22e3e8345758a12debb39ff6929_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RhYmxlOjRmYmI3NzczNmI3ODQ2YmI5MGZmNDJkZmQxNGM5ZTc5L3RhYmxlcmFuZ2U6NGZiYjc3NzM2Yjc4NDZiYjkwZmY0MmRmZDE0YzllNzlfMTMtMTEtMS0xLTA_bc4e7025-8610-49ef-b92d-c6f2eb21b96e"
      unitRef="usd">3051000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODQ5OQ_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODUwNw_78153768-4e50-4f02-a287-a600be40b36d"
      unitRef="usd">228000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ic5e0b7dd02304ae688617c348dea4811_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDg5ODUwMw_6aa9511f-e782-4a41-aa88-788cbca6f704"
      unitRef="usd">86000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AssetImpairmentCharges
      contextRef="i13a2cf9cee0f45fcb02a4c337563805e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18yOC9mcmFnOjQ3MTlkZGY0NTM2OTQwZmRhYzljNDMwYWY4ZmYwMDZjL3RleHRyZWdpb246NDcxOWRkZjQ1MzY5NDBmZGFjOWM0MzBhZjhmZjAwNmNfMzI5ODUzNDkwMTA2Mw_09d1f8d3-9f41-42e8-a4dd-e5b6e01d8e65"
      unitRef="usd">15000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfMTAwNA_3e21380a-b2bb-4fca-b059-766ae28df352">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings (losses) was (1.4)% and 22.5% for the current three and nine months ended March 31, 2021, respectively, and 18.9% and 20.4% for the prior three and nine months ended March 31, 2020, respectively. The substantially lower tax rate on loss before income taxes in the current three month period and higher tax rate on earnings before income taxes in the current nine month period were driven by the partial non-deductibility of impaired VMS goodwill.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAyMw_274cb35c-efcb-4d17-87aa-8f9b0e0d8478"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAzMQ_8498e5b6-c71a-4438-92b0-691849d9f8e4"
      unitRef="number">0.225</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODAzOQ_782a9bce-479c-4968-9f33-6c7b17b10b73"
      unitRef="number">0.189</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zMS9mcmFnOmRkNThjOTAyNDA3YTQzZjc5NmIzNTI0NWE1MjAwYTQ0L3RleHRyZWdpb246ZGQ1OGM5MDI0MDdhNDNmNzk2YjM1MjQ1YTUyMDBhNDRfNDk0NzgwMjMyODA0Nw_eade6177-0ee9-4cdd-ac37-0896fda49d2e"
      unitRef="number">0.204</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RleHRyZWdpb246ZDkxOGZhZTdkYmIzNDQ5ZWFjNDQwOTlkZjhkMzJmNWFfMzUy_2975c0b1-81b5-47b9-bdf6-247b1dd21fb7">NET EARNINGS (LOSSES) PER SHARE (EPS)&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,057&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Since the Company generated net losses attributable to Clorox for the three months ended March 31, 2021, there was no dilutive effect of stock options and other instruments because their impact would be antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RleHRyZWdpb246ZDkxOGZhZTdkYmIzNDQ5ZWFjNDQwOTlkZjhkMzJmNWFfMzQ1_5791e3ee-651f-4738-8701-f9787073c317">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,057&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi0xLTEtMS0w_f9e739c9-0d0e-47d6-a803-dcffb4725093"
      unitRef="shares">125610000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi0zLTEtMS0w_2b084d85-9c1a-41c4-b9a9-c28681e8dff3"
      unitRef="shares">125661000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi01LTEtMS0w_bfde0da0-50e0-4cb5-b51a-bfe26e5aef6e"
      unitRef="shares">126057000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMi03LTEtMS0w_cf4a2777-343e-4813-b195-f74c499ecac7"
      unitRef="shares">125641000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy0xLTEtMS0w_effd1a71-35b7-481d-9158-65f5a3209c65"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy0zLTEtMS0w_6cd778b9-367f-46c1-8a29-5480d2689964"
      unitRef="shares">1667000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy01LTEtMS0w_cdb3b25d-2e23-46ff-897d-7fa40654e573"
      unitRef="shares">1973000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfMy03LTEtMS0w_a141d8b1-3030-49f8-9e1e-c3a6fbbf2921"
      unitRef="shares">1595000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC0xLTEtMS0w_a2506865-1794-4f50-ab78-75a9b249b8e5"
      unitRef="shares">125610000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC0zLTEtMS0w_74e6da35-d2e6-4d78-b510-9b236adf6c71"
      unitRef="shares">127328000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC01LTEtMS0w_ecf9db0b-0513-4674-8e3a-7f7e219f1a80"
      unitRef="shares">128030000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNC03LTEtMS0w_60d05a6a-c23d-44c5-ab96-7a643d273ae7"
      unitRef="shares">127236000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi0xLTEtMS0w_6bcbbae1-6ed5-4a55-8c4c-38999d93a367"
      unitRef="shares">4826000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi0zLTEtMS0w_ce78f789-bafb-499a-9c1c-c9df7ea054e0"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi01LTEtMS0w_b0fa9729-8fea-44e9-add0-c0e726131aff"
      unitRef="shares">428000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNC9mcmFnOmQ5MThmYWU3ZGJiMzQ0OWVhYzQ0MDk5ZGY4ZDMyZjVhL3RhYmxlOmIxZWY2MGZiMTZhMDQxZWE5NWRlMmQ3YjliZTRmYzNlL3RhYmxlcmFuZ2U6YjFlZjYwZmIxNmEwNDFlYTk1ZGUyZDdiOWJlNGZjM2VfNi03LTEtMS0w_2c4a77a5-6ff1-4b80-abce-445abe169810"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RleHRyZWdpb246NWVmMWYzNDczZGM0NGJkM2JjZGI1YWViYWVjMDhhZDlfMTI3_cd0e0dc6-a4f6-419b-90d5-c22581a2b8e1">COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income (loss) attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RleHRyZWdpb246NWVmMWYzNDczZGM0NGJkM2JjZGI1YWViYWVjMDhhZDlfMTMy_6db32f4a-6934-403a-af95-eec29571e54f">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income (loss) attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi0xLTEtMS0w_c4cf85b9-1874-4f70-bba8-af814efcdb41"
      unitRef="usd">-59000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi0zLTEtMS0w_1bb42b5f-8392-46ee-9e0d-f5f35dd4755f"
      unitRef="usd">241000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi01LTEtMS0w_916fb825-1444-48f4-8c68-443a934e7dd9"
      unitRef="usd">619000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMi03LTEtMS0w_5a220418-30cd-43b0-b960-c415732431bc"
      unitRef="usd">629000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC0xLTEtMS0w_8fdb9fcb-5e1c-4e24-958a-54cc507590f5"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC0zLTEtMS0w_d3bf7c3c-9fc6-48a7-ae90-2903a28243e9"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC01LTEtMS0w_ae7d63bd-3586-4749-ab8f-c9758af2124f"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNC03LTEtMS0w_c33c5b13-66b7-4f52-aa5c-bb1805f9a8a5"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS0xLTEtMS0w_d0392315-6d37-47bf-8942-baffb490692a"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS0zLTEtMS0w_420aa332-eece-4408-8e56-f1a5b3869762"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS01LTEtMS0w_75297282-7799-466d-acd0-5f8fffab92d1"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNS03LTEtMS0w_03c2cd54-4c9b-436e-8874-09235460306d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi0xLTEtMS0w_d058a772-bf47-4cd0-8846-3869fb315f34"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi0zLTEtMS0w_bd741138-ff92-44fe-8384-37be8dddccae"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi01LTEtMS0w_d6b4e5b8-b97a-4122-ae62-98bfef4b7e2f"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNi03LTEtMS0w_e5b6a2c1-30e0-402d-b003-375031bd95f2"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy0xLTEtMS0w_aa6cb751-6034-4863-bb27-e4e8ec8dee89"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy0zLTEtMS0w_b628ac8d-fac3-41bf-8b88-1333d4c996f0"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy01LTEtMS0w_03ec8227-256b-4874-9b1b-a051cb3a8b20"
      unitRef="usd">87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfNy03LTEtMS0w_7e67237c-0de1-442a-9102-8cc6fe959b02"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC0xLTEtMS0w_4c2223dc-f98f-40c9-94ca-62590f397ee9"
      unitRef="usd">-37000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC0zLTEtMS0w_d590620d-0a65-4d19-bf53-ffead8464e7d"
      unitRef="usd">186000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC01LTEtMS0w_031ca64d-51e9-477a-bd5d-8c23f0549c28"
      unitRef="usd">706000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOC03LTEtMS0w_b440fa90-7c88-470b-a7fb-fef1254a904e"
      unitRef="usd">575000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS0xLTEtMS0w_a97b5d37-7bf3-420b-971d-bcd143cc89db"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS0zLTEtMS0w_af36c94c-8c71-40e4-93ab-1bb2e1e587f0"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS01LTEtMS0w_6cd0e0f3-c1b0-4dc6-8867-8485b71bd838"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfOS03LTEtMS0w_2849f728-ac23-4404-b6ff-ff660bb6d6f9"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtMS0xLTEtMA_991311b6-9ddf-44b6-999b-e807313affc3"
      unitRef="usd">-39000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtMy0xLTEtMA_68e7568b-5e51-4407-8189-23c35df19328"
      unitRef="usd">186000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtNS0xLTEtMA_09c66261-533b-4a2b-a943-faec96db1830"
      unitRef="usd">700000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN18zNy9mcmFnOjVlZjFmMzQ3M2RjNDRiZDNiY2RiNWFlYmFlYzA4YWQ5L3RhYmxlOmM5MzVjYTI2YjZkMzQ1MTI5NDhjMzkyYWI5MWQzMTAxL3RhYmxlcmFuZ2U6YzkzNWNhMjZiNmQzNDUxMjk0OGMzOTJhYjkxZDMxMDFfMTAtNy0xLTEtMA_ed37ff79-1ae6-4bbb-ae12-1fdc75dd4a18"
      unitRef="usd">575000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyNw_6122e7b7-ad31-4060-9091-bdf23183713b">STOCKHOLDERS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; EQUITY&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.06 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.11 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative effect of accounting changes, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.18 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.33 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Business combinations including purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock retirement &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) As a result of adopting ASU No. 2016-02, &#x201c;Leases (Topic 842),&#x201d; on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2020 the Company retired 28&#160;million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company&#x2019;s overall equity position as a result of the retirement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Open-market purchase program&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Evergreen Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in foreign currency translation adjustments are re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyOA_c173fa55-d398-458e-af23-47edad9454aa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.06 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.11 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative effect of accounting changes, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.18 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders ($3.33 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Business combinations including purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock retirement &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) As a result of adopting ASU No. 2016-02, &#x201c;Leases (Topic 842),&#x201d; on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fac87255172412484f55ebbbbeea3f1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xLTEtMS0w_0a51f156-3b58-4957-94e0-cadec70b0720"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i3fac87255172412484f55ebbbbeea3f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0zLTEtMS0w_f9d10f79-d7fe-4c58-96b3-67c1f3ad05a3"
      unitRef="shares">158741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i621c78ef217946caa48daba642080fc7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy01LTEtMS0w_a4dd5a39-f8a3-4041-8384-d95803fe5b1a"
      unitRef="usd">1062000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47dfa7d737eb4754a2c5b8e3a44f18a3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy03LTEtMS0w_40dc3e41-cd4c-457d-9cb3-b2d038a7e124"
      unitRef="usd">3292000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3432462f36cc45c7bd8205bca273122e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy05LTEtMS0w_13f8210d-1318-4c01-a677-fd0488d52cc4"
      unitRef="usd">-3357000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i3432462f36cc45c7bd8205bca273122e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xMS0xLTEtMA_132ba3eb-cf12-4490-8097-8b117d607bc9"
      unitRef="shares">33717000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77b79f9121d141459b8db7faff712c18_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xMy0xLTEtMA_82cd7e32-57e2-45b8-b493-7d04187d21d8"
      unitRef="usd">-601000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i108954c232d04d49920930c949d00216_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xNS0xLTEtMA_85221c9d-0eb1-478b-825b-097d7de63835"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie032edb36eed4e7fbd867455fbb3151c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMy0xNy0xLTEtMA_b970df38-76c8-4ecf-a1e2-1abe2302a528"
      unitRef="usd">555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNC03LTEtMS0w_ac3c46b1-7d6f-4854-be18-e4697633e8fa"
      unitRef="usd">241000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNC0xNy0xLTEtMA_22aa1b45-6089-4f16-a887-91853032ed0d"
      unitRef="usd">241000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i95af929fa2ea40cfbc21af9dc7f5c5b9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNS0xMy0xLTEtMA_11883090-b7c2-4abb-8dd0-379e149e40fe"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNS0xNy0xLTEtMA_8b9fe3c1-d4bf-4cef-969e-68f3523181f2"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi0wLTEtMS0wL3RleHRyZWdpb246OTc5MmU0MDY2ZTE1NDdkMWFlYjMxYzVlY2M0MTgxYjNfMzk_e0e5f9c6-3409-46df-803b-bc20a0c77c3d"
      unitRef="usdPerShare">1.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi03LTEtMS0w_934ca908-f192-4e3d-93db-2c0c2d02ace7"
      unitRef="usd">135000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNi0xNy0xLTEtMA_69afc6b7-384e-4a95-aca6-23f59e940d3e"
      unitRef="usd">135000000</us-gaap:Dividends>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNy01LTEtMS0w_7078bfbc-7205-4ff3-8f11-28145637b693"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNy0xNy0xLTEtMA_00b75b2e-9e25-422c-816f-37e3f864cb28"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="ia5eb21c17dd64f77bdc300d14e18cfeb_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC01LTEtMS0w_df543f8a-0acb-49b1-b820-b1d9fe582af7"
      unitRef="usd">31000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i38ef891197f249afb4aefe7f093267e0_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC03LTEtMS0w_12981097-7879-4d52-aaa5-4a2c35ddd317"
      unitRef="usd">0</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC05LTEtMS0w_0eb3d079-8ddc-4ecd-911e-78020cf22ea1"
      unitRef="usd">70000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC0xMS0xLTEtMA_53ffe7d6-5df6-46f4-9c75-e386059689a2"
      unitRef="shares">1083000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOC0xNy0xLTEtMA_31e8b295-dbc6-4340-ace8-86e4b52932d6"
      unitRef="usd">101000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS05LTEtMS0w_b099101d-9e66-44d4-8bd6-1de0319f60ff"
      unitRef="usd">30000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i74806957c8f74a7d908ea9583b92ebc1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS0xMS0xLTEtMA_e9b6c50b-f583-4c37-9969-88c18eeec7cd"
      unitRef="shares">184000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfOS0xNy0xLTEtMA_6c79a9a2-68ef-4cc0-9a62-c1446591ca28"
      unitRef="usd">30000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMS0xLTEtMA_cc7514c6-301e-414f-b10f-7ce53ada3872"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMy0xLTEtMA_2d164b23-ffc6-4a66-ac74-612a30ad63bf"
      unitRef="shares">158741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtNS0xLTEtMA_9d0d5fe7-9337-4eb2-a5d3-68873678c8cc"
      unitRef="usd">1111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied37b00018c54177824f2ad238767344_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtNy0xLTEtMA_e8bc7eec-8f45-4acd-bb26-8be0ac438bf6"
      unitRef="usd">3398000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtOS0xLTEtMA_01903937-3181-4d3e-8dc7-8c601c2d8898"
      unitRef="usd">-3317000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTEtMS0xLTA_be209b31-020e-40f4-9a7a-6afc57446db2"
      unitRef="shares">32818000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTMtMS0xLTA_378c514f-5f3f-41a9-a744-fb02a2c7c740"
      unitRef="usd">-656000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTUtMS0xLTA_ea949777-38f4-49c8-a2d5-7de810d7ebf7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTAtMTctMS0xLTA_4dd4af93-3158-46c2-a37e-04bf67d623ce"
      unitRef="usd">695000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i603fda767f6844baadd48df615fb009e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMS0xLTEtMA_ea6f9984-e931-40a5-8ba8-d9af6395781c"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i603fda767f6844baadd48df615fb009e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMy0xLTEtMA_6feb9e8d-4635-4e5b-8f2e-5a10ac351c4f"
      unitRef="shares">130741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ec9af00fbc343c7a22d3f94f5287cdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItNS0xLTEtMA_5f2b02b6-fc46-4f02-88b2-90b51c6aa242"
      unitRef="usd">1176000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27e24c9e768043d999c666a316d95f12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItNy0xLTEtMA_080b1268-6dee-4767-b512-375444f1348f"
      unitRef="usd">1302000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItOS0xLTEtMA_d75ca6d8-93d0-4c54-9e22-69536e48cbde"
      unitRef="usd">-850000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i7d6a02c3cb814bf3a28ea50b90fa3023_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTEtMS0xLTA_b4095c76-8691-41ee-b27f-5157ccf7d6c7"
      unitRef="shares">5017000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6930765739894f11878ad45a82a55846_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTMtMS0xLTA_8933defb-b065-47ca-90f0-d499332f070a"
      unitRef="usd">-575000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf821b273c5e405fb6940c37f931f302_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTUtMS0xLTA_a8090940-d1bb-4af1-9c94-d1379e698845"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56a82930ba8c46a8842474109384e6c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTItMTctMS0xLTA_63f023c3-77e3-4edc-bdfc-6a9dcf2761ee"
      unitRef="usd">1380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtNy0xLTEtMA_1f1f08a5-4685-41cd-9255-66683e2b04dc"
      unitRef="usd">-61000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtMTUtMS0xLTA_0f42f2af-1be4-4614-99b5-e65f51bdce8d"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTMtMTctMS0xLTA_a83cfcaf-7119-4ff8-9d51-364c06e0731f"
      unitRef="usd">-59000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8dff6b4bc5ac419481696f8476fdaa42_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTQtMTMtMS0xLTA_fc897a62-b693-471e-b2c0-f9dad65806af"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTQtMTctMS0xLTA_dd64fb42-258d-4c0c-8cfe-a49995686b21"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjlhMTRkMTUyMjZmZTQ2YjdhY2Y5YzE4MmI0YWE0YTJiXzM5_b294ea3d-dd6f-4fe3-a3ff-40d20cfc513a"
      unitRef="usdPerShare">1.11</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtNy0xLTEtMA_2fda268f-092c-4105-8d4b-d0f2aa3a1c23"
      unitRef="usd">139000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTUtMTctMS0xLTA_062d0169-6bdc-4cc2-ac59-4f88b3d71d06"
      unitRef="usd">139000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ieeab8906f9604a5d845be11928ce5af8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTYtMTUtMS0xLTA_db800de8-59c7-4d10-ba48-6c79f9fa5a4f"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTYtMTctMS0xLTA_430d1a79-077a-440e-ae17-b318193a2aa3"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTctNS0xLTEtMA_1f1bc0d1-47da-48af-b6e7-b4a334914be8"
      unitRef="usd">17000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTctMTctMS0xLTA_efc8a987-3d1a-4bce-b84d-75a9440b2cdd"
      unitRef="usd">17000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i9191a8b330324547a1a27f5a1ad5159d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtNS0xLTEtMA_47ab19fb-8ab9-4756-87bf-061fa423af71"
      unitRef="usd">-3000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i71f72456bad743de8f3f70a5b102f283_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtNy0xLTEtMA_737d0d64-2846-4375-857d-9bfc7eb99997"
      unitRef="usd">-16000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtOS0xLTEtMA_dbbfeda1-1f27-40a0-a2ed-4f930f9b4e72"
      unitRef="usd">44000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtMTEtMS0xLTA_25e7c1b2-28d3-4526-ad77-854cae3c60a0"
      unitRef="shares">283000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTgtMTctMS0xLTA_338a50e4-53f6-4e92-84c3-5370e97383d2"
      unitRef="usd">25000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktOS0xLTEtMA_93539a08-7611-46ff-8ba5-83847e0e2d8f"
      unitRef="usd">305000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8394595d8dfb4106b29d90e52d3688dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTEtMS0xLTA_263554d5-4179-4b30-957d-4defa67f424e"
      unitRef="shares">1648000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTUtMS0xLTMyNDI_2977cd1a-a50c-47b2-a7e7-f8ef7c249b07"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMTktMTctMS0xLTA_20ef848f-fda6-45ac-9870-df552d96136b"
      unitRef="usd">305000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMS0xLTEtMA_6ec88015-f97c-4cd0-9f32-0ba89df6e6cb"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMy0xLTEtMA_1c50bd9e-6d04-4966-8f40-6ec08e0ad135"
      unitRef="shares">130741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i782a0b76608c42b8a82e90d7a7ea4654_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtNS0xLTEtMA_0b4a0684-ad67-4ba9-96d0-a04bdadc2acf"
      unitRef="usd">1190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e407cf409ae4bdb83e47faa0f5730af_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtNy0xLTEtMA_a3fa8a12-aadd-44d4-a0e4-2ec3297394f1"
      unitRef="usd">1086000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtOS0xLTEtMA_26871dd1-55e7-47da-b8af-aa10abd79431"
      unitRef="usd">-1111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTEtMS0xLTA_ce2fe253-16af-4213-bc60-6ea23382e05d"
      unitRef="shares">6382000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTMtMS0xLTA_81bdb408-f36b-4a1c-a95e-f083ed3d36e0"
      unitRef="usd">-553000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0e638f74ad54f28b43e008437b87090_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTUtMS0xLTA_05077fab-72ec-44a9-b359-784d5b08c24a"
      unitRef="usd">195000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjEtMTctMS0xLTA_226e32b8-65b4-4847-880b-6884f303968b"
      unitRef="usd">938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id820cc1b67e64799bfc374a16f6c1038_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMS0xLTEtMA_4b1f6c95-a1be-4d27-891d-d929af42c4fb"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="id820cc1b67e64799bfc374a16f6c1038_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMy0xLTEtMA_8c276944-b5a9-423a-8523-31bb6c239298"
      unitRef="shares">158741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e062e41cfc74e44acb07fd26a397d64_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtNS0xLTEtMA_e657b363-2b28-4cec-94b2-e58e231e216a"
      unitRef="usd">1046000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i637250d82b784de7b529ed70ed515d07_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtNy0xLTEtMA_cb8076d5-588c-4f6a-abba-a1b4a260f3bb"
      unitRef="usd">3150000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtOS0xLTEtMA_159658aa-e31d-487d-b9d5-bf519c48e080"
      unitRef="usd">-3194000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i15a47b1c399740df9fdbc0c71dbd95b4_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTEtMS0xLTA_cd74a9a7-7a9b-4a83-b73c-91cdfd63d872"
      unitRef="shares">33055000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTMtMS0xLTA_580c554e-ba0f-4e0f-8cfa-1b297866cedd"
      unitRef="usd">-602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba474f7dc35d462dbbf5c28ece8066da_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTUtMS0xLTA_8a556c12-d3ab-4e31-9b1a-48d0cdc44eaa"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7e8d63f491f423baa88abae57588736_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjYtMTctMS0xLTA_1ecdf46b-1b1c-44b9-8496-cd8766bfd49d"
      unitRef="usd">559000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida1ef0e38ead43729ec512b3ee29802f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjctNy0xLTEtMA_2503f2a7-3a70-43d1-89d2-a263b46ce00c"
      unitRef="usd">22000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a8d54a976ed4611b6e63671c8bd89e7_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjctMTctMS0xLTA_1930128a-a2de-41e4-9970-725bc3f838eb"
      unitRef="usd">22000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjgtNy0xLTEtMA_9962877c-5259-4d8f-8394-0cd04ca01093"
      unitRef="usd">629000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjgtMTctMS0xLTA_355002be-c71b-4a64-b8cd-54b13f2d8b86"
      unitRef="usd">629000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id11b8ffb8d49487096c194160392c5dd_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjktMTMtMS0xLTA_08a54651-4c9e-4195-824b-3fa15882a297"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMjktMTctMS0xLTA_1e50c249-d1e9-46f4-b710-11cb3e4048f3"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjAwZGUzYmZiNmQ4MjQzYmVhMDcwOTBjNDAzZDA3MzdkXzM4_2e42a0d8-ddc5-45ee-aa23-601601c62487"
      unitRef="usdPerShare">3.18</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtNy0xLTEtMA_59ec0a34-6b7d-4d6f-b0c0-971d5ec3c4d0"
      unitRef="usd">402000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzAtMTctMS0xLTA_f1fdedaf-79b9-4357-9fd6-014aff96cdd3"
      unitRef="usd">402000000</us-gaap:Dividends>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzEtNS0xLTEtMA_5314c9e6-5636-4661-8a7e-f785e370d2d8"
      unitRef="usd">37000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzEtMTctMS0xLTA_685059aa-944c-4802-a277-bb29dcf40444"
      unitRef="usd">37000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i27bfc0d3f296405f888fa1bb7b43c889_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItNS0xLTEtMA_61ab58ff-8b8d-4f67-969d-28406ae753c5"
      unitRef="usd">28000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i9f1b9ef6a943411c86ede7bc1aad976f_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItNy0xLTEtMA_7ef37db4-8813-4879-a53d-4867343c8dbe"
      unitRef="usd">-1000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItOS0xLTEtMA_d038ea9e-1070-47f5-bae5-33a053355fcd"
      unitRef="usd">96000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItMTEtMS0xLTA_9f32dfa7-306d-4e2f-839f-5c8690e217bd"
      unitRef="shares">1661000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzItMTctMS0xLTA_b75e8db2-ca6c-47f8-b094-1d5fc64ec109"
      unitRef="usd">123000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtOS0xLTEtMA_7638ce5d-ec56-4a9f-b2cc-1f47f5f09120"
      unitRef="usd">219000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i615fd03c3d114f5aa28d294aeb27e670_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtMTEtMS0xLTA_857691ee-da24-43b6-b73b-51918f1f7b9a"
      unitRef="shares">1424000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzMtMTctMS0xLTA_40edda66-1de5-4733-bf05-2d88b64e1d79"
      unitRef="usd">219000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMS0xLTEtMA_edc2b753-b49f-4878-af1b-755ce6ed338c"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i0da205cd9b70413683ab2bbaa7533b9c_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMy0xLTEtMA_3f0f5de4-4c61-4caa-8806-89ee10bc93cb"
      unitRef="shares">158741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8b0546079c54b89b17c5204ab8ddbb9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtNS0xLTEtMA_b28e46b9-eb12-4b53-be20-d56e2b5378fb"
      unitRef="usd">1111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied37b00018c54177824f2ad238767344_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtNy0xLTEtMA_3e96abc3-944d-401e-8da2-89e6caee0f5c"
      unitRef="usd">3398000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtOS0xLTEtMA_50197e84-819a-4b75-bc9f-12d3a919a161"
      unitRef="usd">-3317000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i6a1026fe1c8944ff86a32c927ef217f4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTEtMS0xLTA_ef94abba-0934-47f5-95cc-2e12027adf51"
      unitRef="shares">32818000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTMtMS0xLTA_a8b9e819-9b91-461f-b52a-bbf6ee4d8e40"
      unitRef="usd">-656000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d35422f1e284ab3b21dcec0a5f87dd1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTUtMS0xLTA_f56a2c7f-46f3-4f94-a7b3-c0cd16dbdb95"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i996c29b523bf485f8accca37c4bb6e71_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzQtMTctMS0xLTA_aa3088b3-c745-42dc-ba58-9cf9a7ebe98b"
      unitRef="usd">695000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida18a217ec684932b3629eb9e338973a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMS0xLTEtMA_701493ff-6f73-487a-991d-032a6b9cd1fc"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ida18a217ec684932b3629eb9e338973a_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMy0xLTEtMA_65ce20f0-522b-4843-bf16-8321c333cd8f"
      unitRef="shares">158741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d4c6fa0129c464ab8995dcf39d5f97f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtNS0xLTEtMA_08ccfd53-18e7-41e4-909c-01287ac0b22c"
      unitRef="usd">1137000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb1ba4ba9cb441a0b2d31c4fd01bcf43_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtNy0xLTEtMA_7d85e01b-0643-495b-a0eb-b7027aee270f"
      unitRef="usd">3567000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95eac61641474597a335d7aa40b97c09_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtOS0xLTEtMA_45d5f441-7135-448a-a551-162430110a91"
      unitRef="usd">-3315000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i95eac61641474597a335d7aa40b97c09_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTEtMS0xLTA_5780962d-59b8-4bdb-8555-9d9383a4d4ef"
      unitRef="shares">32543000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTMtMS0xLTA_a2f3dc46-e1a4-4deb-a3e5-91598fed3e63"
      unitRef="usd">-640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27d44bf18a1a4061ac3a7e5409698cba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTUtMS0xLTA_55cfe1fc-149c-458c-9055-57d83c5b792d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzYtMTctMS0xLTA_68dfd76c-9c11-4ccb-ba56-0915f051803b"
      unitRef="usd">908000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctNy0xLTEtMA_cb4e5cc9-e1f1-439a-8511-07072ab312f6"
      unitRef="usd">613000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctMTUtMS0xLTA_e5ef80a2-5f74-4351-a9bc-6078b679cecb"
      unitRef="usd">6000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzctMTctMS0xLTA_a39de25b-a392-42bc-9b54-52592a02a84c"
      unitRef="usd">619000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idb5b41725ce84b268abfb90cdf704e87_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzgtMTMtMS0xLTA_c6051ac1-80c2-401f-ace3-f7cbd29053b9"
      unitRef="usd">87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzgtMTctMS0xLTA_eaa76140-0b2d-4ccc-a25d-9adfdf03015f"
      unitRef="usd">87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmNjZjQwZTRjODU2MTQwZWVhMjE1NTE2MmJlNzNjMGI3XzM4_4cdddeba-5f14-4a3a-94cb-330ed79298a9"
      unitRef="usdPerShare">3.33</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktNy0xLTEtMA_f4aaeeb5-580e-4a6c-9850-fdee34085a47"
      unitRef="usd">421000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfMzktMTctMS0xLTA_eb4aee6e-05d2-411b-a681-73f7968fad36"
      unitRef="usd">421000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDAtMTUtMS0xLTA_68228826-8dff-415d-b0cd-3f7c3550a6d2"
      unitRef="usd">9000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDAtMTctMS0xLTA_f94e7105-c4c7-4b31-8139-6d26926c9adb"
      unitRef="usd">9000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDEtMTUtMS0xLTA_586ae770-dd43-4e0f-a71f-c0be1ad11971"
      unitRef="usd">198000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDEtMTctMS0xLTA_a97f183a-0b96-4a6a-94ff-570e21347626"
      unitRef="usd">198000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDItNS0xLTEtMA_516783b6-345c-4bec-9f18-a98c3c8ef025"
      unitRef="usd">52000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDItMTctMS0xLTA_593f0a64-b051-4cc0-8c3b-8d051af04ee3"
      unitRef="usd">52000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i82902ea9744d4b06b829e97693e715b5_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtNS0xLTEtMA_588c240d-e90f-4210-a6b0-1b574b418509"
      unitRef="usd">1000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtNy0xLTEtMA_a5fe7836-d170-48ea-8dcd-b0aea779b766"
      unitRef="usd">-33000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtOS0xLTEtMA_34ebb220-2c76-4949-9f2a-075da7d0054b"
      unitRef="usd">141000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtMTEtMS0xLTA_45535a1a-248e-44f5-92df-f4e2ce483915"
      unitRef="shares">1233000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDMtMTctMS0xLTA_edf7c32f-d564-49f6-84ae-4e0ee381943f"
      unitRef="usd">109000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtOS0xLTEtMA_dcde1170-dbe9-476d-ab19-544a3d6c0b8b"
      unitRef="usd">605000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtMTEtMS0xLTA_a4042dfb-b117-416d-b9a9-c577614daceb"
      unitRef="shares">3072000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDQtMTctMS0xLTA_04af46c7-f944-4515-a1a0-d46b130dac52"
      unitRef="usd">605000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMS0xLTEtMA_896a1eec-51e3-4855-8bf0-40dea00253ae"
      unitRef="usd">28000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ia7f52dbcc7194bf5a439f31226a2e6ed_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMy0xLTEtMA_2c58452e-bafe-4e11-9b9d-148ac9297de9"
      unitRef="shares">28000000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5806947a885c43eabab88a1bd7699531_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtNy0xLTEtMA_4d9c6283-3a65-4893-a053-13168d677b00"
      unitRef="usd">2640000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtOS0xLTEtMA_d3e299e0-7230-47c9-8650-be81982f3229"
      unitRef="usd">-2668000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="iadaf769931a14483bf937ae29c61736e_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTEtMS0xLTA_0712540e-a825-4936-89bf-ae59ef0ea89e"
      unitRef="shares">28000000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iea42ebb583a1420983cfa5cbca8e3112_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTUtMS0xLTA_2977cd1a-a50c-47b2-a7e7-f8ef7c249b07"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDUtMTctMS0xLTA_2de967f4-57f7-4bb2-a15b-b61093f2e9e4"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMS0xLTEtMA_3a6ad14f-825d-40e1-98bd-636efaff938e"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i22da98082521415a9ea0e1210c75a6c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMy0xLTEtMA_5a49b7fd-a981-4328-9308-025c424ef5d5"
      unitRef="shares">130741000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i782a0b76608c42b8a82e90d7a7ea4654_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtNS0xLTEtMA_3e8bea64-73b6-41d1-8070-5a62ee9f9de2"
      unitRef="usd">1190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e407cf409ae4bdb83e47faa0f5730af_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtNy0xLTEtMA_bef66f8f-4202-4a40-84e9-df85aa62e790"
      unitRef="usd">1086000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtOS0xLTEtMA_a7ff27a3-2eb2-4678-b6b8-9d6a0c9f4539"
      unitRef="usd">-1111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="icac622ad60c646dd848b717d07c7c1c6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTEtMS0xLTA_fe9ac126-2edc-4158-8dc6-5efc2b483964"
      unitRef="shares">6382000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTMtMS0xLTA_e2511d80-694f-47b2-9090-398c31ccdbba"
      unitRef="usd">-553000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0e638f74ad54f28b43e008437b87090_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTUtMS0xLTA_47b40160-3085-4260-9469-beea631da6f7"
      unitRef="usd">195000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjhlOTNhMzhhNDY4OTRlZTc5NDhjNGMwYmMxZDE0MTA0L3RhYmxlcmFuZ2U6OGU5M2EzOGE0Njg5NGVlNzk0OGM0YzBiYzFkMTQxMDRfNDYtMTctMS0xLTA_8dbc1af2-fbbe-49b2-81b4-73c9b160e435"
      unitRef="usd">938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ieb1218945cd84b80a0826a8dedfda008_D20201118-20201118"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNDE2_fa0aea55-790f-4db1-b62c-45e284e19fa6"
      unitRef="shares">28000000</us-gaap:TreasuryStockSharesRetired>
    <clx:NumberOfRepurchasePrograms
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNjA0_36f19861-d0ec-49d1-b57f-a2239ac9925a"
      unitRef="repurchaseprogram">2</clx:NumberOfRepurchasePrograms>
    <clx:NumberOfRepurchasePrograms
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNjA0_8fef8200-ac57-45f2-8ac7-5449b502925d"
      unitRef="repurchaseprogram">2</clx:NumberOfRepurchasePrograms>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i018e05de2fce4bcaae18e50cf9517af9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfNzIw_ad0c87af-1bf6-40f5-880f-f161f36312f8"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <clx:StockRepurchaseProgramAuthorizationLimit
      contextRef="i01b3d2ba010b48fbb9e64b975eb1f926_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfODc4_9d759736-8afe-4a99-96c3-a887a1136cd3"
      unitRef="usd">0</clx:StockRepurchaseProgramAuthorizationLimit>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyMw_017580d4-adc7-493b-87b6-20678a29e7ba">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Open-market purchase program&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Evergreen Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <clx:NumberOfRepurchasePrograms
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfOTc1_36f19861-d0ec-49d1-b57f-a2239ac9925a"
      unitRef="repurchaseprogram">2</clx:NumberOfRepurchasePrograms>
    <clx:NumberOfRepurchasePrograms
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfOTc1_8fef8200-ac57-45f2-8ac7-5449b502925d"
      unitRef="repurchaseprogram">2</clx:NumberOfRepurchasePrograms>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i75957ffb916249c88259d57dddd74735_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xLTEtMS0w_5f15729c-5816-47af-afc5-c95f22443fd3"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i75957ffb916249c88259d57dddd74735_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0zLTEtMS0w_9ff2f889-849c-4d6e-825c-236e851cb57d"
      unitRef="shares">1088000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy01LTEtMS0w_f3cb2318-6ddd-4290-95b4-8f6426fb329a"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6bc179ff24404d34a31d298d0916353f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy03LTEtMS0w_d2ec81d8-4346-4209-9376-950ddf9aa576"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy05LTEtMS0w_80e424cc-0a0d-4e9a-9eef-b65d02e6aa3c"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8e619b37b3c34959b5016ccbfd542545_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xMS0xLTEtMA_eb4bb576-a04a-491a-af87-03c2b4be0f9c"
      unitRef="shares">1088000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if27d27b067a347619468898121fdfd72_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xMy0xLTEtMA_0231f6ff-de23-4dd7-9a19-feb3dea59bec"
      unitRef="usd">85000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if27d27b067a347619468898121fdfd72_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfMy0xNS0xLTEtMA_51348617-dd86-418b-9509-684e3007148b"
      unitRef="shares">577000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xLTEtMS0w_5514d7c1-112c-4135-b49d-86cba69fc557"
      unitRef="usd">105000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib01fe3cb92194f1f8c3dba0dedbbf2a2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0zLTEtMS0w_b68c8bdf-a632-491b-a2a1-f0b07d38249b"
      unitRef="shares">560000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC01LTEtMS0w_0bab3d5c-4691-4531-9a49-839afeecdda0"
      unitRef="usd">30000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i69af30071b37462bae0b9dfcd45082ef_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC03LTEtMS0w_a02acb5d-9435-45d5-a4ac-3bd61af0abcd"
      unitRef="shares">184000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC05LTEtMS0w_c34670e4-5e1a-493f-aa0f-3c4eb51a390f"
      unitRef="usd">405000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ieb55aa3cf6af46a3bd612291bafc3605_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xMS0xLTEtMA_230a991b-4467-4364-a705-4d7093df41ee"
      unitRef="shares">1984000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xMy0xLTEtMA_6b10df87-1690-4bae-90ed-2d1872937123"
      unitRef="usd">134000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic1856948020a48dfbd14e4f98441b325_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNC0xNS0xLTEtMA_c2d9db7d-4a37-4183-a1fb-df1eb68f11bf"
      unitRef="shares">847000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xLTEtMS0w_dc3ab64f-3830-4a10-ace6-0420d68b7529"
      unitRef="usd">305000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0zLTEtMS0w_78728366-cdf5-45ff-ad0e-389e0e3157b3"
      unitRef="shares">1648000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS01LTEtMS0w_d57df376-3bca-4250-a585-92b3901b2662"
      unitRef="usd">30000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS03LTEtMS0w_477a6720-5356-430d-85af-295121b8a471"
      unitRef="shares">184000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS05LTEtMS0w_8c229f0d-4087-478f-98ca-a053cb09bf75"
      unitRef="usd">605000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xMS0xLTEtMA_51bfe511-e437-4b11-a070-fabf334edc9d"
      unitRef="shares">3072000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xMy0xLTEtMA_e0d2e7d4-c3ca-4a1a-997c-b7a067d47b31"
      unitRef="usd">219000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjFkNGZhZjliNjQzNTQ4Njg5MmYzNDY0Mzk5NmIwMDExL3RhYmxlcmFuZ2U6MWQ0ZmFmOWI2NDM1NDg2ODkyZjM0NjQzOTk2YjAwMTFfNS0xNS0xLTEtMA_b0c320f0-b49f-4883-a4f1-15ebbb702084"
      unitRef="shares">1424000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTUyNA_dbe33a33-a60b-47f5-9eb0-6fc7f3554dea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="if7cc8b46a7c6407daee478103960b9cf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi0xLTEtMS0w_55598a2a-2e1c-4290-be34-dcd14b83778b"
      unitRef="usd">-421000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4a6b8cee95f47f38c868dc0f83738cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi0zLTEtMS0w_c172d7e7-bd3a-4efd-aa43-fd327c787609"
      unitRef="usd">-17000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f82341c90d8488392c430a697f9ad8d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi01LTEtMS0w_490ef8e1-b506-4dc7-945e-32af1974d558"
      unitRef="usd">-163000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i77b79f9121d141459b8db7faff712c18_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMi03LTEtMS0w_470eeb69-ee1e-4cf5-b547-6575a131efd7"
      unitRef="usd">-601000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy0xLTEtMS0w_90cfe264-19ac-407e-9c84-aa7d2ce9789a"
      unitRef="usd">-49000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy0zLTEtMS0w_04841bcc-4db5-47bd-8e71-0e179bba7329"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy01LTEtMS0w_c73f7541-5750-4394-a076-09685e7d4d32"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMy03LTEtMS0w_207fb0e5-7c6a-4c45-ae71-4acfedd66abd"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC0xLTEtMS0w_dbf3f3b9-c534-4093-9dbe-56a2defec0f6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC0zLTEtMS0w_ffff7830-1971-4fc8-b0a9-fedb6d6597a5"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC01LTEtMS0w_ac3e3b7f-44dc-4538-96be-b05ac2adef7d"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNC03LTEtMS0w_99f25fae-9409-4fd9-9acd-44d6cfd85358"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS0xLTEtMS0w_acb0c0e8-2fda-4603-a5d2-7f6b8cad6155"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS0zLTEtMS0w_28b267d0-b347-4e7b-ab47-17fd286d278f"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS01LTEtMS0w_fea1644d-559f-46a4-ae4f-15397789a66e"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNS03LTEtMS0w_a3da0755-18b4-4620-8cd0-fa5d5a7822e2"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idc6e66b58e254b3b9923f88d7588154b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi0xLTEtMS0w_87a8aadc-b015-4a1b-8d88-844aeb0f081d"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifa537994e90945ce89b0d01443a0375f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi0zLTEtMS0w_c506cf7d-9d3f-4245-a84e-69d3343afdbb"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1f1701f16774db48bc21fa6a190cac2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi01LTEtMS0w_97df0ad8-d73b-46f0-816b-f7e18d5f6ae5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNi03LTEtMS0w_a60662e6-cff8-415d-af8a-461e233e23d4"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id3a85957e12343c3b6d10c076ee4eb33_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy0xLTEtMS0w_645b1670-f379-483f-ab34-6ab2afe10be0"
      unitRef="usd">-472000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic31a8c3f66c64539b477a0e822466880_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy0zLTEtMS0w_8b74e949-b440-46fb-935c-a27ac95e3b18"
      unitRef="usd">-22000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i419066cdc87943e4af8d2639f21bf325_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy01LTEtMS0w_e41ef6bc-c14b-4cde-a726-aec7f6f5db90"
      unitRef="usd">-162000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfNy03LTEtMS0w_901c241d-8800-43e8-9369-13d3404f8ea4"
      unitRef="usd">-656000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e20738f6dc4450bbd4b15b69a7e6581_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS0xLTEtMS0w_bf2c1cd8-82b0-4399-8f89-b3dde102f420"
      unitRef="usd">-403000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8d3d6307a914434b95e460604d9d99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS0zLTEtMS0w_7727079d-e9a7-476e-acb8-46fa38542187"
      unitRef="usd">-3000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib8ec840bf78e43008b395cb5e1e9dc56_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS01LTEtMS0w_58d5d194-df56-4b3e-b1ce-67a37ad44f4c"
      unitRef="usd">-169000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6930765739894f11878ad45a82a55846_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfOS03LTEtMS0w_34169cf6-38df-4133-be7a-12d43d0ca412"
      unitRef="usd">-575000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtMS0xLTEtMA_f40fbbf0-8a5a-4d63-bfd0-4f0bfdd90ce1"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtMy0xLTEtMA_85a017e3-e366-402d-8d34-78d3c27ff949"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtNS0xLTEtMA_7a3930b5-13fd-4506-8a12-e07355f61cc2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTAtNy0xLTEtMA_010b788e-8e36-4308-9667-3e00e412b421"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtMS0xLTEtMA_47ab69d4-70c1-4caf-a738-fcf22ab171de"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtMy0xLTEtMA_94d5af31-84e1-4491-9188-ff4b77946ed1"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtNS0xLTEtMA_f8dfad30-9302-4d46-b95c-3a4a624b5d91"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTEtNy0xLTEtMA_bcc5467d-344f-469f-a7f3-cfba02bf6ef7"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItMS0xLTEtMA_319dec10-8a06-445c-a089-9daa74e5ff45"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItMy0xLTEtMA_3eff70e5-310d-468c-8d34-5780c928b0b7"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItNS0xLTEtMA_9251e101-c189-44a5-b684-b3782c59be46"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTItNy0xLTEtMA_d6136b01-ad1e-43f0-93f5-f299f42932a5"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i96147fbdc91a40b19c7a9a2dfd45424a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtMS0xLTEtMA_bf8c2fda-8366-4715-9855-47b4ce834bcf"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3527aa3c4c8f4ed9b7a2579740a2950f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtMy0xLTEtMA_2084d1b3-1853-4e50-9d62-2323b4c7a15b"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61e5fc909f104e4dbe4dd3a68050f8e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtNS0xLTEtMA_37d05685-8a2a-4e5e-98f9-d37dc2769a5e"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTMtNy0xLTEtMA_86da447f-c34e-4a98-b65a-d6a7cde2bd74"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id61ae387d81f4cd787169a4aa986b749_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtMS0xLTEtMA_5a0a28b6-6267-48f2-8c46-29d72664af8b"
      unitRef="usd">-410000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i648911325f984984a9226827d9c4ade9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtMy0xLTEtMA_16c8bf49-d3b4-4a41-8ba4-848e34e29047"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i287ed9572278419fa5ed70f8a892d17b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtNS0xLTEtMA_807c935c-e027-4e3d-a119-f04bab9d51af"
      unitRef="usd">-167000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTQtNy0xLTEtMA_3e717ee9-ba7a-46ee-b69c-65516af37705"
      unitRef="usd">-553000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida1829b8f6a940fa9109f3a38603cdcc_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtMS0xLTEtMA_f75031f1-1277-4b19-888a-5b7570f04697"
      unitRef="usd">-414000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e31ef39780c49909cf68f429ec68689_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtMy0xLTEtMA_38dde837-9144-4b03-87e1-9ec915d39a89"
      unitRef="usd">-23000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8e05a3f921945f18703bab7f65ac87c_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtNS0xLTEtMA_2ffe13e4-0af4-4449-98ef-1afac1a261d6"
      unitRef="usd">-165000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a225e2c011c40babaaef3b0cd29dd9b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTgtNy0xLTEtMA_7e63b211-86b6-4a08-87d0-49ad96a0f4ef"
      unitRef="usd">-602000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktMS0xLTEtMA_feb848fe-db91-402b-8a17-0e229443e766"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktMy0xLTEtMA_32155803-a9c3-4f42-af81-96ebcb35ee5a"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktNS0xLTEtMA_4d2eac97-848f-4a7e-a004-f47013d58f0f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMTktNy0xLTEtMA_4a881d07-591d-4bd4-9ba5-c52476bd1a52"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtMS0xLTEtMA_6c84fa43-be8d-4c85-85f0-3a0796e48b68"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtMy0xLTEtMA_f79ceb54-abf6-4b48-bf51-059331c143f0"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtNS0xLTEtMA_aecd3a4b-4f3f-4c54-83ef-51617beb149e"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjAtNy0xLTEtMA_e244cd9a-fe33-403a-9d7e-0d2b2d589697"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtMS0xLTEtMA_a44c8be4-9198-4c8a-8168-39bed7c77ee0"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtMy0xLTEtMA_4f97e4bd-6273-454a-9724-fece3701e3a4"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtNS0xLTEtMA_ca0d9b47-ce4c-4621-88ed-9efe6c87d9a3"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjEtNy0xLTEtMA_0d7057ad-91b9-4ecb-8d67-b61ac25e35db"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1843eb48b0ff45a6aa04ebed491b06cd_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItMS0xLTEtMA_da7bf81d-07e9-4734-aa97-bda58f16976b"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8431e9e6846e4ed7ab89d92f5f41350d_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItMy0xLTEtMA_c874cb00-09f9-46f4-a2d1-8a2a0ca8bb89"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9b1dd615a5f426b85a76a63ba6523af_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItNS0xLTEtMA_0a992bcc-38ca-4030-a35f-738c7ab64691"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjItNy0xLTEtMA_70d79913-cbef-4736-b0c1-18d76fc8edcd"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id3a85957e12343c3b6d10c076ee4eb33_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtMS0xLTEtMA_ddcad85c-6537-4cc5-8e04-161f13e27005"
      unitRef="usd">-472000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic31a8c3f66c64539b477a0e822466880_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtMy0xLTEtMA_9789c1ec-d1bc-461b-8eb5-b72eb26afb32"
      unitRef="usd">-22000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i419066cdc87943e4af8d2639f21bf325_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtNS0xLTEtMA_8ec4f4c5-ecc1-4178-aadb-0ae6f90f6d88"
      unitRef="usd">-162000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f4941b28a4c48dea7dba1c3f8efdeb1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjMtNy0xLTEtMA_acd42322-912a-4922-84f9-fb71db746eb7"
      unitRef="usd">-656000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15cda9f6bf6342a597e07a9eec7230e9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtMS0xLTEtMA_13030d39-ea7a-46b5-8664-e642aa75f126"
      unitRef="usd">-450000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2fa822c4df064199a3d14eff7dcc4d7e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtMy0xLTEtMA_9d9e829b-dc2d-4bbb-91c7-329ab1b81edb"
      unitRef="usd">-18000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97439b6734784a439903d4ca1f2ab98b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtNS0xLTEtMA_07c47360-3ad0-4d15-be18-22cb9ec92020"
      unitRef="usd">-172000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fbc75f4e9704dd1a3ff580fe420db5f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjUtNy0xLTEtMA_e904d61a-1523-4381-9714-9c812354ed51"
      unitRef="usd">-640000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtMS0xLTEtMA_415a2b74-1d7a-4d9c-bc20-cca598dbb74d"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtMy0xLTEtMA_fc99996a-c68b-4fb0-a069-941f05b80e00"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtNS0xLTEtMA_8dba3e30-5b19-4e3b-b858-821b6f8b9e94"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjYtNy0xLTEtMA_cbe0691a-c1e8-47e5-95f2-34e91ecbd432"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctMS0xLTEtMA_a3868d4a-d3c7-437a-b250-f1ea917803eb"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctMy0xLTEtMA_622b1435-07d6-485b-bdbe-1d011500f346"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctNS0xLTEtMA_9917dc98-20ec-46f3-a652-192b5a7e7c88"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjctNy0xLTEtMA_0e43e8c7-4d60-4899-82f4-ed3a4c38efaa"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtMS0xLTEtMA_ee8fc03b-4312-455a-bc3f-913f19823876"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtMy0xLTEtMA_698d7ec5-e471-4acf-bdb5-ed8afcf163b6"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtNS0xLTEtMA_2002a391-1dad-489e-a117-7c8b0d56965f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjgtNy0xLTEtMA_b92c84b0-c8d5-4d55-9b8a-7ecf7decf54a"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia73131cafe54405cb0a8c699316877c1_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktMS0xLTEtMA_eb42b6bd-fcea-40ec-916d-eac42b617eca"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i69efbcf5afaf4d268020876850a93f1b_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktMy0xLTEtMA_6efb9e3a-cbfd-4de0-8958-a45a99da2cef"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i32cb2202eeda4a2382709f73fb38b499_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktNS0xLTEtMA_f47184b5-481b-46ae-80b4-8e5563211eac"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMjktNy0xLTEtMA_4c079d59-b8bc-42eb-8be0-f7634c3a9389"
      unitRef="usd">87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id61ae387d81f4cd787169a4aa986b749_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtMS0xLTEtMA_26d076f0-34c7-48a8-adc7-09e7168b7c7e"
      unitRef="usd">-410000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i648911325f984984a9226827d9c4ade9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtMy0xLTEtMA_c947f866-72d9-42d4-8084-d91cedd8254b"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i287ed9572278419fa5ed70f8a892d17b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtNS0xLTEtMA_97f90b59-e8ab-4748-9671-ded8dd1f7b4d"
      unitRef="usd">-167000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i148c7405ee9c472db3556c314ddfc829_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RhYmxlOjY3ZGMyZmFlYjYzZjQxZTQ5OGNmN2FjOWJkY2VjYzMyL3RhYmxlcmFuZ2U6NjdkYzJmYWViNjNmNDFlNDk4Y2Y3YWM5YmRjZWNjMzJfMzAtNy0xLTEtMA_690f822d-ca35-4af5-b641-cadd45b47886"
      unitRef="usd">-553000000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i62293d2d37bf4c4988f6c74ea00a7c89_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_38c7cbdf-dee1-4153-983a-b600031c1653"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie6d9925f9b914e0993a80905523974d8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_62f88ba3-2807-4dc0-8260-a2a7b04fb0bd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iababf4350ccf465da7e9156cd84d16b3_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_b86a34da-9127-4f7b-ad49-04977004799e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i173c3aa326c84df085c6251cbd51be86_D20190701-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180MC9mcmFnOjIzNDdjMzdhODRmOTQ1MWY4NDAyOWFkNTViMWMyMzc4L3RleHRyZWdpb246MjM0N2MzN2E4NGY5NDUxZjg0MDI5YWQ1NWIxYzIzNzhfMTM5MA_e38c9519-735f-46b6-912a-4c5a2d977344"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfODAy_476937db-a550-4c39-8bdf-3f1ad665e643">EMPLOYEE BENEFIT PLANS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic benefit cost for the Company&#x2019;s retirement health care plans was $0 for both the three months ended March 31, 2021 and 2020, and $(1) for both the nine months ended March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2021 and 2020, the Company made $6 and $7 in contributions to its domestic retirement income plans, respectively. During the nine months ended March 31, 2021 and 2020, the Company made $10 in contributions to its domestic retirement income plans. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs are reflected in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfODAz_a01c6591-11b5-4713-b697-41ba6fd52d4c">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi0xLTEtMS0w_5c36899c-50c1-45a2-88e3-94c122dfd68e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi0zLTEtMS0w_9a00d6c8-70b5-4e38-9eb8-2d93897c2bca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi01LTEtMS0w_6b745049-c623-4318-bcea-f79e0df6cb70"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMi03LTEtMS0w_536d4a7c-8b6e-4744-a1dd-540f7bef67ae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy0xLTEtMS0w_33da99d5-96af-4ce5-b0c1-164e7969949f"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy0zLTEtMS0w_355a9578-82d3-48d7-8d74-de95d50c3054"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy01LTEtMS0w_607edf48-4927-49b6-a987-351ccf1dc977"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfMy03LTEtMS0w_d5504718-6438-4fa5-90d3-dee1bca6e5db"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC0xLTEtMS0w_219fbf71-82e9-40a5-b712-d320d5ac9abf"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC0zLTEtMS0w_47d03858-106f-44bb-9d37-18afc9138adb"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC01LTEtMS0w_86a39d26-0397-4677-8fc3-42dda9166d84"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNC03LTEtMS0w_8461c56c-7b62-4dfa-8371-be8410abfbd5"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS0xLTEtMS0w_7cdaff46-3e06-416a-9b7a-b441c9c54d7d"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS0zLTEtMS0w_8deb25c4-a4c0-4ba9-9e7a-24a46d9ccab9"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS01LTEtMS0w_31291e57-3357-4142-acf4-ba871187d2e6"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNS03LTEtMS0w_69aabda4-a7ab-448d-b255-7fbc289a8522"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6781163730824d28bacaadf6145e3cd6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi0xLTEtMS0w_520971fa-e6f0-4410-8a5d-65d602561826"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i231dec8719174078bc40595afca4dbde_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi0zLTEtMS0w_0fcc1405-c745-4274-b451-ee73118b9b48"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i291dd0d85d1449c3b26a67beefb696bc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi01LTEtMS0w_71279c8e-d9a6-406d-8dcf-2ca792dc687b"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ife71daed3a804771b19315df743bc445_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RhYmxlOjBjZmQ0NjI5ZTM5ZjQ0ZDY4MmNmZTM0ZDc4YTVkODU2L3RhYmxlcmFuZ2U6MGNmZDQ2MjllMzlmNDRkNjgyY2ZlMzRkNzhhNWQ4NTZfNi03LTEtMS0w_8c5c2d2a-32b1-4d8e-99cb-0fad4aadf442"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMjk2_86d9c549-f954-49f2-b8dc-ae6ced7aaa0f"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc1NA_e0df81ab-6bb8-49c2-b111-0d4c47ebbc27"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc1NA_eb724770-c7b8-4829-b371-2405321a9623"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2NA_119bca42-12eb-4700-bb1f-a8f2c09961f1"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2NA_beb66e43-4223-455f-b1cb-10b0709f53f5"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1ec03781c4364b8eb6a53fc946376745_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfMTA5OTUxMTYyODc2Nw_c22807a3-d57a-4e1b-94be-5f8443a5a40c"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i94703f8812a94078aa3f69523823f506_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNTM0_d82c2710-30ba-4474-b195-02a36b825d3b"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i0a83729a2ab84c53a192961000f37527_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNjY4_6942ca2a-314f-4ffc-a120-cf323877ea4d"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if1379ef5a7284cb29a9aed3da06988b6_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180My9mcmFnOmFkOTFlYzZhOTllNDQxYzA4ZGE4ZmJlMTQ2MTBlNTg3L3RleHRyZWdpb246YWQ5MWVjNmE5OWU0NDFjMDhkYThmYmUxNDYxMGU1ODdfNjY4_99a32b7a-d63e-40f6-bdb8-5741f8deef20"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <clx:OTHERCONTINGENCIESANDGUARANTEESTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDU1Nw_600dc279-002b-4834-b4ec-d912ce6839b1">OTHER CONTINGENCIES AND GUARANTEES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $27 and $28 as of March&#160;31, 2021 and June&#160;30, 2020, respectively, for its share of aggregate future remediation costs related to these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One matter, which accounted for $14 of the recorded liability as of March&#160;31, 2021 and June&#160;30, 2020, relates to environmental costs associated with one of the Company&#x2019;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. As a result, the Company recorded in Other (income) expense, net an undiscounted liability for costs estimated to be incurred over a 30-year period, based on the option recommended in the Feasibility Study. However, as a result of ongoing discussions with regulators, in June 2017, the Company increased its recorded liability to $14, which reflects anticipated costs to implement additional remediation measures at this site. While the Company believes its latest estimate is reasonable, regulators could require the Company to implement one of the other options evaluated in the Feasibility Study, with estimated undiscounted costs of up to $28 over an estimated 30-year period, or require the Company to take other actions and incur costs not included in the study. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Another matter in Dickinson County, Michigan, at the site of one of the Company&#x2019;s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability, as of March&#160;31, 2021 and June&#160;30, 2020. This amount reflects the Company&#x2019;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#x2019;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. The Company&#x2019;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements, and the future availability of alternative clean-up technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had not recorded any material liabilities on the aforementioned guarantees as of March&#160;31, 2021 and June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company was party to a letter of credit of $11, related to one of its insurance carriers, of which $0 had been drawn upon.&lt;/span&gt;&lt;/div&gt;</clx:OTHERCONTINGENCIESANDGUARANTEESTextBlock>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMjE2_7add3bbf-c6b2-42a4-bccb-32413f55f09a"
      unitRef="usd">27000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTA5OTUxMTYzMjM3NA_9e5c2270-c723-4bda-ad6d-e9f026ffedc3"
      unitRef="usd">28000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMzQ3_87c15ddf-7a39-4edd-825b-e5501d0ad375"
      unitRef="usd">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ic8784fe904d7468a9509d946755aa75a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMzQ3_a6b60c4b-add4-44c3-8c0e-3c0c7047398a"
      unitRef="usd">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:RemediationPeriod
      contextRef="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfOTAy_e2cba7ae-2176-410a-9878-26ff183f7b28">P30Y</clx:RemediationPeriod>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="id29606025bd94286b0f0595ed8010676_I20170630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTA5OQ_e6cf7e0a-e255-4ff1-84e6-edae8e346a9d"
      unitRef="usd">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:MaximumExposureUndiscountedCost
      contextRef="i62bf445f2ad44e8b93ec0a75ceebfabe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTQxMQ_dd737f82-e2b7-4628-ab10-4652d0410853"
      unitRef="usd">28000000</clx:MaximumExposureUndiscountedCost>
    <clx:RemediationPeriod
      contextRef="i43d7ecd5617d4e93b6ce0d26d2d67bd8_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTQzMg_e4b7e9a7-8c09-41e2-b047-2c83b15e2bcf">P30Y</clx:RemediationPeriod>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ib3d430c56b2d45ea938542ba1ac62191_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTcwNg_552e0b25-4796-4907-9994-6efcd31cc37f"
      unitRef="usd">10000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="id75803f96d3a484c8dbb2e4d3901e6b9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTcwNg_79b5602e-2f1a-43a2-9a31-cb765b887b62"
      unitRef="usd">10000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:SiteContingencyAgreedPercentageOfCostSharing
      contextRef="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMTgxNQ_75c33f6d-a3b3-496f-92dc-bf6417fdb1e4"
      unitRef="number">0.243</clx:SiteContingencyAgreedPercentageOfCostSharing>
    <clx:RemediationPeriod
      contextRef="iba60e5c2af804247870b24c10bd88a2c_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfMjMzMw_1d963435-85ed-4d13-b42d-40d7d80fb1f5">P30Y</clx:RemediationPeriod>
    <clx:LetterOfCreditBorrowingCapacity
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDQ3NA_e22fabf0-4a2e-407a-9b0a-5024c7956107"
      unitRef="usd">11000000</clx:LetterOfCreditBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180Ni9mcmFnOmNjMWJjMzk3M2QwNDQ2ZmE4MWU0MmQzYzc0M2VmNzU4L3RleHRyZWdpb246Y2MxYmMzOTczZDA0NDZmYTgxZTQyZDNjNzQzZWY3NThfNDUyOQ_ae8fed5c-3f7a-4e26-981a-fa584ae19694"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU3NA_903d63ce-e22d-42f2-a8d5-ed108ffdfebc">SEGMENT RESULTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company operates through SBUs that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The earnings (losses) before income taxes for the Health and Wellness segment include a $329 non-cash goodwill, trademark and other asset impairment charge for the VMS SBU for the three and nine months ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intersegment sales are eliminated and are not included in the Company&#x2019;s reportable segments&#x2019; net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales to the Company&#x2019;s largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 24% for each of the three and nine months ended March 31, 2021, respectively, and 25% for each of the three and nine months ended March 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales for the Company&#x2019;s SBUs and for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU3Ng_14f5fd50-b4a3-472d-85d0-da9c6d465dcf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company operates through SBUs that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTE2_a6bbb8ff-3b0d-407d-94f8-580c1441587e"
      unitRef="reportablesegment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTU4Mg_0d0b86c6-e5c7-4a4a-ae75-090e68dfb5d8">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The earnings (losses) before income taxes for the Health and Wellness segment include a $329 non-cash goodwill, trademark and other asset impairment charge for the VMS SBU for the three and nine months ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales for the Company&#x2019;s SBUs and for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy0yLTEtMS0w_588994de-df87-4604-ab12-c9a17713350e"
      unitRef="usd">680000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy00LTEtMS0w_0875cccc-fe75-4646-a08b-8240424c870b"
      unitRef="usd">736000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy02LTEtMS0w_7703b505-924f-4476-89c0-7c8782b0cd2f"
      unitRef="usd">2310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMy04LTEtMS0w_e8b487fd-f1ce-43e5-b2aa-2a84a0ed2278"
      unitRef="usd">1944000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC0yLTEtMS0w_8cd8b607-cd74-45a4-beee-7db35260ce5c"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC00LTEtMS0w_9cc26a96-cab0-453a-b01e-55906169a1dc"
      unitRef="usd">480000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC02LTEtMS0w_53dd4f99-ab19-4302-b928-310e6e2933a5"
      unitRef="usd">1421000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNC04LTEtMS0w_adda1069-b5d1-4868-a07f-7bdc5e0b9d93"
      unitRef="usd">1183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS0yLTEtMS0w_d2b46299-7576-4ca1-b3eb-f3a447c9e07e"
      unitRef="usd">293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS00LTEtMS0w_fa1218ed-51a1-4c8f-9c76-f10308bd6979"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS02LTEtMS0w_fba1d6b1-b48b-489b-9b1a-6f975428eb03"
      unitRef="usd">928000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNS04LTEtMS0w_94b6c8af-6f10-45e8-bf18-2e5204ba8cf0"
      unitRef="usd">856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi0yLTEtMS0w_18823479-d751-43d2-847c-c0cad802f718"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi00LTEtMS0w_79afe52f-73bb-45dd-aed9-94cfb44a3158"
      unitRef="usd">273000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi02LTEtMS0w_6e17622e-44a3-401b-9803-67fdac247cc3"
      unitRef="usd">880000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNi04LTEtMS0w_c694c938-7cb2-43d9-8a35-d74d3430bad5"
      unitRef="usd">755000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i975190927cc64325b214048019388e7e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy0yLTEtMS0w_be9b0ddd-acd8-4847-b7da-f7231f00d268"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy00LTEtMS0w_3cfbf865-dbd0-4786-ac3b-8a9e6afa5c62"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy02LTEtMS0w_cc4b5f3a-a886-444d-8838-00361c7bfb73"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfNy04LTEtMS0w_bf6a7849-46dc-4753-a04c-bb1be122454c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC0yLTEtMS0w_db16ffeb-56e7-489b-96b3-5bfec0589e91"
      unitRef="usd">1781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC00LTEtMS0w_9160fcad-b479-4dd8-a1d5-8682f8b83294"
      unitRef="usd">1783000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC02LTEtMS0w_a95d05d2-304b-44b0-8e22-3bf9335eb5f1"
      unitRef="usd">5539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfOC04LTEtMS0w_2c4a0050-d3b4-4c69-b14a-cb5b9a8c2329"
      unitRef="usd">4738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia270747bb3544c57a3c19524a92ff970_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtMi0xLTEtMA_8ef347ac-3072-4b7b-bf65-a5ed8ae56fa0"
      unitRef="usd">-183000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8af5188dfc324e1d8b5e98a64c051cdc_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtNC0xLTEtMA_3301f02d-6db7-4c87-9046-84f4c0bc6a17"
      unitRef="usd">210000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3a2201dfab0942c9b95c0e3dc5f27a70_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtNi0xLTEtMA_38e5bcac-6147-4640-a016-f13a4e086750"
      unitRef="usd">315000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i22b6d17342ed4b54ad6f6cc1ce64c31b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTMtOC0xLTEtMA_d63f3748-9978-4495-b036-8d3b941fb96b"
      unitRef="usd">514000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic2720cbdea344f8d87e8fef7cd7faf1e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtMi0xLTEtMA_d27bb336-376b-4445-b1e3-9377ad01999f"
      unitRef="usd">97000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8f07d4416a4e4d468d104082d9c7dab4_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtNC0xLTEtMA_2d160d12-7ea6-4ce9-8d77-a86e3746558b"
      unitRef="usd">114000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf0bf8fb7f9e4ca2a64934261698aa95_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtNi0xLTEtMA_c37cd2ac-8c27-40a3-a860-52ef7cb5b0f2"
      unitRef="usd">266000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie646130f862a4b6dbcfd81d3d1eaa61f_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTQtOC0xLTEtMA_4bba7886-461c-4fbc-ab26-3bc14b56d476"
      unitRef="usd">190000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i857115812559475a93c38c2cf6cc1f54_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtMi0xLTEtMA_74b9a8bc-9d4a-4cab-a0b5-9e87dbf510b6"
      unitRef="usd">68000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if81ceacb7ddf4f229b05077fdf1e053b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtNC0xLTEtMA_d37f52e0-79ca-4bd1-a5ca-5d4ddf600dc4"
      unitRef="usd">80000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifdd5004b79cc4444ab5cf37a85698d73_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtNi0xLTEtMA_9bb033b4-8e65-47ba-ad32-d6f5e7d19c43"
      unitRef="usd">259000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i486a8e0225664b339a6df91b057d28bb_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTUtOC0xLTEtMA_023455bd-9699-4f24-af40-4c6332d5c0bb"
      unitRef="usd">242000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2395d9e2497d492f953727ebbf7d0d51_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtMi0xLTEtMA_1aaab681-3302-46f4-8df8-5ccf6839593b"
      unitRef="usd">30000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife316d170bf94fb8a042e286f23ca5d2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtNC0xLTEtMA_9fff68cf-1b5c-418a-95c7-9fc062a48178"
      unitRef="usd">36000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5f6ec4e330404887a5b9b798936e5b1f_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtNi0xLTEtMA_3461cb6e-d935-4de0-9556-9c0110cd4289"
      unitRef="usd">184000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2fc4e45c604f4a62b3429a64faf1b22c_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTYtOC0xLTEtMA_42bbe2de-b796-4a65-b770-e128c1fba019"
      unitRef="usd">106000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i975190927cc64325b214048019388e7e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctMi0xLTEtMA_6f999b78-fa68-4471-8f43-9264ca23c7bf"
      unitRef="usd">-71000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6ae0ab78a3ab4c028985b10ac4595c52_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctNC0xLTEtMA_b26772b5-b9b6-45b4-ac06-e5ed0d21987c"
      unitRef="usd">-143000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia5e17ec85fe946ed94914713bf1c95cc_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctNi0xLTEtMA_8729d945-e234-4c34-abfa-55bd0a4935b4"
      unitRef="usd">-225000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7b65488854574173bb4dccd7a3554c63_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTctOC0xLTEtMA_0dbe9b45-c7e1-4a96-89db-6330bf9942ae"
      unitRef="usd">-262000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtMi0xLTEtMA_2952de06-a8ba-40d5-a22d-25c9874001d0"
      unitRef="usd">-59000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70a25c0a2dda4835adc92860735de6be_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtNC0xLTEtMA_0076b9cc-3a6f-470c-9db5-d05737190ce4"
      unitRef="usd">297000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtNi0xLTEtMA_2e154791-43e1-4452-b08b-e74e11c152d3"
      unitRef="usd">799000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4fecaa361b14604ab8e9c420646a88b_D20190701-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjVkMjQ0MGJlNGQwMjQ5MzRiZjk3MmMzYzc0YjcyMjYzL3RhYmxlcmFuZ2U6NWQyNDQwYmU0ZDAyNDkzNGJmOTcyYzNjNzRiNzIyNjNfMTgtOC0xLTEtMA_b390493a-b465-4722-bc2f-1b084ef9c258"
      unitRef="usd">790000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8ab916301dd545dfb13bfebce18db895_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMzI5ODUzNDg4NTQyNw_a8f5f7a6-9324-40ea-aaab-df73ff73f1ac"
      unitRef="usd">329000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4ad2a51e50b3452cb6ae64126212de08_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTI2MQ_2f997b5e-9e91-4990-bf8e-8ae5c6f4148b"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9cfe0f219db7465c981c5d00e3d79dcc_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTI2MQ_a0541c9c-3a32-4815-b701-09579c7a3b4a"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7e65e42dcaee41a8aa5344602e39584a_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTM0Mw_0950caa5-e2be-4fd4-9217-512b22ea552e"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8eac904b7e824f788b24e686c7bc1d56_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RleHRyZWdpb246Njc5ODM4MjY5YzUzNGVhZTg3NzI0MWYxMWJkZjQwNDFfMTM0Mw_306f5db4-4d2a-4dab-8fe2-7b8ccfd914da"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5699b6f9a46b48c5bec7a3e5ba13b8a7_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy0yLTEtMS0w_88d30e15-c6a8-428f-8d2b-448515c470bf"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0bd7644fe81e43fcb2a9ae7f33ce5f3b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy00LTEtMS0w_dbfa692b-ff6f-4e3f-a4c2-823570622837"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2eb102946ac9445592b664e481c220fb_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy02LTEtMS0w_f8e6e7f4-ffe0-4d7e-85b2-301e68a3636e"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia632e6efb55e4038b06caacaa950ee58_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMy04LTEtMS0w_1a5e27e8-7b18-4946-a2f1-78de7d140733"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if62aad3baf484220b5c2b3c5607bcf73_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC0yLTEtMS0w_798f901d-6e40-4847-8735-fc01fd2ffd0f"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3fc121a4a2da4a36b4069a1d12d0b8ca_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC00LTEtMS0w_899e62ef-7f6b-4f79-acd6-7c82debd6a3d"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c504e6a0e8e49379abef45f151e6867_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC02LTEtMS0w_e527f8cf-6ecd-48a8-ac7c-6213291f64e6"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i506a64ba3d1741e8a790673d8cd8f3c6_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNC04LTEtMS0w_55a1ad0b-23a0-4573-ad40-0ffd615dd71d"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i15818785c195423aa0fecc36f1c2582f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS0yLTEtMS0w_ad691d0b-7425-4739-bfa0-a6beba73e17b"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie147f6c9542045d2bc2b75081d38abde_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS00LTEtMS0w_cab34fce-c338-4192-bf7a-5ec395fbfa16"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8caf281c758e491a861b00f823d7979d_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS02LTEtMS0w_01e5c936-50ff-45ef-896b-c599872b7298"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i53b9ae5110404e8e812297d5d6b2d42b_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNS04LTEtMS0w_1eea05a5-2713-4f58-8324-91274553b0a6"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i47db18debc494da4b9575bc13dde6879_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi0yLTEtMS0w_f43761db-bb32-4c16-af98-8431c5c0003c"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i64ad656aa5c747ea869192f42c6b654f_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi00LTEtMS0w_72205885-ebf8-4dc4-89d8-e3561b4b9208"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8812b42a862f45728955cc5a6fd0e98d_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi02LTEtMS0w_f45cfe33-1f18-450d-b6f2-ac6f3e4f3768"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i128d754517744d14bf0d13fc3d3cf0b3_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNi04LTEtMS0w_81b72422-11d3-46ce-bc8d-bf5dc95c24fb"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1c55fd9240674a3b9f72e4cbb7d515dc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy0yLTEtMS0w_bcd74438-c73f-4d9f-af8f-c4cec660823b"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifad0e0cfdad747e9bf36f5473f6d8f03_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy00LTEtMS0w_6ffafc51-d323-43e5-b2e9-607577baff73"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if2e1002466a64130bc0c173f011c16d7_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy02LTEtMS0w_59b1f7c2-2865-493e-bf22-31d16c2720c2"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i58e0648e0b884c8184d3468dad255a59_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfNy04LTEtMS0w_0c650735-4898-430c-a84f-1f70e32618fb"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i187b861787ca41e3b58b23b46c5faf63_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC0yLTEtMS0w_c93aa08d-ae36-493f-ae22-2b135d7287da"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0b809796270b46368d7995f9e91a9c90_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC00LTEtMS0w_c1038898-fea4-4f66-949e-d1735e3ff868"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id1e24f176213492e981a7a7fe85e20a0_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC02LTEtMS0w_5aec7482-a151-44cf-9a5f-3678e62c96bb"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib3a795ff3b4c4adaa82835e56a401845_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOC04LTEtMS0w_578552dd-0a82-4717-910a-1460d3b25a88"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idc2ea66f0180479c96f3dd09cab6e243_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS0yLTEtMS0w_3dbc52cd-7279-4df2-8764-321bed4abec0"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia1a5a929489a4b42bb6fce0495516584_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS00LTEtMS0w_b88ec184-b68b-481b-9832-ebb807e9681c"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie3d5d2046dae465496bfa06a4ce81663_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS02LTEtMS0w_c6a6fe14-154a-4f53-a6d8-9802e0e6f21c"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia6de7ab384894152aca3960aaa565203_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfOS04LTEtMS0w_d06a4d87-404e-40e2-8739-7de4ffad41e4"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i37a114b1ca84437a9ecaf7bf79fb57ca_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtMi0xLTEtMA_5e8a081b-57f5-4947-b4c5-482bd1a0a768"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i237934c2afde4ed0a6ab8a5fa7df13eb_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtNC0xLTEtMA_01f3e019-78e1-47ff-ab2f-a16e66954bf6"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i93f613b6d1e54231bf06050b363647cd_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtNi0xLTEtMA_71ca9314-aaf8-4e59-8599-0d2b3660beff"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i88583fbc1c434496bf8b9e52b80d9067_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTAtOC0xLTEtMA_99c49143-06a3-43f4-8eee-ea8d7753cdcd"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i483c1116882345a89188168be2d76bc8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtMi0xLTEtMA_b909acf5-6954-4fdb-95b7-bc566826f05f"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia02727d1fe8147ce863007dd69cdd4ef_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtNC0xLTEtMA_b9b4da71-7b6d-4901-b196-945d5ea9f4c2"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6479f56abf874bc88fcc7c452a280a08_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtNi0xLTEtMA_40fe1efe-bfbd-4f21-a4ff-3c40122e71bf"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if10aa250273f4428bc10f6ba3c689231_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTEtOC0xLTEtMA_06c6d21d-010d-4a99-9e73-128605191ec9"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic8ec145f089a480fb32a14926e0eec81_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItMi0xLTEtMA_c14dcf4c-5f6a-4004-b2b7-d85fc0386049"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i61184552c2644513b3d633d0928a8112_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItNC0xLTEtMA_8794985b-161f-482e-abcc-48a46991ae44"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iba7f614f662c4fdaac724b9dbdc9b0ec_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItNi0xLTEtMA_e8d57707-ff4a-44b8-b184-05a20c9e98bd"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i053ab554d68d4004b7cc5e97f743f92d_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTItOC0xLTEtMA_ee210ab7-3b6f-463f-b0c6-932e0bf27914"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie08eb37c570741b6adbb80e59db8e81b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtMi0xLTEtMA_f83b76db-8392-42e1-917b-d29cf450048e"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i005732996c5443e98325ccaca9851e73_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtNC0xLTEtMA_824c2f3c-f458-4e0c-b45a-7583daa9310d"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i88cf12ca5cc441158bed63419f14048d_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtNi0xLTEtMA_4827f6aa-5603-47f0-a2dd-170f48199379"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i55cd924b746a43e7bb45ffa60c315720_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTMtOC0xLTEtMA_f8dc0f4c-cd60-41c2-8035-147d8791bde3"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18be5d4fbe524e47a3029107ff86582b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtMi0xLTEtMA_001f76e5-e5a2-45f3-a1cc-e6bde617b0e0"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic4c74269eba445e0b373d38d49c2ea96_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtNC0xLTEtMA_9ab4b78d-a724-4635-9e17-43cbfe128253"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie9e2335ca8894224947f5ebe34faec14_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtNi0xLTEtMA_bc109c5e-beb1-48ba-8417-854fbd06cf00"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifd2e74bb030744169bd9895fd5ff97e7_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTQtOC0xLTEtMA_02828141-dad1-4e16-88c1-83e0937865f9"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie49d4996c5414e89885bb395950c44cf_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtMi0xLTEtMA_023c152d-df4e-4951-8d2f-10c60be76ce9"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia7f4b076b16b412f97df8f6635593f56_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtNC0xLTEtMA_9751b79b-64fc-4cb8-bbd4-d00d8fddf7df"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i816a0ac0739d40dbb754308ccc3bb074_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtNi0xLTEtMA_31464d5e-ba9f-44da-a99d-595c04bd996d"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8a5bde4bb3614689b5997373fdce9d38_D20190701-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTUtOC0xLTEtMA_6e783269-9824-494f-a07c-a8d6642652fa"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i647346da3c594fa1b168b90be5aab738_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtMi0xLTEtMA_8c5a9584-139a-47cd-9358-a0182d74bd59"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2b50c8db5f674487bbe612c1077374b8_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtNC0xLTEtMA_913b676a-7f0a-46ed-8747-648bf1539466"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie0e050195d1c47c698983818dc2bb144_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtNi0xLTEtMA_3b262920-cef5-4f88-8ee1-466014433b74"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0d206ce9aae94891b7aefcc647ef716b_D20190701-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIzYjYwZGI4MjZhODRiZWQ5ZmJlNmFlOWUyZjc0MWM3L3NlYzpiM2I2MGRiODI2YTg0YmVkOWZiZTZhZTllMmY3NDFjN180OS9mcmFnOjY3OTgzODI2OWM1MzRlYWU4NzcyNDFmMTFiZGY0MDQxL3RhYmxlOjM5ZTU0YTY3NWU5NjQ4ODA4M2YzNjI4MjljZTc4NTgyL3RhYmxlcmFuZ2U6MzllNTRhNjc1ZTk2NDg4MDgzZjM2MjgyOWNlNzg1ODJfMTYtOC0xLTEtMA_118a2be0-e9fc-4f88-a5d3-b5e6480fac97"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318322776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-07151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE CLOROX COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0595760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1221 Broadway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oakland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94612-1888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">271-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock - $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,372,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017312930312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,781<span></span>
</td>
<td class="nump">$ 1,783<span></span>
</td>
<td class="nump">$ 5,539<span></span>
</td>
<td class="nump">$ 4,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">951<span></span>
</td>
<td class="nump">3,008<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">774<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">2,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherExpenseIncomeNet', window );">Other (income) expense, net</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Clorox</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 613<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings (losses) per share attributable to Clorox</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share (in dollars per share)</a></td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share (in dollars per share)</a></td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
<td class="nump">$ 4.78<span></span>
</td>
<td class="nump">$ 4.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">125,610<span></span>
</td>
<td class="nump">125,661<span></span>
</td>
<td class="nump">126,057<span></span>
</td>
<td class="nump">125,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">125,610<span></span>
</td>
<td class="nump">127,328<span></span>
</td>
<td class="nump">128,030<span></span>
</td>
<td class="nump">127,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (37)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Clorox</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherExpenseIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherExpenseIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017312774408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">2,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net of accumulated depreciation and amortization of $2,351 and $2,224, respectively</a></td>
<td class="nump">1,251<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TrademarksNet', window );">Trademarks, net</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,441<span></span>
</td>
<td class="nump">6,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,819<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,483<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">819<span></span>
</td>
<td class="nump">767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,503<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of March&#160;31, 2021 and June 30, 2020, respectively; and 124,359,712 and 126,198,606 shares outstanding as of March&#160;31, 2021 and June 30, 2020, respectively</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">1,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">3,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 6,381,749 and 32,542,855 shares as of March&#160;31, 2021 and June 30, 2020, respectively</a></td>
<td class="num">(1,111)<span></span>
</td>
<td class="num">(3,315)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(553)<span></span>
</td>
<td class="num">(640)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Clorox stockholders&#8217; equity</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,441<span></span>
</td>
<td class="nump">$ 6,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TrademarksNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TrademarksNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017315705384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property, plant and equipment, accumulated depreciation and amortization</a></td>
<td class="nump">$ 2,351<span></span>
</td>
<td class="nump">$ 2,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">130,741,461<span></span>
</td>
<td class="nump">158,741,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">124,359,712<span></span>
</td>
<td class="nump">126,198,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">6,381,749<span></span>
</td>
<td class="nump">32,542,855<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314985240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 619<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(220)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes payable / prepaid</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operations</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(232)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Businesses acquired, net of cash acquired</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(341)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Notes and loans payable, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock purchased</a></td>
<td class="num">(605)<span></span>
</td>
<td class="num">(225)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to Clorox stockholders</a></td>
<td class="num">(420)<span></span>
</td>
<td class="num">(399)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Cash dividends paid to noncontrolling interests</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther', window );">Issuance of common stock for employee stock plans and other</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used for financing activities</a></td>
<td class="num">(944)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(382)<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract', window );"><strong>Cash, cash equivalents, and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset And Liability, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OperatingLeaseRightofUseAssetAndLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017310046712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2020, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, &#8220;Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,&#8221; which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div>In January 2017, the FASB issued ASU No. 2017-04, &#8220;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#8221; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company&#8217;s consolidated financial statements at the time of adoption. The impairment identified in the third quarter of fiscal year 2021 was calculated in accordance with this guidance. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311239720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUIRED<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUIRED</a></td>
<td class="text">BUSINESS ACQUIRED<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Saudi Joint Venture Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 9, 2020, the Company increased its investment in each of the two entities comprising its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture). The joint venture offers customers in the Gulf region a range of cleaning and disinfecting products. The Company had previously accounted for its 30 percent investment of $27 as of June 30, 2020, under the equity method of accounting. Subsequent to the closing of this transaction, the Company&#8217;s total ownership interest in each of the entities increased to 51 percent. The Company has consolidated this joint venture into the Company&#8217;s consolidated financial statements from the date of acquisition and reflects operations within the International reportable segment. The equity and income attributable to the other joint venture owners is recorded and presented as noncontrolling interests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total purchase consideration of $111 consisted of $100 cash paid, which was sourced from operations, and $11 from the net effective settlement of preexisting arrangements between the Company and the joint venture. The assets and liabilities of the joint venture were recorded at their respective estimated fair value as of the acquisition date using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill in the International reportable segment in the amount of $208. The goodwill is primarily attributable to the synergies expected to arise after the acquisition and reflects the value of further growth anticipated in the Gulf region. None of the goodwill is deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of this transaction, the carrying value of the Company&#8217;s previously held equity investment was remeasured to fair value, and resulted in an $85 non-recurring, non-cash gain recorded in Other (income) expense, net in the condensed consolidated statement of earnings and adjusted in Other operating activities in the condensed consolidated statement of cash flows for the first quarter of fiscal year 2021. The fair values of the noncontrolling interests and previously held equity interest were determined using a discounted cash flow (DCF) method under the income approach. Under this approach, the Company estimates future cash flows and discounts these cash flows at a rate of return that reflects the entities&#8217; relative risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price allocation was finalized during the second quarter of fiscal year 2021. The following table summarizes the final purchase price allocation for the fair value of the joint venture&#8217;s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Venture</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired rights (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital, net (includes cash acquired of $26)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of previously held equity interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Included in the Company&#8217;s results for the three and nine months ended March 31, 2021 was $19 and $65, respectively, of net sales from the joint venture. Pro forma results reflecting this transaction were not presented because it is not significant to the Company&#8217;s consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311286088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES, NET</a></td>
<td class="text">INVENTORIES, NET<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311327032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, as a result of lower than expected actual and projected net sales growth and operating performance for the Vitamins, Minerals and Supplements (VMS) strategic business unit (SBU), a strategic review was initiated by management that resulted in updated financial and operational plans. These events were considered a triggering event requiring interim impairment assessments to be performed on the VMS reporting unit, indefinite-lived trademarks and other assets. Based on the outcome of these assessments, the following pre-tax impairment charges were recorded:</span></div><div style="margin-bottom:6pt;margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment Charge</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of $62 due to the partial tax deductibility of these charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment charges are a result of a higher level of competitive activity than originally assumed, accelerated declines in the channel where the business is over-developed, and higher than anticipated investments to grow the business, which have adversely affected the assumptions used to determine the fair value of the respective assets held by the VMS reporting unit for growth and the estimates of expenses necessary to achieve that growth. These impairment charges are based on the Company&#8217;s current estimates regarding the future financial performance of the VMS SBU and macroeconomic factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of the VMS reporting unit, the Company used a DCF method under the income approach. Under this approach, the Company estimated the future cash flows of the VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates, and a terminal growth rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2021 from June&#160;30, 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:30.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes $(4) purchase price allocation adjustment related to the Saudi joint venture acquisition. Refer to Note 2 of the Notes to Condensed Consolidated Financial Statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the estimated fair values of the VMS related indefinite-lived trademarks, which were included within the Health and Wellness reportable segment, the Company used the income approach. This approach requires significant judgments in determining the royalty rates and the assets&#8217; estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $13 as of March 31, 2021, were changed from indefinite to definite beginning on April 1, 2021, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is&#160;16 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"/><td style="width:33.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense relating to the Company&#8217;s intangible assets was $8 and $23 for the three and nine months ended March&#160;31, 2021, respectively, and $3 and $10 for the three and nine months ended March&#160;31, 2020, respectively. Estimated amortization expense for these intangible assets is $8, $32, $30, $29 and $28 for the remainder of fiscal year 2021 and fiscal years 2022, 2023, 2024 and 2025, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017237791112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity exchange traded futures and over-the-counter swap contracts, which are generally no longer than 2 years, to fix the price of a portion of its forecasted raw material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the notional amount of commodity derivatives was $24, of which $15 related to soybean oil futures used for the Food products business and $9 related to jet fuel swaps used for the Grilling business. As of June&#160;30, 2020, the notional amount of commodity derivatives was $27, of which $14 related to soybean oil futures and $13 related to jet fuel swaps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $68 and $70, respectively, as of March&#160;31, 2021 and June&#160;30, 2020. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate forward or swap contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage the Company&#8217;s level of fixed and floating rate debt. These interest rate forward or swap contracts historically have had durations of less than 3 years. The interest rate contracts are measured at fair value using information quoted by U.S. government bond and interest rate derivative dealers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notional amounts of outstanding interest rate contracts used by the Company were $300 and $225, respectively, as of March&#160;31, 2021 and June&#160;30, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These contracts represent forward starting interest rate swap contracts with a maturity date of September 2022 to manage the exposure to interest rate volatility associated with future interest payments on a forecasted debt issuance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward and futures contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate forward contracts for forecasted interest payments as cash flow hedges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of March&#160;31, 2021, that is expected to be reclassified into Net earnings (losses) within the next twelve months is $2. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of March&#160;31, 2021 and June&#160;30, 2020, $1 and $3, respectively, contained such terms. As of March&#160;31, 2021 and June&#160;30, 2020, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both March&#160;31, 2021 and June&#160;30, 2020, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange-traded futures contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of March&#160;31, 2021 and June&#160;30, 2020, the Company maintained cash margin balances related to exchange-traded futures contracts of $0 and $2, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has held interests in mutual funds and cash equivalents as part of the trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which to invest their compensation deferrals in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and June&#160;30, 2020, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:24.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.479%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate forward contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:24.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, impairment charges of $329 were recorded during the third quarter of fiscal 2021, of which $228, $86, and $15 related to the goodwill of the VMS reporting unit, certain indefinite-lived trademarks and other assets, respectively. These adjustments were included as non-cash charges in the condensed consolidated statement of earnings. The non-recurring fair values utilized included unobservable Level 3 inputs based on management&#8217;s best estimates and assumptions. For additional information, refer to Note 4 of the Notes to Condensed Consolidated Financial Statements</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311226344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings (losses) was (1.4)% and 22.5% for the current three and nine months ended March 31, 2021, respectively, and 18.9% and 20.4% for the prior three and nine months ended March 31, 2020, respectively. The substantially lower tax rate on loss before income taxes in the current three month period and higher tax rate on earnings before income taxes in the current nine month period were driven by the partial non-deductibility of impaired VMS goodwill.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017237852632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET EARNINGS (LOSSES) PER SHARE (EPS)</a></td>
<td class="text">NET EARNINGS (LOSSES) PER SHARE (EPS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,610</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,661</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,057</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,641</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,610</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,328</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,030</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,236</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,826</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic net earnings (losses) per share and Diluted net earnings (losses) per share are calculated on Net earnings (losses) attributable to Clorox.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since the Company generated net losses attributable to Clorox for the three months ended March 31, 2021, there was no dilutive effect of stock options and other instruments because their impact would be antidilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017326365016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017238021384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,357)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,717)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.06 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,818)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.11 per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,648)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,111)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,382)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,194)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,055)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of accounting changes, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.18 per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,818)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,567&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,315)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,543)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.33 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business combinations including purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,072)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock retirement </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,111)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,382)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) As a result of adopting ASU No. 2016-02, &#8220;Leases (Topic 842),&#8221; on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings. </span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2020 the Company retired 28&#160;million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company&#8217;s overall equity position as a result of the retirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.021%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-market purchase program</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evergreen Program</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock repurchases</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311425464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text">EMPLOYEE BENEFIT PLANS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $0 for both the three months ended March 31, 2021 and 2020, and $(1) for both the nine months ended March 31, 2021 and 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021 and 2020, the Company made $6 and $7 in contributions to its domestic retirement income plans, respectively. During the nine months ended March 31, 2021 and 2020, the Company made $10 in contributions to its domestic retirement income plans. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs are reflected in Other (income) expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311376856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherContingenciesAndGuaranteesAbstract', window );"><strong>OTHER CONTINGENCIES AND GUARANTEES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock', window );">OTHER CONTINGENCIES AND GUARANTEES</a></td>
<td class="text">OTHER CONTINGENCIES AND GUARANTEES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $27 and $28 as of March&#160;31, 2021 and June&#160;30, 2020, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted for $14 of the recorded liability as of March&#160;31, 2021 and June&#160;30, 2020, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. As a result, the Company recorded in Other (income) expense, net an undiscounted liability for costs estimated to be incurred over a 30-year period, based on the option recommended in the Feasibility Study. However, as a result of ongoing discussions with regulators, in June 2017, the Company increased its recorded liability to $14, which reflects anticipated costs to implement additional remediation measures at this site. While the Company believes its latest estimate is reasonable, regulators could require the Company to implement one of the other options evaluated in the Feasibility Study, with estimated undiscounted costs of up to $28 over an estimated 30-year period, or require the Company to take other actions and incur costs not included in the study. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability, as of March&#160;31, 2021 and June&#160;30, 2020. This amount reflects the Company&#8217;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements, and the future availability of alternative clean-up technologies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned guarantees as of March&#160;31, 2021 and June&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company was party to a letter of credit of $11, related to one of its insurance carriers, of which $0 had been drawn upon.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherContingenciesAndGuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherContingenciesAndGuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017310028360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT RESULTS</a></td>
<td class="text">SEGMENT RESULTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates through SBUs that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,539&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The earnings (losses) before income taxes for the Health and Wellness segment include a $329 non-cash goodwill, trademark and other asset impairment charge for the VMS SBU for the three and nine months ended March 31, 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 24% for each of the three and nine months ended March 31, 2021, respectively, and 25% for each of the three and nine months ended March 31, 2020, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales for the Company&#8217;s SBUs and for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food Products</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017316344392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three and nine months ended March 31, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2020, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, &#8220;Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,&#8221; which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div>In January 2017, the FASB issued ASU No. 2017-04, &#8220;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#8221; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company&#8217;s consolidated financial statements at the time of adoption. The impairment identified in the third quarter of fiscal year 2021 was calculated in accordance with this guidance. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and June&#160;30, 2020, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Results</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates through SBUs that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311230072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUIRED (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the final purchase price allocation for the fair value of the joint venture&#8217;s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Venture</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired rights (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships (included in Other intangible assets, net)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital, net (includes cash acquired of $26)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of previously held equity interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311344744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017310037704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock', window );">Schedule of Impaired Intangible Assets</a></td>
<td class="text">Based on the outcome of these assessments, the following pre-tax impairment charges were recorded:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment Charge</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of Goodwill as of March&#160;31, 2021 from June&#160;30, 2020, were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:30.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes $(4) purchase price allocation adjustment related to the Saudi joint venture acquisition. Refer to Note 2 of the Notes to Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"/><td style="width:33.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the carrying amount of trademarks and other intangible assets as of March&#160;31, 2021 and as of June&#160;30, 2020:&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"/><td style="width:33.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization / Impairments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks not subject to amortization</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#b3b3b3;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks subject to amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#b3b3b3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b3b3b3;padding:0 1pt"/><td colspan="2" style="background-color:#b3b3b3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#b3b3b3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017312326360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Assets and Liabilities for Fair Value Disclosure</a></td>
<td class="text">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:24.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.479%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate forward contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:24.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311376296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,610</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,661</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,057</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,641</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,610</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,328</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,030</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,236</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,826</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017237989368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017311418136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,357)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,717)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.06 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,818)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.11 per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,648)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,111)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,382)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,194)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,055)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of accounting changes, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.18 per share declared)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,818)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,741&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,567&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,315)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,543)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($3.33 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business combinations including purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,072)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock retirement </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,190&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,111)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,382)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) As a result of adopting ASU No. 2016-02, &#8220;Leases (Topic 842),&#8221; on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchases Under Authorized Programs</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.021%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-market purchase program</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evergreen Program</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock repurchases</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017309981400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017309972408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Information Relating to the Company's Segments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,539&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The earnings (losses) before income taxes for the Health and Wellness segment include a $329 non-cash goodwill, trademark and other asset impairment charge for the VMS SBU for the three and nine months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales for the Company&#8217;s SBUs and for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food Products</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314441240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUIRED (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">$ 111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities', window );">Loss on settlement</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,574,000,000<span></span>
</td>
<td class="nump">$ 1,803,000,000<span></span>
</td>
<td class="nump">$ 1,574,000,000<span></span>
</td>
<td class="nump">$ 1,793,000,000<span></span>
</td>
<td class="nump">$ 1,577,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss', window );">Non-recurring, non-cash gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod', window );">Joint venture net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember', window );">Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">208,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">The weighted-average estimated useful life of intangible assets subject to amortization</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=clx_JointVentureInKingdomOfSaudiArabiaMember', window );">Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clx_JointVentureInKingdomOfSaudiArabiaMember', window );">Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Revenue Reported By Acquired Entity For Current Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_BusinessCombinationSettlementOfPreExistingNetLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Settlement Of Pre-Existing Net Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_BusinessCombinationSettlementOfPreExistingNetLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=clx_JointVentureInKingdomOfSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=clx_JointVentureInKingdomOfSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clx_JointVentureInKingdomOfSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clx_JointVentureInKingdomOfSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318881672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,574<span></span>
</td>
<td class="nump">$ 1,803<span></span>
</td>
<td class="nump">$ 1,793<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember', window );">Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet', window );">Working capital, net (includes cash acquired of $26)</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Noncurrent liabilities, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of net assets</a></td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Less: Fair value of noncontrolling interests</a></td>
<td class="num">(198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Less: Fair value of previously held equity interest</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual Rights [Member] | Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Reacquired rights (included in Other intangible assets, net)</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships (included in Other intangible assets, net)</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Reacquired rights (included in Other intangible assets, net)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships (included in Other intangible assets, net)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Working Capital, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017236674376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES, NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and packaging</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO allowances</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 688<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314176536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Property, plant and equipment, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017312958376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit', window );">Impairment, tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Amortization, remainder of fiscal year</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization, year one</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization, year two</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization, year three</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization, year four</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=clx_ImpairedTrademarksMember', window );">Impaired Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Not subject to amortization</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Not subject to amortization</a></td>
<td class="nump">$ 683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=clx_ImpairedTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=clx_ImpairedTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318174216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 1,803<span></span>
</td>
<td class="nump">$ 1,793<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember', window );">Joint Venture In Kingdom Of Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation adjustments and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 616<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clx_JointVentureInKingdomOfSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017312114504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">$ 459<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment', window );">Not subject to amortization, before impairment</a></td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Not subject to amortization</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Subject to amortization, gross</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Subject to amortization, net</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Subject to amortization, gross</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Subject to amortization, accumulated amortization</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Subject to amortization, net</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318312232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Maximum duration, foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits', window );">Derivative instruments subject to contractually defined counterparty liability position limits</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">329,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">329,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">228,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill, trademark and other asset impairments</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">228,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1', window );">Maximum duration, interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember', window );">Purchases of Inventory | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">68,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember', window );">Total Commodity Purchase Derivative Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum duration, commodity contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_SoybeanOilFuturesMember', window );">Soybean Oil Futures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_SoybeanOilFuturesMember', window );">Soybean Oil Futures | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarginDepositAssets', window );">Cash margin balances amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_JetFuelSwapsMember', window );">Jet Fuel Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments subject to contractually defined counterparty liability position limits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarginDepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarginDepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_SoybeanOilFuturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommodityPurchaseDerivativeContractsAxis=clx_SoybeanOilFuturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_JetFuelSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommodityPurchaseDerivativeContractsAxis=clx_JetFuelSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314918024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017321761128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 871<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,441<span></span>
</td>
<td class="nump">6,213<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,503<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,783<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total other assets in the fair value hierarchy</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total other liabilities in the fair value hierarchy</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets | Fair Value, Inputs, Level 1 | Reported Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets | Fair Value, Inputs, Level 1 | Estimate of Fair Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets | Fair Value, Inputs, Level 2 | Reported Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Fair Value, Inputs, Level 2 | Reported Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Fair Value, Inputs, Level 2 | Reported Value Measurement | Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Trust Assets for nonqualified deferred compensation plans | Fair Value, Inputs, Level 1 | Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Trust Assets for nonqualified deferred compensation plans | Fair Value, Inputs, Level 1 | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 1 | Reported Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 1 | Estimate of Fair Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 2 | Reported Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 2 | Reported Value Measurement | Foreign Exchange Forward Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Commodity Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Foreign Exchange Forward Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Fair Value, Inputs, Level 1 | Reported Value Measurement | Investments, including money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Fair Value, Inputs, Level 1 | Estimate of Fair Value Measurement | Investments, including money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Fair Value, Inputs, Level 2 | Reported Value Measurement | Time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember', window );">Current maturities of long-term debt and Long-term debt | Fair Value, Inputs, Level 2 | Reported Value Measurement | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="nump">2,783<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember', window );">Current maturities of long-term debt and Long-term debt | Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="nump">$ 2,944<span></span>
</td>
<td class="nump">$ 3,051<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017326742456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate on earnings from continuing operations</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
<td class="nump">22.50%<span></span>
</td>
<td class="nump">20.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314837784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">125,610<span></span>
</td>
<td class="nump">125,661<span></span>
</td>
<td class="nump">126,057<span></span>
</td>
<td class="nump">125,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and other (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">125,610<span></span>
</td>
<td class="nump">127,328<span></span>
</td>
<td class="nump">128,030<span></span>
</td>
<td class="nump">127,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive stock options and other (in shares)</a></td>
<td class="nump">4,826<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017236210552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017313982584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">$ (59)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="nump">27<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Pension and postretirement benefit adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(37)<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Clorox</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318666648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 18, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,380<span></span>
</td>
<td class="nump">$ 555<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="nump">$ 559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="num">(402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Business combinations including purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (305)<span></span>
</td>
<td class="num">$ (30)<span></span>
</td>
<td class="num">$ (605)<span></span>
</td>
<td class="num">$ (219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(3,072)<span></span>
</td>
<td class="num">(1,424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect of Accounting Changes, Net of Tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, beginning (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,741<span></span>
</td>
<td class="nump">158,741<span></span>
</td>
<td class="nump">158,741<span></span>
</td>
<td class="nump">158,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retirement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, ending (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,741<span></span>
</td>
<td class="nump">158,741<span></span>
</td>
<td class="nump">130,741<span></span>
</td>
<td class="nump">158,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176<span></span>
</td>
<td class="nump">$ 1,062<span></span>
</td>
<td class="nump">$ 1,137<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">3,567<span></span>
</td>
<td class="nump">3,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">613<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="num">(402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member] | Cumulative Effect of Accounting Changes, Net of Tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (850)<span></span>
</td>
<td class="num">$ (3,357)<span></span>
</td>
<td class="num">$ (3,315)<span></span>
</td>
<td class="num">$ (3,194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, beginning (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,017<span></span>
</td>
<td class="nump">33,717<span></span>
</td>
<td class="nump">32,543<span></span>
</td>
<td class="nump">33,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (305)<span></span>
</td>
<td class="num">$ (30)<span></span>
</td>
<td class="num">$ (605)<span></span>
</td>
<td class="num">$ (219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(3,072)<span></span>
</td>
<td class="num">(1,424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retirement (in shares)</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,111)<span></span>
</td>
<td class="num">$ (3,317)<span></span>
</td>
<td class="num">$ (1,111)<span></span>
</td>
<td class="num">$ (3,317)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, ending (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,382<span></span>
</td>
<td class="nump">32,818<span></span>
</td>
<td class="nump">6,382<span></span>
</td>
<td class="nump">32,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive net (loss) income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (575)<span></span>
</td>
<td class="num">$ (601)<span></span>
</td>
<td class="num">$ (640)<span></span>
</td>
<td class="num">$ (602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(553)<span></span>
</td>
<td class="num">(656)<span></span>
</td>
<td class="num">(553)<span></span>
</td>
<td class="num">(656)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Business combinations including purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017315054120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 18, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>repurchaseProgram</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>repurchaseProgram </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NumberOfRepurchasePrograms', window );">Number of repurchase programs | repurchaseProgram</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="num">$ (4,000,000)<span></span>
</td>
<td class="num">$ (14,000,000)<span></span>
</td>
<td class="num">$ (11,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember', window );">Long-Term Inter-Company Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired | shares</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember', window );">$2 Billion Open-Market Purchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember', window );">Evergreen Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_StockRepurchaseProgramAuthorizationLimit', window );">Authorization limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NumberOfRepurchasePrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Repurchase Programs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NumberOfRepurchasePrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_StockRepurchaseProgramAuthorizationLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Authorization Limit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_StockRepurchaseProgramAuthorizationLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314637672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of shares repurchased</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">1,648<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">3,072<span></span>
</td>
<td class="nump">1,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember', window );">$2 Billion Open-Market Purchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of shares repurchased</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember', window );">Evergreen Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of shares repurchased</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareRepurchaseProgramsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareRepurchaseProgramsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_A2BillionOpenMarketPurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017318454152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive (loss) income</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(403)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
<td class="num">(414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive (loss) income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="num">(410)<span></span>
</td>
<td class="num">(472)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net unrealized gains (losses) on derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">33<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive (loss) income</a></td>
<td class="nump">27<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and postretirement benefit adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(169)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive (loss) income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive net (loss) income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(575)<span></span>
</td>
<td class="num">(601)<span></span>
</td>
<td class="num">(640)<span></span>
</td>
<td class="num">(602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">$ (553)<span></span>
</td>
<td class="num">$ (656)<span></span>
</td>
<td class="num">$ (553)<span></span>
</td>
<td class="num">$ (656)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314241528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Weighted average long-term expected rate or return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member] | Retirement Income Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017327137480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314060680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LetterOfCreditBorrowingCapacity', window );">Letter of credit</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit, amount outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember', window );">Alameda County, California Matter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_MaximumExposureUndiscountedCost', window );">Maximum undiscounted costs</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember', window );">Dickinson County, Michigan Matter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SiteContingencyAgreedPercentageOfCostSharing', window );">Percentage of liability for aggregate remediation and associated costs, other than legal fees</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LetterOfCreditBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LetterOfCreditBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MaximumExposureUndiscountedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MaximumExposureUndiscountedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RemediationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RemediationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SiteContingencyAgreedPercentageOfCostSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SiteContingencyAgreedPercentageOfCostSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314481256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Narrative) (Details) - reportableSegment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer [Member] | Customer Concentration Risk [Member] | Walmart Stores, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=clx_WalmartStoresIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=clx_WalmartStoresIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140017314326072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,781<span></span>
</td>
<td class="nump">$ 1,783<span></span>
</td>
<td class="nump">$ 5,539<span></span>
</td>
<td class="nump">$ 4,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 799<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness | Cleaning [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness | Professional Products [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember', window );">Health and Wellness | Vitamins, Minerals and Supplements [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household | Bags and Wraps [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household | Cat Litter [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household | Grilling [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle | Food Products [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle | Natural Personal Care [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle | Water Filtration [Member] | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International | Product Concentration Risk [Member] | Revenue from Contract with Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 680<span></span>
</td>
<td class="nump">$ 736<span></span>
</td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(183)<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
<td class="nump">1,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">928<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">$ (71)<span></span>
</td>
<td class="num">$ (143)<span></span>
</td>
<td class="num">$ (225)<span></span>
</td>
<td class="num">$ (262)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CatLitterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CatLitterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_GrillingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_GrillingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_FoodProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_FoodProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>69
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<"171A'HS4Q+[PW*PI_II6V3-5=DPT,TR],B4= *A5?<#^(EF>VBN0Q+.>(
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M_ILJG((4%$R;QC2N375Y?+WVDU2%Y/5X+$!0, 0M;5 4!?,A:&6#PB1(.]"
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MK'TK-V9($O<DL9/D[_6 GN3U(GYZH'J&*@K6Z-;;,-M,O@#&3&P <YY&)F'
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M&1\;8LH" &+%QN5E&)E>(F&W1'+$I,F)_R 1VJ:&J6*581L$I(H-2LP3D14
MLE-E=G034%+^4E_!"$5X5\GF%+?[VEWSW-27&\;W6_]BX0/?E_[%JKG$Z=TW
M=TKWA+_DE4 %?59->=-$#1QOKFF:%\FV]3W$$Y.2E?7CAI*,<@U0_W]F3!Y>
M= /=9=GUOU!+ P04    " #Y@9Y2Y)XC4O4&  !D'   &    'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;*U9:6_<.!+]*T1/$"1 .RV2NMH7D#C8W0PF,T$\
MV?U,2[1;B"3VD)2/^?53E-2M;O&PLX@!VSJJBJ^*Q7I%ZOQ!R.]JP[E&CTW=
MJHO%1NOMZ6JEB@UOF'HGMKR%-[="-DS#K;Q;J:WDK.R5FGI%HBA=-:QJ%Y?G
M_;,O\O)<=+JN6OY%(M4U#9-/'W@M'BX6>+%[\+6ZVVCS8'5YOF5W_)KK;]LO
M$NY6>RMEU?!65:)%DM]>+-[CTRN:&85>XK\5?U 'U\BX<B/$=W/SJ;Q81 81
MKWFAC0D&_^[Y%:]K8PEP_#4:7>S'-(J'USOK_^J=!V=NF.)7HOY?5>K-Q2)?
MH)+?LJ[67\7#?_CH4&+L%:)6_5_T,,I&"U1T2HMF5 8$3=4._]GC&(@#!1Q[
M%,BH0%ZJ0$<%VCLZ(.O=^L@TNSR7X@%)(PW6S$4?FUX;O*E:,XW76L+;"O3T
MY95H2Y@47B*X4J*N2J;AY@.K65MP=&T,*_3F6\NZLH(W;]$)^G;]$;UY]1:]
M0E6+/E=U#?.ASE<:X!BCJV(<^L,P-/$,_9G)=XCB)2(1P0[UJ[#ZKUT+ZE&O
M'AVKKR (^TB0?21(;X_Z(M%)R5N-F%+@<L @W1NDO<'89Y"I#6)MB0ISP?_J
MJGM6PPC.4 VFTMZ467KWE_&:G*_N#^-AR^09WLL<88SW&.,@QJ^\X #KIN9J
MB5JN7= &"\G!L&E,9]!<,KD;6K*'E@2A?6KO(5A"5@%HB3ULGL^@V3)Q$KNA
MI7MH:1#:%\FWK"H1?]R:M:/Z619ZPR4L67\6#9A3"P^FZQEF6R;.W)"S/>0L
M"/E/H5G] G29C6Z=SA/1%AK6H M@O@>8/Q-3H":IGY9H"Z5']R$U:V8+G*'[
M!$#B%JI^T35=W=>HD@-Q%14;Z #$62.DKOX>'H#P*[*D">Y?P24A\1*(1VUY
MSQSUD\O]W':?)'CFOD,(1]3M_GKO_CKH_A_@/ !O[U#-@960-/1S(FY/.KCQ
M3]?:@D+)? '8,F3M*1LXFF@C"N+]MQ#E Y1^9]F/[  E63R#Y9;RI#D^X#,<
M3G3)2NATH OR5HW1PE'96%OP;*$L3SSH)H[!)#S-?9&H6LW:NPJJ[CBU?JC$
MGKPXG4.UA7"T]D"=V N'Z6N ZD^]4?TH]W(+FD.(>(@!3Z2%PZPU%+, -!<=
MQ?-E[)(BV+..\41;.'E1'U%7[*:J*PW\%6@F\,0Y.$PZ.[O0NG:R-VMJ7"W:
MNQ/-90/E\,:=0C:9T"B:Q\(6\M1S/#$.#E/.#K"8E39O8$:\-KO8M<.623V<
MCB<"PF$&>E\4HH/V#&W9$^O7IN&4HI =D,USH!V<$,?)'+9#BA+?2IVH X>Y
MXU-;B(8CS1[Y'KP3I,T$5AXXR,)3],C$%23,%<>]QS.1) Y:R/&\07))Q=A3
M6,A$'B1,'K\]NYJ(30LDSN?ML$LJRSTKBASL4,+L,<'[P35%;(:@T3P['4(
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M!)KNY-.0[$O$-!1)I4]1NJ0YAKQ=]]E!R3*)R3)/DGW&_\QLHC;#GV#XF<?
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M6$ 73)4U@/VEE.9Y8ONLMJ^>_@%02P,$%     @ ^8&>4L>8W 16!@  [1@
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MC1.&Z80EP(9G/A!=QBWCJ%.+>J!W*'<L<BE73/PL4(0BIAHL>0"Z,/I;>*A
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M1>8Y]$1'Y^S3U C]0/OA"!S@,Q(H>UFY^ZI"-6O\92H6SCFU5E.EN1_X>N'
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MC1'ENIV>PV#H_^W7KR-Z_87AIN)-7D^R#5[RM1(/IW!BUZ19V4PQ_LP8O6K
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MD$JL%3))E/@@K#3>P=_>2E?*V)8N+'8RCEWPI1-CI+!"2WRW@),;+2M9"$W
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M =$DQUC<.>&I9J^$,@8I 0?"^#1YCH>S,WW3EGY=)LBUA-6K"&:MYMO:LJU
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MU#L=!*";8=ELK*K\@*(2H7'GEU2,.6HG0/<KI>QVXPQT_U@FWP%02P,$%
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MBF?-E"=UE=P-YV&*6SN[;3Y ZY8&6>9D#<N_E%1KK:!N Q!J1+DGA!+]4[.
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M3TP7-'HZ@.<KA^)K+LA ]SW[\G=02P,$%     @ ^8&>4IEC;:1;!@  QP\
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ME0R=53+NDD>NN&V!_/[;)(G';RW"5R!C9>Y#>XF]S')5^>6<FP)V$BZH$76
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M]<;#3CAXU3].K_U5[4X[4(O_7.*F+0P)8'RNM:M_:('F[G[\-U!+ P04
M" #Y@9Y2 \L\Y^D(  "^%@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6S-6&USVS82_BL8W\R-/2-+LIS$J>-X1E;C1+TX\5EQ.YV;^P"1D(2&!!@
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M%O3A@I8%Z#XWQF\W[*#]%)K\ U!+ P04    " #Y@9Y28@&8;HT"   R!0
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MT2'A.V08S.DTINFH#B)6&)IH )-%7-?>R[4,8>=3H2A<1S. ZURY(V6$F=
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MM>LXIG4\B$:7K3R,X=WI\K$L:9#XG*W*[T =W!49_TJ*;DG#ZU>3)$[>0$Q
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M4H1G=BJ.C:*OG'!F=/8XOKF]'(_A]/S/QYO[RPMX=\N48G:"',"["S2,"WT
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M=35>-8S,RYO91!JZYY6/<V2T?=@.]'TJI7EIV,M>_0^*T7]02P,$%     @
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MS92KA<H3KHYE+E]+$(>(2D T /RT);'V4 **<XTDG-4C(VZ^C5IFH_:I!)1
M<A2HZX(_&BM,;C 'I)-^E)O<KZUVXJGL-3)720773A+HO-WAG^XX8>D7L;R)
M_BJ+_JHP^K&)\J3*"@JKGC'7OZ",&YE:HS".PXFIST]RD$,Y\23_6N.TDBKY
MR72=PZGO%-J8[TNH*(/NT27B?D$.7>^@Y_WO+*:,QR59K[U+HWUTCT:8KTT#
M(V#)ME0FYV*VFC5)'=,:O%OONM<]-V?=UTV5N;</]$E'I@[G-:$"0KQ24L[E
ME?J_>=+D)!/)8G.++YA4/8$9;E1CB+G>H-ZO&)/[B1;(6LWV'U!+ P04
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M6-JXI0-!5[K1F%$AVQ;]N)3-+F;*0+X/*17O Q4@;Y_[OP%02P,$%     @
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M O!]Q;G:O^@)BO]4]/\'4$L#!!0    ( /F!GE(:A;PI'00  -(1   9
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M8YM=]*X-2+'U"Y96WBW[4+NNK/GH1#9UJ]6E]#0YGG?'"2>,I!Q-\BQOXV'
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MZBEX-/<?_U>E"[1T.UG0<P&#;NN"WJXPT)7LRC"019K" ##HZC%XE# X;G7
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MXG!)\(RP7$#<GU/*?YWDG_!5GVR>_0]02P,$%     @ ^8&>4J^EY;UV @
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M<BZZD">O+A#51+*U/B'G3,)YJX<IW+D(5P'P?LF8W$W4!LTM;O /4$L#!!0
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MFLS:-^[/$X\M41KO94#8.=$F(!_7Z>FBV6)R?S63!=,,;,Y VPU3"*/%PAF
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M7(I8.FT-D-_?YGGU^*'^@=7N-W[G_P=02P,$%     @ ^8&>4NKW33/+ P
M+ X  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULQ5=;;]LV%/XKA%!@
M#M!$%U];V 827]!@;N/%SH:AV ,C'UM$2-$E*;L9^N-'4K)\B:1XV-#HP1:E
M\WWGJG/([I:+)QD!*/2=T5CVG$BI]4?7E6$$#,LKOH98OUERP;#22[%RY5H
M7E@0HV[@>2V781([_:Y]-A7]+D\4)3%,!9()8U@\WP#EVY[C.[L']V05*?/
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MDEKG'NR;S3E*?P8KHN<0A:7&>%=M'2J1'DW2A>)KNY5^Y$IOS.UMI(]S((R
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M"UZ5<;/-2_&[?LJ:&^J11=I,<DR1[GHM:VZV-Z@CE):FSK+A9@>2NY]5:L#
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MR14FIAG&^&T 0A_ _17G:C?1 O771O ;4$L#!!0    ( /F!GE*9L.DK6P@
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MDC'*."9(NL&:0&M!KH7 :T&PA4!L0;*%P&Q!M(5 ;4&VA<!M0;B%0&Y!NH7
M;D&\A4!O1;V50&]%O95 ;[WYV";06U%O)=!;46\ET%M1;R706U%O)=!;46\E
MT%M1;R706U%O)=#;4&\CT-M0;R/0VU!O(]#;;C9+"/0VU-L(]#;4VPCT-M3;
M"/0VU-L(]#;4VPCT-M3;"/1VU-L)]';4VPGT=M3;"?1VU-L)]/:;S6X"O1WU
M=@*]'?5V KT=]78"O1WU=@*]'?5V KUKU+N^I]XIG]J8KCT_:WS^/:G.YWOC
M]?&7Y<])?%_4%YP#_/U=? -02P,$%     @ ^8&>4H"$^)W  0   !X  !,
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MW9C57_^3;.YII8OZF,_:'[_33U!+ 0(4 Q0    ( /F!GE('04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ ^8&>4A@_EUWO    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ ^8&>4IE<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #Y@9Y2
M#"-_7#$%  !2%0  &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ ^8&>4N 6S_0Y!@  .!L  !@
M     ("!=0T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M /F!GE+DGB-2]08  &0<   8              " @>03  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " #Y@9Y2MJ1,BF4#  !C"P  &
M            @($/&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ ^8&>4L>8W 16!@  [1@  !@              ("!JAX  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( /F!GE*+AM.$308  !D/
M   8              " @38E  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " #Y@9Y2Q4:$,-0'   7%   &               @(&Y*P
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ^8&>4B-I\AI\
M @  +@4  !@              ("!PS,  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( /F!GE).K@]1F0@  %45   8              "
M@74V  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #Y@9Y2
M#!E"4(P.   B,   &0              @(%$/P  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( /F!GE(=Z Q5B0,  /0'   9
M      " @0=.  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ ^8&>4K>;(9-A P  Q0<  !D              ("!QU$  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #Y@9Y2'2:*5U$#  !C!P
M&0              @(%?50  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( /F!GE(9TNIFF0D  ,PC   9              " @>=8  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ ^8&>4L18;1"&
M P  O0@  !D              ("!MV(  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " #Y@9Y2+(41NZX(  #;%@  &0
M@(%T9@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( /F!
MGE*98VVD6P8  ,</   9              " @5EO  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ ^8&>4@/+/.?I"   OA8  !D
M         ("!ZW4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " #Y@9Y2%,<I62 $   6"0  &0              @($+?P  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /F!GE)B 9ANC0(  #(%
M   9              " @6*#  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ ^8&>4LL1JJT:!0  = \  !D              ("!)H8
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #Y@9Y2532'
M/Q4&  #3$@  &0              @(%WBP  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( /F!GE+OGGWF!@,  '\&   9
M  " @<.1  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M^8&>4NZL._]B P  50<  !D              ("! )4  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " #Y@9Y2@5;*R"8(  ##(   &0
M            @(&9F   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( /F!GE(]!B44"0,  ) &   9              " @?:@  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ ^8&>4L7Q.;K>!
MEPL  !D              ("!-J0  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " #Y@9Y2VB)L/$T$  "L$   &0              @(%+
MJ0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /F!GE+@
MFLNGI 0  -P1   9              " @<^M  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ ^8&>4O31VEN- @  P08  !D
M     ("!JK(  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /F!GE(?V=JZHP4  +48   9              "
M@7?&  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ ^8&>
M4AJ%O"D=!   TA$  !D              ("!4<P  'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " #Y@9Y2VN'8O\L'  "^.0  &0
M        @(&ET   >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( /F!GE*OI>6]=@(  .L&   9              " @:?8  !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ ^8&>4@[_+T8F P  T0D
M !D              ("!5-L  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " #Y@9Y2<OA<!(L"  #.!@  &0              @(&QW@
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( /F!GE*"VFGP
M%@0  # .   9              " @7/A  !X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ ^8&>4@K^"FJ*"0  [S<  !D
M ("!P.4  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #Y
M@9Y2ZO=-,\L#   L#@  &0              @(&![P  >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /F!GE*/1HMW<P,  "@-   9
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M970T."YX;6Q02P$"% ,4    " #Y@9Y2K3T.B,P"  !Y"   &0
M    @('," $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M /F!GE*9L.DK6P@  %H\   9              " @<\+ 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ ^8&>4KV^"4K_ @  B0\   T
M             ( !810! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #Y@9Y2
MEXJ[',     3 @  "P              @ &+%P$ 7W)E;',O+G)E;'-02P$"
M% ,4    " #Y@9Y2S@,%JU0$  "=(0  #P              @ %T& $ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ ^8&>4CB#;R;$ 0  #1X  !H
M         ( !]1P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ ^8&>4H"$^)W  0   !X  !,              ( !\1X! %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     #H .@#-#P  XB !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>334</ContextCount>
  <ElementCount>319</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>69</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - BUSINESS ACQUIRED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/BUSINESSACQUIRED</Role>
      <ShortName>BUSINESS ACQUIRED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - INVENTORIES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNET</Role>
      <ShortName>INVENTORIES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140111 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142112 - Disclosure - SEGMENT RESULTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTS</Role>
      <ShortName>SEGMENT RESULTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - BUSINESS ACQUIRED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/BUSINESSACQUIREDTables</Role>
      <ShortName>BUSINESS ACQUIRED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/BUSINESSACQUIRED</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - INVENTORIES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETTables</Role>
      <ShortName>INVENTORIES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNET</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2337308 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - SEGMENT RESULTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSTables</Role>
      <ShortName>SEGMENT RESULTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - BUSINESS ACQUIRED (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails</Role>
      <ShortName>BUSINESS ACQUIRED (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/BUSINESSACQUIREDTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/BUSINESSACQUIREDTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - INVENTORIES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETDetails</Role>
      <ShortName>INVENTORIES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNETTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INCOMETAXES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails</Role>
      <ShortName>NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2444422 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails</Role>
      <ShortName>SEGMENT RESULTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="clx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails</Role>
      <ShortName>SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="clx-20210331.htm">clx-20210331.htm</File>
    <File>clx-20210331.xsd</File>
    <File>clx-20210331_cal.xml</File>
    <File>clx-20210331_def.xml</File>
    <File>clx-20210331_lab.xml</File>
    <File>clx-20210331_pre.xml</File>
    <File>clxq3fy21exhibit101.htm</File>
    <File>clxq3fy21exhibit102.htm</File>
    <File>clxq3fy21exhibit103.htm</File>
    <File>clxq3fy21exhibit104.htm</File>
    <File>clxq3fy21exhibit105.htm</File>
    <File>clxq3fy21exhibit106.htm</File>
    <File>clxq3fy21exhibit107.htm</File>
    <File>clxq3fy21exhibit108.htm</File>
    <File>clxq3fy21exhibit311.htm</File>
    <File>clxq3fy21exhibit312.htm</File>
    <File>clxq3fy21exhibit32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clx-20210331.htm": {
   "axisCustom": 1,
   "axisStandard": 29,
   "contextCount": 334,
   "dts": {
    "calculationLink": {
     "local": [
      "clx-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clx-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "clx-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clx-20210331_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clx-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "clx-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 439,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 5
   },
   "keyCustom": 20,
   "keyStandard": 299,
   "memberCustom": 28,
   "memberStandard": 37,
   "nsprefix": "clx",
   "nsuri": "http://www.clorox.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.clorox.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - INCOME TAXES",
     "role": "http://www.clorox.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS)",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS",
     "shortName": "COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:OTHERCONTINGENCIESANDGUARANTEESTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140111 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:OTHERCONTINGENCIESANDGUARANTEESTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142112 - Disclosure - SEGMENT RESULTS",
     "role": "http://www.clorox.com/role/SEGMENTRESULTS",
     "shortName": "SEGMENT RESULTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - BUSINESS ACQUIRED (Tables)",
     "role": "http://www.clorox.com/role/BUSINESSACQUIREDTables",
     "shortName": "BUSINESS ACQUIRED (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - INVENTORIES, NET (Tables)",
     "role": "http://www.clorox.com/role/INVENTORIESNETTables",
     "shortName": "INVENTORIES, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337308 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables",
     "shortName": "EMPLOYEE BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - SEGMENT RESULTS (Tables)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSTables",
     "shortName": "SEGMENT RESULTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - BUSINESS ACQUIRED (Narrative) (Details)",
     "role": "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails",
     "shortName": "BUSINESS ACQUIRED (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8efd9ad1895b43c2ad836b7a181ac255_D20200709-20200709",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details)",
     "role": "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i4df9eff9aad24233b734b8a995abf5f0_I20200709",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - INVENTORIES, NET (Details)",
     "role": "http://www.clorox.com/role/INVENTORIESNETDetails",
     "shortName": "INVENTORIES, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details)",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Impairment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TangibleAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details)",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Additional Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "clx:ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i56a82930ba8c46a8842474109384e6c6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details)",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Schedule of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i69b5e8efae404d60976021d1249edef6_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS (Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i1dd2366b5b7844fe8e3445d45c197945_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "role": "http://www.clorox.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details)",
     "role": "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails",
     "shortName": "NET EARNINGS (LOSSES) PER SHARE (EPS) (Dividends Per Share Declared) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i56a82930ba8c46a8842474109384e6c6_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "clx:NumberOfRepurchasePrograms",
       "span",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "clx:NumberOfRepurchasePrograms",
      "reportCount": 1,
      "unitRef": "repurchaseprogram",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "ie6d9925f9b914e0993a80905523974d8_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i75957ffb916249c88259d57dddd74735_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "ib5adb4380e32440f8bb1a3f6ac7769a0_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i1ec03781c4364b8eb6a53fc946376745_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "iea208e28d4fd4ebd8d74f86ebd666ac6_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444422 - Disclosure - SEGMENT RESULTS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
     "shortName": "SEGMENT RESULTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i8ab916301dd545dfb13bfebce18db895_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails",
     "shortName": "SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i647346da3c594fa1b168b90be5aab738_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - BUSINESS ACQUIRED",
     "role": "http://www.clorox.com/role/BUSINESSACQUIRED",
     "shortName": "BUSINESS ACQUIRED",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - INVENTORIES, NET",
     "role": "http://www.clorox.com/role/INVENTORIESNET",
     "shortName": "INVENTORIES, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS",
     "role": "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS",
     "shortName": "GOODWILL, TRADEMARK AND OTHER ASSETS IMPAIRMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20210331.htm",
      "contextRef": "i710c6d69e4bf4fe1af7f82be420000f4_D20200701-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 69,
   "tag": {
    "clx_A2BillionOpenMarketPurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2 Billion Open-Market Purchase Program [Member]",
        "label": "$2 Billion Open-Market Purchase Program [Member]",
        "terseLabel": "$2 Billion Open-Market Purchase Program [Member]"
       }
      }
     },
     "localname": "A2BillionOpenMarketPurchaseProgramMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_AlamedaCountyCaliforniaMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alameda County, California Matter [Member]",
        "label": "Alameda County, California Matter [Member]",
        "terseLabel": "Alameda County, California Matter [Member]"
       }
      }
     },
     "localname": "AlamedaCountyCaliforniaMatterMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_BagsWrapsAndContainersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bags, Wraps, And Containers [Member]",
        "label": "Bags, Wraps, And Containers [Member]",
        "terseLabel": "Bags and Wraps [Member]"
       }
      }
     },
     "localname": "BagsWrapsAndContainersMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Revenue Reported By Acquired Entity For Current Period",
        "label": "Business Acquisition Revenue Reported By Acquired Entity For Current Period",
        "terseLabel": "Joint venture net sales"
       }
      }
     },
     "localname": "BusinessAcquisitionRevenueReportedByAcquiredEntityForCurrentPeriod",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Working Capital, Net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Working Capital, Net",
        "terseLabel": "Working capital, net (includes cash acquired of $26)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_BusinessCombinationSettlementOfPreExistingNetLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Settlement Of Pre-Existing Net Liabilities",
        "label": "Business Combination, Settlement Of Pre-Existing Net Liabilities",
        "terseLabel": "Loss on settlement"
       }
      }
     },
     "localname": "BusinessCombinationSettlementOfPreExistingNetLiabilities",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_CatLitterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cat Litter [Member]",
        "label": "Cat Litter [Member]",
        "terseLabel": "Cat Litter [Member]"
       }
      }
     },
     "localname": "CatLitterMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CleaningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cleaning [Member]",
        "label": "Cleaning [Member]",
        "terseLabel": "Cleaning [Member]"
       }
      }
     },
     "localname": "CleaningMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Axis]",
        "label": "Commodity Purchase Derivative Contracts [Axis]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Axis]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsAxis",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Domain]",
        "label": "Commodity Purchase Derivative Contracts [Domain]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Domain]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsDomain",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Maturities of Long-term Debt and Long-term Debt [Member]",
        "label": "CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember",
        "verboseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instruments subject to contractually defined counterparty liability position limits.",
        "label": "Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits",
        "terseLabel": "Derivative instruments subject to contractually defined counterparty liability position limits"
       }
      }
     },
     "localname": "DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_DickinsonCountyMichiganMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dickinson County, Michigan Matter [Member]",
        "label": "Dickinson County, Michigan Matter [Member]",
        "terseLabel": "Dickinson County, Michigan Matter [Member]"
       }
      }
     },
     "localname": "DickinsonCountyMichiganMatterMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_EvergreenProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evergreen Program [Member]",
        "label": "Evergreen Program [Member]",
        "terseLabel": "Evergreen Program [Member]"
       }
      }
     },
     "localname": "EvergreenProgramMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments and fair value measurements.",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clx_FinancialInstrumentsAndFairValueMeasurementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Instruments and Fair Value Measurements [Abstract]",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsAndFairValueMeasurementsAbstract",
     "nsuri": "http://www.clorox.com/20210331",
     "xbrltype": "stringItemType"
    },
    "clx_FoodProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Food Products [Member]",
        "label": "Food Products [Member]",
        "terseLabel": "Food Products [Member]"
       }
      }
     },
     "localname": "FoodProductsMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_GrillingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grilling [Member]",
        "label": "Grilling [Member]",
        "terseLabel": "Grilling [Member]"
       }
      }
     },
     "localname": "GrillingMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HealthAndWellnessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health and Wellness",
        "label": "Health and Wellness [Member]",
        "terseLabel": "Health and Wellness"
       }
      }
     },
     "localname": "HealthAndWellnessMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HouseholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Household [Member]",
        "label": "Household [Member]",
        "terseLabel": "Household"
       }
      }
     },
     "localname": "HouseholdMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_ImpairedTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impaired Trademarks",
        "label": "Impaired Trademarks [Member]",
        "terseLabel": "Impaired Trademarks"
       }
      }
     },
     "localname": "ImpairedTrademarksMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)",
        "label": "Impairment of Intangible Assets (Excluding Goodwill), Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Impairment, tax benefit"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwillIncomeTaxExpenseBenefit",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill), Before Impairment",
        "terseLabel": "Not subject to amortization, before impairment"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.",
        "label": "Issuance Of Common Stock For Employee Stock Plans And Other",
        "terseLabel": "Issuance of common stock for employee stock plans and other"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForEmployeeStockPlansAndOther",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_JetFuelSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jet Fuel Swaps [Member]",
        "label": "Jet Fuel Swaps [Member]",
        "terseLabel": "Jet Fuel Swaps"
       }
      }
     },
     "localname": "JetFuelSwapsMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_JointVentureInKingdomOfSaudiArabiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture In Kingdom Of Saudi Arabia",
        "label": "Joint Venture In Kingdom Of Saudi Arabia [Member]",
        "terseLabel": "Joint Venture In Kingdom Of Saudi Arabia"
       }
      }
     },
     "localname": "JointVentureInKingdomOfSaudiArabiaMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_LetterOfCreditBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.",
        "label": "Letter of credit",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditBorrowingCapacity",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_LifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lifestyle [Member]",
        "label": "Lifestyle [Member]",
        "terseLabel": "Lifestyle"
       }
      }
     },
     "localname": "LifestyleMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_LongTermInterCompanyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term inter-company loans included in foreign currency adjustments.",
        "label": "Long-Term Inter-Company Loans [Member]",
        "terseLabel": "Long-Term Inter-Company Loans [Member]"
       }
      }
     },
     "localname": "LongTermInterCompanyLoansMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_MaximumExposureUndiscountedCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.",
        "label": "Maximum Exposure, Undiscounted Cost",
        "terseLabel": "Maximum undiscounted costs"
       }
      }
     },
     "localname": "MaximumExposureUndiscountedCost",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_NaturalPersonalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natural Personal Care [Member]",
        "label": "Natural Personal Care [Member]",
        "terseLabel": "Natural Personal Care [Member]"
       }
      }
     },
     "localname": "NaturalPersonalCareMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_NumberOfRepurchasePrograms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Repurchase Programs",
        "label": "Number Of Repurchase Programs",
        "terseLabel": "Number of repurchase programs"
       }
      }
     },
     "localname": "NumberOfRepurchasePrograms",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "clx_OTHERCONTINGENCIESANDGUARANTEESTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.",
        "label": "OTHER CONTINGENCIES AND GUARANTEES [Text Block]",
        "terseLabel": "OTHER CONTINGENCIES AND GUARANTEES"
       }
      }
     },
     "localname": "OTHERCONTINGENCIESANDGUARANTEESTextBlock",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clx_OperatingLeaseRightofUseAssetAndLiabilityNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "label": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "terseLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAndLiabilityNet",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherContingenciesAndGuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CONTINGENCIES AND GUARANTEES [Abstract]",
        "terseLabel": "OTHER CONTINGENCIES AND GUARANTEES [Abstract]"
       }
      }
     },
     "localname": "OtherContingenciesAndGuaranteesAbstract",
     "nsuri": "http://www.clorox.com/20210331",
     "xbrltype": "stringItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Amount",
        "terseLabel": "Other employee stock plan activities"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesAmount",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Shares",
        "terseLabel": "Other employee stock plan activities (in shares)"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesShares",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clx_OtherExpenseIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.",
        "label": "Other Expense (Income), Net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNet",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_ProfessionalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional Products [Member]",
        "label": "Professional Products [Member]",
        "terseLabel": "Professional Products [Member]"
       }
      }
     },
     "localname": "ProfessionalProductsMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_PurchasesofInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of Inventory [Member]",
        "label": "Purchases of Inventory [Member]",
        "terseLabel": "Purchases of Inventory"
       }
      }
     },
     "localname": "PurchasesofInventoryMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_RemediationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.",
        "label": "Remediation period",
        "terseLabel": "Remediation period"
       }
      }
     },
     "localname": "RemediationPeriod",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_RetirementIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement Income [Member]",
        "label": "Retirement Income Plans [Member]",
        "terseLabel": "Retirement Income Plans [Member]"
       }
      }
     },
     "localname": "RetirementIncomeMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_ShareRepurchaseProgramsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Repurchase Programs [Line Items]",
        "terseLabel": "Share Repurchase Programs [Line Items]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramsLineItems",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clx_ShareRepurchaseProgramsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share repurchase programs and shares repurchased.",
        "label": "Share Repurchase Programs [Table]",
        "terseLabel": "Share Repurchase Programs [Table]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramsTable",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clx_SiteContingencyAgreedPercentageOfCostSharing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.",
        "label": "Percentage of liability for aggregate remediation and associated costs, other than legal fees",
        "terseLabel": "Percentage of liability for aggregate remediation and associated costs, other than legal fees"
       }
      }
     },
     "localname": "SiteContingencyAgreedPercentageOfCostSharing",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clx_SoybeanOilFuturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Soybean Oil Futures [Member]",
        "label": "Soybean Oil Futures [Member]",
        "terseLabel": "Soybean Oil Futures"
       }
      }
     },
     "localname": "SoybeanOilFuturesMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_StockRepurchaseProgramAuthorizationLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Authorization Limit",
        "label": "Stock Repurchase Program, Authorization Limit",
        "terseLabel": "Authorization limit"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizationLimit",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_TotalCommodityPurchaseDerivativeContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Commodity Purchase Derivative Contracts [Member]",
        "label": "Total Commodity Purchase Derivative Contracts [Member]",
        "terseLabel": "Total Commodity Purchase Derivative Contracts"
       }
      }
     },
     "localname": "TotalCommodityPurchaseDerivativeContractsMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_TrademarksNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.",
        "label": "Trademarks, net",
        "terseLabel": "Trademarks, net"
       }
      }
     },
     "localname": "TrademarksNet",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trust Assets For Nonqualified Deferred Compensation Plans [Member]",
        "label": "Trust Assets for nonqualified deferred compensation plans [Member]",
        "terseLabel": "Trust Assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "TrustAssetsForNonqualifiedDeferredCompensationPlansMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_VitaminsMineralsAndSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, Minerals and Supplements [Member]"
       }
      }
     },
     "localname": "VitaminsMineralsAndSupplementsMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WalmartStoresIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart Stores, Inc. and its affiliates [Member]",
        "label": "Walmart Stores, Inc. [Member]",
        "terseLabel": "Walmart Stores, Inc. [Member]"
       }
      }
     },
     "localname": "WalmartStoresIncMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WaterFiltrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Water Filtration [Member]",
        "label": "Water Filtration [Member]",
        "terseLabel": "Water Filtration [Member]"
       }
      }
     },
     "localname": "WaterFiltrationMember",
     "nsuri": "http://www.clorox.com/20210331",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r148",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r174",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r148",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r174",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r106",
      "r111",
      "r192",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect of Accounting Changes, Net of Tax [Member]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r106",
      "r111",
      "r192",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r106",
      "r111",
      "r192",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r184",
      "r260",
      "r261",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r184",
      "r260",
      "r261",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r287",
      "r346",
      "r351",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r528",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r287",
      "r346",
      "r351",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r528",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r481",
      "r483",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r15",
      "r186",
      "r187"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r227",
      "r230",
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Liability for aggregate future remediation costs"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r11",
      "r494",
      "r511"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r54",
      "r60",
      "r62",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension and postretirement benefit adjustments [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r33",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r53",
      "r60",
      "r62",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Net unrealized gains (losses) on derivatives [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r18",
      "r57",
      "r59",
      "r60",
      "r513",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r60",
      "r62",
      "r103",
      "r104",
      "r105",
      "r418",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive net (loss) income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r52",
      "r60",
      "r62",
      "r418",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustments [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "The weighted-average estimated useful life of intangible assets subject to amortization"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r357",
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r353",
      "r354",
      "r361",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r92",
      "r207",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive stock options and other (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r92",
      "r222"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Goodwill, trademark and other asset impairments",
        "totalLabel": "Goodwill, trademark and other asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r99",
      "r156",
      "r169",
      "r176",
      "r191",
      "r411",
      "r419",
      "r465",
      "r493",
      "r510"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r48",
      "r99",
      "r191",
      "r411",
      "r419",
      "r465"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total other assets in the fair value hierarchy"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r430",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r342",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r342",
      "r347",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Less: Fair value of noncontrolling interests"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r400",
      "r401",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUIRED"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIRED"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Customer relationships (included in Other intangible assets, net)",
        "verboseLabel": "Reacquired rights (included in Other intangible assets, net)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total fair value of net assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "negatedTerseLabel": "Noncurrent liabilities, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Combination, Separately Recognized Transactions [Line Items]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Line Items]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Table]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Table]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "negatedLabel": "Less: Fair value of previously held equity interest"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net",
        "terseLabel": "Non-recurring, non-cash gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r31",
      "r94"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash, cash equivalents, and restricted cash:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r89",
      "r94",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r89",
      "r466"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r231",
      "r498",
      "r518"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r288",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity Contract"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSDividendsPerShareDeclaredDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r14",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of March\u00a031, 2021 and June 30, 2020, respectively; and 124,359,712 and 126,198,606 shares outstanding as of March\u00a031, 2021 and June 30, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r65",
      "r67",
      "r68",
      "r76",
      "r504",
      "r523"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss) attributable to Clorox"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r67",
      "r75",
      "r409",
      "r410",
      "r423",
      "r503",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Total comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r67",
      "r74",
      "r408",
      "r423",
      "r502",
      "r521"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income (loss)",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r73",
      "r81",
      "r501",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r140",
      "r141",
      "r184",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r140",
      "r141",
      "r184",
      "r462",
      "r463",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r140",
      "r141",
      "r184",
      "r462",
      "r463",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r140",
      "r141",
      "r184",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r137",
      "r140",
      "r141",
      "r142",
      "r462",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r140",
      "r141",
      "r184",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual Rights [Member]"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r79",
      "r488"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r138",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r100",
      "r372",
      "r377",
      "r378",
      "r379"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r265",
      "r303",
      "r330",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of unrecognized items"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r311",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Weighted average long-term expected rate or return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r280",
      "r288",
      "r290",
      "r334",
      "r336",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Discretionary contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r265",
      "r302",
      "r329",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r265",
      "r269",
      "r301",
      "r328",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r299",
      "r326",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Total",
        "verboseLabel": "Net periodic benefit cost (benefit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r267",
      "r300",
      "r327",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r92",
      "r151"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r49",
      "r50",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r431",
      "r434",
      "r439",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r428",
      "r431",
      "r439",
      "r443",
      "r444",
      "r447",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r49",
      "r50",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r436",
      "r439",
      "r445",
      "r446",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r252",
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r341",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan [Member]"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net earnings (losses) per share attributable to Clorox"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r117",
      "r119",
      "r124",
      "r125",
      "r126",
      "r131",
      "r132",
      "r505",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r119",
      "r124",
      "r125",
      "r126",
      "r131",
      "r132",
      "r505",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r127",
      "r129",
      "r130",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET EARNINGS (LOSSES) PER SHARE (EPS)"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate on earnings from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r134",
      "r192",
      "r245",
      "r252",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r32",
      "r157",
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r452",
      "r453",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r452",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities for Fair Value Disclosure"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r336",
      "r453",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r452",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r288",
      "r290",
      "r295",
      "r336",
      "r453",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r288",
      "r290",
      "r295",
      "r336",
      "r453",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r336",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Total other liabilities in the fair value hierarchy"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Subject to amortization, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization, year one"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Amortization, remainder of fiscal year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization, year four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization, year three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization, year two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r208",
      "r211",
      "r214",
      "r218",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r214",
      "r490"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Subject to amortization, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r208",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r214",
      "r489"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Subject to amortization, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r288",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward Contract"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r195",
      "r197",
      "r492"
     ],
     "calculation": {
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDFairValueOfAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r92",
      "r196",
      "r199",
      "r204"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r200",
      "r201",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r78",
      "r99",
      "r156",
      "r168",
      "r172",
      "r175",
      "r178",
      "r191",
      "r465"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r92",
      "r219"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r92",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r156",
      "r168",
      "r172",
      "r175",
      "r178",
      "r491",
      "r499",
      "r508",
      "r525"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (losses) before income taxes",
        "totalLabel": "Earnings (losses) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r375",
      "r380",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r100",
      "r115",
      "r116",
      "r154",
      "r367",
      "r376",
      "r382",
      "r526"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "verboseLabel": "Income taxes payable / prepaid"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r126"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of stock options and other (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r210",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Not subject to amortization"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r210",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r206",
      "r212"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of the entity to which the long-term intercompany foreign balances of the entity relate.",
        "label": "Intercompany Foreign Currency Balance by Description [Axis]",
        "terseLabel": "Intercompany Foreign Currency Balance by Description [Axis]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceByDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name or description of the foreign entity or investment that is of a long-term nature.",
        "label": "Intercompany Foreign Currency Balance, Name [Domain]",
        "terseLabel": "Intercompany Foreign Currency Balance, Name [Domain]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r150",
      "r474",
      "r475",
      "r506"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r288",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES, NET"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r22",
      "r193"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "negatedLabel": "LIFO allowances"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r45"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r24",
      "r25",
      "r193"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and packaging"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r23",
      "r193"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit, amount outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r99",
      "r170",
      "r191",
      "r412",
      "r419",
      "r420",
      "r465"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r99",
      "r191",
      "r465",
      "r497",
      "r516"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r99",
      "r191",
      "r412",
      "r419",
      "r420",
      "r465"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r241",
      "r495",
      "r512"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarginDepositAssets": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.",
        "label": "Margin Deposit Assets",
        "terseLabel": "Cash margin balances amount"
       }
      }
     },
     "localname": "MarginDepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "Maximum duration, foreign exchange contracts"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum duration, commodity contracts"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge",
        "terseLabel": "Maximum duration, interest rate contracts"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r44",
      "r99",
      "r191",
      "r465",
      "r496",
      "r515"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling interest, ownership percentage by parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Investments, including money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used for financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r89",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r63",
      "r66",
      "r72",
      "r93",
      "r99",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r123",
      "r156",
      "r168",
      "r172",
      "r175",
      "r178",
      "r191",
      "r465",
      "r500",
      "r519"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings (losses) attributable to Clorox"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r66",
      "r115",
      "r116",
      "r414",
      "r422"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r253",
      "r395",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Business combinations including purchase accounting adjustments"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r252",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r430",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r55",
      "r57",
      "r408",
      "r417"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Pension and postretirement benefit adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r408",
      "r409",
      "r417"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r60",
      "r467",
      "r469",
      "r473"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r53",
      "r57",
      "r432",
      "r437",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gains (losses) recognized in Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r57",
      "r61",
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r64",
      "r67",
      "r69",
      "r73",
      "r245",
      "r467",
      "r472",
      "r473",
      "r501",
      "r520"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Net current period other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r64",
      "r67",
      "r408",
      "r409",
      "r417"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive (loss) income",
        "totalLabel": "Total other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r58",
      "r73",
      "r367",
      "r381",
      "r383",
      "r467",
      "r470",
      "r473",
      "r501",
      "r520"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r430",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r314",
      "r317",
      "r321",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r83",
      "r86",
      "r101"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Treasury stock purchased"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to Clorox stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedTerseLabel": "Cash dividends paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r84",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Businesses acquired, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r289",
      "r295",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r336",
      "r338",
      "r339",
      "r340",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r29",
      "r30"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Notes and loans payable, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk [Member]"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r63",
      "r66",
      "r88",
      "r99",
      "r107",
      "r115",
      "r116",
      "r156",
      "r168",
      "r172",
      "r175",
      "r178",
      "r191",
      "r408",
      "r413",
      "r415",
      "r422",
      "r423",
      "r465",
      "r508"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings (losses)",
        "totalLabel": "Net earnings (losses)",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r224",
      "r517"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net of accumulated depreciation and amortization of $2,351 and $2,224, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r60",
      "r62",
      "r467",
      "r471",
      "r473"
     ],
     "calculation": {
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified from Accumulated other comprehensive net (loss) income",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r364",
      "r553"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r252",
      "r360",
      "r514",
      "r534",
      "r536"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r192",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374",
      "r531",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r317",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r341",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r317",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r341",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r314",
      "r317",
      "r321",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r314",
      "r317",
      "r321",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r147",
      "r148",
      "r167",
      "r173",
      "r174",
      "r181",
      "r182",
      "r184",
      "r259",
      "r260",
      "r488"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r140",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer [Member]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r60",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.",
        "label": "Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Indefinite-lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on OCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r320",
      "r321",
      "r324",
      "r325",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r208",
      "r213",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r208",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r202",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r202",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.",
        "label": "Schedule of Impaired Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Impaired Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r26",
      "r27",
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories, Net"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/BUSINESSACQUIREDTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r156",
      "r159",
      "r171",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r156",
      "r159",
      "r171",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Selected Financial Information Relating to the Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r41",
      "r97",
      "r135",
      "r136",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchases Under Authorized Programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r143",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r184",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r143",
      "r145",
      "r146",
      "r156",
      "r160",
      "r172",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r183",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT RESULTS"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Results"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, ending (in shares)",
        "periodStartLabel": "Balance, beginning (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r143",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r184",
      "r202",
      "r226",
      "r228",
      "r229",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofGoodwillDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r43",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r134",
      "r192",
      "r245",
      "r252",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r19",
      "r20",
      "r99",
      "r188",
      "r191",
      "r465"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "totalLabel": "Total Clorox stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r99",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r191",
      "r192",
      "r252",
      "r357",
      "r358",
      "r359",
      "r373",
      "r374",
      "r406",
      "r407",
      "r421",
      "r465",
      "r467",
      "r468",
      "r473",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r98",
      "r252",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSSelectedFinancialInformationRelatingToCompanysSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r0",
      "r225"
     ],
     "calculation": {
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSAdditionalInformationDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSIntangibleAssetsDetails",
      "http://www.clorox.com/role/GOODWILLTRADEMARKANDOTHERASSETSIMPAIRMENTSScheduleofImpairmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r42",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r14",
      "r245",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Treasury stock retirement"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r42",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r14",
      "r245",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury stock purchased (in shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r14",
      "r245",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "terseLabel": "Treasury stock retirement (in shares)",
        "verboseLabel": "Treasury stock retired"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r42",
      "r254",
      "r257"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost: 6,381,749 and 32,542,855 shares as of March\u00a031, 2021 and June 30, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r245",
      "r252",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury stock purchased",
        "terseLabel": "Value of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYShareRepurchaseProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r118",
      "r126"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding (in thousands)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r117",
      "r126"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSLOSSESPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=121551529&loc=d3e60009-112784"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r554": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r556": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r557": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r558": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r559": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0000021076-21-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000021076-21-000009-xbrl.zip
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MRM?1-1^9!#F,@JTI>&U*]FOH\\O8+WTM_JY9E%,*CJ**K.BR5S&J8I*V5LE
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M-2UPT;K,0-DK\+8 2&0MY52,-GJ7HUCEDZ4Z'VHT"33MVJOB0,5ASHZ*@0!
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M2%&347-A8S]6@BLQIU"W)D49$OLCJEPR&%" ;9JU7-7PV?QDIC;*U=DO2+X
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ME.NRUJK:2T/UY*1V@8I!I]A>(EM.J)PGH[#!^V@[[KRJ]M+4W$XL3'Z+P@Q
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MC8:E$T6=H:^',F&:%$&Q@;-U&Z=\,"8E@[9D0<%WRJ0S]/60!U+Y[ P8Z1Q
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MI60HN.) EZ!RF\13YU"=0S6NH4AXBMHEXX0#&2WF&+T@PSFJ%B*/;=)0-]7
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M_]V:7WKOQ^DQCN[]&"=W^ 9G/Y_=Y[.[U3;W<3@X&-VM^-'DUI]_^,-&X.2
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MI:#&K5'C3&/AV"3K5$("1AQ0@V*(JI)'''OE69!6,+.R!A%608V"&H]<NBF
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M=K^!@??Z[7DXR76#QB<?22V*DTQG[00PJH#33<"I7>,@.AHC%9$H$9H+VD#
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MIL7SY_?\>KJ4P(%Q*Q$$!L#M'+/(>N\0+,8Q5:7G#6ZBY]_W;C(PA>FU)Y=
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M_Y]WGRK;GS^_V_]<V:W^O;W[J?JNMO_Y%H78%]X8^W5_9\<7L-/,:L:"$!Q
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M./ 4.4XP8BDR09AGAN.R>MBZRN4#1\M*N;Q'N9PUWXT)5JGH4-(8Y#)359B
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MAPIA%.<?=+M%=*=8B'&L(*-0_F1VF-O%^4H!#2.LJ/3J$3Z\9DID<4AKOSL
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MXZ[OCT[>OQC)R<RREXAE*^&V!&\6*="WMS-J38,W-@30EAH422[01WE.T?:
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MR$*NZ/MSB<&$*,6PQLA*1Q$8:Y'R'B,F=2"@ ^ 8<G;(W?.""Z8+\Q8IW>Y
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M(B(V0#)&"""M+4=!\,B)]2XHO[9QYT3!@LSZN@K*6$T$P\1[#MQ'2YB-P;I
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MJ4K"$.F+;E$'\TJ#N?M&ZV"EF^U-,<^W'^CPH.!XM^NG&R'=68,*';W/1:%
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M6IGPU8#JW:HQ<LMM(Y=R;FR]B>IVCB3TAC.7HJUG\TY\09]J4$5(3TQ;WH!
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MW/_RVY>__X1G'ARE_1_?D_U</!,'4,@,PI@ZQ#7+25_1HV (]5%J9AQI=T&
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MX\@"W]L\!C!;7IA,WT$C@T *(&;=O&L-VR'</FILX%Y_\@)3G69G$@^X"!I
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M( 1^3II>_%_7_^'%^2_#CXF0P7P/Z^X$"72CA=SSWM=(X<M.!^0&-HR)$ V
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M Q6.80)G&S_EIS_V.AW;'U1UMX+A.WEY=JKXV4? 35BP:G!D^[$*=FB_OP[
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MZU=YW)>CP]%@6!$VN6'R5J.N'0&Y8FCH%KN#]K>EWS1K-;#*DU<%)O]M9/L
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M>_U. .4S[DXVGT'L= #$X/;I.,#K\&2@0):8WNCP""8"@MN/(/V=AF\/^SV
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M2-;O >\"BR[BLRKT :.Z>:39L"$>-^#>LL*KMW^\^1$1TRQS4_$L/SD>V4_
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M77)KK$U &T?#=PUW9K/ANV:GNMWYRE9*LW4Z'@^TS-EX\_)T\].:@Y$;#$'
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M*N5JDYA5GV75#"AG)YQ*-Z9(MVM(=P])(8Q6X%(^D]-B@#\%"JOZ[SBEQ6!
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MX/J064;XXLVD;F&2Z\!GH^ ]-CCWX&!S(=-BIG\A#0.(210./9^:O;,!:,A
MPM_%K]D(7%_:%:(QZM=/M1(0H"0E"'Z"T'_03UODK!AHTJ5ABM\4>BJ7F/*
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MF+H_2N)[_<BES2SP(M_DF>SC5#(TJ&^R\4I@28)=T.Q\*W:.V43N:&!-L?R
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M:7XZ.6,VVP(Q__7+-8;(R2<J&UW'R9VK"-S@1#<8]70$L%8\ 51P.]$9<\S
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M@?M4B16#Z**VQ!;TGVK",AP'JVQ;=(FF_8,"R,R&=J$9VX6FM@M':A>:6;N
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MDJ7;FO.//K_T/&L"?PS#D?.7_P=02P,$%     @ ^8&>4I]NA $'$   IYD
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M4OVZ\+L7EY<V;%=2,RF#"LD0)80F4MI$/-.:,!J\3!QC"]GD!J;G874I.JM
MCXHVJ,:+N[V2@"9#8[)$!(@(8'Z%?63EKE=O;?0N\29!^Y.=LM809SPZO;E?
M1_G$*,V.J.S*QIU*95>0(P(OI68Q"M'D?/5=$%V:X=:U]4,>KZWDNO?(31<X
M#?V00!J%@JCD)9%)E48P0I&H(2DJJ>*A2;'ADXC:K/*+1(^4A6A2("BC(5)G
M2YQ%T3F7CJOLC4Q-7M^E$7;I7:C#H.4<@$V-5?68^'1V_A0FI851NMP;Y9E
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MYJ> ,?CIQ)]O4 VR\A!-:+>"5"U?WMVSLGLX'8SN-!=\O*3A>E76TDUJ<!J
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MN(3QI ]C7GED[V:]&?2Z+ZI2=(9G9Q+7*?.@19;&F*15L,#-%0-?>7J%?S&
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M1JX*1>PKE)?CZ6Q.P)Y/ES@G4!NT_.3+67P[DD:*K'1BW&I@6H-FX+1B3HH
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MK-;+8"6Y&&1229@FX7K+O*B:KM\IO^+YE-2#[^'S\>=/Y+W@$YR2])8C!)M
M069&YWH!U4M: X1FA8NDG"HQKV=0;;PNT0>6.S7![B:?;V]3#$Y/BT2KFS=Y
MKF;QN'KN[CVR(.M.C,%Z3Q440\D=R%B4EDVV-[H"?4!:&X2K00/-WQ=83B<O
MQ@5'J29<)Y,8JD)1D23F0W#DTI2L"LHL79LVP-N >X :ZIV3%CE8)[/Y<OR_
M<-929=T.HX Z25^0Y1!)U4IFYKT6K$"TO*@2K&B2!7TSK >HE1YY&+:8T[?
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M16X<\^B0&XPNN"9I'ON ?D#Z&YS#X>^Q;L);"T'5BHIH:AUO9UC$9)E-$$5
MQ76;<O@/I(CJ7CIKR=6P'6)^F]=$&%-B<LE2\!0%U@,$P:)7@=E0[^ME%&2H
M@7V%%; 'J)U>N1BX)&9*IR>G$ZC72KXIMS.2OL@2(QG!!%*W<Q1U2\Q,<\XI
M[C8RM$EL[P[U<>FI#[Z&K6_Y"I>CA/17L@M,1C!G17T\ 68E*Z&@MJZP0\<M
M!.MQ*:<K#PWJ3VZ<'*^NK *#-=H*5HH6M2=-9%#K3ZC '0\E@V@S]VP'[P&J
MI@$O#4I*;A#T58P*%"%4DCF+ENGLD/E$D)4'IT+,F?-!M+,)W"-0SMZ<-*@,
MV:6[9"HI1%L8+TF2*2+6Y'%/I(,!5,E#;M+U]Y[6ZMM'.8U8N2M9T3<,ZDJI
M)2U"YE ,@^QH?*AK.PZ:805Y;D)'IY,>N-7%?:S1UTDE>W2&[<+6'>C2N0W<
M'YUA6_&_9[O.7<B[ YH3%B)%$L"4P<AT*):!3YFY'#+Y BF8PA^LUGKL##ND
MU+IP-D1G6..,\H[\Q6!J:;#H$@O2&A9$$J!LR3'F%AHZ?%6VILS=5I&MB]D'
M[@R;0XI)>\,XIZ!3TUK/P"3/0J2/(3@%PC91Q+WN#+N/./HB8_B3M2LSJ4L:
M:SH/4ZI>--:HF-<0":Z3B:91(=0AJL,^,C>[)6L-CMAV*8^Y#>0?I;!;:Z&'
M>L2[$'E'2F&KJ(WATC*5(D&7 5FP1M:%O!1;(%EH<N?ZSFBOYU+80TNO"W]#
MN.+6H$)E$TL^**9++01K:E,I*S#74N"R--'3X5WQYNS=YHYW,?T0N<F_/G]U
M].KI\Z,7SU^]>__V][,N[Z^>_7KT_.U_'+WX_?CE\=&[W]\>KWY_AS3D3H_?
M.^-X]\&L)1<+2,X9[PKW0ENC?2I62\6SX]Q@\:-=Q]6*FI4KMTN>^ XO&92F
M30-;(RN"*P*B<%H+33,Z1*42F.+IZU)2Z$YD71UC*\I>P7P.2YJ%=D_RW^MU
M@])X\V#7"74\(;@<G0A:YAAC-DICUEH*XQSO1.B5-^^WEC[#^?B/U?.^GIK1
MO)U\4I;)% 33SEH6L@7& ;AQRBC@L<5RN@'+OJ["2_@\/CD]>8'3#\N/K\M[
M<L'^AOE#72F?PN+CKY/9GZN?Q2@J6R17%"=:1<M74<!BBIP)=-QP'2Q-F"T&
MO37"X9V+?;6Q[CRT(:/!)M_7@;^:G5W[/CJI9?Q&WACA8T16;&WJYT1A7I#+
MG:+P.0DE3&[\97P/Z/YKHA=3-X@Q-FCUU]D<QQ^F3T_G<YRF+]])=F10Y\RQ
MU@)P!!>S9U& 85$['ZTV"&6HZ>,FG/=?,"V):;!%=\.<MZHK@8OE6UCBVOR'
MV60=/*^Q?#U7"Y:!E9GI!,J+Y 7Y3 ,O1M>C?9":ZIFD!CGSWZ'YC<Q6JXN^
MGSTAYS[5B']<QIC_/EY^'$^_:_'N-7KR0Q53]9(RA8**Q:@SPY1C2-F5*)K4
MQ]P1[_U7UQ!$]9@Q7^]5?C7!\^EB.3]=E8)[=QK_&]/R_>PIX9M#6I["9/+E
M664$\].Z:./\$\R77UZ,(8XGX^67-[/%>11V,EXN1C9*ZS!Q%FV(M?)M/8W3
MP)(4V9EZ9S[)6R+$9N#NK\SN!E\-DO%?POS#>/H,/U549_N9(]3*6T] *$ P
MM*0G9-YJQP1]$%S)4+1M<DRZ <O]54Q?!FZ00K]"\?5&[=./!!$7(\>A=O,S
M3*&SM=R68%X9S2*JXE/RWN0F:]9F./>?^1[,W" /_IJ"Z8HCEF0U0P&RWM%7
M#.I%,B6-+D[X)&*3H/NNU*7OF_P>S'R5?-^R%,+5&QLF("^Z"%:+[S!=O*5I
M2BC&M2W.Z^Q5FUX%G5#>?ZFT(^6J@D)_NW9GB4"AV%A(T>2TU*A, &<^DSM=
M2HE*QI1$:I*.MX9CJ LQ[7;FNIOST)=<JD_\='9R,LO5JSWOQ?)U0!<.\5GV
M1$2A@U2%9<5K 59!0^26?%TI0!@7E8K;%(#>]GV'2J';B\]98[OV7+YN&XSG
MV1#;H-R<#[>S"@Z1U=:.N8[2V,/LAQ.)UI;F^E(8MXZB(@##@M.2$<@4G08?
M7+@'XK@F[>RN::.+M7O6Q/O9$B;;0+WH#P\J@/2.9DTE:DWIVFR^9 ;>IHCH
M,KIMUHZ.KQW.L6S)W&P8L_?<A>#=[$M$F+X>3WX]K94[+^\;U':1.B<F8VVG
M56KZI0?Z.%22(6IIC/9;*.&:QS\XQOLP8]\U;W'YZRE.WOT)GR[1))L=)$.3
M7<UN3#(R7P1Y2Q @&%!@2]J"U*M/?G!\[FF\!B>OJX:,-#*RZGOZ*ZO%J_97
M=$$X9K#VWC.06%2^L!#0B6A##M#JSMXZEOL<!O1EXK:LGRMZ&T M+[Q<0728
MZRQ[<W4]]WL8NLWM@#5@6:7:F2@SGLA'T(X#\REP9C$I4X@UYYODY@S$_"V7
M2=H3W\6^/:_9%PO:8E:>3__ *?W)+^?+#P@!S@C-5*'I3*,5+.@BF8"B$L=,
M44O98NV^_@W#;^_N:?I9[W9KFGOY]2C[[7CQCY5N0]%!)P^L:.V9EG6OV=O"
M9*BW&8R5L<TYX$V@'L)"WIO1&^0Y7?55ZS1VT7MA"VPM%_>;P!UFG>^/RFLU
MTA,/#=;^&S%F9SF K=U9+(4VF4)+7\M'Z&*"0:&*4.EA:.06C^ P$NEB_A8E
M@LZ2A(\_T[HW_7 )\'S14]SGY#*R&&'5B2]0V)L2$QE"3D5IT^:L\$94ASP_
MWI? ]6(_O5F_11>&;W-\OT>&: 3J$ID3A9PAJ10A<X$9"-%(80EJH[(<UT%Z
M0*+HR>X-)HO+#;,U6.162QT39PYRJ+5%*&X*)C.I4PI*:<55D[IAU^!Y0%KH
MP^(-MI-N[HN=K-/%><Z27&V6"L]B,I89%WU!*6WP3=IMWHCJ(<0C_9F]02GY
M[[O*;@.F900R0._XVT*.'MFZL7G\+J9NL#A\#\IZ;21:8"YK8%K1_P1TCD4K
MN)(0I!=-&F4.P/LM8<10M'>Q<,_;BW]#F"P_'DWSWW$RJ4.\:/\LR#_5*C$/
MR.O1EJ6YS44::U$)G!21;W/L?\WC#]THNY/!9_U:JX%[_RN,Y_\!DU-\\F65
MN?JU;E(@-@"%9%$G6J(,YPQ*J$GO 73@$*QN\NU>B^@AK-W]F+O!?:)+8!=U
M(F%Q.L?\>OH6T^E\/IY^> *+\>+WZ2PN</Y'-<3SZ:?3)?WKV32-)^-5(YMO
M1W79 /;V<36M8-UH8 <J==V/?JY3Y5T@O\7V5JOQ"0R99FC)9-84REFMF9<4
M@''(5D9GE4U-.O[=+U'?5E/[?FFZ"^<-M+PJZ_M=,5^98\[>6[*2<.21%%J9
M'/?,N^!*QB!$;M(TYPJ2 ]13OA,D;RJ\O#-#3;9PNU7,C-H9[2#6JXVU*HC+
M#  D Z<3!Y1"F$-4(+TKY9;[] =;4M.DB5?WBIK;0/Y14[FU%GHH;+L+D7>D
MIK(3,12O!'/&\7INZQD@*B:$E:!X%K(<HC/SO:VI/+3TNO W1$WE5#=[1&VL
MH4O=!#*"QB\5"T7'A%FDH)ND6MW/FLJ=V+NMIG(7T]^UFLH7C1IFA5S$XU(P
M+1>SLK$^S3-<C#],:Z-@6-3:2.3*?O=OAZ@BVSO<0:O0MC7V6A5;4$X$J<$%
MS;6Q-FBK3*%?:XP0,':J8ML[\OZ33A<7I;I>7%ZGKX5\/7WH+(0DZIF&HN4@
MTJ]T4!9TBEPTKBAP$[Q>PNZGLY-/<_Q8%]7Z-I(EUI=LK&'V!,ML_DT5L[0*
M-8^F^3U\'F6:"5.HS5=DU+5$7F#!Y,S0QU2T"<*V.1?K=12'3+#H38D;@_>#
M\-RJ'U>7P:P/XVQP=23<9^ERL*P$1%;+@[((%EGB*'VBY3W9)GL"_0WAAUS[
M8[AI=O(&8SWY<KZXO<7)"O;BX_C3DR]G8[T\:G\Q.Q_3E^N2>,\V;(I42,MR
M8M)D^BHATE?I@V:U\'R,M8] ;A(-#C?$X<OJ-%/X'=7%H8OX;)6N'K6-2=O"
MC$\4ID?EF=>2HB^M,H8,&43CI/Z[>"/H;NFHRV6C+GP.?8%D&VP_+AOM1F67
MFR2[\#"X5C+73I%''%!GIF7FM79N9LD6'3,D*7SCFXKWX;)1.XET,/^ ]P<\
MS9;<@659:G) 16U&@+EV*94T86KE5)LNK_?C_D GTK:\/]#%XBUR#V^\]V2R
M<M9&Q8HK!$YQSJ+4@:%1$4L42;?93[I/M\[V$45_UF]RR'?M[:<09; (A$Q9
MDBH/C@%W-&8.9 L%-I<FB\>]N76VCRAZLONUEXT.?O!R=DP%TWQ1UW^,BS*;
M7R82/1LO:OAV.A^H4]\^R YTG+*G"==.3G))Q9CH5#8TI^@4 KD\:+RT"3B/
MW?K_[0.RUQ33H^]>O"$OC?[ J]ET_EV:VM<-$^5X3"8"0U?[>R5+LV^1@6*.
M6!2H+!I=I>QU%/V%$.?M%[*(/ N4K%;!8QI]89",9-P)#UQC\K[Q"=.AFEL<
M3EW7!Q8[D-*T(LXW%AD%GFR.#AA/]8IM4,!"%I[1%&U#0*--;'):L1'-#[GL
M0T^+ !06]2)6_<?Q_YP2OLGJ8M[R*<SG7VC\*].-?'0N<EWE7$L]>9#,"RE8
MTME'K8H'T41#6Z%[S)KJG[X&=^.?8<'YO+:2.OF$T\5JW_C-!*;GLZ:*/G-G
M!0.G+/GHJ]X#-']F)[G72CC(32['WPSK,:NJ1\(:U/DZ1Q%<L5DFQQS/D6E1
M,^F\*HP;XRV:VL"^2=[(#WGL0$"#Z@J;I[X-0<W(>DQ69,F*3+4)IPLL6 ',
MI"R]2)SST.3H;VN$CUE,;6AL<"NXEK]<+$^N0U>T\>CK77AI:%)T8!@H[VI"
MN/*^MC\HHLU6W$VP'K.R>B2L50/#C<"2TAXYT""]KS5WA6,4-Q;FC)0I9%ER
M&V?[6D2/643]T-2@!^*+V?3#>YR?/,.X'$6--#=FS[+%VE!->1:X(D!6.E-0
M.(E-NMQ]"^(QJV1G,AKT1_QN<T'QQ+-(C*M"+IK*R$ 4S83@R(LW/K:I._9C
MQV<O*IKT/(S+KWD5ER8:B>PA9V[(:Z];EM[9FNFJF#?!.\,QB#:-+J[!\YC5
MT@=%&W8(]T]-&$]AFL8P^<8PFQ9$0W&?2H8S:WRH8_?,AWHE+6"*SNJH5)/:
M"UOB>\S2:D'A!JGU79QF)XN=Y9T*)4TF-XR!K'M4$&ISZ@!,B^@$)\??M^D%
MW=L(ADI;OT,B/0CY=R5Y_0E,Z!/%=Q\1+Y.K5ZF/(F+62)\CR$33?T'R)#-]
MHBE@ 3!.!X<ME'P=H$,EK1]('K,&-#4XQ]N$ZZ)^SQ;(6F:C7P_M,+GH_5"X
MA2[VL/^P"JG=O45VB<EZ*U.#"BR +*PD34%+S,FIP::8 V:@#RV,+F9O53WM
M*<V.M'I]5Z*+6PI*==VQ*+6LQ.KVH[6:A22\<KD8;IIDE5X':'C/O2_2-MY0
MW=/BK>Y&?P=(D^)= L]<-K6M OEQX$5F+AJK=0%;<KLKS@^7^YUMW.#S/TII
M=CI=+M[ E^H5D;M$OT..[O=NU5F3C=I8)0G-9$Q0QVT9S7R.*56LME ,QB:7
MA+>'^&!DTHB5!ED]FP]N+[IQ:"6P;GIC$J9VXU L1B(X)9]L*"F!;;+Q?!.H
M!Z.1WBS?8W+.JGOTV<KV$I:G\Y507Y=O#T9JQ/;-CQ=7*;!P'H-@MM $2(JF
M11"48<EA<-+3S^M7FS96R-_EW?=>$(,8O4'JSM>3^<M&LS(7*6RT3(",3*=
MLLU),"!K9"V*=$6U39^X@/*X]S?VI*;!.O,]HJ>PQ ^S^?A_5]_.94WAVQ&V
M+:MZ&\1#55'=C\P;M=$;$TVN3-Z*U&N==1' !-9+G;2:,,]57EWF<]EY)]T
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MP!\FW.M+"+,#L]A@>=QK# ZYB[4FC3*U$CT'^CBE1.:4CLHI^EBAR6V<NZ?
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M!N- ;E-/8=OW#>\Q]\?0K+%Y>]X$//X#YQ_FB-/O$6E>J@.FF81:7RLYS6*
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MV_9(<-K\X!>7I]<.*:CC*%CP0C.MA&0 ",R 4US:+.1Z4;7-B4VWO&>0RKC
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M.^F,2K)U(?&=P3\PJ0U#8MMYZUDE ?,3G-(OEF\F]/%<^6QB*,)99UG6J2:
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M]YX<>=*F RS\D*"$2 Y3&0FUP$D\B*D70QDDC,LHY5QZ-I[0KHAS\WOJ3@B
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M':>KON-2YUWT&:.PL^8SOW,<[;3U]KN,:)9PSTN3 "KWRU>K/($ACI17EM*
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M?O#QLR75FQC93ZXWNGYT .!VSZF;HNJWZ M)R(3'H)_HCA$(19 Q3\#$BV3
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M$J<>DM'H;FHF&AC-D5E;J]6:CNZC9H2Z&;%,@>0;=%C[H5.^[C3P8]MC>VU
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MF]]GZ]X$G^A_%:OW.MGF1GU)NS")4(0QDQ*F/E*L2/P(4DH(]-.(\H CX>/
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MT30CS33;46#"?3T]W42G-- !\: J0*Z^';JE1K%<ZOF6M498LIK)B)C1F2N
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MG3(+^3,[:?;([#IM(YYQ8HS/NY=W5#V4RZ\/4E:_K(KGIRR_W\2:8(ZEX*&
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MG'@4)N;,*09@1"W@T1"Z+0!LK\;,57]'X[1;ZG?\HT8ZE4UMCG69RB@)(S^
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ML;F<)@!-D.$Y*/8M\CY-<#B0#6ITZSC.T4&(E[G0_^A#]V]TJ5>E>^H3+8*
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M\2 -4(K\%%&<&I7P,)!U;ERZJ2NJBW]I;2] K2_P+7/T!O U(T!'J$W,;P.
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M"$H2ZFYN(2(RLHHO'A!V;KS0Z-J$#5YTX6S%1M_Q>^2#D)OQA2L@YS@2SKM
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M_8Z64KSO%2U<1*E:&H;(@R$F4K%!_/]3]Z;-D>-6VNA?0<2\,=..$.9R 4G
M_J3:[)I7M4R5VG-]^T,&5HEV*E,F4]4E__H+<,FD<F$"3)#B.,)=51*)<\X#
M\N$!<!8"28093&6<2AXEB6FIY+)B/"IF;FQ0'8%KA[+<J^'HN#8\#JGE2O!B
MH,9>]QD%&XR:#%=P713Z$FG^7C<.IN5]VT#.X[*O%QJOB[SCDJ9=TO5:>["
MZ[]Z\/D$EU*4'[1RW^1CD\[\17V_7Q>;VX:)%BJF<8(2!C4M4+TN"V-(,QI
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M'[)@Z^&9W)>CW%5@W-W=QT91P)K]#I/C#7YI_G5Z<^.R61BZ@70YLJ^R>V2
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M8A@()A,9QSP,K CMR-ASXZNM>O9[P/MHG=\)OP"#D:ECJ]F O?!]'.PWPR_
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M*,MI$P9'!4:(\!0B&1*($AY#PE ((Q%Q%FI&X:%=\6$'H7-CD$IOT"@./JY
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MJOW<6+8Q$O#&2E-1MC4,T*UECB[8M ^$'5?/=II'9OK*[J-?T&W!]?8A:#$
M'1"J_+P.#)U.O]T^RV:Q6=2_[\!A@NM][Z^_RCSZ_/Y,:\"D7Z]7F9O];]_K
M*'%9^-N"!RFG*&,PBTR+$!)$D,:)_L8AJ11BL<0J7/R0!5N[1F>Y4%%7P/BQ
M1L/BKQ:$2\;B@,*8TLQ43$T@I2HRWW_* Q;1-'/JP#:H5/.$$6L#86)*9!)E
M"4R$*3.F4@&9HK%^ME :4)SA!,G%8]7W^_N&%IOQP-H7,CYD5^"-O,M7)O45
MO*%+$Z<R$,649%0H$4*)$V$:=D:0"8E-D'N*LB@C'.,&Q?<KRZRYX1BV(J9
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M\:YCUTAV=6=__9"4_)'8EDE*5+0OZ53:TKWWT#JZ)"_/%3+. !%<  1%!IC
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M[<]_VOY%_6"TEG_^TS\!4$L#!!0    ( /F!GE)0B=(?;GT  #&:!0 4
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M;]>,9L<E:EKF7FJL-6+$'EH.&0//&'4H01P1G/?1.>Z^W ,\!]%@!P"]HY"
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M=51'N_!WW"XM@U\F[23-#B+=U],0I[/I>HJ;=IYU=,OGQ8R$OJJ1U_K[U5E
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MO5E]Q-_5H I<DY.2N*F#OV,AIA0CK]ME*8'8C2@9-_PF1F]E]>SZSG&CZ\9
M:ZJ +D.1:W.^SM?0IM/6M8^OG.))2B)(1;9>2DT+2=;Y.S5'W-A24*00#1[-
MB=R>['$#[1&]S$::[>(D?/N,@8E2:(UU$J36Y+#$8H#D6>^?=#2:ZQ),D\*2
M[4D<U]T\<O)%(\UUT+GH'LYJN+>Z1Y#"&!."<% 4W\R&U;3N3(+HO6$^LN!Y
M$XNZ.ZG==#\X2L+D4#KK8,\GXW]^S/LD_<?I=(GW=Q6A=9O)*?8@N$-02+N
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MUTO9P28U,3.O,"H./'I1,^X->(I$@4LC&.T+THQ9I=+3=KV'HN^M4ME%ZKW
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MX\; [=&4W17$'VA+>N,FF'NEK8BT=C<Y+C(E"#(JX%;65:Q2;I.DL >MXYX
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MW'(W,UZ#*:E/#%[8YA_20WZTTYAU5MZQ.A"BSI[U!H*I/D<*TO'D.#F91]Y
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MF3T$ ;81:V5E?IF56947*:-I<^_V0IM-[B3Z79I-[B*'#C#U6+O#R%SMQ9E
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M%N>TE!R7WR<9TSMNZB4FTRO:HM]]S?.5S!87F:7LC>.0BTL46@3:-4V0$'/
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MWB1A]G#2QZUU:0+6(\NS P0_HIZ_3"ZOZ*</M/1"Y,2EX!:"X*[VM*#E21.
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M\!ZO'DVM&Y9-Z_5OGL9)7IQ,TV]7.,?I,M,W-_<K@A<9K1.@S6H >E#@K G
M,29BD8OJ_M'.QD.^+5]WR"GE,QR\[<#!/$KOHH"L6 1E:#7.>$M+DD$HQ[17
M>ILE;?F^\495MY#QW>/-)AQ_D39E_V2!+1_<WL*T2!C8!83.*Z$E;3G,)$;[
MCDH0N+9@?#+.).F9L>,;FIO]M.8K_O"6ZRA%<TQ6I$1^B':@=+80L-!>&@TG
MH">61)-LA\WD]&]Y=A'Z?9=F !%T$,8]6,6K;V>X)+_O7;G]\;?5H:V,AMP_
MB<0=A:"DCH#!<N(=MREGKJ)K<LNR/8GCAG)# .(YC TCG>YPMU[5^CPWRRB%
MLZ2&VG%:"@4:(>L$*1KGC$K,Q"8I2D_0U!FR!H+!DVC;7R8CIPN<7.*7G/!U
M/=K]]KJ.X)S-IQ/\ Y?T_)LK\!@"%P)!!$<>H; %7#$6'#,B^JATM&6+W7Z+
M5_6$G -$.FO'WY'A\LLD_G,R7<RFUPOZ8T(L_833'Y;CI,=(C@*$52)T% ;0
MJ0!&!,XC#UGQ;>"RQ:O&/0AJ 9>A^=O=YD7V^/:03-"G<_ %BJJ3J6,J@,PB
M =_I4I2TPC=I^O$X23TAJHU3M!_W.\#128SS*[S\=38_G?XUF<^F]9X;+Q\L
M\,(S@='6 _GB RA6'&"IYQFN)H 5@SFUFBFZ%8$];7+[ ^+AY-#AI3-Z*B5M
MW9.59*ZO@"Y8+@%EKI,?L-;X6'(8&7F-+F J/-J0[^<./))%>>_!G9F=PR!Q
M..M&EOL?^/?DR]67T[^_KBYU_IRFR6*5^Y#3==,)YY5Q:,A?TPJ4%PY<=A8R
M_3B+@B'FN 4*GGG-N!?^#3 Q)%M'1LCY9)GO!I.?YCDG GJL(OJTBC07R_//
M.*</7!AT/-4)S#Q4?ODZ\R6S -K(Q*.GO^Y/5-T(EUW>.6Z9>@/L-&/XR$!Z
MFZMC3^33:R?+5[/Y?/8O6L)K_(JQ3@FR68<4G0:M<@*5O"!?WU<G$&NVGN$R
M^BVP\\QKQJTG;P"7(=G:@>M[O9S%S7K>72T72R3S.?UT\J4:T LNDF*A:/"V
MF!IN*J@J0-]B<B:YDF(3E_<YPL:MVV[DZ@XJC3YO4,]/?_OC].SCA]/S/]]^
MW"<)X]X#!K@1?8JD@4JES_.G&K5\R%]KRQ,2Y_>Z5:Y9\IJV$>MKF@UM*-ZX
M MIR1*NCQ=+D,N<Q@@XN@K[WW$VCFY1.J38'!"_($5/9:$"C/4BO)$NNSAGW
MQUAS=T.W!D')@^KF@27R$LS*WF.T-CYF<!/3<'36HQ!*S# A2H 09#W:+10D
M)Z'JT2YI2ZP5C6V&0[4R--_3QN^_X<VTS.9?5B)Z]6W]C[=0SYY93CLEH$8$
M)>H$.6\-!)OJY#IG56F2B;\GO9T:I%W0]'B[A7:2>PE&:H 6,\\\<'##=92V
M,H_O@BBXE8:\W5)LG3-)^V&)!1*Z[)C.1>*+,F$40-1#AOE**!\FBW]>W\DP
M;G/06D"4E@((@[6A4@A WKVP3BG/6).TB\WD=&J =L'"?0,T -\[B-P?K.+5
MMU<4BW[^@O-_KE)06,Q.&AE!LR! *5L;#8@ UG(FO!$90Y/0XCG"QFXJ=+CP
MG\/3(9+H$EDWJUFG(!CGLW"T]7H7B%F8.:#R-3IABOEL4:E&@P.?)JPS9!T$
M@V<Q=H!,.L#8A_Q7GE[E7XF+JPHDLNG_F"P_O[Y:+&=?;O-15(P%B5D\UPF"
MCD7PUC'@6*QQC >1F^SX6U'7&]H. <2#W@Y#2Z<#R&W0S^\#X*PO/.88@12T
MD/DOA52SZF>,6?O@K6T3'3]!T[@7]\?9)O?B?X]0NC/1K7; D(*T31;N024C
MP6<N(/& J&(@;3R.V]7+S,7!Y/ZL&[^?$'K T]JP/EC2VM**$"/%_!ITSG58
M.$I B08R2I:-"K5A6!-,/4U79[C:5_[W<36@,$;$UF*^O/@#_VLVOUG/8J5Q
MI%*\6*TAUH:%2K  H20'M>,3*RYFZ[9)C*6GWX$1?7<?0IM?/V[FT8";V@#<
M'1D;M:_AN_+#&FX\1^&,R5R!3%&1YRCKV4I1P*,C3O%@1=G&&=H*(H]2,8YM
M&4*LLZ%Y/'(BT3_PDL**Y3E](B_>3./:#"K!4RDF 9%J@)1$@!<R@V/T+\PJ
M[N0VM1B;GSZ>] <2V6Q0_O7@HMRWG6^_9[P4U,RCC[0A2@Y*:U.[""I(TKLD
M*13TIHUW\BA)XR8I'B-VVH_['>#H[*JB_UVY/M*OC%F?\2_JQ+U,OI4!,JA(
M"L8+.,4R6,YXJ.V63= M</0X29TYN'L*?=9$ AU@Z0&#;M-V^866WA1;(EB'
M-1'3.G Z:5"6)YERL6%3,\8&5ND.49V=Z0R#I\&D\!(N[<_SY6H8SJ^3*4[C
M!"_OY"Q\R-=C=#[.ZN0*G'Y;W"C64#?\A[U]\'2  9G1.G> DZ<ED'.P-M7-
MEUE FS70IBM*U%AL;M*1I9/TI^MB3^],SJE #&38E9.U<1S9^:@+%T4PHS V
MX<'NM'::=; +B@Y,>]I98B,?)[RN':$O)VFUC-6FLHJ<5?*J>%J!-)%6(+(G
MC\(F*/6*B+L0N-TFUW>KLX3-)/0R;Z:1U&>#BJ [$-U,WJCU#LXH<%)X4*$6
M>T:>(,3LG4]6XE:F:T\8C7TB-81@G\3)'ESNP/U_]S7/5S[&C6>Q/EDQ3AM:
M2H"8LZ5E8*@IHQF"PJQ0\!)]D_.(1^CI"3?["'HV/-<[ ,_KV9P,,2[SV6RZ
M7LE-_WKE$FWT'F3-;5 ^U ;TQE#(@CEZQK4/348^/$K1.%%C,P -P_D.('1.
M0EB-Q'AUM:!(>O$]PKGN ,9S90X%O6CKU38%O2B1U[&$QBH=N(AM*KN>HJJ7
M04AMG:'A!=0#VJYI7RN@DSQB, 5TK)V:B' (6@;@-BOBEX@8FW12_X&*D5WK
MX:2[N61N#U:/?%7W>\;+Y>>3:?I'OKRL+%D;5MJ O<I:0#&U&Z'*!IP5ACQ%
M%+HP88)Z[B#JB<=W$:SO(ZS9L)P;6_BSJT7^/+M,:](C)DF[9H84HP2E!1+X
MN0>-,CK:2E-)9ANA__C8D7>0881] *?&[NHQ*7FQ_'9Y,T.R1!8T20R4C!I4
M))?),Q7!I93K=$EFW59=/'Y\[,@3@081\B&<&EG(;Z;TG.F*WWBY)M\GVM&D
M8F!D)-\X$!N<]QX$6:,4%/USW&9:P89'CWM9/HRP#^58#_[=55C<=6"<2LXA
MC^3SBD"@-74Z+)(KDU$FHZ51C0;$_TA'+\/!CA0Q'""$OC"T5BAI73:!K)Z.
MC,@FY0+O76U+742V3DA4K5'41:QPB%P?Q\@>3!YY:WE]F7%*ZG-SXE*X0QD8
M%"7KX.G:I\BAHS^<*UYRK\TV_09_?&HWHMY'/+-!>#6RE-_/9^3\+%:[(7V=
MKN+W8]KBN<],<T##"?G:"&*&9)"L5%(4TH>XC<0??\/( <)@TA^(AR,CX3\F
M2_PRF2[^F$SS'"_K_)7SJZ]?+_/=H_NHDK+:Q=JSCN(?&3R!.D7P)>MD8M'B
M?D^4C9C8YETCNQ.#H6-POHZ,DU?X:?&/.7ZM"ZDEGUC7]?T0Q OOK'' =*'0
MJ11!49-,D+2P2FG%L]DFU?NI=XP<A R&B\'X.+:?@,NWDSN3 0H+ELN4@:V@
MK%( M*J B<@<"X;SN,UATKW'CML==$!/X0!NC2SHW^:3R\M;)T=%C\Y$#5(7
M\H[5Z@I.*? 4.@?K11"W,]R?D/./3QVW5^=P8CZ 5R-+^=?9+-US8IB*FDN1
M(?.B0-E(FU,(&KQ1"7.F)46YA:0?/GDK:=O^I7T@ST:6^&IF#'FN]+#JP;XF
MYMW4K\;LZOD7R&(RJ,0H]C61XAB,23.NN.=N"\$_^H*MY._ZE_\P'!R]>(^>
M\^OD<IV>?Y.K4]==7($@:ZY.=!8\DF.JT$JIBI4V;7,?N/'A6XG?]R_^PSG7
MP8'@4[T7''/9)E<[V,MZZQ4L!,_(4Q$L<X8E(AZGS]R./4_:10%'/FP>2C@]
MXNQ.+P812^16<7!:US15C^"SJA<[+!=%L8\OQRD/?0D-47:2^PX-47810@=X
M6OM=C[7@P"B2K,-^@@@,%(L%G'61EF3(-I,I#J))!_&GR>H,5?M*?]9,%!T
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ML#V:E<[BS8RRB:0W"M!;(T.BP^/U7BL=]OV^B5W^8W?T9_=^^%]02P,$%
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M*%$S(REHIF,\KUN3 5'J\Q>#IU22AL.AU$A 3\6I+D$.FPU]891TF0Z(+D?
M05%;'Q99?D#G$5I(7]2U*FIG4 !E'KPY>I6@WBG9:S5*\LP&1)XC8)O!;A@6
MC4;F#-"C7:J4W0$@\ULFS7-0Z!(TUPQ:JQW3"%T,&1A-:-LVAOHHJ5H-B*I'
MP71)O@Z'IC?=BJ,DP^E@R/!H=W_X9'@F2[:>OU5@.Y/_V"R4N)0WR@Z'-I$Q
M*C_2"8]4\T@K'.F&D\N*4BU-63$_[G/RNM<IWD61[*ES4P&GSG5*[M//C3<4
M/VN3[0KQ'3SG_,JA7QS0S*#7(@LNF$3<M;:-UTQF/]6V8H>LNDGS.F._AH;Q
MIA7VD(+Q.(-7<(1@159EG59UB2TG(M,VA<74!7I)S5+Q#L,/L.6E-"60HRS7
M0L,D+;M9#5J<H@8;%7U_T&1ABAU0_NL2FPQ/6K%2,$ 7$TCK!?EPKY7W!>+,
MY0U9M&EJT#,(+\-(BQG&A91,Y_ANIM@IR/N 3Y89+2?Y<&>J@ 'G^1I_44M<
MA*BQ)8PGU<N<[6:-G"5(V+X=;;SI85-A)(6IV*E.^]3["&RPG-$?H2U<UMI:
M--!QS>"!?&TU#837;ZISVEJ:!S;]P^[%+@I^V)A*NU# V0TO".L*U-PH>>IL
M,#QU% IKV/;CM!H6#XWH,QXD6U;/7XS>LIK_3JB/(=3OI"[%][*\4I7XN\SK
MX5A8B8N#H3#/@%,G1+[7.$;ZFAVJL7B1UL4.[*,=_ZV-0_)MT?/1[LO73T?1
M>OM'=!"SFQB$.AB*Z&->UA-04D!RT=YYU846A9=J8VL;A6/K>)LM4Q+LN2'D
MGI4H9T'DIJ3-A!5F#S7M@5=V_*([:(0I$Z&G(&==&RL<:-"^Z'U9N4UTK>72
M5@+4DXPT)FJZ$*NY!IVAIXUM_QJNZ3]->24N,+X9.!A/^/SXXO3X?\1?<C/!
MD";/W*V+TR10[#<,4'D&&/H.2X@1V5R34D9+RR--^#%U#>(?'FCTQ 3[V?K6
MK:J>MAL"!81:X,5 @G:P -\]:&#2 0+<?MHU]+W@>4GH3L["XOO]FFA&;$E[
M!0W3OMGX9/@EXU4YX?B96Y:$0KJHH:72LOLBUI;1$/P1:>6B*A6,YF^F)E\<
M#)1&S@J0A6]3Y?7#X P!Z@#]$=K+-2X-G,4W[^#-_[OC^'+W">6+UML?>&'E
MQ"K48XE'10B?S.^AVZ]JO<0UL6FI)\BE)N9:/>R\NL!0<VXC9N=\2,VJP[;-
MC %RE:"/LIY/>]4^JS&P @P-2W@#>'0":XM$A?0)#X 584<:0@9^.10-P,N-
M06L GV59:62-Q< TU:YQ=S+7:AKAW#Y-I\#R2B)?8F7,E0+8"LX?/]#Q#) P
MZG(L=ZXL,49$5:'Y5RJVXMGJ6\@U&>L>*)7".4;8G%HL<[-6RL^@TQV:A\Y<
M=3@%?.(AR*G[45,@C@R.SJH<VNOC"@@E\QM<*6\WC];#_-/O9_M19WO#>S6L
M(SZ%0P9JQ5K)[BE-@JY!8%D\Q:7(#6A+)0HGF$G'M]2E?%8[' PS2\3<K%!M
M2_CXRQ['GI.-<$1 D<6@8X7'/4?D);P#HE/?B*U7VV(!$YVC4@<LP9!>#C].
MD>%LO=RFN8Q3;EX-YFR-PG)&'CJ<T_1K$>&W4VJ<-K4TG#3V%I1Z<@'?FDCE
MDT&:5T!--GE=;;YR3SX5_W=>^I:78 +M3$HEKW8(M_Y6YBNYML\>E>_U\!RN
M 1_4?# '=11"D$RLX9Q43/\@\WR*(, %VF3DR^C*/U#;G+?KOP]V]_=1ZO&;
MHQ0NB\'0[/-1T*S/Z1@0.H!AJTU&E(Z=9E[HF%5!(4F$$N9KBMH5_J\$,P]R
MA9Z_J9Y6:R1I%$R@-^W_,9@_E4$W%>-C0:^[-AP)!/6-=$14T=)<6A=ZI;.3
M>%2MLP!!UD'K6QH]'.RVF]05>>%R#=HA!5KI@%6%*NU<+SE6]Q/"<P0J?G6I
M[/;_UP3#U-3/->48/1[^^T3I#L\'E^YP[)!3CB2C1)A1<LFAX?[O8E&7L;7U
ME%PJ3EJ*(!4>4M?8AM^'(+\X!?LN-TOZC$>_I1<WWA-'3R&'*7)^I^&AK7;Z
MIS<_70*HC%'6/#SVUOB$-N<0JE9&>(MRH1:3*&^+WV47UQ1=/@OT^<19?+%;
M"K$<WB7E^)0I/2?O=T9]J7,E#EY-=IYC+,<'*##G$.$F\&/@77'(&'W,OE-3
M5Q;3';O]L9?J-D?6@Y(($P>_\%WA,5TJ.JNW='=+D$A\=*MM*V@1DR0=Y726
MN]G^AIH"=',*P^?,-\23X/\G:^=L=WM;HD>='8R-#Q':3IJ]'"5O&EJFQYT)
M074U-R4*U^Z>/C&CNF@R.".062Y7-N2_DLO*TEF)\SH;;2;2=$@KLF(&%GGA
M 4X-^08W\393J+I!A!6%U?'ME;8J.,A:F.2D]QQ0NMVT1D08-(8X*O@4%GK#
M;4Y@-A\4(R[BYBBO%&EQ,G4XM4A/0_X$O(3U-.F\[Y@)L"PI094U1$P+;"T.
M<XBU(/<$3(9[,VW.$X!;F:LX8T%3E.0V;QSJV!+0E.:%AE'^7,,D_&Y,*1&\
MU!1_93ZJ2[^3/-J[0G3,J0N%G)4@>2Z0^)^EQ PM]>9.G%9 ,K8D-\6;3H$,
M\!P^,<LX!B+,W%!LT@[G\HD*!T16,=OHD6-T:),0[,67HSAP._8;G<NV8Z);
M<X"_B1/.F7]$@<7 W>"T<'T9_F:B"C6%9[AVP? -H!>#,X#.<CW37*QBC,PB
M&GZH5 &ZK:^)T)CK;6K*E-6S5IF!*!7'22)K<@ZC>@=T))M&0&HO!T=JWYER
M@;SELUR3W00?N=;(& EO8Q+=0BF!9RYDIGJSN/MRN)---!0W%-2"C2H>C:H3
MUR]H4L@L&T:OB)9?CZ<VQJO!$;#;NXOV^H]5SR*RQ3(_K,IR6+MLZ-4EI="1
MY9DG[-%$ODAN2_* )AU*9P,7M=+9#+1G!(T4-=K'33M>Z_\E.!^TM76PYT.&
M"1D8/3D?+1V^)W!)A6G8=F\BEVP$;7@G.';25-&BPEE<&*<1#G<4PWE47:LG
M.DFO!W>2QLOW1^5BO2!'H;,)-]3I4Z<$^=\W 2WXU*4_:$]>) 5LF1_9_?AF
M7V1R#;.8^I3GB0)Z\>Y(\G3V3,?!S!M$CFN'S8V&2U';'+G!NEI8IHV8_0IH
M;[U#2)T0F#E\V01F2ECN:RQ)U;>4C;<&?3<%+V>OHX39+$+,T:.QI1THW'E]
M-RPC:(Y<NDX-"=QX5DKT.&(+OHF@]MZ?I<@>'W@U=$_9Z6O'>)WEQV7H;$ C
MM['"^-"RT9/P 18Z^#AO4C,1^I+\XWV#N<?%0\F=-UC(C9?#!]WB]CLUG[BH
M,#Q=JE0QBCF,+JX?I8NV5Z5I,1CZ["W':9*'#OJ.?'!]V&LG7<G":/EXNZ9(
MH>!IC#M.L!"?)G$L%\:YEGC'>:<07%JJ*9%(1GYJ5OX$E^!S6/Y221OVJSVY
M:!)C9,MC\BY_+V_THEX,@J-2_"(>#RN"#JM,%:B(7ZU;9XG]H,1#^Y#6*2&M
M-X'4'1-IZK2Q6Z&42/GH= 8"WM]]]4<DT[L2HA\\G=]HS >[^_>/>8R';4P>
MVN.T0OD]A+-V<9OAWK;;P:J2(+R7<Q:\P-J$=PYL",W;G Z*_&*L;&P(N*#1
M/.101;(]^,SZ)+0+#OFG'WJ\, 'AD:-^R+%ZV*COQGBW53-D(4'CB=6:,,!Z
MZ:0LP@#L5 ;-FZ/^ON0UXP#"7R&8?*_GQP?JT3A=EIJR(1_@JXRCR[^#=1\*
MUGTBUNH*1'>"_W0<LMK5F@8%L/:DMXZEW,K4>>PZ(8FW#C9'S#CBX(SDQCTF
MCZC5]0&O_:)*,THA-;02:7=6<LKE:B+3JR<64/\Y&>_#1.6ZNS&\Y/C.EY)Y
MTC))N\+E(W/*$B6 E^V!]@GTI@X./%SG[(B 22.@"EI8P.LE_JK*DFL.P3/(
M;<@_/"UEG;$3V55?Q\QUJD.$G"CIS\VZK11XA#O9_-&5(;_6L%J$_8V1>LPV
MH3-R7<<EQ9LPHA/J8$=K\H/-Y37.8\&U 5C5AS&ZZGVIB.K?BPJK+E6LC<3?
M<P::C=Q6[,KZ6UTH5_)OGXJV'SEGADG3NA09E6RBX5":&+7+#_25)2)WOMM*
M+#OU ;<V)R!TI+_<7:_?"15RFTR4*GBE?.@C]D/QNT$)\OUN$DIRYV;*=ED$
MW+[$]^=</$NDB\H%;V>814M+"#S49:VWU.S&G6/Q0AF89@*?U)53,DV]#,HB
MPPFZ)!\+7>BP\2XA"@(T1U1+^]Q"))FW['9H/BP);UX@'3(&6ML2B?/.RG?<
M.;>O\3*O+9UD]/B0#E"Z AP$]X W[]9^"Z6=D>_WJNAN%I^MSEJ&ZR/ U&[2
M&ZMYJ3S1@NZ*+?'NM$MWQ*LNBP*6'&M2D'=6^4H:;<]E+]VSHAQ1_N6]',(4
M^?JNJ701!&"W6'4?'R/6(@5:(,@:D+5@I;523VKFA1+!IWXIPA1) XM8\"/9
M8>L$[8JGB_T\^^;<5.BN)1O'<ZY0Z"YA)NO"U.(U:&P@N2,W"LYBW;?RQ-@:
MR#2GT9\YS+(-E]30JDUCCVM7B'TVL$QK\47-9$D#](H8GI/^K$?F7OZ"&WJ_
MP6I'W$<7ME(RN)M2WW#D&D9:D/'PN#G:P8"K; +Y;H6T=P<\2BL?=D648:IK
M@1AX7YY62>M'F;@@SZV'Y%><$9[L-KT>B=) P/<%Y#N$[&K!;0+?V2\1ZUPQ
M+IG.92P.T/\B,\/XXQ)3GZ+,C%.393O?P5I<M<H.?5$<,:$$C<+6"VCZ<VDJ
M=YZH;)T'];;AU" SSED.P,*MV[:V7_,&]!M/@LWGZ+SS5)H;;MQME[@TA=.Y
M9YI4RA*-]JZE'GA5"%B%.W*BF W)#;?95,6'Y7XH*5(V14<*KOZ)?"T* 06"
M\ @)#50L.4JT'8 9L 4S6%GJ,>S\KRCU^T1 B*/! 2$:7>I$E14I"2%T^A^!
MDSM&YZ0I^- Z570-T@V]HTZ#:\*MJ.(7V1TA_/[$@LA#VG*/-0%G5@B](O>8
MT'/D/$UIA]9]5;&:@'US@5HX\7'4J<6D(\L$FTQ;%+ !_B^,P.0$%W8#BT=A
MCNJ;_6W&*[27$6N\-7?6;<Z*#B^HF$O'W1OUVXW>(\$2./L$F,#)$&H1J[PY
MQW8_H^(EUR18^&+ MF'='T1'D9#SI737,M=9OF:#)T!8/"ZM*WSX+C%&);0*
M/W7L3!FEW#FT)0F50#VX=7X8H5>T^8FPP"1BO[YV%HF306QQ="LRO=A_<]P5
MKNT\M1=;LVV^98KUQFJ]A*W'0L9=9T&/4;ZH;140=R%G& O,N.(RKL!U=*+Z
M"2%I%,T0\XA/AAN'I;PT*A#H2D6;VN)0/=B/*=-UTP+CW$* /CSCP2CQA%,X
M2N@\(B*,Z^*!%6GJV;QY$R5HM%.\'*A5^$E-Z]*'JJM691Y2)QR%R@:]R&X8
M/H[Q@L\EKBG%EX"-91HIU>*!!?V=N)CL@&^I"->O)XD1"-,W@Q.FEVU$R]FH
M$2UG(=G.@1>\@Y%X1&P>A@#DK5<BOMZ2VPZR2Q7E2N2"1:3+<5P6]6E5K=#7
MU.4#/KFP2>()X:-("84N7*HLXMW1TV'RIA=$*MV&R()S&?3;)J#Z8.A%J])"
MW(4KGBI)WT6^S@90G/;!51FH7&THFM&J,@OB]0Y&%H0G,0T>.*<1(A[E0U38
M$Q>K9<5M[%%7O2$FE=OF-EC/QAIWO>R;[B-GN>F#"R(<=9>-;"P:%ZS#5.E*
MS+FX(3+9QD()39#NT]['$;"V@_WA\+;GCK>-%2QT&=%?!X+)-5FH4J6GG(PB
MT4A0J-LAY#[A-%S2M3K43IY:."H=2!?;L!&=4_JRMPNV7"H.-LOI"-MP=!&-
MHAU\E-6\-9N[$6Q7WH1!D;4>ZW_]\%Y$+,]50>6>.\PLY%V@CL/F23M1B-A)
M>"H8$X7RH!,WGW][[&U@4O ]E]H!2#=@*7CZEZ6K1]SEZ?AC&$2?R8#QE+M6
MDD$G:,:8[E74J#!Q LG$:^C\7*"HN&8JMNZ?=S$[V5,CN8%W-[8C[P<UHO([
MJBW\CIH9"+\^&!R_/D:WIU>*+GMPY"/-&@N1M(W $VLK%9]PNMJ[Z/?ZYA5=
MUXX+A&S.+LE"+2._9N"2/?EF]T0M#3?<1%$=<VDEF#<WGT.CIB3&; 3>5![0
M5\@5&F=,D^6)H9F[ ^:Q%KYI!;KZ- \LS]Q.K?.9#US6MF<Z'.-W-R@UR7QW
M#<3<7ETG&@=6@::@NYB1^[H4TUS=^,3KKC.I<95#ZW[=KJ7.B8NW!6&/RMO)
M<&U"A/Y^=[QN"6N H(RCFZ]"U#<0#JSOUU^]>/VN&0",G>\5B/"38U!%!W1%
MO&-MYT9\P4=HQ<=M9%^V@=-H.X'9.D5U;>ENVFA;P6NGJG9)WGG%>K)I-N(D
M"0$I7*WHBM$84U6J8)U+=Z(V+*M;H-4]@:'HU6@D$7/F-"JO9R-3265M1W$@
M!E1$L#D0QQ9!'F,]!F<]A9WB$&L[-IH0%7D44>)14XFW5A(,?NH%B1:FV^G&
M2>K-6W");I:LOJJ$"7'\ ./(N+SX:9FK;(8?5)%2PJ8B*3-?+W'HJ2_IL7ER
MLTXG :8A.+I<%"SGJ$HICC]<'I5"'QIQ.CWS@&^;&C1K7VH.]: *#AZ?2B^K
M.#*<MJ]1*7P]K&NCT5X\;2!^H'\H4ITV^TUZ$Q"X44(R31K1SX&MYET*;=\#
MR^FJ=4T=+NO2&U,PU"F5/Y*L36$JOOZI8ZLWV:<R7K20P$KK1@:8==BW","N
MNQC5]H(TMRZ">C(? QL;4"D@Q\8^JAEHQ"<!(##2FR;'E*#_%\3&@.URSKGG
MR >^8$@*4:I/# H73BBLZ-:XN!Y'I@.;I5 S- 8S3!P?M6F=4R@>E!%16X>3
M03:+CFQ_149S1^U48?&ZPL&XEWF-X;C-Q[!B7HV %!^)"%]L/LN-8#B72OJY
M]8SOKF&4S453'"'\X%"O\;/&R04AV3.9HBUE@K"PKA4?4W8E3]N65:]1AUR3
ML5LTR,"L>\:58.<)=9WX'I.>?I(H8'0'\BH:?:B$\F_T.DH^,::,\0MT<4@V
MMY^8+7Q@V8N@"%]NV%',[<A6ETH1RJQ'!2_]L8G*".F" "")T'E.(LF@]UP5
MH%2DRBL#7*V3[*]PL:<&-0UT,'H)_1)4L]2_QJZ*4*D#G3U\0W3/H#W'0F4.
M-:H8(,A^$G_8&YTRLM[P[%%=2-9-\19NTJ3II<F:\.@^NR2^3P_EKLKB81-,
M4+L,TOO7)4R&\ H<=T#?% (+,_3#@\(4<HD](^U=B];T^ F<(55OI?YXE%S]
M<D.Y#K-W(N(Q(T>->LU)K43TR+EQ-,C%.*"::U6'M-I'-.UV+:[QC>Q1UL":
M9.4"ZP38C]8)_PIC0Y"'PT4B78=**'!F"[/0J5\0S\@?,^^&;R\-6#L3E] [
M<93MR+I-T_DX[_(84_F +QV4UT>Y&D#%#H(@.X"5=["ZXXREU*2[5K0=Y[RU
M6$#D;J6ZRGV%I3VPV7F:K3>R.?T*EP>)<P:*EN;RAN%"VI[[<FU$[=[/,$I*
M'E..\0_%M"9]\*DO'FL@LAV"I$0L#Y@-T$*@*84V 5[94G7+[T5BC%W2W4)G
MMW1!3I)J[D"ROHNZ(&+%B([S^73[&R65J@%1Z;T6<4CG' "G;66=HFZS1"C;
MTFDV4Y41U9!+=).K-@I=#V@9J9999Z,E$;-UY'91N63-$PQ#&E@12256H@K^
M&*@ /EU9AMT9S3P?LV"]A>8N+<\=<&S!WMC(Q3LE!;%Q^/A4QJ8:. _(:ZLN
MQ 8" WV'E$."_9$_CK7DGX#7VTR/UWTT'<QA.=K=O^>PG)MBY^S&EU\? %\_
MCY*&*5FKZUYII:YB'(P4_7JR +7%53HA KN]X"K[EGW\OL]\LLB]&4.$S\?U
MD1W@,5P&=F^" *I$E'06W=S3%(N598GJC -RD2><,PK4@KS=Y6A5]-E@3L$#
MBJ?T0^V17G*-+'=08B0N;J"K]D5,G('AF:V/)3EE:3/M$$W[?-T$F._/2.G>
M$-ZZ\Z3OJI-9K5EJQ<"0;O"[Y;1T)_R'W8M=<:K0DHZKB%QB$EA=KGTL^P,*
M&[02OF!DI\9]I#P3L>7R%3?FX).MG7NW,:"CF@D4RVXY<._*WH093*7.8_CD
MYLJUL>KL L'R'VSPU\ /\N!P)3Q LS4;C24.:=T@E8(M5)5&NMS,VTM>;#0X
M=(3BWL1D:_C?O%KDW_P+4$L#!!0    ( /F!GE(\*C\:3%,  #GA @ 7
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M<UXUMU/TF;_7C_;_LB\<RC)33*"$35:ZGR14'\V(:_LI1GVK=?LZD.!IM$I
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M,? 1"TN&6 6&.!(%[Z9YG.7.>:%=&P*_&B"A[8_'A0C<^,W(HA8"_0A]/5S
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M&SH<Y<$DC]?P/XMJF?[E_P-02P,$%     @ ^8&>4C:+E2GI,   A2L! !<
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MA7%UICC)G6\1'FC%2S4\"$<YQ]-$B^#"2_4$OHQ]C2!,Q,Z5HXT- 6D714/
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M'TY09HZ$?P1-Q)MV%R>>OD)*/E,+_EX 7((6WE438 ?"D"N0(L:13Y/B<DI
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MMG^!QG[&RM(6DOEG.Y/=)=.J@YQT:UQL+/4PAU+R-?9VK.4.-5M*#A+Z!S<
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M+PI4DKQ5)$A(72ZI'4)J-136A"16OIH<)HH>A\=G'!]OX1N$,%W!A%."X@U
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M_3#EM8EN2OR,DS>P8[$H\IDE^.8,=E8BXB[OHHC+DIDK-FN,@)*NQ[; 5MF
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MU?ZC_>:TBZOH=+NP37A6GNN=GU_ =!=G-+IG%E";M^?^U<5)!A>G)U[G_6
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MB)R<K]#P-Y$@$PY28<NC/$:=H>R3^%>9UN:BO9Y)HRZ[D&QY)28OK7EUI><
MGY*@2BEU/XG,3)PW;"Z8:6NU5I6:LE*3Y?).+#=G2%HPFLS0LJP5,.[F)1+
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MP^_1D,3/MC$)?P>QWW'F27P=^,HOF=)3-W42-7/A=3Z:TOB;FLW#>$&V;)R
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M'78<%R-TGRHWY)1!3D!)+ H2G^D(E28[0083X__%7MC]M\EE?E 9M7$T? ]
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MD@M%V0YMR909Z8)BL"U3PS9FF!"\,%RTE"H[;HW3SP7M)8G48L<+ Y[4X#H
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MW*(_^A[]C %Z! BT>/#7L6YVG+V]90"!)^/87\!_IMDL_,?_ E!+ P04
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MJH+"S%085"W",[CVJ?GP?E49NNDI/-X-/JHU'1HU6FB%\OUTKHW)!^XO.<M
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M"WXPC[#:GM-QN'_P$M>A,ZIE#[4A685WR=!BI!EXT?N@T8=!R(%T0+-L;%=
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MS?2\LF$1[OP7#$O"/H#3&I<%B%QY*0G#\5Q4E8E2H-/Z':RTZ9%-3(*:7*F
M%]?.CYU,O"0JRA*66.7;0G?*U%02T]8?&@J6JN13(DN*N%3$!9/5[JP,RW61
MOB[E>95B)U;M5KVX;A(%"L<2[5"1KUL)1*H.:J6U2#;:QJ2II:1K-D\5"U+)
M'T3&X0YC48P5!47>#= )E"?AI"'RAAOC?,R6+"UU+H;[R,!C=4V]?$1B47.>
M3Y(T_+<RLA&H?O,T1NV3S>U;D=I:\HHK&;)D^9@CB[[=/",U9QR;T *:2]F9
M2_;%PMIJC(KUE"LNZ)+QTXKQD24ER4^3I:KH:K[*R'3*.AMZ8G6:8VYNM$P+
MC6=Z"#I+/B_%"M!8&_<.U+A6;.)=D]4X&(OKM';3EXC2%@;AJC)92D65T,95
M":3?T(*T57?YU2.ZRP3\"53:V%.V)"_]*F:#05[D,#-C*$(CG( &UR<@$<:Y
MG5>D*\$4KKEHN&"^Q_$L',YW0T<98_/D# <A*C/#N? D-+*IZR0,3)!/D,R'
M></&^F JZU*TY(H(H+K8\J.:FU2:6R7\PT"GF.P[9^Z\IZ[/\&>ZAZ\?T3UL
M69&H!2VG2;3I"VA"TTCH)2P$<E5[2P/%!._*944.%8XP,2LBM 1"F2U,H07W
M.*?+9N]>.H^TX;!C-)\:OH+'G&$1\'SS;W@O0+0$[3/V0_8^LM@('V9%\I*6
MY*7,!#>XH0SW<_.O=%8:O)\']4*&$KN<SNN8^P]498K9]'X28]8;1KVA37<6
M*;^@B>+0QT4B$_&B#)'4\";)C;[&&&S)?*:W*._[/M] .6X$10&,J"93N[.#
MAMSA_#\DL"X],MYSI*,$=V*O9)#?8YO549W1"M$T,)S 2#6U!^].9S&[#FA]
M." #-<KOX3D6=_%?0%DW1$?O\RJ)U<'9;^.(X#7#;*0Z6N+R+K/O=5X >RKK
M0$V_L4*XH27&Q$L*M<A0$[$@7*[0P@L6S(FJE>!F!+YABO8DRMJ2Y;/A.]5K
M;0RDWD[A4TL(T<S0JEF2YM68Z-V&4:,PGD,&0D0HF^%@2-H(B="Z7N?257'M
M'N730")=]8H;#<)%95@[3*O!^A;2.Z1>8X*C3ZVWBJ5 T7,JB"2LJ'&$, .S
M%:L;A- =:ULF+MBLY]H+!$Q)EIT919B9"X8VJ#!+B/2@R]/-QJ.0LE@%1/^1
MHO'842K,U1=-XQFJP!LIUB8#F0=A%^,FE(3GF4 936<Y[ P[2PF=84;R*>;;
M^$5"&CK_X@J5)^;RHU[(X2Z=$EC+"-,>ER%KG)W!G*1"1;8G+*6<AIKC%8KE
M4TZT/5K+GMGJ8<=N=)SQ:<=@#X;(&J<*P;*<='(<0IKB=9)\AK6N9 V/==(H
M#=,OXLL;5<)C)DPG$25!%:D4+@.9-4*+N%V:1J[2L0;%)HG1*3Q#TH/(VO 6
M$I]\47[:><#(+VH\1B>S&-RUB1^P,304TZ53: RN*6=C5%\K-,('W#]S-NB*
MFYD3]!91-DHB>+J1W^Q&^O5@/LRBC*/321("31G/8(#.1KYMR.$H02(Q,#K%
MOAN!^,%7Q/*3Y>8YS:1F>.Y]GLYS&B[<#HQT(5)31 T?GWJPEEJBAI%10 <X
M://F^@/]H0]'P.2:N"AI1ZY84+EB]P:[N>=BI[GKAOG5Q+96 UDP#N7=+OJ.
M'A)@5QVD#61B%2Y)O_'./7G9M\/+?OSD9;_K7NO=LHBQ6AXSJ:+E2+2=FXFF
MRQS =YQ@BB@[^'L#&P&"X4\4FEVF&L20E PLA#8F]S8M[%J[9'%E:W%9^G.
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M"JY+:Y8?-0<V*_"4D#P4@,.@XV0A'M_K,''LGB.-QMS(L(@"'MY0]65,>+K
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MF>_PQW:O3;#0N[0$-&V8; >!F G%N)8:_-[L=;I7,/UWYYT/A-;<9W#I"AU
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M)8E-N>@EM/J8)0[A&#,RNOB^A(#(72RD-3^^CFX5V0KZMXY4X)#F#,[.2#C
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M5F=2%&F]:YUH:]<N68E*T3'*]@D"*,PXAQLK_P7151Q>:7^71%Z6XJBJ3B8
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MPQOE;=@M-@ +_6"\*&_50&)M7QO)7G0(9MWX,%;GU1,52H$W8ZZOPSM!&AM
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M:>I4H]L%WUG!/V!QEFC$E6PG@I%'=QP^=2-=I44&ZA?RC,$3\UW_JX(#'T^
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M\J,7O:O7L <;N$NC_6B!"C0:>=%:ZX_$*(@Y++4)J]0N>Z(GD>/>6.SCZZ+
M[\5:.!X]/@^/13[AI_%C=QB)"!(\$K)]=2)G**J(48Q!;"7D._%Y)\D1]B(+
M&_W[X?O#Z 7&K6KRE\F+/J#ZUI0;$V#K>#[?ZQ(UD/MS6M<%2%NQO:YS.%/
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MYY=0%:6+!<J9@B&3]+"7CKY$Q>;#Q93MUX-2U)1YM]9OXTV@=!,#)G:5%DV
ME'S#20W?RV]^N0<_'IS<6;_<[G#,04"JFVD?-TD%&(K?BS]<PO?V>WT*+^M<
M* 6[#BJ"0T4-%S]'=D$) ""!?U8E\+KQB9%T7%#M.=/F1985Z\'&FM)DRTN9
M #9::_*'A&DM'IN>:;S>018Z8B RO!RCXMO\]B&UA^.&Y ()2NK:N0(<7I2&
M)Q1:(-< ^UJJ#K?Q 0U(6*A/Y!^@?0F[>'IE1K'5L,G1J3ZE2YB]+'SO3Y-'
M)XAUAZ>&':?W>6]DZVKUD;0DSY749]P?C\9[:G]O?!9@F=IYM@KA6U1''6_]
M;M[4"$.J(OD\<%4D]QA/%2=GLHZ(5%C!HO-5998Z*$#T*,MK,2\D_13MG>ZS
MLW>+U]/4\2=R,(E66+K:.6_,/VE*E/^H)L>A! G%0>LZ.-]N4=5 #MIT?VA-
M,21P*;F6)C:HU.,G7&B.71FR OU&W:8,@>5(FC>JK/X80)AIU6F_X;W= R]@
MK91< ?;[HB)T7]W%69]@ L;<US=,XUM&7<?',5#0E&;91Z=F.QR->U_WYB;$
M8\^ C2#LV!P@OQN?NO>.8-_-EH:[WW?1.RP'V1C3&[TV 8&.)GJ'& +G?.CI
M-_71MC.T7&$O J <KHYIB>+% ;BA-K%[ZE"?J#:G#%<+; A&*:O^OK)#:\6F
M5"1%Y,K%P97I&X"NT?[P&15E"H*7&C+U'M>6-?B7^29S;SD?O9>$N0',>%/B
MKEY8QTSOWIA=@YUAVTJ$,X9M&;=OA[K4K1R(L]S$H8H/AV["B:'Q%<(GN N1
M(H2V;K;8>&;(;C-%XE&>&XG?X1;@U["35]-0EOM.;-KSN%XISM^M+DLM!!J^
M&R4==G6AU#D1$#89%EL/>/I'&V6_IVZR9]&\%,PD(,,%)V*0-GCG9]VZSQAE
MJ<06R)7,W2O,I+TN%MR#)L4VHS!6D;5P-5U7E1[(3=MD9<)S$^0 JHX.$ 2Z
M9V":5:'_NL+4ZK1:=#PQTL;NB)697U!6E-%Y@A?*MDI]IV$'.%SWFOH4B?=I
M[Y?S=Z_W,8(<1Q/I18FM(YX?1OC+F9#\9#P:1QI[ROS[D'6GXWTS71>30: %
MUL_P/7/?>"4'F6PO>C+KRL3$L#L)R2TUGU-$&W\+O$>#_;K]T! JBO[-$"@;
M@;!IC6).JXVT9[ON;;]7KMF&O93 "IN9.YEP8%<KNH72IQK48MU/[CV0*EU"
M&^(K/;.].0NYEQ@N1\-MHC&SHN$.P[!)%U?2.N4]T"JH<_ ;L+L7Z.GDU(T
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M3[)QR/VDI>YP0Q[PVFC<_VK*M$K2F21_PW/%',./*LW@=#J;&3 Z;ZY>*FI
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M9M!Y82H2O?<RY'T(]Y/H:; J["*/BSH49\@7C%O>RLGS%?\,E=:B"A/VE5!
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M"T$]VO4I#+*"Z>Z2\V>UV%3IC*Q&!K!AK$8.RH,Z8/_NW,=V)&Y4%TJ#WKD
M48N7[&U[4\0A9"+O5;\*0-[SHOA8(89[WL"]B U<"67W%"4F48":I;W4'\JG
MJ?"?:=9H4()LN@]S!N.NH:\LL9-G">9BDBK.JY#NS3%#X:U2[EB-T'<\R(!B
MA<!;#@JIW;NB%6M$]QZ6FIB64=+3UBIOM<HYE]<V>9:F4R:,,SP)L^']#]AM
MKR*&$'2*H6&?WVRCK;;1\3?;: O[!MZD6-\'PL7B>:2OV-$SZ\SR6XR\TE"U
M7 680>[0OGQSHD\TM^5R8;X99O/-0/66^TXU=XI^P?00,[Z2=J<X")?WNZ0W
MCH<R>EW09IWR2S %JQ(T/V":[+$UW4 SM<;,%>H5RF%(4OW;8V%?0(IG<*J@
M\/VN7H5^->R/S1ET:"^V6*\)15@1!?PVY4WI9=!MRX+GR!9*SSS3RGAW/*D0
MI*43 +_G3A0$!\N*O'0ACE1[IB\UK_"V05;+_#>8Q]YGOHJ=2DG*$/*@C)5B
M3 Y;VQT;^"XJ4X]W3)D:$) MX6@Q+M&;.TT3W:52>Q\(/-,J_EYR7D^D>F'=
M!;5I1-'VI0R+U9? GK"UD,W,-&D KHU)7PP @2M(T@ZY8S#Z3F3J1P;(9"N;
MRN7B8M]HWWCI:':<.S5,S^;>DA\IIM*)F+E6M8BQ_14(73A;#MTML4-RYP:X
M;8<GTDI7VS01<AFU1PJ^*&::49+#C-Q]&P,A9Q4[-?I96)C<$$9)5(G%O$W=
M;Z-B<G%J\J[;6JZD&'=]QT/*+I78@<0A$J&@:0-,JB0T2Z\TV>^<(RFLQ&O]
M;!R%6;JK0N?J<%@=VUVV,Q[M#M\9DQ&G@@SJ66'132W\C&_%.3>N5=83,M4J
M1?DJ6'E]R8_.!%/!-;;5E#UD.G02#FJ)(2R\CT#:,R312Y-:@Z_/U5*N'9@B
MEBE0#$N5'W5M^Y$&^>^_L8S"KYBP911>;455%[./R+3H@R77?F%Z/MJ=*S*+
MME58D%[VF?45^!4NKV"\6MK<H#P6PX:$=.Z.D%@*!T$)::'5X\F+0?E] 6*Y
M]93D],W.V6KGG'RS<[:P.)#.]8+55 &:#_OUHMCV'M$T5V/FR+-%T'[,9;W%
MKBZ"<W6V='&@;J/N6EC?#6O+55#!(2$91K)S?0>MA; RZ+&U9X^ULS:E@,*,
MF:4?-?5("-*O:]_+8;S0FT"%)U?+1X>*;BXH17]KV^$ P=QF-7?$[O(KSZG3
M9D1H2RS5IL6:$?H&^[V0I.;\1&2W,+KD5DH*^NTR>N75$E_+$_T3_@)<\0\D
M[&OI.BP_HD4'Y!ULE)^BRUT#I3).&L!1Q5&6ZBMM?>^H_W&G"TH[*<QKK [-
M&5<V,=4=REU4RG8((&'\%8U!HBQ3',7^BJ:JC-]4<2IERX*R8UA_D#1S;RDW
M<V/%R!-H63 D?C$U?BR)O(*=XX-6=F?+[1]8K4"#];(LFM6=)*P= F,@PC+\
M<@B&I=4$D>(-TBIRJ9--Q[R^4?(#5^PQRW(9TG_/4V)4'RA'X[WD:%"%W?8\
MZJ/CR>E^; ,"+&(QP=[K9H: E^R8D$[#L?$$!,U6 UM;H%2'MD8X,JOXY89"
M*[27$G[8 FY#VUCU@6!(-8>K[)HM0/'EDF6459@FZ05Z_XT-/KUZQ#<K#/,T
M.8Y!L!159<,JK^GRP/.OU!2&>V=ODYC7^,R;V:Q9F>?>J[F6B-Q/6F589^IU
M^#;#2OO*5")\%R:;UKW>QH9I8X<*-;GC)*X"V\>!733;R*K-,'MD(2D3M?F;
M_0+6:<+C'M"09_QP@Y=N8G'OP=A\<B;TK0?D&H]XZ2S?#*6MAM+I-T-IBW3H
M4'3(TYS-H8W%D>98G&NL$W;JF\(D6]S-4,^8RN7*+SNO\DN?75&[#?^Z<*MG
MF+@X-'?EH6Q[$P*(HI]L[9@T[E.?_,9]VVRS5H$J5ZCU\L*4JZ/B3M*-E+3[
MS;TQ&GXEH 9>@V109DT4)$. ?&^I]AD2=ZET?[Z><?!)D%K5YTXU)=X"KTB(
MEFOL#MY*0?=L@*+_V#KE:DI*?UUF@#\9"4RIL$785C3H'5:F=@A3AI2I#YT"
ML/XDLS^J*=R0/O<U&L3U*4A?LEG<T/AWJ'%<SQ+^Z"9R ["'!H[F<U# =I@O
M[%!9Z7BHX,F US#=4>C3'@Z(N25U31#LH\0"%/5!JQ"B3P_4D2#>"$Y#!X#%
MJUF"-WS_W?'94P?2*B7'[>8#;5 9#RBD/:LVP;5@'LC'5Z!9"6I)*DJU,*-M
M<_!F+='><$YWDEYWJ$"/Z/4<J30U:9$# ,BF8RUI8Z:1"!:=^6U>%"&LJ\3S
M\#C( J1;Q*M)"HGU^E_=.?C!';.DSNZ&);4S=VR'2@%%5_1K6+N,S)8B(.9;
MU0^RWD;*ZAG%E2^3@@EZ3>GC<AO Z!##,$CE:F&@IVSF>%BDI+V83!])1/%R
M."0CGW@#7"7;.HBL66UC9.'"<-&^\3F7;;AVP9V&USUH:5V<!C!B*]GIS^\>
M</LU]M[I^0GW4U=Z3^6B4:N@'G.\).R(_5HI4YVIRKGR88/B(.6:7'=$ 2'L
MM@?'__N "VZKLY#9ECLY^Q?H8O]LP)"=F?Z'GRZBYZ_>O'OSC^CYFY_?GK_^
MYYU<QK/-YQR!ZQ2Y"W._ 05]4[Q0\7JT1?%Z."V2#?RSJ)?9C_\/4$L#!!0
M   ( /F!GE)T=X-"N0<  /0D   7    8VQX<3-F>3(Q97AH:6)I=#,Q,2YH
M=&WM6FUOXS82_GZ_@LWBMEG ;_)+-G&R =(DQ078V^T%+A;WZ4")E,4+):HD
M9<?]]?<,)3MV[+1)K]<ZBUM@%4L<#F<X#Y\94CK[YNKSY>2?/URSS.>:_?#C
M=Q]O+ME!N]O],KCL=J\F5^QOD[]_9,-.+V(3RPNGO#(%U]WN]:<#=I!Y7XZ[
MW?E\WID/.L9.NY/;+JD:=K4Q3G:$%P?G9_0$5\G%^5_.OFFWV95)JEP6GB56
M<B\%JYPJINR+D.Z.M=N-U*4I%U9-,\_ZO7[$OAA[IV:\;O?*:WF^U'/6K>_/
MNF&0L]B(Q?F94#.FQ(<#)<1)W!^.^OV343+L]88Q3X^C?GP\Y#)Z/SI*_Q7!
MR"[$ZS[.+[3\<)"KHIU)&G\\['?>CTI_.E?"9^.HU_OKP:8HMU-(Q\9[DX^/
M(=D\\:8,MU[>^S;7:EJ,@T?HGAKXW_1/C#9V_*87_IU22SOEN=*+\;<3E4O'
M/LDYNS4Y+[YM.42A[:15:2WHU,\2)F&0<#NO+7X//5H5<NE!U">;K^\S%2O/
M!E$G.NN2_-+O;>]?X%*"$$C[)_ET>7T[N?G^YO)B<O/YTZ93:^Z47 A K*UE
MZL>#HTW[_UTYK]+%_]R!X4X';EKLHRH$9[>R$%JV6"(MF<-\QOW;-Z/CTY=Z
M!6V(R+@=(4Y_DE-19VGT'S_ZZ<:T1+W.B*;AAF5\)IF5,R7GH!R?*<=^JK@%
M=/4"STMC/3,%^][8G$6]]C^82=DDD^P21IM[T%%>\F*!B)R\QHCT]RXBWW&'
M.&#&\P6[*\Q<2S$%_$-@FG ( Q,*@T2!$;@J& + JL+;2L(#I(Z011 GSG+<
M6<4U2WF"1Y:9'$SG32VW)5#(1#K'[8)$<GXG,>Z:3H=G L9@2!U2$,8@@419
MI!R(%>@.2X2T;)ZI)&.NHLM#_[FTLE%"#N3*:>0F2G-SY3,XZ$J9! -);PG3
MC(";,W03+%ZL3\-KA=S@]4!.LE05""KAXR&(+> -XFBV:^VJ2$$1G"HA_$YT
M): 30%F+6 L@4T0K)>),$"7H:OV P2;\[M'0@+D()5:+)"H- 0#/ !UA.!?L
M2;C+6*K-W"U1:>54.8_ZS#-.#VN[865K#5QN:<R6M:\57\.]P]=D(QAOWQSW
MH_>GKD%0D]>) DR:*MR&,-TP;F4 ! *L8BTI<$P"A;%6+B-Q$LM!?T2!="^4
M2[1Q%?H1,5JC:V24UB12X+%CAP""D$!6'>WK^R3CQ52R"W#.;:4A$0UX.QH=
MRG>A:S02]5U]JZBB*VI$DGY&Q+0&U!HX9,NS!THW!DHQ$/GY&+Z0H#S]@KIG
M--PC2![R=_N"R:/.243S<"4=BEQ$)V2H7X=.BY)GPBOW_"Z4Q6()&#0CU7G1
M5!8*0#XSY0*E04H600^5M@]DN$ZH5FH><-4DQ@=LM!JRI48%8H0MSF@EP@;2
M5;%30G&KR %5I^] \05IJAREU+ ,7<B_@0"Q0X5!V#J&3B5*0954FA-OPZU@
MQ$-J1H\ZT:_7)_@52Q($M:*_%"^@TOW";;Q'N!T,MW'[;$+:@N_SJ>S9* ;R
M9TH0.+DS!2?.Y@[ IJJ0$,NM6*('>%8\5EKY!67K7</26@I "QBJE\&&Z%I5
M&5+#?>-06=D2&':AND@28T4P(-274UF@:-" ,EID26N$1% [UW#%6E(EV/G5
M C;9(\#61'L]X[H*;$31E&F* D_-$ >WHU!;U0;/8-?Z=G?M%O")CF!&5U>(
ML:G\TQ8\A__Y2EI2^9O^^@Z%Q<O".BPY6<\$[ GPH@%>(\3$'D&LX<0Z>MLH
MH'UQ4WB%EIU0>P$34GXV25)9BO5:,MRA-3?.XSD= D*72Z"H.59AAT]T20%:
M<-0CZ<9P;&]DV-+3;K^H5G:]JZW*N%M5#L1N >12!-H/\]%0\@(;]SNIF_W]
M(_G6?SU%+P3V7NV;1E_)OBD<Z(GEDF@]D!!QXCHL'_B(@/6"4F*K"%V9QE&(
M>F/=*GN'!U"9Y\I[*7^!\6.#^H#:A8)]0<DAP N"=43@^$OE\'+%R9\J!?/#
MZJJ*)!P#O/O_]NAWR]H7&@46"CX%9-$.E/:RB9* 0I-Y5]N4N>1WE$KK@BLD
MTU JAL/&Y1'-BP#6["CJ_?\.WN("'9U<T=:38&P*3'0!HE 'MNI\[I#,797G
MV!;]+(,S3;K8>9CUJG/U_NU?+I"24PM::"',,C 9@!+.@AM$M>J,IHJ9T3-)
M::W@T^9(VS;D)_-2FX5$ZSPS->/Q#;P"7[]+SN\\&?7-5X%'VZ\"-RF]!H$/
MNZ)&0PQ(2MM&-#0OG1PO?YR"O$O-%V-5A#D-G4YGQ/<H#)JW<QBE>?$Z..GT
M!B-Z]^HM_HNE^N:U;">\ENUZL=UV<MPYZ3W=W.M$J[9NT%WKAYVNY,6'@\'!
MHR4P[I?W+-I\C4CN/S:^GK0_?E$$9Z^ LY IV 4V?)H->JWP*GT5Z35_E[8M
M%8SJ*/[B'/188-"O;M[>OHF.>J>[9NGK\&X(8@C7C1?/+_&W6=!$ '"7A7,X
MMC3]-4W&;YV U^3C9:9DRJ[O95+1:0#[7!?1V^YV _^N98#:WO.SF!J?R Z/
M/I$I3?V-T+@^R)W))S^::?))[Z$+CP&DRC_=Y:EO3G98N'&MOP<*7R:=_P=0
M2P,$%     @ ^8&>4L! ?XG8!P  EB4  !<   !C;'AQ,V9Y,C%E>&AI8FET
M,S$R+FAT;>U::W/;-A;]OK\"=6939T8O2G)LRXYG'-N9>K>;I!EU,_MI!R1
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M!+)"M*]NDXR7$\G.P3F?ZAP2T8"WHX-]^<I/C0Y$N J7BJJZ,B"2UF=$3"M
M#< A71Z]4;JV48J-R,[[\(4$Y>DGU#T'PQV"Y#Y_M2N8?-TYCL@/E]*B]$5T
M?(;Z,G1:E#P37MO'3Z$L%DO H-DIY$5=&RP \IDJZRD-4K+TZU!I>T>&JX1J
M9,X]KIK$>(>-5D.V-*A C-#%ZEP)WZ#:.K9**&X4&:!"^O847])*M:64ZH^A
M]?G7$R Z8"B$UM1/JE *JJ3..?$VS/)*W*5FS B)?K4^P5^Q)$%0*^9+\00J
MW2W<QCN$V\%P$[>/)J0-^#Z>RAZ-8B!_J@2!DUM=<N)L;@%LJ@H)L=R(!7J
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M%#R5#W[6T^S3NYO"8T"P=@]/>>C+E2T:KOV&+Y;\MU-G_P502P,$%     @
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M+3(P,C$P,S,Q+FAT;5!+ 0(4 Q0    ( /F!GE*?;H0!!Q   *>9   0
M          "  7@# @!C;'@M,C R,3 S,S$N>'-D4$L! A0#%     @ ^8&>
M4G(13ULC(P  T64! !0              ( !K1," &-L>"TR,#(Q,#,S,5]C
M86PN>&UL4$L! A0#%     @ ^8&>4@$A(5695@  2+L# !0
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M,#,N:'1M4$L! A0#%     @ ^8&>4C:+E2GI,   A2L! !<
M ( !O5X$ &-L>'$S9GDR,65X:&EB:70Q,#0N:'1M4$L! A0#%     @ ^8&>
M4C(ZBY/J.P  >G(! !<              ( !VX\$ &-L>'$S9GDR,65X:&EB
M:70Q,#4N:'1M4$L! A0#%     @ ^8&>4@>I-VRA,P  @2\! !<
M     ( !^LL$ &-L>'$S9GDR,65X:&EB:70Q,#8N:'1M4$L! A0#%     @
M^8&>4ADS,\3*,   P!T! !<              ( !T/\$ &-L>'$S9GDR,65X
M:&EB:70Q,#<N:'1M4$L! A0#%     @ ^8&>4N#;T#Y6/   )DD! !<
M         ( !SS % &-L>'$S9GDR,65X:&EB:70Q,#@N:'1M4$L! A0#%
M  @ ^8&>4G1W@T*Y!P  ]"0  !<              ( !6FT% &-L>'$S9GDR
M,65X:&EB:70S,3$N:'1M4$L! A0#%     @ ^8&>4L! ?XG8!P  EB4  !<
M             ( !2'4% &-L>'$S9GDR,65X:&EB:70S,3(N:'1M4$L! A0#
M%     @ ^8&>4B389L.^!   H!0  !8              ( !57T% &-L>'$S
G9GDR,65X:&EB:70S,BYH=&U02P4&     !$ $0!Z!   1X(%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
